data = [{"section": "Rheumatology, Allergy, & Immunology", "questions": [{"question": "<p>\n A 22-year-old man is brought\nto the emergency room after being stung by several wasps. He is confused and\nshort of breath. His temperature is 100.4\n <sup>\n  o\n </sup>\n F, pulse is 120/minute,\nblood pressure is 85/55 mm Hg, and respirations are 30/minute. He has hives on\nhis back, wheezing over the posterior lung fields, and pitting edema of the\nankles. Intravenous access is obtained and 0.9% saline is administered. Which\nof the following medicines should be administered next?\n</p>\n", "answers": ["<p>\n <b>\n  Answer F is correct\n </b>\n . The presence of hypotension, tachycardia,\nhives, and bronchospasm after a wasp sting suggests anaphylaxis. Epinephrine is\nthe drug of choice.\n</p>\n"], "tutorial": "<p>\n Anaphylaxis is an acute\nmultiorgan system reaction, potentially fatal, caused by the release of\nchemical mediators from mast cells and basophils. The classic form involves\nprior sensitization to an allergen with later re-exposure, producing symptoms\nvia an immunologic mechanism. The most common organ systems involved include\nthe cutaneous, respiratory, cardiovascular, and gastrointestinal systems. The\nfull-blown syndrome includes urticaria (hives) and/or angioedema with\nhypotension and bronchospasm.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Traditionally, the term\n&ldquo;anaphylaxis&rdquo; is reserved for reactions mediated by immunoglobulin E (IgE), and\nthe term &ldquo;anaphylactoid&rdquo; is reserved for IgE-independent events (which are\nclinically indistinguishable). Anaphylaxis is a type I hypersensitivity response.\nIgE production requires the secretion of cytokines from T\n <sub>\n  H\n </sub>\n 2 cells.\nThese cytokines induce B cells to switch antibody production to the IgE\nclass.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The IgE binds to Fc\uf065\nreceptors on mast cells. When the antigen-binding region of IgE is cross-linked\nby allergens, mast cell degranulation occurs, resulting in anaphylaxis.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;&nbsp;\n </span>\n</p>\n\n<p>\n The physiologic responses to\nthe release of anaphylaxis mediators include smooth muscle spasm in the\nrespiratory and gastrointestinal (GI) tracts, vasodilation, increased vascular\npermeability, and stimulation of sensory nerve endings. Increased mucous\nsecretion and increased bronchial smooth muscle tone, as well as airway edema,\ncontribute to the respiratory symptoms. Cardiovascular effects result from\ndecreased vascular tone and capillary leakage. Hypotension, cardiac\narrhythmias, syncope, and shock may result from intravascular volume loss,\nvasodilation, and myocardial dysfunction. These physiologic events lead to some\nor all of the classic symptoms of anaphylaxis: flushing; urticaria/angioedema;\npruritus; bronchospasm; laryngeal edema; abdominal cramping with nausea,\nvomiting, and diarrhea; and feeling of impending doom.\n</p>\n\n<p>\n Anaphylaxis is a medical\nemergency that requires immediate recognition and intervention. Patients should\nreceive high-flow oxygen, cardiac monitoring, and intravenous access.\nEpinephrine maintains blood pressure, antagonizes the effects of the released mediators,\nand inhibits further release of mediators. Use of epinephrine for anaphylaxis\nhas no absolute contraindications. It is the drug of choice and it is usually\nwell tolerated and potentially lifesaving. Anaphylactic deaths correlate with\ndelayed administration of epinephrine. The initial dose can be repeated as\nnecessary, depending on the response.\n</p>\n", "choices": ["A. Furosemide", "B. Propranolol", "C. Nifedipine", "D. Lisinopril", "E. Atropine", "F. Epinephrine"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 35-year-old woman with a history of systemic lupus\nerythematosus (SLE) is admitted to the hospital with left upper and lower\nextremity weakness. Head CT reveals an ischemic stroke in the right middle\ncerebral artery distribution.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Labs\nreveal thrombocytopenia and a prolonged aPTT.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her husband reports that she had several\nmiscarriages in the second trimester and a deep vein thrombosis several years\nago.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  What is the most likely cause\nof her stroke?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The most likely cause of stroke is antiphospholipid\nsyndrome.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Bacterial endocarditis can cause stroke through septic\nembolization. This patient does not describe fever or chills. No mention is\nmade of a heart murmur or findings suggestive of peripheral embolization (e.g.,\nRoth spots, Osler nodes, Janeway lesions, splinter hemorrhages.) Bacterial\nendocarditis is more likely to cause thrombocytosis than thrombocytopenia and\nwould not explain the history of miscarriages.\n </span>\n</p>\n", "<p>\n <b>\n  Answer B is incorrect\n </b>\n .\nRisk factors for stroke due to atherosclerosis include advanced age, smoking,\ndiabetes, hypertension, hyperlipidemia, and family history of atherosclerotic\ndisease.\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n .\nSystemic lupus erythematosus is associated with CNS vasculitis, which can cause\nstroke. In this patient, the history of deep vein thrombosis and multiple\nmiscarriages and the presence of thrombocytopenia and an elevated aPTT is more\nconsistent with antiphospholipid syndrome.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n .\nCocaine can cause stroke, but it would not explain the other findings in this\npatient.\n</p>\n", "<p>\n <b>\n  Answer F is incorrect\n </b>\n .\nSepsis can result in stroke and multi-organ failure. This patient has no\nsymptoms or signs of systemic infection.\n</p>\n"], "tutorial": "<p>\n Antiphospholipid syndrome\n(APS) is a disorder of coagulation that causes thrombosis in arteries and\nveins, as well as pregnancy-related complications such as miscarriage,\nstillbirth, preterm delivery, and severe preeclampsia. The most common venous\nevent is deep vein thrombosis of the lower extremities; the most common\narterial event is stroke. Other common findings include thrombocytopenia,\nlivedo reticularis, and elevated aPTT. (The elevated aPTT indicates the\npresence of lupus anticoagulant or anti-cardiolipin antibodies, which interfere\nwith phospholipids in the aPTT assay.) Antiphospholipid syndrome is characterized\nby autoimmune production of antibodies against phospholipids, such as\ncardiolipin and &beta;\n <sub>\n  2\n </sub>\n glycoprotein I. The antibodies interfere\nwith the anti-thrombotic effects of phospholipids. Primary antiphospholipid\nsyndrome occurs in the absence of other related disease. Secondary\nantiphospholipid syndrome occurs in conjunction with other autoimmune diseases,\nparticularly systemic lupus erythematosus (SLE). Antiphospholipid syndrome is\ntypically treated with heparin, warfarin, and antiplatelet agents.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Bacterial\n     endocarditis</span></li>\n<li class=\"MsoNormal\"><span>Atherosclerotic\n     disease</span></li>\n<li class=\"MsoNormal\"><span>Antiphospholipid\n     syndrome</span></li>\n<li class=\"MsoNormal\"><span>Vasculitis\n     of the central nervous system</span></li>\n<li class=\"MsoNormal\"><span>Cocaine\n     use</span></li>\n<li class=\"MsoNormal\"><span>Sepsis</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 32-year-old man presents to the clinic with fever, cough,\nand night sweats of one-month duration. He is fatigued and has lost eight\npounds unintentionally.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  His medical\nhistory is significant for ankylosing spondylitis for which he takes\nmethotrexate and infliximab. Which of the following most likely explains his\nsymptoms?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Active tuberculosis most likely explains the patient&rsquo;s\nfever, cough, night sweats, and weight loss.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Ankylosing spondylitis is associated with aortic\ninsufficiency, and anti-TNF&alpha; therapy is associated with worsening heart\nfailure, but this patient does not have symptoms of heart failure, such as\nshortness of breath and leg swelling. Fever and night sweats are not\ncharacteristic of heart failure.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Ankylosing spondylitis increases the risk of interstitial\nlung disease, which is usually mild and associated with apical fibrosis. This\npatient does not have typical symptoms of interstitial lung disease, such as\nexertional dyspnea. Weight loss and night sweats are not characteristic of\ninterstitial lung disease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Anti-TNF therapy increases the risk of lymphoma, but not\nbronchogenic carcinoma.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Methotrexate-induced lung injury is usually dose-related\nand reversible with discontinuation of the medicine. Symptoms include fatigue,\ndry cough, and shortness of breath. Fever, night sweats, and weight loss are\nnot typical of methotrexate-induced lung injury.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n <b>\n  <span>\n   Infliximab\n  </span>\n </b>\n <span class=\"apple-converted-space\">\n  <span>\n   &nbsp;\n  </span>\n </span>\n <span>\n  is a chimeric\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  monoclonal antibody\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  against tumour necrosis factor alpha\n(TNF-&alpha;) used to treat\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  autoimmune\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  diseases. It is approved for the\ntreatment of\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  psoriasis,\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  Crohn's disease,\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  ankylosing spondylitis,\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  psoriatic arthritis, rheumatoid\narthritis, and\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  ulcerative colitis.\nInfliximab works by binding to TNF-&alpha;. TNF-&alpha; is a chemical messenger (cytokine)\nand a key part of the autoimmune reaction. In rheumatoid arthritis, infliximab\nseems to work by preventing TNF-&alpha; from binding to its\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  receptor\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  in the cell. Infliximab is an\nartificial\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  antibody. It was\noriginally developed in mice as a mouse antibody. Because humans have immune\nreactions to mouse proteins, the mouse common domains were replaced with\nsimilar human antibody domains. Because the antibodies were produced from one\ncell grown into a clone of identical cells, it is called a\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  monoclonal antibody. Furthermore, as a\ncombination of mouse and human antibody amino acid sequences, it is called a\nchimeric monoclonal antibody.\n </span>\n</p>\n\n<p>\n <span>\n  In the United States, Infliximab can cost $19,000 to\n$22,000 a year per patient wholesale.\n </span>\n</p>\n\n<p>\n <span>\n  Other monoclonal antibodies targeting TNF-&alpha; are\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  golimumab\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  (Simponi),\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  adalimumab\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  (Humira), and\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  certolizumab pegol\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  (Cimzia).\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  Etanercept\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  also binds and inhibits the action of\nTNF-&alpha;, but is not a monoclonal antibody. (It is instead a fusion of\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  TNF-receptor\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  and an\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  antibody constant region.) Infliximab\nis administered by\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  intravenous\ninfusion, typically at six- to eight-week intervals, at a clinic or hospital.\nIt cannot be administered\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  orally\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  because the digestive system\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  would destroy the drug.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Infliximab is a significant risk factor for reactivation of\nlatent tuberculosis, as well as for development of other serious infections\nlike aspergillosis, blastomycosis, candidiasis, coccidioidomycosis,\nhistoplasmosis, and pneumocystosis. Anti-TNF&alpha; therapy also increases the\nrisk of lymphoma, heart failure, drug-induced lupus, and blood disorders\n(leukopenia, neutropenia, thrombocytopenia).\n </span>\n</p>\n", "choices": ["A. Congestive heart failure", "B. Interstitial lung disease", "C. Bronchogenic carcinoma", "D. Tuberculosis", "E. Methotrexate-induced lung injury"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 68-year-old woman has a 6-month history severe pain and\nswelling of the metacarpophalangeal joints, wrists, elbows, and knees. Previous\ntreatment with ibuprofen and methotrexate did not relieve symptoms. The serum\ncreatinine level is 2.6 mg/dL and the rheumatoid factor level is increased.\nWhich of the following is the most appropriate treatment?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis correct.\n  </span>\n </b>\n <span>\n  Etanercept is a biologic agent and a\nDMARD. It would be an appropriate choice in a patient with active rheumatoid\narthritis who has failed methotrexate therapy.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect.\n  </span>\n </b>\n <span>\n  Acetaminophen is not a DMARD and would\nnot slow disease progression.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect.\n  </span>\n </b>\n <span>\n  Indomethacin is a non-steroidal\nanti-inflammatory drug (NSAID). NSAIDs are not DMARDS and would not be expected\nto slow disease progression. Also, NSAIDs should not be used in patients with\nrenal insufficiency.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect.\n  </span>\n </b>\n <span>\n  Colchicine is used to treat gout, not\nrheumatoid arthritis. The likelihood of toxicity is increased in patients with\nrenal insufficiency.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . Gold salts have been largely replaced\nby more effective agents for treatment of rheumatoid arthritis. They should not\nbe used in patients with renal insufficiency, as they can cause renal disease.\n </span>\n</p>\n"], "tutorial": "<p>\n This patient has rheumatoid\narthritis, as indicated by the pattern of synovitis and the elevated rheumatoid\nfactor level. DMARDs (disease-modifying anti-rheumatic drugs) represent the\nmost important measure in the successful treatment of rheumatoid arthritis.\nThese agents can retard or prevent disease progression and reduce joint\ndestruction and loss of function. Consequently, early therapy with DMARDs is\nthe standard of care for treating rheumatoid arthritis.\n</p>\n\n<p>\n DMARDs can be classified\ninto xenobiotic and biologic agents. The xenobiotic agents include gold salts,\nD-penicillamine, chloroquine and hydroxychloroquine, sulfasalazine,\nmethotrexate, azathioprine, and cyclosporin A. Injectable gold salts and\nD-penicillamine rarely induce sustained remission and have largely been\nsupplanted by more effective agents. Methotrexate and sulfasalazine are the\nmost active compounds and provide the best risk-benefit ratios.\n</p>\n\n<p>\n Methotrexate (alone or in\ncombination with other agents) has become the standard of care for moderate to\nsevere RA.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  &ldquo;Biologic&rdquo; agents have been developed to block tumor\nnecrosis factor (TNF)-alpha and interleukin-1, proinflammatory cytokines that\nare important in the pathogenesis of rheumatoid arthritis. These agents improve\nsymptoms and significantly retard progression of joint erosions. TNF blockers\ninclude etanercept, infliximab, and adalimumab. Most patients receiving TNF\nblockers have a significant response to treatment.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Adverse effects of these agents include development of\ninfection, including reactivation of tuberculosis. Thoroughly searching for\nlatent tuberculosis using chest radiography and/or purified protein derivative\n(PPD) testing is recommended before these agents are started. Rarely,\ndemyelinating disorders, bone marrow suppression, and formation of\nauto-antibodies occur.\n </span>\n</p>\n", "choices": ["A. Acetaminophen", "B. Indomethacin", "C. Colchicine", "D. Gold salts", "E. Etanercept"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 34-year-old man with peptic ulcer disease suddenly\ndevelops pain, redness, and swelling of his right first metatarsophalanegal\njoint. There is no history of injury. The serum uric acid level is 8 mg/dL.\nExamination of the joint aspirate shows negatively birefringent crystals. Which\nof the following drugs is most appropriate to treat the acute symptoms in this\npatient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect\n  </span>\n </b>\n <span>\n  . Allopurinol can be used in the\nlong-term management of gout. It lowers serum uric acid levels by inhibiting\nthe enzyme, xanthine oxidase. It is not useful in the treatment of an acute\ngouty flare.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  . Probenecid can be used in the\nlong-term management of gout. It enhances renal excretion of uric acid. It is\nnot useful in the treatment of an acute gouty flare.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . Sulfinpyrazone can be used in the\nlong-term management of gout. It enhances renal excretion of uric acid. It is\nnot useful in the treatment of an acute gouty flare.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect\n  </span>\n </b>\n <span>\n  . Morphine is an excellent analgesic\nmedicine, but it does not have anti-inflammatory properties, and its potential\nfor abuse makes it an unsatisfactory choice in the treatment of an acute gouty\nflare.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Gout is a common disorder of uric acid metabolism that can\nlead to deposition of monosodium urate (MSU) crystals in soft tissue, recurrent\nepisodes of debilitating joint inflammation, and, if untreated, joint\ndestruction and renal damage. Gout is definitively diagnosed by demonstration\nof urate crystals in aspirated synovial fluid.\n </span>\n</p>\n\n<p>\n Acute monoarticular\narthritis is the initial presentation in 90% of patients. Podagra, inflammation\nof the first metatarsophalangeal joint, is the initial joint manifestation in\n50% of cases (Figure 1). The attack begins abruptly and reaches maximum\nintensity within 8-12 hours. The joint is red, hot, and exquisitely tender;\neven a bed sheet on the swollen joint is uncomfortable. Untreated, the first\nattack resolves spontaneously in less than 2 weeks. Acute flares of gout can be\nprecipitated by events that raise serum uric acid levels, such as consumption\nof beer or liquor, overconsumption of high-purine foods, trauma, hemorrhage,\ndehydration, or the use of medications that raise uric acid levels (e.g.,\nthiazide diuretics).\n</p>\n\n<p>\n Patients with gout are much\nmore likely to develop renal stones than are healthy individuals (by a factor\nof 1000). Although patients with gout often have other risk factors for renal\ndisease (e.g., hypertension and diabetes), chronic urate nephropathy can itself\ncontribute to renal insufficiency. Although gout typically causes joint\ninflammation, it can also cause inflammation of bursae and tendons. Tophi are\ncollections of urate crystals in the soft tissues. They can develop in patients\nwith untreated gout and may appear as lumps or nodules. While the classic\nlocation of tophi is along the helix of the ear, they can be found in other\nlocations, such as the fingers, toes, and olecranon bursae.\n</p>\n\n<p>\n Gout is managed in three\nstages: (1) treating the acute attack, (2) providing prophylaxis to prevent\nacute flares, and (3) lowering excess stores of urate to prevent gouty flares\nand tissue deposition of urate crystals. Options for treating\n <i>\n  acute\n </i>\n gout include nonsteroidal\nanti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids. NSAIDs are\nthe drugs of choice in most patients\n <i>\n  .\n </i>\n</p>\n\n<p>\n <i>\n  Long-term\n </i>\n management of gout focuses on lowering uric acid levels.\n(The goal of therapy is to lower serum uric acid levels to approximately 6\nmg/dL or less.) Agents that lower uric acid levels should not be initiated\nduring an acute attack, as they may intensify and prolong the attack.\nTypically, they should be started a few weeks after the attack has resolved and\nwith the protection of prophylactic colchicine to prevent another attack.\n</p>\n\n<p>\n Medicines available for\n <i>\n  chronic\n </i>\n management of gout include\nallopurinol and febuxostat, which reduce uric acid production by inhibiting the\nenzyme, xanthine oxidase; and probenecid and sulfinpyrzone, which enhance uric\nacid excretion by the kidney.\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"file://localhost/javascript/refimgshow(1)\">\n  <span>\n   <!--[if gte vml 1]><v:shapetype id=\"_x0000_t75\"\n coordsize=\"21600,21600\" o:spt=\"75\" o:preferrelative=\"t\" path=\"m@4@5l@4@11@9@11@9@5xe\"\n filled=\"f\" stroked=\"f\">\n <v:stroke joinstyle=\"miter\"/>\n <v:formulas>\n  <v:f eqn=\"if lineDrawn pixelLineWidth 0\"/>\n  <v:f eqn=\"sum @0 1 0\"/>\n  <v:f eqn=\"sum 0 0 @1\"/>\n  <v:f eqn=\"prod @2 1 2\"/>\n  <v:f eqn=\"prod @3 21600 pixelWidth\"/>\n  <v:f eqn=\"prod @3 21600 pixelHeight\"/>\n  <v:f eqn=\"sum @0 0 1\"/>\n  <v:f eqn=\"prod @6 1 2\"/>\n  <v:f eqn=\"prod @7 21600 pixelWidth\"/>\n  <v:f eqn=\"sum @8 21600 0\"/>\n  <v:f eqn=\"prod @7 21600 pixelHeight\"/>\n  <v:f eqn=\"sum @10 21600 0\"/>\n </v:formulas>\n <v:path o:extrusionok=\"f\" gradientshapeok=\"t\" o:connecttype=\"rect\"/>\n <o:lock v:ext=\"edit\" aspectratio=\"t\"/>\n</v:shapetype><v:shape id=\"Picture_x0020_12\" o:spid=\"_x0000_i1318\" type=\"#_x0000_t75\"\n alt=\"Description: Gout. Acute podagra due to gout in an elderly man.\"\n href=\"file://localhost/javascript/refimgshow(1)\" o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image001.jpg\" o:title=\"Gout. Acute podagra due to gout in an elderly man.\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: Gout. Acute podagra due to gout in an elderly man.\" border=\"0\" height=\"106\" src=\"_%20Tutorials_files/image002.png\" v:shapes=\"Picture_x0020_12\" width=\"152\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Gout: Podagra\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/a/ac/Fluorescent_uric_acid.JPG\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_11\" o:spid=\"_x0000_i1317\" type=\"#_x0000_t75\" alt=\"Description: File:Fluorescent uric acid.JPG\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/a/ac/Fluorescent_uric_acid.JPG\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image003.jpg\" o:title=\"Fluorescent uric acid.JPG\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: File:Fluorescent uric acid.JPG\" border=\"0\" height=\"179\" src=\"_%20Tutorials_files/image004.png\" v:shapes=\"Picture_x0020_11\" width=\"238\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Gout: Needle-like\ncrystals under polarized light\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\n   <span>\n    <span style=\"mso-spacerun:yes\">\n     &nbsp;\n    </span>\n    Proceed to\n   </span>\n  </span>\n </b>\n <a href=\"http://emedicine.medscape.com/article/329958-clinical\">\n  <b>\n   <span>\n    Clinical\nPresentation\n   </span>\n  </b>\n </a>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   A is\ncorrect\n  </span>\n </b>\n <span>\n  . Colchicine can be used in the\ntreatment of an acute gouty flare. It is an acceptable option in a patient with\npeptic ulcer disease in whom NSAIDs should be avoided.\n </span>\n</p>\n", "choices": ["A. Colchicine", "B. Allopurinol", "C. Probenecid", "D. Sulfinpyrazone", "E. Morphine"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 3-year-old girl is brought to clinic because she refuses\nto walk and has stopped playing. Three weeks ago her parents noticed that her\nright knee was swollen and that she was standing with her knee flexed. There is\nno history of injury. Examination shows synovitis, decreased range of motion,\nand a flexion contracture of the right knee. Rheumatoid factor is negative and\nANA is positive at 1:80. Which of the following statements is false?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis correct.\n  </span>\n </b>\n</p>\n", "<p class=\"MsoListParagraphCxSpFirst\">\n <b>\n  <span>\n   Answer A\nis True\n  </span>\n </b>\n <span>\n  : Juvenile idiopathic arthritis of the\noligoarthritis subtype is the most common form of childhood arthritis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer B\nis True\n  </span>\n </b>\n <span>\n  : Uveitis is likely to occur in up to\nhalf of oligoarthritis juvenile idiopathic arthritis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer C\nis True\n  </span>\n </b>\n <span>\n  : ANA-positivity predicts children at\nrisk for asymptomatic uveitis.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer D\nis False\n  </span>\n </b>\n <span>\n  : It is\n  <i>\n   not\n  </i>\n  true that nearly all children with JIA, oligoarthritis subtype,\nwill go on to have disabling adult disease. In fact, most children improve with\nlittle or no residual disease as adults.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer E\nis True\n  </span>\n </b>\n <span>\n  : Rheumatoid factor is usually negative\nin juvenile idiopathic oligoarthritis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  This patient has juvenile idiopathic arthritis (JIA) of the\noligoarthritis subtype. Juvenile idiopathic arthritis is the most common form\nof arthritis in children. It affects girls more than boys (4:1), typically in\nthe 1-5 year age range. Three subtypes exist: oligoarticular, polyarticular,\nand systemic. The oligoarticular type is the most common. All children in this\nsubtype are rheumatoid factor-negative. 50% will only have only one knee\ninvolved. 30-50% develop asymptomatic uveitis. ANA-positivity correlates with\nincreased risk of eye disease. ANA-positive children should have eye exams\nevery three months to look for asymptomatic uveitis. The arthritis usually\nresolves with time, resulting in little or no disease in adulthood. Treatment\nincludes NSAIDS, intraarticular glucocorticoids, and aggressive physical\ntherapy to prevent contractures.\n </span>\n</p>\n", "choices": ["A. ANA+ juvenile idiopathic arthritis of the oligoarthritis subtype is the most common form of childhood arthritis.", "B. Uveitis is likely to occur in up to half of oligoarthritis juvenile idiopathic arthritis.", "C. ANA-positivity strongly predicts children at risk for asymptomatic uveitis.", "D. Nearly all juvenile oligoarthritis patients will go on to have disabling disease.", "E. Rheumatoid factor is usually negative in juvenile idiopathic oligoarthritis."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 45-year-old woman presents with a 3-month history of\nfatigue and painful joints. Her hands, feet, ankles, wrists, and elbows are\nvery stiff in the morning and improve with activity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She is taking naproxen 500 mg twice\ndaily with minimal improvement.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Exam shows bilateral synovitis of the metacarpophalangeal joints,\nproximal interphalangeal joints, wrists, ankles, elbows, and\nmetatarsophalangeal joints.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  You\nsuspect rheumatoid arthritis. Which of the following serological tests would\nbest correlate with aggressive, erosive disease accompanied by extra-articular\nmanifestations?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  Patients with high titres of\nrheumatoid factor and anti-CCP are most likely to have aggressive disease.\n </span>\n <span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Patients with low-titer RF and no anti-CCP are at low risk\nfor aggressive disease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Patients with seronegative rheumatoid arthritis are likely\nto have mild disease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Patients with low-titer anti-CCP and negative RF are\nlikely to have mild disease.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Rheumatoid arthritis (RA) is a\nchronic, systemic, inflammatory disorder of unknown cause. It is characterized\nby symmetrical, polyarticular pain and swelling, morning stiffness, and\nfatigue. RA has a variable course, often with periods of exacerbations and,\nless frequently, true remissions. Outcomes are also variable, ranging from the\nrarely seen remitting disease to severe disease that brings disability and\neven, in some patients, premature death. Without treatment, the majority of\npatients will experience progressive joint damage. In some patients this\nresults in significant disability within just a few years. The past decade has\nseen an unprecedented change in the treatment paradigm for this disease.\nSeveral targeted biologic therapies are available; the most notable are the\nanti-tumor necrosis factor (TNF) therapies.\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"8\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"96%\">\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <b>\n        <span>\n         Clinical Features\n        </span>\n       </b>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P079010\">\n       </a>\n       <span>\n        RA is a symmetrical\n    polyarthritis typically involving the small joints of the hands and feet,\n    the wrists, and the ankles. Other joints frequently involved include the\n    cervical spine, shoulders, elbows, hips, and knees. Any diarthrodial\n    (synovial) joint may be involved, including the apophyseal,\n    temporomandibular, and cricoarytenoid joints. Involved joints are swollen,\n    warm, and tender, and they may have effusions. The synovium, normally a few\n    cell layers thick, becomes palpable on examination&nbsp;\n        <i>\n         (synovitis).\n        </i>\n        &nbsp;Prolonged&nbsp;\n        <i>\n         morning\n    stiffness,\n        </i>\n        &nbsp;usually lasting more than 1 hour and often many hours,\n    is a classic feature in RA, and symptoms are generally improved with\n    moderate activity.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P079011\">\n       </a>\n       <span>\n        Over time, RA\n    progresses to joint destruction and deformity. Erosive lesions of bone and\n    cartilage are radiographically and pathologically visible at the margins of\n    bone and cartilage, the site of synovial attachment.&nbsp;\n        <i>\n         Tenosynovitis,\n        </i>\n        &nbsp;or\n    inflammation of tendon sheaths, leads to tendon malalignment, stretching,\n    and/or shortening. Among common deformities are ulnar deviation at the\n    metacarpophalangeal joints and volar subluxation at these joints, volar\n    subluxation at the wrists, and flexion and extension contractures in the\n    proximal and distal interphalangeal (DIP) joints of the fingers that lead\n    to characteristic\n        <i>\n         swan-neck deformity\n        </i>\n        &nbsp;(flexion contracture at\n    the DIP joint and hyperextension at the proximal interphalangeal joint)\n    or&nbsp;\n        <i>\n         boutonni&egrave;re deformity\n        </i>\n        &nbsp;(flexion contracture at the\n    proximal interphalangeal joint and hyperextension at the DIP joint).\n    Erosions of the ulnar styloid can lead to sharp bony prominences and\n    rupture of extensor tendons. Synovitis at the wrists can lead to median\n    nerve compression and carpal tunnel syndrome. Cervical spine disease may\n    lead to C1-C2 subluxation and spinal cord compression; caution should be\n    taken in moving the neck when the patient is being anesthetized for a\n    surgical procedure. The degree of subluxation can be monitored by looking\n    at the distance between C1 and the odontoid in flexion-extension films.\n    Rupture of synovial fluid from the knee into the calf (Baker cyst) may\n    mimic deep-venous thrombosis or, occasionally, cellulitis.\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"F079001\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"P079012\">\n    </a>\n    <a name=\"T079002\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"324\">\n    <tr>\n     <td width=\"100%\">\n      <p align=\"center\" class=\"MsoNormal\">\n       <b>\n        <span>\n         Characteristics of Rheumatoid Arthritis\n        </span>\n       </b>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <a name=\"T079002.850\">\n    </a>\n    <a name=\"T079002.800\">\n    </a>\n    <a name=\"T079002.750\">\n    </a>\n    <a name=\"T079002.700\">\n    </a>\n    <a name=\"T079002.650\">\n    </a>\n    <a name=\"T079002.600\">\n    </a>\n    <a name=\"T079002.550\">\n    </a>\n    <a name=\"T079002.500\">\n    </a>\n    <a name=\"T079002.450\">\n    </a>\n    <a name=\"T079002.400\">\n    </a>\n    <a name=\"T079002.350\">\n    </a>\n    <a name=\"T079002.300\">\n    </a>\n    <a name=\"T079002.250\">\n    </a>\n    <a name=\"T079002.200\">\n    </a>\n    <a name=\"T079002.150\">\n    </a>\n    <a name=\"T079002.100\">\n    </a>\n    <a name=\"T079002.50\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <div align=\"center\">\n    <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"344\">\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <b>\n         <span>\n          Articular\n         </span>\n        </b>\n        <span>\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Morning\n    stiffness, \"gelling\"\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Symmetrical\n    joint swelling\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Predilection\n    for wrists and proximal interphalangeal, metacarpophalangeal, and\n    metatarsophalangeal joints\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Erosions\n    of bone and cartilage\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Joint\n    subluxation and ulnar deviation\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Inflammatory\n    joint fluid\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Carpal\n    tunnel syndrome\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Baker\n    cyst\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <b>\n         <span>\n          Nonarticular\n         </span>\n        </b>\n        <span>\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Rheumatoid\n    nodules: subcutaneous, pulmonary, scleral\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Lung\n    disease\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Vasculitis,\n    especially skin, and peripheral nerves\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Pleuropericarditis\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Scleritis\n    and episcleritis\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Leg\n    ulcers\n        </span>\n       </p>\n      </td>\n     </tr>\n     <tr>\n      <td valign=\"top\">\n       <p class=\"MsoNormal\">\n        <span>\n         Felty\n    syndrome\n        </span>\n       </p>\n      </td>\n     </tr>\n    </table>\n   </div>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <div align=\"center\">\n    <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"90%\">\n     <tr>\n      <td width=\"100%\">\n       <a name=\"\">\n       </a>\n      </td>\n     </tr>\n    </table>\n   </div>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P079013\">\n       </a>\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n        The clinical course and severity of the arthritis are\n    variable. Some patients have mild, slowly progressive disease with few\n    deformities and little bony destructive change. At the opposite extreme are\n    patients who have a rapidly progressive course that, if left untreated,\n    leads to crippling and deforming arthritis. Most patients fall in between\n    these extremes with various levels of disability; some have a waxing and\n    waning course over a period of years with acute episodes of single- or\n    multiple-joint exacerbations.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P079014\">\n       </a>\n       <span>\n        RA is a systemic\n    disease with constitutional symptoms: fatigue, low-grade fever, weight\n    loss, and myalgia. Anemia is also common. Specific organs other than the musculoskeletal\n    system may be involved. Grossly palpable subcutaneous&nbsp;\n        <i>\n         rheumatoid\n    nodules\n        </i>\n        &nbsp;can occur almost anywhere but are common along other\n    extensor tendon surfaces, especially at the elbows, and less commonly in\n    the lungs, pleura, pericardium, sclerae, and other sites, including the\n    heart in rare cases. The occurrence of multiple pulmonary nodules in\n    patients with RA and pneumoconiosis is known as&nbsp;\n        <i>\n         Caplan syndrome.\n        </i>\n        &nbsp;Pleuritis,\n    pericarditis, and interstitial lung fibrosis occur in a few patients;\n    pericarditis can be severe, and acute interstitial lung disease can be\n    associated with pulmonary hemorrhage. Vasculitis, associated with\n    circulating complexes of immunoglobulin G (IgG) and rheumatoid factor (RF),\n    leads to cutaneous lesions, including ulcers and skin necrosis, and\n    mononeuritis multiplex. Secondary\n        <i>\n         Sj&ouml;gren syndrome\n        </i>\n        &nbsp;(sicca complex)\n    is often present.&nbsp;\n        <i>\n         Felty syndrome\n        </i>\n        (splenomegaly, leukopenia, and\n    recurrent pulmonary infections) is a rare complication and is often\n    accompanied by leg ulcers and vasculitis. Extra-articular manifestations of\n    RA are more commonly seen among patients who test positive for RF. Even in\n    patients without vasculitis or pulmonary or pleuropericardial disease, the\n    mortality rate in RA is increased by a variety of causes, including side effects\n    of therapy and infection. Premature and accelerated atherosclerosis is an\n    increasingly recognized problem among patients with RA and is thought, at\n    least, to be partially a result of the effects of chronic inflammation.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Rheumatoid arthritis (RA) is the most common inflammatory\narthritis. It affects women 2.5 times more than men. It can occur at any age\nbut has a peak incidence in the fourth and fifth decades of life. It is\nassociated with autoantibodies including rheumatoid factor (RF) and anti-cyclic\ncitrullinated peptide (CCP) antibodies. High titers of RF and anti-CCP predict\naggressive erosive disease with more extra-articular manifestations (rheumatoid\nnodules, pulmonary involvement, eye disease, Felty&rsquo;s syndrome, pericarditis,\nmyositis, and vasculitis).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  RF is found in 75-85% of patients with rheumatoid arthritis.\nRF is an antibody directed against the Fc portion of other antibodies. Low\nlevels of RF are found in hepatitis C with cryoglobulinemia, subacute\nendocarditis, and primary biliary cirrhosis. Anti-cyclic citrullinated peptide\nantibodies (anti-CCP) are found in nearly 70% of patients with rheumatoid\narthritis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  They are detectable in\nabout 35% of patients who are RF-negative, and may precede the diagnosis of\nrheumatoid arthritis by as many at 10 years.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Citrullination occurs when arginine\nresidues on proteins (typically vimentin or fillagrin) are deiminated by the\nenzyme peptidylarginine deiminase. The modified proteins become more antigenic,\nleading to autoantibody formation. Anti-CCP antibodies are highly specific for\nrheumatoid arthritis (95%) but low levels can be seen in 10% of patients with\npsoriatic arthritis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. RF 1:80; anti-cyclic citrullinated peptide (anti-CCP) negative", "B. RF negative; anti-CCP negative", "C. RF negative; anti-CCP positive at 42", "D. RF 1:1280; anti-CCP positive at 220"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 42-year-old woman has painful discoloration of her fingers\nwhen exposed to cold and when holding a cold drink.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her fingers turn white, then blue, then\nintensely red during these times.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her hands and distal forearm feel &ldquo;puffy,&rdquo; and the skin in those areas\nhas thickened over the past 6 months. She coughs occasionally and gets short of\nbreath when she walks or climbs stairs. She denies fever, chest pain,\npalpitations, and leg swelling. She also denies muscle aches, joint aches,\nrash, heartburn, and oral ulcers. What is the most likely cause of her exertional\ndyspnea?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This patient most likely has systemic sclerosis, or diffuse scleroderma,\nbased on skin thickening, edematous hands and forearms, and severe Raynaud&rsquo;s.\nSkin thickening above the wrist is suggestive of diffuse scleroderma.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Scleroderma has three phases: edematous,\ntightening, and atrophy (with claw-like hands).\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_18\" o:spid=\"_x0000_s1118\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image005.png\" o:title=\"\"/>\n <w:wrap type=\"square\"/>\n</v:shape><![endif]-->\n <img align=\"left\" height=\"105\" hspace=\"9\" src=\"_%20Tutorials_files/image006.png\" v:shapes=\"Picture_x0020_18\" width=\"150\"/>\n <v:shape id=\"Picture_x0020_17\" o:spid=\"_x0000_s1117\" type=\"#_x0000_t75\">\n  <v:imagedata o:title=\"\" src=\"_%20Tutorials_files/image007.png\">\n  </v:imagedata>\n  <w:wrap type=\"square\">\n  </w:wrap>\n </v:shape>\n <img align=\"left\" height=\"137\" hspace=\"9\" src=\"_%20Tutorials_files/image008.png\" v:shapes=\"Picture_x0020_17\" width=\"105\"/>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_10\" o:spid=\"_x0000_i1316\" type=\"#_x0000_t75\" alt=\"Description: 99CSC-10C07\"\n\n o:bordertopcolor=\"black\" o:borderleftcolor=\"black\" o:borderbottomcolor=\"black\"\n o:borderrightcolor=\"black\">\n <v:imagedata src=\"_%20Tutorials_files/image009.jpg\" o:title=\"99CSC-10C07\"/>\n <w:bordertop type=\"single\" width=\"48\"/>\n <w:borderleft type=\"single\" width=\"48\"/>\n <w:borderbottom type=\"single\" width=\"48\"/>\n <w:borderright type=\"single\" width=\"48\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 99CSC-10C07\" border=\"0\" height=\"262\" src=\"_%20Tutorials_files/image010.png\" v:shapes=\"Picture_x0020_10\" width=\"364\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Scleroderma affects mainly women (&gt;75%) with a peak\nincidence between 30 and 50 years of age. The etiology is unknown.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It is characterized by progressive\nfibrosis of the skin, but may involve internal organs.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Limited Systemic Sclerosis\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Formerly called &ldquo;CREST&rdquo; (an acronym for\ncalcinosis, Raynaud&rsquo;s, esophageal dysmotility, sclerodactyly, telangiectasias)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Skin involvement limited to hands,\nface, and feet\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Nail-fold capillary changes\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10-15% risk of pulmonary hypertension,\nthe most serious complication of limited systemic sclerosis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Renal disease is rare\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-centromere antibody (ACA) in\n70-80%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10-year survival: 75%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diffuse Systemic Sclerosis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hand and face\n  <i>\n   plus\n  </i>\n  more proximal involvement (above the wrists)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  More rapid progression\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Early incidence of heart, lung,\nesophageal, and renal disease\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Heart (hypertension, enlarged heart,\nheart failure)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lung (interstitial lung disease)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Esophagus (dysphagia, gastroesophageal\nreflux)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Renal (scleroderma renal crisis:\nmalignant hypertension causing renal failure; treated with ACE-inhibitor)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  70% lifetime risk of interstitial lung\ndisease, the leading cause of death in diffuse systemic sclerosis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5% risk of pulmonary hypertension\n(late)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-Scl-70 antibodies in 30%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &ndash;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10-year survival: 50%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Interstitial lung disease:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Leading cause of death in Diffuse\nSystemic Sclerosis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Fibrosis begins at lung bases and\nprogresses upward\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Symptoms: cough, exertional dyspnea,\nand eventually respiratory failure\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Therapy: cyclophosphamide or bone\nmarrow transplant\n </span>\n</p>\n", "choices": ["A. Congestive heart failure", "B. Valvular disorder", "C. Pulmonary hypertension", "D. Congenital heart disease", "E. Interstitial lung disease"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 30-year-old woman has had high, spiking fevers daily for a\nweek. She reports sore throat, muscle aches, and severe pain in the knees and\nwrists. She has noticed swollen glands in her neck and a pale, pink rash, which\nappears during the fever and resolves overnight.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Laboratory tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12\ng/dl\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  17,900/mm\n  <sup>\n   3\n  </sup>\n  (70% neutrophils)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelets\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  450,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  AST\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  94\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ALT\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  88\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ESR\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  &gt;100\nmm/h\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ANA\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  RF\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Ferritin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12,000\nng/ml\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The rash is shown here:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_9\" o:spid=\"_x0000_i1315\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image011.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img alt=\"CREATOR: gd-jpeg v1.0 (using IJG JPEG v62), quality = 85\n\" border=\"0\" height=\"164\" src=\"_%20Tutorials_files/image012.png\" v:shapes=\"Picture_x0020_9\" width=\"263\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis correct.\n  </span>\n </b>\n <span>\n  The patient has Still&rsquo;s disease.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Adult-onset Still&rsquo;s disease can occur at any age but peaks\nbetween ages 15 and 35. Nearly all patients complain of fever and joint pain.\nMost have sore throat, muscle aches, lymphadenopathy, and a salmon-pink rash\nthat comes and goes with the daily fevers. Other features include abdominal\npain and hepatosplenomegaly.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Laboratory tests show anemia, leukocytosis, elevated liver enzymes, and\nnegative ANA and RF. A very high ferritin level is classic for Still&rsquo;s disease.\nThe disease tends to relapse and remit. Most patients respond to NSAIDs or\nprednisone.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Subacute bacterial endocarditis (SBE) causes fever, myalgia,\narthralgia, and rash, but the rash is not evanescent as in Still&rsquo;s disease.\nPalpable purpura is the typical rash of SBE. Other cutaneous findings include\nOsler nodes and Janeway lesions. Ferritin levels are elevated, but not as high\nas in Still&rsquo;s disease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Disseminated gonococcus can cause fever, rash, and\narthritis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The arthritis typically\ninvolves the wrists, hands, feet, and ankles. Knees are also commonly involved.\nThe rash often presents as hemorrhagic pustules on an erythematous base. The\nbacterium can be cultured on Thayer-Martin media.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  Acute\nhepatitis B can be associated with fever, myalgia, arthralgia, elevated\nAST/ALT, and rash. The rash usually takes the form of livedo reticularis or\npalpable purpura. ALT and AST are very high in acute hepatitis.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  Human\nparvovirus 19 can cause fever, sore throat, myalgia, arthralgia, and rash. It\ndoes not typically cause elevation of the AST or ALT.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Infection can lead to transient aplastic\nanemia. The rash is usually occurs in children and manifests as &ldquo;slapped\ncheeks&rdquo; or as a maculopapular rash on the trunks and extremities.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Images\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_8\" o:spid=\"_x0000_i1314\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image013.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"173\" src=\"_%20Tutorials_files/image014.png\" v:shapes=\"Picture_x0020_8\" width=\"119\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Palpable purpura are\nassociated with\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  vasculitis and\nbacterial endocarditis.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_7\" o:spid=\"_x0000_i1313\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image015.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"227\" src=\"_%20Tutorials_files/image016.png\" v:shapes=\"Picture_x0020_7\" width=\"183\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Livedo reticularis, a\nlace-like purplish discoloration,\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  is associated with\nvasculitis.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_6\" o:spid=\"_x0000_i1312\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image017.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"138\" src=\"_%20Tutorials_files/image018.png\" v:shapes=\"Picture_x0020_6\" width=\"210\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Disseminated\ngonococcus can appear as a\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  hemorrhagic pustule\non an erythematous base.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_5\" o:spid=\"_x0000_i1311\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image019.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"245\" src=\"_%20Tutorials_files/image020.png\" v:shapes=\"Picture_x0020_5\" width=\"190\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  &ldquo;Slapped cheeks&rdquo;\ncaused by human parvovirus 19\n </span>\n</p>\n", "choices": ["A. Subacute bacterial endocarditis", "B. Disseminated gonococcus", "C. Hepatitis B", "D. Still\u2019s disease", "E. Parvovirus"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 23-year-old woman has a 3-month history of photosensitive\nrash, sores in her mouth, and progressive pain and stiffness in the joints of\nthe hands and feet, which are worse in the morning. Her laboratory tests show\nleukopenia and thrombocytopenia. Her creatinine is elevated at 1.6 mg/dl, and\nher urinalysis shows protein and microscopic hematuria.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Autoantibody tests are ordered. Which of\nthe following serological tests are likely to be positive?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . ANA 1:1280 in a nuclear speckled pattern, anti-Sm, and\nanti-double stranded DNA are most consistent with lupus.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Rheumatoid factor 1:80 and anti-CCP are most consistent\nwith rheumatoid arthritis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  ANA 1:640 in a\nnucleolar pattern and anti-topoisomerase I are most consistent with systemic\nscleroderma.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . ANA 1:40 and RF 1:40 are consistent with a healthy control\n(10-30% of the population has low-titer ANA).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . ANA 1:160 in a nuclear homogenous pattern and\nanti-centromere are most consistent with limited scleroderma or CREST.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  This patient has presumed systemic lupus erythematosus based\non arthralgias, photosensitivity, oral ulcers, leukopenia, and\nthrombocytopenia. There are 11 criteria for lupus. Any combination of 4 or more\nmakes it likely that the patient has lupus.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Systemic Lupus Erythematosus\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Malar rash\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Discoid rash\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Photosensitivity\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Oral ulcers\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Arthritis (non-erosive)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Serositis (pleuritis, pericarditis)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Renal Disorder (proteinuria or\n  cellular casts)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Neurological disorder (seizures or\n  psychosis)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hematologic disorder (hemolytic\n  anemia, lymphopenia, thrombocytopenia)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Immunologic: anti-dsDNA, anti-Sm,\n  and/or anti-phospholipid\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      ANA\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Although the patient has joint pain with morning stiffness\nconsistent with rheumatoid arthritis, the photosensitive rash and oral ulcers\nare not typical of RA. Behcet&rsquo;s disease causes recurrent oral ulcers, as well\nas vaginal or penile ulcers, and can be associated with rash but does not\ntypically cause joint pain or significant cytopenias. Scleroderma is unlikely\nbecause the patient does not have skin thickening, Raynaud&rsquo;s phenomenon, or\nheartburn. Polymyositis and dermatomyositis are unlikely because she does not\nhave muscle pain or weakness.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ANA patterns:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_4\"\n o:spid=\"_x0000_i1310\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image021.png\" o:title=\"\" cropbottom=\"-169f\"\n  cropleft=\"-1106f\" cropright=\"-1034f\"/>\n <o:lock v:ext=\"edit\" aspectratio=\"f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"313\" src=\"_%20Tutorials_files/image022.png\" v:shapes=\"Picture_x0020_4\" width=\"471\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Antibody associations\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-ds (double-stranded) DNA\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Seen in 60% of patients with SLE\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Highly specific for SLE\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Low titer may be seen in other\ninflammatory conditions\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Strongest clinical association with\nnephritis and CNS disease\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-Sm (Smith)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Seen in 10% to 30% of SLE patients\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Highly specific for SLE\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  clinical association with nephritis and\nCNS disease\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-DNA\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  nephritis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-nRNP\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  myositis,\nRaynaud&rsquo;s, milder disease\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-P\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  depression\nand psychosis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-histone\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  drug-induced\nlupus\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-Ro\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  photosensitivity,\npurpura, subacute cutaneous lupus\n  <br/>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  nephritis\n(w/o anti-La), pneumonitis,\n  <br/>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  C2\ndeficiency\n  <br/>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  lymphopenia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  if mother is positive for anti-Ro, baby at risk for neonatal\nheart block and neonatal lupus dermatitis\n  <span>\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-La\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  absence\nof nephritis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Anti-centromere and anti-nucleolar are typical patterns for\nScleroderma. SCL-70 is associated with systemic scleroderma and targets\nDNA-topoiosmerase I.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Anti-centromere antibodies are typically associated with limited\nscleroderma or CREST (calcinosis, Raynaud&rsquo;s, esophageal dysmotility,\nsclerodactyly, telangiectasias).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Rheumatoid factors are typically seen in rheumatoid arthritis\nbut may also be found in other diseases including chronic\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Hepatitis\" title=\"Hepatitis\">\n  <span>\n   hepatitis\n  </span>\n </a>\n <span>\n  C,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Primary_biliary_cirrhosis\" title=\"Primary biliary cirrhosis\">\n  <span>\n   primary biliary cirrhosis\n  </span>\n </a>\n <span>\n  , any chronic viral infection,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Bacterial_endocarditis\" title=\"Bacterial endocarditis\">\n  <span>\n   bacterial endocarditis\n  </span>\n </a>\n <span>\n  ,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Leukemia\" title=\"Leukemia\">\n  <span>\n   leukemia\n  </span>\n </a>\n <span>\n  ,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Dermatomyositis\" title=\"Dermatomyositis\">\n  <span>\n   dermatomyositis\n  </span>\n </a>\n <span>\n  ,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Infectious_mononucleosis\" title=\"Infectious mononucleosis\">\n  <span>\n   infectious mononucleosis\n  </span>\n </a>\n <span>\n  ,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Systemic_sclerosis\" title=\"Systemic sclerosis\">\n  <span>\n   systemic sclerosis\n  </span>\n </a>\n <span>\n  and\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Systemic_lupus_erythematosus\" title=\"Systemic lupus erythematosus\">\n  <span>\n   systemic lupus erythematosus\n  </span>\n </a>\n <span>\n  (SLE).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  High titer RF predicts more aggressive, erosive rheumatoid arthritis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Anti-CCP antibodies are directed again cyclic citrullinated\nprotein\n  <b>\n   .\n  </b>\n  During citrullination, arginine residues in proteins such as\nvimentin can be enzymatically converted into citrulline residues, and if their\nshapes are significantly altered, the proteins may be seen as\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Antigens\" title=\"Antigens\">\n  <span>\n   antigens\n  </span>\n </a>\n <span>\n  by the immune system and autoantibodies against them may\nform. Anti-CCP antibodies are quite specific for rheumatoid arthritis although\nlow levels may be found in psoriatic arthritis. High titer anti-CCP predicts\nmore aggressive disease.\n </span>\n</p>\n", "choices": ["A. Rheumatoid factor 1:80 and anti-CCP", "B. ANA 1:640 in a nucleolar pattern, anti-topoisomerase I", "C. ANA 1:1280 in a nuclear speckled pattern and anti-Sm and anti-double stranded DNA", "D. ANA 1:40, RF 1:40", "E. ANA 1:160 in nuclear homogenous, anti-centromere"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 73-year-old woman has a 3-week history of fever, fatigue,\nand right-sided headache. Today she has blurred vision in the left eye and\nfatigue with chewing. Physical examination shows tenderness over a blood vessel\nin the left temporal area. Histological examination of the vessel shows\nmultinucleated histiocytes infiltrating the wall of a medium-sized artery.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Which of the following is the most\nappropriate management?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis correct.\n  </span>\n </b>\n <span>\n  Prednisone, a glucocorticoid, is the\nmainstay of therapy for temporal arteritis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Temporal arteritis (TA), also known as cranial or giant cell\narteritis, is the most common systemic vasculitis in adults. It primarily\naffects medium-sized arteries of the head and the neck and can cause blindness.\nThe condition may present insidiously with fever, malaise, and/or weight loss.\nIn some patients, symptoms appear abruptly and may include headache, neck pain,\nscalp tenderness, visual disturbance, fatigue with chewing (jaw claudication),\nand fatigue with swallowing. Patients often have fever, headache, anemia, and\nan elevated erythrocyte sedimentation rate (ESR). Polymyalgia rheumatica (PMR)\nwith extreme muscle tenderness of the shoulder and hip girdles may be present.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The diagnosis should be strongly suspected in Caucasians of\nnorthern European descent, especially women above the age of 50, who report\ntemporal headache, scalp tenderness, jaw claudication, and/or visual changes.\nVisual disturbances include diplopia, blurred vision, amaurosis fugax, and\nblindness in one or both eyes. Visual hallucination also can occur. The scalp\nmay be focally or generally tender. Temporal arteries may be tender, inflamed,\ndilated, thickened, or cordlike.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diagnosis is made aided by a temporal artery biopsy,\npreferably bilateral biopsies. Temporal artery biopsies may be negative even\nwhen disease is present secondary to skip lesions (10%). Granulomatous\nvasculitis is seen histologically.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  High-dose glucocorticoids (such as prednisone 60 mg daily)\nare the mainstay of therapy and may prevent permanent visual loss. Steroids\nshould be initiated if temporal arteritis is suspected on clinical\ngrounds.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Clinicians should NOT\ndelay the start of steroids while waiting for a temporal artery biopsy.\n </span>\n</p>\n", "choices": ["A. Administration of ibuprofen", "B. Administration of prednisone", "C. Doppler ultrasound of the carotid arteries", "D. MRI of the head", "E. Surgical removal of the blood vessel"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 32-year-old man with a history of hepatitis B presents to\nthe emergency department with fever, malaise, muscle aches, joint aches, and\nrash on the legs. He describes increasing postprandial periumbilical pain,\nwhich discourages him from eating. Examination reveals a lace-like purplish\ndiscoloration on the legs. You suspect polyarteritis nodosa (PAN). Which of the\nfollowing is least likely to be associated with this condition?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct.\n  </span>\n </b>\n <span>\n  Polyarteritis nodosa is not associated\nwith autoantibodies.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Polyarteritis nodosa (PAN) is a vasculitis of medium-sized\nvessels. It typically affects the gut, kidneys, nerves, muscles, and skin. Both\nmen and women are affected. The condition can occur at any age. 10% of cases\nare associated with hepatitis B. The clinical manifestations are varied and may\ninclude weight loss, myalgias, neuropathy, renal insufficiency (due to renal\nartery involvement, not glomerulonephritis), testicular pain, abdominal angina,\nbowel ischemia, and rash (livedo reticularis, ulcerations, gangrene).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diagnosis cannot be made using blood tests. (PAN is not\nassociated with autoantibodies.) Unlike microscopic polyangiitis and Wegener&rsquo;s\ngranulomatosis, PAN is not associated with ANCA antibodies.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients may present with an elevated\nBUN and creatinine and mild proteinuria but do not typically have active\nurinary sediment (e.g., RBC casts). The ESR and C-reactive protein levels are\nelevated. Biopsy of affected peripheral sites such as skin and muscle are\npreferred for diagnosis. Biopsy typically shows transmural arteritis with\ngranulocytes, fibrinoid necrosis, and disruption of the elastic laminae. Renal\nor mesenteric angiograms may demonstrate typical microaneurysms and strictures\n(beads on a string), which support the diagnosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_16\" o:spid=\"_x0000_s1116\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image023.png\" o:title=\"\"/>\n <w:wrap type=\"square\"/>\n</v:shape><![endif]-->\n <img align=\"left\" height=\"164\" hspace=\"9\" src=\"_%20Tutorials_files/image024.png\" v:shapes=\"Picture_x0020_16\" width=\"218\"/>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_15\"\n o:spid=\"_x0000_s1115\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image025.wmz\" o:title=\"\"/>\n <w:wrap type=\"square\"/>\n</v:shape><![endif]-->\n <img align=\"left\" height=\"167\" hspace=\"9\" src=\"_%20Tutorials_files/image026.png\" v:shapes=\"Picture_x0020_15\" width=\"215\"/>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Fibrinoid necrosis in\nPAN\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Microaneurysms in PAN\n  <br clear=\"all\"/>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  The Vasculitides\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"504\">\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Primary\n  Vasculitis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Predominant\n  Symptoms\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Age at\n  onset\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Male:\n  female\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p class=\"MsoNormal\">\n    <span>\n     Takayasu&rsquo;s\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Arm and leg claudication, bruits,\n  decreased or absent pulses\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p class=\"MsoNormal\">\n    <span>\n     15-25\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     1:9\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p class=\"MsoNormal\">\n    <span>\n     Giant Cell Arteritis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Headache, jaw claudication, scalp\n  tenderness, hip/shoulder stiffness, hand arthralgia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p class=\"MsoNormal\">\n    <span>\n     60-75\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     1:3\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p class=\"MsoNormal\">\n    <span>\n     Polyarteritis Nodosa\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Weight loss, fatigue, livedo\n  reticularis, renal infarcts, hypertension, testicular pain, neuropathy,\n  myopathy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p class=\"MsoNormal\">\n    <span>\n     40-60\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     2:1\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p class=\"MsoNormal\">\n    <span>\n     Churg-Strauss\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Asthma, eosinophilia, neuropathy,\n  pulmonary infiltrates\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p class=\"MsoNormal\">\n    <span>\n     40-60\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     2:1\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p class=\"MsoNormal\">\n    <span>\n     Wegener&rsquo;s\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Upper and lower airways disease,\n  renal disease, neuropathy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p class=\"MsoNormal\">\n    <span>\n     30-60\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     2:1\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p class=\"MsoNormal\">\n    <span>\n     Behcets\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Recurrent oral and genital\n  ulceration, uveitis, thrombophlebitis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p class=\"MsoNormal\">\n    <span>\n     20-35\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     1:1\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"129\">\n   <p class=\"MsoNormal\">\n    <span>\n     Henoch-Schonlein Purpura\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Palpable purpura, arthritis,\n  abdominal pain, bloody diarrhea\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"58\">\n   <p class=\"MsoNormal\">\n    <span>\n     5-20\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     1:1\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Abdominal angiogram showing microaneurysms of the mesenteric vessels.", "B. Full thickness skin biopsy showing patchy transmural arteritis, fibrinoid necrosis, and disruption of the elastic laminae.", "C. Positive P-ANCA", "D. Serum creatinine of 2.5 without red blood cell casts"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 25-year-old man has been coughing up blood intermittently\nfor two hours. He reports low-grade fever, fatigue, chronic sinus drainage, and\nfrequent nosebleeds. On physical examination, he is mildly distressed.\nTemperature is 100\n  <sup>\n   o\n  </sup>\n  F, pulse is 90/minute, blood pressure is 110/60\nmm Hg, and respirations are 28/minute. A raised purplish-red rash is noted on\nhis lower legs. The oxygen saturation is 91% on room air. Chest x-ray shows\nbilateral patchy infiltrates.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_14\" o:spid=\"_x0000_s1114\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image027.png\" o:title=\"\"/>\n <w:wrap type=\"square\"/>\n</v:shape><![endif]-->\n <img align=\"left\" height=\"159\" hspace=\"9\" src=\"_%20Tutorials_files/image028.png\" v:shapes=\"Picture_x0020_14\" width=\"183\"/>\n <v:shape id=\"Picture_x0020_13\" o:spid=\"_x0000_s1113\" type=\"#_x0000_t75\">\n  <v:imagedata o:title=\"\" src=\"_%20Tutorials_files/image029.png\">\n  </v:imagedata>\n  <w:wrap type=\"square\">\n  </w:wrap>\n </v:shape>\n <img align=\"left\" height=\"160\" hspace=\"9\" src=\"_%20Tutorials_files/image030.png\" v:shapes=\"Picture_x0020_13\" width=\"99\"/>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  You suspect vasculitis with possible diffuse alveolar\nhemorrhage. Which antibody is most likely associated with this presentation?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . This patient presents with hemoptysis, nosebleeds, chronic\nsinusitis, patchy lung infiltrates, and palpable purpura, consistent with\nWegener&rsquo;s granulomatosis. Wegener&rsquo;s is associated with C-ANCA.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Anti-CCP is found in rheumatoid arthritis and occasionally\nin psoriatic arthritis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . ANA is typical of lupus, scleroderma, and Sjogren&rsquo;s\ndisease. These diseases can be associated with diffuse alveolar hemorrhage, but\nare not associated with chronic sinus disease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . P-ANCA is the most common antibody found in vasculitis and\nis associated with microscopic polyarteritis, a common cause of diffuse\nalveolar hemorrhage. However, microscopic polyarteritis is typically not\nassociated with chronic sinusitis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Rheumatoid factor is associated with a variety of diseases\nincluding rheumatoid arthritis, chronic hepatitis C, lymphoma, and subacute\nbacterial endocarditis. Rheumatoid arthritis is rarely associated with\npulmonary vasculitis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer F is incorrect\n  </span>\n </b>\n <span>\n  . Anti-glomerular basement membrane is associated with\nGoodpasture&rsquo;s disease, which can lead to diffuse alveolar hemorrhage and\nglomerulonephritis. However, Goodpasture&rsquo;s is not associated with chronic\nsinusitis or palpable purpura.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Wegener&rsquo;s\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Cardinal features: granulomatous\nvasculitis of upper and lower respiratory tract, glomerulonephritis, and\nvariable degrees of disseminated vasculitis (which may produce\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  palpable purpura)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Involves small arteries and veins\n(hence lungs and kidneys are major targets)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Prevalence: 3 per 100,000\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Extremely rare in blacks\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Equal M:F ratio\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Mean age of onset is 40\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Sinus, nasal, or oral inflammation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Chest x-ray: nodules (with or without\ncavitation) or fixed infiltrates\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Microhematuria or red blood cell casts\nin urine\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Biopsy (sinus, lungs, kidney):\ngranulomatous necrotizing vasculitis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ANCA (anti-neutrophil cytoplasmic antibodies): C-ANCA and\nP-ANCA\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C-ANCA: &ldquo;classical&rdquo; antineutrophil cytoplasmic antibodies\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Diffusely granular cytoplasmic staining\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Proteinase-3 (PR-3) is the major target\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Found in &gt;90% of Wegener&rsquo;s\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  (rare in microscopic polyarteritis, SBE)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Titers fluctuate with disease activity\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  P-ANCA: &ldquo;protoplasmic&rdquo; antineutrophil cytoplasmic antibodies\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Peri-nuclear staining\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Myeloperoxidase (MPO) is the major target\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  ~70% microscopic polyarteritis; ~75% Churg-Strauss; 10-30%\nGoodpasture&rsquo;s;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ~10% SLE; 50-80% ulcerative colitis, sclerosing cholangitis,\nautoimmune hepatitis\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_3\" o:spid=\"_x0000_i1309\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image031.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"190\" src=\"_%20Tutorials_files/image032.png\" v:shapes=\"Picture_x0020_3\" width=\"180\"/>\n  <v:shape id=\"Picture_x0020_2\" o:spid=\"_x0000_i1308\" type=\"#_x0000_t75\">\n   <v:imagedata o:title=\"\" src=\"_%20Tutorials_files/image033.jpg\">\n   </v:imagedata>\n  </v:shape>\n  <img border=\"0\" height=\"190\" src=\"_%20Tutorials_files/image034.png\" v:shapes=\"Picture_x0020_2\" width=\"169\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Differential of Palpable Purpura:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hypersensitivity vasculitis (e.g.,\ndrug-induced)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Cryoglobulinemia (hepatitis C)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Paraneoplastic vasculitis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Henoch-Schonlein purpura\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Wegener&rsquo;s granulomatosis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Churg-Strauss vasculitis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Microscopic polyarteritis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Polyarteritis nodosa (hepatitis B)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &bull;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Subacute bacterial endocarditis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diffuse Alveolar Hemorrhage:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Rapidly changing patchy pulmonary\ninfiltrates\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoptysis (usually)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diagnosis: bronchoscopy shows\nprogressive returns of blood\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Therapy: intravenous high-dose\nglucocorticoids\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_1\" o:spid=\"_x0000_i1307\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image035.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"247\" src=\"_%20Tutorials_files/image036.png\" v:shapes=\"Picture_x0020_1\" width=\"398\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Anti-CCP", "B. ANA", "C. P-ANCA", "D. Rheumatoid factor", "E. C-ANCA", "F. Anti-glomerular basement membrane"]}]}, {"section": "Fluid, Electrolytes, & Acid-Base", "questions": [{"question": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_19\" o:spid=\"_x0000_i1306\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image037.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"204\" src=\"_%20Tutorials_files/image038.png\" v:shapes=\"Picture_x0020_19\" width=\"188\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In the diagram above, point X indicates the acid-base status\nof a healthy person. Which of the following is the most likely cause of the\ncondition indicated by point Y?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis correct.\n  </span>\n </b>\n <span>\n  COPD is a chronic disorder\ncharacterized by respiratory acidosis and metabolic compensation. The PCO\n  <sub>\n   2\n  </sub>\n  level is high, the HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  level is high, and the pH is\nnear normal (due to compensation).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect.\n  </span>\n </b>\n <span>\n  Ingestion of strong acid would cause\nan acute metabolic acidosis (low pH, low HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  ).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect.\n  </span>\n </b>\n <span>\n  Prolonged vomiting causes an acute\nmetabolic alkalosis (high pH, high HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  ).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect.\n  </span>\n </b>\n <span>\n  Diarrhea causes an acute metabolic\nacidosis (low pH, low HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  ).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect.\n  </span>\n </b>\n <span>\n  Low oxygen tension at high altitudes\nresults in hyperventilation (to maintain normal blood oxygen levels).\nHyperventilation causes respiratory alkalosis, which, over time, leads to\nmetabolic compensation: the PCO\n  <sub>\n   2\n  </sub>\n  is low, the HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  is low, and the pH is near normal.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Point X represents a normal acid-base status: The pH is 7.4,\nthe PCO\n  <sub>\n   2\n  </sub>\n  is 40 mm Hg, and the HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  is 24\nmEq/L. Point Y represents an abnormal acid-base status: the pH is almost 7.4,\nthe PCO\n  <sub>\n   2\n  </sub>\n  is 60 mm Hg, and the HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  is 40\nmEq/L. Note that the pH is almost identical in both cases: at or near 7.4. The\npoint here is that a normal pH can mean one of two things: either the patient\nhas a normal acid-base status or the patient has two acid-base processes that\nare almost &ldquo;canceling&rdquo; each other out. This &ldquo;canceling out&rdquo; (i.e.,\n&ldquo;compensation&rdquo;) is common in chronic acid-base disorders. In\n  <i>\n   acute\n  </i>\n  disorders, the body doesn&rsquo;t have\ntime to compensate for the change in pH. In\n  <i>\n   chronic\n  </i>\n  disorders, there is time to adapt. Adaptation can be (simplistically) regarded\nas a partnership between lungs and kidneys.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  If the lungs retain too much CO\n  <sub>\n   2\n  </sub>\n  (respiratory\nacidosis), the kidneys respond by retaining more HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  (metabolic alkalosis)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  If the lungs blow off too much CO\n  <sub>\n   2\n  </sub>\n  (respiratory\nalkalosis), the kidneys compensate by eliminating more HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  (metabolic acidosis)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  If the blood is too acidic (metabolic acidosis), the lungs\nrespond by blowing off more CO\n  <sub>\n   2\n  </sub>\n  (respiratory alkalosis)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  If the blood is too alkalotic (metabolic alkalosis), the\nlungs respond by retaining more CO\n  <sub>\n   2\n  </sub>\n  (respiratory acidosis)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Here are some basic rules of compensation:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Compensation rarely produces a normal\npH, although the pH may approach normal.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Overcompensation does not occur (i.e.,\nthe compensatory process does not overwhelm the primary process)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Sufficient time must elapse for\ncompensation to occur (about 24 hours).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  At Point Y, we know that the acid-base status is abnormal\nbecause the PCO\n  <sub>\n   2\n  </sub>\n  and HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <sub>\n  </sub>\n  levels\nare abnormal. The PCO\n  <sub>\n   2\n  </sub>\n  level is high (respiratory acidosis) and the\nHCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <sub>\n  </sub>\n  level is high (metabolic alkalosis).\nThese two processes almost cancel each other out, resulting in a near normal\npH.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which is the primary process? The pH at Point Y is slightly\nlower than at Point X. This suggests that the primary process is respiratory\nacidosis and the compensatory process is metabolic alkalosis. This combination\nis commonly seen in severe chronic obstructive pulmonary disease (COPD),\ncharacterized by chronic retention of CO\n  <sub>\n   2\n  </sub>\n  and compensatory retention\nof HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <sub>\n  </sub>\n  by the kidneys.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Ingestion of strong acid", "B. Prolonged vomiting", "C. Diarrhea", "D. Adaptation to high altitude", "E. Chronic obstructive pulmonary disease (COPD)"]}, {"question": "<p class=\"MsoNormal\">\n <!--[if supportFields]><span><span\n></span><span\nstyle=\"mso-spacerun:yes\">&nbsp;</span>SEQ CHAPTER \\h \\r 1</span><![endif]-->\n <!--[if supportFields]><span\n><span></span></span><![endif]-->\n <span>\n  A 55-year-old woman undergoes routine blood tests prior to\nelective sinus surgery.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The serum\ncalcium level is elevated at 11.3 mg/dl (normal: 8.4 to10.2 mg/dl). The serum\nalbumin concentration is normal. A second blood test shows a serum calcium\nlevel of 11.2 mg/dl and a parathyroid hormone (PTH) level of 58 pg/ml (normal:\n20 to 72 pg/ml).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  What is the most\nlikely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The\nmost likely diagnosis is primary hyperparathyroidism. In a person with a normal\nfeedback mechanism, high serum calcium levels should maximally suppress PTH\nproduction by the parathyroid glands. In this vignette, however, the PTH level\nis inappropriately &ldquo;normal.&rdquo; Thus, the normal feedback mechanism is broken. PTH\nis being autonomously secreted by the parathyroid gland.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . In\nPTH-independent hypercalcemic states, such as milk-alkali syndrome, regulation\nof PTH secretion is normal. Elevated serum calcium levels suppress PTH\nsecretion, causing low PTH levels in the blood.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . In\nPTH-independent hypercalcemic states, such as hypercalcemia of malignancy,\nregulation of PTH secretion is normal. Elevated serum calcium levels suppress\nPTH secretion, causing low PTH levels in the blood.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  .\nSecondary hyperparathyroidism is not associated with hypercalcemia. In\nsecondary hyperparathyroidism (e.g., chronic renal failure), serum PTH levels\nare high and serum calcium levels are low or inappropriately normal.\n </span>\n</p>\n"], "tutorial": "<p>\n Calcium serves two principal\nphysiologic functions. First, insoluble calcium salts (primarily\nhydroxyapatite) provide the structural characteristics that allow bones to\nprotect internal organs, to bear weight, and to function as the levers on which\nmuscles act during locomotion. Second, soluble calcium ions in the\nextracellular fluid (ECF) and cytosol are critical for a myriad of biochemical\nreactions, signaling cascades, and electrical systems that are necessary for\nlife.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Most of the calcium in the body (about 99%) is found in\nbone. Only 1% is contained within the ECF and soft tissues. Therefore, the\nskeleton is called on as a source of calcium when the ECF concentration falls.\nOf the total circulating calcium, the ionized fraction is about 50%, with the\nremainder bound to serum proteins, primarily albumin. Only the ionized fraction\nof total serum calcium is physiologically important, and this component is\nregulated on a minute-to-minute basis.\n </span>\n</p>\n\n<p>\n Hormones and organ systems regulate\nthe ECF ionized calcium concentration such that it is maintained in a very\nnarrow physiologic range. If the calcium level falls below the physiologic\nrange, PTH is rapidly secreted from the parathyroid glands and activates the\nrelease of calcium and phosphate from the skeleton. In the kidney, PTH\nincreases the reabsorption of calcium from the urine while simultaneously\ninhibiting phosphate reabsorption to dispose\n <a name=\"4-u1.0-B978-1-4160-2805-5..50271-8--p189\">\n </a>\n of the phosphate released\nfrom the skeleton. These actions return the calcium concentration back toward\nnormal and thus inhibit further PTH release. When hypocalcemia persists, PTH\nalso stimulates the renal production of 1,25(OH)\n <sub>\n  2\n </sub>\n vitamin D, which\nincreases intestinal calcium absorption.\n</p>\n\n<p>\n In the presence of\n <span class=\"search-hit\">\n  hypercalcemia\n </span>\n , PTH secretion is suppressed, and the\nvarious organs alter their calcium handling in an opposite fashion so\ncirculating calcium levels fall.\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   Causes of\nHypercalcemia in Adults\n  </span>\n </b>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Hyperparathyroidism\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Malignancy-associated hypercalcemia\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Humoral\n  hypercalcemia of malignancy\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Local osteolytic\n  hypercalcemia\n      <b>\n      </b>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Granulomatous disorders\n      </span>\n     </b>\n     <span>\n      (e.g., sarcoidosis)\n      <b>\n      </b>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Endocrine disorders\n      </span>\n     </b>\n     <span>\n      (e.g., h\n     </span>\n     <span>\n      yperthyroidism,\n      <br/>\n      adrenal insufficiency)\n      <b>\n      </b>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Drugs\n      </span>\n     </b>\n     <span>\n      (e.g., thiazide diuretics,\n     </span>\n     <span>\n      Vitamin D intoxication)\n      <b>\n      </b>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Miscellaneous\n      </span>\n     </b>\n     <span>\n      (e.g., m\n     </span>\n     <span>\n      ilk-alkali syndrome*, immobilization)\n      <b>\n      </b>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n *Milk-alkali syndrome is\ncaused by excessive consumption of milk (which is high in calcium) and certain\nantacids, especially\n <span class=\"Hyperlink4\">\n  <span>\n   calcium\ncarbonate\n  </span>\n </span>\n or\n <span class=\"Hyperlink4\">\n  <span>\n   sodium\nbicarbonate\n  </span>\n </span>\n (baking soda), over a long period of time. It is\nassociated with calcium deposits in the kidneys and in other tissues.\nConsumption of excessive amounts of vitamin D, which is usually added to milk\nbought at the supermarket, can worsen this condition.\n <b>\n </b>\n</p>\n", "choices": ["A. Milk-alkali syndrome", "B. Hypercalcemia of malignancy", "C. Primary hyperparathyroidism", "D. Secondary hyperparathyroidism"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 68-year-old woman with type 2 diabetes mellitus and\nhypertension presents to the clinic for a routine visit.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood test results:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  142\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n136-145 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  5.8\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.5-5.0 mEq/L)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  114\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n95-105 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  16\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n22-28 mEq/L)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n7-18 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.0\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n0.6-1.2 mg/dL)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is the most likely cause of hyperkalemia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The presence of hyperkalemia with a normal anion gap\nacidosis suggests a low-aldosterone state. Several conditions are associated\nwith low aldosterone levels. One of the most common is type IV renal tubular\nacidosis (RTA). This condition usually occurs in patients with diabetes\nmellitus and hypertension. Typically, patients with type IV RTA have mild to\nmoderate renal insufficiency. The ability of the kidneys to produce renin is\nimpaired, resulting in suppression of the renin-angiotensin-aldosterone system.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . Increased dietary intake of potassium\nrarely causes hyperkalemia in patients with normal renal function.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  . This patient does not have renal\ninsufficiency, as the BUN and creatinine are normal.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . There is no reason to suspect major\ncellular breakdown.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The principal mechanisms of hyperkalemia are excessive\nintake of potassium, ineffective elimination of potassium, and excessive\nrelease of potassium from cells.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Excessive\nintake of potassium\n  </span>\n </i>\n <span>\n  rarely causes hyperkalemia in patients\nwith normal renal function.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The\nkidneys are proficient at excreting excess potassium. Very high doses of\npotassium are required to overcome the normal renal capacity for elimination.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Ineffective\nelimination of potassium\n  </span>\n </i>\n <span>\n  is usually due to\nrenal insufficiency, drugs, or low-aldosterone states. Renal insufficiency is\ncharacterized by high BUN and creatinine levels. Many drugs, particularly\nACE-inhibitors, potassium-sparing diuretics, and NSAIDs, can cause\nhyperkalemia. Low-aldosterone states should be suspected as a cause of hyperkalemia\nwhen elevated potassium levels are accompanied by a normal-anion gap metabolic\nacidosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Excessive\nrelease of potassium from cells\n  </span>\n </i>\n <span>\n  is\ncaused by large-scale cellular breakdown or by conditions that shift potassium\nfrom the intracellular to extracellular space.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  These mechanisms are summarized below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"361\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mechanisms of Hyperkalemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"361\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"361\">\n    <p class=\"MsoNormal\">\n     <span>\n      Excessive\n  intake of potassium\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"361\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ineffective\n  elimination of potassium\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Renal insufficiency\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Drugs\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      ACE-inhibitors\n  and angiotensin-receptor blockers\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Potassium-sparing\n  diuretics\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      NSAIDs\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Calcineurin\n  inhibitors (e.g., cyclosporin, tacrolimus)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Trimethoprim\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pentamidine\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Mineralcorticoid deficiency or\n  resistance\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Type\n  IV renal tubular acidosis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Addison&rsquo;s\n  disease\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Aldosterone\n  deficiency\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Congenital\n  adrenal hyperplasia (some types)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"361\">\n    <p class=\"MsoNormal\">\n     <span>\n      Excessive\n  release of potassium from cells\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Rhabdomyolysis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Burns\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Tumor lysis syndrome\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Massive blood transfusion\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Massive hemolysis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Conditions that shift potassium from\n  the intracellular to extracellular space\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Acidosis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Low\n  insulin levels\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Beta-blocker\n  therapy\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       o\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Digoxin\n  overdose\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Increased dietary intake of potassium", "B. Decreased mineralcorticoid activity at the distal nephron", "C. Renal insufficiency", "D. Excessive release of potassium from cells"]}, {"question": "<p>\n <span>\n  An 80-year-old man with dementia resides in a nursing home. He develops a\nurinary tract infection, which causes an acute decline in his mental status.\nVital signs and laboratory tests before and after this decline are shown below.\n </span>\n</p>\n\n<p>\n <u>\n  <span>\n   Before\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </u>\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <u>\n   After\n  </u>\n </span>\n</p>\n\n<p>\n <span>\n  Blood pressure\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  130/80\nmm Hg\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  105/60\nmm Hg\n </span>\n</p>\n\n<p>\n <span>\n  Pulse\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  70\n/ minute\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  100\n/ min\n </span>\n</p>\n\n<p>\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  15\ng/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  17\ng/dL\n </span>\n</p>\n\n<p>\n <span>\n  Sodium\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  140\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  150\nmEq/L\n </span>\n</p>\n\n<p>\n <span>\n  Glucose\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  90\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  95\nmg/dL\n </span>\n</p>\n\n<p>\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  13\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  50\nmg/dL\n </span>\n</p>\n\n<p>\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.2\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.3\nmg/dL\n </span>\n</p>\n\n<p>\n <span>\n  Which of the following conditions best explains the changes shown above?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct\n </b>\n . The patient in the clincial vignette has a\nnormal serum sodium level on day 1 and a high serum sodium level on day 5. The\npresence of hypernatremia on day 5 should alert the clinician to the\ndevelopment of dehydration. (Dehydration is the most common cause of\nhypernatremia.) Other findings consistent with dehydration include a drop in\nblood pressure, a rise in pulse, a rise in hemoglobin level\n(hemoconcentration), and an elevation in the BUN / creatinine ratio (due to\nhypovolemia).\n</p>\n", "<p>\n <b>\n  Answer B is incorrect\n </b>\n . Gastrointestinal hemorrhage may result in\nhypotension, tachycardia, and an elevated BUN / creatinine ratio (from\nhypovolemia), but hypernatremia does not usually occur, and the hemoglobin\nconcentration does not rise.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . Diabetic ketoacidosis (DKA) is characterized\nby hyperglycemia, ketosis, and metabolic acidosis. Hypotension, tachycardia,\nand hypovolemia commonly occur. In this clinical vignette, DKA is unlikely\nbecause of the normal serum glucose concentration.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n . Acute renal failure is defined as an abrupt\nor rapid decline in renal filtration, usually marked by a rise in the serum\ncreatinine concentration. In this vignette, there is a slight rise in the\ncreatinine concentration and a large rise in the BUN. The increase in the BUN /\ncreatinine ratio is caused by hypovolemia. The presence of hypernatremia\nsuggests a state of dehydration.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n .\n <span>\n  The\nsyndrome of inappropriate ADH causes hyponatremia, not hypernatremia.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Hypernatremia\n </span>\n is defined as an elevated serum sodium\nconcentration. It is generally not caused by an excess of sodium, but rather by\na relative deficit of free water. Consequently, hypernatremia is usually\nsynonymous with dehydration.\n</p>\n\n<p>\n Water is lost from the body\nin many ways, including perspiration, insensible losses from breathing, and\nfecal and urinary losses. If the amount of water ingested falls below the\namount of water lost, the serum sodium level rises, leading to hypernatremia.\nOrdinarily, a rise in the sodium level triggers thirst, which leads to\nincreased free water intake and subsequent correction of the abnormality.\nHypernatremia usually occurs in individuals who cannot adequately replace fluid\nlosses, such as infants, the mentally impaired, and the elderly.\n</p>\n\n<p>\n Most patients with\nhypernatremia are hypovolemic. In some less common conditions, however,\nhypernatremic patients may be euvolemic or hypervolemic.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"188\">\n    <p align=\"center\">\n     <span>\n      Causes of Hypernatremia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"188\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"188\">\n    <p>\n     <span>\n      Hypovolemia (dehydration)\n     </span>\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Inadequate\n  water intake\n     </span>\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Excessive water\n  loss\n     </span>\n    </p>\n    <p>\n     <span>\n      Euvolemia (diabetes insipidus)\n     </span>\n    </p>\n    <p>\n     <span>\n      Hypervolemia\n     </span>\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Intake of\n  hypertonic fluid (e.g. seawater)\n     </span>\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Mineralcorticoid\n  excess (Conn&rsquo;s syndrome)\n     </span>\n    </p>\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n In most patients,\nhypernatremia is synonymous with dehydration. Symptoms and signs of dehydration\nappear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"268\">\n    <p align=\"center\">\n     <span>\n      Symptoms and Signs of Dehydration\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"268\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"134\">\n    <p>\n     <span>\n      Headache\n     </span>\n    </p>\n    <p>\n     <span>\n      Fatigue\n     </span>\n    </p>\n    <p>\n     <span>\n      Confusion\n     </span>\n    </p>\n    <p>\n     <span>\n      Thirst\n     </span>\n    </p>\n    <p>\n     <span>\n      Dry mouth\n     </span>\n    </p>\n    <p>\n     <span>\n      Dry skin\n     </span>\n    </p>\n    <p>\n     <span>\n      Decreased skin turgor\n     </span>\n    </p>\n    <p>\n     <span>\n      Decreased urination\n     </span>\n    </p>\n    <p>\n     <span>\n      Muscle cramps\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"134\">\n    <p>\n     <span>\n      Dizziness\n     </span>\n    </p>\n    <p>\n     <span>\n      Hypotension (resting or orthostatic)\n     </span>\n    </p>\n    <p>\n     <span>\n      Increased heart rate\n     </span>\n    </p>\n    <p>\n     <span>\n      Increased respiratory rate\n     </span>\n    </p>\n    <p>\n     <span>\n      Hyperthermia\n     </span>\n    </p>\n    <p>\n     <span>\n      Hemoconcentration\n     </span>\n    </p>\n    <p>\n     <span>\n      Hyperalbuminemia\n     </span>\n    </p>\n    <p>\n     <span>\n      Increased BUN/creatinine ratio\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Dehydration", "B. Gastrointestinal hemorrhage", "C. Diabetic ketoacidosis", "D. Acute renal failure", "E. Syndrome of inappropriate ADH (vasopressin)"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A previously\nhealthy 47-year-old nurse visits the emergency department because of recurrent\nepisodes of nervousness, palpitations, and dizziness. The episodes resolve\nafter eating. She has never been hospitalized or undergone surgery. She does\nnot smoke or drink.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Physical\nexamination shows no abnormalities. While in the emergency room, she has an\nepisode, during which her blood glucose level is found to be 43 mg/dL.\nLaboratory studies during the episode show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood\nglucose\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  43\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C\npeptide\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.0\nnmol/mL (N=0.5&ndash;2.5)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Insulin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  15\n&mu;U/mL (N=5&ndash;20)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine\nsulfonylurea\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Insulin-like\ngrowth factor II\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which\nis the most likely cause of hypoglycemia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis correct\n  </span>\n </b>\n <span>\n  . Hypoglycemia normally suppresses\ninsulin production. The C-peptide level should be &lt; 0.2 nmol/L and the\ninsulin level should be &lt;6 &mu;U/mL in hypoglycemic states not induced by\ninsulin. In this vignette, the insulin level (15 &mu;U/mL) is inappropriately\nelevated. Either the patient is producing too much insulin or taking exogenous\ninsulin. If she were taking exogenous insulin, the C-peptide would be\nsuppressed (&lt; 0.2 nmol/L). Because the C-peptide is inappropriately high\n(1.0 nmol/mL) we know that the insulin is endogenously derived. The best\nexplanation for this is insulinoma (an insulin-producing tumor).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\nFactitious insulin use would lead to suppression of the C-peptide (&lt; 0.2\nnmol/L).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\nFactitious sulfonylurea use would produce detectable levels of sulfonylurea in\nthe blood and urine.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Dumping\nsyndrome causes post-prandial hypoglycemia. It occurs in patients who have\nundergone gastric surgery. This patient has no history of gastric surgery.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Most\nnon-beta-cell tumors cause hypoglycemia by elaborating insulin-like growth\nfactor II. In such situations, C-peptide and insulin levels would be\nsuppressed.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Hypoglycemia is defined as an abnormally low plasma glucose\nconcentration. Clinically significant hypoglycemia is defined by Whipple&rsquo;s\ntriad.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"316\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Whipple&rsquo;s\n  triad\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"316\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"316\">\n    <p class=\"MsoNormal\">\n     <span>\n      Signs and symptoms of hypoglycemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"316\">\n    <p class=\"MsoNormal\">\n     <span>\n      Low plasma glucose concentration\n  (&lt;45 mg /dL)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"316\">\n    <p class=\"MsoNormal\">\n     <span>\n      Resolution of symptoms with\n  normalization of glucose levels\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Hormonal regulation of plasma glucose levels relies on\ninsulin and four counter-regulatory hormones (glucagon, epinephrine, growth\nhormone, and cortisol). Insulin is the predominant hormone and glucagon is the\npredominant counter-regulatory hormone. Glucagon and epinephrine are part of\nthe rapid response to hypoglycemia, whereas growth hormone and cortisol are\npart of the delayed response (2 to 3 hours later).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gluconeogenesis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Glycogenolysis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Peripheral Glucose Utilization\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Lipolysis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Proteolysis\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Insulin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Glucagon\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Epinephrine\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Growth hormone\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cortisol\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Symptoms of hypoglycemia appear below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"319\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Symptoms\n  of Hypoglycemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"319\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"161\">\n    <p class=\"MsoNormal\">\n     <span>\n      Blurred vision\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Confusion\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Convulsions\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Decreased alertness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Dizziness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Fainting\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Fatigue\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Hallucinations\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Headache\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Hunger\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"159\">\n    <p class=\"MsoNormal\">\n     <span>\n      Insomnia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Irritability\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Memory loss\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Nervousness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Pallor\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Palpitations\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Sweating\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Tachycardia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Trembling\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Hypoglycemia is classified as &ldquo;fasting&rdquo; or &ldquo;postprandial.&rdquo;\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"401\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes\n  of Hypoglycemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"401\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"401\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fasting hypoglycemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Drugs (e.g., insulin, sulfonylureas, meglitinides,\n  alcohol, beta-blockers)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Critical illness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hormone deficiencies (growth hormone, cortisol,\n  epinephrine, glucagon)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Endogenous hyperinsulinemia (insulinoma)\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Exogenous hyperinsulinemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Non beta-cell tumors, which produce insulin-like growth\n  factor II\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Postprandial hypoglycemia (e.g.,\n  dumping syndrome)*\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The cause of hypoglycemia is often apparent from the medical\nhistory; however, sometimes laboratory tests are needed to make a diagnosis.\nKey laboratory tests include serum glucose, insulin, C-peptide, sulfonylurea,\nand insulin-like growth factor levels.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C-peptide is a marker for\n  <i>\n   endogenous\n  </i>\n  insulin production. (It is not found in\n  <i>\n   exogenously\n  </i>\n  administered insulin.)\nSulfonylureas stimulate insulin secretion by the pancreas. Insulin-like growth\nfactor II (IGF-II), a molecule that has insulin-like effects, is produced by\ncertain non-beta-cell tumors.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The following table shows the utility of laboratory tests in\ndistinguishing various causes of hypoglycemia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"6\" valign=\"top\" width=\"443\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Selected\n  Conditions Causing Fasting Hypoglycemia\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"6\" valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Condition\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Plasma\n  glucose (mg/dL)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Insulin\n  (&mu;U/mL)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     C-Peptide\n  (nmol/L)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Plasma\n  Sulfonylurea (nmol/L)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Insulin-like\n  Growth Factor II\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     5-20\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     0.5-2.5\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Insulinoma\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt; 45\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &gt; 6\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &gt;\n  0.2\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Exogenous insulin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt; 45\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &gt; 6\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt;\n  0.2\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sulfonylurea use\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt; 45\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &gt; 6\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &gt;\n  0.2\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     +\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tumor secreting IGF II\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt; 45\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt; 6\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt;\n  0.2\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     -\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     +\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  *Dumping syndrome occurs in people who have undergone\ngastric surgery (e.g., gastrectomy, gastrojejunostomy, pyloroplasty, gastric\nbypass, or vagotomy), and can be purely a mechanical complication of the\nsurgery. Rapid emptying into the upper small bowel of a meal rich in simple\ncarbohydrates results in abrupt hyperglycemia, early marked hyperinsulinemia,\nand subsequent hypoglycemia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Other\nGI surgery patients may have a more complicated mechanism underlying\npost-prandial hypoglycemia that involves beta cell hyperplasia and GLP-1\nsecretion.\n </span>\n</p>\n", "choices": ["A. Factitious insulin use", "B. Factitious sulfonylurea use", "C. Dumping syndrome", "D. Insulinoma", "E. Non-beta-cell tumor"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n30-year-old woman has been &ldquo;weak and tired&rdquo; for a month. Physical examination\nshows no abnormalities. Laboratory studies show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sodium\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  140\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n136-145 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Potassium\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.2\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.5-5.0 mEq/L)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Chloride\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  84 mEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n95-105 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Bicarbonate\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  34 mEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n22-28 mEq/L)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sodium\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  70\nmEq/24 h\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Potassium\n  <span>\n  </span>\n  150 mEq/24 h\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which\nof the following is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct\n  </span>\n </b>\n <span>\n  . The patient in the vignette has an\nelevated bicarbonate level, indicating metabolic alkalosis. She also has a high\nurinary potassium concentration, indicating renal potassium wasting. Diuretic\nuse is a common cause of metabolic alkalosis and renal potassium wasting.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . Diarrhea causes metabolic acidosis.\nUrinary potassium levels would be low.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect\n  </span>\n </b>\n <span>\n  . Aldosterone excess, not deficiency,\nleads to metabolic alkalosis and renal potassium wasting.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . Laxative abuse results in low urinary\npotassium levels.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect\n  </span>\n </b>\n <span>\n  . Renal tubular acidosis (types I and\nII) causes metabolic acidosis, not alkalosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Potassium is the most abundant intracellular cation.\nPotassium deficiency causes many problems, the most dangerous of which is\ncardiac dysrhythmia. Hypokalemia, defined as an abnormally low serum potassium\nconcentration, may be the result of poor oral intake, potassium redistribution,\nrenal potassium loss, or extrarenal potassium loss. Redistribution refers to\nthe movement of potassium from the extracellular to the intracellular\nspace.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The following conditions are associated with hypokalemia.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes\n  of Hypokalemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inadequate intake\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Extra-renal loss\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      (urine K\n      <sup>\n       +\n      </sup>\n      &lt; 20 mEq/L)\n     </span>\n    </p>\n    <p class=\"MsoListParagraph\">\n     <span>\n      (e.g., diarrhea)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Renal loss\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      (urine K\n      <sup>\n       +\n      </sup>\n      &gt; 20 mEq/L)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Drugs (e.g., diuretics, amphotericin B, cisplatin)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Diabetic ketoacidosis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hypomagnesemia\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      High aldosterone states\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       1.\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Renal artery stenosis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       2.\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cushing syndrome\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       3.\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Primary\n  hyperaldosteronism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Shift from extracellular to\n  intracellular space\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Alkalosis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Drugs (e.g., insulin, epinephrine, &beta;-agonists)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hereditary defects (e.g., hypokalemic periodic paralysis)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The cause of hypokalemia is usually apparent from the\nmedical history. When it is not apparent, the following parameters may be\nuseful diagnostically.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"143\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Important\n  Parameters in\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Evaluating\n  Hypokalemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"143\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"143\">\n    <p class=\"MsoNormal\">\n     <span>\n      Acid-base status\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"143\">\n    <p class=\"MsoNormal\">\n     <span>\n      Urinary potassium level\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"143\">\n    <p class=\"MsoNormal\">\n     <span>\n      Presence of hypertension\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The following table lists common causes of hypokalemia,\nalong with their acid-base and electrolyte patterns.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"4\" valign=\"top\" width=\"359\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Common\n  Causes of Hypokalemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"4\" valign=\"top\" width=\"359\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Condition\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Acid-base status\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Urinary\n  potassium\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      (mEq/L)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Presence\n  of hypertension\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Decreased intake\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normal\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &lt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Vomiting\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic alkalosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      variable\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Diarrhea\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic acidosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &lt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Diuretic use\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic alkalosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &gt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Laxative abuse\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Variable\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &lt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypomagnesemia\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Variable\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &gt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Diabetic Ketoacidosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic acidosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &gt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Renovascular hypertension\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic alkalosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &gt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Yes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Primary hyperaldosteronism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic alkalosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &gt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Yes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cushing&rsquo;s syndrome\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic alkalosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &gt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Yes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"105\">\n    <p class=\"MsoNormal\">\n     <span>\n      Renal tubular acidosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      (types I and II)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"82\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic acidosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"85\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &gt;20\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"87\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Diarrhea", "B. Aldosterone deficiency", "C. Surreptitious use of diuretics", "D. Laxative abuse", "E. Renal tubular acidosis"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A\n65-year-old man presents to the emergency department with vomiting and\nconfusion. Review of the medical record reveals several previous visits for\n&ldquo;gastritis.&rdquo; The patient carries a diagnosis of dementia and neuropathy. The ER\ndoctor tells you that the patient lives &ldquo;under a bridge&rdquo; and is a &ldquo;frequent\nflyer.&rdquo;\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Physical examination shows\naltered sensorium, jaundice, extensive bruising, telangiectasias on the upper\nchest, gynecomastia, ascites, splenomegaly, palmar erythema, and testicular\natrophy.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Blood test\nresults:\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12 gm/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n13.5-17.5 g/dL)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  WBC count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  9,000/mm\n  <sup>\n   3\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n4,500-11,000/mm\n  <sup>\n   3\n  </sup>\n  )\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Platelets\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  80,000/mm\n  <sup>\n   3\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  (Normal:\n150,000-400,000/mm\n  <sup>\n   3\n  </sup>\n  )\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Na\n  <sup>\n   +\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  132\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n136-145 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  K\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.8\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.5-5.0 mEq/L)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  92\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n95-105 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  24\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n22-28 mEq/L)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  16\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n7-18 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.1\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n0.6-1.2 mg/dL)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Mg\n  <sup>\n   ++\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.2\nmEq/L\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal: 1.5-2.0 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Albumin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.8\ngm/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.5-5.5 g/dL)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Bilirubin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3.0\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n0.1-1.0 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  AST\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  160\nU/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n8-20 U/L)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  ALT\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  70 U/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n8-20 U/L)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  PT\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  18\nseconds\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n11-15 seconds)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  aPTT\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  35\nseconds\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n25-40 seconds)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  What is\nthe most likely cause of hypomagnesemia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct\n  </span>\n </b>\n <span>\n  . Chronic alcohol ingestion would\nexplain the myriad abnormal findings in this patient.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Long-term alcohol abuse has many complications, including\ncirrhosis, pancreatitis, gastritis, dementia, polyneuropathy, cardiomyopathy,\nnutritional deficiencies, and sexual dysfunction. The patient in this vignette\nhas signs of cirrhosis: telangiectasias, ascites, palmar erythema,\ngynecomastia, and testicular atrophy. Blood test results are compatible with a\ndiagnosis of cirrhosis: The patient has thrombocytopenia, hyponatremia,\nhyperbilirubinemia, elevated transaminases, hypoalbuminemia, and elevated prothrombin\ntime. Chronic alcohol abuse is the most common cause of cirrhosis. Although no\nhistory of alcohol use is elicited in this confused patient, alcohol abuse\nshould be suspected.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hypomagnesemia is present. The most common causes of\nhypomagnesemia are alcoholism, malnutrition, malabsorption, chronic diarrhea,\nand medication (e.g., diuretics). Hypomagnesemia occurs in 30% of patients with\nalcoholism and 85% of patients with delirium tremens. Malnutrition and chronic\ndiarrhea contribute to the hypomagnesemia. Also, alcohol stimulates renal\nexcretion of magnesium.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Patients with hypomagnesemia are often hypokalemic. The key\nto restoring potassium levels in such patients is to replenish magnesium. As\nlong as magnesium levels remain low, the kidneys will &ldquo;leak&rdquo; potassium. Merely\ngiving potassium is not enough. Both magnesium and potassium must be\nsupplemented. Hypomagnesemia should be suspected when hypokalemia does not\ncorrect with potassium supplementation. (Note: Hypomagnesemia causes\nhypokalemia; hypokalemia does\n  <i>\n   not\n  </i>\n  cause hypomagnesemia.)\n </span>\n</p>\n", "choices": ["A. Renal insufficiency", "B. Autosomal recessive defect", "C. Chronic alcohol ingestion", "D. Hypokalemia"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A\n36-year-old woman presents with mild confusion of three days duration. Her\nmedical history is unremarkable and she takes no medication.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  On physical examination, her supine\nblood pressure and pulse are 110/70 mm Hg and 84/minute; the sitting blood\npressure and pulse are 104/62 mm Hg and 90/minute. (The patient cannot stand\nbecause of confusion and weakness.) The heart is regular, the lungs are clear,\nand the abdomen is scaphoid. There is no peripheral edema and no focal\nneurological findings.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood test results:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  130\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n136-145 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  5.5\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.5-5.0 mEq/L)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  88\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n95-105 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  20\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n22-28 mEq/L)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  26\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n7-18 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cr\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.0\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n0.6-1.2 mg/dL)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  88\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n40-70 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Uric acid\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  8.5\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.0-8.2 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct\n  </span>\n </b>\n <span>\n  . The patient in the vignette has signs\nof volume contraction: drop in blood pressure and rise in pulse when moving\nfrom supine to sitting, high BUN-creatinine ratio, and high serum uric acid\nlevel. Volume contraction occurs in Addison&rsquo;s disease, which is characterized\nby mineralcorticoid (aldosterone) deficiency. Sodium is lost in the urine,\nresulting in volume depletion and appropriate release of ADH, which causes\nhyponatremia. Potassium excretion in the distal tubule is impaired, resulting\nin hyperkalemia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\nFurosemide (Lasix) causes hypokalemia, not hyperkalemia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . This\npatient has no stigmata of chronic liver disease and is not edematous.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . SIADH\nis associated with low serum uric acid levels (due to volume expansion) and\nnormal serum potassium levels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  .\nNephrotic syndrome causes generalized edema (anasarca).\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Hyponatremia is a common disorder with numerous potential\ncauses. Patients with hyponatremia should be classified as 1) edematous, 2)\neuvolemic, or 3) volume-contracted.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Edematous\n  </span>\n </i>\n <span>\n  patients have bilateral, gravity-dependent edema. Common\ncauses of edema include congestive heart failure, hepatic cirrhosis, and\nchronic renal failure (especially nephrotic syndrome). In these conditions, the\nextracellular space is expanded, but the &ldquo;effective circulating fluid volume&rdquo;\nis reduced. The body has excess total body sodium, but due to decreased\neffective circulating volume, ADH is secreted, which causes water retention and\nhyponatremia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Euvolemic\n  </span>\n </i>\n <span>\n  patients are neither orthostatic nor edematous.\nHyponatremia in euvolemic patients may be caused by SIADH (syndrome of\ninappropriate ADH), drugs (many medications cause hyponatremia), polydipsia, or\nhypothyroidism. (Note: Technically, these patients are hypervolemic\n  <i>\n   physiologically\n  </i>\n  , but they are euvolemic\n  <i>\n   clinically\n  </i>\n  . Hyponatremic patients are\nclassified using clinical criteria; consequently, patients who are not\northostatic or edematous are considered euvolemic, even if the extracellular\nvolume is mildly increased.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <i>\n  <span>\n   Hypovolemic\n  </span>\n </i>\n <span>\n  patients\nhave a positive &ldquo;tilt&rdquo; sign; i.e., they have orthostatic hypotension.\n(Orthostatic hypotension is characterized by a drop in systolic blood pressure\nof at least 20 mm Hg and a drop in diastolic blood pressure of at least 10 mm\nHg when moving from a supine to a standing position. Typically the pulse rises\nby at least 10 beats per minute.) In hypovolemic patients, total body sodium is\nlow, resulting in a real decrease in extracellular and circulating fluid. The\nhyponatremia is caused by &ldquo;appropriate&rdquo; release of ADH as a compensatory\nresponse to volume contraction.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Distinguishing\neuvolemia from hypovolemia can be difficult. In this vignette, for example, the\nblood pressure falls as the patient moves from supine to sitting (the patient\ncannot stand), but not by 20 mm Hg. Also, the pulse rises by less than\n10/minute. Thus, the patient could be mildly volume-contracted.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Mild\nvolume-contraction can be identified by measuring the fractional excretion of\nsodium, the serum uric acid level, and the BUN-creatinine ratio.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p align=\"center\" class=\"MsoListParagraphCxSpLast\">\n     <span>\n      Manifestations\n  of Volume Contraction\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoListParagraph\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoListParagraph\">\n     <span>\n      Low fractional excretion of sodium\n  (FE\n      <sub>\n       Na\n      </sub>\n      <u>\n       &lt;\n      </u>\n      1%)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoListParagraph\">\n     <span>\n      High serum uric acid level\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoListParagraph\">\n     <span>\n      High BUN-creatinine ratio (&gt;10)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  The\n  <b>\n   fractional\nexcretion of sodium\n  </b>\n  (FE\n  <sub>\n   Na\n  </sub>\n  ) is the percentage of the sodium\nfiltered by the kidney that is excreted in the urine. The kidneys are very\nsensitive to volume contraction and respond by conserving sodium, leaving very\nlittle sodium in the urine. In a patient who is volume-contracted, the FE\n  <sub>\n   Na\n  </sub>\n  is usually\n  <u>\n   &lt;\n  </u>\n  1%. Volume contraction also raises the serum uric\nacid level. (Uric acid excretion is volume-dependent; consequently, serum uric\nacid levels are inversely proportional to extracellular volume.) Finally,\nvolume contraction raises the BUN-creatinine ratio.\n </span>\n</p>\n", "choices": ["A. Surreptitious use of furosemide", "B. Cirrhosis of the liver", "C. Addison\u2019s disease", "D. SIADH (syndrome of inappropriate ADH)", "E. Nephrotic syndrome"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 30-year-old man experiences vomiting and diarrhea for five\ndays while traveling in Mexico. He is dizzy when he stands. His serum sodium\nconcentration is 129 mEq/L. Which of the following is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis correct\n  </span>\n </b>\n <span>\n  . Hypovolemia activates the renin-angiotensin\nsystem, which leads to increased levels of aldosterone and ADH (vasopressin).\nWater is absorbed from the kidney and the urine concentration (osmolality) is\nincreased.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . Loss of fluid leads to contraction,\nnot expansion, of intravascular volume.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect\n  </span>\n </b>\n <span>\n  . In hypovolemic states, atrial\nbaroreceptors are not stimulated to release atrial natriuretic peptide.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  . Hypovolemia activates the\nrenin-angiotensin system, which raises aldosterone levels.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . Hypovolemia activates the\nrenin-angiotensin system, which raises ADH (vasopressin) levels.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Fluid loss can result in hypovolemia, or decreased blood\nvolume. Common causes include vomiting, diarrhea, sweating, hemorrhage, severe\nburns, and diuretic use. Symptoms include fatigue, muscle cramps, postural\ndizziness, and, in severe cases, syncope and coma. Findings include dry mucous\nmembranes, decreased skin turgor, postural hypotension, postural tachycardia,\nand decreased jugular venous pressure. Hypovolemia results in four major\nphysiological responses:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Baroreflex\nresponse.\n  </span>\n </b>\n <span>\n  In hypovolemic states, baroreceptors\nhave reduced responses due to reduced blood pressure. The reduced activation\nresults in enhanced sympathetic outflow which increases heart rate, increases\ncardiac contractility, and produces arterial vasoconstriction. The results are\nincreased cardiac output and increased total peripheral resistance.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Renal\nresponse.\n  </span>\n </b>\n <span>\n  Hypovolemia activates the\nrenin-angiotensin-aldosterone axis. Specialized cells in the kidney release\nrenin, which initiates the conversion of angiotensinogen to angiotensin I. Angiotensin\nI is converted to angiotensin II by angiotensin-converting enzyme. Angiotensin\nII causes arterial vasoconstriction and stimulates the release of aldosterone\nfrom the adrenal cortex as well as release of ADH (vasopressin) from the\nposterior pituitary. Aldosterone causes the kidneys to reabsorb sodium, which\nleads to water reabsorption. ADH (vasopressin) causes the kidneys to absorb\nwater. The effect is to increase urine osmolality.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Cardiac\nresponse.\n  </span>\n </b>\n <span>\n  In hypovolemic states, atrial\nbaroreceptors are\n  <i>\n   not\n  </i>\n  activated and,\ntherefore, atrial natriuretic peptide is\n  <i>\n   not\n  </i>\n  released. Atrial natriuretic peptide is a potent vasodilator and facilitates\nsalt and water excretion, responses that are opposite to what would be desired\nin hypovolemia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Central\nnervous system response\n  </span>\n </b>\n <span>\n  : Thirst is elicited\nby activation of the renin-angiotensin system and by reduction in atrial\nnatriuretic peptide levels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Increased intravascular volume", "B. Increased serum atrial natriuretic peptide", "C. Decreased serum aldosterone level", "D. Decreased serum ADH (vasopressin) level", "E. Urine osmolality greater than serum osmolality"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 35-year old man with a 5-day history of severe diarrhea\nfeels dizzy when he stands. His blood pressure while supine is 115/75 mm Hg and\nhis pulse is 88/minute. While standing, his blood pressure is 80/60 mm Hg and\nhis pulse is 120/minute. In addition to controlling his diarrhea, which of the\nfollowing is the most appropriate initial therapy for intravenous\nadministration?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  0.9% Saline is &ldquo;normal,&rdquo; or isotonic, saline. It is the most\ncommonly used intravenous fluid for treatment of hypovolemia. Its distribution\nis limited to the extracellular fluid (ECF) space.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Administering 5% Dextrose is the equivalent of administering\npure water. The dextrose (glucose) is rapidly consumed, and the water is\ndistributed throughout the total body water compartment, of which 2/3 is\nintracellular and 1/3 is extracellular. Because most of the fluid goes into the\nintracellular space, it is not a good therapy for hypovolemia. (The goal of\ntreating hypovolemia is to restore extracellular volume.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  5% Dextrose is known as a &ldquo;maintenance&rdquo;\nfluid; 0.9% Saline is known as a &ldquo;replacement&rdquo; fluid.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect.\n  </span>\n </b>\n <span>\n  F\n  <span>\n   resh frozen plasma\n  </span>\n  (FFP) refers to the liquid portion of human\nblood that has been frozen and preserved, and will be used for blood\ntransfusion. FFP is used to treat deficiencies of coagulation proteins for\nwhich specific factor concentrates are unavailable or undesirable.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect.\n  </span>\n </b>\n <span>\n  Desmopressin is a synthetic replacement\nfor the hormone, vasopressin. It is used to treat diabetes insipidus.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The patient in this vignette has orthostatic hypotension, a\nsign of hypovolemia. In severe hypovolemia, the primary goal is to replenish\nintravascular volume. This can be done by administering intravenous fluids.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Two types of fluids are commonly used for intravenous\ntherapy: crystalloid and colloid. Crystalloids are aqueous solutions of mineral\nsalts. An example of a crystalloid solution would be saline solution, which\ncontains sodium chloride. Colloids contain larger insoluble molecules. An\nexample of a colloid solution would be whole blood.\n </span>\n</p>\n\n<p>\n Crystalloids are categorized\nby their tonicity (i.e., osmolality). A fluid that is\n <i>\n  isotonic\n </i>\n has the same number of particles (i.e., the same\nosmolality) as plasma. Isotonic fluids remain confined to the extracellular\nspace. They do not promote fluid shift into or out of cells.\n</p>\n\n<p>\n 0.9% Saline, also known as\n&ldquo;normal&rdquo; or &ldquo;physiologic&rdquo; saline, is the most commonly used isotonic fluid. It\nis the mainstay of resuscitation therapy. Most patients who are hypovolemic\nbecause of vomiting, diarrhea, excessive perspiration, or decreased oral intake\ncan be safely treated with intravenous normal saline. Patients who are\nhypovolemic because of severe blood loss may require blood transfusion.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "choices": ["A. 5% Dextrose in water", "B. Fresh frozen plasma", "C. Desmopressin", "D. 0.9% Saline"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 45-year-old man is brought to the emergency room because\nof blurred vision, headache, abdominal pain, and vomiting. His blood pressure\nis 125/80, pulse is 55, and respirations are 26/min. Lab studies show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Arterial blood gas analysis (on room air):\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pH\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  7.30\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n7.35-7.45)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  104\nmmHg\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n75-105 mm Hg)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pCO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;\n  </span>\n  24\nmmHg\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n33-45 mm Hg)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum chemistries:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  140\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n136-145 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4.5\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.5-5.0 mEq/L)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  85\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n95-105 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  15\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n22-28 mEq/L)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of the following would best explain these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct\n  </span>\n </b>\n <span>\n  . Methanol intoxication causes an\nincreased anion gap acidosis.*\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . Acetaminophen intoxication causes\nliver damage by depleting hepatic glutathione, which leads to accumulation of a\nhepatotoxic metabolite. Treatment with acetylcysteine, a substrate for\nglutathione, can prevent liver damage.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect\n  </span>\n </b>\n <span>\n  . Narcotic intoxication causes\nrespiratory depression, which results in respiratory acidosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . Excessive diuretic use is associated\nwith metabolic alkalosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect\n  </span>\n </b>\n <span>\n  . Pneumonia may be associated with\nrespiratory alkalosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  *Note: Methanol and ethylene glycol intoxication produce\nsimilar symptoms. Methanol is found in gas-line antifreeze, carburetor fluid,\nduplicator fluid, and windshield washer fluid. Ethylene glycol is found in\nanti-freeze and windshield de-icer. Both methanol and ethylene glycol are\nmetabolized by alcohol dehydrogenase. Methanol is metabolized to formic acid;\nethylene glycol is metabolized to glycolate. Both methanol and ethylene glycol\nintoxication are treated with intravenous ethanol (which inhibits alcohol\ndehydrogenase), intravenous sodium bicarbonate (to reverse life-threatening\nacidosis), and hemodialysis (to remove the alcohols and their metabolites). A\nmajor difference between methanol and ethylene glycol intoxication is that\nmethanol causes visual disturbance (blurred vision, decreased visual acuity,\nwhiteness of the visual field), whereas ethylene glycol causes renal failure\n(due to calcium oxalate crystal deposition) and cardiopulmonary failure.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The normal pH of arterial blood is 7.40\n  <u>\n   +\n  </u>\n  0.03. This\npatient has a low pH (7.30), indicating acidosis. Acidosis may be classified as\nrespiratory or metabolic. Respiratory acidosis is characterized by a primary\nincrease in pCO\n  <sub>\n   2\n  </sub>\n  with a compensatory increase in HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  . Metabolic acidosis is characterized by a primary decrease in HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  and a compensatory decrease in pCO\n  <sub>\n   2\n  </sub>\n  . This patient has a low serum\nHCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  of 15 mEq/L (normal is 22-28 mEq/L) and a low\narterial pCO\n  <sub>\n   2\n  </sub>\n  of 24 mmHg (normal is 35-45), indicating metabolic\nacidosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  There are two types of metabolic acidosis: &ldquo;normal anion\ngap&rdquo; and &ldquo;increased anion gap.&rdquo; The anion gap is calculated as follows: Na\n  <sup>\n  </sup>\n  &ndash; (Cl\n  <sup>\n  </sup>\n  +\n  <sup>\n  </sup>\n  HCO\n  <sub>\n   3\n  </sub>\n  ). A normal anion gap\nis 12\n  <u>\n   +\n  </u>\n  2 mmol/L. In this patient, the anion gap is 40. Thus, the\npatient has an increased anion gap metabolic acidosis. The principal causes of\nincreased anion gap metabolic acidosis are:\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"392\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Increased\n  Anion Gap Metabolic Acidosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"392\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       1.\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Ketoacidosis\n  (caused by diabetes, alcohol, or starvation)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       2.\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Lactic acidosis\n  (due to tissue hypoxia)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       3.\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Chronic renal\n  failure (accumulation of sulfates, phosphates, and uric acid)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       4.\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Intoxication\n  (salicylates, ethanol, methanol, formaldehyde, ethylene glycol, paraldehyde,\n  isoniazid, metformin)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  General symptoms of acidosis include headache, fatigue,\nsleepiness, abdominal pain, nausea, and vomiting. Treatment depends on the\nunderlying cause.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Acetaminophen intoxication", "B. Narcotic intoxication", "C. Methanol intoxication", "D. Excessive diuretic use", "E. Pneumonia"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 24-year-old woman is worried about recent weight gain. She\nhas gained 3 lbs in the last 3 months. Her height is 5&rsquo;6&rdquo;. Her weight is 125\nlbs. Her lab tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Arterial blood gas analysis (on room air):\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pH\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  7.34\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n7.35-7.45)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  102\nmmHg\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n75-105 mm Hg)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pCO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  31\nmmHg\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n33-45 mm Hg)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum chemistries:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  140\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n136-145 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.8\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n3.5-5.0 mEq/L)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  113\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n95-105 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  15\nmEq/L\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n22-28 mEq/L)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n7-18 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cr\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.1\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal:\n0.6-1.2 mg/dL)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  UA: pH 6.5; no blood, protein, or casts\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine Na\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  65\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine K\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  8\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine Cl\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  94\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"content1\">\n <b>\n  <span>\n   Answer B is\ncorrect\n  </span>\n </b>\n <span>\n  . This patient has a normal\nanion gap metabolic acidosis. The two most common causes of this are diarrhea\nand renal tubular acidosis, which can be distinguished by calculating the urine\nanion gap. Here, the urine anion gap is 65+8 - 94 = -21 mEq/L. A negative urine\nanion gap is consistent with diarrhea, which could be due to laxative abuse.\n(Laxative abuse occurs in some patients who obsess over weight gain.)\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . Diuretic abuse causes a metabolic\nalkalosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  . Vomiting causes a metabolic\nalkalosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . Renal tubular acidosis causes a\nnormal anion gap metabolic acidosis with a positive urine anion gap. In this\npatient, the urine anion gap is negative.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect\n  </span>\n </b>\n <span>\n  . Ketoacidosis causes an increased\nanion gap metabolic acidosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <i>\n  <span>\n   Note\n  </span>\n </i>\n <span>\n  : All of the choices above &ndash; diuretic abuse, laxative\nabuse, surreptitious vomiting, renal tubular acidosis, and alcoholic\nketoacidosis &ndash; can cause hypokalemia.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  This patient has a low pH of 7.34, indicating acidosis. The\nHCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  is low (15 mEq/L), indicating a metabolic acidosis.\nThe anion gap is normal at 12. Therefore, this patient has a normal anion gap\nmetabolic acidosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The two most common causes of normal anion gap acidosis are:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1)\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Diarrhea\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2)\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Renal tubular acidosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  To distinguish these two, the urine anion gap is calculated.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine anion gap = Urine (Na + K &ndash; Cl).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In normal subjects, the urine anion gap is approximately\nzero\n  <strong>\n   .\n  </strong>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In metabolic acidosis, the kidneys get rid of acid by\nexcreting NH\n  <sub>\n   4\n  </sub>\n  <sup>\n   +\n  </sup>\n  in the urine (if the kidneys are working\nproperly.) When NH\n  <sub>\n   4\n  </sub>\n  <sup>\n   +\n  </sup>\n  is excreted in the urine, Cl\n  <sup>\n   -\n  </sup>\n  is excreted along with it. The rise in urinary Cl\n  <sup>\n   -\n  </sup>\n  causes the urine\nanion gap to become negative, usually ranging from -20 to more than -50 meq/L.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  An example of this situation would be diarrhea, which causes\nmetabolic acidosis. To get rid of the acid, the kidneys excrete NH\n  <sub>\n   4\n  </sub>\n  <sup>\n   +\n  </sup>\n  .\nIn the process of excreting NH\n  <sub>\n   4\n  </sub>\n  <sup>\n   +\n  </sup>\n  , Cl\n  <sup>\n   -\n  </sup>\n  is also\nexcreted. This increases the amount of Cl\n  <sup>\n   -\n  </sup>\n  in the urine, causing the\nurine anion gap to become negative.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"content1\">\n <span>\n  By contrast, if the kidneys cannot excrete NH\n  <sub>\n   4\n  </sub>\n  <sup>\n   +\n  </sup>\n  adequately (e.g., renal tubular acidosis) the urine Cl\n  <sup>\n   -\n  </sup>\n  level does\nnot rise. The result is a positive urine anion gap.\n </span>\n</p>\n\n<p class=\"content1\">\n <span>\n  In summary,\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A positive urine anion gap suggests\nrenal tubular acidosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A negative urine anion gap suggests\ndiarrhea.\n </span>\n</p>\n", "choices": ["A. Diuretic abuse", "B. Laxative abuse", "C. Surreptitious vomiting", "D. Renal tubular acidosis", "E. Alcoholic ketoacidosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 34-year-old man presents with a 3-day history of vomiting.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He feels lightheaded when he stands or\nwalks. Which of the following arterial blood gas values would be expected?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  pH\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  pCO\n  <sub>\n   2\n  </sub>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  (mmHg)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  (mEq/dL)\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Prolonged vomiting is associated with metabolic alkalosis.\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . These values (low pH, low HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  )\nindicate metabolic acidosis with a compensatory decrease in pCO\n  <sub>\n   2\n  </sub>\n  .\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect\n  </span>\n </b>\n <span>\n  . These values (low pH, high pCO\n  <sub>\n   2\n  </sub>\n  )\nindicate respiratory acidosis with a compensatory increase in HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  .\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  . These values are within the normal\nrange.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . These values (high pH, low pCO\n  <sub>\n   2\n  </sub>\n  )\nindicate respiratory alkalosis with a compensatory decrease in HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  .\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Prolonged vomiting causes volume depletion, which reduces\nGFR, thereby stimulating the renin-angiotensin-aldosterone axis. This leads to\nbicarbonate reabsorption in the kidney, which causes metabolic alkalosis.\nMetabolic alkalosis is characterized by an elevated pH and an elevated serum\nbicarbonate (HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  )\n  <b>\n  </b>\n  level. Respiratory compensation (through hypoventilation) increases the\narterial pCO\n  <sub>\n   2\n  </sub>\n  , which blunts the rise in the arterial pH.\n </span>\n</p>\n", "choices": ["A. 7.30 28 15", "B. 7.30 55 27", "C. 7.40 40 24", "D. 7.50 30 22", "E. 7.50 47 35"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 20-year-old man has been weak and dizzy for the past two\ndays. He just returned from Mexico where he developed abdominal cramping and\ndiarrhea that have not yet subsided. The diarrhea is watery, voluminous, and\nnon-bloody. He has mild nausea but no vomiting. On examination, his supine\nblood pressure is 115/65 mm Hg and his pulse is 110/minute. While standing, his\nblood pressure is 80/50 mm Hg and his pulse is 160/minute. He is afebrile and\nhis abdomen is non-tender. The stool is heme-negative. What is the most\nimportant initial treatment?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis correct\n  </span>\n </b>\n <span>\n  . Rehydration is the most important\ninitial treatment in a patient who is severely volume depleted.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Gastrointestinal fluid loss from vomiting or diarrhea can\nlead to severe volume depletion. In such individuals, rehydration is a top\npriority. The presence of orthostatic hypotension in a patient with voluminous\ndiarrhea suggests significant volume depletion. (Orthostatic hypotension is\ndefined as a drop in systolic blood pressure of at least 20 mm Hg or a drop in\ndiastolic blood pressure of at least 10 mm Hg after rising from the supine to\nthe standing position.) The presence of resting tachycardia, as well as\ntachycardia that increases with standing, also suggests volume depletion.\nWorsening hypovolemia can lead to shock and cardiovascular collapse. These\ncomplications can be prevented with prompt rehydration.\n </span>\n</p>\n", "choices": ["A. Ciprofloxacin", "B. Erythromycin", "C. Metronidazole", "D. Rehydration", "E. Potassium chloride"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 59-year-old man with diabetes, hypertension, and chronic\nrenal insufficiency is seen for a routine clinic visit.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He is feeling well.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  His only medicines are metformin and\namlodipine.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lab test results show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  138\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  5.5\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  110\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  19\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  188\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  25\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cr\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.0\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of the following best explains these values?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis correct\n  </span>\n </b>\n <span>\n  . The combination of hyperkalemia and a\nnormal anion gap acidosis suggests type IV RTA, or hyporeninemic\nhypoaldosteronism.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . Diabetic ketoacidosis (DKA) causes a\nhigh-anion gap metabolic acidosis. Hyperglycemia is usually severe. Patients\nfeel ill and must be admitted to the hospital.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  . Lactic acidosis causes a high-anion\ngap metabolic acidosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . End-stage renal disease causes a\nhigh-anion gap metabolic acidosis (usually with a higher serum creatinine level\nthan is seen in this patient).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect\n  </span>\n </b>\n <span>\n  . Diarrhea can cause a normal-anion gap\nmetabolic acidosis, usually associated with hypokalemia, not hyperkalemia.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The low bicarbonate concentration indicates metabolic\nacidosis. The anion gap is normal: 138 - (110+19) = 9. Common causes of a\nnormal-anion gap metabolic acidosis include diarrhea and renal tubular acidosis\n(RTA). Patients with diarrhea usually have low or normal serum potassium\nlevels. Patients with RTA have variable serum potassium levels, depending on\nthe type of RTA. The most common type of RTA is type IV RTA, which usually\noccurs in people with diabetes. Diabetes affects the kidneys in such a way that\nrenin production is impaired. This leads to &ldquo;blunting&rdquo; of the\nrenin-angiotensin-aldosterone axis (renin, angiotensin, and aldosterone levels\nare reduced). Reduction in aldosterone results in hyperkalemia and a\nnormal-anion gap metabolic acidosis. The combination of hyperkalemia and a\nnormal anion gap acidosis suggests type IV RTA, or hyporeninemic\nhypoaldosteronism.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Diabetic ketoacidosis", "B. Hyporeninemic hypoaldosteronism", "C. Lactic acidosis", "D. Metabolic acidosis secondary to end-stage renal disease", "E. Metabolic acidosis secondary to persistent diarrhea"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 54-year-old man presents with a 3-month history of\nexertional shortness of breath. He sleeps on three pillows to breathe\ncomfortably, and often wakes up at night coughing, wheezing, and gasping for\nair. Physical examination shows jugular venous distension, an S3 at the cardiac\napex, late inspiratory crackles in the lung bases, and pitting edema of the\nlegs. The level of which of the following substances found in the pulmonary\ncapillaries would be increased in this patient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis correct.\n  </span>\n </b>\n <span>\n  Angiotensin-converting enzyme is\nproduced mainly by the pulmonary vascular endothelium.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect.\n  </span>\n </b>\n <span>\n  Renin is produced by juxtaglomerular\ncells in the kidney.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect.\n  </span>\n </b>\n <span>\n  Angiotensin I is converted to\nangiotensin II through removal of two C-terminal residues by the enzyme\n  <span>\n   angiotensin-converting enzyme.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect.\n  </span>\n </b>\n <span>\n  Aldosterone is produced by the zona\nglomerulosa cells of the adrenal gland.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect.\n  </span>\n </b>\n <span>\n  Vasopressin is produced by the\nhypothalamus and stored in the posterior pituitary.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The patient has symptoms and signs of congestive heart\nfailure. Left-sided heart failure causes orthopnea (sleeping on three pillows\nto breathe comfortably), paroxysmal nocturnal dyspnea (waking up at night\ncoughing, wheezing, and gasping for air), and pulmonary edema (crackles in the\nlung bases).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Right-sided heart\nfailure causes jugular venous distension and pitting edema of the legs.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Decreased cardiac output results in\ndecreased &ldquo;effective circulating volume,&rdquo; which activates the\nrenin-angiotensin-aldosterone system and the sympathetic nervous system.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  These are the steps in the renin-angiotensin-aldosterone\nsystem:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Decreased perfusion of the\njuxtaglomerular apparatus in the kidney's macula densa stimulates the\njuxtaglomerular cells to release the enzyme renin.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Renin cleaves an inactive peptide,\n  <span>\n   angiotensinogen\n  </span>\n  , converting it into\n  <span>\n   angiotensin I\n  </span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Angiotensin I is converted to\n  <span>\n   angiotensin II\n  </span>\n  by\nangiotensin-converting enzyme (ACE), which is found mainly in lung capillaries.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Angiotensin II is the major bioactive\nproduct of the renin-angiotensin system. It is a potent vasoconstrictor of\narterioles throughout the body. In the kidney, it constricts afferent and\nefferent arterioles within the glomerulus, and stimulates sodium reabsorption\nin the tubules. In the adrenal cortex, it stimulates release of aldosterone\nfrom the zona glomerulosa.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   5.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Aldosterone\n </span>\n <span>\n  stimulates reabsorption of sodium and water and secretion\nof potassium in the distal convoluted tubules of the kidneys. This increases\nblood volume and blood pressure.\n </span>\n</p>\n", "choices": ["A. Renin", "B. Angiotensin-converting enzyme", "C. Angiotensin II", "D. Aldosterone", "E. Vasopressin"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An 82-year-old woman with a history of diabetes mellitus and\nosteoarthritis is brought to the emergency department because of confusion. Her\nblood pressure is 108/52 mm Hg, pulse is 92/minute, and respirations are\n24/minute.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lab studies show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Arterial blood gas analysis (on room air):\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pH\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  7.25\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  97\nmmHg\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pCO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  22\nmmHg\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum chemistries:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  136\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3.9\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  102\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  200\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  18\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cr\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.4\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Ketones\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of the following would best explain these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis correct\n  </span>\n </b>\n <span>\n  . Salicylate intoxication is associated\nwith a high-anion gap metabolic acidosis.\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect\n  </span>\n </b>\n <span>\n  . Diabetic ketoacidosis causes a\nhigh-anion gap metabolic acidosis, but the presence of serum ketones is\nrequired to make the diagnosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect\n  </span>\n </b>\n <span>\n  . Prolonged vomiting causes metabolic\nalkalosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  . Renal tubular acidosis causes a\nnormal-anion gap metabolic acidosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  . Diarrhea causes a normal-anion gap\nmetabolic acidosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The patient has a low pH, indicating acidosis. The serum HCO\n  <sub>\n   3\n  </sub>\n  is also low, indicating metabolic acidosis. The anion gap is elevated at 22.\nThus, the patient has a high-anion gap metabolic acidosis. Salicylate\nintoxication is associated with a high-anion gap metabolic acidosis. (The\nhistory of osteoarthritis in this patient is a clue that she may be taking\naspirin.)\n </span>\n</p>\n", "choices": ["A. Diabetic ketoacidosis", "B. Prolonged vomiting", "C. Renal tubular acidosis", "D. Diarrhea", "E. Salicylate intoxication"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 65-year-old man with a history of congestive heart failure\ndue to coronary artery disease presents with a 4-day history of fever, myalgia,\nproductive cough, and worsening shortness of breath. On exam he is noted to be\nagitated and confused. Temperature is 39.2\n </span>\n <span>\n  <span>\n   &deg;\n  </span>\n </span>\n <span>\n  C,\npulse is 130/minute, blood pressure is 80/40 mmHg, and respirations are\n32/minute. He is flushed and diaphoretic with warm skin. His neck veins are\nflat. Cardiac exam reveals a rapid rate and a short systolic ejection murmur.\nChest exam reveals increased fremitus, dullness to percussion, and crackles in\nthe right mid-lung field. The left chest is unremarkable. Laboratory tests show\na white blood cell count of 16,000/mm\n  <sup>\n   3\n  </sup>\n  . The electrocardiogram is\nunchanged from a previous reading, except for the presence of sinus\ntachycardia. Transthoracic echocardiogram reveals normal chamber size, good biventricular\ncontractility, and a left ventricular ejection fraction of 60%. What is the\nmost likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  The\npresence of fever, productive cough, consolidative findings on lung exam, and\nelevated white blood cell count suggest that the patient has pneumonia and\nhypotension is due to septic shock. Septic shock develops as a consequence of\nvasodilation, particularly of the capacitance vessels, by nitric oxide and\nother mediators produced as part of the generalized systemic inflammatory\nresponse syndrome. The vasodilation causes a relative intravascular volume\ndeficit and large volumes of fluid must be administered to restore the\nintravascular volume. Cardiac output is maintained during the initial stages of\nthe disease, although vasopressors such as norepinephrine are sometimes needed\nto restore the systemic blood pressure and prevent subsequent organ failure.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nCardiogenic shock is unlikely because the patient has no acute EKG changes,\nleft ventricular contractility is well preserved, and lung exam does not show\nevidence of pulmonary edema.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect\n  </span>\n </b>\n <span>\n  .\nThis patient has no history of hematemesis, melena, or trauma.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  .\nHypotension due to massive pulmonary embolism is caused by obstruction of the\npulmonary vasculature and inadequate filling of the left ventricle.\nCharacteristic findings on echocardiogram include an enlarged right ventricle\nwith decreased contractility.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect\n  </span>\n </b>\n <span>\n  .\nCardiac tamponade is associated with jugular venous distension, hypotension,\ntachycardia, and pulsus paradoxus. This patient does not have jugular venous\ndistension, and pericardial fluid was not seen on the echocardiogram.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Shock is\nthe final common pathway for several potentially lethal clinical events,\nincluding severe hemorrhage, extensive trauma or burns, large myocardial\ninfarction, massive pulmonary embolism, and microbial sepsis.\n  <span>\n   Shock is characterized by systemic hypotension\ndue either to reduced cardiac output or to reduced effective circulating blood\nvolume\n  </span>\n  . The consequences are\n  <span>\n   impaired\ntissue perfusion and cellular hypoxia\n  </span>\n  . At the outset the cellular injury\nis reversible; however, prolonged shock eventually leads to irreversible tissue\ninjury that often proves fatal.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The causes\nof shock fall into three general categories:\n  <a name=\"4-u1.0-B978-1-4377-0792-2..50009-2--celi\">\n  </a>\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Cardiogenic\n  shock\n     </span>\n    </i>\n    <span>\n     results from low cardiac output due to myocardial pump failure. This can be\n  due to intrinsic myocardial damage (infarction), ventricular arrhythmias,\n  extrinsic compression (e.g., cardiac tamponade\n     <a name=\"4-u1.0-B978-1-4377-0792-2..50009-2--intr\">\n     </a>\n     ), or outflow obstruction\n  (e.g., pulmonary embolism).\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Hypovolemic\n  shock\n     </span>\n    </i>\n    <span>\n     results from low cardiac output due to the loss of blood or plasma volume,\n  such as can occur with massive hemorrhage or fluid loss from severe burns.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Septic\n  shock\n     </span>\n    </i>\n    <span>\n     results from vasodilation and peripheral pooling of blood as part of a\n  systemic immune reaction to bacterial or fungal infection. Its complex\n  pathogenesis is discussed in further detail below.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <thead>\n   <tr>\n    <td valign=\"bottom\">\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n        Type of Shock\n       </span>\n      </b>\n     </p>\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n       </span>\n      </b>\n     </p>\n    </td>\n    <td valign=\"bottom\">\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n        Clinical Example\n       </span>\n      </b>\n     </p>\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n       </span>\n      </b>\n     </p>\n    </td>\n    <td valign=\"bottom\" width=\"148\">\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n        Principal Mechanisms\n       </span>\n      </b>\n     </p>\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n       </span>\n      </b>\n     </p>\n    </td>\n   </tr>\n  </thead>\n  <tr>\n   <td colspan=\"3\" valign=\"top\" width=\"444\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      &nbsp;\n      <b>\n       CARDIOGENIC\n      </b>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"206\">\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Myocardial\n  infarction\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Ventricular\n  rupture\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Arrhythmia\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Cardiac\n  tamponade\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Pulmonary\n  embolism\n      </span>\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p class=\"MsoNormal\">\n     <span>\n      Failure\n  of myocardial pump resulting from intrinsic myocardial damage, extrinsic\n  pressure, or obstruction to outflow\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       HYPOVOLEMIC\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"206\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fluid\n  loss (e.g., hemorrhage, vomiting, diarrhea, burns, or trauma)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inadequate\n  blood or plasma volume\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      &nbsp;\n      <b>\n       SEPTIC\n      </b>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"206\">\n    <p class=\"MsoNormal\">\n     <span>\n      Overwhelming\n  microbial infections (bacterial and fungal)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Superantigens\n  (e.g., toxic shock syndrome)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p class=\"MsoNormal\">\n     <span>\n      Peripheral\n  vasodilation and pooling of blood; endothelial activation/injury;\n  leukocyte-induced damage, disseminated intravascular coagulation; activation\n  of cytokine cascades\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal signs of shock are low blood pressure, decreased urine output, and\nconfusion, but these are not always present. Common findings in shock are\nlisted below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"243\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Signs and Symptoms\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"236\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Physiology\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"236\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cardiogenic\n  shock\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Distended jugular veins\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Weak or absent pulse\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Arrhythmia (sometimes)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pulsus paradoxus (in the case of tamponade)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"236\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cardiogenic\n  shock\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Central\n  venous pressure: &uarr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cardiac\n  output: &darr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Systemic\n  vascular resistance: &uarr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Venous\n  oxygen saturation: &darr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypovolemic\n  shock\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Tachycardia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Rapid, weak, thready pulse\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cool, clammy skin\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Rapid and shallow respirations\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hypothermia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Thirst and dry mouth\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cold and mottled skin\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"236\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypovolemic\n  shock\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Central\n  venous pressure: &darr;\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cardiac\n  output: &darr;\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Systemic\n  vascular resistance: &uarr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Venous\n  oxygen saturation: &darr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n      Septic\n  shock\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Fever\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Warm and sweaty skin\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"236\">\n    <p class=\"MsoNormal\">\n     <span>\n      Septic\n  shock\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Early\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Central\n  venous pressure: variable\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cardiac\n  output: &uarr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Systemic\n  vascular resistance: &darr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Venous O\n      <sub>\n       2\n      </sub>\n      saturation: &uarr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Late\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Central\n  venous pressure: variable\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cardiac\n  output: &darr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Systemic\n  vascular resistance: &uarr;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Venous O\n      <sub>\n       2\n      </sub>\n      saturation: variable\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Cardiogenic shock", "B. Hemorrhagic shock", "C. Septic shock", "D. Shock due to massive pulmonary embolism", "E. Cardiac tamponade"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 66-year-old\nman with a 30 pack-year smoking history presents with a cough and weight loss\nof three months duration. The cough is productive of bloody sputum. The patient\nhas lost 15 pounds.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Temperature is\n37.4\n  <sup>\n   o\n  </sup>\n  C, blood pressure is 140/70 mm Hg without orthostatic change,\npulse is 80/minute, and respiratory rate is 24/minute.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Lung examination reveals dullness to\npercussion in the right lower posterior lung field. The legs are not edematous.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood test\nresults:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  120\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  4.0 mEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  88 mEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  24 mEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  10\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely cause of hyponatremia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . SIADH is an important\ncause of hyponatremia. Typically, patients with SIADH are clinically\neuvolemic.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A major cause of SIADH\nis small-cell carcinoma of the lung. The findings of weight loss, hemoptysis,\npleural effusion, and tachypnea in this patient are worrisome for lung cancer.\nThe final diagnosis was small cell carcinoma of the lung, which caused SIADH\nand all the presenting symptoms and signs.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  The patient in this vignette is hyponatremic and\nclinically euvolemic. (He is considered &ldquo;euvolemic&rdquo; because he is neither\northostatic nor edematous.) Causes of euvolemic hyponatremia include:\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  SIADH\n(syndrome of inappropriate ADH)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Drugs\n(many medications cause hyponatremia)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Polydipsia\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hypothyroidism\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  SIADH is characterized by &ldquo;inappropriate&rdquo;\nrelease of ADH, i.e., release independent of serum osmolality. Common causes of\nSIADH include small-cell carcinoma of the lung, pneumonia, brain tumor, head\ntrauma, stroke, meningitis, and encephalitis. (SIADH is usually due to\npulmonary or intracranial pathology.) The presence of significant hyponatremia\nin a clinically euvolemic patient should raise concern for SIADH.\n </span>\n</p>\n", "choices": ["A. Congestive heart failure", "B. Diuretic use", "C. SIADH", "D. Starvation"]}]}, {"section": "Molecular & Cellular Systems", "questions": [{"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is\n  <i>\n   not\n  </i>\n  true of\napoptosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Apoptosis does\n  <i>\n   not\n  </i>\n  elicit a major inflammatory\nresponse.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <i>\n  <span>\n   A\n   <span>\n    poptosis\n   </span>\n  </span>\n </i>\n <span>\n  is a pathway of cell\ndeath that is induced by a tightly regulated &ldquo;suicide&rdquo; program in which cells\ndestined to die activate enzymes that degrade the cells&rsquo; own nuclear DNA and\nnuclear and cytoplasmic proteins. Apoptotic cells break up into fragments, called\napoptotic bodies, which contain portions of the cytoplasm and nucleus. The\nplasma membrane of the apoptotic bodies remains intact, but its structure is\naltered in such a way that it becomes a &ldquo;tasty&rdquo; target for phagocytes. The dead\ncell and its fragments are rapidly devoured, before the contents have leaked\nout, and therefore cell death by this pathway does not elicit an inflammatory\nreaction in the host.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Apoptosis\nis a unique mechanism of cell death, distinct from necrosis. Necrosis is\ncharacterized by loss of membrane integrity, enzymatic digestion of cells,\nleakage of cellular contents, and frequently a host reaction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CAUSES OF\nAPOPTOSIS\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Apoptosis\noccurs normally both during development and throughout adulthood, and serves to\neliminate unwanted, aged, or potentially harmful cells. It is also a pathologic\nevent when diseased cells become damaged beyond repair and are eliminated.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Apoptosis\nin Physiologic Situations\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Death\nby apoptosis is a normal phenomenon that serves to eliminate cells that are no\nlonger needed, and to maintain a steady number of various cell populations in\ntissues\n  </span>\n </i>\n <span>\n  .\nIt is important in the following physiologic situations:\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      The\n  programmed destruction of cells during embryogenesis\n     </span>\n    </i>\n    <span>\n     , including\n  implantation, organogenesis, developmental involution, and metamorphosis.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Involution\n  of hormone-dependent tissues upon hormone withdrawal\n     </span>\n    </i>\n    <span>\n     , such as endometrial\n  cell breakdown during the menstrual cycle, ovarian follicular atresia in menopause,\n  the regression of the lactating breast after weaning, and prostatic atrophy\n  after castration.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Cell\n  loss in proliferating cell populations\n     </span>\n    </i>\n    <span>\n     , such as immature lymphocytes in the bone\n  marrow and thymus that fail to express useful antigen receptors\n     <a name=\"4-u1.0-B978-1-4377-0792-2..50006-7--intr\">\n      , B lymphocytes in germinal\n  centers, and epithelial cells in intestinal crypts.\n     </a>\n    </span>\n   </p>\n   <span>\n   </span>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n     </span>\n    </span>\n   </p>\n  </td>\n  <span>\n  </span>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     <i>\n      <span>\n       Elimination of\n  potentially harmful self-reactive lymphocytes\n      </span>\n     </i>\n    </span>\n    <span>\n     <span>\n      , either before or\n  after they have completed their maturation, so as to prevent reactions against\n  one&rsquo;s own tissues.\n     </span>\n    </span>\n   </p>\n   <span>\n   </span>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n     </span>\n    </span>\n   </p>\n  </td>\n  <span>\n  </span>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Death of\n  host cells that have served their useful purpose, such as neutrophils in an\n     <i>\n      acute\n  inflammatory response\n     </i>\n     , and lymphocytes at the end of an\n     <i>\n      immune\n  response\n     </i>\n     . In these situations cells undergo apoptosis because they are\n  deprived of necessary survival signals, such as growth factors.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Apoptosis\nin Pathologic Conditions\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Apoptosis\neliminates cells that are injured beyond repair without eliciting a host\nreaction, thus limiting collateral tissue damage\n  </span>\n </i>\n <span>\n  . Death by apoptosis is\nresponsible for loss of cells in a variety of pathologic states:\n  <a name=\"4-u1.0-B978-1-4377-0792-2..50006-7--celi\">\n  </a>\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      DNA\n  damage\n     </span>\n    </i>\n    <span>\n     .\n  Radiation, cytotoxic anticancer drugs, and hypoxia can damage DNA, either\n  directly or via production of free radicals. If repair mechanisms cannot cope\n  with the injury, the cell triggers intrinsic mechanisms that induce\n  apoptosis. In these situations elimination of the cell may be a better\n  alternative than risking mutations in the damaged DNA, which may result in\n  malignant transformation. These injurious stimuli can cause apoptosis if the\n  insult is mild, but larger doses of the same stimuli may result in necrotic\n  cell death.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Accumulation\n  of misfolded proteins\n     </span>\n    </i>\n    <span>\n     . Improperly folded proteins may arise because of\n  mutations in the genes encoding these proteins or because of extrinsic\n  factors, such as damage caused by free radicals. Excessive accumulation of\n  these proteins in the endoplasmic reticulum results in apoptotic cell death.\n  Apoptosis caused by the accumulation of misfolded proteins may be responsible\n  for certain degenerative diseases of the central nervous system and other\n  organ systems.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Cell\n  death in certain infections\n     </span>\n    </i>\n    <span>\n     , particularly viral infections, in which loss\n  of infected cells is largely due to apoptosis that may be induced by the\n  virus (as in adenovirus and HIV infections) or by the host immune response\n  (as in viral hepatitis). An important host response to viruses consists of\n  cytotoxic T lymphocytes\n     <a name=\"4-u1.0-B978-1-4377-0792-2..50006-7--p26\">\n     </a>\n     specific\n  for viral proteins, which induce apoptosis of infected cells in an attempt to\n  eliminate reservoirs of infection. During this process there can be\n  significant tissue damage. The same T-cell-mediated mechanism is responsible\n  for cell death in\n     <i>\n      tumors\n     </i>\n     and cellular rejection of\n     <i>\n      transplants\n     </i>\n     .\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"7\">\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"4%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      &bull;\n     </span>\n    </b>\n    <span>\n     &nbsp;&nbsp;&nbsp;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Pathologic\n  atrophy in parenchymal organs after duct obstruction\n     </span>\n    </i>\n    <span>\n     , such as occurs in\n  the pancreas, parotid gland, and kidney.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  CELLULAR\nCHANGES IN APOPTOSIS\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Overview.\n  </span>\n </b>\n <span class=\"googqs-tidbit-0\">\n  <span>\n   The\nmorphological features of apoptosis consist of chromatin condensation, cell\nshrinkage, and membrane blebbing, which can be clearly observed by light\n  </span>\n </span>\n <span>\n  microscopy. The\nbiochemical features include DNA fragmentation, protein cleavage at specific locations,\nincreased mitochondrial membrane permeability, and the appearance of\nphosphatidylserine on the cell membrane surface.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Cell\nshrinkage\n  </span>\n </b>\n <span>\n  .\nThe cell is smaller in size; the cytoplasm is dense; and the organelles, though\nrelatively normal, are more tightly packed. (Recall that in other forms of cell\ninjury, an early feature is cell swelling, not shrinkage.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Chromatin\ncondensation\n  </span>\n </b>\n <span>\n  .\nThis is the most characteristic feature of apoptosis. The chromatin aggregates\nperipherally, under the nuclear membrane, into dense masses of various shapes\nand sizes. The nucleus itself may break up, producing two or more fragments.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Formation\nof cytoplasmic blebs and apoptotic bodies\n  </span>\n </b>\n <span>\n  . The apoptotic cell first shows\nextensive surface blebbing, then undergoes fragmentation into membrane-bound\napoptotic bodies composed of cytoplasm and tightly packed organelles, with or\nwithout nuclear fragments.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phagocytosis\nof apoptotic cells or cell bodies, usually by macrophages\n  </span>\n </b>\n <span>\n  . The apoptotic bodies\nare rapidly ingested by phagocytes and degraded by the phagocyte's lysosomal\nenzymes.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Plasma\nmembranes are thought to remain intact during apoptosis, until the last stages,\nwhen they become permeable to normally retained solutes. This classical\ndescription is accurate with respect to apoptosis\n  <a name=\"4-u1.0-B978-1-4377-0792-2..50006-7--p27\">\n  </a>\n  during physiologic conditions\nsuch as embryogenesis and deletion of immune cells. However, forms of cell\ndeath with features of necrosis as well as of apoptosis are not uncommon after\nmany injurious stimuli. Under such conditions the severity rather than the\nnature of the stimulus determines the pathway of cell death, necrosis being the\nmajor pathway when there is advanced ATP depletion and membrane damage.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  On\nhistologic examination, in tissues stained with hematoxylin and eosin, the\napoptotic cell appears as a round or oval mass of intensely eosinophilic\ncytoplasm with fragments of dense nuclear chromatin. Because the cell shrinkage\nand formation of apoptotic bodies are rapid and the pieces are quickly\nphagocytosed, considerable apoptosis may occur in tissues before it becomes\napparent in histologic sections. In addition, apoptosis&mdash;in contrast to\nnecrosis&mdash;does not elicit inflammation, making it more difficult to detect\nhistologically.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347188\"\n o:spid=\"_x0000_i1305\" type=\"#_x0000_t75\" alt=\"Description: Apoptosis\">\n <v:imagedata src=\"_%20Tutorials_files/image039.png\" o:title=\"Apoptosis\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Apoptosis\" border=\"0\" height=\"249\" src=\"_%20Tutorials_files/image040.png\" v:shapes=\"Picture_x0020_347188\" width=\"348\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347187\"\n o:spid=\"_x0000_i1304\" type=\"#_x0000_t75\" alt=\"Description: Necrosis\">\n <v:imagedata src=\"_%20Tutorials_files/image041.jpg\" o:title=\"Necrosis\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Necrosis\" border=\"0\" height=\"264\" src=\"_%20Tutorials_files/image042.png\" v:shapes=\"Picture_x0020_347187\" width=\"399\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. It can occur under normal physiological conditions", "B. It is characterized by chromatin aggregation, nuclear condensation, and cytoplasmic shrinking", "C. It is characterized by partition of the nucleus and cytoplasm into membrane-bound vesicles, which are phagocytized", "D. It elicits a major inflammatory response", "E. It is an energy-dependent process"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 38-year-old woman has a cast removed from her leg after 8 weeks of\nimmobilization. Which of the following best characterizes her gastrocnemius\nmuscle at this time?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  Muscle atrophy, characterized\nby a decrease in the number of muscle fibers, would be expected after eight\nweeks of immobilization.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Atrophy is a reduction in the size of a tissue or organ. It is\nassociated with a reduction in the size and number of cells comprising that\ntissue or organ\n </span>\n <span>\n  .\nAtrophy may be physiologic or pathologic. P\n  <span>\n   hysiologic atrophy\n  </span>\n  is normal; examples include dissolution of\nthe thyroglossal duct during fetal development and decrease in uterine size\nafter childbirth.\n  <span>\n   Pathologic atrophy,\nby contrast,\n  </span>\n  is abnormal and is usually caused by one of the following:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Disuse\n  </span>\n </i>\n <span>\n  . When a fractured bone\nis immobilized in a plaster cast or when a patient is restricted to bed rest,\natrophy of skeletal muscle ensues. At first, there is a decrease in cell size,\nwhich is reversible. With prolonged disuse, there is a decrease in the number\nof muscle fibers due to apoptosis. Muscle atrophy may be accompanied by\nincreased bone resorption, resulting in osteoporosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Denervation\n  </span>\n </i>\n <span>\n  . Nerve damage can cause\nmuscle atrophy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Ischemia\n  </span>\n </i>\n <span>\n  .\n </span>\n <span>\n  Decrease in blood\nsupply to a tissue can cause atrophy. Senile atrophy, for example, is a\nprogressive atrophy of the brain due to atherosclerosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Malnutrition\n  </span>\n </i>\n <span>\n  . Protein-calorie\nmalnutrition (marasmus) can cause muscle atrophy. Muscle protein is broken down\nto produce energy after adipose stores are depleted. &ldquo;Cachexia&rdquo; is a term used\nfor profound muscle wasting. It can occur in marasmus, cancer, and chronic\ninflammatory diseases.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Loss of\nendocrine stimulation\n  </span>\n </i>\n <span>\n  .\nMany tissues are dependent on endocrine stimulation for normal function. Loss\nof estrogen stimulation after menopause results in atrophy of the breast,\nendometrium, and vaginal epithelium.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Pressure\n  </span>\n </i>\n <span>\n  . Prolonged tissue\ncompression causes atrophy. An example would be a decubitus ulcer in a\nbedridden patient.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <a name=\"4-u1.0-B978-1-4377-0792-2..50006-7--p10\">\n  </a>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Atrophy is associated with decreased protein synthesis and increased\nprotein degradation. At first, the\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  cell size\nand the number of organelles is reduced. In muscle cells, there is loss of\nmitochondria and myofilaments. This &ldquo;downsizing&rdquo; reduces the metabolic needs of\nthe cell, allowing it to survive in an adverse environment. If the\nprecipitating cause of atrophy continues, the cell may become irreversibly\ndamaged and die, often by apoptosis.\n </span>\n</p>\n", "choices": ["A. Decrease in number of fibers", "B. Conversion to fast fibers", "C. Increase in cytoplasmic content", "D. Increase in mitochondrial content", "E. Increase in number of satellite cells"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n69-year-old man with a history of prostatic hypertrophy has the recent onset of\nincreased difficulty urinating. Symptoms began shortly after he started taking\na nasal decongestant orally for cold symptoms. Which of the following types of\nreceptors is most likely to be involved in these adverse events?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Oral decongestants\nstimulate alpha-adrenergic receptors, resulting in bladder sphincter\ncontraction. In patients already predisposed to bladder outlet obstruction\nbecause of prostatic hypertrophy, the administration of a nasal decongestant\ncan cause difficulty with urination and urinary retention. Any male patient who\nis having trouble with urination should be asked about his use of nasal\ndecongestants.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  There are\ntwo types of adrenergic receptors: alpha and beta. The beta receptors are\nfurther divided into beta 1 and beta 2. Norepinephrine excites alpha receptors\nmainly. Epinephrine excites alpha and beta receptors equally. Certain alpha\nfunctions are excitatory while others are inhibitory. Likewise, certain beta\nfunctions are excitatory while others are inhibitory. The major adrenergic\nreceptor functions are listed below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"174\">\n    <p class=\"MsoNormal\">\n     <span>\n      Alpha-adrenergic\n  receptor\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"198\">\n    <p class=\"MsoNormal\">\n     <span>\n      Beta-adrenergic\n  receptor\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"174\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"198\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"174\">\n    <p class=\"MsoNormal\">\n     <span>\n      Vasoconstriction\n  (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Pupillary\n  dilatation (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Intestinal\n  relaxation (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Pilomotor\n  contraction (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bladder\n  sphincter contraction(&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"198\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cardiac\n  acceleration (&beta;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  myocardial contractility (&beta;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Vasodilatation\n  (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Intestinal\n  relaxation (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Uterus\n  relaxation (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bronchodilatation\n  (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bladder\n  wall relaxation (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Glycogenolysis\n  (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lipolysis\n  (&beta;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  There are\ntwo types of cholinergic receptors: nicotinic and muscarinic. These receptors\nare activated by acetylcholine. Nicotinic receptors are found in the synapses\nbetween the pre- and postganglionic neurons of both the sympathetic and\nparasympathetic systems and also in the membranes of skeletal muscle fibers at\nthe neuromuscular junction. Muscarinic receptors are found in all effector\ncells stimulated by the postganglionic cholinergic neurons of the\nparasympathetic nervous system. The major muscarinic receptor functions are\nlisted below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Muscarinic receptor\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"230\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pupillary\n  constriction\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Ciliary\n  muscle contraction\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Gland\n  stimulation (nasal, lacrimal, salivary, gastric, pancreatic, sweat)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Cardiac\n  deceleration\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Decreased\n  myocardial contractility\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bronchoconstriction\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  peristalsis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bladder\n  wall contraction\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. \u03b11-adrenergic", "B. \u03b21-adrenergic", "C. \u03b22-adrenergic", "D. nicotinic at the neuromuscular junction", "E. muscarinic"]}, {"question": "<p>\n <span>\n  A 15-year-old boy is severely burned. Nitrogen loss occurs during the\nfirst few days after the burn. During this period, which of the following\nsubstances plays a major role in nitrogen loss?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct\n </b>\n . Major burns result in a severe catabolic\nstate. The rate of catabolism is proportional to the surface area burned. The\nrelease of catabolic hormones &ndash; cortisol, glucagon, epinephrine &ndash;\ntriggers breakdown of carbohydrates, fats, and proteins. Cortisol triggers\nprotein breakdown, which causes muscle wasting and nitrogen loss.\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n . Insulin is an anabolic hormone. It promotes\nglucose uptake by muscle and adipose tissue, stimulates glycogen and fatty acid\nsynthesis, and inhibits lipolysis and proteolysis.\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . Growth hormone stimulates protein synthesis\nand increases muscle mass and mineralization of bone.\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n . Parathyroid hormone promotes release of\ncalcium from bone, absorption of calcium in the kidney, and absorption of\ncalcium in the intestine.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n . Erythropoietin stimulates red blood cell\nproduction.\n</p>\n"], "tutorial": "<p>\n <span>\n  Catabolism\n </span>\n is the process by which large molecules (polymers) are\nbroken into smaller molecules (monomers) to produce energy. Specifically,\npolysaccharides, lipids, proteins, and nucleic acids are broken down into\nmonosaccharides, fatty acids, amino acids, and nucleotides. The monomers may\nthen be used to construct new polymers or they may be broken down further to\nproduce energy. During the breakdown process, waste products are released.\nThese include lactic acid, acetic acid, carbon dioxide, ammonia, and urea. Some\nof the energy released by catabolism is lost as heat; the rest is used to\nsynthesize adenosine triphosphate (ATP). This molecule provides the chemical\nenergy needed for anabolism. Hormones are important regulators of catabolism;\ntraditionally, they have been classified as anabolic or catabolic. The\n&ldquo;classic&rdquo; catabolic hormones are cortisol, glucagon, and epinephrine. These are\nreleased during periods of high stress, such as in burns, sepsis, trauma, or\nsurgery.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p align=\"center\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/1/11/Catabolism_schematic.svg\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347186\" o:spid=\"_x0000_i1303\" type=\"#_x0000_t75\" alt=\"Description: File:Catabolism schematic.svg\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/1/11/Catabolism_schematic.svg\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image043.png\" o:title=\"Catabolism schematic.svg\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: File:Catabolism schematic.svg\" border=\"0\" height=\"217\" src=\"_%20Tutorials_files/image044.png\" v:shapes=\"Picture_x0020_347186\" width=\"235\"/>\n  </span>\n </a>\n</p>\n\n<p align=\"center\">\n Catabolism\n</p>\n\n<p>\n <span>\n  Anabolism, by contrast,\n </span>\n is the process by which molecules are\nconstructed from smaller units. This utilizes energy, usually in the form\nadenosine triphosphate, which is derived from catabolism. Anabolic processes\ntend to &ldquo;build up&rdquo; organs and tissues. They allow growth and differentiation of\ncells and an increase in body size. Examples of anabolic processes include\ngrowth and mineralization of bone and increase in muscle mass &ndash; processes\nthat involve synthesis of complex molecules. The &ldquo;classic&rdquo; anabolic hormones\nare insulin, testosterone, estrogen, and growth hormone.\n</p>\n", "choices": ["A. Insulin", "B. Cortisol", "C. Growth hormone", "D. Parathyroid hormone", "E. Erythropoietin"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Each of\nthe following photomicrographs represents changes in the respiratory epithelium\ncaused by smoking. Which image illustrates squamous metaplasia?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347185\"\n o:spid=\"_x0000_i1302\" type=\"#_x0000_t75\" alt=\"Description: respiratory pathology\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image045.jpg\" o:title=\"respiratory pathology\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: respiratory pathology\" border=\"0\" height=\"291\" src=\"_%20Tutorials_files/image046.png\" v:shapes=\"Picture_x0020_347185\" width=\"462\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </b>\n This\nimage illustrates\n <b>\n </b>\n squamous cell\nmetaplasia, which can occur in the respiratory tract as a response to smoking.\nIn squamous cell metaplasia, bronchial cells are converted from\nmucus-secreting, ciliated, columnar epithelium to non-mucus-secreting,\nnon-ciliated, squamous epithelium.\n</p>\n"], "tutorial": "<p>\n <b>\n  Cellular adaptation\n </b>\n refers to changes made by a cell in response to adverse environmental changes.\nThe adaptation may be physiologic or pathologic. The five major types of\nadaptation are atrophy, hypertrophy, hyperplasia, dysplasia, and metaplasia.\n</p>\n\n<p>\n <b>\n  Atrophy\n </b>\n is a decrease\nin cell size. If enough cells in an organ atrophy, the entire organ will\ndecrease in size. Thymus atrophy in childhood is an example of physiologic\natrophy. Skeletal muscle atrophy is a pathologic adaptation to skeletal muscle\ndisuse. Tissue and organs especially susceptible to atrophy include skeletal\nmuscle, cardiac muscle, secondary sex organs, and the brain.\n</p>\n\n<p>\n <b>\n  Hypertrophy\n </b>\n is an\nincrease in cell size. If enough cells of an organ hypertrophy, the organ\nitself will enlarge. The heart and kidneys are especially susceptible to\nhypertrophy. Hypertrophy may be caused by mechanial signals (e.g., stretch) or\ntrophic signals (e.g., growth factors). Physiologic hypertrophy occurs in\nskeletal muscle with sustained weight-bearing exercise. Pathologic hypertrophy\noccurs in cardiac muscle as a result of hypertension.\n</p>\n\n<p>\n <b>\n  Hyperplasia\n </b>\n is an\nincrease in the number of cells due to increased cell mitosis. Physiologic\nhyperplasia may be compensatory or hormonal. Compensatory hyperplasia permits\ntissue and organ regeneration. It is common in epithelial cells of the\nepidermis and intestine, hepatocytes, bone marrow cells, and fibroblasts.\nHormonal hyperplasia occurs mainly in organs that depend on estrogen (e.g.,\nendometrial cells during pregnancy). Pathologic hyperplasia is an abnormal\nincrease in cell division (e.g., endometriosis).\n</p>\n\n<p>\n <b>\n  Metaplasia\n </b>\n occurs\nwhen a differentiated cell type is replaced by another cell type, which may be\nless differentiated. It is a reversible process. Metaplasia occurs in the\nrespiratory tract as a response to smoking. Bronchial cells convert from\nmucus-secreting, ciliated, columnar epithelium to non-mucous-secreting,\nnon-ciliated, squamous epithelium. The cells may become dysplasic or cancerous\nif the stimulus (e.g., cigarette smoking) is not removed.\n</p>\n\n<p>\n <b>\n  Dysplasia\n </b>\n refers to\nabnormal changes in cellular shape, size, and organization. Sometimes called\n\"atypical hyperplasia,&rdquo; dysplasia is not a true adaptation but, rather,\nthe earliest pre-cancerous lesion recognizable in a biopsy. Tissues prone to\ndysplasia include cervical and respiratory epithelia. Dysplasia can be mild (low-grade),\nmoderate, or severe (high-grade). Mild dysplasia is at low risk of transforming\ninto cancer. Severe dysplasia is at high risk. In most organs, carcinoma\n <i>\n  in situ\n </i>\n (CIS) is synonmyous with severe\n(high-grade) dysplasia. CIS immediately precedes the development of frank\ncarcinoma and resembles invasive carcinoma except for the lack of basement\nmembrane disruption.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <span class=\"search-hit\">\n  Dysplasia\n </span>\n is encountered principally in epithelia, and it is characterized by a\nconstellation of changes that\n <span>\n  include\na loss in the uniformity of the individual cells as well as a loss in their\narchitectural orientation\n </span>\n . Dysplastic cells exhibit considerable\npleomorphism and often contain large hyperchromatic nuclei with a high\nnuclear-to-cytoplasmic ratio. The architecture of the tissue may be disorderly.\nFor example, in squamous epithelium the usual progressive maturation of tall\ncells in the basal layer to flattened squamous cells on the surface may be lost\nand replaced by a scrambling of dark basal-appearing cells throughout the epithelium.\nMitotic figures are more abundant than usual. Frequently, they appear in\nabnormal locations within the epithelium. For example, in dysplastic stratified\nsquamous epithelium, mitoses are not confined to the basal layers but instead\nmay appear at all levels, including surface cells. When dysplastic changes are\nmarked and involve the entire thickness of the epithelium but the lesion\nremains confined by the basement membrane, it is considered a preinvasive\nneoplasm and is referred to as\n <i>\n  carcinoma in situ\n </i>\n . Once the tumor cells\nbreach the basement membrane, the tumor is said to be\n <i>\n  invasive\n </i>\n .\n</p>\n\n<p align=\"center\">\n Photomicrographs\nof normal respiratory epithelium appear below.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347184\"\n o:spid=\"_x0000_i1301\" type=\"#_x0000_t75\" alt=\"Description: respiratory epithelium\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image047.jpg\" o:title=\"respiratory epithelium\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: respiratory epithelium\" border=\"0\" height=\"307\" src=\"_%20Tutorials_files/image048.png\" v:shapes=\"Picture_x0020_347184\" width=\"247\"/>\n </span>\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347183\"\n o:spid=\"_x0000_i1300\" type=\"#_x0000_t75\" alt=\"Description: respiratory epithelium 2\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image049.jpg\" o:title=\"respiratory epithelium 2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: respiratory epithelium 2\" border=\"0\" height=\"264\" src=\"_%20Tutorials_files/image050.png\" v:shapes=\"Picture_x0020_347183\" width=\"353\"/>\n </span>\n</p>\n\n<p>\n Respiratory epithelium\nlining the upper airways is classified as\n <i>\n  ciliated pseudostratified columnar\nepithelium.\n </i>\n Although all cells in the epithelium touch the basement\nmembrane and, therefore, comprise a single layer, the nuclei are not aligned in\nthe same plane. Thus, the epithelium appears to have several layers. The term\n&ldquo;pseudostratified&rdquo; describes this arrangement.\n</p>\n\n<p>\n The majority of cells\ncomposing the\n <i>\n  ciliated pseudostratified columnar epithelium\n </i>\n are of three\ntypes: a) ciliated cells, b) goblet cells, and c) basal cells. The ciliated\ncells are columnar epithelial cells with specialized ciliary modifications.\nGoblet cells, so named because they are shaped like a wine goblet, are columnar\nepithelial cells that secrete mucus. The basal cells are small, nearly cuboidal\ncells that differentiate into other cells types. They respond to epithelial\ninjury by migrating to the denuded site and differentiating to restore the\nepithelial cell layer.\n</p>\n\n<p>\n Some of the earliest changes\nin smoking-damaged respiratory epithelium include goblet cell hyperplasia\n <b>\n  (A)\n </b>\n ,\nbasal cell hyperplasia\n <b>\n  (B)\n </b>\n , and squamous metaplasia\n <b>\n  (C)\n </b>\n . More\nominous changes include the appearance of squamous dysplasia\n <b>\n  (D)\n </b>\n ,\ncharacterized by the presence of disordered squamous epithelium, with loss of\nnuclear polarity, nuclear hyperchromasia, pleomorphism, and mitotic figures.\nSquamous dysplasia may, in turn, progress through the stages of mild, moderate,\nand severe dysplasia. Carcinoma-in-situ (CIS)\n <b>\n  (E)\n </b>\n is the stage that\nimmediately precedes invasive squamous carcinoma\n <b>\n  (F)\n </b>\n , and apart from the\nlack of basement membrane disruption in CIS, the cytologic features are similar\nto those in frank carcinoma. Unless treated, CIS will eventually progress to\ninvasive cancer.\n</p>\n\n<p>\n Here&rsquo;s a key to the images:\n <b>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    A.\n    <span>\n    </span>\n   </span>\n  </span>\n </b>\n <span>\n  Goblet cell hyperplasia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    B.\n    <span>\n    </span>\n   </span>\n  </span>\n </b>\n <span>\n  Basal cell hyperplasia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    C.\n    <span>\n    </span>\n   </span>\n  </span>\n </b>\n <span>\n  Squamous metaplasia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    D.\n    <span>\n    </span>\n   </span>\n  </span>\n </b>\n <span>\n  Squamous dysplasia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    E.\n    <span>\n    </span>\n   </span>\n  </span>\n </b>\n <span>\n  Carcinoma in situ (CIS)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    F.\n    <span>\n    </span>\n   </span>\n  </span>\n </b>\n <span>\n  Squamous carcinoma\n </span>\n</p>\n", "choices": ["<ol type=\"A\"><li><i>See image above</i></li></ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Several\ncontiguous cells are labeled with a fluorescent dye that cannot cross cell\nmembranes. One cell is experimentally bleached with light that destroys the\ndye, but the cell soon recovers dye fluorescence. This recovery is best\nexplained by the presence of which of the following structures between the\nbleached cell and the fluorescent neighbor?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Gap junctions are\nintercellular channels that permit the free passage of small molecules between\ncells.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  In many\ntissues (e.g., connective tissue), each cell is separated from the next by an\nextracellular coating or matrix. In some tissues (e.g.,\n </span>\n <a href=\"http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/A/AnimalTissues.html#epithelial\">\n  <span>\n   epithelia\n  </span>\n </a>\n <span>\n  ), however, the plasma\nmembranes of adjacent cells are pressed together by junctions.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  There are\nthree major types of cellular junction:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Tight junctions\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anchoring junctions\n </span>\n <span>\n  (e.g., desmosomes)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Gap junctions\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <b>\n   <span>\n    Tight\n   </span>\n  </b>\n </span>\n <b>\n  <span>\n   Junctions\n  </span>\n </b>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347182\" o:spid=\"_x0000_i1299\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image051.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\" border=\"0\" height=\"226\" src=\"_%20Tutorials_files/image052.png\" v:shapes=\"Picture_x0020_347182\" width=\"281\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Tight junction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Epithelial\ncells provide the interface between masses of cells and a cavity or space (a\nlumen). The part of the cell exposed to the lumen is called its\n  <span>\n   apical\n  </span>\n  surface. The rest of the cell\n(i.e., its sides and base) make up the\n  <span>\n   basolateral\n  </span>\n  surface.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Tight\njunctions seal adjacent epithelial cells in a narrow band just beneath their\napical surface. They have two major functions:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  They\nprevent the passage of molecules and ions through the space between cells. (In\norder to pass through the tissue, therefore, molecules must enter the cell\nitself by diffusion or active transport.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  They\nblock the movement of membrane proteins between the apical and basolateral\nsurfaces of the cell, allowing the unique function of each surface to be\npreserved (e.g., receptor-mediated endocytosis can be restricted to the apical\nsurface, and exocytosis can be restricted to the basolateral surface.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <b>\n   <span>\n    Anchoring\n   </span>\n  </b>\n </span>\n <b>\n  <span>\n   Junctions\n  </span>\n </b>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347181\" o:spid=\"_x0000_i1298\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image053.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\" border=\"0\" height=\"226\" src=\"_%20Tutorials_files/image054.png\" v:shapes=\"Picture_x0020_347181\" width=\"282\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Belt desmosome\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Anchoring\njunctions provide strong mechanical attachments between adjacent cells. They\nhold epithelial cells together and bind\n  <span>\n   cardiac\nmuscle\n  </span>\n  cells tightly. The most common anchoring junction is the\ndesmosome. &ldquo;Ordinary&rdquo; desmosomes form spot welds between cells. &ldquo;Belt&rdquo;\ndesmosomes form a belt that encircles the cell. Anchoring junctions are built\nfrom\n  <span>\n   cadherins,\n  </span>\n  transmembrane\nproteins with extracellular segments that bind to each other and intracellular\nsegments that bind to stress fibers (e.g., actin, keratin).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Note:\n  <span>\n   Pemphigus\n  </span>\n  is an autoimmune disease\ncharacterized by formation of antibodies against\n </span>\n <a href=\"http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/J/Junctions.html#adherens#adherens\">\n  <span>\n   cadherins\n  </span>\n </a>\n <span>\n  . The loosening of the\nadhesion between adjacent epithelial cells causes blistering.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Gap Ju\n   <span>\n    nctions\n   </span>\n  </span>\n </b>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347180\"\n o:spid=\"_x0000_i1297\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image055.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1\" border=\"0\" height=\"308\" src=\"_%20Tutorials_files/image056.png\" v:shapes=\"Picture_x0020_347180\" width=\"180\"/>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Gap junction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Gap\njunctions are intercellular channels that permit the free passage of ions and\nsmall molecules between cells. They are cylinders constructed from six copies\nof transmembrane proteins (\n  <span>\n   connexins)\n  </span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Because ions can flow through them, gap\njunctions allow changes in the membrane potential to pass from cell to cell.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Examples:\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\naction potential in cardiac muscle flows from cell to cell through gap\njunctions, allowing rhythmic contraction to occur.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  At\nsome &ldquo;electrical synapses&rdquo; in the brain, gap junctions transmit action\npotentials to the postsynaptic cell without release of neurotransmitters. This\nallows for faster signal transmission.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  As\nbirth approaches, gap junctions between smooth muscle cells in the uterus allow\nfor powerful, coordinated contractions.\n </span>\n</p>\n", "choices": ["A. Cell membrane", "B. Basal lamina", "C. Tight junctions", "D. Desmosomes", "E. Gap junctions"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A newborn baby undergoes chromosomal\nanalysis. Some cells have a 46, XY karyotype and others have a 45, X karyotype.\nWhich of the following mechanisms best explains this abnormality?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  47,XX,+21 (trisomy 21) corresponds to\nDown syndrome.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  45,X, (monosomy X) corresponds to Turner\nsyndrome.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  47,XXY corresponds to Klinefelter\nsyndrome.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  46,XX,del(5)(p15)\ncorresponds to cri du chat syndrome. The designation indicates deletion of band\n15 on the short arm (p) of chromosome 5.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  69,XXY is an example of triploidy.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Chromosome\nabnormalities fall into two categories: numerical and structural.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"158\">\n  <tr>\n   <td width=\"158\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Numerical\n      </span>\n     </b>\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347179\"\n   o:spid=\"_x0000_i1296\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image057.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image058.png\" v:shapes=\"Picture_x0020_347179\" width=\"11\"/>\n     </span>\n     <a href=\"http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3393\">\n      <span>\n       Trisomy\n      </span>\n     </a>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347178\"\n   o:spid=\"_x0000_i1295\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image059.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image060.png\" v:shapes=\"Picture_x0020_347178\" width=\"11\"/>\n     </span>\n     <span>\n      Monosomy\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347177\"\n   o:spid=\"_x0000_i1294\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image061.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image062.png\" v:shapes=\"Picture_x0020_347177\" width=\"11\"/>\n     </span>\n     <span>\n      Mosaicism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Structural\n      </span>\n     </b>\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347176\"\n   o:spid=\"_x0000_i1293\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image063.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image064.png\" v:shapes=\"Picture_x0020_347176\" width=\"11\"/>\n     </span>\n     <span>\n      Deletion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347175\"\n   o:spid=\"_x0000_i1292\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image065.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image066.png\" v:shapes=\"Picture_x0020_347175\" width=\"11\"/>\n     </span>\n     <span>\n      Inversion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347174\"\n   o:spid=\"_x0000_i1291\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image067.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image068.png\" v:shapes=\"Picture_x0020_347174\" width=\"11\"/>\n     </span>\n     <span>\n      Duplication\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347173\"\n   o:spid=\"_x0000_i1290\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image069.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image070.png\" v:shapes=\"Picture_x0020_347173\" width=\"11\"/>\n     </span>\n     <span>\n      Insertion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347172\"\n   o:spid=\"_x0000_i1289\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image071.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image072.png\" v:shapes=\"Picture_x0020_347172\" width=\"11\"/>\n     </span>\n     <span>\n      Ring\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347171\"\n   o:spid=\"_x0000_i1288\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image073.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image074.png\" v:shapes=\"Picture_x0020_347171\" width=\"11\"/>\n     </span>\n     <a href=\"http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3246\">\n      <span>\n       Marker\n      </span>\n     </a>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347170\"\n   o:spid=\"_x0000_i1287\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image075.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image076.png\" v:shapes=\"Picture_x0020_347170\" width=\"11\"/>\n     </span>\n     <a href=\"http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3388\">\n      <span>\n       Translocation\n      </span>\n     </a>\n     <span>\n      , reciprocal\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"158\">\n    <p class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347169\"\n   o:spid=\"_x0000_i1286\" type=\"#_x0000_t75\" alt=\"Description:  \">\n   <v:imagedata src=\"_%20Tutorials_files/image077.png\" o:title=\" \"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description:  \" border=\"0\" height=\"3\" src=\"_%20Tutorials_files/image078.png\" v:shapes=\"Picture_x0020_347169\" width=\"11\"/>\n     </span>\n     <a href=\"http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3388\">\n      <span>\n       Translocation\n      </span>\n     </a>\n     <span>\n      , Robertsonian\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <a name=\"Background\">\n </a>\n <b>\n  <span>\n   Abnormalities of\nChromosome Number\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Trisomy\n  </span>\n </i>\n <span>\n  is a type of aneuploidy (abnormal chromosome number) in which there are three\ncopies of a particular chromosome (instead of the usual two). Trisomy is not\nusually compatible with life. An exception is trisomy 21, the cause of Down\nsyndrome.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Monosomy\n  </span>\n </i>\n <span>\n  is a type of aneuploidy in which there is one copy of a chromosome (instead of\nthe usual two). This is almost always fatal. The only complete monosomy\ncompatible with life is Turner syndrome, in which there is one X chromosome\n(instead of the usual pair).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Aneuploidy\nis usually caused by\n  <i>\n   meiotic\n   <span>\n    nondisjunction\n   </span>\n  </i>\n  <span>\n   , which\n  </span>\n  is an error in the production\nof germ cells (eggs and sperm). To produce germ cells with 23 chromosomes,\ncells in the ovary and testes (each with 46 chromosomes) undergo two separate\ncell divisions: meiosis I and meiosis II. With nondisjunction, the chromosomes\ndo not segregate properly during one of these divisions, and one of the\ndaughter cells ends up with too many chromosomes while the other ends up with\ntoo few.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\norigin of the extra chromosome depends on the timing of nondisjunction. If\nnondisjunction occurs in meiosis I, the germ cell will have two different\ncopies of a certain chromosome, one from the individual&rsquo;s mother and one from\nthe father (i.e., the future embryo&rsquo;s grandmother and grandfather). If\nnondisjunction occurs in meiosis II, the germ cell will have two identical\ncopies of a chromosome, either from the individual&rsquo;s mother or father (i.e.,\nthe future embryo&rsquo;s grandmother or grandfather).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347168\" o:spid=\"_x0000_i1285\" type=\"#_x0000_t75\" alt=\"Description: meiotic nondisjunction\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image079.jpg\" o:title=\"meiotic nondisjunction\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: meiotic nondisjunction\" border=\"0\" height=\"289\" src=\"_%20Tutorials_files/image080.jpg\" v:shapes=\"Picture_x0020_347168\" width=\"345\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Meiotic Nondisjunction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"Abnormalities_of_Chromosome_Structure\">\n </a>\n <b>\n  <span>\n   Abnormalities of Chromosome Structure\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Abnormalities\nof chromosomal structure can be either\n  <i>\n   unbalanced\n  </i>\n  or\n  <i>\n   balanced\n  </i>\n  . Unbalanced\nrearrangements have missing or extra genetic material, which usually leads to\nmajor abnormalities. Balanced rearrangements, by contrast, involve no extra or\nmissing genetic material and may occur in healthy individuals.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Unbalanced\nrearrangements include\n  <i>\n   deletions\n  </i>\n  ,\n  <i>\n   duplications\n  </i>\n  ,\n  <i>\n   marker\n  </i>\n  or\n  <i>\n   ring\n  </i>\n  chromosomes, and\n  <i>\n   isochromosomes\n  </i>\n  . A\ndeletion results in loss of a chromosomal segment. A duplication results in\nrepetition of a chromosome segment. Generally, duplications are less harmful\nthan deletions. A marker chromosome is a very small, unidentified chromosome\nthat can be seen on a karyotype. Individuals with a marker chromosome usually\nhave this chromosome in addition to the normal 46 chromosomes. A ring\nchromosome occurs when a chromosome is broken in two places and the ends unite\n(with or without loss of genetic information). An\n  <span>\n   isochromosome\n  </span>\n  is a chromosome that has lost one of its arms and\nreplaced it with an exact copy of the other arm. (A person with 46 chromosomes\ncontaining an isochromosome has a single copy of one arm, and three copies of\nthe other arm.)\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347167\" o:spid=\"_x0000_i1284\" type=\"#_x0000_t75\" alt=\"Description: three\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image081.png\" o:title=\"three\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: three\" border=\"0\" height=\"182\" src=\"_%20Tutorials_files/image082.png\" v:shapes=\"Picture_x0020_347167\" width=\"250\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  Deletion\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Duplication\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Inversion\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347166\" o:spid=\"_x0000_i1283\" type=\"#_x0000_t75\" alt=\"Description: marker\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image083.png\" o:title=\"marker\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: marker\" border=\"0\" height=\"243\" src=\"_%20Tutorials_files/image084.png\" v:shapes=\"Picture_x0020_347166\" width=\"316\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Marker chromosome (mar)\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347165\" o:spid=\"_x0000_i1282\" type=\"#_x0000_t75\" alt=\"Description: ring\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image085.jpg\" o:title=\"ring\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: ring\" border=\"0\" height=\"250\" src=\"_%20Tutorials_files/image086.png\" v:shapes=\"Picture_x0020_347165\" width=\"388\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Ring Chromosome\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347164\" o:spid=\"_x0000_i1281\" type=\"#_x0000_t75\" alt=\"Description: isochromosome\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image087.png\" o:title=\"isochromosome\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: isochromosome\" border=\"0\" height=\"234\" src=\"_%20Tutorials_files/image088.png\" v:shapes=\"Picture_x0020_347164\" width=\"204\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Isochromosome\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Balanced\nrearrangements include\n  <i>\n   inversions\n  </i>\n  (\n  <i>\n   pericentric\n  </i>\n  or\n  <i>\n   paracentric\n  </i>\n  ) and\n  <i>\n   translocations\n  </i>\n  (\n  <i>\n   Robertsonian or reciprocal\n  </i>\n  ). An\ninversion occurs when there are two breaks in a chromosome and the area in\nbetween is inverted (turned around) and reinserted. The inversion is called\npericentric if the centromere is included and paracentric if the centromere is\nnot included. Many inversions in the general population are considered normal\nvariants.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Translocations\n </span>\n <span>\n  are of two major types. A Robertsonian\ntranslocation occurs when two acrocentric chromosomes fuse near the centromere\nregion with loss of the short arms. (An acrocentric chromosome is a chromosome\nwith the centromere near one end.) The resulting balanced karyotype has only 45\nchromosomes, including the translocation chromosome, which, in effect, is made\nup of the long arms of two chromosomes.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347163\" o:spid=\"_x0000_i1280\" type=\"#_x0000_t75\" alt=\"Description: robertsonian.gif\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image089.png\" o:title=\"robertsonian.gif\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: robertsonian.gif\" border=\"0\" height=\"139\" src=\"_%20Tutorials_files/image090.png\" v:shapes=\"Picture_x0020_347163\" width=\"249\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Robertsonian translocation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\nreciprocal translocation involves the breakage of nonhomologous chromosomes\nwith an even exchange of broken-off segments. Usually two chromosomes are\ninvolved and the total number of chromosomes is unchanged. Reciprocal\ntranslocations are relatively common and are usually harmless.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347162\" o:spid=\"_x0000_i1279\" type=\"#_x0000_t75\" alt=\"Description: reciprocal.png\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image091.png\" o:title=\"reciprocal.png\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: reciprocal.png\" border=\"0\" height=\"164\" src=\"_%20Tutorials_files/image092.png\" v:shapes=\"Picture_x0020_347162\" width=\"210\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a name=\"Mosaicism\">\n </a>\n <span>\n  Reciprocal Translocation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Mosaicism\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Most\nchromosomal anomalies appear in every cell of the body. However, sometimes\ndifferent cells have different chromosomal constitutions. For example, a person\nmay have 46 chromosomes in half of their cells and 45 in the other half. This\nis known as mosaicism.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mosaicism\nis usually caused by\n  <i>\n   mitotic\nnondisjunction\n  </i>\n  . The effects of mosaicism depend on the timing of\nnondisjunction, the chromosomal anomaly, the fraction of the body's cells\ncarrying the anomaly, and the tissues affected. Generally a person with\nmosaicism is less severely affected than someone carrying the genetic anomaly\nin every cell.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Genetic imprinting and\nUniparental disomy\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Genomic imprinting\n  </span>\n </i>\n <span>\n  is a phenomenon in\nwhich expression of alleles is influenced by chemical changes to the DNA, such\nas covalent modification or methylation, rather than changes to the sequence\nitself. Genomic imprinting is a reversible type of gene inactivation because\nthe sequence is not changed.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Uniparental disomy\n  </span>\n </i>\n <span>\n  is a phenomenon in\nwhich both paired chromosomes originate from a single parent. (Normally, the\nchromosomes originate from different parents.) The presence of two identical\nchromosomes from the same parent is called\n  <i>\n   isodisomy\n  </i>\n  .\nThe presence of different chromosomes from the same parent is called\n  <i>\n   heterodisomy\n  </i>\n  . Prader-Willi syndrome\n(&ldquo;rag doll&rdquo; syndrome) and Angelman syndrome (&ldquo;happy puppet&rdquo; syndrome) are the\nprincipal examples of uniparental disomy.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347161\" o:spid=\"_x0000_i1278\" type=\"#_x0000_t75\" alt=\"Description: isodisomy\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image093.jpg\" o:title=\"isodisomy\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: isodisomy\" border=\"0\" height=\"209\" src=\"_%20Tutorials_files/image094.png\" v:shapes=\"Picture_x0020_347161\" width=\"305\"/>\n </span>\n <span>\n </span>\n</p>\n\n<div>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n    Testing\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n   A fetus can be tested\nfor chromosomal abnormalities using amniocentesis and chorionic villus\nsampling. With both techniques, pictures of the chromosomes are taken,\nproducing a karyotype.\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n   The chromosomes are\nevaluated for size and structure.\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n   </span>\n  </b>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n    Answer A is correct\n   </span>\n  </b>\n  <span>\n   . M\n   <span>\n    osaicism\n   </span>\n   denotes the presence of two populations of cells with different genotypes in a\nsingle individual. It is caused by mitotic nondisjunction.\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n    Answer B is incorrect\n   </span>\n  </b>\n  <span>\n   . A reciprocal translocation involves breakage\nof nonhomologous chromosomes with an even exchange of broken-off segments.\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n    Answer C is incorrect\n   </span>\n  </b>\n  <span>\n   . A Robertsonian translocation occurs when two\nacrocentric chromosomes fuse near the centromere region with loss of the short\narms.\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n    Answer D is incorrect\n   </span>\n  </b>\n  <span>\n   .\n   <i>\n   </i>\n   Genomic\nimprinting is a phenomenon in which the expression of alleles is influenced by\nchemical changes to the DNA (e.g., methylation) rather than changes in the\nsequence itself.\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <span>\n  </span>\n </p>\n <p class=\"MsoNormal\">\n  <b>\n   <span>\n    Answer E is incorrect\n   </span>\n  </b>\n  <span>\n   . Uniparental disomy occurs when both paired\nchromosomes originate from a single parent.\n  </span>\n </p>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n1-week-old newborn has microcephaly, intrauterine growth retardation, widely\nspaced eyes, and a cat-like cry. Which of the following karyotypes is most\nlikely?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  47,XX,+21\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  45,X\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  47,XXY\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  46,XX,del(5)(p15)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  69,XXY\n </span>\n</p>\n\n<p>\n <b>\n  Down syndrome\n </b>\n</p>\n\n<p>\n Down syndrome is\ncharacterized by the presence of an extra copy of genetic material from\nchromosome 21, either in whole (trisomy 21) or in part (such as due to\ntranslocations). The syndrome is usually associated with impaired cognitive\nability and physical growth. Features include small chin, round face, big\ntongue, almond-shapes eyes, upslanting palpebral fissures, short limbs, a\nsingle transverse palmar crease, poor muscle tone, and a larger than normal\nspace between the big and second toes. Affected individuals are at higher risk\nof congenital heart defects, gastroesophageal reflux disease, recurrent ear\ninfections, obstructive sleep apnea, and thyroid dysfunction. Three cytogenetic\nvariants cause Down syndrome: trisomy 21, chromosomal translocation, and\nmosaicism.\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Trisomy 21\n  </span>\n </i>\n <span>\n  accounts for nearly 95% of all patients\nwith Down syndrome and is due to meiotic nondisjunction. With nondisjunction, a\ngamete (\n  <span>\n   i.e.\n  </span>\n  , a sperm or egg\ncell) is produced with an extra copy of chromosome 21; the gamete thus has 24\nchromosomes. When combined with a normal gamete from the other parent, the\nembryo now has 47 chromosomes, with three copies of chromosome 21. The\nlikelihood of nondisjunction in the mother increases with maternal age.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n <i>\n  Robertsonian translocation\n </i>\n in one of the parents is responsible for\n2-3% of Down cases. The long arm of chromosome 21 becomes attached to another\nchromosome, often chromosome 14. A person with such a translocation is phenotypically\nnormal. During reproduction, normal disjunctions have a significant chance of\ncreating a gamete with an extra chromosome 21, producing a child with Down\nsyndrome. &ldquo;Translocation Down syndrome&rdquo; is often referred to as &ldquo;\n <span>\n  familial Down syndrome\n </span>\n .&rdquo;\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Mosaicism\n  </span>\n </i>\n <span>\n  explains 1-2% of Down cases. In mosaic Down,\nsome cells in the body are normal and others have trisomy 21. This is due to\nmitotic nondisjunction during an early cell division in a normal embryo.\nIndividuals with mosaic Down have a normal cell line and usually milder\nphysical stigmata.\n </span>\n</p>\n\n<p>\n <b>\n  Turner syndrome\n </b>\n</p>\n\n<p>\n <span>\n  Turner syndrome\n </span>\n encompasses several conditions, of which monosomy\nX (absence of an entire sex chromosome, the Barr body) is most common. Monosomy\nX is caused by meiotic nondisjunction in either parent. In some individuals\nwith Turner syndrome, the X chromosome is missing in some cells but not others,\na condition referred to as mosaicism. Mosaicism is caused by mitotic\nnondisjunction.\n</p>\n\n<p>\n Affected individuals are\nphenotypic females with features that include short stature, broad chest, low\nhairline, low-set ears, and webbed neck. Gonadal dysfunction (non-working\novaries) results in amenorrhea and sterility. Other potential findings include\ncognitive deficits, congenital heart disease, diabetes, hypothyroidism, and\ndifficulty with vision and hearing.\n</p>\n\n<p>\n <b>\n  Klinefelter syndrome\n </b>\n</p>\n\n<p>\n Klinefelter syndrome is the\nmost common chromosomal disorder to be associated with male hypogonadism and\ninfertility. The &ldquo;classic&rdquo; karyotype is 47, XXY, although some individuals have\nadditional X and Y chromosomes. The syndrome is characterized by hypogonadism\n(small testes, aspermia), gynecomastia in late puberty, psychosocial problems,\nand elevated urinary gonadotropin levels.\n</p>\n\n<p>\n The XXY karyotype can be\ncaused by nondisjunction in the first meiotic division in the mother,\nnondisjunction in the second meiotic division in the mother, or nondisjunction\nin the first meiotic division of the father. The XXY karyotype cannot be caused\nby nondisjunction in the second meiotic division of the father. The likelihood\nof nondisjunction in the mother increases with maternal age.\n</p>\n\n<p>\n <b>\n  Patau syndrome\n </b>\n</p>\n\n<p>\n Patau syndrome (trisomy 13)\nis the least common and most severe of the viable autosomal trisomies. Median\nsurvival is fewer than 3 days.\n</p>\n\n<p>\n <b>\n  Edwards syndrome\n </b>\n</p>\n\n<p>\n <span>\n  Edwards syndrome\n </span>\n (trisomy 18) is the second most common autosomal\ntrisomy (after Down syndrome). The survival rate is very low due to heart and\nkidney abnormalities.\n</p>\n\n<p>\n <b>\n  Cri du chat syndrome\n </b>\n</p>\n\n<p>\n <span>\n  Cri du chat syndrome\n </span>\n , also known as\n <span>\n  Lejeune syndrome\n </span>\n , is a rare genetic disorder caused by partial\ndeletion of the short arm of chromosome 5. Its name refers to the cat-like\n&ldquo;meow&rdquo; of affected children (cry of the cat, in French). Features include\nmicrocephaly, mental retardation, intrauterine growth retardation, and widely\nspaced eyes.\n</p>\n\n<p>\n <b>\n  Prader-Willi syndrome\n </b>\n</p>\n\n<p>\n Prader-Willi syndrome is a\ndisorder caused by loss of expression of genes on\n <i>\n  paternally\n </i>\n derived chromosome 15. It is an example of genomic\n&ldquo;imprinting,&rdquo; in which certain genes are expressed in a parent-of-origin-specific\nmanner. Features include diminished fetal activity, obesity, mental\nretardation, hypotonia, short stature, and small hands and feet.\n</p>\n\n<p>\n <b>\n  Angelman syndrome\n </b>\n</p>\n\n<p>\n Angelman syndrome is a\ndisorder caused by loss of expression of genes on\n <i>\n  maternally\n </i>\n derived chromosome 15. It is an example of genomic\n&ldquo;imprinting,&rdquo; in which certain genes are expressed in a\nparent-of-origin-specific manner. Features include intellectual and\ndevelopmental delay, seizures, jerky movements (especially hand-flapping),\nfrequent laughter or smiling, and usually a happy demeanor.\n</p>\n\n<p>\n <b>\n  Triploidy\n </b>\n</p>\n\n<p>\n Triploidy is a chromosomal\nabnormality where three complete sets of the haploid genome instead of the\nnormal two sets are present within the conceptus. A triploid conceptus will\npossess 69 chromosomes. Generally, triploidy is incompatible with life, and is\nassociated with miscarriage and hydatidiform moles.\n</p>\n", "choices": ["A. Nondisjunction in mitosis", "B. Reciprocal translocation", "C. Robertsonian translocation", "D. Genetic imprinting", "E. Uniparental disomy"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n21-year-old man is admitted to the emergency room with fever, headache,\nsomnolence, irritability, muscle aches, and vomiting of 24 hours duration. He\nhas been hospitalized three times prior to this for meningococcal meningitis.\nOne of his brothers was hospitalized six months ago with meningococcal\nmeningitis. On physical examination, the patient is disoriented and lethargic.\nHis temperature is 102.6\n  <sup>\n   o\n  </sup>\n  F; blood pressure is 90/60 mm Hg. Nuchal\nrigidity is noted. Petechiae are present on the upper and lower extremities.\nCerebrospinal fluid (CSF) tests show the following:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Color\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  turbid\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cell count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  5300/mm\n  <sup>\n   3\n  </sup>\n  (normal: 0-5/mm\n  <sup>\n   3\n  </sup>\n  )\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  97% neutrophils\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  3% monocytes\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  rare red blood cells\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  70\nmg/dL (normal: 40-70 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Protein\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  45\nmg/dL (normal: &lt;40 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CSF Gram\nstain shows gram-negative diplococci. The patient is treated with ceftriaxone,\nwhich leads to clinical improvement. Blood cultures grow\n  <i>\n   Neisseria\nmeningitidis\n  </i>\n  . After immunization against pneumococcus, meningococcus, and\n  <i>\n   Haemophilus\ninfluenzae\n  </i>\n  , the patient has no more episodes of meningitis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following conditions has most likely predisposed the patient to recurrent\ninfection?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct\n  </span>\n </b>\n <span>\n  .\n  <span>\n  </span>\n  Complement deficiencies in the late phase can\ncompromise formation of the membrane attack complex (MAC) and inhibit lysis of\ntarget cells. The problem may not be apparent until the late teenage years.\nPatients with terminal complement deficiency often have recurrent infections\nwith\n  <i>\n   Neisseria meningitidis\n  </i>\n  , which can be fatal. It is not unusual for\npatients to have recurrent infections with the same serotype, usually Y or\nW135. In this vignette, the patient had a deficiency of C8.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nPatients with Bruton&rsquo;s agammaglobulinemia usually suffer from recurrent\npyogenic bacterial infections in the first year of life due to lack of\nopsonizing antibodies. The defect is in the gene coding for Bruton&rsquo;s tyrosine\nkinase, an enzyme essential to B cell, but not T cell, development.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  T cell numbers and function are normal,\nso patients typically do not have problems with viral or other intracellular\ninfections.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Most cases are\nX-linked, affecting predominantly males, although females with two defective\ngenes will have the disease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect\n  </span>\n </b>\n <span>\n  .\nComplement deficiencies in the early phase (e.g., C2) can result in poor\nopsonization and increased susceptibility to infection. This is usually\nobserved early in life (not in a 21-year-old, as in this case). Any deficiency\nof early components of the classical, alternative, or MBL (mannose-binding\nlectin) pathways &ndash; or in C3b itself &ndash; can compromise opsonization.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  .\nAsplenic patients are at a high risk for infection with encapsulated\nbacteria.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The spleen plays an\nimportant role in the removal of opsonized bacteria, senescent cells, and other\nparticles, such as immune complexes. Asplenic infants under six months of age\nare susceptible to Gram-negative pathogens such as\n  <i>\n   Escherichia coli\n  </i>\n  and\n  <i>\n   Klebsiella\n  </i>\n  ,\nwhereas older infants and adults are susceptible to\n  <i>\n   Streptococcus\npneumoniae, Haemophilus influenza type b,\n  </i>\n  and\n  <i>\n   Neisseria meningitidis\n  </i>\n  .\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect\n  </span>\n </b>\n <span>\n  .\nPatients with Chronic Granulomatous Disease (CGD) are not unduly susceptible to\ninfection with\n  <i>\n   Neisseria meningitidis\n  </i>\n  . CGD results from a defect in the\nphagocyte oxidase enzyme complex, which results in deficient production of\nreactive oxygen species in phagocytes. These ions are important in the\nbactericidal activity of phagocytes. Patients with CGD disease are susceptible\nto bacterial and fungal infections, particularly with catalase-positive\norganisms. These include\n  <i>\n   Staphylococcus aureus, Aspergillus fumigatus,\n  </i>\n  and\n  <i>\n   Candida albicans\n  </i>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n The complement system helps,\nor &ldquo;complements,&rdquo; the ability of antibodies and phagocytic cells to clear\npathogens. It is part of the innate immune system, which is not adaptable and\ndoes not change over the course of an individual's life. However, it can be\nrecruited and brought into action by the adaptive immune system.\n</p>\n\n<p>\n The complement system\nconsists of a number of small proteins found in the blood, generally\nsynthesized by the liver, and normally circulating as inactive precursors\n(pro-proteins). When stimulated by one of several triggers, proteases in the\nsystem cleave specific proteins to release cytokines and initiate an amplifying\ncascade of further cleavages. The end-result is massive amplification of the\nresponse and activation of the cell-killing membrane attack complex (MAC).\n</p>\n\n<p>\n Over 25 proteins and protein\nfragments make up the complement system, including serum proteins, serosal\nproteins, and cell membrane receptors. Most of these proteins are synthesized\nby hepatocytes, but significant numbers are produced by tissue macrophages,\nblood monocytes, and epithelial cells. Complement accounts for about 5% of the\nglobulin fraction of blood serum. The basic functions of complement are listed\nbelow.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Opsonization\n- enhancing phagocytosis of antigens\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Chemotaxis\n- attracting macrophages and neutrophils\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lysis\n- rupturing membranes of foreign cells\n </span>\n</p>\n\n<p>\n Three biochemical pathways\nactivate the complement system: the classical pathway, the alternative pathway,\nand the mannose-binding lectin (MBL) pathway (Figure 1).\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  All three\npathways generate variants of the protease, C3-convertase. The classical\npathway typically requires antigen/antibody complexes for activation (specific\nimmune response), whereas the alternative and mannose-binding lectin (MBL)\npathways are activated by C3 hydrolysis or by antigens without the presence of\nantibodies (non-specific immune response).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In all\nthree pathways, a C3-convertase cleaves and activates C3, creating C3a and C3b.\nThis causes a cascade of further cleavage and activation. C3b binds to the\nsurface of pathogens, leading to greater internalization by phagocytic cells\n(opsonization).\n  <span class=\"text\">\n   C3a, C5a, and, to a lesser extent, C4a are\ncalled &ldquo;anaphylatoxins&rdquo; because they stimulate histamine release from mast\ncells, which increases vascular permeability and causes vasodilation. C5a is a\npowerful chemotactic agent for neutrophils, monocytes, eosinophils, and\nbasophils.\n  </span>\n  C5b initiates the membrane attack pathway, which results in\nthe membrane attack complex (MAC), consisting of C5b, C6, C7, C8, and polymeric\nC9. The MAC is the cytolytic end-product of the complement cascade; it forms a\ntransmembrane channel, which causes osmotic lysis of the target cell (Figure\n2).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Figure 1\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347160\"\n o:spid=\"_x0000_i1277\" type=\"#_x0000_t75\" alt=\"Description: http://www.surgicalnotes.co.uk/files/images/complement.gif\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image095.png\" o:title=\"//www.surgicalnotes.co.uk/files/images/complement.gif\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.surgicalnotes.co.uk/files/images/complement.gif\" border=\"0\" height=\"235\" src=\"_%20Tutorials_files/image096.png\" v:shapes=\"Picture_x0020_347160\" width=\"272\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Figure 2\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347159\"\n o:spid=\"_x0000_i1276\" type=\"#_x0000_t75\" alt=\"Description: 008006\">\n <v:imagedata src=\"_%20Tutorials_files/image097.jpg\" o:title=\"008006\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 008006\" border=\"0\" height=\"469\" src=\"_%20Tutorials_files/image098.png\" v:shapes=\"Picture_x0020_347159\" width=\"471\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Bruton\u2019s agammaglobulinemia", "B. Complement C2 deficiency", "C. Terminal complement deficiency", "D. Asplenia", "E. Chronic granulomatous disease"]}, {"question": "<p>\n A 52-year-old man with\nhepatic cancer is treated with a new chemotherapeutic agent that, as a side\neffect, blocks kinesin. One week later, he develops skeletal muscle weakness.\nWhich of the following most likely explains his weakness?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Kinesins interact with\nmicrotubules to move &ldquo;cargo&rdquo; (e.g., vesicles, organelles) in an anterograde\ndirection (usually from the cell body to the periphery). In neurons, they\ntransport vesicles (e.g., neurotransmitter vesicles) from the cell body, where\nthey are manufactured, to the synapse, where they are released. Interference\nwith this process by a chemotherapeutic agent would decrease the number of\npre-synaptic neurotransmitter vesicles.\n </span>\n</p>\n"], "tutorial": "<p>\n The\n <span>\n  cytoskeleton\n </span>\n is a cellular \"scaffolding\" or\n\"skeleton\" within the cytoplasm. It is composed of protein and plays\nan important role in both intracellular transport (e.g., the movement of\nvesicles and organelles) and cellular division. Eukaryotic cells contain three\nmain kinds of cytoskeletal filaments: microfilaments, intermediate filaments,\nand microtubules. (Microfilaments and intermediate filaments are the &ldquo;cables&rdquo;;\nmicrotubules are the &ldquo;support beams.&rdquo;)\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <span class=\"mw-headline\">\n  <i>\n   Microfilaments\n  </i>\n  (actin filaments)\n  <b>\n  </b>\n  a\n </span>\n re the thinnest filaments of\nthe cytoskeleton. They are composed of linear polymers of actin subunits, which\ngenerate force by elongation at one end and shrinkage at the other, causing net\nmovement of the intervening strand. Actin filaments serve as tracks for the\nmovement of myosin molecules, which attach to the microfilaments and\n\"walk\" along them.\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Intermediate filaments\n  </span>\n </i>\n <span>\n  are more heterogeneous\nand stable than actin filaments. Like actin, they maintain cell shape by\nbearing tension. They anchor organelles, provide structural support for the\nnuclear lamina and sarcomere, and participate in some cell-cell and cell-matrix\njunctions.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nfollowing proteins are found in various intermediate filaments:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  vimentins,\nwhich provide structural support to many cells\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  keratin,\nfound in skin, hair, and nails\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  neurofilaments,\nfound in neural cells\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  lamin,\nwhich gives structural support to the nuclear envelope\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Microtubules\n  </span>\n </i>\n <span>\n  are hollow cylinders that play a key\nrole in the mitotic spindle and in intracellular transport. They are comprised\nof polymers of alpha and beta tubulin and are typically organized by the\ncentrosome. Microtubules employ proteins called kinesins and dyneins to\ntransport vesicles and organelles (e.g., mitochondria) within the cell.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Kinesins\ntransport cargo in an anterograde direction (usually from the cell center to\nthe periphery). Dyneins transport cargo in a retrograde direction (usually from\nthe periphery to the center). Kinesins and dyneins &ldquo;walk&rdquo;unidirectionally along\nmicrotubule tracks, using one molecule of ATP at each step. Thse movements\nallow mitosis, meiosis, and intracellular transport (e.g., axonal transport) to\noccur.\n </span>\n</p>\n\n<p>\n <span>\n  To\ntransmit nerve impulses, neurons release neurotransmitters from the terminal of\nthe axon. The neuron must constantly supply new materials\u2005to the terminal\nto replenish substances lost by exocytosis. Molecules must be synthesized in\nthe cell body and transported down the axon (in some cases, several meters in\nlength) to the synapse. This process of axonal transport occurs on\nmicrotubules.\n  <span>\n   Anterograde transport\nusing\n  </span>\n  kinesins proceeds from the cell body to the synapse and is\nresponsible for axonal growth and renewal of synaptic vesicles. R\n  <span>\n   etrograde transport, by contrast, is used to\nmove\n  </span>\n  &ldquo;old&rdquo; materials from the synapse to cell body where they can be degraded\nby lysosomes.\n </span>\n</p>\n", "choices": ["A. Decrease in the number of pre-synaptic neurotransmitter vesicles", "B. Decrease in the number of post-synaptic neurotransmitter receptors", "C. Decrease in pre-synaptic neuron calcium permeability", "D. Impaired motorneuron action potential conduction", "E. Impaired skeletal muscle action potential conduction"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An\n11-month-old girl is developmentally delayed and has had three seizures in the\npast month. Her skin is fair and her hair is lighter in color than that of\nother family members. Her diapers have a musty odor. She was born at home and\ndid not undergo neonatal screening. Which of the following substances will most\nlikely be found in high concentrations in the urine?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Seizures, fair skin,\nlight-colored hair, a musty body odor, and developmental delays suggest a\ndiagnosis of phenylketonuria (PKU). PKU is caused by deficiency of\nphenylalanine hydroxylase, the enzyme that converts phenylalanine to tyrosine.\nPhenylacetic acid appears in high concentrations in the urine.\n </span>\n</p>\n", "<p>\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Isoleucine is a branched-chain amino acid. Patients with\nmaple syrup urine disease have an accumulation of branched-chain amino acids\n(leucine, isoleucine, and valine) due to a deficiency in\n </span>\n branched-chain\nalpha-keto dehydrogenase complex\n <span>\n  . Symptoms include po\n </span>\n or\nfeeding, vomiting, dehydration, lethargy, hypotonia, seizures, hypoglycemia,\nketoacidosis, and neurological decline.\n <span>\n  The urine\nsmells sweet, not musty as in phenylketonuria.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Homocysteine\naccumulates in patients with cystathionine beta synthase deficiency\n(homocystinuria). This results in a Marfan-like syndrome. Symptoms include\ndislocation of the lens of the eye; tall, thin body habitus; curved spine;\nchest deformity; elongated limbs; and long, spiderlike fingers. Patients with\nhomocystinuria are predisposed to thromboembolic events.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Homogentisic acid\nappears in the urine of patients with alkaptonuria (\n  <span>\n   black urine disease),\n  </span>\n  which is a rare, autosomal recessive\ndisorder of phenylalanine and tyrosine metabolism. A defect in the enzyme\nhomogentisate\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Homogentisate_1,2-dioxygenase\" title=\"Homogentisate 1,2-dioxygenase\">\n </a>\n <span>\n  1, 2-dioxygenase results in accumulation of\nhomogentisic acid. This leads to ochronosis (blue or brownish-blue\ndiscoloration of cartilage and connective tissue, especially in the ears,\nsclerae, and joints). Patients with alkaptonuria have black urine, skin\npigmentation, and arthritis. Heart valve deformities and kidney stones are\ncommon.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Phenylketonuria\n(PKU) is an autosomal recessive disorder and one of the most common disorders\nof amino acid metabolism. The most important disorders of amino acid metabolism\nare listed below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Disorders\n  of Amino Acid Metabolism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Phenylketonuria\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Maple Syrup Urine Disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Homocystinuria\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Tyrosinemia\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Hereditary\ndisorders of amino acid processing can result from defects either in the\nbreakdown of amino acids or in the body's ability to get amino acids into\ncells. Because these disorders cause symptoms early in life, newborns are\nroutinely screened for several common ones. In the U.S., newborns are commonly\nscreened for phenylketonuria, maple syrup urine disease, homocystinuria, and\ntyrosinemia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   PHENYLKETONURIA (PKU)\n   <a name=\"sec23-ch282-ch282c-1447\">\n   </a>\n   <span>\n   </span>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1447a\">\n </a>\n <a name=\"sec23-ch282-ch282c-1448\">\n </a>\n <span>\n  Phenylketonuria (PKU) is\na disorder that causes a buildup of the essential amino acid phenylalanine.\n(Essential amino acids cannot be synthesized in the body and must be consumed\nin food.) Excess phenylalanine is normally converted to tyrosine, another amino\nacid, and eliminated from the body. Without the enzyme that converts it to\ntyrosine (phenylalanine hydroxylase), phenylalanine builds up in the blood and\nis toxic to the brain, causing intellectual disability. PKU is usually caused\nby deficiency of phenylalanine hydroxylase; however, rare cases have been\nassociated with impaired metabolism of biopterin, an essential cofactor in the\nphenylalanine hydroxylase reaction.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347158\" o:spid=\"_x0000_i1275\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image099.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n   <img border=\"0\" height=\"194\" src=\"_%20Tutorials_files/image100.png\" v:shapes=\"Picture_x0020_347158\" width=\"186\"/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1448a\">\n </a>\n <a name=\"Symptoms\">\n </a>\n <b>\n  <span>\n   Symptoms\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1450\">\n </a>\n <span>\n  Newborns with PKU rarely have symptoms right\naway, although sometimes they are sleepy or eat poorly. If not treated, affected\ninfants progressively develop intellectual disability over the first few years\nof life. Other symptoms include seizures, nausea and vomiting, eczema-like\nrash, lighter skin and hair than their family members, aggressive or\nself-injurious behavior, hyperactivity, and psychiatric symptoms. Untreated\nchildren often give off a musty body and urine odor as a result of a by-product\nof phenylalanine (phenylacetic acid) in the urine and sweat.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1450a\">\n </a>\n <a name=\"Diagnosis\">\n </a>\n <b>\n  <span>\n   Diagnosis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1450b\">\n </a>\n <span>\n  PKU is usually diagnosed with a blood test.\n  <a name=\"sec23-ch282-ch282c-1450c\">\n  </a>\n  Amniocentesis or chorionic villus sampling\nwith DNA analysis can be done to determine whether a fetus has the disorder.\n  <a name=\"sec23-ch282-ch282c-1450d\">\n  </a>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1450e\">\n </a>\n <a name=\"Prognosis\">\n </a>\n <b>\n  <span>\n   Prognosis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1450f\">\n </a>\n <span>\n  A phenylalanine-restricted diet, if started\nearly and maintained well, allows for normal development. However, if very\nstrict control of the diet is not maintained, affected children may begin to\nhave difficulties in school.\n  <a name=\"sec23-ch282-ch282c-1450g\">\n  </a>\n  A\nphenylalanine-restricted diet should continue for life, otherwise intelligence\nmay decrease and neurologic and psychiatric problems may ensue.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"Prevention%0Aand_Treatment\">\n </a>\n <a name=\"sec23-ch282-ch282c-1450h\">\n </a>\n <b>\n  <span>\n   Prevention and Treatment\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1451\">\n </a>\n <span>\n  To prevent intellectual disability, people must\nrestrict phenylalanine intake (but not eliminate it altogether because people\nneed some phenylalanine to live) beginning in the first few weeks of life.\nBecause all natural sources of protein contain too much phenylalanine for\nchildren with PKU, affected children cannot have meat, milk, or other common\nfoods that contain protein. Instead, they must eat a variety of\nphenylalanine-free processed foods, which are specially manufactured.\nLow-protein natural foods, such as fruits, vegetables, and restricted amounts\nof certain grain cereals can be eaten. Special nutritional products, including\ninfant formula without phenylalanine, are also available.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1454\">\n </a>\n <b>\n  <span>\n   Maple Syrup Urine\nDisease\n  </span>\n </b>\n</p>\n\n<p>\n <a name=\"sec23-ch282-ch282c-1454a\">\n </a>\n <a name=\"sec23-ch282-ch282c-1455\">\n </a>\n Maple\nsyrup urine disease (MSUD), also called branched-chain ketoaciduria, is an\nautosomal recessive metabolic disorder affecting branched-chain amino acids.\nThe condition gets its name from the distinctive sweet odor of affected\ninfants&rsquo; urine.\n</p>\n\n<p>\n MSUD is caused by a\ndeficiency of the branched-chain alpha-keto dehydrogenase complex (BCKDH),\nleading to a buildup of the branched-chain amino acids (leucine, isoleucine,\nand valine) and their toxic by-products in the blood and urine.\n</p>\n\n<p>\n The disease is characterized\nby the presence of sweet-smelling urine, with an odor similar to that of maple\nsyrup. Infants with this disease seem healthy at birth but if left untreated\nsuffer severe brain damage and eventually die. From early infancy, symptoms\ninclude poor feeding, vomiting, dehydration, lethargy, hypotonia, seizures,\nhypoglycemia, ketoacidosis, and neurological decline.\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1457\">\n </a>\n <span>\n  In the U.S., newborns are routinely screened for\nmaple syrup urine disease with a blood test.\n  <a name=\"sec23-ch282-ch282c-1458\">\n  </a>\n  Children with the disease must consume a special artificial diet that is low in\nthree amino acids (leucine, isoleucine, and valine).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1459\">\n </a>\n <b>\n  <span>\n   Homocystinuria\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1459a\">\n </a>\n <a name=\"sec23-ch282-ch282c-1460\">\n </a>\n <span>\n  Homocystinuria, also\ncalled cystathionine beta synthase deficiency, is an autosomal recessive\ndisorder. Children with the condition are unable to metabolize the amino acid\nhomocysteine, which, along with certain toxic by-products, builds up to cause a\nvariety of symptoms.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347157\"\n o:spid=\"_x0000_i1274\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image101.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"204\" src=\"_%20Tutorials_files/image102.png\" v:shapes=\"Picture_x0020_347157\" width=\"385\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Infants\nwith this disorder are normal at birth. Early symptoms begin after three years\nof age and include dislocation of the lens of the eye. Most children have\nskeletal abnormalities, including osteoporosis. Children are usually tall and\nthin with a curved spine, chest deformities, elongated limbs, and long,\nspiderlike fingers. Homocystinuria has several features in common with Marfan syndrome,\nbut unlike Marfan syndrome in which the joints tend to be &ldquo;loose,&rdquo; the joints\nin homocystinuria tend to be &ldquo;tight.&rdquo; Without early diagnosis and treatment,\npsychiatric disorders and intellectual disability occur. Homocystinuria causes\na hypercoagulable state, resulting in strokes and other thromboembolic events.\n  <a name=\"sec23-ch282-ch282c-1462\">\n  </a>\n  In the U.S., newborns are routinely screened\nfor homocystinuria with a blood test.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1464\">\n </a>\n <b>\n  <span>\n   Tyrosinemia\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"sec23-ch282-ch282c-1464a\">\n </a>\n <span>\n  There are three types of tyrosinemia. Each is\n  <a name=\"sec23-ch282-ch282c-1465\">\n  </a>\n  characterized by deficiency of a specific\nenzyme involved in the metabolism of tyrosine. Accumulation of toxic\nby-products may result in liver failure, renal failure, and mental retardation.\n </span>\n</p>\n", "choices": ["A. Phenylacetic acid", "B. Isoleucine", "C. Homocysteine", "D. Homogentisic acid"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An inherited metabolic disorder is characterized by increased\nconcentrations of hepatic glycogen and no detectable increase in glucose levels\nafter oral administration of fructose. Deficiency of which of the following\nenzymes is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  Glucose-6-phosphatase catalyzes the final step in gluconeogeneis and\nglycogenolysis. Deficiency of the enzyme results in fasting hypoglycemia and\nhigh concentrations of hepatic glycogen. Hypoglycemia occurs because of\nimpaired gluconeogenesis. Fructose administration does not solve the problem\nbecause gluconeogenesis is needed to convert fructose to glucose. Glycogen\naccumulates in the liver because it cannot be broke down into glucose (due to\nimpaired glycogenolysis).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Glucokinase is an\nenzyme that phosphorylates glucose to produce glucose-6-phosphate. This is the\nfirst step in glycolysis and glycogen synthesis. Deficiency of this enzyme\ncauses hyperglycemia. In fact, mutations of the glucokinase gene are\nresponsible for certain types of diabetes.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Fructokinase is an\nenzyme that phosphorylates fructose to produce fructose-1-phosphate. Enzyme\ndeficiency results in high fructose levels in the serum and urine (after\nfructose ingestion). This is a benign condition.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Phosphoglucomutase\ninterconverts glucose 1-phosphate and glucose 6-phosphate. This is important in\nglycogen synthesis and glycogenolysis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Glycogen synthase\nconverts short glucose polymers into long polymers. Enzyme deficiency results\nin glycogen deficiency. Glyogen is needed to produce glucose in the fasting\nstate. If glycogen stores are inadequate, fasting results in hypoglycemia.\nAfter a meal, glucose is used to make glycogen. If glycogen synthesis is\nimpaired, glucose levels rise, causing postprandial hyperglycemia.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Glycogen storage disease type I\n </span>\n <span>\n  (\n  <span>\n   GSD I\n  </span>\n  ),\nor\n  <span>\n   von Gierke's disease\n  </span>\n  , is the\nmost common glycogen storage disease. It is an autosomal recessive disease\ncaused by deficiency of glucose-6-phosphatase. This deficiency inhibits two\npathways needed to produce glucose in the liver: glycogenolysis and\ngluconeogenesis. The result is hypoglycemia, which occurs during periods of\nfasting. Glycogen accumulates in the liver and kidneys, causing enlargement of\nthese organs.\n </span>\n</p>\n\n<p>\n Hepatic glycogen serves as a\nform of rapidly accessible glucose, allowing blood glucose levels to be maintained\nbetween meals. For about three hours after a carbohydrate-containing meal,\ninsulin directs liver cells to take glucose from the blood, convert it to\nglucose-6-phosphate, and add this molecule to glycogen strands (glycogen\nsynthesis).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n When digestion of a meal is\ncomplete, insulin levels fall and glucose molecules are removed from glycogen\nin the form of glucose-6-phosphate. This process is called glycogenolysis. The\nglucose-6-phosphate remains in the liver cell until phosphate is cleaved by\nglucose-6-phosphatase. This dephosphorylation produces free glucose, which can\nbe transported out of the liver and into the blood, where it can travel to the\nbrain and other organs. Glycogenolysis can supply glucose needs for 12&ndash;18\nhours.\n</p>\n\n<p>\n When fasting continues for\nmore than a few hours, falling insulin levels permit catabolism of\ntriglycerides in adipose tissue and protein in muscle tissue. The products of\nthese processes are free fatty acids and amino acids, respectively. Free fatty\nacids are converted to acetyl-CoA, some of which is diverted to produce\nketones. Amino acids are used to synthesize new glucose-6-phosphate in liver\ncells by the process of gluconeogenesis. The last step of gluconeogenesis, like\nthe last step of glycogenolysis, is the dephosphorylation of\nglucose-6-phosphate to free glucose by glucose-6-phosphatase.\n</p>\n\n<p>\n Thus, glucose-6-phosphatase\nmediates the final steps in both pathways of glucose production: glycogenolysis\nand gluconeogenesis.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal metabolic effects of glucose-6-phosphatase deficiency (glycogen\nstorage disease type I, or von Gierke&rsquo;s disease) are:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hypoglycemia\n(fasting)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lactic\nacidosis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hyperuricemia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hypertriglyceridemia\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Hypoglycemia\n  </span>\n </b>\n <span>\n  is &ldquo;fasting&rdquo; or\n&ldquo;post-absorptive&rdquo; because it occurs after digestion of the meal (usually about\nfour hours later). The inability to maintain adequate blood glucose levels\nduring a fast occurs because of impaired glycogenolysis and gluconeogenesis.\nFasting hypoglycemia is the most significant complication of GSD I. Chronic\nhypoglycemia results in chronically low insulin levels and high levels of\nglucagon and cortisol.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Lactic\nacidosis\n  </span>\n </b>\n <span>\n  occurs because of impaired gluconeogenesis. In the liver and muscle, lactic\nacid is oxidized to form pyruvic acid, which is then converted to\nglucose-6-phosphate through gluconeogenesis. Accumulation of\nglucose-6-phosphate inhibits conversion of lactate to pyruvate.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Hyperuricemia\n  </span>\n </b>\n <span>\n  is due to several\nfactors. First of all, patients with GSD I are in a catabolic state, and purine\ncatabolism produces uric acid. Also, uric acid is produced when excess\nglucose-6-phosphate is metabolized via the pentose phosphate pathway. Finally,\nuiric acid competes with lactic acid and other organic acids for renal\nexcretion in the urine.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Clinical\nmanifestations of GSD I are discussed below.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Post-absorptive\nhypoglycemia can be mild, cause developmental delays, or lead to seizures and\ncoma.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Tissue\naccumulation of glycogen causes liver and kidney enlargement.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lactic\nacidosis causes vomiting and hyperventilation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hyperuricemia\ncan cause gout and renal disease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   5.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Impaired\ngrowth occurs because of chronically low insulin levels, high levels of\ncounterregulatory hormones, acidosis, decreased caloric intake, and\nmalabsorption.\n </span>\n</p>\n\n<p>\n The diagnosis of GSD I is\nmade by genetic testing and/or liver biopsy with an assay for\nglucose-6-phosphatase activity. The mainstay of treatment is frequent ingestion\nof food that is high in glucose or starch. (Starch is readily digested to\nglucose).\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347156\"\n o:spid=\"_x0000_i1273\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image103.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"288\" src=\"_%20Tutorials_files/image104.png\" v:shapes=\"Picture_x0020_347156\" width=\"339\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Fructose metabolism\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fructose\ndid not result in increased blood glucose, so the block must be in an enzyme\nthat is common to all pathways leading to free glucose secretion in the liver.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347155\"\n o:spid=\"_x0000_i1272\" type=\"#_x0000_t75\" alt=\"Description: TXT-200812288725161\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image105.png\" o:title=\"TXT-200812288725161\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: TXT-200812288725161\" border=\"0\" height=\"303\" src=\"_%20Tutorials_files/image106.png\" v:shapes=\"Picture_x0020_347155\" width=\"332\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Glucokinase\n  </span>\n </i>\n <span>\n  : phosphorylates glucose to produce\nglucose-6-phosphate\n  <i>\n  </i>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Fructokinase\n  </span>\n </i>\n <span>\n  :\n  <span>\n  </span>\n  phosphorylates\nfructose to produce fructose-1-phosphate\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Glucose-6-phosphatase\n  </span>\n </i>\n <span>\n  : hydrolyzes\nglucose-6-phosphate to produce glucose\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Phosphoglucomutase\n  </span>\n </i>\n <span>\n  : interconverts glucose\n1-phosphate and glucose 6-phosphate\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Glycogen synthase\n  </span>\n </i>\n <span>\n  : converts short\npolymers of glucose into long polymers\n </span>\n</p>\n", "choices": ["A. Glucokinase", "B. Fructokinase", "C. Glucose-6-phosphatase", "D. Phosphoglucomutase", "E. Glycogen synthase"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n3-year-old girl with a history of fractures of the right humerus and left tibia\npresents with pain in her left forearm after a fall. Physical examination shows\nblue sclerae. Which of the following is true?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct\n </b>\n . Osteogenesis imperfecta is an autosomal\ndominant disorder characterized by defects in type I collagen. It is the most\ncommon genetic cause of osteoporosis. The disorder is characterized by a triad\nof symptoms: fragile bones, blue sclerae, and early deafness.\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Common\ninherited disorders of connective tissue appear below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inherited\n  Disorders of Connective Tissue\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Marfan\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Ehlers-Danlos\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Osteogenesis Imperfecta\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Marfan syndrome\n  </span>\n </b>\n <span>\n  is an autosomal\ndominant disorder with an incidence of about 1 in 10,000 births. Nearly 30% of\ncases are due to spontaneous (sporadic) mutations. The condition is caused by\nabnormal biosynthesis of fibrillin-1, a protein that is the major component of\nelastic tissue and nonelastic tissues such as aortic adventitia and the\nsuspensory ligament of the eye. In Marfan syndrome, elastic fibers in the\nextracellular matrix are not correctly formed.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n <a name=\"4-u1.0-B978-1-4160-2450-7..50702-7--cese\">\n </a>\n Individuals with Marfan are\ntypically tall, with long limbs and long thin fingers. The most serious\ncomplications are defects of the heart valves and aorta. There are no unique\nsigns or symptoms, but the constellation of long limbs, dislocated lenses, and\naortic root dilation is sufficient to make the diagnosis. More than thirty\nclinical features are associated with the syndrome, most involving the\nskeleton, skin, and joints. Considerable variability exists within families\ncarrying the same mutation.\n</p>\n\n<p>\n Skeletal abnormalities\ninclude scoliosis, pectus excavatum or pectus carinatum, and abnormal joint\nflexibility. Ocular abnormalities include dislocation of the lens (80%),\nnear-sightedness, astigmatism, detachment of the retina, and glaucoma. Affected\nindividuals are predisposed to spontaneous pneumothorax. The most serious\ncomplications involve the cardiovascular system and include prolapse of the\nmitral and aortic valves resulting in regurgitation, aortic aneurysm, and\nangina. Heart problems may be unapparent until weakening of the connective\ntissue (cystic medial degeneration) in the ascending aorta causes aortic\ndissection.\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"search-hit\">\n  <b>\n   <span>\n    Ehlers\n   </span>\n  </b>\n </span>\n <b>\n  <span>\n   -\n   <span class=\"search-hit\">\n    Danlos\n   </span>\n   syndrome\n  </span>\n </b>\n <span>\n  is a group of\ngenetically heterogeneous connective tissue disorders in which the essential\ndefect is a deficiency of fibrillar collagen. The syndrome is characterized by\n  <a name=\"4-u1.0-B978-1-4160-2450-7..50486-2--intr\">\n  </a>\n  soft, velvety skin that is\nhyperelastic; lax, hypermobile joints that are easily subluxed; easy bruising\ndue to fragile skin and blood vessels; delayed wound healing; and unusual\nscarring. More than ten variants have been described. The most serious variants\nare associated with rupture of visceral organs.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Osteogenesis imperfecta (OI)\n  </span>\n </b>\n <span>\n  , or brittle bone\ndisease, is an autosomal dominant disorder characterized by structural and/or\nquantitative defects in type I collagen, the primary component of the extracellular\nmatrix of bone and skin. It is a generalized disorder of connective tissue and\nthe most common genetic cause of osteoporosis. The clinical spectrum is broad,\nranging from a lethal form in infancy to a mild form in adults. The prevalence\nin infants is about\n  <a name=\"4-u1.0-B978-1-4160-2450-7..50701-5--p288\">\n  </a>\n  1 in\n20,000. The disorder is characterized by a triad of symptoms: fragile bones,\nblue sclerae, and early deafness. Bone fractures occur with only mild trauma.\nOther findings include dental abnormalities, easy bruising, joint laxity, and\nshort stature.\n </span>\n</p>\n\n<p>\n [Collagen is the main\ncomponent of connective tissue and is the most abundant protein in mammals,\nmaking up about 25% to 35% of the whole-body protein content. It is found in\nfibrous tissues, such as tendon, ligament and skin, and is also abundant in cornea,\ncartilage, bone, blood vessels, the gut, and intervertebral disc. Fibroblasts\ncreate collagen. Collagen molecules are comprised of three polypeptide strands.\nEach strand forms a helix, and the three helices are twisted together into a\ntriple helix or &ldquo;super helix,&rdquo; stabilized by numerous hydrogen bonds. Collagen\nis broken down by a special group of collagenases called matrix\nmetalloproteinases.]\n</p>\n", "choices": ["A. Her condition is transmitted as an autosomal dominant trait", "B. Her condition results from a defect in type 1 collagen", "C. Her condition is associated with early deafness", "D. Her condition is associated with osteoporosis", "E. All of the above"]}, {"question": "<p>\n A 3-month-old boy is\nunresponsive when he arrives in the emergency room. His mother says that he\nstopped eating the previous day and has been vomiting. Examination shows\nhepatomegaly. Serum studies show hypoglycemia. Ketones are absent in the serum\nand urine. The boy regains consciousness after glucose infusion. Which of the\nfollowing is most likely?\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct\n </b>\n .\nMedium-chain acyl CoA dehydrogenase (MCAD) is an enzyme involved in fatty acid\noxidation (&beta;-oxidation). If the enzyme is deficient, fatty acids cannot be\ncatabolized in response to falling glucose levels. The result is lipid\naccumulation and liver enlargement. Ketones are not produced. The patient\ndevelops\n <i>\n  non-ketotic\n </i>\n hypoglycemia.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n .\nFructose-1,6-bisphosphatase is necessary for gluconeogenesis. It converts\nfructose-1,6-bisphosphate to fructose-6-phosphate. Deficiency of this enzyme\ninhibits gluconeogenesis, and impaired gluconeogenesis results in hypoglycemia.\nKetone production is not inhibited because fatty acid metabolism still takes\nplace.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer B is incorrect\n </b>\n .\nGlucose-6-phosphatase is an enzyme that catalyzes the final step in\ngluconeogenesis and glycogenolysis. Enzyme deficiency leads to fasting\nhypoglycemia. This condition is called glycogen storage disease type 1, or von\nGierke&rsquo;s disease. It is the most common glycogen storage disorder. Glycogen\naccumulates in the liver causing hepatomegaly. Lactic acidosis occurs because\nof impaired gluconeogenesis. Ketosis occurs because breakdown of fatty acids\nremains intact.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Methylmalonyl-CoA\nmutase converts methylmalonyl CoA to succinyl CoA, a metabolite in the Krebs\ncycle. Deficiency of this enzyme leads to methylmalonic acidemia, a type of\norganic acidemia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n .\nOrnithine carbamoyltransferase is a urea cycle enzyme. It converts ornithine to\ncitrulline. Enzyme deficiency results in hyperammonemia and neurological\nproblems. Ornithine carbamoyltransferase deficiency is the most common urea\ncycle disorder.\n</p>\n"], "tutorial": "<p>\n In this vignette, the infant\npresents with hypoglycemia. Answering the question requires an understanding of\ncarbohydrate and lipid metabolism.\n</p>\n\n<p>\n The brain depends on glucose\nfor fuel. The importance of glucose to the brain is apparent from the number of\nnervous, hormonal, and metabolic responses to falling glucose levels. The three\nmost important responses are\n <i>\n  glycogenolysis\n </i>\n ,\n <i>\n  gluconeogenesis\n </i>\n , and\n <i>\n  fatty acid oxidation.\n </i>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When the body is denied glucose for more\nthan 4 hours, hepatic glycogen is used for fuel. Through glycogenolysis,\nglycogen is broken down to glucose monomers. The liver contains about 12 hours\nworth of glycogen. When hepatic glycogen is depleted, three events occur. 1)\nMuscle glycogen is broken down, which may continue for days. 2) Gluconeogenesis\noccurs, in which glucose is generated from non-carbohydrate substrates. 3)\nLipolysis occurs, in which fats (triglycerides) are broken down into glycerol\nand fatty acids.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Each triglyceride molecule is composed of\none glycerol and three fatty acid molecules. Fatty acids are transported from\nthe cytosol to the mitochondria by carnitine (a quaternary ammonium compound).\nIn the mitochondria, fatty acids are broken down through beta-oxidation to\nproduce acetyl CoA, which enters the Krebs cycle to produce energy. If fatty\nacid breakdown is excessive, the Krebs cycle is overwhelmed and &ldquo;extra&rdquo; acetyl\nCoA is used to produce ketones, which the brain uses for energy. (The brain\ncannot use fatty acids directly because they do not cross the blood-brain\nbarrier.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The three metabolic responses to\nhypoglycemia are regulated by hormones. As glucose levels drop, insulin\nsecretion is suppressed and counter-regulatory hormone secretion is enhanced.\nCounter-regulatory hormones (glucagon, epinephrine, norepinephrine, cortisol,\nand growth hormone) oppose insulin action.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hypoglycemia may be ketotic or\nnon-ketotic. Ketones are formed by fatty acid oxidation. The principal ketones\nare acetoacetate and beta-hydroxybutyrate. Prolonged fasting causes ketosis\nbecause a fall in blood glucose triggers lipolysis, fatty acid oxidation, and\nketone production. In patients with disorders that impede fatty acid oxidation,\nketone production will be impaired. These patients will develop a non-ketotic\nhypoglycemia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The infant in this vignette has\n  <i>\n   non-ketotic\n  </i>\n  hypoglycemia, suggesting a disorder of fatty acid oxidation. Of the five\ninherited metabolic disorders listed, only one represents a disorder of fatty\nacid metabolism: medium-chain acyl-CoA dehydrogenase deficiency.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347154\" o:spid=\"_x0000_i1271\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image107.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"365\" src=\"_%20Tutorials_files/image108.png\" v:shapes=\"Picture_x0020_347154\" width=\"430\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Glycolysis\nand Gluconeogenesis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347153\" o:spid=\"_x0000_i1270\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image109.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"427\" src=\"_%20Tutorials_files/image110.png\" v:shapes=\"Picture_x0020_347153\" width=\"424\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347152\" o:spid=\"_x0000_i1269\"\n type=\"#_x0000_t75\" alt=\"Description: FA-Ox\">\n <v:imagedata src=\"_%20Tutorials_files/image111.png\" o:title=\"FA-Ox\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: FA-Ox\" border=\"0\" height=\"275\" src=\"_%20Tutorials_files/image112.png\" v:shapes=\"Picture_x0020_347152\" width=\"415\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Ketogenesis\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347151\" o:spid=\"_x0000_i1268\"\n type=\"#_x0000_t75\" alt=\"Description: Ketogenesis\">\n <v:imagedata src=\"_%20Tutorials_files/image113.png\" o:title=\"Ketogenesis\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Ketogenesis\" border=\"0\" height=\"417\" src=\"_%20Tutorials_files/image114.png\" v:shapes=\"Picture_x0020_347151\" width=\"313\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Fructose-1,6-bisphosphatase deficiency", "B. Glucose-6-phosphatase deficiency", "C. Medium-chain acyl CoA dehydrogenase deficiency", "D. Methylmalonyl-CoA mutase deficiency", "E. Ornithine carbamoyltransferase deficiency"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 2-week-old baby girl\ndelivered at term is brought to the physician by her mother because of an\nincreasingly severe diaper rash since birth. No congenital anomalies were noted\nafter delivery. Physical examination shows a red and swollen umbilical remnant\nthat has not separated. There are ulcerations of the skin but no purulent\nexudate in the area of the diaper. A culture of one of the ulcers grows\n  <i>\n   Staphylococcus\naureus\n  </i>\n  . Despite antibiotic therapy, 1 month later she develops a perirectal\nfissure, culture of which grows\n  <i>\n   Escherichia\ncoli\n  </i>\n  but a smear of which shows scarce segmented neutrophils. Laboratory\nstudies show:\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <u>\n   Patient&rsquo;s\nvalue\n  </u>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <u>\n   Normal\nvalue\n  </u>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12.6\ng/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  11-17\ng/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hematocrit\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  38%\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  30-40%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mean corpuscular volume\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  98 &mu;m\n  <sup>\n   3\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  86-110\n&mu;m\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Leukocyte count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  89,000/mm\n  <sup>\n   3\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  6-17.5/\nmm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Neutrophils\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  89%\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  31%\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Bands\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  6%\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  6-14%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Lymphocytes\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3%\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  61%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Monocytes\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2%\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  5%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelet count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  250,000/mm\n  <sup>\n   3\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  250-475,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  IgA\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  92\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0-5\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  IgG\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  766\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  831-1231\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  IgM\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  101\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  6-16\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Peripheral blood smear:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  normochromic,\nnormocytic erythrocytes\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  leukocytes\nwith normal morphology\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  This patient most likely\nhas which of the following conditions?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is correct.\n  </span>\n </b>\n <span>\n  The\npresence of recurrent, hard-to-eradicate bacterial infections in a newborn is\nworrisome for some hereditary defect of immunity or leukocyte function. Several\nclues in the vignette reveal the diagnosis. The skin ulcers are infected, but\nthere is no purulence. Also, the perirectal fissure is infected, but neutrophils\nare scarce. Clearly, something is inhibiting the normal neutrophil response to\nbacterial infection. One might suspect that the patient is neutropenic and\ncannot generate an inflammatory response, but the opposite is true. The patient\nhas a profound leukocytosis. (The leukocyte count is 89,000/mm\n  <sup>\n   3\n  </sup>\n  .)\nThus, the patient is mounting a dramatic response to infection, but the\nleukocytes cannot make their way to the site of infection. This can be\nexplained by leukocyte adhesion deficiency (LAD), a genetic disorder associated\nwith a defect in integrins or in the ligand for selectins, which are necessary\nfor leukocyte adhesion, an important step in the leukocytic response to\ninfection. (Also, of note, the patient has omphalitis, which occurs in LAD.)\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect.\n </b>\n Acute\nmyeloid leukemia (AML), also known as acute myelogenous leukemia, is a cancer\nof the myeloid line of blood cells, characterized by the rapid growth of\nabnormal white blood cells that accumulate in the bone marrow and interfere\nwith the production of normal blood cells. (The word &ldquo;myeloid&rdquo; is used to\ndescribe any leukocyte that is not a lymphocyte). AML is the most common acute\nleukemia affecting adults, and its incidence increases with age. Symptoms are\ncaused by replacement of normal bone marrow with leukemic cells, which causes a\ndrop in red blood cells, platelets, and normal white blood cells. This can\nresult in fatigue, shortness of breath, easy bruising and bleeding, and\nincreased risk of infection. Several risk factors and chromosomal abnormalities\nhave been identified, but the specific cause is not clear. As an acute\nleukemia, AML progresses rapidly and is typically fatal within weeks or months\nif left untreated.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n Acquired\nimmunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus\n(HIV), a retrovirus that primarily infects cells of the immune system, such as\nCD4\n <sup>\n  +\n </sup>\n T cells, macrophages, and dendritic cells. The virus\nprogressively weakens the immune system, leaving individuals susceptible to\nopportunistic infections and tumors.\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect.\n  </span>\n </b>\n <span>\n  Ch&eacute;diak-Higashi\nsyndrome is a rare autosomal recessive disorder caused by a mutation in the\nlysosomal trafficking regulator gene, LYST. The mutation disrupts microtubule\npolymerization, resulting in impaired phagolysosome formation. (A phagolysosome\nis a membrane-enclosed organelle that forms when a phagosome fuses with a\nlysosome. Under normal conditions, after fusion, the pathogen contained within\nthe phagosome is digested by enzymes in the lysosome.) Ch&eacute;diak-Higashi syndrome\nis characterized by recurrent pyogenic infections, partial albinism, and\nperipheral neuropathy.\n </span>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect.\n </b>\n Common\nvariable immunodeficiency (CVID) is a group of approximately 150 disorders\ncharacterized by low serum immunoglobulin levels. Affected individuals are\npredisposed to recurrent infection of the ears, sinuses, and respiratory\nsystem, as well as digestive problems, blood disorders, and cancer. Symptoms\ntypically occur in children ages 2 to 8 or in adults above age 30.\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Because leukocytes play\na central role in host defense, defects in leukocyte function, both inherited\nand acquired, lead to increased vulnerability to infection. Impairments of\nvirtually every phase of leukocyte function have been identified &ndash; from\nadherence to vascular endothelium to microbicidal activity. These include the\nfollowing:\n  <a name=\"4-u1.0-B978-1-4377-0792-2..50007-9--celi\">\n  </a>\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" class=\"MsoNormalTable\" width=\"95%\">\n <tr>\n  <td valign=\"top\" width=\"3%\">\n   <p class=\"MsoNormal\">\n    <span>\n     &bull;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Inherited\n  defects in leukocyte adhesion\n     </span>\n    </b>\n    <span>\n     . Peripheral blood leukocytes undergo a\n  sequence of activation that leads to migration of cells into the site of\n  inflammation. First, the cells roll along endothelial surfaces, a process\n  that requires expression of selectins on the endothelial cells and their\n  ligands on leukocytes. Next, cells adhere to the endothelial surface and\n  enter the tissues by diapedesis; this process requires the family of\n  integrins. Genetic defects of integrins and selectin-ligands cause\n     <i>\n      leukocyte\n  adhesion deficiencies\n     </i>\n     (LAD) types 1 and 2. LAD is characterized by marked\n  leukocytosis and localized bacterial infections that are difficult to detect\n  until they have progressed extensively (due to lack of leukocyte recruitment\n  at the site of infection). Affected individuals suffer from bacterial\n  infections beginning in the neonatal period. Infections such as omphalitis\n  (infection of the umbilical cord stump), pneumonia, gingivitis, abscesses,\n  and peritonitis are common and often life-threatening.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"3%\">\n   <p class=\"MsoNormal\">\n    <span>\n     &bull;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Inherited\n  defects in phagolysosome function\n     </span>\n    </b>\n    <span>\n     . One such disorder is\n     <i>\n      Ch&eacute;diak-Higashi\n  syndrome\n     </i>\n     , an autosomal recessive condition characterized by defective\n  fusion of phagosomes and lysosomes in phagocytes (causing susceptibility to\n  infection), as well as abnormalities in 1) melanocytes (leading to albinism),\n  2) nerve cells (associated with nerve defects), and 3) platelets (causing\n  bleeding disorders). The main leukocyte abnormalities are neutropenia\n  (decreased numbers of neutrophils), defective degranulation, and delayed\n  microbial killing. Leukocytes contain giant granules, which can be readily\n  seen in peripheral blood smears and are thought to result from aberrant\n  phagolysosome fusion.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"3%\">\n   <p class=\"MsoNormal\">\n    <span>\n     &bull;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Inherited\n  defects in microbicidal activity\n     </span>\n    </b>\n    <span>\n     . The importance of oxygen-dependent\n  bactericidal mechanisms is shown by the existence of a group of congenital\n  disorders called\n     <i>\n      chronic granulomatous disease\n     </i>\n     , which are\n  characterized by defects in bacterial killing and render patients susceptible\n  to recurrent bacterial infection. Chronic granulomatous disease results from\n  inherited defects in the genes encoding components of phagocyte oxidase,\n  which generates\n     <span>\n      superoxide\n     </span>\n     . The name of\n  the disease comes from the macrophage-rich chronic inflammatory reaction that\n  tries to control the infection when the initial neutrophil defense is\n  inadequate. This often leads to collections of activated macrophages that\n  wall off microbes, forming aggregates called granuloma\n     <i>\n      s\n     </i>\n     .\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"3%\">\n   <p class=\"MsoNormal\">\n    <span>\n     &bull;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Acquired\n  deficiencies\n     </span>\n    </b>\n    <span>\n     .\n  Clinically, the most frequent cause of leukocyte defects is\n     <i>\n      bone marrow\n  suppression\n     </i>\n     , leading to\n     <a name=\"4-u1.0-B978-1-4377-0792-2..50007-9--p56\">\n     </a>\n     decreased\n  production of leukocytes. This is seen following therapies for cancer\n  (radiation and chemotherapy) and when the marrow space is compromised by\n  tumors, which may arise in the marrow (e.g., leukemias) or be metastatic from\n  other sites.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4377-0792-2..50007-9--ceta\">\n </a>\n <span>\n  <br/>\n  Defects in Leukocyte Function\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <span>\n      Disease\n     </span>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <span>\n      Defect\n     </span>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td colspan=\"2\" valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     GENETIC\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Leukocyte\n  adhesion deficiency 1\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Defective\n  leukocyte adhesion because of mutations affecting &beta; chain of CD11/CD18\n     <i>\n      integrins\n     </i>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Leukocyte\n  adhesion deficiency 2\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Defective\n  leukocyte adhesion because of mutations affecting enzyme required for\n  synthesis of ligand for\n     <i>\n      selectins\n     </i>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Chronic\n  granulomatous disease\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n  oxidative burst\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Myeloperoxidase\n  deficiency (MPO)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n  microbial killing because of defective MPO&mdash;H\n     <sub>\n      2\n     </sub>\n     O\n     <sub>\n      2\n     </sub>\n     system\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ch&eacute;diak-Higashi\n  syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n  leukocyte functions because of mutations affecting protein involved in\n  lysosomal membrane traffic\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     ACQUIRED\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Bone\n  marrow suppression: tumors, radiation, and chemotherapy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Production\n  of leukocytes\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Diabetes,\n  malignancy, sepsis, chronic dialysis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Adhesion\n  and chemotaxis\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Leukemia,\n  anemia, sepsis, diabetes, malnutrition\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Phagocytosis\n  and microbicidal activity\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Acute myelogenous leukemia", "B. Acquired immunodeficiency syndrome", "C. Ch\u00e9diak-Higashi syndrome", "D. Common variable immunodeficiency", "E. Leukocyte adhesion deficiency"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 2-year-old boy with mental retardation\npresents with weakness and a protuberant abdomen. Physical examination shows\nhepatosplenomegaly. His blood hemoglobin level is 9 mg/dl and his platelet\ncount is 20,000/mm\n  <sup>\n   3\n  </sup>\n  . Bone marrow examination shows lipid-laden\nmacrophages. Additional studies show accumulation of glucocerebroside in the\nreticuloendothelial cells (macrophage system). Which of the following enzymes\nis most likely deficient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The patient has Gaucher disease, caused by\n&beta;-Glucosidase deficiency.\n </span>\n</p>\n"], "tutorial": "<p>\n <a href=\"http://en.wikipedia.org/wiki/Lysosome\" title=\"Lysosome\">\n </a>\n Lysosomes are\norganelles that serve as the cell&rsquo;s &ldquo;recycling center.&rdquo; They process unwanted\nmaterials into substances that the cell can use. Specific enzyme deficiencies\ncan result in lysosomal storage diseases (LSDs), a group of about forty\ndisorders in which intracellular accumulation of lipid, glycoprotein, or\n <a href=\"http://en.wikipedia.org/wiki/Mucopolysaccharides\" title=\"Mucopolysaccharides\">\n  mucopolysaccharide\n </a>\n results in organ failure.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The most common lysosomal storage\ndisease is Gaucher disease. Other lysosomal storage diseases include Tay-Sachs,\nNiemann-Pick, Fabry, Farber, and Hurler disease.\n</p>\n\n<p>\n <b>\n  Gaucher disease\n </b>\n is the most common of the lysosomal storage\ndiseases. It is an aut\n <span>\n  osomal recessive\n </span>\n disorder\ncharacterized by the accumulation of lipid in certain cells (e.g., macrophages)\nand organs. The disease is caused by a hereditary deficiency of the enzyme\nglucocerebrosidase (also known as acid &beta;-glucosidase). When the enzyme is\ndeficient, glucocerebroside accumulates, particularly in the liver, spleen,\nkidneys, lungs, brain, and bone marrow. Symptoms include distended abdomen;\nenlarged liver, spleen, and lymph nodes; anemia and thrombocytopenia; skeletal\ndisorders; severe neurologic complications, including mental retardation; and\nyellow fatty deposits on the sclerae. Affected individuals are predisposed to\ninfection. Some forms of Gaucher's disease may be treated with enzyme\nreplacement therapy.\n</p>\n\n<p>\n Ceramidase deficiency causes\n <b>\n  Farber disease\n </b>\n , an autosomal\nrecessive disorder that results in arthritis, hepatosplenomegaly, dysphagia,\nand mental retardation. Swollen joints and joint contractures occur.\n</p>\n\n<p>\n &alpha;-Galactosidase\ndeficiency causes\n <b>\n  Fabry disease\n </b>\n , an\nX-linked disorder that results in renal failure, cardiomyopathy,\nangiokeratomas, anhidrosis, Raynaud&rsquo;s phenomenon, neuropathy, and keratopathy.\n</p>\n\n<p>\n Hexosaminidase deficiency\ncauses\n <b>\n  Tay-Sach disease\n </b>\n , an\nautosomal recessive disorder that results in blindness, deafness, neurological\nimpairment, and paralysis. A &ldquo;cherry-red&rdquo; macula is seen in all patients.\nHepatosplenomegaly does not occur.\n</p>\n\n<p>\n &alpha;-L-Iduronidase\ndeficiency causes\n <b>\n  Hurler syndrome\n </b>\n ,\nan autosomal recessive disorder that results in mental retardation, an abnormal\nface, dwarfism, and hepatosplenomegaly.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Sphingomyelinase deficiency\ncauses\n <b>\n  Niemann-Pick disease\n </b>\n , an\nautosomal recessive disorder that results in ataxia, dysarthria, dysphagia,\ndystonia, hepatosplenomegaly, and thrombocytopenia.\n</p>\n", "choices": ["A. Ceramidase", "B. \u03b1-Galactosidase", "C. \u03b2-Glucosidase", "D. Hexosaminidase", "E. \u03b1-L-Iduronidase", "F. Sphingomyelinase"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n3-year-old boy has a tendency toward self-mutilation. He bites his fingers and\nlips. He has choreoathetosis, delayed motor development, and arthritis. Serum\nuric acid levels are very high. Which of the following is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct\n  </span>\n </b>\n <span>\n  .\nHPRT is part of the &ldquo;salvage&rdquo; pathway. It recaptures intermediate breakdown\nproducts, preventing further degradation to uric acid. Deficiency of this\nenzyme blocks the salvage pathway, forcing intermediate products to be further\ndegraded to uric acid.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nPhosphoribosylpyrophosphate (PRPP) synthetase converts ribose-5-phosphate to\nPRPP. This is the first step of\n  <i>\n   de novo\n  </i>\n  purine synthesis. Deficiency of\nthis enzyme inhibits purine metabolism and reduces uric acid formation. PRPP\nsynthetase\n  <i>\n   overactivity\n  </i>\n  , not deficiency, is associated with high uric\nacid levels.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect\n  </span>\n </b>\n <span>\n  .\nAdenine phosphoribosyltransferase (APRT) converts adenine to AMP. Deficiency of\nthis enzyme reduces uric acid production.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect\n  </span>\n </b>\n <span>\n  .\nAllopurinol is a drug used in the treatment of gout. It works by inhibiting\nxanthine oxidase. Xanthine oxidase converts 1) hypoxanthine to xanthine and 2)\nxanthine to uric acid. By blocking xanthine oxidase, allopurinol lowers uric\nacid levels, thus preventing gouty attacks, which are caused by the deposition\nof uric acid crystals in joints.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Uric acid\nis a product of purine metabolism. Purines are essential for life. In addition\nto being part of DNA and RNA, they are components of ATP, GTP, cAMP, NADH, and\ncoenzyme A. The most common purines appear below.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347150\"\n o:spid=\"_x0000_i1267\" type=\"#_x0000_t75\" alt=\"Description: Purines.gif\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image115.png\" o:title=\"Purines.gif\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Purines.gif\" border=\"0\" height=\"209\" src=\"_%20Tutorials_files/image116.png\" v:shapes=\"Picture_x0020_347150\" width=\"349\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Adenine\nand guanine are purines that are used to make DNA. Their breakdown results in\nuric acid. The following conditions are associated with elevated serum uric\nacid levels (hyperuricemia).\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"479\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Causes of Hyperuricemia\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Increased Urate Production (10%)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Decreased Urate Excretion (90%)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ethanol\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Disorders\n  of purine metabolism\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpFirst\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     PRPP synthetase\n  overactivity\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpMiddle\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     HPRT deficiency\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpMiddle\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Glucose-6-phosphatase\n  deficiency\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpMiddle\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     G6PD deficiency\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpLast\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Fructose-1-phosphate\n  aldolase deficiency\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Conditions\n  with increased cell turnover\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpFirst\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Cytotoxic drugs (tumor\n  lysis syndrome)\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpMiddle\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Myeloproliferative\n  diseases\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpLast\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Sickle cell disease,\n  thalassemia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dehydration\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Renal\n  insufficiency\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Acidosis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Hypothyroidism\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Drugs\n  (e.g., diuretics, low-dose salicylates)\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  To\nunderstand how specific enzyme disorders can increase uric acid levels, one\nmust understand purine metabolism. A schematic of purine metabolism appears\nbelow.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347149\"\n o:spid=\"_x0000_i1266\" type=\"#_x0000_t75\" alt=\"Description: Purine metabolism.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image117.jpg\" o:title=\"Purine metabolism.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Purine metabolism.jpg\" border=\"0\" height=\"245\" src=\"_%20Tutorials_files/image118.png\" v:shapes=\"Picture_x0020_347149\" width=\"390\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PRPP:\nPhosphoribosylpyrophosphate\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HPRT:\nHypoxanthine-guanine phosphoribosyltransferase\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  APRT:\nAdenine phosphoribosyltransferase\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Purine\nmetabolism has three major components:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  <span>\n   De novo\n  </span>\n </i>\n <span>\n  synthesis of purines via PRPP\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Purine\ninterconversion (GMP &harr; IMP &harr; AMP)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  &ldquo;Salvage&rdquo;\npathways that recapture intermediate breakdown products, preventing further\nbreakdown to uric acid\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Many\nenzymes are involved in purine metabolism. These enzymes include PRPP\nsynthetase, PRPP amidotransferase, APRT, and xanthine oxidase. Deficiency (or\ninhibition) of any of these enzymes will decrease uric acid production.\n  <i>\n   Deficiency\nof hypoxanthine-guanine phosphoribosyltransferase (HPRT), however, has the\nopposite effect\n  </i>\n  . This enzyme participates in the\n  <i>\n   salvage pathway\n  </i>\n  of\npurine metabolism. It converts hypoxanthine to IMP and guanine to GMP.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Deficiency of this enzyme\n  <i>\n   increases\n  </i>\n  uric acid production because intermediate breakdown products have no other\n&ldquo;path&rdquo; to follow.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HPRT\ndeficiency results in Lesch-Nyhan syndrome, which is a rare X-linked disorder\ncharacterized by self-mutilating behavior, neurological impairment, and\narthritis. Uric acid levels are extremely high.\n </span>\n</p>\n", "choices": ["A. Phosphoribosylpyrophosphate (PRPP) synthetase deficiency", "B. Adenine phosphoribosyltransferase (APRT) deficiency", "C. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency", "D. Xanthine oxidase inhibition"]}, {"question": "<p>\n The control curve in the\ngraph below illustrates the relationship between initial velocity of reaction\nand substrate concentration for an enzyme obeying Michaelis-Menten kinetics.\nWhich of the following curves best represents the results that would be obtained\nby halving the amount of enzyme?\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347148\"\n o:spid=\"_x0000_i1265\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image119.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"170\" src=\"_%20Tutorials_files/image120.png\" v:shapes=\"Picture_x0020_347148\" width=\"215\"/>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  Halving the amount of\nenzyme is the functional equivalent of using a noncompetitive inhibitor to\ninactivate half of the enzymes present. The curve produced by halving the\namount of enzyme would, therefore, resemble the curve for non-competitive\ninhibition. In both cases, t\n  <span>\n   he velocity\nof reaction would be reduced for all concentrations of substrate, and V\n   <sub>\n    max\n   </sub>\n   would be reduced as well.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;\n   </span>\n   <sub>\n   </sub>\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n Enzymes speed up the rate of\na chemical reaction without being consumed in the process. They achieve this by\ntemporarily binding to a\n <span>\n  substrate,\nthereby l\n </span>\n owering the activation energy needed to convert it to a\nproduct.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The rate\nat which an enzyme works is influenced by several factors:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Substrate\nconcentration. Adding more substrate keeps the enzyme active site occupied more\noften, thus allowing the reaction to occur more frequently. This makes the\napparent rate of reaction higher. At higher substrate concentrations, however,\nthe enzyme will eventually be saturated and the observed rate is maximized.\nThis is evidenced by the plateau in the curve at high substrate\nconcentrations.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Temperature.\nHigher temperatures accelerate the reaction.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Inhibitors.\nAdding inhibitors keeps the active site from working on the productive\nreaction, thus the apparent rate of reaction is lower.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Acidity.\nThe pH affects protein conformation and charge state, which influence enzymatic\nactivity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The study\nof the rate at which an enzyme works is called\n  <span>\n   enzyme kinetics\n  </span>\n  . The following figure shows the relationship\nbetween substrate concentration and velocity of reaction.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347147\"\n o:spid=\"_x0000_i1264\" type=\"#_x0000_t75\" alt=\"Description: Michaelis_Menten\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image121.png\" o:title=\"Michaelis_Menten\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Michaelis_Menten\" border=\"0\" height=\"250\" src=\"_%20Tutorials_files/image122.png\" v:shapes=\"Picture_x0020_347147\" width=\"202\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  From the\nfigure, we see that\n  <a name=\"Michaelis_Menten\">\n  </a>\n  at low levels of substrate,\nthe velocity of reaction rises almost linearly with increased substrate\nconcentration. As substrate levels rise further, the gains in velocity level\noff. The asymptote represents the maximum velocity of the reaction. The\nsubstrate concentration that produces a velocity that is one-half of the\nmaximum velocity is called the Michaelis-Menten constant (\n  <span>\n   K\n   <sub>\n    m\n   </sub>\n  </span>\n  ). This constant is\ninversely related to the affinity between substrate and enzyme. The lower the\n  <span>\n   K\n   <sub>\n    m\n   </sub>\n  </span>\n  , the greater is the\naffinity.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  There are\ntwo types of enzyme inhibitors.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Competitive\ninhibitors &ldquo;compete&rdquo; with a substrate for a specific site on an enzyme. By\nbinding to that site, the inhibitor prevents the substrate from binding\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Noncompetitive\ninhibitors bind to the enzyme at a different site, taking it &ldquo;out of\ncommission.&rdquo;\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ndifference between competitive and noncompetitive inhibition is illustrated\nbelow.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347146\"\n o:spid=\"_x0000_i1263\" type=\"#_x0000_t75\" alt=\"Description: Michaelis_Menten2\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image123.png\" o:title=\"Michaelis_Menten2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Michaelis_Menten2\" border=\"0\" height=\"164\" src=\"_%20Tutorials_files/image124.png\" v:shapes=\"Picture_x0020_347146\" width=\"191\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   Competitive Inhibition\n  </span>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When a\ncompetitive inhibitor is present, higher substrate concentrations are needed to\ndisplace the inhibitor and achieve the same velocity.\n  <span>\n   V\n   <sub>\n    max\n   </sub>\n  </span>\n  can still be reached if enough substrate is\navailable. The\n  <span>\n   K\n   <sub>\n    m\n   </sub>\n  </span>\n  is\nlarger because the enzyme&rsquo;s affinity for substrate is diminished by the\ninhibitor.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"Noncompetitive_Inhibition\">\n  <span>\n   Noncompetitive Inhibition\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When a\nnoncompetitive inhibitor is present, it binds to the enzyme, taking it &ldquo;out of\ncommission.&rdquo; The velocity of reaction is reduced for all substrate\nconcentrations. The\n  <span>\n   K\n   <sub>\n    m\n   </sub>\n  </span>\n  is unchanged, however, because enzymes still &ldquo;in commission&rdquo; have the same\naffinity for substrate.\n </span>\n</p>\n", "choices": ["A. Curve 1", "B. Curve 2", "C. Curve 3", "D. Control curve"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A normal\npeptide has 100 amino acids. Following mutation, it has only 20. Amino acids\n1-10 are the same as the normal peptide; 11-20 differ from the normal peptide.\nWhich of the following mutations occurred?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct.\n </b>\n A granuloma is an organized collection of\nmacrophages. T cells recruit monocytes into tissues where they differentiate to\nform macrophages. T cells also elaborate cytokines that activate macrophages.\nIn patients with AIDS, T cells are depleted and granuloma formation is\nimpaired.\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The effect\nof a genetic mutation depends on its location and its ability to alter protein\nfunction.\n  <span>\n   The major types of mutation\nappear below.\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Substitution.\n  </span>\n </b>\n <span>\n  A\n </span>\n <span>\n  single nucleotide is exchanged for another. There are three\nbasic types:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Silent\nmutation, which codes for the same amino acid\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Missense\nmutation, which codes for a different amino acid\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Nonsense\nmutation, which codes for a stop codon\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Insertion.\n  </span>\n </b>\n <span>\n  One or more nucleotides\nis inserted into DNA. The mutation is often reversible. The reading frame may\nbe altered.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Deletion.\n  </span>\n </b>\n <span>\n  O\n </span>\n <span>\n  ne or more nucleotides is deleted from DNA. The mutation is\nusually irreversible. The reading frame may be altered.\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Frameshift.\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </b>\n    <span>\n     If the number\n  of nucleotides inserted or deleted is not divisible by three, a frameshift\n  mutation occurs. This is because each codon contains three nucleotides. The\n  addition or deletion of only one or two nucleotides alters the reading frame,\n    </span>\n    <span>\n     resulting\n  in a completely different protein.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Answer B is correct.\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </b>\n    <span>\n     In the clinical vignette, amino acids\n  1-10 are unchanged and amino acids 11-20 are different. Thus, the first amino\n  acid to be altered is amino acid 11, indicating that the mutation must be in\n  codon 11 (which codes for amino acid 11). Could this mutation be a\n  substitution? Consider the following: If a silent mutation had occurred, the\n  amino acid sequence would not have changed. If a missense mutation had\n  occurred, amino acid 11 would have changed, but amino acids 12-20 would have\n  been the same. If a nonsense mutation had occurred, the sequence would have\n  ended at amino acid 10, not amino acid 20. Therefore, a substitution mutation\n  cannot explain the new sequence. The only way to explain a change in sequence\n  that encompasses the entire remaining length of the protein is with a\n  frameshift mutation. This mutation could be an insertion or a deletion.\n  Either way, the number of nucleotodes inserted or deleted would not be\n  divisible by three. (If the number were divisible by three, the reading frame\n  would not have &ldquo;shifted.&rdquo;) The answer is, therefore, B (i.e., a deletion in\n  codon 11) because this is the only option that produces a frameshift mutation\n  at codon 11. Also, we can assume that the frameshift mutation resulted in a\n  nonsense codon at position 21, since the protein was terminated at amino acid\n  20.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  In patients with AIDS, the failure to form granulomas in tissues infected\nby\n  <i>\n   Mycobacterium tuberculosis\n  </i>\n  is most\nlikely due to which of the following?\n </span>\n</p>\n\n<p>\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Inability of T lymphocytes to provide helper\nfunctions for B lymphocytes\n </span>\n</p>\n\n<p>\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Inability of T lymphocytes to recruit and\nimmobilize monocytes\n </span>\n</p>\n\n<p>\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Clonal deletion of T lymphocytes reactive to\nmycobacterial antigens\n </span>\n</p>\n\n<p>\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Decreased production of tumor necrosis\nfactor-&alpha; by macrophages\n </span>\n</p>\n\n<p>\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Poor phagocytic activity of macrophages\n </span>\n</p>\n\n<p>\n <span>\n  A granuloma\n </span>\n is an\n <b>\n </b>\n <span>\n  organized\ncollection of macrophages\n </span>\n that have gathered around a microorganism or\nforeign substance to &ldquo;wall it off&rdquo; from the body (see Figure 1). Macrophages\n(also known as histiocytes) define the granuloma.\n <span>\n  They originate as monocytes, which are recruited by T-cells into tissues\nwhere they differentiate into macrophages. Cytokines produced by T-cells\n&ldquo;activate&rdquo; macrophages, rendering them more &ldquo;aggressive.&rdquo;\n </span>\n</p>\n\n<p>\n Granulomatous macrophages\nare sometimes called &ldquo;epithelioid&rdquo; because they resemble epithelial cells.\nThese macrophages form a tight &ldquo;ball&rdquo; around the microorganism or foreign\nsubstance. They are so tightly clustered that the borders of individual cells\nare difficult to appreciate. The &ldquo;ball&rdquo; of macrophages is surrounded by a\ncollar of lymphocytes, which produce cytokines that keep the macrophages\nactivated. Some macrophages fuse to form multinucleated giant cells (Langhans\ngiant cells). (See Figure 2.)\n</p>\n\n<p>\n Granulomas form in response\nto antigens that are resistant to \"first-responder\" inflammatory\ncells, such as neutrophils and eosinophils. Thus, granulomas represent a type\nof chronic inflammation. Some granulomas contain areas of necrosis. The\nidentification of necrosis usually indicates that the granuloma has an\ninfectious cause. The term &ldquo;caseation&rdquo; (turning into cheese) is used to describe\nnecrosis that looks &ldquo;cheese-like&rdquo; to the unaided eye. Caseating necrosis is\ntypical of tuberculosis.\n</p>\n\n<p>\n T\n <span>\n  uberculosis is the prototypic granulomatous disease and should always\nbe considered in the differential diagnosis in patients with granulomatous inflammation.\n </span>\n Granulomas occur in the following conditions.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <thead>\n   <tr>\n    <td valign=\"top\">\n     <p class=\"MsoNormal\">\n      <b>\n       <span>\n        Disease\n       </span>\n      </b>\n     </p>\n    </td>\n    <td valign=\"top\">\n     <p class=\"MsoNormal\">\n      <b>\n       <span>\n        Cause\n       </span>\n      </b>\n     </p>\n    </td>\n   </tr>\n  </thead>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Tuberculosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Mycobacterium\n  tuberculosis\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Leprosy\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Mycobacterium\n  leprae\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Syphilis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Treponema\n  pallidum\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fungal\n  disease\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Histoplasma,\n  Coccidioides, Cryptococcus\n      </span>\n     </i>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cat-scratch\n  disease\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Bartonella\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Sarcoidosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Unknown\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Crohn&rsquo;s\n  disease\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Unknown\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Wegener&rsquo;s\n  granulomatosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Unknown\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p align=\"center\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/f/f2/Necrogran10x.jpg\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347145\" o:spid=\"_x0000_i1262\" type=\"#_x0000_t75\" alt=\"Description: File:Necrogran10x.jpg\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/f/f2/Necrogran10x.jpg\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image125.jpg\" o:title=\"Necrogran10x.jpg\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: File:Necrogran10x.jpg\" border=\"0\" height=\"212\" src=\"_%20Tutorials_files/image126.png\" v:shapes=\"Picture_x0020_347145\" width=\"281\"/>\n  </span>\n </a>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Figure 1. Granuloma in a patient with tuberculosis\n </span>\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347144\"\n o:spid=\"_x0000_i1261\" type=\"#_x0000_t75\" alt=\"Description: giant_cell_S98-40211-03\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image127.jpg\" o:title=\"giant_cell_S98-40211-03\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: giant_cell_S98-40211-03\" border=\"0\" height=\"181\" src=\"_%20Tutorials_files/image128.png\" v:shapes=\"Picture_x0020_347144\" width=\"269\"/>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Figure 2. Langhans giant cells\n </span>\n</p>\n", "choices": ["A. Nucleotide substitution in codon 11 (the codon that codes for amino acid 11)", "B. Nucleotide deletion in codon 11", "C. Nucleotide substitution in codon 20", "D. Nucleotide deletion in codon 20", "E. Nucleotide insertion in codon 20"]}, {"question": "<p>\n <span>\n  A specific congenital form of deafness results from mutation of a\nsequence of connexin 26 that encodes the channel within the connexin of the gap\njunction. The mutation is most likely to affect which of the following domains\nof the protein?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct.\n </b>\n Mutation of the connexin 26 gene causes a\ndefect in the transmembrane region of the connexin protein.\n</p>\n"], "tutorial": "<p>\n <span>\n  Gap junction beta-2\n </span>\n (GJB2) also known as\n <b>\n  connexin-26\n </b>\n <b>\n  (Cx26)\n </b>\n is a protein that in humans is\nencoded by the\n <i>\n  GJB2\n </i>\n gene. Defects in this gene lead to the most common\nform of congenital deafness in developed countries, called DFNB1, also known as\nConnexin 26 deafness or GJB2-related deafness.\n <span>\n  The\nprevalence and availability of interventions makes identifying those individuals\nwith hearing loss a public health issue. Universal newborn screening for\nhearing loss has been widely adopted since it is known that early\nidentification and management of deafness is important for the development of\nlanguage and social skills. Research has shown that children with hearing loss\nidentified before six months of age and who have begun appropriate\ninterventions immediately after diagnosis demonstrate superior language skills\nover those identified after six months of age.\n </span>\n</p>\n\n<p class=\"MsoBodyText\">\n About one in 1000 infants has profound hearing loss, with\nat least half of these cases thought to be of genetic origin. Despite this\nnumber, genetic causes of hearing loss are frequently undiagnosed. Also,\nchildren who are the only deaf individuals in their families may have a genetic\nor inherited cause for their deafness. There are many genes that contribute to\nhearing loss. These genes may be inherited in a variety of fashions: autosomal\ndominant, autosomal recessive, X-linked, or mitochondrial.\n <span>\n  Infection in the mother during pregnancy or illness of the\ninfant requiring care in a neonatal intensive care unit may result in isolated\nor sporadic cases of newborn hearing loss within families.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The most\ncommon cause of congenital deafness in children is caused by a mutation\n(autosomal recessive) of a gene called GBJ2. The gap junction gene called GJB2\nencodes the protein connexin 26(Cx26). Many people simply refer to the gene as\nthe &ldquo;\n  <span>\n   connexin 26 gene\n  </span>\n  .&rdquo; In\ntwo-thirds of persons with Cx26-related deafness, a single mutation is found\ncalled 35delG. This mutation causes a defect in the transmembrane region of the\nconnexin protein. Connexins are expressed in many different tissues. Connexin\n26 functions in the inner ear and is involved in junctions that allow the transport\nof materials between cells.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  **\n </span>\n</p>\n\n<p>\n <b>\n  Presbycusis\n </b>\n , or\nage-related hearing loss, is the cumulative effect of aging on hearing. It is\ndefined as a progressive bilateral symmetrical age-related sensorineural\nhearing loss. The hearing loss is most marked at higher frequencies. Hearing\nloss that accumulates with age but is caused by factors other than normal aging\nis not presbycusis. Deterioration in hearing has been found to start from about\nthe age of 18 years. Age affects high frequencies more than low frequencies and\nmen more frequently than women. One early consequence is that even young adults\nmay lose the ability to hear very high frequency tones. Despite this,\nage-related hearing loss may only become noticeable later in life. The effects\nof age can be exacerbated by exposure to environmental noise, whether at work\nor in leisure time (shooting, music, etc.). With presbycusis, detection of\nhigh-pitched sounds becomes more difficult, and speech perception is affected.\n</p>\n", "choices": ["A. Amino terminus", "B. Carboxyl terminus", "C. Cytoplasmic loop", "D. Extracellular loop", "E. Transmembrane region"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 31-year-old woman with type 1 diabetes mellitus stops taking her\ninsulin. Two days later she develops nausea, vomiting, abdominal pain, and\nfrequent urination. Blood tests reveal a metabolic acidosis with increased\nanion gap. While performing the physical examination, her physician notices\nthat her breath has &ldquo;fruity&rdquo; odor. Which of the following substances most\nlikely explains that odor?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  In this patient with\ntype 1 diabetes mellitus, failure to take insulin has led to a state of\ndiabetic ketoacidosis (DKA). (In the absence of insulin, glucose cannot enter\nthe cell. The cell is &ldquo;starved&rdquo; of glucose, and ketogenesis occurs.) DKA is\ncommonly associated with nausea, vomiting, abdominal pain, and frequent\nurination (due to hyperglycemia). Ketones are produced in abundance, resulting\nin a metabolic acidosis with an increased anion gap. The main ketones are\nacetoacetate, &beta;-hydroxybutyrate, and acetone. Acetone is responsible for\nthe &ldquo;fruity&rdquo; breath of people with DKA.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Ketones\n  <b>\n  </b>\n </span>\n are by-products of fatty acid oxidation, produced\nmainly in the mitochondria of liver cells. They are a fuel source for the brain\nand are synthesized when glucose levels are low and when carbohydrate stores\n(e.g., glycogen) have been exhausted.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Fatty acids are\nenzymatically broken down during &beta;-oxidation to form acetyl-CoA. Under\nnormal conditions, acetyl-CoA is further oxidized and its energy transferred as\nelectrons to NADH, FADH\n <sub>\n  2\n </sub>\n , and GTP in the citric acid cycle (TCA\ncycle). However, if the amount of acetyl-CoA generated in &beta;-oxidation\n(fatty acid oxidation) overwhelms the processing capacity of the TCA cycle,\nacetyl-CoA is then used instead in the biosynthesis of ketones.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  After they\nare produced in the liver, ketones are transported to other tissues, such as\nthe brain and heart. Ketones can cross the blood-brian barrier and enter the\ncentral nervous system. In the brain, they can be reconverted to acetyl-CoA to\nproduce energy, via the citric acid cycle. The heart has little need for\nketones, as it can burn fatty acids. The brain cannot burn fatty acids and must\nrely on ketones when glucose is not available.\n </span>\n</p>\n\n<p>\n The three principal ketones\nare acetoacetic acid, beta-hydroxybutyric acid, and acetone. Acetone is\nproduced by spontaneous decarboxylation of acetoacetate. It is not used as an\nenergy source, but is instead exhaled or excreted as waste. It is responsible\nfor the characteristic &ldquo;fruity&rdquo; odor of the breath of persons in ketoacidosis.\n</p>\n\n<p>\n Ketogenesis may or may not\noccur, depending on levels of available carbohydrates in the cell or body.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  When\nthe body has ample carbohydrates available as energy source, glucose is\ncompletely oxidized to CO\n  <sub>\n   2\n  </sub>\n  ; acetyl-CoA is formed as an intermediate\nin this process, first entering the citric acid cycle followed by complete\nconversion of its chemical energy to ATP in oxidative phosporylation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  When\nthe body has excess carbohydrates available, some glucose is fully metabolized,\nand some of it is stored by using acetyl-CoA to create fatty acids.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  When\nthe body has no free carbohydrates available, fat must be broken down into\nacetyl-CoA in order to get energy. Acetyl-CoA is not being recycled through the\ncitric acid cycle because the citric acid cycle intermediates (mainly\noxaloacetate) have been depleted to feed the gluconeogenesis pathway, and the\nresulting accumulation of acetyl-CoA activates ketogenesis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Ketone\nbodies are created at moderate levels in everyone&rsquo;s bodies, such as during\nsleep and other times when no carbohydrates are available. However, when\nketogenesis happens at higher-than-normal levels, the body is said to be in a\nstate of ketosis. Both acetoacetate and beta-hydroxybutyrate are acidic, and, if\nlevels of these ketones are too high, the pH of the blood drops, resulting in\nketoacidosis. Ketoacidosis occurs in individuals with untreated type I diabetes\nmellitus (diabetic ketoacidosis) and in alcoholics after prolonged\nbinge-drinking without sufficient intake of carbohydrates (alcoholic\nketoacidosis). Ketoacidosis produces an increased-anion-gap metabolic acidosis.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Ketogenesis\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347143\"\n o:spid=\"_x0000_i1260\" type=\"#_x0000_t75\" alt=\"Description: ketogenesis_pathway\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image129.jpg\" o:title=\"ketogenesis_pathway\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: ketogenesis_pathway\" border=\"0\" height=\"328\" src=\"_%20Tutorials_files/image130.png\" v:shapes=\"Picture_x0020_347143\" width=\"303\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Oxaloacetate", "B. Malate", "C. Fumarate", "D. Succinate", "E. Acetone"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n14-year-old boy falls and scrapes his knee. Which of the following complement\ncomponents will enhance vascular permeability and attract inflammatory cells to\nthe area of injury?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Complement components C5a, C3a, and C4a\nare mediators of inflammation. Their actions include vasodilation, increased\nvascular permeability, and leukocyte chemotaxis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\nprincipal mediators of inflammation (and their actions) are listed below.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Mediator\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Principal\n   Sources\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Actions\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td colspan=\"3\" valign=\"top\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      CELL-DERIVED\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Histamine\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mast\n  cells, basophils, platelets\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vasodilation,\n  increased vascular permeability, endothelial activation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Serotonin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Platelets\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vasodilation,\n  increased vascular permeability\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Prostaglandins\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mast\n  cells, leukocytes\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vasodilation,\n  pain, fever\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Leukotrienes\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mast\n  cells, leukocytes\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n  vascular permeability, chemotaxis, leukocyte adhesion and activation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Platelet-activating\n  factor\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Leukocytes,\n  mast cells\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vasodilation,\n  increased vascular permeability, leukocyte adhesion, chemotaxis,\n  degranulation, oxidative burst\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Reactive\n  oxygen species\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Leukocytes\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Killing\n  of microbes, tissue damage\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Nitric\n  oxide\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Endothelium,\n  macrophages\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vascular\n  smooth muscle relaxation, killing of microbes\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cytokines\n  (TNF, IL-1)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Macrophages,\n  endothelial cells, mast cells\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Local\n  endothelial activation (expression of adhesion molecules),\n  fever/pain/anorexia/hypotension, decreased vascular resistance (shock)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Chemokines\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Leukocytes,\n  activated macrophages\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Chemotaxis,\n  leukocyte activation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"3\" valign=\"top\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      PLASMA\n  PROTEIN&ndash;DERIVED\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Complement\n     </span>\n    </b>\n    <span>\n     products (C5a, C3a, C4a)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Plasma (produced\n  in liver)\n    </span>\n   </p>\n  </td>\n  <td rowspan=\"3\" valign=\"top\">\n   <table border=\"0\" cellpadding=\"0\" class=\"MsoNormalTable\">\n    <tr>\n     <td width=\"1\">\n      <p class=\"MsoNormal\">\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </p>\n     </td>\n     <td valign=\"top\" width=\"4%\">\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n     </td>\n     <td>\n      <p class=\"MsoNormal\">\n       <span>\n        Leukocyte\n    chemotaxis and activation, vasodilation (mast cell stimulation)\n       </span>\n      </p>\n     </td>\n    </tr>\n    <tr>\n     <td width=\"1\">\n      <p class=\"MsoNormal\">\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </p>\n     </td>\n     <td valign=\"top\" width=\"4%\">\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n     </td>\n     <td>\n      <p class=\"MsoNormal\">\n       <span>\n        Increased\n    vascular permeability, smooth muscle contraction, vasodilation, pain\n       </span>\n      </p>\n     </td>\n    </tr>\n    <tr>\n     <td width=\"1\">\n      <p class=\"MsoNormal\">\n       <span>\n        &nbsp;&nbsp;\n       </span>\n      </p>\n     </td>\n     <td valign=\"top\" width=\"4%\">\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n     </td>\n     <td>\n      <p class=\"MsoNormal\">\n       <span>\n        Endothelial\n    activation, leukocyte recruitment\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Kinins\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Plasma (produced\n  in liver)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Proteases\n  activated during coagulation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Plasma\n  (produced in liver)\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <a name=\"4-u1.0-B978-1-4377-0792-2..50007-9--spar\">\n    </a>\n    <span>\n     IL-1 = interleukin-1; MAC = membrane\n  attack complex; TNF = tumor necrosis factor\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. C1q", "B. C4b", "C. C5a", "D. C7", "E. C9"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Each of\nthe following conditions is associated with necrosis of a specific\nmorphological type. Match each condition with the corresponding type of\nnecrosis.\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answers\n  </span>\n </b>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Tissue\nnecrosis can be classified into several distinct morphological categories.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Morphological Patterns of Tissue Necrosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p class=\"MsoNormal\">\n     <span>\n      Coagulative necrosis\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p class=\"MsoNormal\">\n     <span>\n      Liquefactive necrosis\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p class=\"MsoNormal\">\n     <span>\n      Gangrenous necrosis\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p class=\"MsoNormal\">\n     <span>\n      Caseous necrosis\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fat necrosis\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fibrinoid necrosis\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Coagulative\nnecrosis\n  </span>\n </b>\n <span>\n  is the type of necrosis seen in\n  <span>\n   infarcts\n(ischemic necrosis) of any organ\n  </span>\n  except the brain. The basic tissue\narchitecture is preserved for at least a few days. Cell outlines can still be\nseen by light microscopy. Proteolysis of dead cells does not occur and the\ntissue retains a firm texture. Eosinophilic, anucleate cells may be present for\ndays or weeks.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347142\"\n o:spid=\"_x0000_i1259\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image131.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\" border=\"0\" height=\"173\" src=\"_%20Tutorials_files/image132.png\" v:shapes=\"Picture_x0020_347142\" width=\"452\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Coagulative\nnecrosis.\n  <b>\n   A.\n  </b>\n  Wedge-shaped kidney infarct (yellow).\n  <b>\n   B.\n  </b>\n  Microscopic\nview of the edge of the infarct, with normal kidney (N) and necrotic cells in\nthe infarct (I) showing preserved cellular outlines with loss of nuclei and an\ninflammatory infiltrate (which is difficult to discern at this magnification).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  ***\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Liquefactive\nnecrosis\n  </span>\n </b>\n <span>\n  occurs in bacterial\n  <b>\n  </b>\n  and sometimes\nfungal infection. Micro-organisms attract leukocytes, and the enzymes of the\nleukocytes digest (&ldquo;liquefy&rdquo;) tissue. Dead cells are completely digested, and\nthe tissue is transformed into a viscous material. Following acute\ninflammation, the material may be creamy yellow (pus). Note: Although ischemia\ncauses coagulative necrosis in most tissues, it causes liquefactive necrosis in\nthe brain.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347141\"\n o:spid=\"_x0000_i1258\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image133.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\" border=\"0\" height=\"226\" src=\"_%20Tutorials_files/image134.png\" v:shapes=\"Picture_x0020_347141\" width=\"284\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Liquefactive necrosis. An infarct in the brain, showing\ndissolution of the tissue.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  ***\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Gangrenous\nnecrosis\n  </span>\n </b>\n <span>\n  is not a distinctive pattern, but the term is commonly used in clinical\npractice. It usually applies to a limb that has lost its blood supply. If an\nischemic limb becomes secondarily infected with bacteria, &ldquo;dry gangrene&rdquo; may\nturn into &ldquo;\n  <span>\n   wet gangrene,&rdquo; which is a\nmixture of\n  </span>\n  coagulative necrosis (from ischemia) and liquefactive\nnecrosis (from bacterial infection).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  ***\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Caseous\nnecrosis\n  </span>\n </b>\n <span>\n  is characteristic of tuberculous infection. The term &ldquo;caseous&rdquo; (cheese-like) is\nderived from the friable, yellow-white appearance of the necrotic area seen\nwith the unaided eye. On microscopic examination, the necrotic focus appears as\na collection of lysed cells with an amorphous granular\n  <a name=\"4-u1.0-B978-1-4160-2973-1..50004-1--p11\">\n  </a>\n  appearance. The tissue\narchitecture is obliterated and cellular outlines cannot be seen. Foci of\nnecrosis may be enclosed within a distinctive inflammatory border, producing a\n&ldquo;granuloma.&rdquo;\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347140\"\n o:spid=\"_x0000_i1257\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image135.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\" border=\"0\" height=\"226\" src=\"_%20Tutorials_files/image136.png\" v:shapes=\"Picture_x0020_347140\" width=\"284\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Caseous\nnecrosis. Tuberculosis of the lung, with a large area of caseous necrosis\ncontaining yellow-white, cheesy debris.&nbsp;\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  ***\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Fat\nnecrosis\n  </span>\n </b>\n <span>\n  occurs with acute pancreatitis. Pancreatic enzymes leak out of acinar cells and\nducts, liquefying the membranes of fat cells in the peritoneum. Lipase breaks\ndown the triglyceride esters. Fatty acids are released, which combine with\ncalcium to produce a chalky white substance (fat saponification).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347139\"\n o:spid=\"_x0000_i1256\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image137.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\" border=\"0\" height=\"189\" src=\"_%20Tutorials_files/image138.png\" v:shapes=\"Picture_x0020_347139\" width=\"284\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fat\nnecrosis. The areas of white chalky deposits represent foci of fat necrosis\nwith calcium soap formation (saponification) at sites of lipid breakdown in the\nmesentery.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  ***\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Fibrinoid\nnecrosis\n  </span>\n </b>\n <span>\n  occurs in certain types of vasculitis (e.g., polyarteritis nodosa). Immune\ncomplexes are deposited in the walls of arteries. When stained with H&amp;E,\nthese immune complexes, together with fibrin that has leaked out of the\nvessels, have a bright, pink appearance, called &ldquo;fibrinoid.&rdquo;\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347137\"\n o:spid=\"_x0000_i1255\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image139.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1\" border=\"0\" height=\"189\" src=\"_%20Tutorials_files/image140.png\" v:shapes=\"Picture_x0020_347137\" width=\"284\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fibrinoid\nnecrosis in an artery. The wall of the artery shows a circumferential bright\npink area of necrosis.&nbsp;\n </span>\n</p>\n", "choices": ["A. Abscess due to Staphylococcus aureus", "B. Active tuberculosis", "C. Acute pancreatitis", "D. Polyarteritis nodosa", "E. Renal infarction", "1. Coagulation necrosis", "2. Liquefactive necrosis", "3. Caseous necrosis", "4. Fat necrosis", "5. Fibrinoid necrosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Most children with Severe Combined\nImmunodeficiency Disease (SCID) appear normal at birth but begin to have\nrepeated infections at two to four months of age, which corresponds with waning\nlevels of maternal IgG acquired\n  <i>\n   in utero\n  </i>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Most cases of SCID are due to mutations\nin the gene encoding the common gamma chain (&gamma;\n  <sub>\n   c\n  </sub>\n  ), a protein\nthat is shared by the receptors for interleukins IL-2, IL-4, IL-7, IL-9, IL-15\nand IL-21. These interleukins and their receptors are involved in the\ndevelopment and differentiation of T and B cells. Because the common gamma\nchain is shared by many interleukin receptors, mutations that result in a\nnon-functional common gamma chain cause widespread defects in interleukin\nsignaling. The result is a near complete failure of the immune system to\ndevelop and function, with low or absent T cells and NK cells and\nnon-functional B cells. The second most common form of SCID is caused by a\ndefective enzyme, adenosine deaminase (ADA), necessary for the breakdown of\npurines. Numerous other mutations are associated with SCID (including mutations\nof Janus kinase 3,\n  <i>\n   RAG-1\n  </i>\n  ,\n  <i>\n   RAG-2\n  </i>\n  ,\n  <i>\n  </i>\n  and\n  <i>\n   Artemis\n  </i>\n  ).\nSerious viral infections, lack of peripheral B and T lymphocytes, radiographic\nabsence of a thymic shadow, absence of tonsils, and absence of palpable lymph\nnodes are all consistent with a diagnosis of SCID.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients with severe congenital\nneutropenia present with very low circulating neutrophil counts and severe\ninfections, which usually occur when the absolute neutrophil count is &lt;500\ncells/mm\n  <sup>\n   3\n  </sup>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Infections\noccur in the oral and mucosal surfaces (gingivitis, periodontitis), skin,\nperirectal and genital areas, lungs, GI tract, and bloodstream. The condition\nhas its onset in infancy. Affected children can be treated with exogenous\nG-CSF.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients with Bruton&rsquo;s agammaglobulinemia\nusually suffer from recurrent pyogenic bacterial infections due to a lack of\nopsonizing antibodies.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The defect\nis in Bruton&rsquo;s tyrosine kinase, an enzyme essential to B-cell, but not T-cell,\ndevelopment.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  T-cell number and\nfunction are normal, so patients typically do not have problems with viral or\nother intracellular infections.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Most cases are X-linked, but females with two defective genes will also\nhave the disease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Children with DiGeorge syndrome suffer\nfrom recurrent viral and fungal infections within the first year of life.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  They also exhibit\n  <i>\n   c\n  </i>\n  ardiac\ndefects,\n  <i>\n   a\n  </i>\n  bnormal facial features,\n  <i>\n   t\n  </i>\n  hymic hypoplasia,\n  <i>\n   c\n  </i>\n  left\npalate,\n  <i>\n   h\n  </i>\n  ypocalcemia, and chromosome 22 deletion (CATCH-22).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  DiGeorge syndrome occurs when there is\ndefective embryogenesis that affects the thymus and other organs that derive\nfrom the third and fourth pharyngeal pouches.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Because these patients have little to no\nthymic tissue, T cells are low to absent.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The number of B cells is not affected, although patients will exhibit\nreduced immunoglobulin levels due to a paucity of T helper cells.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect.\n  </span>\n </b>\n <span>\n  Children with Wiskott-Aldrich syndrome (WAS) present with thrombocytopenia\nassociated with petechiae, purpura, mucosal bleeding, and intermittent bloody diarrhea.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  They have eczema, as well as\nrecurrent bacterial and viral infections, especially in the ear.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The disease is due to a mutation of the\nWAS protein, which is important for reorganization of the actin\ncytoskeleton.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Cell adhesion and\nmigration is affected, which impairs the function of hematopoietic-derived\ncells.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The disease is X-linked, so\nmales with the gene will be affected, while females will be asymptomatic\ncarriers. Patients typically have decreased IgM and increased IgA and IgE\nlevels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  T cell subsets are usually\ndecreased.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nF is incorrect.\n  </span>\n </b>\n <span>\n  Ataxia-telangiectasia\nis a rare, inherited, neurodegenerative disease that causes severe disability.\nPatients present with poor coordination (because of cerebellar dysfunction) and\nsmall, dilated blood vessels in the skin and mucous membranes\n(telangiectasias).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The immune\nsystem is affected in the majority of patients. Symptoms usually begin in early\nchildhood (toddler stage) with imbalance, slurred speech, and increased\ninfections. The condition is caused by a defect in the ATM gene, which is\nresponsible for recognizing and correcting errors in duplicating DNA.\n </span>\n</p>\n", "<p>\n <b>\n  Answer G is incorrect.\n </b>\n Common\nvariable immunodeficiency (CVID) is a group of 20-30 immunological disorders\nmanifested by hypogammaglobulinemia. Patients are predisposed to infection with\ncommon bacterial and viral pathogens. CVID is the most commonly encountered\nprimary immunodeficiency.\n</p>\n", "<p>\n <b>\n  Answer H is incorrect.\n </b>\n Hyper-IgM\nsyndrome is a heterogeneous group of disorders in which a defect in the CD40\nligand on T helper cells inhibits &ldquo;class switch&rdquo; between immunoglobulin\nsubtypes. Patients have high IgM levels and undetectable IgG and IgA levels.\nThis predisposes them to recurrent upper and lower respiratory tract\ninfections.\n</p>\n", "<p>\n <b>\n  Answer I is incorrect.\n </b>\n Job&rsquo;s\nsyndrome (Hyperimmunoglobulin E syndrome) is a group of disorders characterized\nby abnormal neutrophil chemotaxis. T-cell production of interferon gamma is\nimpaired. Patients present with recurrent \"cold\" staphylococcal\ninfections, unusual eczema-like skin rashes, severe lung infections resulting\nin pneumatoceles (balloon-like lesions in the lung), and very high\nconcentrations of the serum IgE.\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nJ is incorrect.\n  </span>\n </b>\n <span>\n  Selective\nIgA deficiency is a disorder of B-cell maturation resulting in decreased or\nabsent serum IgA levels. Serum IgG and IgM levels are normal. Patients may be\nasymptomatic or may have recurrent ear, sinus, or lung infections.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  A\n4-month-old white female was admitted to the hospital with a two-week history\nof fever, nasal congestion, and cough. She was well until two months ago when\nshe developed an oral ulcer, intermittent fever, recurrent otitis, decreased\nappetite, and weight loss. On physical examination, tonsils are absent and\nlymph nodes are not palpable. Bilateral wheezing is heard over the anterior and\nposterior lung fields. Chest radiograph shows patchy infiltrates and no thymic\nshadow. A nasal-wash viral culture is positive for parainfluenza 3 virus, and a\nblood PCR is positive for adenovirus. She is treated with trimethoprim /\nsulfamethoxazole for suspected infection with\n  <i>\n   Pneumocystis jiroveci\n  </i>\n  ;\nhowever, she dies on the fifth hospital day due to overwhelming adenoviral infection.\nHer parents had premature twin girls who died shortly after birth. Currently,\nthey have a healthy two-year-old son.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Immunologic\nData\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Patient&rsquo;s\nValue\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Normal\nValue\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum\nimmunoglobulins\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  IgG,\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  65\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  192&ndash;515\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  IgA,\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12&ndash;31\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  IgM,\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  39&ndash;92\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  IgE,\nIU/mL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  5\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0&ndash;150\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Anti-A,\ntiter, counts per minute\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  &gt;1:32\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Anti-B,\ntiter, counts per minute\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  &gt;1:16\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diphtheria\ntoxoid antibody, IU/mL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0.19\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  &gt;0.10\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Tetanus\ntoxoid antibody, IU/mL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0.05\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  &gt;0.16\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lymphocyte\nsubpopulations, cells per mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CD3+\nT cells\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1111&ndash;5183\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CD20+\nB cells\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  144&ndash;671\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CD16+\nNK cells\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  142\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  152&ndash;709\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CD56+\nNK cells\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  134\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  223&ndash;1040\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is the most likely diagnosis?\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Severe\ncongenital neutropenia\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Bruton&rsquo;s\nagammaglobulinemia\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Severe\ncombined immunodeficiency\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  DiGeorge\nsyndrome\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Wiskott-Aldrich\nsyndrome\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Ataxia-telangiectasia\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Common\nvariable immunodeficiency\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hyper-IgM\nSyndrome\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Job&rsquo;s\nsyndrome (Hyperimmunoglobulin E syndrome)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   J.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Selective\nIgA deficiency\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Immunodeficiency Syndromes\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Severe\n  combined immunodeficiency (SCID)\n    </span>\n   </p>\n   <p class=\"MsoListParagraph\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : Stem cell disorder\n  causing near complete failure of the immune system (B and T cells), usually\n  due to a defect in common gamma chain protein or adenosine deaminase\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent infection\n  with viral, bacterial, and fungal pathogens; chronic diarrhea, ear\n  infections, profuse oral candidiasis, recurrent pneumonia; death by age 1 if\n  untreated\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ataxia-telangiectasia\n    </span>\n   </p>\n   <p class=\"MsoListParagraph\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : Defect in DNA repair\n  caused by a mutation in the ATM gene\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent\n  infections, imbalance, slurred speech, poor coordination, telangiectasias,\n  IgA deficiency\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Job&rsquo;s\n  syndrome (Hyperimmunoglubulin E syndrome)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </b>\n    <span>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : Failure of T helper\n  cells to produce interferon-&gamma; (a macrophage-activating factor)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent &ldquo;cold&rdquo;\n  staphylococcal infections, eczema-like skin rash, severe lung infections with\n  pneumatoceles, and very high IgE levels\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Bruton&rsquo;s\n  agammaglobulinemia\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : X-linked disorder; mutation\n  of tyrosine kinase gene impairs B-cell maturation\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent infection\n  with extracellular, pyogenic bacteria (\n     <i>\n      Staphylococcus aureus,\n  Streptococcus pneumoniae, Streptococcus pyogenes, Hemophilus influenzae\n     </i>\n     );\n  no circulating B cells; low serum levels of all antibody classes; normal T\n  lymphocyte levels\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Common\n  variable immunodeficiency\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : Group of disorders\n  resulting in inadequate antibody production\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent\n  infections; low serum levels of IgG, IgA, and IgM; normal B and T lymphocyte\n  levels\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hyper-IgM\n  syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : Defect in CD40\n  ligand on T helper cells inhibits &ldquo;class switch&rdquo; between immunoglobulin\n  subtypes\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent upper and\n  lower respiratory tract infections, high IgM levels, undetectable IgG and IgA\n  levels\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Selective\n  IgA deficiency\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : Defect of B-cell\n  maturation that impairs IgA production\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Usually healthy; may\n  have recurrent ear, sinus, and lung infections; low serum IgA levels\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     Wiskott-Aldrich\n  Syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : X-linked disorder;\n  mutation of WASp gene impairs IgM response to bacteria\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent pyogenic\n  infections, eczema, thrombocytopenia (classic triad); low serum levels of\n  IgM; high serum levels of IgA and IgE; normal IgG levels\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"443\">\n   <p class=\"MsoNormal\">\n    <span>\n     DiGeorge\n  Syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Description\n     </span>\n    </i>\n    <span>\n     : Deletion of small\n  piece of chromosome 22 causing maldevelopment of thymus and parathyroid\n  glands, results in T cell deficiency and hypocalcemia\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Manifestation\n     </span>\n    </i>\n    <span>\n     : Recurrent infections\n  with viral and fungal pathogens; T cell deficiency; CATCH mnemonic (Cardiac\n  abnormality, Abnormal faces, Thymic aplasia, Cleft palate, Hypocalcemia)\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Selected\ngene mutations resulting in devastating immunodeficiency diseases are shown\nbelow\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347136\" o:spid=\"_x0000_i1254\"\n type=\"#_x0000_t75\" alt=\"Description: S9781416046882-012-f002\" o:bordertopcolor=\"black\"\n o:borderleftcolor=\"black\" o:borderbottomcolor=\"black\" o:borderrightcolor=\"black\">\n <v:imagedata src=\"_%20Tutorials_files/image141.jpg\" o:title=\"S9781416046882-012-f002\"/>\n <w:bordertop type=\"single\" width=\"6\"/>\n <w:borderleft type=\"single\" width=\"6\"/>\n <w:borderbottom type=\"single\" width=\"6\"/>\n <w:borderright type=\"single\" width=\"6\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: S9781416046882-012-f002\" border=\"0\" height=\"338\" src=\"_%20Tutorials_files/image142.png\" v:shapes=\"Picture_x0020_347136\" width=\"450\"/>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n", "choices": ["B. 3", "C. 4", "D. 5", "E. 1"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n4-year-old boy presents with recurrent pyogenic infections. He had normal\nantibody responses to childhood immunizations and recovered normally from\nchicken pox and measles. Deficiency or dysfunction of which of the following\ncells is most likely to explain his condition?\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The patient in this vignette had a\nnormal antibody response to childhood immunizations, suggesting adequate\nB-lymphocyte function. He also recovered normally from two viral infections,\nchicken pox and measles, suggesting adequate T-lymphocyte function. Neutrophil\ndeficiency or dysfunction is, therefore, the likely source of the problem.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Possible causes include congenital\nneutropenias and chronic granulomatous disease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Pus\n </span>\n is a viscous exudate, typically whitish-yellow that forms at\nthe site of an infection. An accumulation of pus in an enclosed tissue space is\nknown as an abscess, whereas a visible collection of pus within or beneath the\nepidermis is known as a pustule. Pus is comprised of dead leukocytes (mostly\nneutrophils) in a protein-rich fluid. The fluid is usually whitish-yellow, but\nother colors can occur. (Blue-green pus may result from infection with\n <i>\n  Pseudomonas\naeruginosa\n </i>\n <span>\n  and brown pus is\ntypical of a\n </span>\n moebic abscesses in the liver.)\n</p>\n\n<p>\n During infection,\nmacrophages and other cells of the innate immune system release chemokines that\ntrigger neutrophils to seek the site of infection (chemotaxis). The neutrophils\nengulf and destroy bacteria.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Some\nbacteria fight back by releasing toxins called leukocidins.\n <a href=\"http://en.wikipedia.org/wiki/Pus#cite_note-Biology-1#cite_note-Biology-1\">\n </a>\n As neutrophils die, they are engulfed and destroyed by macrophages, forming\nviscous pus.\n</p>\n\n<p>\n Bacteria causing pus\nformation are called\n <span>\n  suppurative\n </span>\n ,\n <span>\n  pyogenic\n </span>\n , or\n <span>\n  purulent\n </span>\n . &ldquo;Pyogenic&rdquo; means\npus-forming. Examples of pyogenic bacteria include\n <i>\n  Staphylococcus aureus\n </i>\n <span>\n  and\n </span>\n <i>\n  Streptococcus pneumoniae.\n </i>\n <span>\n </span>\n</p>\n\n<p>\n Defense against pyogenic\nbacteria depends on intact neutrophil function and adequate humoral immunity.\nHumoral immunity depends on antibodies, which are produced by B-lymphocytes.\nB-lymphocytes are assisted by T helper cells. Therefore, neutrophils,\nB-lymphocytes, and T-lymphocytes are all involved in defense against pyogenic\ninfections.\n</p>\n", "choices": ["A. B lymphocyte", "B. T lymphocyte", "C. Neutrophil", "D. Macrophage", "E. Eosinophil"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  [Note: The\nimportance of neutrophils in protecting against pyogenic infection is apparent\nfrom studies done on patients with Job&rsquo;s syndrome (hyperimmunoglobulin-E\nsyndrome). These patients have impaired neutrophil chemotaxis, which\npredisposes them to recurrent staphylococcal infections.]\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nillustration below shows the dose-response curve for drug X. Which curve\nrepresents the dose-response curve for drug X plus a non-competitive receptor\nantagonist?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_31\"\n o:spid=\"_x0000_i1253\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image143.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"164\" src=\"_%20Tutorials_files/image144.png\" v:shapes=\"Picture_x0020_31\" width=\"204\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Curve C represents the\ndose-response curve for drug X plus a non-competitive receptor antagonist.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  A\nnon-competitive receptor antagonist binds\n  <i>\n   irreversibly\n  </i>\n  to the receptor. This reduces the efficacy, or maximum response, of the drug.\nBecause the binding is irreversible, the drug cannot overcome the antagonism\neven if it is administered in high doses. Consequently, the height of the curve\nis shortened (Curve C), meaning that the\n  <i>\n   efficacy\n  </i>\n  of the drug is reduced.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  By\ncontrast, a competitive antagonist binds\n  <i>\n   reversibly\n  </i>\n  to the receptor. Antagonism\n  <i>\n   can\n  </i>\n  be\novercome by increasing the dose of the drug. Thus, the efficacy of the drug is\n  <i>\n   not\n  </i>\n  reduced. The drug can still produce\na maximum response if administered at high enough doses. The\n  <i>\n   potency\n  </i>\n  of the drug, however, is\nreduced, because more drug is needed to produce the same effect. (Potency is\ninversely related to the amount of drug needed to produce a given effect.) This\nreduction in potency produced by a competitive antagonist is represented by\nCurve D.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Non-competitive\nantagonists reduce efficacy. Competitive antagonists reduce potency.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Dose-response curve\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_30\"\n o:spid=\"_x0000_i1252\" type=\"#_x0000_t75\" alt=\"Description: competitive%20and%20noncompetitive%20antagonist\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image145.png\" o:title=\"competitive%20and%20noncompetitive%20antagonist\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: competitive%20and%20noncompetitive%20antagonist\" border=\"0\" height=\"304\" src=\"_%20Tutorials_files/image146.png\" v:shapes=\"Picture_x0020_30\" width=\"249\"/>\n </span>\n</p>\n", "choices": ["A. A", "B. B", "C. C", "D. D", "E. E"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n30-year-old woman presents with fatigue, weakness, body aches, and\nlight-headedness upon standing. She is found to have primary adrenal\ninsufficiency (Addison disease). Treatment is initiated with prednisone, a\nglucocorticoid. Through which of the following receptor types do\nglucocorticoids produce their effects?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  The glucocorticoid\nreceptor is a nuclear receptor. It functions, therefore, as a transcriptional\nactivator. Nuclear receptors are multi-domain proteins consisting of a ligand\nbinding domain (LBD), transactivation domain (AD), and DNA-binding domain (DBD).\nThe effect of ligand binding has differing effects depending on the specific\nhormone receptor.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Receptors are proteins that &ldquo;translate&rdquo; extracellular signals into\nintracellular effects. T\n </span>\n hey may be located in the cell membrane or\nwithin the cytoplasm or nucleus. Molecules (e.g., drugs, hormones,\nneurotransmitters) that bind to receptors are called ligands. Ligands may\nactivate or inactivate a receptor. Activated receptors regulate cellular\nbiochemical processes (e.g., ion conductance, enzymatic activity, DNA\ntranscription).\n</p>\n\n<p>\n Receptors are\n <span>\n  classified into four major types:\n </span>\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <span>\n  1.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n Ligand-gated ion channels. These transmembrane\nreceptors contain a central pore, or ion channel, which opens in response to\nthe binding of a ligand. The channel is usually selective to one or more ions\n(e.g., Na\n <sup>\n  +\n </sup>\n , K\n <sup>\n  +\n </sup>\n , Ca\n <sup>\n  2+\n </sup>\n , or Cl\n <sup>\n  -\n </sup>\n ). Ion\nchannels are especially important at certain neuronal synapses, where they\nconvert chemical signals from neurotransmitters to electrical signals in the\npostsynaptic neuron. The prototype of a ligand-gated ion channel is the\nnicotinic acetylcholine receptor. When acetylcholine binds to the receptor, the\nreceptor&rsquo;s configuration changes, allowing the pore to open. Na\n <sup>\n  +\n </sup>\n ions flow down an electrochemical gradient into the cell. When many channels\nopen at once, the intracellular Na\n <sup>\n  +\n </sup>\n concentration rises to a level\nat which the positive charge within the cell is enough to depolarize the\nmembrane, initiating an action potential.\n</p>\n\n<p>\n <span>\n  2.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n G-protein-coupled receptors.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n These transmembrane receptors do\n <i>\n  not\n </i>\n contain a central pore, or ion\nchannel. Instead, they are\n <i>\n  indirectly\n </i>\n linked with ion channels through G- proteins, which serve as signal\ntransducers. G-proteins may activate other enzymes, such as adenyl cyclase or\nphospholipase. Because several steps exist between receptor activation and ion\nchannel opening, these ion channels take longer to open than ligand-gated ion\nchannels &ndash; and they stay open longer than ligand-gated channels.\nG-protein-coupled receptors include receptors for norepinephrine, epinephrine,\ndopamine, serotonin, histamine, muscarinic acetylcholine, and GABA\n <sub>\n  B\n </sub>\n .\n</p>\n\n<p>\n <span>\n  3.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n <span>\n  Enzyme-linked\nreceptors. These\n </span>\n transmembrane receptors have enzymatic activity on the\nintracellular side, triggered by ligand binding on the extracellular side. Most\nenzyme-linked receptors are tyrosine kinases, which phosphorylate tyrosine\nresidues. Tyrosine kinases include the receptors for insulin, peptide hormones,\nand growth factors (e.g., epidermal growth factor, fibroblast growth factor,\nvascular endothelial growth factor).\n</p>\n\n<p>\n <span>\n  4.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n <span>\n  Nuclear\nreceptors. These receptors are located in the cytosol or in the nucleus (rather\nthan in the cell membrane). They\n </span>\n have the ability to directly bind DNA\nand regulate the expression of adjacent genes. These receptors are considered\ntranscriptional activators. Steroid hormones and thyroid hormones bind to\nnuclear receptors. There are two major types of nuclear receptors. Class I\nreceptors are located in the cytosol. When activated by ligand, they\ntranslocate to the nucleus, bind to a specific DNA sequence, and enhance DNA\ntranscription. Class II receptors are located in the nucleus (regardless of\nligand-binding status). When bound by ligand, they promote DNA transcription.\n</p>\n\n<div align=\"center\">\n <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"375\">\n  <tr>\n   <td colspan=\"4\" width=\"375\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Types of Receptors\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"92\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Type\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"123\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Structure\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"71\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Cellular Location\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"89\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Examples\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"92\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ligand-gated\n  ion channels\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"123\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape\n   id=\"Picture_x0020_29\" o:spid=\"_x0000_i1251\" type=\"#_x0000_t75\" alt=\"Description: MMPE_20RX_TAB304_01a_eps\"\n  >\n   <v:imagedata src=\"_%20Tutorials_files/image147.png\" o:title=\"MMPE_20RX_TAB304_01a_eps\"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description: MMPE_20RX_TAB304_01a_eps\" border=\"0\" height=\"44\" src=\"_%20Tutorials_files/image148.png\" v:shapes=\"Picture_x0020_29\" width=\"87\"/>\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"71\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cell\n  surface transmembrane\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"89\">\n    <p class=\"MsoNormal\">\n     <span>\n      Acetylcholine\n  (nicotinic)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      GABA\n      <sub>\n       A\n      </sub>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"92\">\n    <p class=\"MsoNormal\">\n     <span>\n      G-protein&ndash;coupled\n  receptors\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"123\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape\n   id=\"Picture_x0020_28\" o:spid=\"_x0000_i1250\" type=\"#_x0000_t75\" alt=\"Description: MMPE_20RX_TAB304_01b_eps\"\n  >\n   <v:imagedata src=\"_%20Tutorials_files/image149.png\" o:title=\"MMPE_20RX_TAB304_01b_eps\"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description: MMPE_20RX_TAB304_01b_eps\" border=\"0\" height=\"44\" src=\"_%20Tutorials_files/image150.png\" v:shapes=\"Picture_x0020_28\" width=\"114\"/>\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"71\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cell\n  surface transmembrane\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"89\">\n    <p class=\"MsoNormal\">\n     <span>\n      Acetylcholine\n  (muscarinic)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      GABA\n      <sub>\n       B\n      </sub>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Norepinephrine\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Epinephrine\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Dopamine\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Serotonin\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Histamine\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Eicosanoids\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"92\">\n    <p class=\"MsoNormal\">\n     <span>\n      Enzyme-linked\n  receptors\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"123\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape\n   id=\"Picture_x0020_27\" o:spid=\"_x0000_i1249\" type=\"#_x0000_t75\" alt=\"Description: MMPE_20RX_TAB304_01c_eps\"\n  >\n   <v:imagedata src=\"_%20Tutorials_files/image151.png\" o:title=\"MMPE_20RX_TAB304_01c_eps\"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description: MMPE_20RX_TAB304_01c_eps\" border=\"0\" height=\"59\" src=\"_%20Tutorials_files/image152.png\" v:shapes=\"Picture_x0020_27\" width=\"84\"/>\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"71\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cell\n  surface transmembrane\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"89\">\n    <p class=\"MsoNormal\">\n     <span>\n      Insulin\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Peptide\n  hormones\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Growth\n  factors\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"92\">\n    <p class=\"MsoNormal\">\n     <span>\n      Nuclear\n  receptors\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"123\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      <!--[if gte vml 1]><v:shape\n   id=\"Picture_x0020_26\" o:spid=\"_x0000_i1248\" type=\"#_x0000_t75\" alt=\"Description: MMPE_20RX_TAB304_01d_eps\"\n  >\n   <v:imagedata src=\"_%20Tutorials_files/image153.png\" o:title=\"MMPE_20RX_TAB304_01d_eps\"/>\n  </v:shape><![endif]-->\n      <img alt=\"Description: MMPE_20RX_TAB304_01d_eps\" border=\"0\" height=\"61\" src=\"_%20Tutorials_files/image154.png\" v:shapes=\"Picture_x0020_26\" width=\"101\"/>\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"71\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cytoplasm\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"89\">\n    <p class=\"MsoNormal\">\n     <span>\n      Steroid hormones\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Thyroid\n  hormone\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Vitamin\n  D\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Vitamin\n  A\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"4\" valign=\"top\" width=\"375\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      GABA = &gamma;-aminobutyric acid; GTP =\n  guanosine triphosphate; GDP = guanosine diphosphate.\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Ligand-gated ion channel", "B. G-protein coupled receptor", "C. Enzyme-linked receptor", "D. Nuclear receptor", "E. Immunoglobulin-like receptor"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  The\nglucocorticoid receptor is a soluble protein found in the cytosol and nucleus.\nIn the absence of ligand, it is tethered to other proteins in large aggregates\nin the cytosol. Upon binding to glucocorticoid, the conformation of the\nreceptor is altered, which allows its release from the protein aggregate. The\nfreed receptor then travels into the nucleus and binds to specific elements in\nthe promoters of certain genes. This binding causes the transactivation domain\nto recruit and facilitate assembly of the RNA polymerase II initiation complex,\nwhich transcribes DNA.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_25\"\n o:spid=\"_x0000_i1247\" type=\"#_x0000_t75\" alt=\"Description: iMac HD:Users:Karla:Downloads:ch10f67.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image155.jpg\" o:title=\"ch10f67.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: iMac HD:Users:Karla:Downloads:ch10f67.jpg\" border=\"0\" height=\"249\" src=\"_%20Tutorials_files/image156.png\" v:shapes=\"Picture_x0020_25\" width=\"434\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Southern\nblot analysis is performed on a patient with sickle cell trait. The single\nbase-pair mutation destroys the MstII restriction enzyme site marked by the\nasterisk. The arrows show restriction enzyme-binding sites. DNA from this\npatient is treated with MstII and run on an electrophoresis gel. The fragments\nare then hybridized with a labeled probe that binds to the normal gene at the\nposition shown on the map. Which lane in this Southern blot analysis represents\nthe patient?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_24\" o:spid=\"_x0000_i1246\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image157.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"104\" src=\"_%20Tutorials_files/image158.png\" v:shapes=\"Picture_x0020_24\" width=\"239\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Patients with sickle\ncell trait are heterozygous for the sickle cell gene. The &beta;\n  <sub>\n   A\n  </sub>\n  globin gene results in a 1.15-Kb fragment after treatment with MstII. The\n&beta;\n  <sub>\n   S\n  </sub>\n  globin gene results in a 1.35-Kb fragment due to loss of the\nMst restriction site.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Lane A represents a\npatient with sickle cell anemia (homozygous for the &beta;\n  <sub>\n   S\n  </sub>\n  globin\ngene).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Lane C represents a\nnormal patient (homozygous for the &beta;\n  <sub>\n   A\n  </sub>\n  globin gene).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answers D, E, and F are incorrect\n  </span>\n </b>\n <span>\n  . These lanes represent\nno patient. The probe does not bind the 0.2-Kb fragment that results from MstII\ncleavage.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. A", "B. B", "C. C", "D. D", "E. E", "F. F"]}, {"question": "<p>\n A 7-month-old boy is brought\nto the clinic because his eyes have been crossed for 3 days. Physical\nexamination shows strabismus and a white pupillary reflex in the left eye.\nOphthalmologic examination shows a solitary retinal tumor in the left eye.\nMolecular analysis of the tumor shows two faulty copies of a gene for a protein\nthat serves as an important inhibitor of cell-cycle progression. Where in the\ncell cycle does this regulatory protein exert its effect?\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_23\"\n o:spid=\"_x0000_i1245\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image159.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"156\" src=\"_%20Tutorials_files/image160.png\" v:shapes=\"Picture_x0020_23\" width=\"241\"/>\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer D is correct.\n </b>\n The retinoblastoma gene codes for\nretinoblastoma protein (pRb), which blocks the cell cycle so that the cell\ncannot leave the G\n <sub>\n  1\n </sub>\n phase and enter the S phase.\n</p>\n"], "tutorial": "<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_22\"\n o:spid=\"_x0000_i1244\" type=\"#_x0000_t75\" alt=\"Description: CellCycle\">\n <v:imagedata src=\"_%20Tutorials_files/image161.png\" o:title=\"CellCycle\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: CellCycle\" border=\"0\" height=\"287\" src=\"_%20Tutorials_files/image162.png\" v:shapes=\"Picture_x0020_22\" width=\"390\"/>\n </span>\n</p>\n\n<p>\n The cell cycle consists of\nfour phases: G\n <sub>\n  1\n </sub>\n phase, S phase (synthesis), G\n <sub>\n  2\n </sub>\n phase, and\nM phase (mitosis). The M phase (mitosis) is composed of two processes: mitosis,\nin which the cell's chromosomes are divided between the two daughter cells, and\ncytokinesis, in which the nucleus, cytoplasm, organelles, and cell membrane are\nseparated in two. In the G\n <sub>\n  1\n </sub>\n (Gap 1) phase, cell growth occurs. This\nphase is marked by protein synthesis, cytoplasmic enlargement, and organelle\nproduction. In the S phase (synthesis), DNA replication occurs. In the G\n <sub>\n  2\n </sub>\n (Gap 2) phase, the cell resumes its growth and prepares for mitosis. The G\n <sub>\n  0\n </sub>\n phase is a state of quiescence in which cells have temporarily or reversibly\nstopped dividing.\n</p>\n\n<p>\n <span>\n  Retinoblastoma\n </span>\n is the most common primary malignant intraocular tumor\nof childhood. Hereditary and nonhereditary forms exist. The hereditary form is\nusually bilateral and multifocal, whereas the nonhereditary form is usually\nunilateral and unifocal.\n <a name=\"4-u1.0-B978-1-4160-2450-7..50631-9--p260\">\n </a>\n In\nmost patients, the initial sign is a white pupillary reflex (leukocoria),\ncaused by the reflection of light off the white tumor (see image below). The\nsecond most common sign is strabismus. The cure rate for retinoblastoma is\napproximately 95%.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_21\"\n o:spid=\"_x0000_i1243\" type=\"#_x0000_t75\" alt=\"Description: cancer4\">\n <v:imagedata src=\"_%20Tutorials_files/image163.jpg\" o:title=\"cancer4\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: cancer4\" border=\"0\" height=\"116\" src=\"_%20Tutorials_files/image164.png\" v:shapes=\"Picture_x0020_21\" width=\"152\"/>\n </span>\n</p>\n\n<p align=\"center\">\n Leukocoria\nin child with retinoblastoma\n</p>\n\n<p>\n The hereditary form of\nretinoblastoma is associated with inactivation of the\n <span class=\"search-hit\">\n  <span>\n   retinoblastoma\n  </span>\n </span>\n <span>\n  gene (RB1), a tumor suppressor gene\n </span>\n located\non chromosome 13.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Tumor suppressor\ngenes are sometimes called &ldquo;anti-oncogenes.&rdquo; They protect cells from\nprogressing to cancer. Mutations of these genes facilitate progression to\ncancer.\n <span>\n  Unlike oncogenes\n </span>\n , tumor\nsuppressor genes generally follow the &ldquo;two-hit hypothesis&rdquo;; i.e., two\nmutational events are required for tumor development\n <a name=\"4-u1.0-B978-1-4160-2450-7..50504-1--intr\">\n </a>\n .\n</p>\n\n<p>\n In the inherited form of\n <span class=\"search-hit\">\n  retinoblastoma\n </span>\n , both RB1 alleles are usually mutated.\nOne mutation is inherited through the germinal cells; the other occurs later in\nsomatic retinal cells. (Usually both alleles must be mutated because a single\nnormal allele can produce enough protein to prevent progression to cancer.)\nMutations of tumor suppressor genes are usually recessive; mutations of\noncogenes, by contrast, are usually dominant.\n</p>\n\n<p>\n Tumor-suppressor genes work\nby inhibiting the cell cycle or by promoting apoptosis. The first\ntumor-suppressor gene discovered was the retinoblastoma gene, which codes for\nretinoblastoma protein (pRb). This protein blocks the cell cycle so that the\ncell cannot leave the G\n <sub>\n  1\n </sub>\n phase and enter the S phase. Thus, the cell\nremains stalled in the G\n <sub>\n  1\n </sub>\n phase. This is a protective mechanism. It\nprevents damaged DNA from replicating. If the retinoblastoma gene is mutated,\nreplication of damaged DNA goes unregulated, and cancer can occur.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_20\"\n o:spid=\"_x0000_i1242\" type=\"#_x0000_t75\" alt=\"Description: Figure 24-9. The seven types of proteins that participate in controlling cell growth.\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image165.jpg\" o:title=\"Figure 24-9. The seven types of proteins that participate in controlling cell growth.\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Figure 24-9. The seven types of proteins that participate in controlling cell growth.\" border=\"0\" height=\"397\" src=\"_%20Tutorials_files/image166.png\" v:shapes=\"Picture_x0020_20\" width=\"347\"/>\n </span>\n</p>\n\n<h3>\n <span class=\"Title1\">\n  <span>\n   The seven types of proteins that\nparticipate in controlling cell growth\n  </span>\n </span>\n</h3>\n\n<p>\n <span>\n  Cancer\ncan result from expression of mutant forms of these proteins: growth factors\n(I), growth factor receptors (II), signal-transduction proteins (III),\ntranscription factors (IV), pro- or anti-apoptotic proteins (V), cell cycle\ncontrol proteins (VI), and DNA repair proteins (VII). Mutations changing the\nstructure or expression of proteins in classes I\u2005&ndash;\u2005IV\ngenerally give rise to dominantly active\n  <i>\n   oncogenes\n  </i>\n  .\nThe class VI proteins mainly act as\n  <i>\n   tumor\nsuppressors\n  </i>\n  ; mutations in the genes encoding these proteins act recessively\nto release cells from control and surveillance, greatly increasing the\nprobability that the mutant cells will become tumor cells. Class VII mutations\ngreatly increase the probability of mutations in the other classes.\nVirus-encoded proteins that activate growth-factor receptors (Ia) also can\ninduce cancer.\n </span>\n</p>\n", "choices": ["A. A", "B. B", "C. C", "D. D"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Smoking\nincreases the risk of each of the following\n  <i>\n   except\n  </i>\n  :\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Smokers have an\nincreased risk of developing Crohn&rsquo;s disease and a decreased risk of developing\nulcerative colitis.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   Health Hazards of Tobacco Use\n  </span>\n </b>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n  <tr>\n   <td valign=\"top\" width=\"50%\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       CANCER\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lung\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Larynx\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Oral\n  cavity\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Esophagus\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Pancreas\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bladder\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Kidney\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Stomach\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Leukemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Cervix\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       CARDIOVASCULAR\n  DISEASE\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Sudden\n  death\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Acute\n  myocardial infarction\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Unstable\n  angina\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Stroke\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Peripheral\n  arterial occlusive disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Aortic\n  aneurysm\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       PULMONARY\n  DISEASE\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lung\n  cancer\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Chronic\n  bronchitis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Emphysema\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Asthma\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Susceptibility\n  to pneumonia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Susceptibility\n  to pulmonary tuberculosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  morbidity from viral respiratory infection\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"50%\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       GASTROINTESTINAL\n  DISEASE\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Peptic\n  ulcer\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Gastroesophageal\n  reflux\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Crohn's\n  disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       REPRODUCTIVE\n  DISTURBANCES\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Reduced\n  fertility\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Premature\n  birth\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lower\n  birth weight\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Spontaneous\n  abortion\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Abruptio\n  placentae\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Premature\n  rupture of membranes\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  perinatal mortality\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       ORAL\n  DISEASE\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Oral\n  cancer\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Leukoplakia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Gingivitis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Gingival\n  recession\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Tooth\n  staining\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       OTHER\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Non&ndash;insulin-dependent\n  diabetes mellitus\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Earlier\n  menopause\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Osteoporosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Cataract\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Tobacco\n  amblyopia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Age-related\n  macular degeneration\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Premature\n  skin wrinkling\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Graves'\n  disease, including ophthalmopathy\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Aggravation\n  of hypothyroidism\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Altered\n  drug metabolism or effects\n      <b>\n      </b>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Pancreatic cancer", "B. Aortic aneurysm", "C. Susceptibility to pneumonia", "D. Ulcerative colitis", "E. Spontaneous abortion", "F. Leukoplakia", "G. Osteoporosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  In each of\nfour tubes is placed a DNA fragment with DNA polymerase, a radiolabeled primer,\nand the adenine, thymine, cytosine, and guanine deoxynucleotides. Each tube\ncontains one of the four bases as dideoxynucleotides. The tubes are run on\nelectrophoresis gel and viewed by autoradiography. What is this technique\ncalled?\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Sequencing uses\ndideoxynucleotides to terminate growing DNA strands. DNA fragments are\nseparated by gel electrophoresis and the sequence is determined by the position\nof the bands on the gel.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . In the Northern blot\ntechnique, RNA is separated by electrophoresis, denatured, and transferred to\nfilter paper. Radiolabeled DNA is used as a probe. The hybridized DNA/RNA\nstrand is visualized by autoradiography.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . In the Southern blot\ntechnique, DNA is separated by electrophoresis, denatured, and transferred to\nfilter paper. Radiolabeled DNA is used as a probe. The hybridized DNA/DNA\nstrand is visualized by autoradiography.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . In the Western blot\ntechnique, protein is separated by electrophoresis and labeled antibodies are\nused as a probe.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Polymerase chain\nreaction (PCR) is used to produce many copies of a DNA segment. The DNA segment\nis mixed with primer, polymerase, and deoxynucleotides. The solution is heated\nto denature the DNA and cooled to allow synthesis. Through repeated cycles of\nheating a cooling, DNA can be amplified more than a million times.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer F is incorrect\n  </span>\n </b>\n <span>\n  . In the enzyme-linked\nimmunosorbent assay (ELISA), labeled antibodies are used to determine if the\nserum contains antibodies against a specific antigen on the ELISA plate.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer G is incorrect\n  </span>\n </b>\n <span>\n  . Allele-specific\noligonucleotide probes are short, radiolabeled DNA sequences complementary to\nan allele of interest. The probes can be used to detect disease-causing\nmutations.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. Northern blot", "B. Southern blot", "C. Western blot", "D. Sequencing", "E. Polymerase chain reaction (PCR)", "F. Enzyme-linked immunosorbent assay (ELISA)", "G. Allele-specific oligonucleotide probe"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 42-year-old woman receives an allogeneic bone marrow transplant from a\nmatched, unrelated donor. She is treated with cyclosporine. One month later she\ndevelops fever, enteritis, hepatitis, and dermatitis. Which of the following\nbest explains these findings?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A. Hyperacute transplant rejection\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B. Acute transplant rejection\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C. Chronic transplant rejection\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D. Graft-versus-host disease\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Transplant rejection\n </span>\n <span>\n  occurs when the host&rsquo;s immune system attacks a transplanted\norgan or tissue.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"320\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Types of Transplant\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"68\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"252\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"68\">\n    <p class=\"MsoNormal\">\n     <span>\n      Autograft\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"252\">\n    <p class=\"MsoNormal\">\n     <span>\n      Tissue\n  transplanted from one part of the body to another in the same individual\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"68\">\n    <p class=\"MsoNormal\">\n     <span>\n      Isograft\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"252\">\n    <p class=\"MsoNormal\">\n     <span>\n      Donor\n  and recipient are genetically identical individuals\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"68\">\n    <p class=\"MsoNormal\">\n     <span>\n      Allograft\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"252\">\n    <p class=\"MsoNormal\">\n     <span>\n      Donor\n  and recipient are genetically non-identical members of the same species\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"68\">\n    <p class=\"MsoNormal\">\n     <span>\n      Xenograft\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"252\">\n    <p class=\"MsoNormal\">\n     <span>\n      Donor\n  and recipient belong to different species\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Transplant\nrejection is a normal occurrence because the immune system is designed to\ndistinguish &ldquo;self&rdquo; from &ldquo;foreign&rdquo; antigens as a means of protecting the\nindividual from foreign invasion. The main types of transplant rejection are\nhyperacute, acute, and chronic.\n </span>\n</p>\n\n<p>\n <i>\n  Hyperacute rejection\n </i>\n usually occurs within 24 hours of\ntransplantation. The response is so quick that the graft never becomes\nvascularized. Hyperacute rejection is characterized by thrombotic occlusions\nand hemorrhages of the graft vasculature that begin minutes to hours after the\ngraft is placed. These occur because of preexisting host antibodies that bind\nto antigens present in the graft endothelium. The complement system is\nactivated and there is an influx of neutrophils. Endothelial cells and\nplatelets shed lipid particles, which promote coagulation. The resulting\ninflammation prevents vascularization of the graft. The graft suffers\nirreversible damage from ischemia.\n</p>\n\n<p>\n There are several\nexplanations for the preexisting antibodies that initiate hyperacute rejection.\nRecipients of blood transfusions sometimes develop antibodies to major\nhistocompatibility class (MHC) antigens from the transfused blood. If some of\nthese antigens match those in a graft, then hyperacute rejection may occur.\nMultiple pregnancies may also expose woman to the paternal antigens of the\nfetus, resulting in the creation of antibodies. Finally, prior recipients of\ntransplants may have already formed antibodies to other MHC antigens &ndash;\nantibodies that may be present at the time of a second transplant. Usually\nhyperacute rejection can be avoided by screening for anti-graft antibodies\n(crossmatching).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Acute rejection\n  </span>\n </i>\n <span>\n  usually begins a week\nafter transplantation and most likely occurs to some degree in all transplants\n(except between identical twins). It is caused by mismatched HLA antigens that\nare present on all cells. HLA antigens are polymorphic; therefore, the chance\nof a perfect match is extremely rare. The reason that acute rejection occurs a\nweek after transplantation is because the T cells involved in rejection must\ndifferentiate and the antibodies must be produced before rejection is\ninitiated. Some T cells cause graft cells to lyse; others produce cytokines\nthat recruit other inflammatory cells, eventually causing necrosis of allograft\ntissue. Endothelial cells in vascularized grafts such as kidneys are some of\nthe earliest victims of acute rejection. Damage to the endothelial lining is an\nearly predictor of irreversible acute graft failure. The risk of acute\nrejection is highest in the first three months after transplantation and is\nlowered by immunosuppressive agents. The diagnosis of acute rejection is based\non clinical data, laboratory testing, and tissue biopsy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Chronic rejection\n  </span>\n </i>\n <span>\n  occurs months to years\nfollowing transplantation. It is characterized by graft arterial occlusions,\nwhich result from the proliferation of smooth muscle cells and the production\nof collagen by fibroblasts. This process, termed accelerated or graft\narteriosclerosis, results in fibrosis, which can cause ischemia and cell death.\nThe fibrous lesions occur without evidence of an overt cause (such as vascular\ninjury or infection), although it is hypothesized that chronic rejection is the\nresult of multiple acute rejections. This hypothesis is based on the knowledge\nthat the resulting fibrosis is similar to the fibrosis that accompanies the\nnatural healing of a wound. Now that there are treatments for acute rejection,\nchronic rejection is the major cause of graft loss. Most recipients must take\nimmunosuppressive drugs for the rest of their lives, and even that may not be\nenough to combat chronic rejection. This poses a dilemma in the trend of\nimmunotherapy, since immunosuppression is highly focused to prevent acute\nrejection and does not substantially address chronic rejection mechanisms.\n </span>\n</p>\n\n<p>\n <i>\n  Graft-versus-host disease\n </i>\n (GVHD) is a common complication of\nallogeneic bone marrow\n <a href=\"http://en.wikipedia.org/wiki/Hematopoietic_stem_cell_transplantation\" title=\"Hematopoietic stem cell transplantation\">\n </a>\n transplantation in which\nfunctional T cells in the transplanted marrow recognize the recipient as\n\"foreign\" and mount an immunologic attack.\n <i>\n  Acute\n </i>\n graft-versus-host-disease occurs within the first 100 days\nand is characterized by selective damage to the gastrointestinal tract, liver,\nand skin. Gastrointestinal involvement may result in severe intestinal\ninflammation, sloughing of the mucosal membrane, severe diarrhea, abdominal pain,\nnausea, and vomiting. Liver involvement results in hepatitis and serum\nbilirubin elevation. Skin disease may manifest as a diffuse, often lacy,\nmaculopapular rash.\n <i>\n  Chronic\n </i>\n graft-versus-host disease occurs more than 100 days after transplantation. As\nin acute disease, the gastrointestinal tract, liver, and skin are affected.\nAdditionally, connective tissue and exocrine glands may be damaged.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347138\"\n o:spid=\"_x0000_i1241\" type=\"#_x0000_t75\" alt=\"Description: GvHdisease\"\n o:gfxdata=\"UEsDBBQABgAIAAAAIQBP7BGHCQEAABUCAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBBG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\nLmpwZWdQSwUGAAAAAAYABgB9AQAAR5sEAAAA\n\">\n <v:imagedata src=\"_%20Tutorials_files/image167.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: GvHdisease\" border=\"0\" height=\"278\" src=\"_%20Tutorials_files/image168.png\" v:shapes=\"Picture_x0020_347138\" width=\"330\"/>\n </span>\n</p>\n\n<p align=\"center\">\n Rash\nin graft-versus-host disease\n</p>\n\n<p>\n The most commonly used drugs\nin transplant patients include steroids, which block cytokine secretion;\ncyclosporine and tacrolimus, which inhibit calcineurin; and azathioprine and\nmycophenolate mofetil, which block T-cell proliferation.\n</p>\n\n<p>\n <b>\n  Answer D is correct\n </b>\n . Acute graft-versus-host disease (GVHD) occurs\nwhen T cells in the transplanted marrow attack host cells. It typically\npresents as enteritis, hepatitis, and dermatitis within 100 days of allogeneic\nbone marrow transplant.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <b>\n  Answer A is incorrect\n </b>\n . Hyperacute transplant rejection is an\nimmediate antibody and complement-mediated response to transplanted tissue\ncaused by pre-existing antibodies to tissue antigens.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n\n<p>\n <b>\n  Answer B is incorrect\n </b>\n . Acute transplant rejection occurs when host\nT cells attack transplanted tissue cells because of HLA mismatch.\n</p>\n\n<p>\n <b>\n  Answer C is incorrect\n </b>\n . Chronic transplant rejection occurs months\nto years after transplantation and results in fibrosis of the graft.\n</p>\n\n<p class=\"MsoNormal\">\n <span lang=\"EN-GB\">\n  Bilateral ovarian masses are identified on pelvic\nexamination of a 40-year-old woman. Ultrasound examination reveals\nmultiloculated cystic masses involving both ovaries. The patient is treated\nwith total abdominal hysterectomy with removal of both adnexa. Pathologic\nexamination demonstrates papillary carcinoma producing serous fluid. Which of\nthe following tumor markers would be most useful in monitoring for recurrence?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct.\n </b>\n <span lang=\"EN-GB\">\n  Serous papillary cystadenocarcinomas of the ovaries are derived from the\nsurface epithelium of the ovaries and express CA-125.\n </span>\n <b>\n </b>\n</p>\n"], "tutorial": "<p>\n Tumor markers are substances\nthat are produced by cancer cells or by other cells of the body in response to\ncancer. Most tumor markers are made by normal cells as well as by cancer cells;\nhowever, they are produced at much higher levels in cancerous conditions. These\nsubstances can be found in the blood, urine, stool, tumor tissue, or other\ntissues or bodily fluids of some patients with cancer. Most tumor markers are\nproteins. However, more recently, patterns of gene expression and changes to\nDNA have also begun to be used as tumor markers. Markers of the latter type are\nassessed in tumor tissue specifically.\n</p>\n\n<p>\n Thus far, more than 20\ndifferent tumor markers have been characterized and are in clinical use. Some\nare associated with only one type of cancer, whereas others are associated with\ntwo or more cancer types. There is no &ldquo;universal&rdquo; tumor marker that can detect\nany type of cancer.\n</p>\n\n<p>\n There are some limitations\nto the use of tumor markers. Sometimes, noncancerous conditions can cause the\nlevels of certain tumor markers to increase. In addition, not everyone with a\nparticular type of cancer will have a higher level of a tumor marker associated\nwith that cancer. Moreover, tumor markers have not been identified for every\ntype of cancer.\n</p>\n\n<p>\n Some of the most commonly\nused tumor markers appear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Tumor Marker\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Cancer Type\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Tissue Analyzed\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       How Used\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Alpha-fetoprotein (AFP)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Liver cancer;\n      <br/>\n      germ cell tumors\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To help diagnose liver cancer and follow\n  response to treatment; to assess stage, prognosis, and response to treatment\n  of germ cell tumors\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Beta-2-microglobulin (B2M)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Multiple myeloma; chronic lymphocytic\n  leukemia; some lymphomas\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood, urine, or cerebrospinal fluid\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To determine prognosis and to follow response\n  to treatment\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Beta-human chorionic gonadotropin (Beta-hCG)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Choriocarcinoma;\n      <br/>\n      testicular cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Urine or blood\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To assess stage, prognosis, and response to\n  treatment of testicular cancer\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      BCR-ABL\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Chronic myeloid leukemia\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood and/or bone marrow\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To confirm diagnosis and monitor disease\n  status\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      CA19-9\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Pancreatic cancer;\n      <br/>\n      gallbladder cancer;\n      <br/>\n      bile duct cancer;\n      <br/>\n      gastric cancer\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &nbsp;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To assess whether treatment is working\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      CA-125\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Ovarian cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To help in diagnosis, assessment of response\n  to treatment, and evaluation of recurrence\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Calcitonin\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Medullary thyroid cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To aid in diagnosis, to check whether\n  treatment is working, and to assess recurrence\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Carcinoembryonic antigen (CEA)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Colorectal cancer; breast cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To check whether colorectal cancer has spread;\n  to look for breast cancer recurrence and assess response to treatment\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Estrogen receptor (ER)/progesterone receptor\n  (PR)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Breast cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Tumor tissue\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To determine whether treatment with hormonal\n  therapy (such as tamoxifen) is appropriate\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      HER2/neu\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Breast cancer; gastric cancer; esophageal\n  cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Tumor tissue\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To determine whether treatment with\n  trastuzumab is appropriate\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Immunoglobulins\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Multiple myeloma; Waldenstrom\n  macroglobulinemia\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood and urine\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To help diagnose disease, assess response to\n  treatment, and look for recurrence\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Prostate-specific antigen (PSA)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Prostate cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Blood\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To help in diagnosis, assess response to\n  treatment, and &nbsp;look for recurrence\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"96\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Thyroglobulin\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"105\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Thyroid cancer\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Tumor tissue\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"110\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      To evaluate response to treatment and to look\n  for recurrence\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Alpha-fetoprotein", "B. Beta-2-microglobulin", "C. BCR-ABL", "D. CA 19-9", "E. CA-125", "F. CEA", "G. Her2/neu"]}, {"question": "<p class=\"MsoNormal\">\n <span class=\"search-hit\">\n  <span>\n   A 15-year-old boy has a lifelong history of\ndevelopmental delays and unusual movements such as hand-flapping. He has a\nmeager vocabulary. Two maternal uncles have mental retardation. Physical\nexamination shows coarse facial features and large testes. DNA testing shows an\nexpansion of a trinucleotide repeat. The patient has four sisters. If the\nparents appear healthy, on average how many of the sisters are likely to be\ncarriers of the gene mutation?\n  </span>\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct\n </b>\n . The patient in the clinical vignette has\nFragile X syndrome, an X-linked disorder. As expected, only males in the family\nare affected (which in this case includes the patient and two maternal uncles).\nThe patient&rsquo;s mother must be a carrier of the mutation because males get their\nX chromosome from the mother (and their Y chromosome from the father). The\nmother is healthy, so only one of her X chromosomes is affected. The father is\nalso healthy, so his X chromosome is fine. The mother and father have four daughters.\nEach has inherited an X chromosome from the mother and an X chromosome from the\nfather. The X chromosome from the father is normal; the X chromosome from the\nmother has a 50% chance of being abnormal. (The mother has one normal and one\nabnormal X chromosome). Therefore, each daughter has a 50% chance of inheriting\nthe &ldquo;bad&rdquo; X chromosome (and becoming a carrier). Because there are four\ndaughters, two of them will, on average, carry the mutated gene.\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span class=\"search-hit\">\n  <span>\n   Fragile\n  </span>\n </span>\n <span>\n  <span class=\"search-hit\">\n   X\n  </span>\n  syndrome\n </span>\n <span>\n  is the most common heritable form of mental\nretardation. The syndrome is named after a &ldquo;fragile site&rdquo; on the\n  <span class=\"search-hit\">\n   X\n  </span>\n  chromosome that prevents chromatin from condensing\nproperly during mitosis. The syndrome is inherited as an\n  <span class=\"search-hit\">\n   X\n  </span>\n  -linked disorder. Testing for F\n  <span class=\"search-hit\">\n   ragile\n  </span>\n  <span class=\"search-hit\">\n   X\n  </span>\n  syndrome is a common indication for DNA\nanalysis and genetic counseling.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ndisorder is caused by massive expansion of the trinucleotide gene sequence,\nCGG, in a gene called\n  <i>\n   FMR1\n  </i>\n  (\n  <span class=\"search-hit\">\n   fragile\n  </span>\n  <span class=\"search-hit\">\n   X\n  </span>\n  mental retardation 1). In normal individuals, this\nsequence is repeated less than 60 times. In patients with F\n  <span class=\"search-hit\">\n   ragile\n  </span>\n  <span class=\"search-hit\">\n   X\n  </span>\n  syndrome, up to\nseveral thousand repeats occur. These additional repeats interfere with DNA\nreplication and chromatin condensation.\n </span>\n</p>\n\n<p>\n Prominent features of the\nsyndrome include mental retardation, long face, large ears, flat feet, and\nlarge testes (macroorchidism). Behavioral features include stereotypic\nmovements (e.g., hand-flapping) and atypical social development, particularly\nshyness and limited eye contact. Some individuals meet the diagnostic criteria\nfor autism.\n</p>\n\n<p>\n Because the syndrome is\nX-linked, males are predominantly affected, and their mothers are obligatory\ncarriers of the abnormal gene.\n</p>\n", "choices": ["A. 0", "B. 1", "C. 2", "D. 3", "E. 4"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 30-year-old woman has severe abdominal pain, nausea,\nvomiting, and diarrhea, and is admitted to the hospital for 2 weeks for a\nsuspected intestinal infection. Evaluation, including upper and lower\nendoscopies, does not establish a definite cause for her symptoms. She gradually\nimproves and is discharged after 2 weeks. Symptoms recur 2 years later, leading\nto multiple emergency department visits. She is admitted to a psychiatric unit\nwith mental status changes and hallucinations, and then transferred to the\nemergency department with abdominal pain, a grand mal seizure, and\nhyponatremia. On admission to a medical unit her pulse is 120 bpm and BP is\n174/114 mmHg. She is disoriented but has no focal neurologic signs. MRI shows\nsubcortical abnormalities, and the spinal fluid is normal. After\ncholecystectomy for a distended gallbladder, she is discharged and stays with a\nfamily member in another city because her symptoms are worse and muscle\nweakness has developed. She is admitted to the hospital and progresses to\nquadriparesis, respiratory failure, and aspiration pneumonia. Urinary\nporphobilinogen (PBG) is reported as 44 mg/24 hours (reference range 0-4).\nFollowing treatment with intravenous glucose and stopping harmful drugs\n(including phenytoin), she improves gradually and is discharged for physical\ntherapy and rehabilitation. She recovers almost completely over a period of\nseveral months, although residual painful hyperesthesia of the lower\nextremities, mild proximal muscle weakness, and impaired short-term memory are\nnoted. Deficiency of which of the following enzymes is most likely in this\npatient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is\ncorrect.\n  </span>\n </b>\n <span>\n  The presence of intermittent acute attacks of\nsevere abdominal pain associated with neuropsychiatric findings, hyponatremia,\nand a hyperadrenergic response, with elevated levels of urinary\nporphobilinogen, suggests a diagnosis of acute intermittent porphyria. The\ndeficient enzyme is porphobilinogen deaminase.\n </span>\n</p>\n"], "tutorial": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Porphyrias\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064019\">\n    </a>\n    <i>\n     <span>\n      Porphyria\n     </span>\n    </i>\n    <span>\n     &nbsp;is the name given to a group of genetic\n  or acquired diseases associated with deficient synthesis of heme. Heme is an\n  essential cofactor for the structure and function of hemoglobin and proteins\n  such as cytochrome P-450. Bone marrow produces more than 80% of body heme.\n  Liver produces about 15% of total heme, but its synthesis can be increased\n  10-fold. For example, heme synthesis will be induced by ingestion of a drug\n  that relies on a heme-containing enzyme for detoxification. This induction of\n  hepatic heme synthesis underlies the important observation that certain drugs\n  trigger porphyria attacks.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<div align=\"center\">\n <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       List of Drugs Precipitating Attacks of Acute Intermittent\n  Porphyria\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Barbiturates\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Carbamazepine\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Chlorpropamide\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Chlordiazepoxide\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Danazol\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Dapsone\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Ergot preparations\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Estrogens\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Ethanol\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Glutethimide\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Griseofulvin\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Meprobamate\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Oral contraceptives\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Phenytoin\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Progestins\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Pyrazinamide\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Sulfonamide\n  antibiotics\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Theophylline\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Tolbutamide\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Valproic acid\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064020\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Porphyrias result from\n  partial deficiency of one of seven enzymes involved in biosynthesis of heme.\n  Attacks of porphyria are associated with the accumulation of the biochemical\n  intermediates in the heme synthesis pathway that precede the deficient\n  enzyme. Some of these intermediates are toxic and can lead to the observable\n  sign of dark, reddish urine. The two major classes of porphyria, bone marrow\n  and hepatic, derive from the organ accounting for the overproduction of heme\n  synthesis intermediates.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Most hepatic\n  porphyrias (e.g., acute intermittent porphyria and porphyria cutanea tarda)\n  have acute onset of pain as a result of the accumulation of early\n  intermediates of heme synthesis such as &delta;-aminolevulinic acid (ALA) and\n  porphobilinogen (PBG). Named&nbsp;\n     <i>\n      acute\n     </i>\n     &nbsp;for their hallmark abrupt\n  presentation (and sometimes resolution), these porphyrias also have chronic\n  features, including pain, neuropathy, and depression. Excess porphyrins,\n  produced in bone marrow porphyrias (e.g., erythropoietic porphyria) deposit\n  in skin and absorb light, which confers photosensitivity and results in\n  cutaneous manifestations such as blistering of sun-exposed skin.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     The three most common\n  porphyrias are discussed below.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"HC064013\">\n    </a>\n    <span>\n     ACUTE INTERMITTENT\n  PORPHYRIA\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064021\">\n    </a>\n    <i>\n     <span>\n      Acute\n  intermittent porphyria\n     </span>\n    </i>\n    <span>\n     &nbsp;(AIP)\n  is an autosomal dominant disorder due to diminished activity of\n  porphobilinogen (PBG) deaminase. PBG deaminase is the third enzyme in the\n  pathway of heme biosynthesis. There is accumulation of the two intermediates\n  of the pathway before this enzyme (ALA and PBG). A high urinary PBG level\n  during an attack is a critical diagnostic feature, although the level is\n  often normal between attacks. Finding deficient PBG deaminase enzyme activity\n  in red blood cells confirms the diagnosis.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064022\">\n    </a>\n    <span>\n     Acute attacks\n  punctuate prolonged well periods in patients with AIP. The acute presentation\n  of AIP can be dramatic and life-threatening. Abdominal pain, largely thought\n  to be the result of neurotoxicity, is present in more than 90% of patients\n  with acute attacks. Abdominal pain may be severe enough to prompt surgical\n  evaluation for an acute abdomen and can be associated with nausea, vomiting,\n  and bowel dysmotility. Neuropathy is evidenced by decreased sensation or\n  muscle weakness that may involve cranial and respiratory nerves. Sympathetic\n  tone is high with hypertension and tachycardia. Central nervous system\n  manifestations include anxiety, paranoia, depression, and seizures, which may\n  result in part from hyponatremia due to inappropriate secretion of\n  antidiuretic hormone.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064024\">\n    </a>\n    <span>\n     Most patients suffer\n  their initial attack after puberty. Triggers of attacks include drugs,\n  particularly barbiturates, carbamazepine, and sulfonamides. Caloric\n  restriction, fasting, surgery, and infections can precipitate attacks.\n  Treatment of patients starts with prevention. Adequate caloric intake,\n  particularly carbohydrates, and avoidance of triggers such as alcohol and\n  offending drugs are important. Intravenous formulations of heme, such as\n  hematin, are effective in reducing the duration and severity of attacks.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"HC064015\">\n    </a>\n    <span>\n     PORPHYRIA CUTANEA\n  TARDA\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064027\">\n    </a>\n    <i>\n     <span>\n      Porphyria\n  cutanea tarda\n     </span>\n    </i>\n    <span>\n     &nbsp;(PCT) is the\n  most common porphyria and shows the cardinal feature of bullous involvement\n  of sun-exposed skin. This results from accumulation of uroporphyrinogen,\n  which absorbs light and confers photosensitivity. PCT is due to decreased\n  activity of the hepatic enzyme uroporphyrinogen decarboxylase. More than 75%\n  of patients have sporadic&nbsp;disease. Most other cases occur in people\n  heterozygous for a mutation in&nbsp;\n     <i>\n      UROD\n     </i>\n     , the gene that codes the\n  enzyme.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064028\">\n    </a>\n    <span>\n     PCT typically begins\n  in early adulthood with subacute appearance of fragile skin and includes\n  vesicles and bullae, grayish skin discoloration, and hypertrichosis of the\n  face. Liver disease is typical. Increased porphyrins in plasma, urine, and\n  feces are required to attribute clinical manifestations to PCT. Avoiding and\n  minimizing liver toxins such as alcohol and excess iron is a mainstay of\n  therapy. Treatment includes avoiding triggers or removing any excess iron by\n  phlebotomy and chloroquine (which forms a complex with porphyrin that\n  improves excretion).\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"HC064016\">\n    </a>\n    <span>\n     ERYTHROPOIETIC\n  PORPHYRIA\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P064031\">\n    </a>\n    <i>\n     <span>\n      Erythropoietic\n  porphyria\n     </span>\n    </i>\n    <span>\n     &nbsp;(EPP) results\n  from deficiency of the last enzyme in heme biosynthesis, ferrochelatase.\n  Large amounts of protoporphyrin accumulate and produce serious cutaneous\n  damage through a photodynamic reaction as observed in patients with PCT. A\n  brief exposure to sunlight can produce burning, redness, and edema suggestive\n  of angioedema developing within hours and resolving over several days.\n  Manifestations of EPP typically occur in childhood. A massive increase in\n  erythrocyte protoporphyrin levels is the diagnostic hallmark of EPP, so much\n  so that fluorescent red blood cells can sometimes be visualized on a blood\n  smear. Avoidance of sun or use of potent sunscreens is the mainstay of\n  prevention.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <!--[if gte vml 1]><v:shape\n   id=\"Picture_x0020_347254\" o:spid=\"_x0000_i1240\" type=\"#_x0000_t75\">\n   <v:imagedata src=\"_%20Tutorials_files/image169.jpg\" o:title=\"\"/>\n  </v:shape><![endif]-->\n     <img border=\"0\" height=\"279\" src=\"_%20Tutorials_files/image170.png\" v:shapes=\"Picture_x0020_347254\" width=\"470\"/>\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Ferrochelatase", "B. Porphobilinogen deaminase", "C. Protoporphyrinogen oxidase", "D. Uroporphyrinogen decarboxylase", "E. Uroporphyrinogen III cosynthase"]}]}, {"section": "Microbiology & Infectious Diseases", "questions": [{"question": "<p class=\"MsoNormal\">\n <span>\n  A\n32-year-old man with AIDS and a CD4 count of 50/mm\n  <sup>\n   3\n  </sup>\n  develops an\ninfection that affects the eyes, lungs, gastrointestinal tract, and central\nnervous system.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A tissue biopsy is\nshown below.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347241\"\n o:spid=\"_x0000_i1239\" type=\"#_x0000_t75\" alt=\"Description: Histopathology_of_cytomegalovirus_infection_of_kidney_-_PHIL_09G0036_lores\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image171.jpg\" o:title=\"Histopathology_of_cytomegalovirus_infection_of_kidney_-_PHIL_09G0036_lores\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Histopathology_of_cytomegalovirus_infection_of_kidney_-_PHIL_09G0036_lores\" border=\"0\" height=\"147\" src=\"_%20Tutorials_files/image172.png\" v:shapes=\"Picture_x0020_347241\" width=\"212\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following organisms is the most likely cause of infection?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  The infection is most\nlikely caused by cytomegalovirus.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Cells\ninfected with cytomegalovirus (CMV) typically have a large, round intranuclear\ninclusion with a perinuclear halo. This resembles an &ldquo;owl&rsquo;s eye.&rdquo;\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  CMV infection may cause retinitis,\npneumonitis, inflammation of the GI tract, and inflammation of the nervous\nsystem. In patients with HIV, infection usually occurs when the CD4 count is\nless than 100/mm\n  <sup>\n   3\n  </sup>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Candida albicans\n  </span>\n </i>\n <span>\n  has a range of clinical\npresentations, from superficial mucocutaneous disease in immunocompetent\nindividuals to invasive illness in immunocompromised hosts. Histologically, the\nfungus may appear as ovoid yeast cells, hyphae, or pseudohyphae.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347240\"\n o:spid=\"_x0000_i1238\" type=\"#_x0000_t75\" alt=\"Description: candida\">\n <v:imagedata src=\"_%20Tutorials_files/image173.jpg\" o:title=\"candida\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: candida\" border=\"0\" height=\"150\" src=\"_%20Tutorials_files/image174.png\" v:shapes=\"Picture_x0020_347240\" width=\"247\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <i>\n  <span>\n   Candida albicans\n  </span>\n </i>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (potassium hydroxide preparation)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Cryptococcus neoformans\n  </span>\n </i>\n <span>\n  causes meningitis in\npeople with AIDS. The fungus is visualized by methenamine silver or periodic\nacid-Schiff stain, and appears as a round or oval yeast with a polysaccharide\ncapsule.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347239\"\n o:spid=\"_x0000_i1237\" type=\"#_x0000_t75\" alt=\"Description: 01G0018_lores\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image175.jpg\" o:title=\"01G0018_lores\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 01G0018_lores\" border=\"0\" height=\"170\" src=\"_%20Tutorials_files/image176.png\" v:shapes=\"Picture_x0020_347239\" width=\"242\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <i>\n  <span>\n   Cryptococcus neoformans\n  </span>\n </i>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (methenamine silver stain)\n  <br/>\n  <br/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Herpes\nsimplex virus causes recurrent orolabial, genital, and perianal lesions in\nHIV-infected individuals. Tzanck smear shows multinucleated epithelial giant\ncells.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347238\"\n o:spid=\"_x0000_i1236\" type=\"#_x0000_t75\" alt=\"Description: f4-u1\">\n <v:imagedata src=\"_%20Tutorials_files/image177.jpg\" o:title=\"f4-u1\" gain=\"1.25\"\n  blacklevel=\"3277f\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: f4-u1\" border=\"0\" height=\"165\" src=\"_%20Tutorials_files/image178.png\" v:shapes=\"Picture_x0020_347238\" width=\"218\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Multinucleated giant cell caused by herpes simplex\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (Tzanck smear)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Mycobacterium avium\n  </span>\n </i>\n <span>\n  causes disseminated\ndisease in immunocompromised hosts. The bacterium travels by blood from the\nlungs to the liver, spleen, and bone marrow. Bacteria can be seen in\nmacrophages, granulomas, and giant cells with acid-fast staining.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347237\"\n o:spid=\"_x0000_i1235\" type=\"#_x0000_t75\" alt=\"Description: AIDS071\">\n <v:imagedata src=\"_%20Tutorials_files/image179.jpg\" o:title=\"AIDS071\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: AIDS071\" border=\"0\" height=\"161\" src=\"_%20Tutorials_files/image180.png\" v:shapes=\"Picture_x0020_347237\" width=\"244\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <i>\n  <span>\n   Mycobacterium avium\n  </span>\n </i>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Macrophages containing numerous acid-fast bacilli\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Pneumocystis jiroveci\n  </span>\n </i>\n <span>\n  causes pneumonia in\npeople with AIDS.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347236\"\n o:spid=\"_x0000_i1234\" type=\"#_x0000_t75\" alt=\"Description: pneuomcyst\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image181.jpg\" o:title=\"pneuomcyst\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: pneuomcyst\" border=\"0\" height=\"195\" src=\"_%20Tutorials_files/image182.png\" v:shapes=\"Picture_x0020_347236\" width=\"280\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <i>\n  <span>\n   Pneumocystis jiroveci\n  </span>\n </i>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (fungal cysts stained with methenamine silver)\n </span>\n</p>\n", "choices": ["A. Candida albicans", "B. Cryptococcus neoformans", "C. Cytomegalovirus", "D. Herpes simplex", "E. Mycobacterium avium", "F. Pneumocystis jiroveci"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Match each\nof the following organisms with the most appropriate clinical scenario.\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answers\n  </span>\n </b>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  6.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   Group\nB Streptococcus (GBS)\n  </span>\n  , or &ldquo;\n  <i>\n   <span>\n    Streptococcus\nagalactiae\n   </span>\n  </i>\n  <span>\n   ,&rdquo;\n  </span>\n  is the leading cause of sepsis, pneumonia, and meningitis in\nnewborns in the United States and Europe.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The bacterium, which colonize the mother&rsquo;s vagina, is transmitted to the\nbaby during delivery. In pregnant women, GBS causes urinary tract infection,\nchorioamnionitis, postpartum endometritis, and peripartum bacteremia. Its\nvirulence is largely due to a capsular polysaccharide that resists phagocytic\ningestion. In the U.S., testing for GBS is recommended at the 36-week antenatal\nappointment of every pregnancy. The vagina and rectum are swabbed and cultures\nare grown in enriched media. Prophylactic antibiotics are given to all women\nwho test positive. This strategy has led to a marked reduction in newborn\ninfection.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  1.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Streptococcus\nbovis\n  </i>\n  bacteremia is associated with colon cancer (for unknown reasons).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  7.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Hemophilus\ninfluenzae\n  </i>\n  , type B, is the most common cause of epiglottitis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  3.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Legionella\npneumophila\n  </i>\n  causes Legionnaire&rsquo;s disease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Pseudomonas\naeruginosa\n  </i>\n  causes &ldquo;hot tub folliculitis.&rdquo;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  4.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Children with sickle cell disease are\npredisposed to osteomyelitis caused by salmonella.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  8.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Yersinia\nenterocolita\n  </i>\n  can cause an appendicitis-like syndrome characterized by\nterminal ileitis and mesenteric lymphadenitis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  9.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Bartonella\nhenselae\n  </i>\n  causes &ldquo;cat scratch disease.&rdquo;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Chlamydia\ntrachomatis\n  </i>\n  is the most common cause of non-gonococcal urethritis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   J.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10.\n  <i>\n   Rickettsia rickettsii\n  </i>\n  <span>\n   causes\nRocky Mountain spotted fever.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   K.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  12.\n  <i>\n   Helicobacter pylori\n  </i>\n  is a gram-negative, curved bacterium that can\ninhabit various areas of the stomach, particularly the antrum. It causes a\nchronic low-level inflammation of the stomach lining and is strongly linked to\nthe development of duodenal and gastric ulcers and stomach cancer. Over 80% of\nindividuals infected with the bacterium are asymptomatic. The bacterium\nproduces urease, which converts urea to ammonia and carbon dioxide. Four tests\nare available for detecting\n  <i>\n   H. pylori\n  </i>\n  <span>\n   : blood antibody test, urea breath test, stool antigen test, and\nstomach biopsy. During the urea breath test, p\n  </span>\n  atients swallow urea\nlabelled with an uncommon isotope, either radioactive carbon-14 or\nnon-radioactive carbon-13. In the subsequent 10&ndash;30 minutes, the detection\nof isotope-labelled carbon dioxide in exhaled breath indicates that the urea\nwas split; this indicates that urease is present in the stomach, and hence that\n  <i>\n   H. pylori\n  </i>\n  bacteria are present. The\n  <span>\n   Rapid urease test\n  </span>\n  , also known as the CLO test (Campylobacter-like\norganism test), is a rapid test for diagnosis of\n  <i>\n   Helicobacter pylori\n  </i>\n  .\nThe test is performed at the time of gastroscopy. A biopsy of mucosa is taken\nfrom the antrum of the stomach, and is placed into a medium containing urea and\nan indicator such as phenol red. The urease produced by\n  <i>\n   H. pylori\n  </i>\n  hydrolyzes urea to ammonia, which raises the pH of the medium, and changes the\ncolor of the specimen from yellow (negative) to red (positive).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   L.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  11.\n  <i>\n   Clostridium difficile\n  </i>\n  <span>\n   is the\nmost common infectious cause of antibiotic-associated colitis.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   M.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  13.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Respiratory syncytial virus (\n </span>\n <span>\n  RSV) is the most common\ncause of bronchiolitis (and pneumonia) in children under 1 year of age.\nSymptoms include coughing, wheezing, and shortness of breath. Fever,\ntachycardia, and tachypnea\n  <span>\n   are\ntypical.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   N.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  14.\n  <i>\n   Proteus mirabilis\n  </i>\n  is a gram-negative rod\nwith urease activity.\n </span>\n <span>\n  Urease\nhydrolyzes urea to ammonia (NH\n  <sub>\n   3\n  </sub>\n  ), which gives the urine an aromatic\nsmell. Ammonia makes the urine more alkaline (pH of 9, in this example). If\nleft untreated, the increased alkalinity can lead to the formation of crystals\nof struvite, calcium carbonate, and/or apatite. The bacteria can be found\nthroughout the stones, and these bacteria lurking in the stones can reinitiate\ninfection after antibiotic treatment.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   O.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  16.\n  <i>\n   Mycoplasma pneumoniae\n  </i>\n  <span>\n   is\nassociated with pneumonia and cold agglutinins in the serum.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   P.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  15.\n  <i>\n   Rhizopus oryzae\n  </i>\n  <span>\n   is the\nprincipal cause of mucormycosis, an aggressive fungal disease characterized by\n  </span>\n  invasion\nof the vasculature, resulting in thrombosis and death of surrounding tissue.\nAffected skin progresses from erythematous to black, due to necrosis.\nMucormycosis predominates in individuals with poorly controlled diabetes\nmellitus.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   Q.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  17.\n  <i>\n   Pasteurella multocida\n  </i>\n </span>\n <span class=\"Hyperlink3\">\n  <span>\n  </span>\n </span>\n <span lang=\"EN-GB\">\n  Pasteurella multocida is\na gram-negative rod that is normal flora of the oral cavity of dogs and cats.\nIt often causes a local abscess following introduction under the skin by an\nanimal bite. Most cases occur in children who are injured while playing with a\npet.\n </span>\n <span>\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. Streptococcus agalactiae", "B. Streptococcus bovis", "C. Hemophilus influenzae", "D. Legionella pneumophila", "E. Pseudomonas aeruginosa", "F. Salmonella enteritidis", "G. Yersinia enterocolita", "H. Bartonella henselae", "I. Chlamydia trachomatis", "J. Rickettsia rickettsii", "K. Helicobacter pylori", "L. Clostridium difficile", "M. Respiratory syncytial virus", "N. Proteus mirabilis", "O. Mycoplasma pneumoniae", "P. Rhizopus oryzae", "Q. Pasteurella multocida", "1. 63-year-old man with colon cancer and bacteremia", "2. 9-year-old girl with a pruritic, erythematous rash that develops days after soaking in a hot tub", "3. 50-year-old man who developed fever and cough ten days after attending a convention. Two colleagues developed similar symptoms after the convention. Temperature is 101oF, pulse is 76/minute, blood pressure is 130/70 mm Hg, and respirations are 18/minute. Chest X-ray shows a patchy infiltrate in the right lower lobe. Sputum Gram stain shows neutrophils and small gram-negative rods that stain poorly. Sputum cultures grow opal-like colonies on yeast extract.", "4. 13-year-old girl with sickle cell disease has pain in the right arm. X-ray shows bony lesions consistent with osteomyelitis", "5. 24-year-old man has pain with urination for three days. He is sexually active with three partners and does not use condoms. His temperature is 37\u00b0C (98.6\u00b0F). Physical examination is normal except for a clear, watery urethral discharge. Urinalysis shows 10\u201320 white blood cells per high-powered field, but no bacteria.", "6. 1-year-old baby evaluated for sepsis has gram-positive cocci in pairs and chains in the blood. The bacteria agglutinate with group B antiserum.", "7. 8-year-old boy has fever, difficulty with swallowing, drooling, hoarseness, and stridor. He holds his head forward and insists on sitting in bed.", "8. 6-year-old boy has fever, abdominal pain, tenderness in the right lower quadrant, and leukocytosis. At surgery, he is found to have a normal appendix, terminal ileitis, and mesenteric lymphadenitis.", "9. 16-year-old boy has fever, malaise, and a red nodule on his forearm one week after playing with a kitten. He develops axillary lymphadenopathy.", "10. 43-year-old man develops fever, malaise, headache, and a petechial rash on his palms and soles four days after hiking in the woods", "11. 80-year-old woman develops watery diarrhea and mild abdominal cramping soon after completing a ten-day course of clindamycin.", "12. 32-year-old man with one-week history of epigastric burning that is worse on an empty stomach and improved after eating. The urea breath test is positive.", "13. An 8-month-old girl has a 1-day history of rapid breathing. Her temperature is 38.4oC (101.1oF), pulse is 160/minute, respirations are 60/minute, and blood pressure is 100/70 mm Hg. Bilateral expiratory wheezing and crackles are heard on auscultation. Chest x-ray shows areas of atelectasis and hyperinflation.", "14. A 65-year-old woman has a two-day history of fever, flank pain, and burning with urination. She has had three urinary tract infections in the past year. Her temperature is 39.1oC (102.3oF). Physical examination reveals right flank tenderness. Her white blood cell count is 16,000/mm3. The urine has an aromatic smell. Urine pH is 9, with numerous white blood cells and >100,000 bacterial colonies/mL. Urine culture grows a urease-positive organism.", "15. A 40-year-old woman with poorly controlled type 1 diabetes mellitus has a one-week history of facial pain and swelling. Examination shows ecchymoses over the left orbital and periorbital regions with proptosis. There is a necrotic lesion with a black eschar in the left naris. Microscopic examination of the lesion shows broad, irregularly shaped, nonseptate hyphae with braches at right angles.", "16. A 32-year-old woman has a three-day history of fever and dry cough. Laboratory tests show cold agglutinating antibodies in the serum. Routine blood and sputum cultures are negative. A chest x-ray is abnormal.", "17. A 38-year-old letter carrier is severely bitten by a pit bull guarding a junkyard. Several days later, the wound is inflamed and purulent. The exudate is cultured on blood agar and yields gram-negative rods."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A newborn\ngirl has fever, irritability, a deformed nasal bridge, and a rash on the palms\nand soles. Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  The most likely\ndiagnosis is congenitally acquired syphilis.\n </span>\n</p>\n"], "tutorial": "<p>\n The TORCH complex is a group\nof congenital infections with similar presentations. TORCH is an acronym for\ntoxoplasmosis, other (syphilis), rubella, cytomegalovirus, and herpes simplex.\nThese conditions may be associated with abnormalities of the brain, heart,\nskin, eyes, and ears. Findings include fever, poor feeding, irritability, low\nbirth weight, microcephaly, mental retardation, visual impairment, hearing\nimpairment, hepatosplenomegaly, jaundice, and a &ldquo;blueberry muffin&rdquo; rash.\n(&ldquo;Blueberry muffin&rdquo; rash, originally described in infants with congenital\nrubella syndrome, can occur with any of the TORCH organisms.) Typically, the\ninfected mother is asymptomatic or mildly symptomatic.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347235\"\n o:spid=\"_x0000_i1233\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image183.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"124\" src=\"_%20Tutorials_files/image184.png\" v:shapes=\"Picture_x0020_347235\" width=\"145\"/>\n </span>\n</p>\n\n<p align=\"center\">\n &ldquo;Blueberry\nmuffin&rdquo; rash\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In\nnewborns,\n  <b>\n   congenital syphilis\n  </b>\n  is\nassociated with fever, irritability, deformity of the nasal bridge (saddle\nnose), and a rash affecting the palms and soles. In older infants and young\nchildren, findings include bone pain, clouding of the cornea, blindness,\ndeafness, peg-shaped teeth (Hutchinson teeth), joint swelling, and saber shins.\nNewborns may have a rash around the mouth, genitalia, and anus that eventually\nscars.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347234\" o:spid=\"_x0000_i1232\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image185.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"171\" src=\"_%20Tutorials_files/image186.png\" v:shapes=\"Picture_x0020_347234\" width=\"119\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  &ldquo;Saddle nose&rdquo; deformity\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347233\" o:spid=\"_x0000_i1231\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image187.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"127\" src=\"_%20Tutorials_files/image188.png\" v:shapes=\"Picture_x0020_347233\" width=\"170\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Hutchinson teeth\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347232\" o:spid=\"_x0000_i1230\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image189.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img alt=\"Taken from:004-01, v4htp/tp page 168Extracted on 31/10/2003\" border=\"0\" height=\"274\" src=\"_%20Tutorials_files/image190.png\" v:shapes=\"Picture_x0020_347232\" width=\"179\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  &ldquo;Saber shin&rdquo; deformity\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347231\" o:spid=\"_x0000_i1229\" type=\"#_x0000_t75\" alt=\"Description: Secondary Syphilis\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image191.jpg\" o:title=\"Secondary Syphilis\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Secondary Syphilis\" border=\"0\" height=\"207\" src=\"_%20Tutorials_files/image192.png\" v:shapes=\"Picture_x0020_347231\" width=\"141\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Syphilitic rash affecting the palms and soles\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Congenital toxoplasmosis\n  </span>\n </b>\n <span>\n  is associated with\nhepatosplenomegaly, jaundice, retinal disease, hearing loss, and rash\n(petechial or ecchymotic).\n </span>\n</p>\n\n<p>\n The classic triad of\n <b>\n  congenital rubella syndrome\n </b>\n is\nsensorineural deafness, ocular abnormalities (especially cataracts and\nmicrophthalmia), and congenital heart disease (especially patent ductus\narteriosus).\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Cytomegalovirus\n  </span>\n </b>\n <span>\n  (CMV) infection is\nassociated with hepatosplenomegaly, jaundice, retinal disease, seizures,\nmicrocephaly, and rash (petechial).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Congenital herpes\nsimplex\n  </span>\n </b>\n <span>\n  is associated with encephalitis, meningitis, and blisters.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Congenitally acquired toxoplasmosis", "B. Congenitally acquired syphilis", "C. Congenitally acquired rubella", "D. Congenitally acquired cytomegalovirus", "E. Congenitally acquired herpes simplex"]}, {"question": "<p class=\"NormalWeb9\">\n Which\nof the following organisms is the most frequently identified parasite causing\nchronic diarrhea in AIDS?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis correct.\n  </span>\n </b>\n <i>\n  <span>\n   Cryptosporidium parvum\n  </span>\n </i>\n <span>\n  is the most frequently\nidentified parasite causing chronic diarrhea in AIDS.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Isospora\nbelli\n  </i>\n  is found thus far only in the human small intestine.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It is transmitted by fecal-oral route\nand may cause diarrhea in immunocompetent hosts.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It can cause prolonged and severe\ndiarrhea in AIDS patients.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Giardia\nlamblia\n  </i>\n  is a flagellated protozoan and is a common cause of diarrhea\nworld-wide.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It is transmitted by\ningestion of the cyst from contaminated water.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The trophozoite form lives in the upper\nsmall intestine and causes irritation leading to gastrointestinal\nsymptoms.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients with giardiasis\nhave a characteristic light-colored fatty stool with abdominal pain, cramps\nwith flatulence.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Entamoeba\nhistolytica\n  </i>\n  commonly causes diarrhea and dysentery in developing countries\nwhere sanitation is poor.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Humans\nare the only host and it is acquired by ingesting the cyst stage.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Blood and mucus are found in the stools\nand if the disease progress, the bowel may become perforated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The organism may also spread to the\nliver and cause abscesses.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"NormalWeb9\">\n More\nthan one hundred million individuals around the world are currently infected\nwith the human immunodeficiency virus (HIV). A very substantial number of these\npatients have developed or will ultimately develop diarrhea. Diarrhea occurs in\nabout 50% of the HIV-infected individuals in the United States. Specific\nenteric pathogens can be isolated (if patients undergo very exhaustive and\nintensive evaluation) in most individuals with severe diarrhea.\n</p>\n\n<p class=\"NormalWeb9\">\n Clinical\npresentations vary among patients with AIDS-related diarrhea. Small-bowel\ndiarrhea tends to produce postprandial stools that are very large in volume.\nThese patients also often have severe postprandial peri-umbilical abdominal\npain. Diarrhea can be lessened by the avoidance of food and nutrients. Weight\nloss commonly occurs in these patients. By contrast, large-intestinal diarrhea,\nalso called &ldquo;colitic diarrhea,&rdquo; is associated with frequent, small-volume\nstools. These patients do not commonly become dehydrated. Colonic diarrhea may\nalso be associated with the presence of visible blood and mucus. Patients with\nlarge-bowel diarrhea often have lower quadrant abdominal pain and/or the\nsensation of rectal urgency (tenesmus).\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\nlarge number of organisms have been identified in the stools or\ngastrointestinal tract mucosa of patients with refractory AIDS-related\ndiarrhea.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347230\" o:spid=\"_x0000_i1228\" type=\"#_x0000_t75\" alt=\"Description: cello_table_01\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image193.png\" o:title=\"cello_table_01\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: cello_table_01\" border=\"0\" height=\"212\" src=\"_%20Tutorials_files/image194.png\" v:shapes=\"Picture_x0020_347230\" width=\"339\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nmajor identified causes of AIDS-related diarrhea are\n  <i>\n   Cryptosporidium\n  </i>\n  and\n  <i>\n   Microsporidium\n  </i>\n  protozoa. Enteric pathogenic bacteria such as\n  <i>\n   Salmonella\n  </i>\n  ,\n  <i>\n   Campylobacter\n  </i>\n  ,\n  <i>\n   Shigella\n  </i>\n  , and\n  <i>\n   Clostridium difficile\n  </i>\n  , along\nwith other pathogens such as mycobacterium (principally\n  <i>\n   Mycobacterium avium\n  </i>\n  complex or MAC), and occasionally\n  <i>\n   Mycobacterium tuberculosis\n  </i>\n  , can also\ncause diarrhea. Viruses and fungi also can play a significant role in\nAIDS-related diarrhea. Classifying the etiology of HIV-infected patients with\ndiarrhea can be a problem because many different organisms may be found in the\nstools of patients with AIDS who have refractory diarrhea. It is not known if\nthese organisms are true pathogens, but they are clearly associated with the\nstools of patients with refractory diarrhea.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  <span>\n   Cryptosporidium parvum\n  </span>\n </i>\n <span>\n  is the most frequently identified\nparasite causing chronic diarrhea in AIDS, even in developed countries. This\norganism is extracellular, lining the brush border of the enterocytes in the\nsmall bowel and less frequently the large bowel.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Cytomegalovirus\n(CMV) is a parenteral infection, which can involve the gastrointestinal tract\nanywhere from the mouth to the anus. CMV typically is associated with very\nlarge ulcers that disproportionately involve the right colon. However, very\ncharacteristic of early CMV in the gut are submucosal hemorrhages, not\ndissimilar to those seen with ischemic colitis. CMV is very well named, and it\ntends to produce both large intranuclear and intracytoplasmic inclusions. The\ninfected cell is gigantic in size.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Mycobacterium\navium complex includes atypical mycobacteria that involve the\nreticuloendothelial system. Characteristically, MAC-infected patients have\nextensive adenopathy, very large livers, and large spleens. They also have\nsubstantial systemic illness, with fevers, anorexia, and massive infiltration\nof the gut lamina propria mononuclear cells. The organism is visible with\nacid-fast stains.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Microsporidia are unique\nintracellular organisms. These organisms are found in the supranuclear apical\nsurfaces of the enterocytes. Various life cycles of the organism, all of which\nare intracellular, can be seen with the use of special stains. Microsporidia\nare a major cause of diarrhea in patients with AIDS.\n  <span>\n  </span>\n </span>\n</p>\n", "choices": ["A. Cryptosporidium parvum", "B. Isospora belli", "C. Giardia lamblia", "D. Entamoeba histolytica"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A patient\nwho was treated with clindamycin for aspiration pneumonia develops diarrhea.\nThe stool contains a toxin that kills cultured epithelial cells. Stool culture\ngrows an anaerobic gram-positive rod. The same organism is cultured from the\nbedpan. Which of the following is most likely to sterilize the bedpan?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  .\n  <i>\n   Clostridium difficile\n  </i>\n  can exist as an endospore, which is resistant\nto standard techniques of disinfection. Sterilization is necessary to eliminate\nendospores. The most common method of sterilization is autoclaving, by which\nmaterials are subjected to high-pressure saturated steam at 121&nbsp;&deg;C or\nmore, typically for 15&ndash;20 minutes.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Disinfection\n  </span>\n </b>\n <span>\n  : the process of\neliminating most pathogenic microorganisms, but\n  <i>\n   not\n  </i>\n  bacterial spores\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Sterilization\n  </span>\n </b>\n <span>\n  : the process of killing all living\nmicroorganisms,\n  <i>\n   including\n  </i>\n  bacterial\nspores\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  ***\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  This\npatient has\n  <i>\n   Clostridium difficile\n  </i>\n  colitis, a common cause of diarrhea usually occurring in patients who have been\ntreated with broad-spectrum antibiotics.\n  <i>\n   C.\ndifficile\n  </i>\n  is an anaerobic, gram-positive, toxin-producing rod, which can\nexist as an endospore.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  An\nendospore is a &ldquo;stripped-down,&rdquo; dormant form of a bacterium. It is not a true\nspore (i.e. not an offspring). Most bacteria cannot convert themselves into\nendospores, but bacteria of the genera\n  <i>\n   Bacillus\n  </i>\n  and\n  <i>\n   Clostridium\n  </i>\n  can.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  When these bacteria are exposed\nto an inhospitable environment (e.g., desiccation), they can convert themselves\nfrom a vegetative form to an endospore form. The endospore enables the bacteria\nto survive for years, even millennia, in an untoward environment. When the\nenvironment becomes favorable, the endospore converts back to the bacterium&rsquo;s\nvegetative state.\n </span>\n</p>\n\n<p>\n An endospore consists of a\nbacterium's DNA and part of its cytoplasm, surrounded by a very tough outer\ncoating. Endospores can survive without nutrients. They are resistant to\nultraviolet radiation, desiccation, high temperature, extreme freezing, and\nchemical disinfectants. Common anti-bacterial agents that destroy vegetative\ncell walls do not destroy endospores. Household cleaning products are\nineffective, as are most alcohols, quaternary ammonium compounds (e.g.\nbenzalkonium chloride), and detergents. Endospores are able to survive boiling\nat 100&deg;C for hours. While resistant to extreme heat and radiation, endospores\n <i>\n  can\n </i>\n be destroyed by autoclaving. An\n <span>\n  autoclave\n </span>\n sterilizes material by\nsubjecting it to high pressure saturated steam at 121&nbsp;&deg;C or more,\ntypically for 15&ndash;20 minutes.\n</p>\n", "choices": ["A. Boiling for 45 minutes", "B. Exposure to benzalkonium chloride for 1 hour", "C. Exposure to ethyl alcohol for 1 hour", "D. Exposure to high-pressure saturated steam (121oC) for 15 minutes", "E. Heating in an oven at 150oC for 30 minutes"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n14-year-old boy presents with a 2-day history of left ear pain. He swims every\nmorning. The left ear canal is red and swollen. He experiences pain when the auricle\nis pulled and when the tragus is pushed. What is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  The most likely\ndiagnosis is external otitis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Otitis externa\n  </span>\n </b>\n <span>\n  , or swimmer&rsquo;s ear, is inflammation of\nthe external auditory canal, usually caused by bacterial infection (although\nsometimes caused by fungal infection). Patients have ear pain and erythema and\nswelling of the ear canal, occasionally with discharge. The pain worsens when\nthe auricle is pulled and when the tragus is pushed. Excessive moisture and\ntrauma are the most common precipitants.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Otitis media\n  </span>\n </b>\n <span>\n  (inflammation of the middle ear) often\noccurs with viral upper respiratory tract infection. The ear gets congested,\nwith mild discomfort and popping. If bacterial contamination occurs, pus and\npressure may develop, causing fever and severe, continuous ear pain. Otoscopic\nexamination will then show a bulging, erythematous ear drum with indistinct\nlandmarks and displacement of the light reflex. In severe cases, the ear drum\nmay perforate. Rare complications include mastoiditis and meningitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Serous otitis media\n  </span>\n </b>\n <span>\n  is a collection of\nfluid in the middle ear caused by negative pressure resulting from Eustachian\ntube dysfunction. The fluid may accumulate after a viral upper repiratory tract\ninfection or before or after acute bacterial otitis media.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Bullous myringitis\n  </span>\n </b>\n <span>\n  is an inflammatory\ncondition of the ear drum, characterized by severe ear pain and painful,\nfluid-filled vesicles on the ear drum. It is usually associated with acute\nbacterial otitis media.\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Mastoiditis\n  </span>\n </b>\n <b>\n  <span>\n  </span>\n </b>\n <span>\n  is\nan infection of the mastoid process (the portion of the temporal bone located\nbehind the ear). It is usually caused by untreated acute bacterial otitis\nmedia.\n </span>\n</p>\n", "choices": ["A. Acute bacterial otitis media", "B. Serous otitis media", "C. Bullous myringitis", "D. External otitis", "E. Mastoiditis"]}, {"question": "<p>\n A 57-year-old woman with a\nhistory of frequent urinary tract infections has fever, nausea, flank pain, and\nmuscle aches. Her temperature is 39.7\n <sup>\n  o\n </sup>\n C (103.5\n <sup>\n  o\n </sup>\n F) and her\nblood pressure is 80/50 mm Hg. Blood cultures are positive for a Gram-negative\nrod. Which of the following is the most likely cause of hypotension?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Endotoxin is the main\ncause of fever and hypotension in patients with Gram-negative sepsis.\nInflammation and activation of the coagulation cascade occur.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Superantigens\n  </span>\n  are produced by many different micro-organisms.\nThey stimulate T-cell activation, resulting in massive cytokine release.\nCompared to a normal T-cell response in which .001-.0001% of T-cells are\nactivated, superantigens activate up to 20% of T-cells. Toxic Shock Syndrome\nToxin 1 (TSST-1) is a superantigen produced by\n  <i>\n   Staphylococcus aureus\n  </i>\n  .\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  .\n  <b>\n  </b>\n  <span>\n   Erythrogenic toxin, produced by\n  </span>\n  <i>\n   Streptococcus\npyogenes\n  </i>\n  , is the cause of scarlet fever.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Hemolysins\n  </span>\n  are exotoxins that cause\nlysis of red blood cells\n  <i>\n   in vitro\n  </i>\n  . Visualization of hemolysis on agar\nplates facilitates the categorization of some bacteria, such as\n  <i>\n   Streptococcus\n  </i>\n  and\n  <i>\n   Staphylococcus\n  </i>\n  .\n </span>\n</p>\n"], "tutorial": "<p>\n An endotoxin is a structural\npart of a bacterium. The prototypical example of an endotoxin is\nlipopolysaccharide (LPS), which is found in the cell wall of most Gram-negative\nbacteria.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n LPS consists of a core\npolysaccharide chain, O-specific polysaccharide side chains (O-antigen), and a\nlipid component, Lipid A,\n <span>\n </span>\n which is\nresponsible for the toxic effects. Injection of a small amount of endotoxin in\nhuman volunteers causes fever, hypotension, and activation of inflammation and\ncoagulation. Endotoxins are largely responsible for the dramatic clinical\nmanifestations of infections with pathogenic Gram-negative bacteria.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347229\"\n o:spid=\"_x0000_i1227\" type=\"#_x0000_t75\" alt=\"Description: http://www.glycosan.com/images/endotoxin_structure.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image195.jpg\" o:title=\"//www.glycosan.com/images/endotoxin_structure.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.glycosan.com/images/endotoxin_structure.jpg\" border=\"0\" height=\"233\" src=\"_%20Tutorials_files/image196.png\" v:shapes=\"Picture_x0020_347229\" width=\"231\"/>\n </span>\n</p>\n\n<p align=\"center\">\n Endotoxin\n</p>\n\n<p>\n A comparison of endotoxin\nand exotoxins appears below.\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Endotoxin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Exotoxin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Disease\n  (examples)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gram-negative\n  sepsis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tetanus,\n  Botulism, Diphtheria\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Source\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Lipopolysaccharide\n  found in the cell wall of most gram-negative bacteria; released when lysed\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Polypeptide\n  secreted by certain species of gram-positive and gram-negative bacteria\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gene\n  location\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Bacterial\n  chromosome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Plasmid\n  or bacteriophage\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Clinical\n  effects\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Fever,\n  shock\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Depends\n  on toxin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Antigenicity\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Poorly\n  antigenic\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Induces\n  high-titer antibodies, called antitoxins\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vaccines\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     None\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Toxoids\n  used as vaccines\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Heat\n  stability\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Stable\n  at 100\n     <sup>\n      o\n     </sup>\n     C for 1 hour\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Destroyed\n  rapidly at 60\n     <sup>\n      o\n     </sup>\n     C\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Endotoxin", "B. Superantigen", "C. Erythrogenic toxin", "D. Hemolysin"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Each of\nthe following clinical vignettes describes a condition that is caused by an\nexotoxin-producing bacterium. Match the vignette with the causative organism.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n72-year woman develops fever, abdominal pain, and non-bloody diarrhea after\nbeing treated for aspiration pneumonia with clindamycin. Sigmoidoscopy shows\npatches of yellow exudate in the distal colon.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n4-year old boy in Uzbekistan develops low-grade fever, sore throat, and a\nthick, tough, gray-to-black coating in the back of the throat.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n26-year old man in India has vomiting and profuse, watery diarrhea, which\nresults in hypotension and death within hours.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n3-year old boy has bloody diarrhea. Blood tests show a low hemoglobin\nconcentration, a low platelet count, and an elevated serum creatinine level.\nThe reticulocyte count is elevated and the haptoglobin level is low.\nExamination of a peripheral blood smear shows a few schistocytes.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   5.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n10-year old girl has sneezing, runny nose, and a mild cough. Two weeks later,\nshe develops uncontrollable fits of coughing followed by an inspiratory gasp.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   6.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n64-year old man with peripheral arterial disease sustains a deep injury to his\nleg. The area becomes swollen and painful, its color changes from red to bronze\nto blackish green, and a foul-smelling discharge develops. Large blisters\nappear, and gas bubbles are felt beneath the skin.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   7.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n24-year old woman develops high fever, delirium, and a sunburn-like rash, which\nis intensely red and affects the entire body, including eyes, lips, mouth,\npalms, and soles. She is hypotensive. Her delirium progresses to coma, and she\ndevelops multi-organ failure. The rash desquamates ten days later.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   8.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n13-year old girl develops high fever, sore throat, and a rash that begins on\nher neck and spreads to her chest and back. The rash is red, fine, and\nrough-textured. It is worse in the skin folds. (Converging erythematous lines\nappear in the axilla and groin.) Examination reveals tonsillar exudate,\ncervical lymphadenopathy, and a bright, red &ldquo;strawberry&rdquo; tongue. The rash peels\nfive days later. Anti-streptolysin O titers are elevated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   9.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  After\neating home-canned asparagus, a 42-year old man develops blurred vision and\ndifficulty with swallowing and speaking, followed by weakness of the arms and\nlegs.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   10.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Seven\ndays after injuring his leg, a 32-year old man develops tightening of his jaw,\nstiffness of his neck, and trouble swallowing. This is followed by tightening\nof the pectoral and calf muscles. His temperature, pulse, and blood pressure\nare elevated.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   11.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n1-month old neonate develops a diffuse, erythematous rash with blistering.\nLarge patches of skin can be seen peeling away. Gentle stroking causes the skin\nto separate.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   12.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Two\nhours after eating a sandwich of sliced meat, a 43-year old woman becomes\nviolently ill with nausea, vomiting, abdominal pain, and diarrhea. Her symptoms\nresolve the following day.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   13.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n43-year old man who makes drums out of animal hide develops a boil-like lesion\non his forearm, which evolves into a large, painless, necrotic ulcer.\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <span>\n  Answers\n </span>\n</p>\n"], "tutorial": "<p>\n <i>\n  Clostridium difficile\n </i>\n colitis should be suspected when diarrhea\noccurs in a patient who has recently taken antibiotics. The diarrhea is usually\nnon-bloody and may be accompanied by fever and abdominal pain.\n <i>\n  Clostridium difficile\n </i>\n colitis is\nclassically associated with clindamycin use, but any broad-spectrum antibiotic\ncan cause the condition. &ldquo;Pseudomembranes,&rdquo; patches of yellowish exudate\ncomprised of inflammatory debris, can be seen using sigmoidoscopy or\ncolonoscopy (hence, the term &ldquo;pseudomembranous colitis&rdquo;).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Clostridia are Gram-positive, anaerobic,\nspore-forming bacilli.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Eradication\nof normal gut flora with antibiotic use causes overpopulation of these\nbacteria, which naturally reside in the colon. The bacteria release toxins that\ncan cause bloating, diarrhea, and abdominal pain. There are several known\ntoxins. The best-characterized are enterotoxin (\n <span>\n  toxin A\n </span>\n ) and cytotoxin (\n <span>\n  toxin\nB\n </span>\n ), both of which cause diarrhea and inflammation. Enzyme-linked\nimmunoabsorbant assays (ELISA) are available for detecting toxins A and B in\nthe stool. Experts recommend sending as many as three stool samples for ELISA\ntesting if initial tests are negative. Patients with\n <i>\n  C. difficile\n </i>\n <span>\n  colitis should be treated with oral\n </span>\n metronidazole\nor vancomycin. If treatment is effective, the toxin clears from the stool.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n D\n <span>\n  iphtheria\n </span>\n is an upper respiratory tract illness caused by\n <i>\n  Corynebacterium\ndiphtheriae\n </i>\n , a Gram-positive bacterium. The condition is characterized by\nsore throat, low fever, and an adherent membrane (a &ldquo;\n <span>\n  pseudomembrane&rdquo;\n </span>\n ) on the tonsils, pharynx, or nasal cavity.\nPatients may present with a &ldquo;bull&rdquo; neck. Diphtheria has largely been eradicated\nin industrialized nations through widespread vaccination. The vaccine is\ncomposed of the diphtheria toxoid.\n</p>\n\n<p>\n <span>\n  Cholera\n </span>\n is an infection of the small intestine caused by the\nbacterium\n <i>\n  Vibrio cholerae\n </i>\n . The main symptoms are profuse watery diarrhea\nand vomiting. The diarrhea is frequently described as \"rice water.\"\nAn untreated person may produce 10-20 liters of stool a day. Disease\ntransmission is primarily through consumption of contaminated water or food.\nThe severity of the diarrhea and vomiting can lead to rapid dehydration and\nelectrolyte imbalance. Primary treatment is rehydration. Cholera affects 3-5\nmillion people worldwide and causes more than 100,000 deaths each year.\n</p>\n\n<p>\n <i>\n  <span>\n   Escherichia coli\n  </span>\n </i>\n <span>\n  O157:H7\n </span>\n is an enterohemorrhagic strain of the bacterium\n <i>\n  Escherichia\ncoli\n </i>\n <span>\n  .\n </span>\n Infection often leads\nto hemorrhagic diarrhea and, occasionally, to renal failure, especially in\nyoung children and the elderly. Transmission is via the fecal-oral route.\n <i>\n  E.\ncoli\n </i>\n is a Gram-negative bacillus, of which there are hundreds of serotypes.\nMost are harmless. Serotype O157:H7, however, can produce Shiga-like toxins,\nwhich cause severe illness. In some individuals (particularly children under\nfive years of age and the elderly), infection can lead to hemolytic uremic\nsyndrome (HUS), a condition characterized by hemolytic anemia,\nthrombocytopenia, and acute renal failure. In HUS, bacterial toxins stimulate\nplatelet activation and the formation of microthrombi in arterioles and\ncapillaries. Platelets are consumed and red blood cells are damaged as they\nsqueeze through the narrowed blood vessels. This process is called\n\"microangiopathic hemolysis.\" Schistocytes, or fragments of sheared\nred blood cells, appear in the blood and are a key finding in the diagnosis of\nHUS.\n</p>\n\n<p>\n <span>\n  Pertussis\n </span>\n , also known as\n <span>\n  whooping\ncough,\n </span>\n is a highly contagious disease caused by the bacterium\n <i>\n  Bordetella\npertussis\n </i>\n . The condition lasts about six weeks and is named after the\n\"whoop\" sound made from the inspiration of air after a cough. (The\nhigh-pitched &ldquo;whoop&rdquo; occurs mainly in infants and children.) The classic\nsymptoms are paroxysmal cough, inspiratory whoop, and post-tussive vomiting\n(after-cough vomiting). The cough is violent and has been associated with\nsubconjunctival hemorrhage, rib fracture, and syncope. Patients present with\nmild respiratory symptoms, such as sneezing, runny nose, and cough (catarrhal\nstage). After one to two weeks, the cough develops into uncontrollable fits,\neach followed by a high-pitched \"whoop\" (in younger children) or a\ngasp (in older children). This is the paroxysmal stage. The &ldquo;whoop&rdquo; or gasp\noccurs as the patient struggles to inhale. Between coughing fits, the patient\noften appears well. The pertussis vaccine, an acellular vaccine, saves many\nlives each year.\n</p>\n\n<p>\n <span>\n  Gas gangrene\n </span>\n (also known as \"Clostridial myonecrosis\" or\n\"myonecrosis\") is a deadly form of gangrene usually caused by\n <i>\n  Clostridium\nperfringens.\n </i>\n The condition usually occurs at the site of trauma or a recent\nsurgical wound. The onset of illness is sudden and dramatic. Predisposing\nconditions include peripheral arterial disease and diabetes. Clostridia produce\nmany different toxins that can cause potentially deadly syndromes. The site of\ninfection becomes inflamed, swollen, and very tender. Palpation of the region\nelicits crackling because of subcutaneous gas. Vesicles appear which merge into\nlarge blisters. A serosanguinous discharge is common. The edge of the infected\narea may expand over minutes. High fever, tachycardia, sweating, and exquisite\npain are typical.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n If the condition\nis not treated, shock ensues and death soon follows.\n</p>\n\n<p>\n Toxic shock syndrome usually\nresults from infection with\n <i>\n  Staphylococcus aureus\n </i>\n <span>\n  . Patients present with\n </span>\n high fever, low blood pressure, and\nconfusion, which may progress rapidly to stupor, coma, and multi-organ failure.\nThe characteristic rash, often seen early in the course of illness, resembles\nsunburn, and can involve any region of the body, including the lips, mouth,\neyes, palms and soles. D\n <span>\n  esquamation\noccurs\n </span>\n after 10&ndash;14 days. Toxic shock syndrome is caused by a\nsuperantigen toxin, which is produced by\n <i>\n  Staphylococcus aureus\n </i>\n <span>\n  . The superantigen is called toxic shock\nsyndrome toxin 1 (TSST-1).\n </span>\n</p>\n\n<p>\n <span>\n  Scarlet fever\n </span>\n is caused by an exotoxin (&ldquo;erythrogenic toxin&rdquo;)\nproduced by\n <i>\n  Streptococcus pyogenes\n </i>\n . The disease is characterized by high\nfever, sore throat, tonsillar exudate, cervical lymphadenopathy, bright red\ntongue (&ldquo;strawberry tongue&rdquo;), and characteristic rash. The rash is fine, red,\nand rough-textured. It usually appears on the neck and face, often leaving a\nclear unaffected area around the mouth. It then spreads to the chest, back, and\nextremities. Classic red streaks that run together (Pastia lines) appear in body\ncreases, especially the axillae, elbows, and groin. The rash blanches with\npressure and fades by the sixth day. The affected skin desquamates. Blood tests\nshow marked leukocytosis and an elevated antistreptolysin O titer. Streptococci\nmay be cultured from the throat. Two types of complications are possible:\n&ldquo;septic&rdquo; and &ldquo;immune.&rdquo; Septic complications result from bacteremia, and include\nsinusitis, pneumonia, and meningitis. Immune complications include acute\nglomerulonephritis, rheumatic fever and erythema nodosum.\n</p>\n\n<p>\n <span>\n  Botulism\n </span>\n is a paralytic illness caused by botulinum toxin, which\nis produced by the bacterium\n <i>\n  Clostridium botulinum\n </i>\n <span>\n  . The toxin prevents the release of\nacetylcholine at motor nerve endings in the parasympathetic system. It\n </span>\n enters the body in one of three ways: by colonization of the digestive tract by\nthe bacterium, by ingestion of toxin from foods, or by bacterial wound\ncontamination.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n All forms lead to\nparalysis, which typically starts with the muscles of the face and spreads to\nthe limbs. Initial manifestations include blurred vision, ptosis, loss of\nfacial expression, swallowing problems, and difficulty speaking. Severe\nbotulism can lead to respiratory failure. The autonomic nervous system may be\nimpaired, causing dry mouth, postural hypotension, and constipation.\n</p>\n\n<p>\n <span>\n  Tetanus\n </span>\n is characterized by prolonged contraction of skeletal\nmuscle. The condition is caused by a neurotoxin produced by the Gram-positive,\nanaerobic bacterium\n <i>\n  Clostridium tetani\n </i>\n . The toxin acts by binding\ninhibitory neurons, blocking the release of neurotransmitters. Infection\ngenerally occurs through wound contamination.\n <span>\n  Generalized tetanus\n </span>\n occurs in 80% of cases and follows a\ndescending pattern. The first sign is trismus (&ldquo;lockjaw&rdquo;) and facial spasm,\nfollowed by stiffness of the neck, difficulty swallowing, and rigidity of\npectoral and calf muscles. Other findings include elevated temperature,\nelevated blood pressure, rapid heart rate, and sweating. The tetanus vaccine,\ncomposed of tetanus toxoid, is very effective at preventing disease.\n</p>\n\n<p>\n <span>\n  Staphylococcal scalded skin syndrome\n </span>\n is induced by epidermolytic\nexotoxins A and B, which are released by\n <i>\n  Staphylococcus aureus\n </i>\n and cause\ndetachment within the epidermal layer. The exotoxins are proteases that cleave\ndesmoglein-1, which holds the granulosum and spinosum layers of the epidermis\ntogether. The disease most commonly affects neonates and usually begins with\nfever, irritability, and a faint rash. Within 1-2 days, the rash progresses to\na blistering eruption. Tissue paper-like wrinkling of the epidermis occurs and\nlarge bullae appear. As sheets of epidermis are shed, a moist erythematous base\nis revealed. Although the clinical picture is dramatic, the process usually\nends with desquamation, and healing is complete in 5-7 days.\n</p>\n\n<p>\n Staphylococcal food\npoisoning is caused by enterotoxins produced by\n <em>\n  Staphylococcus aureus\n </em>\n <em>\n  <span>\n   . The bacteria multiply in\nfood, where they produce heat-resistant enterotoxins (toxins that cannot be\ndestroyed by cooking). When ingested, the\n  </span>\n </em>\n toxins are fast-acting,\nsometimes causing illness in as little as thirty minutes. On average, symptoms\noccur one to six hours after eating, and include nausea, vomiting, abdominal\npain, and diarrhea. The illness is usually brief, and most patients recover in\none to three days.\n <span>\n  Foods associated with staph food\npoisoning include meats; poultry and egg products; salads such as egg, tuna,\nchicken, potato, and macaroni; bakery products such as cream-filled pastries,\ncream pies, and chocolate &eacute;clairs; sandwich fillings; and milk and dairy\nproducts.\n </span>\n</p>\n\n<p>\n <span>\n  Anthrax\n </span>\n is a disease caused by the bacterium\n <i>\n  Bacillus anthracis\n </i>\n .\nThe bacterium enters the body through the lungs, intestines, or skin. Symptoms\ndepend on site of entry. Lung infection causes flu-like symptoms, followed by\nrespiratory collapse. Intestinal infection causes abdominal pain, hematemesis,\nand diarrhea. Cutaneous infection results in a boil-like lesion that forms a\nlarge, painless, necrotic ulcer. Anthrax can be contracted in laboratory\naccidents or by handling infected animals or their wool or hides.\n</p>\n", "choices": ["A. Staphylococcus aureus", "B. Streptococcus pyogenes", "C. Corynebacterium diphtheriae", "D. Vibrio cholerae", "E. Escherichia coli 0157:H7", "F. Bordetella pertussis", "G. Clostridium perfringens", "H. Clostridium tetani", "I. Clostridium botulinum", "J. Clostridium difficile", "K. Bacillus anthracis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  J\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  C\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  D\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  E\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   5.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  F\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   6.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  G\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   7.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   8.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  B\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   9.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  I\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   10.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  H\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   11.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   12.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   13.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  K\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following molecules is considered an endogenous pyrogen?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  A pyrogen is a substance\nthat causes fever. Exogenous pyrogens are usually microbes or their products.\nThe best studied exogenous pyrogens are the lipopolysaccharides of\ngram-negative bacteria (commonly called endotoxins) and\n  <i>\n   Staphylococcus aureus\n  </i>\n  toxin, which causes toxic shock syndrome.\nExogenous pyrogens usually cause fever by inducing release of endogenous\npyrogens. The principal endogenous pyrogens are interlekin-1, interleukin-6,\nand tumor necrosis factor-&alpha;. They stimulate production of Prostaglandin E2,\nwhich plays a critical role in adjusting the hypothalamic set point.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Histamine is a vasoactive amine released by mast\ncells upon activation and promotes inflammation by altering permeability of the\nendothelium.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It is responsible for\nmany of the symptoms associated with allergies.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Serotonin (5-hydroxytryptamine) is a monoamine\nneurotransmitter found in the gastrointestinal tract and the CNS.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It affects intestinal movements, mood,\nappetite, sleep, muscle contraction, hemostasis, and blood clotting.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Nitric oxide (NO) is produced from arginine by\nthree forms of nitric oxide synthase, depending on the cell type.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Inside of a phagocyte, NO is\nmicrobicidal but NO also mediates vasodilation.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Platelet-activating factor (PAF) is a\nphospholipid mediator released by platelets, endothelial cells, neutrophils,\nmonocytes, and macrophages.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  PAF is\nproinflammatory in that it attracts leukocytes, amplifies production of lipid\nmediators and activates neutrophils, eosinophils, and platelets.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Infection\ncan be defined as invasion of a pathogen that triggers an immune response.\nManifestations of infection are protean and are due as much to our immune\nresponse as to the attributes of the particular pathogen. The inflammatory\nresponse that accompanies infection is usually marked by fever.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fever is\nan elevation in body temperature above the normal range in response to a\ncentral nervous system change in the set point. Normal oral temperature ranges\nfrom 36.0 to 37.7&deg; C, with a circadian variation of 1&deg; C or more between the\nmorning nadir and the evening peak. Mean oral temperature in healthy adults is\n36.8 &plusmn; 0.4&deg; C, with women exhibiting slightly higher values than men. Rectal\ntemperatures are 0.4&deg; C higher than oral and 0.8&deg; C higher than aural (tympanic\nmembrane) temperatures. Clinicians generally define significant fever as a\ntemperature higher than 38.3&deg; C (101.0&deg; F).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The vast\nmajority of acute febrile illnesses lasting less than two weeks have an\ninfectious cause. These infections occur predominantly where body surfaces\ninteract with the environment, such as the upper and lower respiratory tracts,\ngastrointestinal and genitourinary systems, and skin. The majority of acute\nrespiratory and gastrointestinal infections are viral in nature. As the duration\nof the febrile illness lengthens beyond three weeks, other inflammatory\nillnesses become more prominent in the differential diagnosis. Most chronic\nfebrile illnesses are not caused by infection.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4377-1604-7..00288-8--s001\">\n </a>\n <a name=\"4-u1.0-B978-1-4377-1604-7..00288-8--st00\">\n </a>\n <span>\n  Infection ensues when a pathogen overcomes both\nnonspecific innate and specific adaptive humoral and cellular immune responses.\nThe normal indigenous microflora, host physical barriers (e.g., skin, mucous\nmembranes, cilia), and soluble factors (e.g., cytokines, complement) provide\nimportant barricades to pathogen invasion. Disruption of these barriers, which\nprovide a first line of defense, permits the invasion of pathogens.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The acute\nphase response triggered by such disruption provides direct antimicrobial\nactivity and prompts the development of adaptive immunity mediated by\nlymphocytes and macrophages. This inflammatory response plays an important role\nin containing infection. Unfortunately, an exaggerated response may worsen the\nclinical condition.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Body\ntemperature is regulated both physiologically and behaviorally. Basal metabolic\nprocesses, governed especially by thyroid hormones but also by catecholamines\nand growth hormone, are responsible for the normal resting body temperature.\nThermogenesis may be increased up to 80% by hyperthyroidism and decreased as\nmuch as 50% by hypothyroidism. Moderate activity increases thermogenesis and\nresults in a transiently increased temperature until heat-dissipating processes\nare engaged.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nhypothalamus contains temperature-sensitive neurons that have receptors for\npro-inflammatory and anti-inflammatory cytokines, which are continuously\nbalanced to maintain a homeothermic set point. When body temperature becomes\nelevated, cutaneous vasodilation and sweating occur, and people may reduce\nactivity and seek a cooler environment. In contrast, low body temperature is\nincreased by shivering, piloerection, cutaneous vasoconstriction, adding\nclothes, and seeking a warmer environment.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In febrile\nillness, symptoms are often due to the fever itself. Malaise is the rule, and many\nfebrile patients experience myalgia secondary to muscle contractions used to\nraise temperature. The chill associated with rigors may be related to surface\nvasoconstriction that accompanies the increase in core temperature. The body&rsquo;s\nthermoregulatory mechanisms rarely allow fevers to exceed 41&deg; C (106&deg; F).\nTemperatures exceeding 41&deg; C are often due to a drug-induced imbalance in these\nmechanisms and may cause direct cellular damage.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fever is a\ncomplex physiologic process involving metabolic and immunologic responses.\nBacteria release cell wall products such as peptidoglycans and endotoxin, as\nwell as enterotoxins, which bind to Toll-like receptors (TLRs) on phagocytes\n(neutrophils, macrophages) and endothelial cells. As a result, pyrogenic\ncytokines such as interleukin-1, interleukin-6, and tumor necrosis factor\n(TNF)-&alpha; are released into the circulation and bind to cytokine receptors\nin the hypothalamus. This stimulates the brain to produce prostaglandin E\n  <sub>\n   2\n  </sub>\n  (PGE\n  <sub>\n   2\n  </sub>\n  ) and cyclic adenosine monophosphate (cAMP), which trigger\nneurons in the thermoregulatory center to raise the hypothalamic thermostatic\nset point. In addition, neuronal signals to the cortex prompt behavioral\nchanges to conserve heat (e.g., shivering, adding clothing). The hypothalamus\nalso triggers sympathetic peripheral efferent nerves that constrict peripheral\nblood vessels and conserve central heat.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Leukocytosis\noften occurs in response to infection. Neutrophilia is the norm in most acute\ninfections, whatever the cause. Neutropenia may be seen in rickettsial, severe\nviral and overwhelming bacterial infections. Eosinophilia is typical of\ninvasive helminthic and some protozoal infections. Lymphocytosis may accompany\nmany viral and rickettsial infections and is common during convalescence from\nacute bacterial infection. Monocytosis may be seen in tuberculosis. Virtually\nall infections have an impact on the erythroid system, but given the long\nhalf-life of erythrocytes, usually only chronic infections or other\ninflammatory diseases result in anemia. Few acute infections produce anemia.\n </span>\n</p>\n", "choices": ["A. Interleukin-1", "B. Histamine", "C. Serotonin", "D. Nitric oxide", "E. Platelet-activating factor"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A healthy\n42-year old man travels to California. Six weeks later, he develops fever,\ncough, pleuritic chest pain, sore muscles, and left knee swelling. Red tender\nnodules appear on his shins. A chest x-ray shows a left pleural effusion. Which\nof the following conditions is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . This patient has both\nrespiratory and rheumatologic symptoms. Endemic mycoses can produce\nrheumatologic symptoms, such as pleuritis, arthritis, and erythema nodosum (red\ntender nodules on the shins). This patient most likely has coccidioidomycosis\n(also known as California disease, desert rheumatism, San Joaquin Valley fever,\nand Valley fever) given his recent travel to California.\n  <i>\n   Coccidioides immitis\n  </i>\n  appears in tissue as a spherule with\nendospores.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Histoplasmosis is an\nendemic mycosis of the Mississippi and Ohio River Valleys.\n  <i>\n   Histoplasma capsulatum\n  </i>\n  appears in tissue (often macrophages) as\nintracellular yeasts.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Blastomycosis is an\nendemic mycosis of the Mississippi and Ohio River Valleys.\n  <i>\n   Blastomyces dermatitidis\n  </i>\n  appears in tissue as broad-based budding\nyeasts.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Aspergillosis affects\nmainly immunocompromised individuals.\n  <i>\n   Aspergillus\nsp.\n  </i>\n  appears in tissue as branching, septate hyphae.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Cryptococcus is best\nknown for causing meningitis in patients with AIDS.\n  <i>\n   Cryptococcus neoformans\n  </i>\n  appears in tissue as encapsulated yeast.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer F is incorrect\n  </span>\n </b>\n <span>\n  . Mucormycosis occurs in\nimmunocompromised hosts, especially those with diabetes. The most common sites\nof infection are sinus, brain, and lung.\n  <i>\n   Mucor\nspp.\n  </i>\n  appears in tissue as coenocytic hyphae branching with wide angles.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Fungal\npathogens can be classified as endemic or opportunistic. Endemic pathogens,\nwhich occur in specific geographic areas, can cause disease in immunocompetent\nindividuals. Opportunistic pathogens, which are ubiquitous, cause disease in\nimmunocompromised hosts. In the proper setting, all can cause pneumonia and\nother respiratory diseases.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"3\" valign=\"top\" width=\"338\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Fungal Pathogens\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"3\" valign=\"top\" width=\"338\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"3\" valign=\"top\" width=\"77\">\n    <p class=\"MsoNormal\">\n     <span>\n      Endemic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"109\">\n    <p class=\"MsoNormal\">\n     <span>\n      Coccidioidomycosis\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"152\">\n    <p class=\"MsoNormal\">\n     <span>\n      Southwestern\n  U.S.\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"109\">\n    <p class=\"MsoNormal\">\n     <span>\n      Histoplasmosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"152\">\n    <p class=\"MsoNormal\">\n     <span>\n      Mississippi\n  and Ohio Rivers\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"109\">\n    <p class=\"MsoNormal\">\n     <span>\n      Blastomycosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"152\">\n    <p class=\"MsoNormal\">\n     <span>\n      Mississippi\n  and Ohio Rivers\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"3\" valign=\"top\" width=\"338\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"4\" valign=\"top\" width=\"77\">\n    <p class=\"MsoNormal\">\n     <span>\n      Opportunistic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"109\">\n    <p class=\"MsoNormal\">\n     <span>\n      Candidiasis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"152\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ubiquitous\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"109\">\n    <p class=\"MsoNormal\">\n     <span>\n      Aspergillosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"152\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ubiquitous\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"109\">\n    <p class=\"MsoNormal\">\n     <span>\n      Mucormycosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"152\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ubiquitous\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"109\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cryptococcosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"152\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ubiquitous\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Risk\nfactors for endemic pathogens include travel to endemic regions and exposure to\nbird, bat, or rodent droppings. Risk factors for opportunistic pathogens\ninclude immunocompromised states, such as HIV infection, immunosuppressive\ntherapy, and oncologic therapy. Symptoms of fungal lung infection include\nfever, cough, chest pain, and shortness of breath.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Endemic\nmycoses are prone to causing rheumatologic symptoms, such as pericarditis,\npleuritis, arthritis, and rash (e.g., erythema multiforme and erythema\nnodosum.)(See images below.) Lymphadenopathy is common and may result in large\nairway obstruction (pressure effect). In a minority of patients, fungemia leads\nto disseminated disease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Erythema nodosum: red, tender nodules, usually on the shins\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  .\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347228\"\n o:spid=\"_x0000_i1226\" type=\"#_x0000_t75\" alt=\"Description: erythem nodosum\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image197.png\" o:title=\"erythem nodosum\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: erythem nodosum\" border=\"0\" height=\"248\" src=\"_%20Tutorials_files/image198.png\" v:shapes=\"Picture_x0020_347228\" width=\"377\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Erythema multiforme: &ldquo;target lesions&rdquo;\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/6/68/EMminor09.JPG\">\n  <span>\n   <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347227\"\n o:spid=\"_x0000_i1225\" type=\"#_x0000_t75\" alt=\"Description: File:EMminor09.JPG\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/6/68/EMminor09.JPG\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image199.jpg\" o:title=\"EMminor09.JPG\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: File:EMminor09.JPG\" border=\"0\" height=\"272\" src=\"_%20Tutorials_files/image200.png\" v:shapes=\"Picture_x0020_347227\" width=\"362\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n", "choices": ["A. Coccidioidomycosis", "B. Histoplasmosis", "C. Blastomycosis", "D. Aspergillosis", "E. Cryptococcosis", "F. Mucormycosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 40-year\nold man with AIDS is started on highly active antiretroviral therapy (HAART).\nHe subsequently notices increased abdominal fat, thinning of the arms and legs,\nprominence of the superficial veins, and a &ldquo;hallowing out&rdquo; of the face. These\nchanges are probably caused by a medicine in which of the following classes?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Protease inhibitors\ncan cause a redistribution of fat. This may result in truncal obesity, thinning\nof the arms and legs, prominence of the superficial veins, and a &ldquo;hallowed out&rdquo;\nface. The following drugs are protease inhibitors: saquinavir, ritonavir, indinavir,\nnelfinavir, and amprenavir.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Some nucleoside analog\nreverse transcriptase inhibitors (NARTIs) can cause anemia, bone marrow\nsuppression, pancreatitis, peripheral neuropathy, and gastrointestinal\ndisturbance. The following drugs are NARTIs: zidovudine,&nbsp;didanosine,\nzalcitabine, stravudine, lamivudine, abacavir, emtricitabine, entecavir, and\napricitabine.&nbsp;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Nucleotide analog\nreverse transcriptase inhibitors (NtARTIs) can cause gastrointestinal\ndisturbance. Tenofovir is an NtARTI.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Some non-nucleoside\nreverse transcriptase inhibitors (NNRTIs) can cause hepatitis and rash. The\nfollowing drugs are NNRTIs: efavirenz, nevirapine, delavirdine, etravirine,\nrilpivirine&nbsp;\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . The fusion inhibitor,\ninfuvirtide, can cause a reaction at the injection site. This drug is not\nrecommended for HAART.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Antiretroviral drugs\n </span>\n are medications for the treatment of\ninfection by retroviruses, primarily HIV. When several such drugs, typically\nthree or four, are taken in combination, the approach is known as\n <span>\n  Highly Active Antiretroviral Therapy\n </span>\n ,\nor\n <span>\n  HAART\n </span>\n . The National\nInstitutes of Health and other organizations recommend offering antiretroviral\ntreatment to all patients with AIDS. Because of the complexity of selecting and\nfollowing a regimen, the severity of the side-effects, and the importance of\ncompliance to prevent viral resistance, such organizations emphasize the\nimportance of involving patients in therapy choices, and recommend analyzing\nthe risks and the potential benefits to patients with low viral loads.\n <b>\n </b>\n</p>\n", "choices": ["A. Protease inhibitor", "B. Nucleoside analog reverse transcriptase inhibitor (NARTI)", "C. Nucleotide analog reverse transcriptase inhibitor (NtARTI)", "D. Non-nucleoside reverse transcriptase inhibitor (NNRTI)", "E. Fusion inhibitor"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 60-year-old\nwoman has never been vaccinated for hepatitis B. Her serological tests show the\nfollowing:\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  HBsAg\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  HBeAg\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  HBcAb IgM\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  HBcAb IgG\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  positive\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  HBsAb\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  positive\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which is\ncorrect?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . The presence of HBcAb IgG and HBsAb\nindicates that she has been exposed to hepatitis B and has produced antibodies\nconferring immunity.\n </span>\n</p>\n", "<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . The presence of HBcAb IgG and HBsAb\nindicates previous infection with hepatitis B.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . In the acute phase of\ndisease, hepatitis B surface antigen (HBsAg) is positive and hepatitis B\nsurface antibody (HBsAb) is negative.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . In the serological\n&ldquo;window,&rdquo; hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody\n(HBsAb) are negative, while IgM hepatitis B core antibody (IgM HBcAb) is\npositive.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . In chronic infection,\nhepatitis B surface antigen (HBsAg) is positive and hepatitis B surface\nantibody (HBsAb) is negative.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Hepatitis\nB Serology\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What do\nthe different Hepatitis B serologic markers mean?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hepatitis B surface antigen (HBsAg):\n </span>\n <span>\n  A protein on the surface of HBV; it can be\ndetected in high levels in serum during acute or chronic HBV infection. The\npresence of HBsAg indicates that the person is infectious. The body normally\nproduces antibodies to HBsAg as part of the normal immune response to\ninfection. HBsAg is the antigen used to make Hepatitis B vaccine.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hepatitis B surface antibody (anti-HBs):\n </span>\n <span>\n  The presence of anti-HBs indicates\nrecovery and immunity from HBV infection. Anti-HBs develop in people who have\nbeen successfully vaccinated against Hepatitis B.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Total Hepatitis B core antibody (anti-HBc):\n </span>\n <span>\n  Appears at the onset of\nsymptoms in acute Hepatitis B and persists for life. The presence of anti-HBc\nindicates previous or ongoing infection with HBV in an undefined time frame.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  IgM antibody to Hepatitis B core antigen (IgM anti-HBc):\n </span>\n <span>\n  Indicates recent\ninfection with HBV (&le;6 months). Its presence indicates acute infection.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hepatitis B e antigen (HBeAg):\n </span>\n <span>\n  A secreted product of the nucleocapsid gene of\nHBV that is found in serum during acute and chronic Hepatitis B. Its presence\nindicates that the virus is replicating and the infected person has high levels\nof HBV.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hepatitis B e antibody (HBeAb or anti-HBe):\n </span>\n <span>\n  Produced by the immune system\ntemporarily during acute HBV infection or consistently during or after a burst\nin viral replication.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Spontaneous\nconversion from e antigen to e antibody (a change known as seroconversion) is a\npredictor of long-term clearance of HBV in patients undergoing antiviral\ntherapy and indicates lower levels of HBV.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  How to interpret Hepatitis B serologic test results\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nfollowing table provides interpretations for Hepatitis B serologic markers.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"95%\">\n <thead>\n  <tr>\n   <td colspan=\"3\" valign=\"top\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Interpretation of Hepatitis B\n   Serologic Test Results\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td width=\"102\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Tests\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"106\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Results\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"249\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Interpretation\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     HBsAg\n     <br/>\n     anti-HBc\n     <br/>\n     anti-HBs\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     negative\n     <br/>\n     negative\n     <br/>\n     negative\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Susceptible\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     HBsAg\n     <br/>\n     anti-HBc\n     <br/>\n     anti-HBs\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     negative\n     <br/>\n     positive\n     <br/>\n     positive\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Immune due to natural infection\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     HBsAg\n     <br/>\n     anti-HBc\n     <br/>\n     anti-HBs\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     negative\n     <br/>\n     negative\n     <br/>\n     positive\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Immune due to Hepatitis B vaccination\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     HBsAg\n     <br/>\n     anti-HBc\n     <br/>\n     IgM anti-HBc\n     <br/>\n     anti-HBs\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     positive\n     <br/>\n     positive\n     <br/>\n     positive\n     <br/>\n     negative\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Acutely infected\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     HBsAg\n     <br/>\n     anti-HBc\n     <br/>\n     IgM anti-HBc\n     <br/>\n     anti-HBs\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     positive\n     <br/>\n     positive\n     <br/>\n     negative\n     <br/>\n     negative\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Chronically infected\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     HBsAg\n     <br/>\n     anti-HBc\n     <br/>\n     anti-HBs\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     negative\n     <br/>\n     positive\n     <br/>\n     negative\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Interpretation\n  unclear; four possibilities:\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      1.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     &nbsp;Resolved infection (most common)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      2.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     False-positive anti-HBc, thus susceptible\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      3.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     \"Low level\" chronic infection\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      4.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Resolving acute infection\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347226\"\n o:spid=\"_x0000_i1224\" type=\"#_x0000_t75\" alt=\"Description: http://pathmicro.med.sc.edu/virol/hepb-cd1.gif\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image201.png\" o:title=\"//pathmicro.med.sc.edu/virol/hepb-cd1.gif\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://pathmicro.med.sc.edu/virol/hepb-cd1.gif\" border=\"0\" height=\"205\" src=\"_%20Tutorials_files/image202.png\" v:shapes=\"Picture_x0020_347226\" width=\"306\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347225\"\n o:spid=\"_x0000_i1223\" type=\"#_x0000_t75\" alt=\"Description: http://pathmicro.med.sc.edu/virol/hepb-cd2.gif\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image203.png\" o:title=\"//pathmicro.med.sc.edu/virol/hepb-cd2.gif\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://pathmicro.med.sc.edu/virol/hepb-cd2.gif\" border=\"0\" height=\"205\" src=\"_%20Tutorials_files/image204.png\" v:shapes=\"Picture_x0020_347225\" width=\"306\"/>\n </span>\n</p>\n", "choices": ["A. She was exposed to hepatitis B but was not infected.", "B. She was exposed to hepatitis B and is in the acute disease phase", "C. She was exposed to hepatitis B and is in the \u201cwindow\u201d phase", "D. She was exposed to hepatitis B and is chronically infected", "E. She was exposed to hepatitis B and has recovered"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n41-year-old woman develops high spiking fevers and chills a week after\nreturning from central Africa. Which of the following tests on the patient&rsquo;s\nblood will most likely establish the diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Spiking fevers and chills in a patient\nwho has visited central Africa is suggestive of malaria. The diagnosis can be made\nby detecting the parasite (Plasmodium) on a Giemsa-stained blood smear.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\n  <b>\n   Gram\n  </b>\n  stain is the most\ncommonly used stain in microbiology. Bacteria are categorized as gram-positive\nor gram-negative based on their ability to take up the stain. Those with large\namounts of peptidoglycan in their cell walls retain methyl (or crystal) violet and\nare called gram-positive. Those with walls composed mainly of lipids and\nlipopolysaccharides do not retain methyl (or crystal) violet and are called\ngram-negative.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347224\" o:spid=\"_x0000_i1222\"\n type=\"#_x0000_t75\" alt=\"Description: Gram Positive and Gram Negative Bacteria\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image205.jpg\" o:title=\"Gram Positive and Gram Negative Bacteria\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Gram Positive and Gram Negative Bacteria\" border=\"0\" height=\"186\" src=\"_%20Tutorials_files/image206.png\" v:shapes=\"Picture_x0020_347224\" width=\"424\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  Gram-positive\nStaphylococcus\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Gram-negative E. Coli\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\n  <b>\n   Giemsa\n  </b>\n  stain is the principal\nstain used in the diagnosis of malaria. It is an effective stain for detecting\nprotozoa, such as trichomonas, cryptosporidium, giardia, toxoplasma, and\nleishmania. It is also effective for\n  <i>\n   Helicobacter pylori\n  </i>\n  and for bacteria\nthat lack peptidoglycan cell walls (e.g., rickettsia, chlamydia).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347223\" o:spid=\"_x0000_i1221\"\n type=\"#_x0000_t75\" alt=\"Description: 070525090316-large\">\n <v:imagedata src=\"_%20Tutorials_files/image207.jpg\" o:title=\"070525090316-large\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 070525090316-large\" border=\"0\" height=\"160\" src=\"_%20Tutorials_files/image208.png\" v:shapes=\"Picture_x0020_347223\" width=\"235\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Malaria:\nGiemsa stain\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Silver\n  </span>\n </b>\n <span>\n  stains are primarily\nused when Gram and Giemsa stains are ineffective. Because silver stains are\nlaborious to implement, they are usually reserved for cases in which the\nsuspected pathogen is a spirochete, legionella, bartonella, or\n  <i>\n   H. pylori.\n  </i>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347222\" o:spid=\"_x0000_i1220\"\n type=\"#_x0000_t75\" alt=\"Description: T\">\n <v:imagedata src=\"_%20Tutorials_files/image209.jpg\" o:title=\"T\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: T\" border=\"0\" height=\"216\" src=\"_%20Tutorials_files/image210.png\" v:shapes=\"Picture_x0020_347222\" width=\"310\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Syphilis:\nSilver stain\n  <span>\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Acid-fast\n  </span>\n </b>\n <span>\n  stains are primarily\nused for mycobacteria, such as\n  <i>\n   Mycobacterium tuberculosis\n  </i>\n  . These\nbacteria have thick, waxy cell walls, which contain large amounts of a lipid\ncalled mycolic acid. Mycolic acid resists staining and decolorization by\nacid-alcohol (hence, the term &ldquo;acid-fast&rdquo;).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347221\" o:spid=\"_x0000_i1219\"\n type=\"#_x0000_t75\" alt=\"Description: M tuberculosis acid fast\">\n <v:imagedata src=\"_%20Tutorials_files/image211.jpg\" o:title=\"M tuberculosis acid fast\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: M tuberculosis acid fast\" border=\"0\" height=\"196\" src=\"_%20Tutorials_files/image212.png\" v:shapes=\"Picture_x0020_347221\" width=\"304\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Tuberculosis:\nAcid-fast stain\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\n  <b>\n   KOH\n  </b>\n  (potassium hydroxide)\nstain is commonly used to diagnose fungal infections of the skin and nails. The\nstain dissolves debris, allowing the fungal hyphae to be visualized.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347220\" o:spid=\"_x0000_i1218\"\n type=\"#_x0000_t75\" alt=\"Description: Fungus\">\n <v:imagedata src=\"_%20Tutorials_files/image213.jpg\" o:title=\"Fungus\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Fungus\" border=\"0\" height=\"198\" src=\"_%20Tutorials_files/image214.png\" v:shapes=\"Picture_x0020_347220\" width=\"271\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Dermatophyte:\nKOH\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   India Ink\n  </span>\n </b>\n <span>\n  can be used to\nvisualize the capsule of\n  <i>\n   Cryptococcus neoformans\n  </i>\n  . By staining the\nbackground, the capsule becomes visible.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347219\" o:spid=\"_x0000_i1217\"\n type=\"#_x0000_t75\" alt=\"Description: 180px-Cryptococcus_neoformans_using_a_light_India_ink_staining_preparation_PHIL_3771_lores\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image215.jpg\" o:title=\"180px-Cryptococcus_neoformans_using_a_light_India_ink_staining_preparation_PHIL_3771_lores\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 180px-Cryptococcus_neoformans_using_a_light_India_ink_staining_preparation_PHIL_3771_lores\" border=\"0\" height=\"184\" src=\"_%20Tutorials_files/image216.png\" v:shapes=\"Picture_x0020_347219\" width=\"273\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Cryptococcus:\nIndia ink\n </span>\n</p>\n", "choices": ["A. Gram stain", "B. Giemsa stain", "C. Silver stain", "D. Acid-fast stain", "E. KOH stain", "F. India ink stain"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 32-year\nold man had unprotected anal intercourse with a male prostitute seven days ago.\nHe is asymptomatic but worried that he may have acquired HIV. He underwent HIV\ntesting 3 and 6 months ago. Both tests were negative. Which of the following\nprovides the earliest evidence of HIV infection?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The polymerase chain\nreaction can be used to amplify viral RNA, allowing HIV to be detected as early\nas four days following infection.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . The CD4 count is\nneither sensitive nor specific for early diagnosis of acute HIV infection.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . The Western blot assay\nis used to detect antibodies to HIV. These antibodies usually appear 3-4 weeks\nafter infection.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . The enzyme-linked\nimmunosorbent assay (ELISA) is used to detect antibodies to HIV. These\nantibodies usually appear 3-4 weeks after infection.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347218\"\n o:spid=\"_x0000_i1216\" type=\"#_x0000_t75\" alt=\"Description: HIV_Virion-en-2\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image217.png\" o:title=\"HIV_Virion-en-2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: HIV_Virion-en-2\" border=\"0\" height=\"263\" src=\"_%20Tutorials_files/image218.png\" v:shapes=\"Picture_x0020_347218\" width=\"376\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p>\n HIV is a retrovirus. A\n <span>\n  retrovirus\n </span>\n is an RNA virus that is\nduplicated in a host cell using the reverse transcriptase enzyme to produce DNA\nfrom its RNA genome. The DNA is then incorporated into the host cell&rsquo;s genome\nby an integrase enzyme. This allows the virus to replicate as part of the host\ncell&rsquo;s DNA. HIV is composed of two copies of single-stranded RNA, which is\nbound to reverse transcriptase, integrase, and proteins that protect the RNA\nfrom nucleases. The RNA is enclosed by a capsid, or protein shell. The capsid\nis surrounded by a matrix, which ensures the integrity of the virion. The\nmatrix, in turn, is surrounded by an envelope, which is comprised of plasma\nmembrane from the host cell and viral glycoproteins.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HIV\nis most commonly diagnosed by testing blood or saliva for antibodies to the\nvirus. Antibody tests include Western blot assay and ELISA (enzyme-linked\nimmunosorbent assay). These tests are not accurate immediately after infection\nbecause up to 12 weeks are needed to form antibodies to the virus. In rare\ncases, six months may elapse before antibodies are detected. By contrast,\nnucleic acid-based tests (NAT) allow HIV to be detected as early as four days\nfollowing infection. A commonly used NAT employs the polymerase chain reaction\nto amplify viral RNA.\n </span>\n</p>\n", "choices": ["A. CD4 cell count", "B. Western blot assay", "C. RNA polymerase chain reaction (PCR)", "D. Enzyme-linked immunosorbent assay (ELISA)"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n22-year-old man receives the tetanus vaccine. Six hours later, he has pain and\nmassive swelling at the site of injection. The following day, the skin breaks\ndown, forming an ulcer at the site. Which of the following events plays a\ncritical role in this reaction?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The patient in the\nvignette has had an Arthus reaction to the tetanus vaccine. This is a type III\nhypersensitivity reaction, characterized by deposition of immune complexes and\nactivation of complement.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Local release of\nhistamine occurs in type I hypersensitivity reactions.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . IgM binding to antigen\noccurs in some type II hypersensitivity reactions.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Antigen capture by\nLangerhans cells occurs in type IV hypersensitivity reactions.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Mononuclear cell\naccumulation occurs in type IV hypersensitivity reactions.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Hypersensitivity\nrefers to excessive and undesirable reactions produced by the normal immune\nsystem. Hypersensitivity reactions require a pre-sensitized (immune) host\nstate. They are divided into four types based on mechanism and time taken for\nthe reaction. A particular clinical condition may involve more than one type of\nreaction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Type I Hypersensitivity\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Type I\nhypersensitivity is known as immediate or anaphylactic hypersensitivity. The\nreaction may involve skin (urticaria and eczema), eyes (conjunctivitis),\nnasopharynx (rhinitis), bronchopulmonary tissues (asthma), or gastrointestinal\ntract (gastroenteritis). Reactions range from minor to deadly, and typically\noccur 15-30 minutes after antigen exposure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Immediate\nhypersensitivity is mediated by\n  <b>\n  </b>\n  IgE. The primary cellular component is\nthe mast cell or basophil. The reaction is amplified by neutrophils,\neosinophils, and platelets. Biopsy of affected tissue demonstrates mainly\n  <b>\n  </b>\n  mast\ncells and eosinophils. IgE is produced in response to certain allergens. It has\na very high affinity for receptor on mast cells and basophils. Subsequent\nexposure to the same allergen cross-links the cell-bound IgE and triggers mast\ncell degranulation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mast cells\ncan be triggered by other stimuli, such as exercise, emotional stress,\nchemicals, and anaphylotoxins (\n  <i>\n   e.g.\n  </i>\n  , C4a, C3a, C5a,\n  <i>\n   etc.\n  </i>\n  ). These\nnon-IgE-mediated reactions are not hypersensitivity reactions, although they\nproduce similar symptoms.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diagnostic\ntests for immediate hypersensitivity include skin tests, measurement of total\nIgE, and measurement of specific IgE to a suspected allergen. Total IgE and\nspecific IgE are measured by enzyme immunoassay (ELISA).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Type II Hypersensitivity\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Type II\nhypersensitivity is known as cytotoxic hypersensitivity. It is primarily\nmediated by complement and antibodies of the IgM or IgG class. Triggering\nantigens are usually endogenous, although some exogenous antigens can attach to\ncells and cause type II hypersensitivity. Drug-induced hemolytic anemia,\nGoodpasture&rsquo;s syndrome, and pemphigus are examples of type II hypersensitivity.\nThe reaction occurs minutes to hours after antigenic exposure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diagnosis\ninvolves detection of antibodies against affected tissue. These antibodies may\nbe circulating or may be found in biopsied tissue by immunofluorescent\nstaining. The staining pattern is smooth and linear. Treatment often involves\nanti-inflammatory or immunosuppressive agents.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Type III Hypersensitivity\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Type III\nhypersensitivity is known as immune complex hypersensitivity. The reaction may\nbe general (\n  <span>\n   e.g.\n  </span>\n  , serum\nsickness) or may involve an individual organ, such as the skin (systemic lupus\nerythematosus, Arthus reaction), kidneys (lupus nephritis), lungs (aspergillosis),\nblood vessels (polyarteritis), or joints (rheumatoid arthritis). Many\nmicroorganisms elicit a type III hypersensitivity reaction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nreaction, which occurs 3-10 hours after exposure to an antigen, is mediated by\nsoluble immune complexes, usually of the IgG class, sometimes of the IgM class.\nThe antigen may be exogenous (chronic bacterial, viral, or parasitic infection)\nor endogenous (systemic lupus erythematosus). The antigen is soluble and not\nattached to the involved organ. Lesions are composed of soluble immune\ncomplexes and complement. Damage is wrought by neutrophils and platelets.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diagnosis\ninvolves detection of immune complexes in the serum or biopsied tissue. The\nimmunofluorescent pattern is &ldquo;granular&rdquo; (as opposed to the &ldquo;linear&rdquo; pattern of\ntype II hypersensitivity). Serum complement levels are depleted. Treatment\nincludes anti-inflammatory and immunosuppressive agents.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Type IV Hypersensitivity\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Type IV\nhypersensitivity is known as cell-mediated or delayed-type hypersensitivity.\nThe classical example is the tuberculin (Montoux) reaction, which peaks 48\nhours after injection of antigen and is characterized by erythema and\ninduration.&nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Type IV\nhypersensitivity occurs in many infectious diseases (e.g., tuberculosis,\nleprosy, blastomycosis, histoplasmosis, toxoplasmosis, leishmaniasis).\nGranulomas are a product of type IV hypersensitivity. Contact dermatitis due to\npoison ivy, chemicals, and heavy metals is another example of delayed\nhypersensitivity. &nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Damage is\nwrought by T lymphocytes and monocytes or macrophages. Cytotoxic T cells cause\ndirect damage; helper T cells secrete cytokines, which activate cytotoxic T\ncells and recruit monocytes and macrophages. Corticosteroids and other\nimmunosuppressive agents are used in treatment.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   Hypersensitivity Reactions\n  </span>\n </b>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Type of Reaction\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Prototypic\n   Disorder\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Immune\n   Mechanisms\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Pathologic\n   Lesions\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Immediate\n  (type I) hypersensitivity\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Anaphylaxis\n     <sup>\n      1\n     </sup>\n     ,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Allergic\n  rhinitis,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Bronchial\n  asthma (atopic forms)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Production\n  of IgE antibody; immediate release of vasoactive amines and other mediators\n  from mast cells; later recruitment of inflammatory cells\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vascular\n  dilation, edema, smooth muscle contraction, mucus production, tissue injury,\n  inflammation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Antibody-mediated\n  (type II) hypersensitivity\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Autoimmune\n  hemolytic anemia,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Goodpasture\n  syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     IgG, IgM\n  binding to antigen on target cell or tissue; complement activation; lysis or\n  phagocytosis of target cell; recruitment of leukocytes\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Phagocytosis\n  and lysis of cells; inflammation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Immune\n  complex&ndash;mediated (type III) hypersensitivity\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Systemic\n  lupus erythematosus,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Glomerulonephritis\n  (some types),\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Serum\n  sickness\n     <sup>\n      2\n     </sup>\n     , Arthus reaction\n     <sup>\n      3\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Deposition\n  of antigen-antibody complexes;\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     complement activation; recruitment of leukocytes; release of enzymes\n  and other toxic molecules\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Inflammation,\n  necrotizing vasculitis (fibrinoid necrosis)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Cell-mediated\n  (type IV) hypersensitivity\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Contact\n  dermatitis, Multiple sclerosis,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Type I\n  diabetes, Rheumatoid arthritis, Inflammatory bowel disease\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Tuberculosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cytokine\n  release by activated T cells; inflammation and macrophage activation; T-cell\n  mediated cytotoxicity\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Perivascular\n  cellular infiltrates; edema; granuloma formation; cell destruction\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  1.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n <b>\n  Anaphylaxis\n </b>\n is an acute, multi-system, severe, type I hypersensitivity reaction caused by\nIgE-mediated degranulation of mast cells and basophils. Symptoms develop over\nminutes to hours and can include hypotension; swelling of the lips, tongue and\nthroat; cardiac ischemia; stridor; wheezing; shortness of breath; abdominal\npain; vomiting; diarrhea; flushing; hives; and loss of consciousness. Common\ntriggers include insect bites or stings, foods, medication, and latex.\nAnaphylaxis is a medical emergency that may require resuscitation measures,\nsuch as airway management, supplemental oxygen, and intravenous fluids.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Epinephrine (adrenaline) is the primary\ntreatment for anaphylaxis. It improves airway patency and blood pressure, and\nmay be life-saving.\n</p>\n\n<p>\n <span>\n  2.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n <b>\n  Serum sickness\n </b>\n can develop as a result\nof exposure to antibodies derived from animals. These sera are generally\nadministered in order to prevent or treat an infection or envenomation. When\nantiserum is given, the immune system can mistake the proteins for harmful antigens.\nAntibodies are produced, which combine with these proteins to form immune\ncomplexes. Symptoms include fever, malaise, rash, arthralgia, and\nlymphadenopathy. Hypotension, splenomegaly, glomerulonephritis, and proteinuria\nmay occur.\n</p>\n\n<p>\n <span>\n  3.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n <b>\n  Arthus reactions\n </b>\n (type III\nhypersensitivity reactions) can occur after vaccination for tetanus or\ndiphtheria. The reactions are characterized by local vasculitis, immune complex\ndeposition, and complement activation. Immune complexes form in the setting of\nhigh concentrations of vaccine antigen and circulating antibody. Severe pain,\nswelling, induration, edema, hemorrhage, and even necrosis occur 4&ndash;12\nhours after vaccination.\n</p>\n", "choices": ["A. Local release of histamine", "B. Predominant synthesis of IgM antibodies", "C. Local fixation of complement by preformed circulating antibodies", "D. Antigen capture by Langerhans cells in the epidermis", "E. Accumulation of mononuclear cells at the site of injection"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An\n11-year-old girl is brought to the emergency department because of a 4-day\nhistory of fever and an 8-hour history of lethargy. Her parents say that she\nhas been sleeping most of the day and has been unresponsive when awake. Her\ntemperature is 102.6\n  <sup>\n   o\n  </sup>\n  F. Physical examination shows nuchal rigidity\nand numerous petechial hemorrhages. A lumbar puncture yields cloudy\ncerebrospinal fluid (CSF). Microscopic examination of the CSF shows numerous\nsegmented neutrophils and a Gram stain shows gram-negative diplococci. Which of\nthe following is correct?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  The patient has\nmeningitis due to\n  <i>\n   Neisseria meningitidis\n  </i>\n  as indicated by the Gram stain (gram-negative diplococci) and the presence of\npetechial hemorrhages. This condition is associated with spread by respiratory\ndroplets (often by sneezing or coughing). Suspected cases should be placed\nunder &ldquo;droplet precautions.&rdquo; Droplets are not generally communicable beyond\nthree feet; therefore, a negative-pressure room is unnecessary.\n(Negative-pressure rooms are used to prevent airborne pathogens, such as\n  <i>\n   M. tuberculosis\n  </i>\n  , from escaping the room\nwhen the door is open.) Gowns are not needed because spread occurs through the\nrespiratory route, not by contact.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Gowns are used for\ncontact precautions, not droplet precautions.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  A negative-pressure room\nis used for airborne precautions, not droplet precautions.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  A private room is\nrecommended for droplet precautions. A gown is not needed.\n </span>\n</p>\n"], "tutorial": "<p>\n There are two tiers of\nprecautions to prevent transmission of infectious agents: standard precautions\nand transmission-based precautions. Standard precautions apply to all patients,\nregardless of diagnosis. Transmission-based precautions apply to patients who\nmay be infected or colonized with infectious agents that require additional\nmeasures to prevent transmission. Since the infecting agent is often unknown at\nthe time of admission, transmission-based precautions may be applied\nempirically according to the clinical syndrome or likely etiologic agent, and\nthen modified when the pathogen is identified or ruled out. There are three\ncategories of transmission-based precautions: contact, droplet, and airborne.\n</p>\n\n<p>\n <strong>\n  Contact Precautions.\n </strong>\n Contact precautions reduce transmission of infectious agents spread by direct\nor indirect contact with the patient. (&ldquo;Indirect&rdquo; contact is contact with\npotentially contaminated materials.) These precautions apply to patients with\nexcessive wound drainage and fecal incontinence. A single-patient room is\nrecommended. Healthcare personnel should wear a gown and gloves. Conditions for\nwhich contact precautions apply include certain\n <span>\n  gastrointestinal\ninfections (e.g., C. difficile colitis), skin and wound infections (e.g.\nimpetigo), and colonization with multidrug-resistant organisms (e.g., MRSA).\n </span>\n</p>\n\n<p>\n <strong>\n  Droplet Precautions.\n </strong>\n <strong>\n  <span>\n   Droplet\nprecautions\n  </span>\n </strong>\n <span>\n  reduce transmission of\ninfectious agents released by sneezing or coughing. Large droplet sprays can\nspread as far as three feet.\n </span>\n A single-patient room is recommended.\nHealthcare personnel should wear a mask.\n <span>\n  Conditions\nfor which droplet precautions apply include influenza, meningococcal\nmeningitis, mumps, rubella, and pertussis.\n </span>\n</p>\n\n<p>\n <strong>\n  Airborne Precautions\n </strong>\n <strong>\n  <span>\n   Airborne\nprecautions\n  </span>\n </strong>\n <span>\n  reduce transmission of\nairborne particles (i.e., particles so small that they can be suspended in the\nair for long periods of time).\n </span>\n Patients should be placed in an\nairborne-infection isolation room (AIIR), which is a single-patient room with\nspecial air handling capacity (e.g., negative pressure ventilation, frequent\nair exchanges, adequate exhaust system). Healthcare personnel should wear a\nrespirator or mask. Conditions for which airborne precautions apply include\ntuberculosis, measles, and chicken pox.\n</p>\n", "choices": ["A. She should be placed in a private room. Hospital personnel should wear a mask.", "B. She should be placed in a private room. Hospital personnel should wear a gown.", "C. She should be placed in a negative-pressure room.", "D. She may be placed in a semi-private room. Hospital personnel should wear a gown."]}, {"question": "<p>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   A 37-year-old woman presents to the\nemergency department with a fever. Chest x-ray film shows multiple patchy\ninfiltrates in both lungs. Echocardiography and blood cultures suggest a\ndiagnosis of acute bacterial endocarditis limited to the tricuspid valve. Which\nof the following is the most probable etiology?&nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer B is correct.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   The most\nprobable etiology of bacterial endocarditis involving the tricuspid valve is\nillicit intravenous drug use, which can introduce skin organisms into the\nvenous system that then attack the tricuspid valve. Staphylococcus aureus\naccounts for most cases of endocarditis in intravenous drug users.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer A is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   The\nendocarditis associated with congenital heart disease typically involves either\ndamaged valves or atrial or ventricular septal defects. The tricuspid valve is\nnot particularly vulnerable.&nbsp;\n  </span>\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer C is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Rheumatic\nfever most commonly damages the mitral and aortic valves, and tricuspid damage\nis usually less severe and seen only when the mitral and aortic valves are\nheavily involved.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer D is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Rheumatoid\narthritis is not associated with bacterial endocarditis.&nbsp;\n  </span>\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer E is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Systemic\nlupus erythematosus can produce small, aseptic vegetations on valves, but is\nnot associated with bacterial endocarditis.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Infective\nendocarditis (IE) can be clinically classified as follows:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Native\nvalve endocarditis (NVE)\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nfollowing are the main underlying causes of NVE:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Rheumatic\nvalvular disease - Primarily involves the mitral valve followed by the aortic\nvalve\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Congenital\nheart disease - Underlying etiologies include a patent ductus arteriosus,\nventricular septal defect, tetralogy of Fallot, or any native or surgical\nhigh-flow lesion.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Mitral\nvalve prolapse with an associated murmur\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Degenerative\nheart disease - Including calcific aortic stenosis due to a bicuspid valve,\nMarfan syndrome, or syphilitic disease\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Approximately\n70% of infections in NVE are caused by\n  <i>\n   Streptococcus\n  </i>\n  species, including\n  <i>\n   S\nviridans, Streptococcus bovis\n  </i>\n  , and enterococci.\n  <i>\n   Staphylococcus\n  </i>\n  species cause 25% of cases and generally demonstrate a more aggressive acute\ncourse.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Prosthetic\nvalve endocarditis (PVE)\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Early PVE,\nwhich presents shortly after surgery, has a different bacteriology and\nprognosis than late PVE, which presents in a subacute fashion similar to NVE.\nInfection associated with aortic valve prostheses is particularly associated\nwith local abscess and fistula formation, and valvular dehiscence. This may\nlead to shock, heart failure, heart block, pericardial tamponade, and\nperipheral emboli to the central nervous system and elsewhere. Early PVE may be\ncaused by a variety of pathogens, including\n  <i>\n   S aureus\n  </i>\n  and\n  <i>\n   S\nepidermidis\n  </i>\n  . Late disease is most commonly caused by streptococci.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   IVDA\ninfective endocarditis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Diagnosis\nof endocarditis in intravenous drug users can be difficult and requires a high\nindex of suspicion. Two thirds of patients have no previous history of heart\ndisease or murmur on admission. A murmur may be absent in those with tricuspid\ndisease, owing to the relatively small pressure gradient across this valve.\nPulmonary manifestations may be prominent in patients with tricuspid infection:\none third have pleuritic chest pain, and three quarters demonstrate chest\nradiographic abnormalities.\n  <i>\n   S aureus\n  </i>\n  is the most common etiologic\norganism in patients IE die to intravenous drug use.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Healthcare-associated\ninfective endocarditis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Endocarditis\nmay be associated with new therapeutic modalities involving intravascular\ndevices such as central or peripheral intravenous catheters, rhythm control\ndevices such as\n </span>\n <span>\n  <span>\n   pacemakers\n  </span>\n </span>\n <span>\n  and defibrillators,\nhemodialysis shunts and catheters, and chemotherapeutic and hyperalimentation\nlines. Thr most coomon cause of health-care associated IE is\n  <i>\n   S aureus.\n  </i>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Fungal\nendocarditis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fungal\nendocarditis is found in intravenous drug users and intensive care unit\npatients who receive broad-spectrum antibiotics.\n </span>\n <a href=\"file://localhost/javascript/showrefcontent('refrenceslayer')%3B\">\n </a>\n <sup>\n  <span>\n  </span>\n </sup>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Congenital heart disease", "B. Illicit drug use", "C. Rheumatic fever", "D. Rheumatoid arthritis", "E. Systemic lupus erythematosus"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Pandemics\nof influenza type A occurred in 1918 (Spanish flu), 1957 (Asian flu), 1968\n(Hong Kong flu). Which of the following best explains these pandemics?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Antigenic shift best\nexplains pandemics.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347217\"\n o:spid=\"_x0000_i1215\" type=\"#_x0000_t75\" alt=\"Description: http://www.chm.bris.ac.uk/webprojects2006/Kelly/influenzafigure1.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image219.jpg\" o:title=\"//www.chm.bris.ac.uk/webprojects2006/Kelly/influenzafigure1.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.chm.bris.ac.uk/webprojects2006/Kelly/influenzafigure1.jpg\" border=\"0\" height=\"175\" src=\"_%20Tutorials_files/image220.png\" v:shapes=\"Picture_x0020_347217\" width=\"297\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ninfluenza virus has hemagglutinin (HA) and neuraminidase (NA) molecules on its\nsurface. These molecules allow the virus to penetrate the host cell.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Hemagglutinin, named for its ability to\nagglutinate red blood cells, binds to sialic acid receptors, allowing fusion of\nthe virus with the host cell. Neuraminidase degrades neuraminic acid, a\ncomponent of mucin, which protects the airways.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Humans\ndevelop immunity to a particular strain of influenza by producing antibodies to\nHA and NA. A change in either of these molecules impedes recognition of the\nvirus by the host&rsquo;s immune system. Pandemic spread can occur when two different\nstrains of the influenza virus infect the same cell and exchange RNA. This is\ncalled antigenic shift. An example of this is &ldquo;avian flu,&rdquo; in which a human\ninfluenza virus and an avian influenza virus infect the same porcine host and\nexchange RNA, producing a new virus.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Flu\nstrains are named after the HA and NA molecules on their surface (e.g., H3N2).\nHere&rsquo;s an example of antigenic shift: An H3N2 virus and an H5N1virus infect the\nsame cell, exchange RNA, and produce a new virus, H3N1. H3N1 would not be\nrecognized by the host&rsquo;s pre-existing antibodies.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Antigenic\nshift differs from antigenic drift, in which minor changes in HA and NA are\ncaused by genetic mutations. Such mutations make the virus less antigenic to\npre-existing antibodies. The molecular changes occurring with antigenic shift\nare more dramatic than those that occur with antigenic drift. Increases in\nviral toxicity are usually greater with antigenic shift, though they may be\nquite great with antigenic drift.\n </span>\n</p>\n", "choices": ["A. Degradation of nucleoprotein and involution of the lipid envelope", "B. Absence of hemagglutinin", "C. Absence of neuraminidase", "D. Antigenic drift", "E. Antigenic shift"]}, {"question": "<p>\n <span>\n  A scientific investigator injects an experimental animal with a newly\ndiscovered strain of bacteria to evaluate T-lymphocyte activation. It is found\nthat bacterial engulfment by macrophages results in the presentation of\nbacterial-derived peptide ligands to CD4+ T lymphocytes. Which of the following\ncell surface molecules on the macrophage is most directly involved in the\npresentation of the processed peptides?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Class II MHC molecules\nare found on certain immune cells, chiefly macrophages, B cells, and dendritic\ncells, collectively known as professional antigen-presenting cells (APCs).\nThese APCs specialize in the uptake of pathogens and subsequent processing into\npeptide fragments within phagosomes. The Class II MHC molecules on APCs present\nthese fragments to helper T cells (CD4+ lymphocytes).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  CD28 is a molecule on the surface of T cells\nthat recognizes B7-1 (CD80) and B7-2 (CD86) on professional antigen presenting\ncells.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This interaction is the\n&ldquo;second&rdquo; signal required for T cell activation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Fc receptors are expressed on a wide\nrange of cells and serve to recognize the Fc portion of an immunoglobulin\nmolecule.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Thus, Fc receptors for\nIgG are designated Fc\uf067 and so on.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  These receptors facilitate the effector function of the different\nclasses of antibodies.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  For example,\nmacrophages and neutrophils express Fc\uf067 receptors and bind to IgG-coated\npathogens to facilitate phagocytosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The IL-2 receptor on resting T cells is\ncomposed of 2 subunits, alpha and beta.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Following activation of T cells, the &alpha; subunit (CD25) is expressed\nresulting in a high-affinity receptor for IL-2.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  IL-2 serves as an autocrine growth\nfactor to stimulate proliferation of T cells in response to activation signals.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Membrane immunoglobulins are integral\nproteins on B cell surfaces that bind foreign antigens and are critically\ninvolved in the regulation of the immune response.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Na&iuml;ve B cells express membrane-bound IgM\nand IgD.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Plasmablasts express high\nlevels whereas plasma cells express low levels of membrane\nimmunoglobulins.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  The major histocompatibility complex\n </span>\n (\n <span>\n  MHC\n </span>\n ) is a large gene family that encodes MHC molecules. MHC\nmolecules play an important role in the immune system and autoimmunity.\n</p>\n\n<p>\n Proteins are continually\nsynthesized and destroyed in the cell. These include normal proteins (self) and\nmicrobial pathogens (nonself). The MHC proteins act as &ldquo;signposts&rdquo; that serve\nto alert the immune system if foreign material is present inside a cell. They\nachieve this by displaying fragmented pieces, or\n <i>\n  antigens\n </i>\n <span>\n  ,\n </span>\n on the host cell&rsquo;s surface. These\nantigens may be\n <i>\n  self\n </i>\n or\n <i>\n  nonself\n </i>\n . (The protein fragment is\nsometimes compared to a hot dog, and the MHC protein to the bun.) The\npresentation of MHC/peptide on cell surfaces allows for pathogen surveillance\nby immune cells, usually T cells or natural killer (NK) cells. If T cells or NK\ncells recognize an MHC/peptide combination, the cells become activated and\nlaunch an immune response against the presented antigen.\n</p>\n\n<p>\n Because MHC genes must\ndefend against a great variety of microbes in the environment, the MHC\nmolecules (coded for by the MHC genes) must be able to present a wide range of\npeptides. MHC genes achieve this through several mechanisms: (1) the MHC locus\nis polygenic, (2) MHC genes are highly polymorphic and numerous alleles exist,\nand (3) several MHC genes are codominantly expressed.\n</p>\n\n<p>\n There are two general\nclasses of MHC molecules: Class I and Class II. Class I MHC molecules are found\non all nucleated cells and present peptides to cytotoxic T cells. Class II MHC\nmolecules are found on certain immune cells, chiefly macrophages, B cells and\ndendritic cells, collectively known as professional antigen-presenting cells\n(APCs). These APCs specialize in the uptake of pathogens and subsequent\nprocessing into peptide fragments within phagosomes. The Class II MHC molecules\non APCs present these fragments to helper T cells, which stimulate an immune\nreaction from other cells.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  There are\ntwo classical pathways by which proteins can be processed and displayed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Phagocytic cells such as\nmacrophages and immature dendritic cells engulf pathogens in a process known as\nphagocytosis. Pathogen-containing endosomes then fuse with lysosomes and\nmediate their destruction. Degraded particles are then loaded onto MHC Class II\nmolecules and trafficked to the cell surface.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  All nucleated cells can\nalso present cytosolic peptides on their class I MHC. This pathway is\nparticularly important during infection by a bacterium or virus, or if the cell\nis cancerous. In a normal cell, class I MHC continually present self-peptides\nderived from basal protein turnover and defective ribosomal products. However,\nduring a viral infection or tumor development, peptides loaded onto class I MHC\nwill include those of processed pathogens degraded in the proteasome.\n </span>\n</p>\n", "choices": ["A. CD28", "B. Class II MHC", "C. Fc receptor", "D. Interleukin-2 receptor", "E. Membrane immunoglobulin"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Malaria\ncan be caused by any of four major species of Plasmodium. Which species causes\ncerebral malaria? Which species have a dormant phase in the liver? And which\nspecies produces the longest interval between febrile episodes?\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cerebral\n  malaria\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n      Dormant\n  phase in liver\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Longest\n  interval between febrile episodes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      A.\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  falciparum\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  vivax, P. ovale\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  malariae\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      B.\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  malariae\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  falciparum, P. vivax\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  ovale\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      C.\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  ovale\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P. malariae,\n      </span>\n     </i>\n     <span>\n      <i>\n       P. falciparum\n      </i>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  vivax\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      D.\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  vivax\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  ovale, P. malariae\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       P.\n  falciparum\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Malaria is\ncaused by parasites of the genus Plasmodium. Four major species can infect\nhumans:\n  <i>\n   P. falciparum\n  </i>\n  <span>\n   ,\n   <i>\n    P.\nvivax\n   </i>\n  </span>\n  ,\n  <i>\n   P. ovale\n  </i>\n  <span>\n   ,\n  </span>\n  and\n  <i>\n   P. malariae\n  </i>\n  <span>\n   .\n   <i>\n    P.\nfalciparum\n   </i>\n   is the most deadly;\n   <i>\n    P. vivax\n   </i>\n  </span>\n  ,\n  <i>\n   P.\n  </i>\n  <i>\n   ovale\n  </i>\n  and\n  <i>\n   P. malariae\n  </i>\n  cause milder disease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Symptoms\nof malaria include fever, chills, vomiting, anemia (due to intravascular\nhemolysis), arthralgias, and seizures. Malaria is characterized by recurrent\nepisodes of chills and rigors followed by fevers and sweating.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  These recurrences typically occur every\nthree days with\n  <i>\n   P. malariae\n  </i>\n  <span>\n   ,\n  </span>\n  every\ntwo days with\n  <i>\n   P. vivax\n  </i>\n  and\n  <i>\n   P. ovale\n  </i>\n  , and every 36-48 hours with\n  <i>\n   P.\nfalciparum\n  </i>\n  <span>\n   (although\n  </span>\n  a less\npronounced, almost continuous, fever can occur with\n  <i>\n   P. falciparum\n  </i>\n  <span>\n   )\n  </span>\n  .\n </span>\n</p>\n\n<p>\n Severe malaria is caused\nalmost exclusively by\n <i>\n  P. falciparum\n </i>\n . Cerebral ischemia may result in\nencephalopathy, stroke, seizure, coma, and death. Young children and pregnant\nwomen are especially vulnerable. Other findings may include splenomegaly,\nhepatomegaly, hypoglycemia, hemolytic anemia with hemoglobinuria, and renal\nfailure. (In &ldquo;blackwater fever,&rdquo; hemoglobin from lysed red blood cells darkens\nthe urine and causes renal failure.) Falciparum malaria can progress rapidly\nand cause death within hours or days. The morbidity and mortality of falciparum\nmalaria are due to the high levels of parasitemia and the adherence of\nparasites to erythrocytes. Sticky erythrocytes bind to the endothelium,\nclogging the capillaries in the central nervous system and elsewhere.\n</p>\n\n<p>\n Infection with\n <i>\n  P. vivax\n </i>\n and\n <i>\n  P. ovale\n </i>\n (but not\n <i>\n  P. falciparum\n </i>\n <span>\n  ) can cause chronic malaria. (Parasites r\n </span>\n emain dormant in the\nliver for months or years, then re-emerge in the blood, causing disease.)\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Malaria\ndevelops in two phases: exoerythrocytic and erythrocytic. During a mosquito\nbite, sporozoites enter the blood and migrate to the liver, where they infect\nhepatocytes and multiply into merozoites (exoerythrocytic phase). The\nmerozoites then escape into the blood, where they infect red blood cells and\ndevelop into ring forms (erythrocytic phase).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ndiagnosis of malaria is usually made by detecting ring forms of the parasite in\nblood smears.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347216\"\n o:spid=\"_x0000_i1214\" type=\"#_x0000_t75\" alt=\"Description: Malaria1\">\n <v:imagedata src=\"_%20Tutorials_files/image221.jpg\" o:title=\"Malaria1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Malaria1\" border=\"0\" height=\"179\" src=\"_%20Tutorials_files/image222.png\" v:shapes=\"Picture_x0020_347216\" width=\"243\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  Severe malaria,\nincluding cerebral malaria, is caused almost exclusively by\n  <i>\n   P. falciparum\n  </i>\n  .\nCerebral ischemia may result in encephalopathy, stroke, seizure, coma, and\ndeath.\n  <i>\n   P. vivax\n  </i>\n  and\n  <i>\n   P. ovale\n  </i>\n  <span>\n   are the only species that have a dormant phase in the liver. Patients\ninfected with these organisms may be asymptomatic for months or years, and then\nbecome ill when the parasites leave the liver and enter the blood.\n   <i>\n    P. vivax\n   </i>\n  </span>\n  and\n  <i>\n   P. ovale\n  </i>\n  <span>\n   are the only\nspecies of\n   <i>\n    Plasmodium\n   </i>\n   associated with relapse, which can occur even in\npeople who were adequately treated for malaria initially. On average, infection\nwith\n   <i>\n    P. malariae\n   </i>\n  </span>\n  is associated with the longest interval between\n  <span>\n   febrile episodes &ndash; three days.\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  An 18-year-old man is brought to the\nemergency department because of fever, a poorly localized headache, and a stiff\nneck for 12 hours. The symptoms were preceded by nasal congestion, muscle\naches, and chills 3 days ago. His temperature is 38.7&deg;C (101.6&deg;F). Physical\nexamination shows nuchal rigidity and photophobia. There is no papilledema.\nNeurologic examination shows no focal findings. Which of the following is the\nmost likely diagnosis?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct.\n </b>\n Fever, headache, stiff neck, and photophobia\nsuggest a diagnosis of acute meningitis.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n Cluster headaches are excruciating\nunilateral headaches of extreme intensity. The duration of the common attack\nranges from as short as 15 minutes to three hours or more. The onset of an\nattack is rapid, and most often without the preliminary signs that are\ncharacteristic of a migraine. Cluster headaches occur periodically: spontaneous\nremissions interrupt active periods of pain. The pain may be very sharp and may\ncause pain around the eye area and may also be a pain within the back of the\neye.\n</p>\n", "<p>\n <b>\n  Answer C is incorrect.\n </b>\n <span>\n  Idiopathic\nintracranial hypertension\n </span>\n , also called\n <span>\n  pseudotumor cerebri\n </span>\n , is a neurological disorder characterized by\nincreased intracranial pressure in the absence of a tumor or other diseases.\nThe main symptoms are headache, nausea and vomiting, as well as pulsatile\ntinnitus, double vision, and other visual symptoms. If untreated, it may lead\nto swelling of the optic disc in the eye (papilledema), which can progress to\nvision loss. Fever and nuchal rigidity are not typical.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect.\n </b>\n The typical migraine headache is unilateral\nand pulsating and lasts from two to 72 hours. Symptoms include nausea,\nvomiting, photophobia (increased sensitivity to light) and phonophobia (increased\nsensitivity to sound). Approximately one-third of people who suffer from\nmigraine headaches perceive an aura &ndash; transient visual, sensory,\nlanguage, or motor disturbances signaling the migraine will soon occur. Fever\nand nuchal rigidity are not typical of migraine.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect.\n </b>\n A\n <span>\n  subarachnoid\nhemorrhage\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Wikipedia:IPA_for_English#Key\" title=\"Wikipedia:IPA for English\">\n </a>\n is bleeding into the subarachnoid\nspace&mdash;the area between the arachnoid membrane and the pia mater\nsurrounding the brain. This may occur spontaneously, usually from a ruptured\ncerebral aneurysm, or may result from head injury. Symptoms of SAH include a\nsevere headache with a rapid onset (&ldquo;thunderclap headache&rdquo;), vomiting,\nconfusion or a lowered level of consciousness, and sometimes seizures. The\ndiagnosis is generally confirmed with a CT scan of the head, or occasionally by\nlumbar puncture.\n</p>\n", "<p>\n <b>\n  Answer F is incorrect.\n </b>\n <span>\n  Giant-cell\narteritis\n </span>\n is an inflammatory disease of blood vessels most commonly\ninvolving large and medium arteries of the head. It is a form of vasculitis.\nThe name giant cell arteritis reflects the type of inflammatory cell involved\nas seen on a biopsy. The terms &ldquo;giant-cell arteritis&rdquo; and &ldquo;temporal arteritis&rdquo;\nare sometimes used interchangeably, because of the frequent involvement of the\ntemporal artery. However, it can involve other large vessels (such as the\naorta). The disease typically affects older people. Symptoms include fever,\nmalaise, headache, scalp tenderness, jaw claudication, tongue claudication, and\nvisual changes. Diagnosis is made by temporal artery biopsy. Corticosteroids\nare the mainstay of treatment.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer G is incorrect.\n </b>\n A\n <span>\n  tension\nheadache\n </span>\n is the most common type of primary headache. The pain can\nradiate from the neck, back, eyes, or other muscle groups in the body. It is\noften described as a constant pressure, as if the head were being squeezed in a\nvise, and it is frequently bilateral and typically mild to moderate in severity.\nFever and nuchal rigidity are not characteristic of trension-type headache.\n</p>\n"], "tutorial": "<p>\n <span>\n  Meningitis\n </span>\n is inflammation of the protective membranes covering\nthe brain and spinal cord, known collectively as the meninges. The inflammation\nis usually caused by microbial infection and less commonly by certain drugs.\nMeningitis can be life-threatening because of the inflammation&rsquo;s proximity to\nthe brain and spinal cord; therefore the condition is classified as a medical\nemergency.\n</p>\n\n<p>\n The most common symptoms of\nmeningitis are headache and neck stiffness associated with fever, confusion or\naltered consciousness, vomiting, and an inability to tolerate light\n(photophobia) or loud noises (phonophobia). Sometimes, especially in small\nchildren, only nonspecific symptoms may be present, such as irritability and\ndrowsiness. If a rash is present, it may indicate a particular cause of\nmeningitis; for instance, meningitis caused by meningococcal bacteria may be\naccompanied by a characteristic rash.\n</p>\n\n<p>\n A lumbar puncture may be\nused to diagnose or exclude meningitis. This involves inserting a needle into\nthe spinal canal to extract a sample of cerebrospinal fluid (CSF), the fluid\nthat envelops the brain and spinal cord. The CSF is then examined in a medical\nlaboratory. The usual treatment for meningitis is the prompt application of\nantibiotics (for bacterial meningitis).\n</p>\n\n<p>\n Meningitis can lead to\nserious long-term consequences such as deafness, epilepsy, hydrocephalus and\ncognitive deficits, especially if not treated quickly. Some forms of meningitis\n(such as those associated with meningococci,\n <i>\n  Haemophilus influenzae\n </i>\n type\nB, pneumococci or mumps virus infections) may be prevented by immunization.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In adults,\na severe headache is the most common symptom of meningitis &ndash; occurring in\nalmost 90% of cases of bacterial meningitis, followed by nuchal rigidity\n(inability to flex the neck forward passively due to increased neck muscle tone\nand stiffness). The classic triad of diagnostic signs consists of nuchal\nrigidity, sudden high fever, and altered mental status; however, all three\nfeatures are present in less than half of all cases of bacterial meningitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Nuchal\nrigidity occurs in 70% of adult cases of bacterial meningitis. Other signs of\nmeningism include the presence of positive Kernig sign or Brudzinski sign.\nKernig sign is assessed with the patient lying supine, with the hip and knee flexed\nto 90 degrees. In a patient with a positive Kernig sign, pain limits passive\nextension of the knee. A positive Brudzinski's sign occurs when flexion of the\nneck causes involuntary flexion of the knee and hip. Although Kernig and\nBrudzinski signs are both commonly used to screen for meningitis, the\nsensitivity of these tests is limited. They do, however, have very good\nspecificity for meningitis: the signs rarely occur in other diseases.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Meningitis\ncaused by the bacterium\n  <i>\n   Neisseria meningitidis\n  </i>\n  (known as &ldquo;meningococcal\nmeningitis&rdquo;) can be differentiated from meningitis with other causes by a\nrapidly spreading petechial rash which may precede other symptoms. The rash\nconsists of numerous small, irregular purple or red spots (&ldquo;petechiae&rdquo;) on the\ntrunk, lower extremities, mucous membranes, conjuctiva, and (occasionally) the\npalms of the hands or soles of the feet. The rash is typically non-blanching:\nthe redness does not disappear when pressed with a finger or a glass tumbler.\nAlthough this rash is not necessarily present in meningococcal meningitis, it\nis relatively specific for the disease.\n </span>\n</p>\n\n<p>\n The types of bacteria that\ncause bacterial meningitis vary by age group. In premature babies and newborns\nup to three months old, common causes are\n <i>\n  group B streptococci\n </i>\n (which\nnormally inhabit the vagina and are mainly a cause during the first week of\nlife) and those that normally inhabit the digestive tract such as\n <i>\n  Escherichia\ncoli\n </i>\n (carrying K1 antigen).\n <i>\n  Listeria monocytogenes\n </i>\n may affect the\nnewborn and occurs in epidemics. Older children are more commonly affected by\n <i>\n  Neisseria\nmeningitidis\n </i>\n (meningococcus),\n <i>\n  Streptococcus pneumoniae\n </i>\n (serotypes 6,\n9, 14, 18 and 23) and those under five by\n <i>\n  Haemophilus influenzae\n </i>\n type B\n(mainly in countries that do not offer vaccination). In adults,\n <i>\n  N.\nmeningitidis\n </i>\n and\n <i>\n  S. pneumoniae\n </i>\n together cause 80% of all cases of\nbacterial meningitis, with increased risk of\n <i>\n  L. monocytogenes\n </i>\n in those\nover 50 years old. Since the pneumococcal vaccine was introduced, however,\nrates of pneumococcal meningitis have declined in children and adults.\n</p>\n\n<p>\n Recent trauma to the skull\ngives bacteria in the nasal cavity the potential to enter the meningeal space.\nSimilarly, individuals with a cerebral shunt or related device are at increased\nrisk of infection through those devices. In these cases, infections with\nstaphylococci are more likely, as well as infections by pseudomonas and other\nGram-negative bacilli. The same pathogens are also more common in those with an\nimpaired immune system. In some people, an infection in the head and neck area,\nsuch as otitis media or mastoiditis, can lead to meningitis. Tuberculous\nmeningitis, meningitis due to infection with\n <i>\n  Mycobacterium tuberculosis\n </i>\n ,\nis more common in those from countries where tuberculosis is common, but is\nalso encountered in those with immune problems, such as AIDS.\n</p>\n\n<p>\n A literature review of 363\nreported cases of\n <i>\n  recurrent\n </i>\n meningitis showed that 59% of cases are due to anatomical abnormalities, 36%\ndue to immune deficiencies (such as complement deficiency, which predisposes\nespecially to recurrent meningococcal meningitis), and 5% due to ongoing\ninfections in areas adjacent to the meninges.\n</p>\n\n<p>\n The term\n <i>\n  aseptic\nmeningitis\n </i>\n refers loosely to all cases of meningitis in which no bacterial\ninfection can be demonstrated. This is usually due to viruses, but it may be\ndue to bacterial infection that has already been partially treated, with\ndisappearance of the bacteria from the meninges, or by infection in a space\nadjacent to the meninges (e.g. sinusitis). Endocarditis (infection of the heart\nvalves with spread of small clusters of bacteria through the bloodstream) may\ncause aseptic meningitis. Aseptic meningitis may also result from infection\nwith spirochetes, a type of bacteria that includes\n <i>\n  Treponema pallidum\n </i>\n (the cause of syphilis) and\n <i>\n  Borrelia burgdorferi\n </i>\n (known for causing Lyme\ndisease). Meningitis may be encountered in cerebral malaria (malaria infecting\nthe brain). Fungal meningitis, e.g. due to\n <i>\n  Cryptococcus neoformans\n </i>\n , is\ntypically seen in people with immune deficiency such as AIDS.\n</p>\n\n<p>\n Meningitis may occur as the\nresult of several non-infectious causes: spread of cancer to the meninges (\n <i>\n  malignant\nmeningitis\n </i>\n ) and certain drugs (mainly non-steroidal anti-inflammatory drugs\nand antibiotics). It may also be caused by several inflammatory conditions such\nas sarcoidosis (which is then called neurosarcoidosis), connective tissue\ndisorders such as systemic lupus erythematosus, and certain forms of vasculitis\nsuch as Beh&ccedil;et's disease.\n</p>\n\n<p>\n The most important test in\nidentifying or ruling out meningitis is analysis of the cerebrospinal fluid\nthrough lumbar puncture (LP, spinal tap). However, lumbar puncture is\ncontraindicated if there is a mass in the brain or the intracranial pressure\n(ICP) is elevated, as it may lead to brain herniation. If someone is at risk\nfor either a mass or raised ICP (recent head injury, a known immune system\nproblem, localizing neurological signs, or evidence on examination of a raised\nICP), a CT or MRI scan is recommended prior to the lumbar puncture. If a CT or\nMRI is required before LP, or if LP proves difficult, professional guidelines\nsuggest that antibiotics should be administered first to prevent delay in\ntreatment, especially if this may be longer than 30&nbsp;minutes.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"4\" width=\"390\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       CSF Findings in\n  Meningitis\n      </span>\n     </b>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"4\" width=\"390\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Type of\n      </span>\n     </b>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       meningitis\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Glucose\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Protein\n      </span>\n     </b>\n    </p>\n   </td>\n   <td width=\"170\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Cells\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n   <td width=\"170\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Acute\n  bacterial\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      low\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      high\n     </span>\n    </p>\n   </td>\n   <td width=\"170\">\n    <p class=\"MsoNormal\">\n     <span>\n      Neutrophils\n  predominate;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      WBCs\n  &gt; 500/mm&sup3;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Acute\n  viral\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      normal\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      normal or high\n     </span>\n    </p>\n   </td>\n   <td width=\"170\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lymphocytes\n  predominate;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      WBCs\n  &lt; 100/mm&sup3;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Tuberculous\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      low\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      high\n     </span>\n    </p>\n   </td>\n   <td width=\"170\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lymphocytes\n  predominate;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      WBC\n  count variable\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Fungal\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      low\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      high\n     </span>\n    </p>\n   </td>\n   <td width=\"170\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lymphocytes\n  predominate;\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      WBC\n  count variable\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Acute meningitis", "B. Cluster headache", "C. Idiopathic intracranial hypertension", "D. Migraine", "E. Subarachnoid hemorrhage", "F. Temporal arteritis", "G. Tension-type headache"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An\n18-year-old man presents to his physician with fever, headache, and malaise.\nPhysical examination shows exudative pharyngitis, cervical lymphadenopathy, and\nhepatosplenomegaly.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The white blood\ncell (WBC) count is 13,000/mm\n  <sup>\n   3\n  </sup>\n  with 60% lymphocytes. Atypical\nlymphocytes are seen on peripheral blood smear. The heterophile antibody test\nis positive. Which organism is the most likely cause of this condition?\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . The prototype of a\nmononucleosis syndrome is infectious mononucleosis, caused by the Epstein-Barr\nvirus. (The Epstein-Barr virus infects B lymphocytes.) Infectious mononucleosis\nis characterized by fever, malaise, and sore throat. Physical examination may\nshow exudative pharyngitis, cervical lymphadenopathy, and hepatosplenomegaly.\nThe white blood cell (WBC) count is usually elevated with a preponderance of\natypical lymphocytes. A positive heterophile antibody test is specific for the\ndisease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Cytomegalovirus (CMV)\ninfection is usually asymptomatic in immunocompetent hosts. Cervical\nlymphadenopathy and exudative pharyngitis are rare. In immunocompromised hosts,\nCMV can cause retinitis, hepatitis, and colitis. Congenital CMV is associated\nwith low birth weight, microcephaly, seizures, hepatosplenomegaly, and a\npetechial rash similar to the \"blueberry muffin\" rash of congenital\nrubella syndrome.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . The protozoan,\n  <i>\n   Toxoplasma gondii\n  </i>\n  , is transmitted by\ningesting undercooked meat or food contaminated by cat feces. Toxoplasmosis is\nusually asymptomatic in immunocompetent hosts. In immunocompromised\nindividuals, it can present as a brain lesion with focal neurological deficits.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Two to four weeks after\nexposure the HIV, patients often develop a flu-like illness characterized by fever,\nmalaise, sore throat, lymphadenopathy, and rash. The symptoms usually subside\nwithin fourteen days. The diagnosis of acute HIV infection is based on a\npositive HIV-1 RNA test and a negative HIV antibody test (by enzyme-linked\nimmunosorbent antibody assay (ELISA) and Western blot analysis). (The ELISA and\nWestern blot tests are negative because the host has not yet developed\nantibodies to the virus.)\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Group A beta-hemolytic\nstreptococcus causes pharyngitis (&ldquo;strep throat&rdquo;). As in infectious\nmononucleosis, patients usually have fever, cervical lymphadenopathy, and\nexudative pharyngitis. Unlike the Epstein-Barr virus, however, Group A\nStreptococcus does not cause hepatosplenomegaly. Also, the heterophile antibody\ntest would be negative in Group A streptococcal infection. Throat culture is\nthe gold standard for diagnosing &ldquo;strep throat.&rdquo;\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347215\"\n o:spid=\"_x0000_i1213\" type=\"#_x0000_t75\" alt=\"Description: http://nmagz.files.wordpress.com/2009/09/190px-tonsillitis.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image223.jpg\" o:title=\"//nmagz.files.wordpress.com/2009/09/190px-tonsillitis.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://nmagz.files.wordpress.com/2009/09/190px-tonsillitis.jpg\" border=\"0\" height=\"176\" src=\"_%20Tutorials_files/image224.png\" v:shapes=\"Picture_x0020_347215\" width=\"231\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Exudate on the tonsils\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347214\"\n o:spid=\"_x0000_i1212\" type=\"#_x0000_t75\" alt=\"Description: http://farm1.static.flickr.com/56/145052719_6d46149085.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image225.jpg\" o:title=\"//farm1.static.flickr.com/56/145052719_6d46149085.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://farm1.static.flickr.com/56/145052719_6d46149085.jpg\" border=\"0\" height=\"175\" src=\"_%20Tutorials_files/image226.png\" v:shapes=\"Picture_x0020_347214\" width=\"232\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Blood smear with atypical lymphocytes\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lymphocytosis\ncan be reactive or malignant. Reactive lymphocytosis is usually caused by viral\ninfection. The lymphocytes may be normal or &ldquo;atypical.&rdquo; Normal lymphocytes have\na large, dark-staining nucleus with scant cytoplasm. The nucleus is about the\nsize of a red blood.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347213\"\n o:spid=\"_x0000_i1211\" type=\"#_x0000_t75\" alt=\"Description: http://upload.wikimedia.org/wikipedia/commons/1/17/Lymphocyte2.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image227.jpg\" o:title=\"//upload.wikimedia.org/wikipedia/commons/1/17/Lymphocyte2.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://upload.wikimedia.org/wikipedia/commons/1/17/Lymphocyte2.jpg\" border=\"0\" height=\"154\" src=\"_%20Tutorials_files/image228.png\" v:shapes=\"Picture_x0020_347213\" width=\"224\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Normal lymphocyte\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  &ldquo;Atypical&rdquo;\nlymphocytes are larger and have abundant basophilic cytoplasm and a large\nirregularly-shaped nucleus. They resemble monocytes, hence the term\n&ldquo;mononucleosis.&rdquo;\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347212\"\n o:spid=\"_x0000_i1210\" type=\"#_x0000_t75\" alt=\"Description: atypical lymphocyte\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image229.jpg\" o:title=\"atypical lymphocyte\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: atypical lymphocyte\" border=\"0\" height=\"164\" src=\"_%20Tutorials_files/image230.png\" v:shapes=\"Picture_x0020_347212\" width=\"215\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Atypical lymphocyte\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Several\ninfectious agents cause a &ldquo;mononucleosis-like&rdquo; pattern on peripheral blood\nsmear.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mononucleosis-like Syndromes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Epstein-Barr Virus\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Cytomegalovirus\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Toxoplasmosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      HIV\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Epstein-Barr virus", "B. Cytomegalovirus", "C. Toxoplasma gondii", "D. HIV", "E. Streptococcus, group A"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  After\ninfection with the measles virus, an 8-year old boy produces antibodies to all\neight viral proteins. The next year he is again exposed to the measles virus.\nAntibodies to which of the following viral proteins are most likely to be\nprotective?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Each of the\nparamyxoviruses has a viral attachment protein in its envelope. For the measles\nvirus, the attachment protein is hemagglutinin. Antibodies to hemagglutinin\nwould protect the host from infection.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347211\"\n o:spid=\"_x0000_i1209\" type=\"#_x0000_t75\" alt=\"Description: 5769426\">\n <v:imagedata src=\"_%20Tutorials_files/image231.jpg\" o:title=\"5769426\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 5769426\" border=\"0\" height=\"245\" src=\"_%20Tutorials_files/image232.png\" v:shapes=\"Picture_x0020_347211\" width=\"326\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p>\n Paramyxoviruses include the\n <span>\n  measles,\n </span>\n mumps,\n <span>\n  parainfluenza,\n </span>\n and\n <span>\n  respiratory syncytial (RSV) viruses.\n </span>\n These viruses are transmitted in respiratory droplets and initiate infection in\nthe respiratory tract. The measles virus causes a generalized infection\ncharacterized by a maculopapular rash\n <span>\n  (rubeola)\n </span>\n .\nParainfluenza virus causes upper and lower respiratory tract infection,\nprimarily in children, including pharyngitis, croup, bronchitis, bronchiolitis,\nand pneumonia. The mumps virus causes a systemic infection whose most prominent\nmanifestation is parotitis. RSV causes mild upper respiratory tract infections\nin children and adults, but can cause life-threatening pneumonia in infants.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nparamyxoviruses have similar morphologies. They consist of a negative-sense,\n  <span>\n   single-stranded ribonucleic acid (RNA)\n  </span>\n  molecule in a helical nucleocapsid surrounded by an\n  <span>\n   envelope\n  </span>\n  . The envelope contains a viral attachment protein. For\nthe measles virus, the attachment protein is hemagglutinin (H). For the mumps\nand parainfluenza viruses, the attachment protein is\nhemagglutinin-neuraminidase (HN). For the respiratory syncytial virus, the\nattachment protein is glycoprotein (G). In addition to having an attachment\nprotein, the envelope of each of these viruses contains a fusion protein (F).\n </span>\n</p>\n\n<p>\n Replication of the\nparamyxoviruses begins with the binding of H, HN, or G proteins to sialic acid\nresidues on the host cell surface. This allows the virus to fuse with the\nplasma membrane and penetrate the cell. The RNA then replicates in the\ncytoplasm, and the virion exits the cell by budding from the plasma membrane.\nThe measles and mumps virus have only\n <span>\n  one\nserotype. The use of l\n </span>\n ive attenuated vaccines has made these conditions\nrare in developed countries.\n</p>\n", "choices": ["A. Nucleocapsid", "B. Polymerase", "C. Matrix", "D. Hemagglutinin", "E. Nonstructural"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Eight\nweeks after a renal transplant, a patient develops fever and leukopenia,\nfollowed by prostration and severe pulmonary and hepatic dysfunction. Which of\nthe following is the most likely viral cause?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  CMV is the most\nimportant and prevalent viral pathogen after transplantation. It can infect\nmany systems and cause severe pneumonitis, hepatitis, GI inflammation, and\nleukopenia.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Lifelong\nimmunosuppression is generally necessary for all recipients of solid organ\ntransplants. As a result, infection is the primary cause of mortality after\ntransplantation. Two-thirds of transplant patients have at least one\nsignificant infection. Signs of\n  <span class=\"search-hit\">\n   infection\n  </span>\n  are\noften blunted by an impaired inflammatory response. Feverishness or mild,\nnon-specific symptoms may herald a severe\n  <span class=\"search-hit\">\n   infection\n  </span>\n  .\nAggressive management usually translates into increased patient survival and\ngraft function.\n </span>\n</p>\n\n<p>\n The timing of post-transplant\n <span class=\"search-hit\">\n  infection\n </span>\n can be separated into three periods.\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n &lt;1 month\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n 1-6 months\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n &gt;6 months\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   First Month after Transplant\n  </span>\n </i>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  These\ninfections are likely to be related to the transplant procedure, catheters, or\nintubation, although &ldquo;standard&rdquo; infections may also occur. Nosocomial pathogens\nare especially prominent.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Months 1 through 6\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </i>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  These\ninfections are divided into two general types: immunomodulating viral\ninfections and opportunistic infections. Immunomodulating viruses include\ncytomegalovirus (CMV), hepatitis B and C, BK polyomavirus, human herpesvirus 6,\nand Epstein-Barr virus (EBV). Opportunistic infections include\n  <i>\n   Pneumocystis\n  </i>\n  ,\n  <i>\n   Listeria\n  </i>\n  , and fungal species.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CMV is the\nmost important and prevalent viral pathogen after transplantation. It can\ninfect many systems and cause severe pneumonitis, hepatitis, GI inflammation,\nand leukopenia. CMV infection may be primary or secondary due to reactivation\nof latent virus in lymphocytes. Although survival has improved with earlier\ndiagnosis (bronchoscopy) and early treatment (gangcyclovir and CMV-specific\nimmunoglobulin), CMV infection is often fatal.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  EBV can\nalso infect transplant recipients. It causes a mononucleosis-like syndrome,\nassociated with lymphadenopathy, weakness, and low-grade fever. EBV is also\nassociated with B-cell lymphoproliferative disease\n  <a name=\"4-u1.0-B978-0-323-05472-0..00182-1--s004\">\n  </a>\n  <a name=\"4-u1.0-B978-0-323-05472-0..00182-1--st00\">\n  </a>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   After 6 Months\n  </span>\n </i>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Six months\nafter transplant, patients receiving immunosuppressive therapy are divided into\nthree groups relative to infection susceptibility: healthy transplant, chronic\nrejection, and chronic (and typically progressive) viral infection. The latter\ngroup includes infection with CMV, EBV, varicella, herpes simplex, or viral\nhepatitis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Parvovirus B19", "B. Influenza virus", "C. Cytomegalovirus", "D. Coxsackie virus", "E. Adenovirus type 12"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  CMV is a\nmember of the Human Herpesvirus family and is a double-stranded enveloped virus\nwith icosahedral symmetry.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The\nvirus attaches to C3 receptors on B cells and after entering the cell, it\nreplicates its genome and matures in the nucleus.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  After the primary infection, the virus\nmay remain latent in WBCs for an indefinite period of time.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Transplant patients can acquire CMV from\ndonor tissues or lymphocytes or from an endogenous reactivation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  CMV prophylaxis is essential in\ntransplant patients.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 27-year-old man with AIDS is brought to\nthe hospital 30 minutes after having a seizure. He currently takes no\nmedications. A CT scan of the head shows multiple ring-enhancing lesions. Which\nof the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Toxoplasmosis would be\nthe most likely cause of multiple ring-enhancing lesions in the brain of a\npatient with AIDS.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347210\" o:spid=\"_x0000_i1208\" type=\"#_x0000_t75\" alt=\"Description: F2\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image233.png\" o:title=\"F2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: F2\" border=\"0\" height=\"313\" src=\"_%20Tutorials_files/image234.png\" v:shapes=\"Picture_x0020_347210\" width=\"332\"/>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n  <span>\n   ring-enhancing lesion\n  </span>\n  is an abnormal\nfinding on CT scan obtained using radiocontrast. On the image there is an area\nof decreased radiodensity surrounded by a bright rim from concentration of the\nenhancing contrast dye.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Multiple ring-enhancing lesions\n  </span>\n </b>\n <span>\n  of the brain can be\ncaused by a variety of infectious, neoplastic, inflammatory, or vascular\ndiseases. Although newer imaging techniques are useful in making a diagnosis,\nearly brain biopsy is often needed because several of these diseases are\npotentially life-threatening.The differential diagnosis of multiple\nring-enhancing lesions depends on the age and the immune status of the patient.\nIn the immunocompetent host, malignancies (both primary and metastatic) and\npyogenic abscesses remain the most likely diagnoses in patients with\nlarge-sized lesions. Primary and metastatic tumors, on imaging, often manifest\nas rounded, well-circumscribed, ring-enhancing lesions of variable sizes\nsurrounded by a variable amount of edema. Metastatic tumors are the most common\nintracranial neoplasm in adults. Lung cancer, breast cancer and melanoma\naccount for the majority of patients with metastasis in the brain. Pyogenic\nbrain abscesses are often caused by hematogenous spread of bacteria from a\nprimary source. The likely sources of primary infection include cyanotic heart\ndisease, endocarditis, suppurative lung diseases, skin infection, and abdominal\nand pelvic infections.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Abscesses caused by\natypical microorganisms and demyelinating disease should also be considered in\nthe differential diagnosis of multiple enhancing lesions of the brain. In\ntropical countries, cysticercus granuloma frequently needs to be differentiated\nfrom intracranial tuberculoma. Cysticercosis is an infection by a parasite,\n  <i>\n   Taenia\nsolium\n  </i>\n  (a pork tapeworm) that creates cysts in different areas in the body.\nThe organism is acquired by eating undercooked meat that contain the larvae or\nby ingesting eggs from contaminated food and water.\n  <span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n  The term &ldquo;neurocysticercosis&rdquo; is\nused when cysts appear in the brain parenchyma. Neurocysticercosis is the most\ncommon parasitic disease of the CNS and is a major cause of seizures worldwide.\nTuberculomas are frequently encountered brain lesions in tropical countries.\nIntracranial tuberculoma can occur with or without tuberculous meningitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In\nHIV-infected patients, the leading causes of multiple enhancing lesions are\ntoxoplasmosis and primary CNS lymphoma. Toxoplasmosis is a common cause of\nmultiple intracranial mass lesions in patients with acquired immunodeficiency\nsyndrome (AIDS).\n  <i>\n   Toxoplasma gondii\n  </i>\n  is\nthe etiologic agent and is acquire by ingestion of oocysts from cat feces or\ntissue cysts from undercooked meat.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It is also one of the TORCH infections, which are transmitted\ntransplacentally.\n  <span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n  It occurs in 3-10% of patients with AIDS in the United States and\nin up to 50% of the patients in Europe and Africa. For an immunosuppressed\npatient who presents with focal neurologic signs and multiple ring-enhancing\nlesions of the brain on imaging, cerebral toxoplasmosis would be the most\nlikely diagnosis, and current guidelines suggest that all such patients be\ntreated with antitoxoplasma treatment. Combination of pyrimethamine/sulfadiazine\nand folinic acid is considered the standard regime for the treatment of\ncerebral toxoplasmosis. After approximately two weeks of treatment, a decrease\nin the number and size of lesions with reduction in edema should be observed. A\nlack of response to such therapy should alert the clinician about the\npossibility of other conditions such as CNS lymphoma or progressive multifocal\nleukoencephalopathy.\n </span>\n</p>\n", "choices": ["A. Amoebiasis", "B. Cysticercosis", "C. Echinococcosis", "D. Schistosomiasis", "E. Toxoplasmosis", "F. Trichinosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 26-year-old man with multiple sexual\npartners has a painful ulcer on his penis. Physical examination shows a 1-cm\nulcer with no induration on the frenulum. Tender lymphadenopathy is noted in\nthe right inguinal region. A culture of the ulcer grows colonies on\nsupplemented chocolate agar. A Gram stain of the colonies shows gram-negative\ncoccobacilli. Which of the following organisms is the most likely cause of\ndisease?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   Haemophilus ducreyi\n  </i>\n  <span>\n   is the cause of chancroid, which is\ncharacterized by painful, non-indurated ulceration and tender lymphadenopathy.\nThe organism is a gram-negative coccobacillus.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\n  <i>\n   Treponema pallidum\n  </i>\n  <span>\n   is the cause of syphilis. Primary syphilis\nusually presents as a chancre, which is a painless, indurated ulcer, usually\nassociated with non-tender lymphadenopathy. The organism is a spirochete.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Herpes genitalis\nusually presents with shallow, painful ulceration and tender lymphadenopathy.\nIt is usually caused by herpes simplex virus 2, but may be caused by herpes\nsimplex virus 1. The Tzank smear shows multi-nucleated giant cells. Herpes\nsimplex is a DNA virus.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect\n  </span>\n </b>\n <span>\n  .\n  <i>\n   Neisseria gonorrhoeae\n  </i>\n  <span>\n   usually\npresents with genital discharge, not genital ulceration. Gram stain shows\ngram-negative diplococci.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect\n  </span>\n </b>\n <span>\n  .\n  <i>\n   Trichomonas vaginalis\n  </i>\n  <span>\n   is a\nprotozoan that causes vaginitis, not genital ulceration.\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  A useful\nclinical approach to evaluating sexually transmitted diseases (STDs) is based\non the pattern of presenting symptoms. Four basic patterns exist: genital\ndischarge syndromes, genital ulcer syndromes, pelvic inflammatory disease, and\ndermatologic syndromes.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      STD Patterns\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Genital\n  discharge syndromes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Genital\n  ulcer syndromes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pelvic\n  inflammatory disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Dermatologic\n  syndromes\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Genital\ndischarge syndromes.\n  </span>\n </b>\n <span>\n  &nbsp;Discharge\nsyndromes can be further divided into those causing urethritis/cervicitis and\nthose causing vaginitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal causes of urethritis and cervicitis are\n  <i>\n   Neisseria gonorrhoeae\n  </i>\n  and\n  <i>\n   Chlamydia trachomatis\n  </i>\n  . Concurrent infection with these organisms\noften occurs. Their clinical manifestations are similar and patients are often\ntreated presumptively for both organisms.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"3\" valign=\"top\" width=\"479\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     STDs Causing Genital Discharge\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <i>\n     <span>\n      Neisseria gonorrhoeae\n     </span>\n    </i>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <i>\n     <span>\n      Chlamydia trachomatis\n     </span>\n    </i>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Gram\n  Stain\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Gram-negative diplococci\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     ---\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Incubation\n  period\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     2-30 days\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     1-3 weeks\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Manifestations\n    </span>\n   </p>\n  </td>\n  <td colspan=\"2\" valign=\"top\" width=\"319\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Urethritis,\n  cervicitis, epididymitis, prostatitis, orchitis, conjunctivitis, pharyngitis,\n  proctitis, pelvic inflammatory\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     disease,\n  and perihepatitis (Fitz-Hugh&ndash;Curtis syndrome)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Symptoms\n    </span>\n   </p>\n  </td>\n  <td colspan=\"2\" valign=\"top\" width=\"319\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Men:\n  Dysuria, penile discharge, scrotal pain\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Female:\n  May be asymptomatic; symptoms may include dysuria, vaginal discharge, pelvic\n  pain, abnormal vaginal bleeding\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Special\n  features\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Disseminated\n  gonococcal infection\n     <sup>\n      1\n     </sup>\n     :\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     1)\n  arthritis-dermatitis syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     2)\n  septic arthritis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     3)\n  endocarditis, myocarditis meningitis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Diagnosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     1) Gram\n  stain\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     2)\n  Culture\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     3)\n  Nucleic acid amplification tests\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     1) Cell\n  culture\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     2)\n  Nucleic acid amplification tests\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-0-323-05472-0..00096-7--f005\">\n </a>\n <sup>\n  <span>\n   1\n  </span>\n </sup>\n <span>\n  Disseminated gonococcal\ninfection (DGI) results from gonococcal bacteremia. The principal manifestation\nis the arthritis-dermatitis syndrome, characterized by fever, chills,\nmonoarticular or oligoarticular arthritis, non-itchy rash, and tenosynovitis.\nThe rash consists of tender, hemorrhagic pustules on an erythematous base,\nusually on the distal extremities. The second most common manifestation is\nseptic arthritis, which presents as an acute monoarticular or oligoarticular\narthritis. The knees are most commonly involved. The affected joint is warm,\nerythematous, swollen, and tender. DGI can also cause endocarditis,\nmyocarditis, and meningitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The principal conditions\nassociated with vaginitis are listed below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td colspan=\"5\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Vaginitis\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Condition\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Vaginal\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      pH\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Discharge\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Appearance\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Wet mount\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Treatment\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Bacterial*\n  vaginosis\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     &gt;4.5\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Gray,\n  white, milky/creamy; amine odor present\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Clue\n  cells**\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Metronidazole\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Trichomonas\n     </span>\n    </i>\n    <span>\n     infection\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     &gt;4.5\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Gray,\n  yellow, greenish, or white; often frothy; homogeneous\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Trichomonads\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Metronidazole\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Candida\n     </span>\n    </i>\n    <span>\n     ***\n     <i>\n     </i>\n     infection\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     &lt;4.5\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     White,\n  often curdy\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Mycelia\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Fluconazole,\n  intravaginal imidazoles\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  *The role\nof sexual activity in transmitting bacterial vaginosis is unknown.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  **Clue\ncells are vaginal\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Epithelial\" title=\"Epithelial\">\n  <span>\n   epithelial\n  </span>\n </a>\n <span>\n  cells that are covered\nwith\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Bacteria\" title=\"Bacteria\">\n  <span>\n   bacteria\n  </span>\n </a>\n <span>\n  , causing a stippled\nappearance.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ***\nCandida vaginitis is not an STD.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Genital\nulcer syndromes.\n  </span>\n </b>\n <span>\n  &nbsp;The\nvast majority of genital ulcers are caused by herpes simplex virus and\nsyphilis. Other important causes include chancroid and lymphogranuloma\nvenereum.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td colspan=\"6\" width=\"472\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      STDs Causing Genital Ulcers\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"97\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Disease\n     </span>\n    </p>\n   </td>\n   <td width=\"88\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Ulcer\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Incubation period\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Pain with ulcer\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Inguinal adenopathy\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Diagnostic test\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td width=\"97\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td width=\"88\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td width=\"97\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Syphilis\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (primary)\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (\n     <i>\n      Treponema pallidum\n     </i>\n     )\n    </span>\n   </p>\n  </td>\n  <td width=\"88\">\n   <p class=\"MsoNormal\">\n    <span>\n     Chancre:\n  papule that ulcerates;\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     painless\n  and indurated (firm); clean base with sharp borders; single lesion (usually);\n  heals spontaneously; leaves thin, atrophic scar\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     10&ndash;90\n  days (average 21 days)\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     No\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Firm,\n  discrete, movable, nontender, nonsuppurative, may last for months\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Darkfield\n  examination;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     VDRL\n  positive (77%);\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     FTA-ABS\n  positive\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     (86%)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"97\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Herpes genitalis\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (HSV-2, HSV-1)\n    </span>\n   </p>\n  </td>\n  <td width=\"88\">\n   <p class=\"MsoNormal\">\n    <span>\n     Multiple\n  small grouped vesicles on a red base, which form shallow ulcers; may\n  coalesce; resolve spontaneously, but recurrence is common; associated fever\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     2&ndash;7\n  days\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Yes\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Bilateral,\n  soft, tender\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Tzank\n  smear positive;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Tissue\n  culture isolation;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     HSV-2\n  antigen\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"97\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Chancroid\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (\n     <i>\n      Haemophilus ducreyi\n     </i>\n     )\n    </span>\n   </p>\n  </td>\n  <td width=\"88\">\n   <p class=\"MsoNormal\">\n    <span>\n     Soft,\n  non-indurated, very painful ulcer\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     3&ndash;6\n  days\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Yes\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Unilateral\n  (usually), very tender, suppurative\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Gram stain\n  (Gram-negative coccobacillus);\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Culture\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"97\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Lymphogranuloma venereum*\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (\n     <i>\n      Chlamydia trachomatis\n     </i>\n     )\n    </span>\n   </p>\n  </td>\n  <td width=\"88\">\n   <p class=\"MsoNormal\">\n    <span>\n     Transient\n  ulcer, often not noticed; usually single\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     5&ndash;21\n  days\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     No\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Firm,\n  tender, matted, caseating, suppurative; sinus tracts; fistulas; multiple\n  abscesses\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Lymphogranuloma\n  venereum complement fixation\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  *Lymphogranuloma\nvenereum may be associated with fever, arthritis, pericarditis, proctitis,\nmeningoencephalitis, keratoconjunctivitis, preauricular adenopathy, edema of\neyelids, erythema nodosum\n </span>\n</p>\n\n<p>\n <b>\n  Pelvic inflammatory\ndisease.\n </b>\n Pelvic inflammatory disease (PID) is characterized by inflammation\nof the upper female genital tract.\n <i>\n  C. trachomatis\n </i>\n and\n <i>\n  N\n </i>\n .\n <i>\n  gonorrhoeae\n </i>\n are the most common causes. Low abdominal pain is the dominant symptom. Fever,\nmalaise, and anorexia are common. Vaginal discharge is often present.\nExamination usually shows low abdominal tenderness, cervical motion tenderness,\nand bilateral adnexal tenderness, sometimes with a palpable mass. Most women\nhave signs of cervicitis. Right upper quadrant abdominal tenderness is\nsometimes present due to Fitz-Hugh-Curtis syndrome, in which intra-abdominal\nextension of infection results in perihepatitis, which can mimic acute\ncholecystitis or viral hepatitis. Complications of PID include ectopic\npregnancy and infertility.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Dermatologic\nsyndromes.\n  </span>\n </b>\n <span>\n  &nbsp;The\nmost common STDs with primarily dermatologic presentations are listed below.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"3\" valign=\"top\" width=\"479\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     STDs with Skin Manifestations\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Organism\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Condition\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Description\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Human\n  papillomavirus\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Genital\n  warts (condyloma acuminata)\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Discrete,\n  papillary, cauliflower-like lesions on a moist surface\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Treponema\n  pallidum\n     </span>\n    </i>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Secondary\n  syphilis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      1)\n      <span>\n       &nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     rash\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      2)\n      <span>\n       &nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     condyloma lata\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Symmetrical,\n  reddish-pink, non-itchy lesions on trunk and extremities, often involving\n  palms and soles. In moist areas (vulva, scrotum), rash produces flat, broad,\n  whitish, wart-like lesions called\n     <i>\n      condyloma lata\n     </i>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Neisseria\n  gonorrhea\n     </span>\n    </i>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Disseminated\n  gonococcal infection\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hemorrhagic\n  pustules on an erythematous base, usually on distal extremities\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Phthirus\n  pubis\n     </span>\n    </i>\n    <span>\n     (crab louse)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     &ldquo;Crabs&rdquo;\n  or &ldquo;Pubic lice&rdquo; (pediculosis pubis)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Itching;\n  lice and nits on pubic hairs\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Sarcoptes\n  scabiei\n     </span>\n    </i>\n    <span>\n     (mite)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Scabies\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n     Itching;\n  trails of burrowing mites with pimple-like &ldquo;bites&rdquo;\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347209\"\n o:spid=\"_x0000_i1207\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image235.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"210\" src=\"_%20Tutorials_files/image236.png\" v:shapes=\"Picture_x0020_347209\" width=\"280\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <i>\n  <span>\n   Neisseria gonorrhoeae\n  </span>\n </i>\n <span>\n  :\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Gram-negative diplococci\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347208\"\n o:spid=\"_x0000_i1206\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image237.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"188\" src=\"_%20Tutorials_files/image238.png\" v:shapes=\"Picture_x0020_347208\" width=\"290\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Disseminated Gonococcal Infection (DGI):\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  hemorrhagic pustule on an erythematous base\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347207\"\n o:spid=\"_x0000_i1205\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image239.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"224\" src=\"_%20Tutorials_files/image240.png\" v:shapes=\"Picture_x0020_347207\" width=\"194\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <i>\n  <span>\n   Trichomonas vaginalis\n  </span>\n </i>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347206\"\n o:spid=\"_x0000_i1204\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image241.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"226\" src=\"_%20Tutorials_files/image242.png\" v:shapes=\"Picture_x0020_347206\" width=\"337\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Herpetic ulcers\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347205\"\n o:spid=\"_x0000_i1203\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image243.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"140\" src=\"_%20Tutorials_files/image244.png\" v:shapes=\"Picture_x0020_347205\" width=\"206\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Primary syphilis:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Chancre\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347204\"\n o:spid=\"_x0000_i1202\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image245.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"341\" src=\"_%20Tutorials_files/image246.png\" v:shapes=\"Picture_x0020_347204\" width=\"250\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Secondary syphilis:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Erythematous rash on palms and soles\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347203\"\n o:spid=\"_x0000_i1201\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image247.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"171\" src=\"_%20Tutorials_files/image248.png\" v:shapes=\"Picture_x0020_347203\" width=\"262\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Secondary syphilis:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Condyloma lata\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347202\"\n o:spid=\"_x0000_i1200\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image249.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"183\" src=\"_%20Tutorials_files/image250.png\" v:shapes=\"Picture_x0020_347202\" width=\"242\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Condyloma acuminatum\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (genital warts)\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347201\"\n o:spid=\"_x0000_i1199\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image251.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"187\" src=\"_%20Tutorials_files/image252.png\" v:shapes=\"Picture_x0020_347201\" width=\"251\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Crab louse\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (causes &ldquo;crabs,&rdquo; or pediculosis pubis)\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347200\"\n o:spid=\"_x0000_i1198\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image253.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"241\" src=\"_%20Tutorials_files/image254.png\" v:shapes=\"Picture_x0020_347200\" width=\"261\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Scabies mite\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347199\"\n o:spid=\"_x0000_i1197\" type=\"#_x0000_t75\" alt=\"Description: clue2\">\n <v:imagedata src=\"_%20Tutorials_files/image255.jpg\" o:title=\"clue2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: clue2\" border=\"0\" height=\"150\" src=\"_%20Tutorials_files/image256.png\" v:shapes=\"Picture_x0020_347199\" width=\"252\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Clue cells:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Bacterial vaginosis\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347198\"\n o:spid=\"_x0000_i1196\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image257.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"241\" src=\"_%20Tutorials_files/image258.png\" v:shapes=\"Picture_x0020_347198\" width=\"403\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Candida\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347197\"\n o:spid=\"_x0000_i1195\" type=\"#_x0000_t75\" alt=\"Description: tzank\">\n <v:imagedata src=\"_%20Tutorials_files/image259.jpg\" o:title=\"tzank\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: tzank\" border=\"0\" height=\"289\" src=\"_%20Tutorials_files/image260.png\" v:shapes=\"Picture_x0020_347197\" width=\"434\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Tzank smear:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Multinucleated giant cells associated with herpes infection\n </span>\n</p>\n", "choices": ["A. Treponema pallidum", "B. Herpes simplex virus", "C. Neisseria gonorrhoeae", "D. Trichomonas vaginalis", "E. Haemophilus ducreyi"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is\n  <i>\n   not\n  </i>\n  true of\n  <i>\n   Staphylococcus aureus\n  </i>\n  ?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer I is correct\n  </span>\n </b>\n <span>\n  .\n  <i>\n   Staphylococcus aureus\n  </i>\n  is not a major cause of spontaneous bacterial\nperitonitis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Spontaneous bacterial\nperitonitis is usually caused by gram-negative bacteria, especially\n  <i>\n   Escherichia coli\n  </i>\n  and\n  <i>\n   Klebsiella pneumoniae\n  </i>\n  . Other causes\ninclude streptococci (often pneumococcus) and enterococci.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347196\"\n o:spid=\"_x0000_i1194\" type=\"#_x0000_t75\" alt=\"Description: 191428_xlarge\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image261.jpg\" o:title=\"191428_xlarge\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 191428_xlarge\" border=\"0\" height=\"265\" src=\"_%20Tutorials_files/image262.png\" v:shapes=\"Picture_x0020_347196\" width=\"353\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Staphylococci\nare gram-positive, catalase-positive cocci that occur in microscopic clusters\nresembling grapes. These bacteria are identified by latex agglutination. (The\nbacteria clump latex beads coated with fibrinogen and IgG). Bacteriologic\ncultures of the nose and skin of normal humans invariably yields staphylococci.\nDifference between\n  <i>\n   Staphylococcus aureus\n  </i>\n  and\n  <i>\n   Staphylococcus\nepidermidis\n  </i>\n  <span>\n   are summarized below.\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <i>\n      <span>\n       Staphylococcus aureus\n      </span>\n     </i>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <i>\n      <span>\n       Staphylococcus epidermidis\n      </span>\n     </i>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n      </span>\n     </i>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n      </span>\n     </i>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Large\n  yellow colonies\n      <span>\n      </span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Small\n  white colonies\n      <span>\n      </span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hemolytic\n  on blood agar\n      <span>\n      </span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Non-hemolytic\n  on blood agar\n      <span>\n      </span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Coagulase-positive\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Coagulase-negative\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Often pathogenic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Usually non-pathogenic (but may cause disease in\n  the hospital setting)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Staphylococcus\naureus\n  </span>\n </i>\n <span>\n  causes a variety of suppurative (pus-forming) infections and toxic states. It\ncauses superficial skin lesions such as\n  <span>\n   boils\n  </span>\n  ,\n  <span>\n   sties,\n  </span>\n  and\n  <span>\n   furuncules\n  </span>\n  ; more serious infections,\nsuch as\n  <span>\n   pneumonia\n  </span>\n  ; and\ndeep-seated infections, such as endocarditis,\n  <span>\n   osteomyelitis, and septic arthritis\n  </span>\n  .\n  <i>\n   S. aureus\n  </i>\n  is a major\ncause of\n  <span>\n   hospital acquired (nosocomial)\npneumonia,\n  </span>\n  surgical wound infections, and infections associated with\nintravascular catheters and indwelling medical devices. The organism causes\n  <span>\n   food poisoning\n  </span>\n  by releasing\nenterotoxins into food,\n  <span>\n   toxic shock\nsyndrome\n  </span>\n  by releasing superantigens (principally toxic shock syndrome\ntoxin-1, or TSST-1) into blood, and scalded skin syndrome by releasing\nexfoliatin toxin.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   S.\naureus\n  </span>\n </i>\n <span>\n  expresses many potential\n  <span>\n   virulence\nfactors\n  </span>\n  : (1)\n  <span>\n   surface proteins\n  </span>\n  that promote colonization of host tissues; (2) invasins that promote bacterial\nspread in tissues (\n  <span>\n   leukocidin\n  </span>\n  ,\n  <span>\n   kinases\n  </span>\n  ,\n  <span>\n   hyaluronidase\n  </span>\n  ); (3) surface factors that inhibit phagocytic\nengulfment (\n  <span>\n   capsule\n  </span>\n  ,\n  <span>\n   Protein A\n  </span>\n  ); (4) biochemical properties\nthat enhance their survival in phagocytes (\n  <span>\n   carotenoids\n  </span>\n  ,\n  <span>\n   catalase\n  </span>\n  production); (5) immunological disguises (\n  <span>\n   Protein A\n  </span>\n  ,\n  <span>\n   coagulase\n  </span>\n  );\n(6) membrane-damaging toxins that lyse eukaryotic cell membranes (\n  <span>\n   hemolysins\n  </span>\n  ,\n  <span>\n   leukotoxin\n  </span>\n  ,\n  <span>\n   leukocidin)\n  </span>\n  ;\n(7) exotoxins that damage host tissues; and (8) inherent and acquired\n  <span>\n   resistance to antimicrobial agents\n  </span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hospital\nstrains of\n  <i>\n   S. aureus\n  </i>\n  are usually resistant to a variety of different\nantibiotics. A few strains are resistant to all clinically useful antibiotics\nexcept vancomycin, and vancomycin-resistant strains are increasingly reported.\nThe term &ldquo;\n  <span>\n   MRSA&rdquo;\n  </span>\n  refers to m\n  <span>\n   ethicillin-resistant\n   <i>\n    Staphylococcus aureus\n   </i>\n  </span>\n  .\nMethicillin resistance is widespread and most methicillin-resistant strains are\nalso multi-drug-resistant.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The principal mechanism by which\n  <i>\n   Staphylococcus\naureus\n  </i>\n  resists beta-lactam antibiotics (e.g. penicillin) is production of\nbeta-lactamase.\n </span>\n <span>\n  Genes\nencoding for beta-lactamase are widespread in the bacterial kingdom and are\nfound on the chromosome and on plasmids.\n  <a name=\"4-u1.0-B978-0-323-04475-2..50037-6--p487\">\n  </a>\n  The\n  <span class=\"search-hit\">\n   beta\n  </span>\n  -\n  <span class=\"search-hit\">\n   lactamases\n  </span>\n  of gram-positive bacteria (e.g.\n  <i>\n   Staphylococcus aureus\n  </i>\n  ) are released into\nthe extracellular environment. The\n  <span class=\"search-hit\">\n   beta\n  </span>\n  -\n  <span class=\"search-hit\">\n   lactamases\n  </span>\n  of gram-negative bacteria remain within the\nperiplasm.\n  <b>\n  </b>\n  <span>\n   (The\n   <b>\n   </b>\n   periplasm\n  </span>\n  is the space between the peptidoglycan cell wall and the external outer\nmembrane of gram-negative bacteria.) Hundreds of different\n  <span class=\"search-hit\">\n   beta\n  </span>\n  -\n  <span class=\"search-hit\">\n   lactamase\n  </span>\n  enzymes\nhave been described. All have the same function but with differing amino acid\nsequences that influence their affinity for different\n  <span class=\"search-hit\">\n   beta\n  </span>\n  -lactam\nsubstrates.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Staphylococcal\ndisease has been a perennial problem in the hospital environment since the\nbeginning of the antibiotic era.\n  <i>\n   S aureus\n  </i>\n  has responded to the\nintroduction of antibiotics by the usual bacterial means of developing drug\nresistance: (1) mutation in chromosomal genes and (2) acquisition of resistance\ngenes as extrachromosomal plasmids.\n  <span>\n   MRSA\nrepresents an increasingly large proportion of\n  </span>\n  staphylococcal infections\noccurring in and out of the hospital.\n </span>\n</p>\n", "choices": ["A. It is a gram-positive, cluster-forming coccus.", "B. It is a catalase-positive, coagulase-positive bacterium.", "C. It is most commonly identified by latex agglutination (It clumps latex beads coated with fibrinogen and IgG.)", "D. It colonizes the skin and nares.", "E. It is the most common cause of suppuration (pus-formation).", "F. It is the most common cause of boils and abscesses.", "G. It is the most common cause of osteomyelitis and septic arthritis.", "H. It is a major cause of surgical wound infections.", "I. It is a major cause of spontaneous bacterial peritonitis.", "J. It is a major cause of intravascular catheter-related infections.", "K. It produces enterotoxins, which cause vomiting and diarrhea.", "L. It produces toxic shock syndrome toxin (TSST-1), the main cause of toxic shock syndrome.", "M. It produces exfoliatin toxin, which causes scalded skin syndrome."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following clinical scenarios is\n  <i>\n   least\n  </i>\n  likely to be associated with\n  <i>\n   Streptococcus\npyogenes\n  </i>\n  infection?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer F is correct.\n  </span>\n </b>\n <span>\n  Neonatal sepsis\nassociated with streptococcal bacteremia would be due to Group B &ldquo;strep&rdquo; (\n  <i>\n   <span>\n    Streptococcus agalactiae\n   </span>\n  </i>\n  <span>\n   ), not Group A\n&ldquo;strep&rdquo; (\n   <i>\n    Streptococcus pyogenes\n   </i>\n   ).\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Group A streptococcus\ncauses streptococcal pharyngitis (Strep throat), which is characterized by the\nfollowing triad: high fever, tonsillar exudate, and cervical\nlymphadenopathy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n Acute rheumatic fever (ARF) is a\ncomplication of pharyngeal respiratory infection with Group A streptococcus.\nInfection triggers the formation of antibodies, which cross-react with\nauto-antigens on interstitial connective tissue particularly of the endocardium\nand synovium. Findings may include pancarditis (inflammation of the\nendocardium, myocardium, and pericardium); migratory polyarthritis;\nsubcutaneous nodules; rash; and Sydenham&rsquo;s chorea (involuntary, purposeless\nmovement). The most common clinical finding is a migratory arthritis involving\nmultiple joints. The test for anti-streptolysin O (ASO) antibodies is often\nused to make the diagnosis.\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Post-streptococcal\nglomerulonephritis (PSGN) is an uncommon complication of either respiratory or\nskin infection with Group A streptococcus. It is classified as a type III\nhypersensitivity reaction. Symptoms develop within 10 days of developing &ldquo;strep\nthroat&rdquo; or within 3 weeks of acquiring a skin infection. PSGN is characterized\nby hematuria, renal insufficiency, edema, and a rise in blood pressure.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Group A streptococcus is\nthe cause of scarlet fever, which is characterized by fever; sore throat; a\nbright red, &ldquo;strawberry&rdquo; tongue; and a fine, red &ldquo;sandpaper-like&rdquo; rash.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Group A streptococcus\nis the cause of erysipelas, which is characterized by a red, painful rash with\na sharply-demarcated raised border.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The classification of Streptococcus is shown\nbelow:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/9/9d/Strep_Classification.svg\">\n  <span>\n   <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347195\"\n o:spid=\"_x0000_i1193\" type=\"#_x0000_t75\" alt=\"Description: File:Strep Classification.svg\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/9/9d/Strep_Classification.svg\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image263.png\" o:title=\"Strep Classification.svg\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: File:Strep Classification.svg\" border=\"0\" height=\"234\" src=\"_%20Tutorials_files/image264.png\" v:shapes=\"Picture_x0020_347195\" width=\"392\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p>\n <i>\n  <span>\n   Streptococcus pyogenes\n  </span>\n </i>\n (Group A, beta-hemolytic streptococcus)\ncan cause pharyngitis (Strep throat), rheumatic fever, post-streptococcal\nglomerulonephritis, erysipelas, and scarlet fever.\n <i>\n  <span>\n   Streptococcus agalactiae\n  </span>\n </i>\n (Group B, beta-hemolytic\nstreptococcus) can cause neonatal sepsis and meningitis (if the bacterium\ncolonizes the mother&rsquo;s vagina and is transmitted to the newborn during\ndelivery).\n <i>\n  <span>\n   Streptococcus pneumoniae\n  </span>\n </i>\n <span>\n  can cause a\nnumber of different conditions, including\n </span>\n pneumonia, acute sinusitis,\notitis media, meningitis, cellulitis, and spontaneous bacterial peritonitis.\n <i>\n  <span>\n   Streptococcus viridans\n  </span>\n </i>\n <span>\n  can cause dental\ncaries and endocarditis.\n </span>\n</p>\n", "choices": ["A. 8-year old boy with sore throat is found to have high fever, tonsillar exudate, and cervical lymphadenopathy.", "B. 8-year old boy has fever, shortness of breath, and migratory arthitis two weeks after developing a sore throat. Examination shows a new heart murmur, non-tender subcutaneous nodules, and a serpiginous rash.", "C. 8-year old boy has hematuria, renal insufficiency, edema, and mild elevation of blood pressure ten days after developing a sore throat", "D. 8-year old boy develops fever and sore throat. Examination shows a bright red, tongue with a \u201cstrawberry\u201d appearance, and a fine, red \u201csandpaper-like\u201d rash on the chest.", "E. 8-year old boy develops fever and a red, swollen, warm, hardened and painful rash on the arm. The rash has the consistency of an orange peel and has a raised, sharply demarcated border.", "F. 1-day old newborn evaluated for sepsis has blood cultures that grow gram-positive cocci in pairs and chains. The bacteria agglutinate with group B antiserum."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 33-year-old woman living in Maryland has a one-week history of\nlow-grade fever, fatigue, and a red rash over the skin behind her left knee.\nShe is an avid hiker. Her temperature is 38\n  <sup>\n   o\n  </sup>\n  C (100.4\n  <sup>\n   o\n  </sup>\n  F).\nPhysical examination shows an 8-cm, warm, nontender, erythematous lesion with\npartial central clearing over the skin of the left popliteal area. Which of the\nfollowing is the most likely causal organism?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  The skin lesion in the\npopliteal area, which resembles a bullseye, is called erythema chronicum\nmigrans. This is a common characteristic of Lyme disease, which is caused by\nthe spirochete,\n  <i>\n   <span>\n    Borrelia burgdorferi\n   </span>\n  </i>\n  <span>\n   .\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  <b>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <i>\n  <span>\n   Ehrlichia chaffeensis\n  </span>\n </i>\n <span>\n  causes ehrlichiosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <i>\n  <span>\n   Francisella tularensis\n  </span>\n </i>\n <span>\n  causes tularemia.\n </span>\n <span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <i>\n  <span>\n   Rickettsia rickettsii\n  </span>\n </i>\n <span>\n  causes\n </span>\n <span>\n  Rocky\nMountain spotted fever.\n  <i>\n   <span>\n    <span style=\"mso-spacerun:yes\">\n     &nbsp;\n    </span>\n   </span>\n  </i>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <i>\n  <span>\n   Babesia microti\n  </span>\n </i>\n <span>\n  causes babesiosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Rocky\nMountain spotted fever\n  </span>\n </b>\n <span>\n  is the most lethal and most frequently reported rickettsial\nillness in the United States. The disease is caused by\n  <i>\n   Rickettsia rickettsii\n  </i>\n  ,\nan intracellular species of bacterium that is spread to humans by\n  <i>\n   Dermacentor\n  </i>\n  ticks. The disease can be difficult to diagnose in the early stages, and can be\nfatal without prompt treatment.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The name\n&ldquo;Rocky Mountain spotted fever&rdquo; is a misnomer, as the disease is broadly\ndistributed throughout the continental United States, and occurs as far north\nas Canada and as far south as Central America and parts of South America.\nPeople infected with\n  <i>\n   R. rickettsii\n  </i>\n  usually notice symptoms after an\nincubation period of one to two weeks. The early clinical presentation is\nnonspecific. Initial symptoms include fever, severe headache, nausea, vomiting,\nand muscle pain. Later signs and symptoms include maculopapular rash, petechial\nrash, abdominal pain, and joint pain.\n </span>\n</p>\n\n<p>\n The classic triad of\nfindings is fever, rash, and history of tick bite; however, this combination is\noften not identified when the patient presents initially. The rash has a\ncentripetal pattern of spread, meaning it begins at the extremities and courses\ntoward the trunk.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347194\"\n o:spid=\"_x0000_i1192\" type=\"#_x0000_t75\" alt=\"Description: RMSF\">\n <v:imagedata src=\"_%20Tutorials_files/image265.jpg\" o:title=\"RMSF\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: RMSF\" border=\"0\" height=\"139\" src=\"_%20Tutorials_files/image266.png\" v:shapes=\"Picture_x0020_347194\" width=\"217\"/>\n </span>\n</p>\n\n<p>\n The rash first appears after\nthe onset of fever and is often subtle. Most often it begins as small, flat,\npink, non-itchy spots (macules) on the wrists, forearms, and ankles. These turn\npale when pressure is applied and eventually become raised. The characteristic\nred, spotted, petechial rash is usually not seen until the sixth day or later,\nbut this type of rash occurs in less than 60% of patients. The rash involves\nthe palms or soles in as many as 50% to 80%; however, this distribution may not\noccur until later in the course of the disease. 10-15% may never develop a\nrash.\n</p>\n\n<p>\n Abnormal laboratory findings\ninclude thrombocytopenia and elevated liver enzyme levels. The disease can be\nvery severe, and patients often require hospitalization.\n <i>\n  R. rickettsii\n </i>\n can infect endothelial cells throughout the body, causing dysfunction of the\nrespiratory, gastrointestinal, renal, and neurologic systems. Diagnostic tests\ninclude IFA on blood samples, immunostaining of biopsy of the rash, or PCR on\nblood and skin biopsies.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Appropriate antibiotic treatment should be initiated\n <span>\n  immediately.\n </span>\n Doxycycline is the\ntreatment of choice. (Failure to respond to a tetracycline antibiotic argues\nagainst a diagnosis of Rocky Mountain spotted fever.)\n</p>\n\n<p>\n <b>\n  Lyme disease\n </b>\n is the\nmost common tick-borne disease in the Northern Hemisphere.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n It is named after the town of Lyme,\nConnecticut, where a number of cases were identified in 1975. Lyme disease is\ncaused by spirochetes belonging to the genus\n <i>\n  Borrelia\n </i>\n . Most cases are\ncaused by\n <i>\n  Borrelia burgdorferi.\n </i>\n <i>\n  Borrelia\n </i>\n is transmitted to humans\nby the bite of infected ticks belonging to the genus\n <i>\n  Ixodes\n </i>\n (&ldquo;hard\nticks&rdquo;).\n</p>\n\n<p>\n Lyme disease can produce a\nrange of symptoms. The incubation period is usually one to two weeks, but can\nbe shorter (days) or longer (months to years). The disease usually occurs\nduring tick season (May to September). Asymptomatic infection occurs in less\nthan 7% of infected individuals. Early symptoms include fever, malaise,\nheadache, and muscle soreness. A classic sign is a circular, outwardly\nexpanding rash, called erythema chronicum migrans. It appears at the site of\nthe tick bite within a month of the bite. The rash is red, may be warm, and is\ngenerally painless. Classically, the innermost part is dark red and indurated\n(firm), the outer edge remains red, and the portion in between clears. This\ngives the lesion the appearance of a bullseye (see figure). Erythema chronicum\nmigrans is thought to occur in 80% of infected patients.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347193\"\n o:spid=\"_x0000_i1191\" type=\"#_x0000_t75\" alt=\"Description: lyme-disease-rash\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image267.jpg\" o:title=\"lyme-disease-rash\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: lyme-disease-rash\" border=\"0\" height=\"190\" src=\"_%20Tutorials_files/image268.png\" v:shapes=\"Picture_x0020_347193\" width=\"161\"/>\n </span>\n</p>\n\n<p>\n Days to weeks after\ninfection, the bacteria may spread through the bloodstream. Symptoms of early\ndissemination include migrating pain in the muscles, joints, and tendons, and\nheart palpitations due to arrhythmia. Various neurological problems may occur,\nincluding facial palsy, meningitis, and encephalitis (resulting in memory loss,\nsleep disturbance, or mood change). After several months, untreated patients\nmay go on to develop chronic symptoms that affect the brain, nerves, eyes,\njoints, and heart.\n</p>\n\n<p>\n The diagnosis of Lyme\ndisease is based on symptoms, objective physical findings (such as erythema\nmigrans, facial palsy, or arthritis), history of possible exposure to infected\nticks, and serological blood tests. The classic &ldquo;bullseye&rdquo; rash is considered\nsufficient to establish a diagnosis, even when serologic blood tests are\nnegative. Doxycycline is the drug of choice in adults.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Ehrlichiosis\n  </span>\n </b>\n <span>\n  (sometimes called Rocky Mountain\n&ldquo;spotless&rdquo; fever) is a tick-borne disease caused by bacteria belonging to the\ngenus\n  <em>\n   Ehrlichia\n  </em>\n  <em>\n   <span>\n    or\n   </span>\n   Anaplasma\n  </em>\n  <em>\n   <span>\n    . Most cases are caused by\n   </span>\n  </em>\n  <i>\n   Ehrlichia chaffeensis\n  </i>\n  <span>\n   , a\n  </span>\n  tiny, obligate intracellular\nbacterium that resembles\n  <em>\n   Rickettsia\n  </em>\n  <em>\n   <span>\n    . The organism\n   </span>\n  </em>\n  infects white blood\ncells, multiplies within the cytoplasm, and forms large, mulberry-shaped\naggregates, called morulae. The incubation period is 1-2 weeks. Symptoms are\nusually acute and range from mild to severe. Most patients have fever, chills,\nmalaise, headache, and myalgias. Cough, vomiting, arthralgias, neurologic\nsymptoms (e.g. altered sensorium and neck stiffness) also occur, but rash is\nuncommon. Laboratory abnormalities include leukopenia, thrombocytopenia, and\nelevated hepatic transaminase levels. The estimated death rate is 1% to 10%;\nhospitalization rates are as high as 60%. Most deaths are due to cardiac,\nrespiratory, or renal failure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Tularemia\n  </span>\n </b>\n <span>\n  is a\nserious disease caused by the bacterium\n  <i>\n   Francisella tularensis\n  </i>\n  <span>\n   ,\n  </span>\n  a gram-negative coccobacillus. The\ndisease affects a variety of wild animals, including rabbits, deer, squirrels,\nmuskrat, and beaver. Humans can acquire the bacteria from direct contact with\nthese animals, from the bite of a tick or fly that has fed on an infected\nanimal, or from contaminated food or water. Tularemia usually occurs in the\nsummer months and is most common in people who have had contact with infected\nanimals (e.g. hunters, furriers, butchers, laboratory workers, game wardens,\nand veterinarians). In the U.S., most cases occur in the southeastern and Rocky\nMountain states. The primary vectors are ticks and deer flies.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This organism is also listed on the\nCDC&rsquo;s list of category A biological weapons.\n </span>\n</p>\n\n<p>\n The incubation period is\n1-14 days. Symptoms include fever, chills, malaise, anorexia, rash, and\nenlarged lymph nodes. There are five characteristic clinical syndromes:\nulceroglandular/glandular (the most common type, representing 75% of all\nforms), oropharyngeal, pneumonic, oculoglandular, and typhoidal. In\nulceroglandular fever, a tender red bump appears in the area of the tick bite.\nWithin a few weeks, the bump ulcerates. Nearby lymph nodes swell enormously,\nbecome very tender, and may drain purulent fluid (see figure). Smears of\naspirates from enlarged lymph nodes usually contain the organisms.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Streptomycin and gentamicin are the\ndrugs of choice for treating tularemia.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347192\"\n o:spid=\"_x0000_i1190\" type=\"#_x0000_t75\" alt=\"Description: tularemia_2\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image269.jpg\" o:title=\"tularemia_2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: tularemia_2\" border=\"0\" height=\"186\" src=\"_%20Tutorials_files/image270.png\" v:shapes=\"Picture_x0020_347192\" width=\"190\"/>\n </span>\n</p>\n\n<p>\n <b>\n  Babesiosis\n </b>\n is a\ntick-borne disease caused by the malaria-like parasite,\n <i>\n  Babesia\n </i>\n <span>\n  .\n </span>\n In North America, the disease is\nprimarily found in eastern Long Island, Fire Island, Nantucket Island, and\nMartha's Vineyard off of the coast of Massachusetts. It is sometimes called\n&ldquo;the malaria of the Northeast.&rdquo;\n <span>\n </span>\n Most\ncases of\n <i>\n  Babesia\n </i>\n infection are asymptomatic. Some individuals have mild\nfever and diarrhea. In severe cases, symptoms resemble malaria, with fevers up\nto 40.5&deg;C (105&deg;F), shaking chills, and severe hemolytic anemia. Organ failure\nmay follow. Fulminant cases occur mostly in the very young, the very old, and\nin people who are asplenic or otherwise immunocompromised. Diagnosis is made by\nidentifying parasites (which resemble a &ldquo;Maltese cross&rdquo;) on a Giemsa-stained\nthin blood smear (see figure). Treatment is usually a two-drug regimen (quinine\nand clindamycin or atovaquone and azithromycin).\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347191\"\n o:spid=\"_x0000_i1189\" type=\"#_x0000_t75\" alt=\"Description: cow40_answer2\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image271.jpg\" o:title=\"cow40_answer2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: cow40_answer2\" border=\"0\" height=\"181\" src=\"_%20Tutorials_files/image272.png\" v:shapes=\"Picture_x0020_347191\" width=\"213\"/>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n", "choices": ["A. Borrelia burgdorferi", "B. Ehrlichia chaffeensis", "C. Francisella tularensis", "D. Rickettsia rickettsii", "E. Babesia microti"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A&nbsp;38-year-old\nman presents to the emergency department with a two-day history of cough\nproductive of blood-tinged sputum. He reports fevers, night sweats, and a\n15-pound weight loss. He smokes two packs of cigarettes a day and occasionally\nuses intravenous drugs.&nbsp;He lives in a homeless shelter and is\nHIV-positive.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood\ntests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12 g/dl\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  11,500/mm3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelet\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  380,000/mm3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Chest\nX-ray shows a cavitary lesion in the right upper lobe.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The patient has symptoms and risk factors of active pulmonary\ntuberculosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nBronchogenic carcinoma is uncommon in people under the age of 40, although it\ncan occur. Squamous cell carcinoma is particularly prone to cavitation.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Alcoholism and drug abuse can produce\naltered levels of consciousness predisposing to aspiration pneumonia. The right\nlower lobe is usually involved and cavitation may occur.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  .&nbsp;&nbsp;Aspergillus\ninfection is more common in patients undergoing chemotherapy. An aspergilloma\nis a fungal mass that colonizes a pre-existing cavity formed by a necrotizing\ninfection.\n </span>\n</p>\n"], "tutorial": "<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Risk Factors for Tuberculosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Immunosuppression\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Diseases\n      </span>\n     </i>\n     <span>\n      : HIV/AIDS, diabetes,\n  end-stage renal disease, cancer, silicosis, gastrectomy\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Drugs\n      </span>\n     </i>\n     <span>\n      : glucocorticoids,\n  chemotherapeutic agents, immunosuppressive drugs\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Close\n  contact with infected person\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Migration\n  from country with high rate of TB\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Advanced\n  age\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Substance\n  abuse\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Malnutrition\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Lack\n  of medical care\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Living\n  or working in residential care facility\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Living\n  in refugee camp or shelter\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Health\n  care work\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"244\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       International\n  travel\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Pulmonary\ntuberculosis can produce fever, night sweats, weight loss, cough, hemoptysis,\nand adenopathy. The patient in this vignette has several symptoms of active\ntuberculosis and several risk factors as well: homelessness, HIV infection, and\nsubstance abuse. Cavitation in the upper lobe is highly suspicious for\ntuberculosis. The patient should be placed in negative-pressure&nbsp;isolation\nroom. Three&nbsp;sputum samples should be obtained, stained, and cultured for\nacid-fast bacilli (AFB). If the patient has active tuberculosis, treatment\nshould be started with a four-drug regimen: isoniazid, pyrazinamide, rifampin,\nand ethambutol. &ldquo;Direct observed therapy&rdquo; (DOT) may be continued in the\noutpatient setting. (Note: HIV-positive patients often do not generate a robust\nresponse to the tuberculin skin test. Induration &lt;5 mm is often seen.)\n </span>\n</p>\n", "choices": ["A. Squamous cell carcinoma of the lung", "B. Tuberculosis", "C. Lung abscess from chronic aspiration", "D. Aspergilloma"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n43-year-old man presents with a chronic cough, night sweats, and weight loss. A\nchest x-ray shows infiltrates in the right upper lobe. A lung biopsy shows\nmultiple necrotizing granulomas. Acid-fast staining of the granulomatous tissue\nshows numerous acid-fast bacilli. Tissue culture grows\n  <i>\n   Mycobacterium\ntuberculosis\n  </i>\n  . Which of the following inflammatory mediators is principally\nresponsible for controlling tuberculous infection?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347190\" o:spid=\"_x0000_i1188\" type=\"#_x0000_t75\" alt=\"Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/cheese1.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image273.jpg\" o:title=\"//pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/cheese1.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/cheese1.jpg\" border=\"0\" height=\"205\" src=\"_%20Tutorials_files/image274.png\" v:shapes=\"Picture_x0020_347190\" width=\"154\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Caseous necrosis of tuberculosis\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347189\" o:spid=\"_x0000_i1187\" type=\"#_x0000_t75\" alt=\"Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/afb.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image275.jpg\" o:title=\"//pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/afb.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/afb.jpg\" border=\"0\" height=\"148\" src=\"_%20Tutorials_files/image276.png\" v:shapes=\"Picture_x0020_347189\" width=\"149\"/>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Acid-fast stain:\n  <i>\n   Mycobacterium tuberculosis\n  </i>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Bradykinin\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Interferon-&gamma;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Leukotriene B4\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Prostaglandin E2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  E.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Trimolecular complex (C567)\n </span>\n</p>\n\n<p>\n <a name=\"4-u1.0-B978-1-4377-0792-2..50013-4--p368\">\n </a>\n Macrophages are the primary\ncells infected by\n <i>\n  M.\n  <span class=\"search-hit\">\n   tuberculosis\n  </span>\n </i>\n . Early\nin infection, the bacilli replicate essentially unchecked, while later in\ninfection, the cell response stimulates macrophages to contain the\nproliferation of bacteria.\n <a name=\"4-u1.0-B978-1-4377-0792-2..50013-4--celi\">\n </a>\n</p>\n\n<p>\n <span class=\"text\">\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </span>\n <span class=\"text\">\n  <i>\n   M.\n  </i>\n </span>\n <span class=\"search-hit\">\n  <i>\n   tuberculosis\n  </i>\n </span>\n <span class=\"text\">\n  enters macrophages\nby endocytosis\n </span>\n</p>\n\n<p>\n <span class=\"text\">\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </span>\n <span class=\"text\">\n  Once inside the\nmacrophage,\n  <i>\n   M.\n  </i>\n </span>\n <span class=\"search-hit\">\n  <i>\n   tuberculosis\n  </i>\n </span>\n <span class=\"text\">\n  replicates within the phagosome by blocking fusion of the phagosome\nand lysosome.\n </span>\n Infected macrophages are eventually destroyed and bacteria\nare released, causing bacteremia, seeding of multiple sites, and infection of\nother macrophages.\n <span class=\"text\">\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Despite the bacteremia, most people at\nthis stage are asymptomatic or have a mild flu-like illness.\n </span>\n</p>\n\n<p>\n <span class=\"text\">\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </span>\n <span class=\"text\">\n  Antigen-presenting cells\n(i.e., dendritic cells) encounter mycobacterial antigens in draining lymph\nnodes. These APCs produce IL-12, which allows differentiation of T\n  <sub>\n   H\n  </sub>\n  1\ncells. (This process occurs about 3 weeks after infection and represents the\nbody&rsquo;s mounting of an immune response).\n </span>\n</p>\n\n<p>\n <span class=\"text\">\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </span>\n <span class=\"text\">\n  Mature T\n  <sub>\n   H\n  </sub>\n  1\ncells produce IFN-&gamma;.\n  <i>\n   INF-\n  </i>\n  &gamma;\n  <i>\n   is the critical mediator that\nenables macrophages to contain the M.\n  </i>\n </span>\n <span class=\"search-hit\">\n  <i>\n   tuberculosis\n  </i>\n </span>\n <span class=\"text\">\n  <i>\n   infection\n  </i>\n  . IFN-&gamma; stimulates formation of the\nphagolysosome in infected macrophages, exposing the bacteria to an inhospitable\nacidic environment. IFN-&gamma; also stimulates expression of inducible nitric\noxide synthase, which produces nitric oxide, capable of destroying several\nmycobacterial constituents, from cell wall to DNA.\n </span>\n</p>\n\n<p>\n <span class=\"text\">\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </span>\n <span class=\"text\">\n  T\n  <sub>\n   H\n  </sub>\n  1 cells also\norchestrate the formation of granulomas and caseous necrosis. They produce\nIFN-&gamma;, which causes macrophages to differentiate into the &ldquo;epithelioid\nhistiocytes&rdquo; that characterize the granulomatous response. Some of these\nepithelioid histiocytes fuse to form giant cells. In many people this response\nhalts the infection before significant tissue destruction occurs. In others,\nthe infection progresses due to advanced age or immunosuppression, and the\nongoing immune response results in tissue destruction with caseation and\ncavitation.\n </span>\n</p>\n\n<p>\n <span class=\"text\">\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </span>\n <span class=\"text\">\n  Activated macrophages\nsecrete tumor necrosis factor (TNF), which recruits monocytes. The importance\nof TNF is underscored by the fact that patients with rheumatoid arthritis who\nare treated with a TNF antagonist have an increased risk of\n </span>\n <span class=\"search-hit\">\n  tuberculosis\n </span>\n <span class=\"text\">\n  reactivation.\n </span>\n</p>\n\n<p>\n In summary, immunity to\n <i>\n  M.\n  <span class=\"search-hit\">\n   tuberculosis\n  </span>\n </i>\n is primarily mediated by T\n <sub>\n  H\n </sub>\n 1\ncells, which stimulate macrophages to kill the bacteria via\n <span class=\"text\">\n  IFN-&gamma;\n </span>\n .\nThis immune response, while largely effective, comes at the cost of\nhypersensitivity and tissue destruction. Reactivation of the infection or\nre-exposure to the bacilli in a previously sensitized host results in rapid\nmobilization of a defensive reaction, but also increased tissue necrosis. Just\nas hypersensitivity and resistance are correlated, so, too, the loss of\nhypersensitivity (indicated by tuberculin negativity in a previously\ntuberculin-positive individual) may be an ominous sign that resistance to the\norganism has faded.\n</p>\n\n<p>\n <b>\n  Answer B is correct\n </b>\n .\n <span class=\"text\">\n  Mature T\n  <sub>\n   H\n  </sub>\n  1 cells produce IFN-&gamma;, a critical mediator\nthat enables macrophages to contain the M.\n </span>\n <span class=\"search-hit\">\n  tuberculosis\n </span>\n <span class=\"text\">\n  infection. IFN-&gamma; stimulates formation of the phagolysosome in\ninfected macrophages, exposing the bacteria to an inhospitable acidic\nenvironment. IFN-&gamma; also stimulates expression of inducible nitric oxide\nsynthase, which produces nitric oxide, capable of destroying several\nmycobacterial constituents, from cell wall to DNA.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nBradykinin is a small vasoactive peptide produced in response to injured blood\nvessels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Factor XII initiates the\nkinin cascade by activating kallikrein. This cascade produces bradykinin, which\nincreases vascular permeability and permits the efflux of plasma proteins into\ninjured tissue. This contributes to the pain associated with inflammation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect\n  </span>\n </b>\n <span>\n  .\nLeukotriene B4 is a lipid mediator of inflammation. It acts as a\nchemoattractant for leukocytes and increases vascular permeability.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Leukotrienes and prostaglandins are\nderived from arachidonic acid, which is generated from membrane\nphospholipids.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  .\nProstaglandin E2 is a lipid mediator of inflammation. It is a vasodilator and\nan inducer of fever. Prostaglandins and leukotrienes are derived from\narachidonic acid, which is generated from membrane phospholipids.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect\n  </span>\n </b>\n <span>\n  .\nThe trimolecular complex (C567) is part of the terminal complement pathway,\nwhich generates the membrane attack complex (MAC).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The MAC appears on the surface of\nintruding bacteria and produces transmembrane channels, which disrupt the\nphospholipid bilayer, leading to osmotic lysis and cell death.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 4-year-old boy is brought to the\nphysician because of a 2-day history of fever and an itchy rash. The rash began\non his face and then spread to his trunk, arms, and legs. Several children at\nhis day-care center have had similar symptoms. His temperature is 38.9&deg;C\n(102&deg;F), pulse is 100/min, respirations are 20/min, and blood pressure is\n110/60 mm Hg. Physical examination shows multiple red papules and vesicles over\nthe face, trunk, and upper and lower extremities. Some vesicles contain clear\nfluid, whereas others are crusted. Which of the following is the most likely\ncausal virus?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct.\n </b>\n The rash described in the vignette is typical\nof chickenpox, which is caused by the varicella-zoster virus.\n</p>\n"], "tutorial": "<p>\n <b>\n  Measles\n </b>\n , also known\nas\n <span>\n  rubeola\n </span>\n or\n <span>\n  morbilli\n </span>\n , is an infection of the\nrespiratory system caused by a paramyxovirus of the genus\n <i>\n  Morbillivirus\n </i>\n .\nMorbilliviruses, like other paramyxoviruses, are enveloped, single-stranded RNA\nviruses.\n</p>\n\n<p>\n Classic symptoms of measles\ninclude four-day fevers and the three Cs &ndash; cough, coryza (runny nose) and\nconjunctivitis (red eyes). The fever may reach 40&deg;C (104&deg;F). Koplik's spots\ninside the mouth are pathognomonic (diagnostic) for measles, but are not often\nseen because they are transient, disappearing within a day. The characteristic\nrash is a generalized erythematous maculopapular rash that begins several days\nafter fever commences. The rash, often itchy, starts on the head and spreads to\nmost of the body. It appears two to four days after initial symptoms, lasts for\nup to eight days, and changes color from red to brown before disappearing.\n</p>\n\n<p>\n Measles is spread through\ndroplets from a person&rsquo;s nose or mouth, and is highly contagious &ndash; 90% of\nthose sharing a living space with an infected person will catch it.\nComplications are relatively common and include diarrhea, pneumonia, and acute\nencephalitis.\n</p>\n\n<p>\n <b>\n  Rubella\n </b>\n , commonly\nknown as\n <span>\n  German measles\n </span>\n , is a\ndisease caused by the rubella virus, a member of the togaviridae family. The\nname &ldquo;rubella&rdquo; is derived from the Latin word meaning\n <i>\n  little red\n </i>\n . The\ndisease is transmitted via airborne droplets from the upper respiratory tract\nand is usually mild, lasting 1-3 days. Children recover more quickly than\nadults. Infection of the mother during pregnancy can be serious; if the mother\nis infected within the first 20 weeks of pregnancy, the child may be born with\ncongenital rubella syndrome (CRS).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n The primary finding is rash\non the face that spreads to the trunk and limbs, and usually fades after three\ndays (hence, the term &ldquo;three-day measles&rdquo;). Other symptoms include fever,\nlymphadenopathy, joint pains, headache, and conjunctivitis. The fever rarely\nrises above 38\n <sup>\n  o\n </sup>\n C (100.4\n <sup>\n  o\n </sup>\n F), and the rash (usually\nitchy) is pink or light red. It disappears with no staining or peeling of the\nskin.\n</p>\n\n<p>\n <b>\n  Herpes simplex virus-1 (HSV-1)\n </b>\n is a double-stranded DNA virus and\nbelongs to the Alpha Herpesvirus family.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Herpesviruses can establish latent infection and persist indefinitely in\nthe host.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n HSV-1is acquired via\nclose contact to the virus from mucosal or genital and oral secretions.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Primary HSV infection results in\norolabial herpes or gingovostomatitis and recurrent infections manifest as cold\nsores and fever blisters.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n HSV-1\ninfection in neonates or immunocompromised hosts can be very severe.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Symptoms associated with orolabial\nherpes include fever, chills, mayalgias, cervical lymphadenopathy, and\nirritability.\n</p>\n\n<p>\n <b>\n  Erythrovirus B19\n </b>\n causes &ldquo;slapped cheek syndrome&rdquo; or Fifth&rsquo;s\ndisease.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n This single-stranded DNA\nvirus belongs to the parvoviridae family and can be spread by aerosal, fomites\nor transplacental transmission.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Most cases are subclinical and occur in late winter to early spring.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n After a 7-10 day incubation, most\npatients present with low-grade fever, headache, and mild respiratory\nsymptoms.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n A slapped-cheek rash\nappears 7 days later.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The rash\nspreads and red blotches extend down to the trunk, arms, and legs.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The rash, which has a lacy net-like\nappearance, usually spares the palms and soles.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Serious complications include still\nbirths if the mother is infected during the second trimester and transient\naplastic crises in sickle-cell patients.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The virus lyses immature erythroid precursors.\n</p>\n\n<p>\n <b>\n  Varicella zoster virus\n </b>\n (\n <b>\n  VZV\n </b>\n ) is one of eight herpes viruses known to infect humans. It commonly\ncauses chickenpox in children and zoster (shingles) in adults. Primary\ninfection results in chickenpox (varicella), a highly contagious disease spread\nby coughing and sneezing and by direct contact with fluid from infected\nvesicles on the skin.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Initial symptoms may include\nfever, malaise, headache, sore throat, myalgia, and itching. The chicken pox\nrash begins on the face and trunk and spreads to the extremities. Lesions start\nas 2-4 mm erythematous papules that develop an irregular outline (rose petal).\nA thin-walled, clear vesicle (dew drop) develops on top of the erythematous\narea. This &ldquo;dew drop on a rose petal&rdquo; is characteristic of chicken pox. After\n8-12 hours, the fluid gets cloudy and the vesicle breaks, leaving a crust. The\nfluid is highly contagious, but once the lesions crust over, the patient is no\nlonger infectious. The crust usually falls off after 7 days. Each lesion goes\nthrough this cycle in about 7 days, and new lesions crop up daily. Rare\ncomplications include pneumonia and encephalitis.\n</p>\n\n<p>\n When clinical symptoms have\nresolved, VZV remains dormant in the nervous system, particularly in the\ntrigeminal and dorsal root ganglia. In about 10&ndash;20% of cases, the virus\nreactivates later in life causing shingles. Shingles usually presents with pain\nand vesicular rash in a dermatomal distribution. Complications include\npostherpetic neuralgia (severe pain in the distribution of the affected nerve).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The rash described in the vignette is\ntypical of chickenpox, which is caused by the varicella-zoster virus.\n</p>\n", "choices": ["A. Measles", "B. Rubella", "C. Herpes simplex virus 1", "D. Erythrovirus B19", "E. Varicella-zoster virus"]}, {"question": "<p>\n HIV-1 is sensitive to\nsolvents such as chloroform and 20% diethyl ether, whereas hepatitis A virus is\nresistant to such solvents. This resistance is best explained by the absence of\nwhich of the following in hepatitis A virus?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Enveloped viruses possess an outer\ncoating, or envelope, which is composed of a lipid layer (fat-like substance\nthat is water insoluble). The envelope is relatively sensitive to detergents\nand is needed to aid in attachment of the virus to the host cell. Loss of the\nenvelope results in loss of infectivity. Enveloped viruses are easily\ninactivated by routine surface cleaning and disinfection. HIV-1 has an\nenvelope; hepatitis A virus does not. This explains why HIV is more sensitive\nto detergents than hepatitis A.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n Many viruses have an\n <span>\n  envelope\n </span>\n surrounding the protein\ncapsid. The envelope is usually derived from portions of the host cell membrane\n(which is comprised of phospholipids and proteins), but also includes virally\nderived glycoproteins. Functionally, the envelope is used by viruses to enter\nthe host cell. Glycoproteins on the surface of the envelope bind to receptor\nsites on the host&rsquo;s membrane. The viral envelope then fuses with the host&rsquo;s\nmembrane, allowing the capsid and viral genome to enter the host.\n</p>\n\n<p>\n The viral envelope, which is\ncomposed of a lipid bilayer, is relatively sensitive to desiccation, heat, and\ndetergents. Consequently, enveloped viruses are easier to sterilize than\nnon-enveloped viruses. They have limited survival outside the host and\ntypically must transfer directly from host to host.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p>\n     Naked DNA viruses\n    </p>\n   </td>\n   <td valign=\"top\" width=\"216\">\n    <p>\n     Enveloped DNA viruses\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"216\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p>\n     Adenovirus\n    </p>\n    <p>\n     Human papillomavirus\n    </p>\n    <p>\n     Jacob-Creutzfeld\n    </p>\n    <p>\n     Parvovirus (e.g., B19)\n    </p>\n    <p>\n    </p>\n    <p>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"216\">\n    <p>\n     Hepatitis B virus\n    </p>\n    <p>\n     Herpesvirus\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Epstein-Barr virus\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Cytomegalovirus\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Herpes simplex virus 1\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Herpes simplex virus 2\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Varicella zoster virus\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Roseola virus (HHV-6)\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Kaposi&rsquo;s sarcoma virus (HHV-8)\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n     </span>\n    </p>\n    <p>\n     Smallpox\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p>\n     Naked RNA viruses\n    </p>\n   </td>\n   <td valign=\"top\" width=\"216\">\n    <p>\n     Enveloped RNA viruses\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"216\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"131\">\n    <p>\n     Hepatitis A virus\n    </p>\n    <p>\n     Poliovirus\n    </p>\n    <p>\n     Rhinovirus\n    </p>\n    <p>\n     Coxsackievirus\n    </p>\n    <p>\n     Norwalk virus\n    </p>\n    <p>\n     Rotavirus\n    </p>\n    <p>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"216\">\n    <p>\n     Hepatitis C\n    </p>\n    <p>\n     HIV\n    </p>\n    <p>\n     Influenza\n    </p>\n    <p>\n     Parainfluenza\n    </p>\n    <p>\n     Measles\n    </p>\n    <p>\n     Mumps\n    </p>\n    <p>\n     Rubella\n    </p>\n    <p>\n     Respiratory syncitial\n  virus\n    </p>\n    <p>\n     Rabies\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Single-stranded RNA", "B. Reverse transcriptase", "C. Spherical structure", "D. Icosahedral symmetry", "E. Viral envelope"]}]}, {"section": "Heart & Lung", "questions": [{"question": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Chest Pain\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  3.\nMild persistent chest pain with tenderness over a costochondral junction\nsuggests a diagnosis of costochondritis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2.\nEsophageal rupture may be precipitated by endoscopy.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  12.\nGastroesophageal reflux commonly produced &ldquo;heartburn.&rdquo; It is worse after meals\nand in the supine position.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10.\nMyocardial infarction typically produces severe chest pain with radiation,\nshortness of breath, nausea, and diaphoresis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5.\nAcute pericarditis may be viral in origin. The pain is often sharp and worsened\nin the supine position. A scratchy friction rub may be heard on physical\nexamination.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  4.\nPleuritis, which is often viral in origin, produces a sharp pain that worsens\nwith inspiration.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  6.\nPneumonia typically produces fever, chills, productive cough, bronchial breath\nsounds, egophony, and whispered pectoriloquy.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  1.\nSpontaneous pneumothorax is associated with sudden onset chest pain, diminished\nbreath sounds, and hyperresonance to percussion.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  7.\nSudden onset chest pain and shortness of breath soon after surgery is worrisome\nfor pulmonary embolism.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   J.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  9.\nStable angina is characterized by chest pressure that worsens with activity and\nimproves with rest.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   K.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  8.\nThoracic aortic dissection is associated with sudden, severe &ldquo;tearing&rdquo; chest\npain and unequal blood pressure readings in the upper extremities.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   L.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  11.\nVaricella-zoster is associated with pain and a vesicular rash in a dermatomal\ndistribution.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\nevaluation of chest pain begins with a complete medical interview. The history\nmay reveal nuances in the quality, location, duration, provoking events, and\nrelieving measures, which serve to accurately focus the subsequent evaluation.\nHowever, with few exceptions, such as evident injury to the chest wall, a\nspecific diagnosis cannot be made with complete confidence from the clinical\nhistory alone. Physical examination may reveal evidence of pleural, lung\nparenchymal, or airway disease; localized chest wall involvement; or signs of\nmitral valve prolapse, aortic valve stenosis, or other cardiac abnormalities.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  For adults\nwho present to the emergency department with new-onset chest pain, the\nimmediate concern is to properly identify and characterize potentially\nlife-threatening conditions, such as myocardial infarction, acute pulmonary\nembolism, or tension pneumothorax that requires urgent management. Some\ndiagnostic features are listed in the table below.\n  <a name=\"4-u1.0-B978-1-4160-4710-0..00030-4--t001\">\n  </a>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   Differential Diagnosis\nof Chest Pain\n  </span>\n </b>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Diagnosis\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Pain\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       ECG\n      </span>\n     </b>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       CXR\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Angina pectoris\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Substernal, constricting;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     transient,\n  effort-related; relieved by nitroglycerin\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Local ST depression;\n  occasional elevation\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Myocardial infarction\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Acute, severe,\n  persistent, substernal, crushing pain;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     radiation to the jaw or\n  arm; S4 gallop; sometimes last systolic murmur; possible hypotension; &uarr;\n  troponin\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Local ST elevation or\n  depression\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Possible vascular\n  congestion or cardiomegaly\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Pulmonary embolism\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden onset, pleuritic\n  pain; dyspnea; tachycardia; sometimes mild fever, sometimes hemoptysis; shock\n  if severe; risk factors for venous thrombosis\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Nonspecific; occasional\n  RV strain\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal or opacities &plusmn;\n  small pleural effusion\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Pulmonary artery\n  hypertension\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Gradual onset; dyspnea,\n  fatigue, and edema\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Tall right precordial R\n  waves, right axis deviation, RV strain\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Prominent pulmonary\n  arteries\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Bacterial pneumonia\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Pleuritic pain; onset in\n  minutes to hours; fever; chills; cough; purulent sputum; often dyspnea and\n  tachycardia; signs of consolidation\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Consolidation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Pneumothorax\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden, sharp, unilateral\n  pain; dyspnea; maybe diminished breath sounds; maybe subcutaneous air;\n  asthenic habitus; tendency toward recurrence\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Collapsed lung\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Tension pneumothorax\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Significant shortness of\n  breath, hypotension, neck vein distension; unilateral diminished breath\n  sounds and hyperresonance to percussion; sometimes subcutaneous air\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Collapsed lung; tracheal\n  deviation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Pericarditis\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Constant or intermittent,\n  sharp, pleuritic pain; often aggravated by breathing, swallowing food, or\n  supine position; relieved by sitting and leaning forward; pericardial\n  friction rub\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Generalized ST elevation\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Possible enlarged\n  silhouette\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Aortic dissection\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden, severe,\n  substernal, tearing pain; radiation to the back; may have syncope, stroke, or\n  leg ischemia; pulse or BP may be unequal in limbs; age &gt;55; history of\n  hypertension; prostration; aortic insufficiency\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Nonspecific; LVH or\n  inferior MI\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Widened mediastinum\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Esophageal reflux\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Recurrent, burning,\n  substernal pain; radiating from epigastrium to throat; exacerbated by bending\n  down or lying down; relieved by antacids; may mimic angina\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Musculoskeletal\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Persistent; worsened by\n  cough or deep breathing; diffuse or focal tenderness; increased\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Herpes zoster\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Sharp, band-like pain in\n  mid-thorax (unilaterally); linear, vesicular rash; pain may precede rash by several\n  days; dysesthesia\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  CXR, chest\nx-ray; ECG, electrocardiogram; LVH, left ventricular hypertrophy; MI,\nmyocardial infarction; NTG, nitroglycerin; RV, right ventricular\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A standard\n12-lead electrocardiogram (ECG), appropriate chest imaging, measurement of\noxygen saturation and arterial blood gases, and blood chemistry profiles (e.g.,\ntroponin, D-dimer) often provide important data. In the appropriate clinical\nsetting, some patients may require echocardiography or pulmonary function testing.\nMany other noninvasive or invasive tests are available for the evaluation of\npain believed to be of respiratory, cardiac, or gastrointestinal origin. If\ndiagnosis remains uncertain, admission to chest pain observation units that\noffer a safe and effective means of care for patients with possible unstable\nangina who are considered to be at intermediate risk for cardiovascular events\nmay be considered.\n </span>\n</p>\n", "choices": ["A. Costochondritis", "B. Esophageal rupture", "C. Gastroesophageal reflux", "D. Myocardial infarction", "E. Pericarditis", "F. Pleuritis", "G. Pneumonia", "H. Pneumothorax", "I. Pulmonary embolism", "J. Stable angina", "K. Thoracic aortic dissection", "L. Varicella-zoster", "1. 28-year-old man develops sudden-onset chest pain and shortness of breath while standing. The pain is sharp. Physical examination reveals diminished breath sounds and hyperresonance to percussion over the right lung.", "2. 29-year-old woman experiences sudden, severe chest pain while undergoing esophagogastroduodenoscopy.", "3. 32-year-old woman presents with mild, left-sided chest pain. The pain began three days ago and is constant. Physical examination reveals tenderness over the ribs near the upper left sternum.", "4. 37-year-old woman presents with low-grade fever, sore throat, dry cough, and diffuse muscle and joint aches. She develops a sharp localized pain in the right chest pain that worsens with inspiration.", "5. 38-year-old woman \u201ccatches a cold\u201d and, soon afterward, develops chest pain. The pain is sharp and constant. It is worse when she is supine and relieved with sitting and leaning forward.", "6. 48-year-old woman has a three-day history of fever, chills, and productive cough. Today she has a sharp pain in the right lower chest. The pain is worse with inspiration. Physical examination reveals bronchial breath sounds and egophony over the right lower lung field.", "7. 51-year-old woman suddenly develops chest pain and shortness of breath three days after undergoing hip surgery. The pain is sharp and worsened by deep breathing.", "8. 57-year-old man with hypertension is brought to the emergency department with a sudden, excruciating pain in the chest. The pain is described \u201cripping\u201d and \u201ctearing.\u201d Blood pressures are unequal in both arms.", "9. 58-year-old man with hypertension visits the clinic because of mid-sternal chest pressure that occurs when he walks two or three blocks. The pressure goes away with rest.", "10. 62-year-old man with a 30-pack-year smoking history is brought to the emergency department with severe, crushing pain in the chest that radiates to the left arm and jaw. The pain is a deep, heavy pressure that won\u2019t go away. It has been present for more than an hour and is accompanied by shortness of breath, sweating, and nausea.", "11. 70-year-old man presents with sharp pain and a vesicular rash over the right chest. The pain and rash have a band-like distribution.", "12. 72-year-old man visits his physician because of chest \u201cburning\u201d that is worse after meals, especially when he is supine."]}, {"question": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Shortness of Breath\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  4. Diabetic ketoacidosis results from insulin\ndeficiency. Symptoms include abdominal pain, fatigue, urinary frequency, and\nshortness of breath. Increased ventilation is part of respiratory compensation\nfor metabolic acidosis.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  13. Anemia may result from occult blood loss in\nthe stool. Mild shortness of breath may occur.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  3. Psychogenic shortness of breath may associated\nwith anxiety, palpitations, dizziness, and numbness and tingling in the fingers.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  6. Asthma is often associated with cough and\nwheezing. Common precipitants include cold air, exercise, pollen, and mold.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  9. Lung cancer usually occurs in smokers and may\nbe associated with fatigue, anorexia, weight loss, and hemoptysis. Hyponatremia\ndue to SIADH occurs with small cell lung cancer.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  11. Emphysema is associated with gradually\nprogressive shortness of breath, prolonged expiratory phase, wheezing, and\nhyperresonance to percussion.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10. Heart failure may be associated with jugular\nvein distension, an S3, bibasilar late-inspiratory crackles, and pitting edema\nof the legs and ankles.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5. Laryngeal dysfunction causes stridor &ndash;\nhigh-pitched inspiratory wheezing.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  8. Pericardial effusion with impending tamponade\nis associated with jugular vein distension, distant heart sounds, and pulsus\nparadoxus.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   J.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  12. Pleural effusion is associated with decreased\nbreath sounds and dullness to percussion.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   K.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  7. Pneumonia is associated with fever, chills,\ncough, bronchial breath sounds, egophony, and whispered pectoriloquy.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   L.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2. Pneumothorax is associated with diminished\nbreath sounds and hyperresonance to percussion.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   M.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  1. Severe pulmonary hypertension can cause jugular vein distension and\nan accentuated S2 over the left 2\n  <sup>\n   nd\n  </sup>\n  intercostal space.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <i>\n  <span>\n   Dyspnea\n  </span>\n </i>\n <span class=\"apple-converted-space\">\n  <span>\n   &nbsp;\n  </span>\n </span>\n <span>\n  (shortness of\nbreath) is a common complaint of patients with pulmonary disease. Timing and\nacuity of onset, exacerbating and alleviating factors, and degree of functional\nimpairment are key elements of the history. Associated symptoms such as cough,\nhemoptysis, chest pain, wheezing, orthopnea, and paroxysmal nocturnal dyspnea,\nas well as environmental triggers, should be elicited and are helpful in\ndeveloping a differential diagnosis. If dyspnea is recent, of sudden onset, and\naccompanied by chest pain, then diseases such as pneumothorax, pulmonary\nembolism, and pulmonary edema should come to mind. If the dyspnea is\nlong-standing and is slowly progressive, then chronic conditions such as\nchronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pulmonary\narterial hypertension, and neuromuscular disorders are in the differential\ndiagnosis. The progression of chronic dyspnea may be insidious. Asking specific\nquestions to quantify changes in functional status over time is important.\nDyspnea may occur during exertion or at rest and may be episodic or continuous.\nEpisodic dyspnea associated with exertion suggests parenchymal lung disease or\ncardiac dysfunction. Dyspnea that is seasonal or triggered by environmental\nexposure suggests diseases such as asthma and hypersensitivity pneumonitis.\nPositional dyspnea can occur in patients with severe obstructive lung disease,\ndiaphragmatic paralysis, or neuromuscular weakness.\n </span>\n</p>\n", "choices": ["A. Acidosis (metabolic)", "B. Anemia", "C. Psychogenic", "D. Asthma", "E. Bronchogenic carcinoma", "F. Emphysema", "G. Heart failure", "H. Laryngeal dysfunction", "I. Pericardial effusion", "J. Pleural effusion", "K. Pneumonia", "L. Pneumothorax", "M. Pulmonary arterial hypertension", "1. 26-year-old woman with longstanding amphetamine use presents with shortness of breath. Physical examination reveals jugular venous distension and an accentuated S2 over the left 2nd intercostal space.", "2. 28-year-old man suddenly develops chest pain and shortness of breath while standing. Physical examination reveals diminished breath sounds and hyperresonance to percussion over the right lung.", "3. 33-year-old woman visits the emergency room with palpitations, shortness of breath, dizziness, and numbness and tingling in the fingers. She appears anxious and frightened. Heart and lung examination are normal.", "4. 34-year-old woman with type 1 diabetes mellitus ran out of insulin three days ago. Today she has fatigue, nausea, abdominal pain, urinary frequency, and shortness of breath.", "5. 38-year-old woman presents with cough and shortness of breath. Examination reveals high-pitched wheezing during inspiration. Exhalation is normal.", "6. 42-year-old woman has cough and shortness of breath whenever she jogs in cold weather.", "7. 50-year old man has high fever, chills, and a productive cough. Physical examination reveals bronchial breath sounds, dullness to percussion, and egophony in the right lower lung field.", "8. 54-year-old woman with breast cancer presents with fatigue and shortness of breath. Physical examination reveals jugular venous distension, distant heart sounds, and pulsus paradoxus.", "9. 57-year-old man with a 30-pack-year smoking history presents with fatigue, weight loss, shortness of breath, and coughing up blood. The serum sodium concentration is 120 mEq/L.", "10. 58-year-old man presents with shortness of breath on exertion and bilateral ankle swelling. Physical examination reveals jugular venous distension, an S3, and bibasilar late-inspiratory crackles.", "11. 63-year-old man with a 30-pack-year smoking history has progressive shortness of breath over five years. Lung examination reveals diffusely diminished breath sounds, increased expiratory phase, and hyperresonance to percussion over all lung fields.", "12. 69-year-old woman with breast cancer presents with shortness of breath. Physical examination reveals decreased breath sounds and dullness to percussion over the left lower lung field.", "13. 87-year-old man has fatigue and shortness of breath with exertion. Heart and lung examination are normal. Fecal occult blood testing is positive."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n43-year-old woman with asthma visits the clinic.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She reports shortness of breath and\nwheezing about three times per week. She wakes up at night coughing and\nwheezing about three times per month.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She uses a short-acting beta-agonist inhaler to relieve her symptoms.\nShe has been hospitalized only once for asthma.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her most recent pulmonary function test\nshowed an FEV\n  <sub>\n   1\n  </sub>\n  of 80% of predicted. Her only medication is albuterol\ninhaler.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  How would you classify her\nasthma and what change would you make to her treatment regimen?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  The patient&rsquo;s asthma is\nclassified as &ldquo;mild persistent&rdquo; based on frequency of symptoms (daytime and\nnighttime), as well as the FEV1. All patients with mild persistent asthma\n&ndash; or more severe forms &ndash; should be treated with a controller\nmedication. Airway inflammation is characteristic of asthma. Regular use of a\ncontroller medicine reduces inflammation. All patients with asthma, except\nthose in the very mildest class, should be treated with a controller\nmedication. The preferred choice is an inhaled glucocorticoid.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Asthma\n </span>\n is a chronic inflammatory disease of the airways\ncharacterized by variable and recurring symptoms, reversible airflow\nobstruction, and bronchospasm. Symptoms include wheezing, coughing, chest\ntightness, and shortness of breath. Asthma is clinically classified according\nto the frequency of symptoms, forced expiratory volume in 1 second (FEV1), and\npeak expiratory flow rate.\n</p>\n\n<p>\n It is thought to be caused\nby a combination of genetic and environmental factors. Treatment of acute\nsymptoms is usually with an inhaled short-acting beta-2 agonist. Symptoms can\nbe prevented by avoiding triggers, such as allergens and irritants, and by\nusing &ldquo;controller&rdquo; medicines, such as inhaled corticosteroids and oral\nleukotriene antagonists.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nclinical classification of asthma in adults appears below.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"4\" valign=\"top\" width=\"469\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Classification of Asthma by Severity in Adults\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"107\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Severity\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"114\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Symptom frequency (daytime)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"135\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Symptom frequency\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (nighttime)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"112\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     FEV\n     <sub>\n      1\n     </sub>\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (% of predicted)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"107\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"114\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"135\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"112\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Intermittent\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"114\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &le;2\n  per week\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"135\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &le;2\n  per month\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"112\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &ge;80%\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Mild persistent\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"114\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &gt;2\n  per week,\n     <br/>\n     but not daily\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"135\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     3-4\n  per month\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"112\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &ge;80%\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Moderate persistent\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"114\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Daily\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"135\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &gt;1\n  per week but not nightly\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"112\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     60&ndash;80%\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Severe persistent\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"114\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Throughout\n  the day\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"135\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Frequent\n  (often 7x/week)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"112\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &lt;60%\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  FEV1:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Forced\nexpiratory volume in 1 second\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Management of patients with asthma has four components.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Monitoring of symptoms and lung\nfunction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Patient education\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Controlling environmental factors\nand co-morbid conditions\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Pharmacologic therapy\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The goals\nof asthma management are:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Freedom from frequent or troublesome\nsymptoms of asthma (cough, chest tightness, wheezing, or shortness of breath),\nincluding symptoms that disturb sleep\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Minimal need (&le;2 times per week) of\ninhaled short-acting beta-agonists\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Optimization of lung function\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Maintenance of normal daily\nactivities\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Satisfaction with asthma care on the\npart of patients and families\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Prevention of recurrent\nexacerbations\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Pharmacologic\ntreatment is the mainstay of management in most patients. A stepwise approach\nis recommended, as outlined below.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"h32\">\n  <span>\n   Intermittent\n(Step 1).\n  </span>\n </span>\n <span>\n  &nbsp;Patients\nwith mild intermittent asthma are best treated with a short-acting inhaled\nbeta-agonist.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Mild persistent (Step 2).\n  </span>\n </b>\n <span>\n  &nbsp;Patients with mild persistent asthma should be treated\nwith a controller medication. The preferred choice is a low-dose inhaled\nglucocorticoid. Regular use of inhaled glucocorticoids reduces the frequency of\nsymptoms, reduces the need for beta-agonists, improves quality of life, and\ndecreases asthma exacerbations. Short-acting beta-agonists can still be used\nfor symptomatic relief.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Moderate persistent (Step 3).\n  </span>\n </b>\n <span>\n  For moderate persistent asthma, a long-acting inhaled\nbeta-agonist may be added to the low-dose glucocorticoid inhaler.\nAlternatively, the dose of inhaled glucocorticoid may be raised.&nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Severe persistent (Steps 4, 5, 6).\n  </span>\n </b>\n <span>\n  For severe persistent asthma, the preferred treatment is\nmedium or high-dose inhaled glucocorticoids in combination with a long-acting\ninhaled beta-agonist. Anti-IgE therapy may be beneficial in some patients. Oral\nglucocorticoids are sometimes needed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Note: In some patients, leukotriene modifiers, theophylline,\nor cromolyn may be used at various stages.\n </span>\n</p>\n", "choices": ["A. The patient\u2019s asthma is \u201cintermittent.\u201d No change is medicine is needed.", "B. The patient\u2019s asthma is \u201cmild persistent.\u201d A steroid inhaler should be added to her regimen.", "C. The patient\u2019s asthma is \u201cmoderate persistent.\u201d A long-acting bronchodilator inhaler should be added to her regimen.", "D. The patient\u2019s asthma is \u201csevere persistent.\u201d Oral steroids should be added to her regimen."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Beta-blockers\nhave which of the following cardiovascular effects?\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Choice\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Heart Rate\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Blood Pressure\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Contractility\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     End-diastolic volume\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Ejection time\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     A\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     no effect\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     no effect\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     no effect\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     B\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     C\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     D\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     E\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"74\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Beta-blockers decrease\nheart rate, blood pressure, and cardiac contractility. Decreasing heart rate\nallows more time for ventricular filling (increased end-diastolic volume) and\nfor systolic ejection (increased ejection time). Beta-blockers also reduce\nrenin secretion, thereby dampening the renin-angiotensin-aldosterone cascade.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. A", "B. B", "C. C", "D. D", "E. E"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 5-year-old boy has fever, purulent\nnasal discharge, and a cough productive of green, foul-smelling mucus. He has\nhad many similar episodes over the past three years. His height and weight are\nbelow the 10th percentile. The cardiac apex is located in the right chest.\nCoarse rhonchi are heard bilaterally. A chest radiograph shows findings\nconsistent with bronchiectasis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of the following is the most likely\ndiagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Primary ciliary\ndyskinesia is associated with recurrent sinusitis, pneumonia, bronchiectasis,\nand dextrocardia. (The location of the apical impulse in the right chest\nindicates dextrocardia.)\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n . Patients with acute bronchopulmonary\naspergillosis have asthma, eosinophilia, elevated serum IgE levels, positive\nimmunonologic tests for\n <i>\n  Aspergillus\n </i>\n ,\nand central bronchiectasis.\n</p>\n", "<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Patients with\nalpha-1-antitrypsin deficiency develop emphysema and cirrhosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Cystic fibrosis and\nprimary ciliary dyskinesia can have similar presentations. Both are associated\nwith recurrent lung infections, poor growth, and bronchiectasis; however,\ndextrocardia is not a feature of cystic fibrosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Bronchiectasis\nis a type of obstructive lung disease characterized by localized, irreversible\ndilation of bronchi and bronchioles. Damage to the bronchial tree occurs\nbecause of repeated cycles of airway infection and inflammation. Patients with\nbronchiectasis typically present with chronic cough and copious mucopurulent\nsputum. Other symptoms may include dyspnea, hemoptysis, fatigue, and weight\nloss. Recurrent infections ultimately cause loss of lung function. Pulmonary\nfunction tests show airflow obstruction. The diagnosis is confirmed by\nhigh-resolution chest CT.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Several\ncongenital and acquired diseases can cause bronchiectasis. This tutorial will\nfocus on congenital diseases associated with bronchiectasis.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes of Bronchiectasis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n      Congenital\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cystic fibrosis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Primary ciliary\n  dyskinesia (Kartagener&rsquo;s syndrome)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Alpha-1-antitrypsin\n  deficiency\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Acquired\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Postinfectious\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Aspiration /\n  Gastroesophageal reflux disease (GERD)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Immune deficiency\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Rheumatoid arthritis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Inflammatory bowel\n  disease\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Acute bronchopulmonary\n  aspergillosis (ABPA)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Idiopathic\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Congenital Causes of Bronchiectasis\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <i>\n  Cystic fibrosis\n </i>\n is an autosomal recessive disease caused by a\nmutation in the gene encoding the cystic fibrosis transmembrane conductance\nregulator (CFTR). This gene is required to regulate the components of mucus,\nsweat, and digestive juices. The disease affects several different organs, but\nmost morbidity and mortality is related to pulmonary infections. Pancreatic\ninsufficiency is also a common cause of morbidity. The hallmark symptoms are\nsalty-tasting skin; poor growth despite normal food intake; accumulation of thick,\nsticky mucus; recurrent sinus infections; frequent chest infections with\ncoughing and shortness of breath; and diarrhea. Males may be infertile because\nof congenital absence of the vas deferens. Symptoms often appear in infancy and\nchildhood. Bowel obstruction due to meconium ileus occurs in newborn babies. As\nthe child grows, he or she must struggle to expectorate thick mucus. (Ciliated\nepithelial cells have a mutated protein that results in abnormally viscous\nmucus production.) Poor growth in children is the result of chronic lung\ninfection, poor absorption of nutrients through the gastrointestinal tract, and\nincreased metabolic demand due to chronic illness.\n</p>\n\n<p>\n <i>\n  Primary ciliary dyskinesia\n </i>\n (\n <i>\n  <span>\n   PCD\n  </span>\n </i>\n ), also known as\n <span>\n  immotile ciliary syndrome\n </span>\n or\n <span>\n  Kartagener&rsquo;s Syndrome,\n </span>\n is a rare,\nautosomal recessive disorder characterized by impaired ciliary action along the\nlining of the respiratory tract and fallopian tubes. Cilia are complex\norganelles that beat synchronously in the respiratory tract, moving mucus\ntoward the throat. In PCD, ciliary dysfunction results in impaired mucus\nclearance, which predisposes the patient to sinusitis, bronchitis, otitis\nmedia, bronchiectasis, and pneumonia. Infertility is common because of\ndefective ciliary action in the fallopian tubes and diminished sperm motility.\n50% of individuals with PCD develop situs inversus, where the laterality of the\ninternal organs is the mirror-image of normal. Situs inversus can occur with or\nwithout dextrocardia, a condition in which the heart is located on the right\nside of the body.\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Alpha 1-antitrypsin deficiency\n  </span>\n </i>\n <span>\n  is an autosomal\nrecessive disorder characterized by decreased alpha 1-antitrypsin activity in\nthe lungs and deposition of abnormal alpha 1-antitrypsin protein in the liver.\nUntreated, the condition results in emphysema and cirrhosis.\n </span>\n</p>\n", "choices": ["A. Acute bronchopulmonary aspergillosis", "B. Alpha-1-antitrypsin deficiency", "C. Cystic fibrosis", "D. Primary ciliary dyskinesia (Kartagener\u2019s syndrome)"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  The\ncardiac ventricular action potential is depicted below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Phase 2 of the action potential involves\ninflux of which of the following ions?\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://en.wikipedia.org/wiki/File:Action_potential\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347253\" o:spid=\"_x0000_i1186\" type=\"#_x0000_t75\" alt=\"Description: Plot of membrane potential versus time. The initial resting phase (region 4) is negative and constant flowed by sharp rise (0) to a peak (1).  The plateau phase (2) is slightly below the peak. The plateau phase is followed by a fairly rapid return (3) back to the resting potential (4).\"\n href=\"http://en.wikipedia.org/wiki/File:Action_potential\" o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image277.png\" o:title=\"Plot of membrane potential versus time. The initial resting phase (region 4) is negative and constant flowed by sharp rise (0) to a peak (1).  The plateau phase (2) is slightly below the peak. The plateau phase is followed by a fairly rapid return (3) bac\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: Plot of membrane potential versus time. The initial resting phase (region 4) is negative and constant flowed by sharp rise (0) to a peak (1).  The plateau phase (2) is slightly below the peak. The plateau phase is followed by a fairly rapid return (3) back to the resting potential (4).\" border=\"0\" height=\"97\" src=\"_%20Tutorials_files/image278.png\" v:shapes=\"Picture_x0020_347253\" width=\"163\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  Phase\n2 of the action potential is associated with an influx of calcium ions.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  At the same time, potassium ions leave\nthe cell, prolonging phase 2.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   Cardiac Action Potentials\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   &ldquo;Fast\nResponse&rdquo; Action Potentials\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fast\naction potentials are found in atrial and ventricular myocytes and fast\nconducting Purkinje fibers.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347252\" o:spid=\"_x0000_i1185\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image279.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"218\" src=\"_%20Tutorials_files/image280.png\" v:shapes=\"Picture_x0020_347252\" width=\"290\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoCaption\">\n <span>\n  Figure\n </span>\n <!--[if supportFields]><span\n><span></span><span\nstyle=\"mso-spacerun:yes\">&nbsp;</span>SEQ Figure \\* ARABIC <span\n></span></span><![endif]-->\n <span>\n  <span>\n   1\n  </span>\n </span>\n <!--[if supportFields]><span\n><span></span></span><![endif]-->\n <span>\n  :\n </span>\n <span>\n  Major currents during the phases of the\nfast response action potential.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase 0\n  </span>\n </b>\n <span>\n  : rapid activation of\nthe voltage-gated sodium channel when membrane potential reaches a threshold of\n-65 mV.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The inward Na\n  <sup>\n   +\n  </sup>\n  causes rapid depolarization.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  After\napproximately 1-2 msec the channel inactivates.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The Na\n  <sup>\n   +\n  </sup>\n  channel remains in\nthe inactive state until the membrane repolarizes (which occurs at\napproximately -55 mV) during Phase 3.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The conduction rate of action potentials in cardiac tissue is dependent\non the rate of rise in the depolarization of the action potential (dV/dt).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  The faster the rate of rise, the\nfaster the conduction of the action potentials thought the tissue.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase 1\n  </span>\n </b>\n <span>\n  : activation of\ntransient potassium channels (I\n  <sub>\n   to\n  </sub>\n  ).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  These channels allow K\n  <sup>\n   +\n  </sup>\n  to\npass out of the cell and produce a brief, limited repolarization.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This repolarization produces a &ldquo;notch&rdquo;\nin the fast action potential in certain regions of the heart.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The size of the &ldquo;notch&rdquo; is due to the\nnumber of transient potassium channels expressed in that region.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase 2\n  </span>\n </b>\n <span>\n  : activation of L-type\ncalcium channels and delayed rectifier potassium channels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The L-type Ca\n  <sup>\n   ++\n  </sup>\n  channels are\nslow to activate and inactivate and produce a &ldquo;long-lasting&rdquo; Ca\n  <sup>\n   ++\n  </sup>\n  current.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The L-type Ca\n  <sup>\n   ++\n  </sup>\n  channels activate at approximately -20 mV.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The inward calcium currents drive the membrane potential toward the Ca\n  <sup>\n   ++\n  </sup>\n  equilibrium potential (+120 mV to + 130mV).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  At the same time voltage-gated potassium\nchannels are activated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The K\n  <sup>\n   +\n  </sup>\n  current is due to activation of several types of delayed rectifier K\n  <sup>\n   +\n  </sup>\n  channels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The outward K\n  <sup>\n   +\n  </sup>\n  current counterbalances the inward Ca\n  <sup>\n   ++\n  </sup>\n  current producing a\nsustained plateau.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Differences\nin the shapes of Phase 2 of the fast action potentials among different regions\nof the heart are due to the differences in the distributions of K\n  <sup>\n   +\n  </sup>\n  channels expressed in the myocardial cells.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase\n3:\n  </span>\n </b>\n <span>\n  the\nrepolarization of the action potential is initiated by the slow inactivation of\nthe voltage-gated Ca\n  <sup>\n   ++\n  </sup>\n  channels while K\n  <sup>\n   +\n  </sup>\n  conduction is\nmaintained.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Once the Ca\n  <sup>\n   ++\n  </sup>\n  channels are inactive, the K\n  <sup>\n   +\n  </sup>\n  conductance causes repolarization of\nthe membrane potential.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The\nrepolarization phase is produced by activation of two types of K\n  <sup>\n   +\n  </sup>\n  channels, the rapidly activating (I\n  <sub>\n   Kr\n  </sub>\n  ,\n  <i>\n   HERG\n  </i>\n  ) and the slowly\nactivating (I\n  <sub>\n   Ks\n  </sub>\n  ) channels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The I\n  <sub>\n   Kr\n  </sub>\n  activates at approximately -45 mV and causes a rapid\nrepolarization of the membrane potential.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Further repolarization is caused by the activation of the I\n  <sub>\n   Ks\n  </sub>\n  channels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  During this\nrepolarization, the Na channels make the transition from the inactive state to\nthe closed state.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Inhibition\nof the I\n  <sub>\n   Ks\n  </sub>\n  can cause the prolongation of the fast action potential\nand the long Q-T syndrome.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Inhibition can be caused by genetic mutations or by drugs.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase\n4:\n  </span>\n </b>\n <span>\n  Na\n  <sup>\n   +\n  </sup>\n  and Ca\n  <sup>\n   ++\n  </sup>\n  are removed from the cytoplasm by various active transport\nprocesses.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  K\n  <sup>\n   +\n  </sup>\n  conductance though leak channels and the inward rectifier maintain the membrane\npotential at resting levels (-90 to -80 mV).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   &ldquo;Slow\nResponse&rdquo; Action Potentials\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  These\npacemaker action potentials are present in the SA node and the AV node and are\nresponsible for the automaticity of these tissues.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Automaticity refers to the ability of\nthese cells to depolarize on their own and thus initiate a heart beat.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Slow\nresponse action potentials have distinctive phases 0, 3 and 4.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  There is no phase 1 and the plateau\nphase 2 is brief.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347251\" o:spid=\"_x0000_i1184\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image281.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"214\" src=\"_%20Tutorials_files/image282.png\" v:shapes=\"Picture_x0020_347251\" width=\"258\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoCaption\">\n <span>\n  Figure\n </span>\n <!--[if supportFields]><span\n><span></span><span\nstyle=\"mso-spacerun:yes\">&nbsp;</span>SEQ Figure \\* ARABIC <span\n></span></span><![endif]-->\n <span>\n  <span>\n   2\n  </span>\n </span>\n <!--[if supportFields]><span\n><span></span></span><![endif]-->\n <span>\n  :\n </span>\n <span>\n  Major currents during the slow response\naction potential.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase\n4:\n  </span>\n </b>\n <span>\n  slow\ndepolarization due to inward Na\n  <sup>\n   +\n  </sup>\n  conductance through F-type\n(&ldquo;funny&rdquo;, I\n  <sub>\n   f\n  </sub>\n  ) channels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The I\n  <sub>\n   f\n  </sub>\n  channels are activated by hyperpolarization of the\nmembrane potential below\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  -50\nmV.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  When the membrane potential\ndepolarizes to -55 mV, T-type channels Ca\n  <sup>\n   ++\n  </sup>\n  channels are activated\ncausing further depolarization due to the inward Ca\n  <sup>\n   ++\n  </sup>\n  current.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase\n0:\n  </span>\n </b>\n <span>\n  depolarization\ndue to inward Ca\n  <sup>\n   ++\n  </sup>\n  conductance through L-Type channels.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Phase\n3:\n  </span>\n </b>\n <span>\n  repolarization due inactivation of L-type Ca\n  <sup>\n   ++\n  </sup>\n  channels and outward\nK\n  <sup>\n   +\n  </sup>\n  conductance through delayed rectifier K\n  <sup>\n   +\n  </sup>\n  channels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The repolarization of the\nmembrane potential activates the I\n  <sub>\n   f\n  </sub>\n  channels and phase 4 slow\ndepolarization.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Autonomic\nNervous System Regulation of Cardiac action potentials\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Automaticity\ncan be affected by altering the slow response action potential (pacemaker\npotential).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The slow wave action\npotentials can be altered by changing the slope of the phase 4 depolarization,\nchanging the maximum negativity in phase 4 (aka end diastolic potential) or\nchanging the threshold for the phase 0 depolarization.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347250\" o:spid=\"_x0000_i1183\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image283.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"218\" src=\"_%20Tutorials_files/image284.jpg\" v:shapes=\"Picture_x0020_347250\" width=\"218\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoCaption\">\n <span>\n  Figure\n </span>\n <!--[if supportFields]><span\n><span></span><span\nstyle=\"mso-spacerun:yes\">&nbsp;</span>SEQ Figure \\* ARABIC <span\n></span></span><![endif]-->\n <span>\n  <span>\n   3\n  </span>\n </span>\n <!--[if supportFields]><span\n><span></span></span><![endif]-->\n <span>\n  :\n </span>\n <span>\n  Effects of sympathetic and parasympathetic\nstimulation on slow response action potentials.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Parasympathetic\nnervous system\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Parasympathetic\nstimulation of the SA node 1)\n  <b>\n   decreases\n  </b>\n  the slope of the phase 4\ndepolarization though reduction of the I\n  <sub>\n   f\n  </sub>\n  current and the Ca\n  <sup>\n   ++\n  </sup>\n  current and 2)\n  <b>\n   hyperpolarizes\n  </b>\n  the maximum negativity membrane potential\nby activating K\n  <sup>\n   +\n  </sup>\n  channels (K\n  <sub>\n   ACh\n  </sub>\n  ).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Both of these effects cause a decrease\nfrequency of the slow response action potential and decrease heart rate.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Parasympathetic\nstimulation has similar effects on the slow response action potential in the AV\nnode, and the result is to decrease conduction velocity through the AV node.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sympathetic\nnervous system\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sympathetic\nstimulation of the SA node causes an\n  <b>\n   increase\n  </b>\n  in the slope of the phase\n4 depolarization through activation of I\n  <sub>\n   f\n  </sub>\n  and Ca\n  <sup>\n   ++\n  </sup>\n  currents.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Increasing the slope of\nthe phase 4 depolarization causes an increase in heart rate.\n </span>\n</p>\n", "choices": ["A. Sodium", "B. Potassium", "C. Calcium", "D. Magnesium"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n31-year-old woman has a two-day history of constant pain in the mid-chest. The\npain is worse when she lies down and improves when she sits and leans forward.\nTemperature is 36.8\n  <sup>\n   o\n  </sup>\n  C, pulse is 80/minute, blood pressure is 125/80\nmm Hg, and respiratory rate is 18/minute. The heart rhythm is regular. A\nfriction rub is heard in the left parasternal area. The lungs are clear to\nauscultation. A 12-lead ECG shows widespread ST-segment elevation and\nconcomitant PR-segment depression. What is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The chest pain associated with acute\npericarditis is worse at rest and better with sitting and leaning forward.\nPhysical examination may reveal a pericardial friction rub. (Also, the ECG may\nshow widespread ST-segment elevation and concomitant PR-segment depression. By\ncontrast, the ST-segment elevation associated with myocardial infarction is\nlocalized, not diffuse, and not associated with concomitant PR-segment\ndepression.)\n </span>\n</p>\n"], "tutorial": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td width=\"468\">\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"4-u1.0-B978-1-4160-4710-0..00030-4--sp00\">\n       </a>\n       <span>\n        ACUTE PERICARDITIS\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P011002\">\n       </a>\n       <span>\n        Acute pericarditis, inflammation of the visceral and parietal\n    pericardium, can result from a number of different causes. Although a\n    definitive cause is often not determined (and the condition is then\n    called&nbsp;\n        <i>\n         idiopathic pericarditis\n        </i>\n        ), viral infection is probably\n    the most common cause.&nbsp;\n        <i>\n         Viral pericarditis\n        </i>\n        &nbsp;is usually\n    self-limiting, although occasionally the symptoms may recur once or more\n    before complete resolution. Although less common, pericarditis caused by\n    bacterial infection or tuberculosis can be life-threatening. Pericardial\n    inflammation can also result from direct pericardial injury (trauma, injury\n    early after myocardial infarction or pericardiotomy) due to autoimmune\n    mechanisms (late after myocardial infarction-Dressler syndrome, in\n    connective tissue disease) or to uremia.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P011003\">\n       </a>\n       <span>\n        The classic clinical presentation of pericarditis is chest\n    pain, typically abrupt in onset, sharp, worse in supine position, and\n    relieved by sitting upright and leaning forward. On heart auscultation, the\n    presence of a&nbsp;\n        <i>\n         pericardial rub\n        </i>\n        &nbsp;indicates contact between\n    two inflamed layers of the pericardium. Pericardial rub usually has a\n    characteristic high-pitched, leathery quality, with three components that\n    correspond to movement of the heart during the cardiac cycle (ventricular\n    systole, early ventricular diastole, and atrial contraction; not all three\n    components are always audible). Serial auscultation is advised because the\n    rub may be intermittent and vary in intensity. The absence of an audible\n    rub does not exclude the diagnosis of pericarditis. Chest pain from\n    myocardial ischemia or pulmonary embolism may mimic pericarditis, and these\n    conditions should be considered in the differential diagnosis.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P011004\">\n       </a>\n       <span>\n        Electrocardiogram (ECG) changes are common. During the acute\n    phase, depression of the PR segments and diffuse ST-segment elevations are\n    typical and result from inflammation of the myocardium adjacent to visceral\n    pericardium. Flattening and inversion of T waves may also be present. Most\n    of the ECG abnormalities resolve over several days to weeks, but T-wave\n    abnormalities may persist longer. ST-segment elevations in pericarditis may\n    be mistaken for the current of injury seen in ST-elevation myocardial\n    infarction. In pericarditis, however, multiple leads are affected,\n    reciprocal ST-segment depressions are not seen, and ECG changes evolve much\n    slower than in acute myocardial infarction.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"P011005\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T011001\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T011001.50\">\n    </a>\n    <a name=\"T011001.100\">\n    </a>\n    <a name=\"T011001.150\">\n    </a>\n    <a name=\"T011001.200\">\n    </a>\n    <a name=\"T011001.250\">\n    </a>\n    <a name=\"T011001.300\">\n    </a>\n    <a name=\"T011001.350\">\n    </a>\n    <a name=\"T011001.400\">\n    </a>\n    <a name=\"T011001.450\">\n    </a>\n    <a name=\"T011001.500\">\n    </a>\n    <a name=\"T011001.550\">\n    </a>\n    <a name=\"T011001.600\">\n    </a>\n    <a name=\"T011001.650\">\n    </a>\n    <a name=\"T011001.700\">\n    </a>\n    <a name=\"T011001.750\">\n    </a>\n    <a name=\"T011001.800\">\n    </a>\n    <a name=\"T011001.850\">\n    </a>\n    <a name=\"T011001.900\">\n    </a>\n    <a name=\"T011001.950\">\n    </a>\n    <a name=\"T011001.1000\">\n    </a>\n    <a name=\"T011001.1050\">\n    </a>\n    <a name=\"T011001.1100\">\n    </a>\n    <a name=\"T011001.1150\">\n    </a>\n    <a name=\"T011001.1200\">\n    </a>\n    <a name=\"T011001.1250\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <div align=\"center\">\n    <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"90%\">\n     <tr>\n      <td width=\"100%\">\n      </td>\n     </tr>\n    </table>\n   </div>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P011006\">\n       </a>\n       <span>\n        The treatment of acute pericarditis is directed at managing\n    the underlying cause and providing pain relief. For most patients,\n    nonsteroidal anti-inflammatory drugs are effective in relieving the chest\n    discomfort and facilitating the resolution of inflammation; colchicine can\n    be an effective alternative. Glucocorticoids are used if the former therapy\n    is not sufficiently effective. Although most cases of idiopathic and viral\n    pericarditis are self-limited, complications include recurrences, large\n    pericardial effusion, cardiac tamponade, and pericardial constriction.\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Acute myocardial infarction", "B. Acute pericarditis", "C. Pneumonia", "D. Pulmonary embolism", "E. Pneumothorax", "F. Gastroesophageal reflux"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A two-week\nold female baby is brought to the emergency room. Examination reveals mild\ncyanosis of the face and trunk and moderate cyanosis of the extremities. Which\nof the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct\n </b>\n .\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Tetralogy of Fallot is the most common cause of cyanosis in the first\nfew weeks of life.\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347249\"\n o:spid=\"_x0000_i1182\" type=\"#_x0000_t75\" alt=\"Description: 18088\">\n <v:imagedata src=\"_%20Tutorials_files/image285.jpg\" o:title=\"18088\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 18088\" border=\"0\" height=\"242\" src=\"_%20Tutorials_files/image286.png\" v:shapes=\"Picture_x0020_347249\" width=\"302\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Tetralogy of Fallot\n  </span>\n </b>\n <span>\n  is the most common\ncause of cyanosis in the first few weeks of life. The condition is associated\nwith ventricular septal defect, overriding aorta, right ventricular\nhypertrophy, and pulmonary stenosis. Cyanosis, caused by a right-to-left shunt,\nmay be worsened by agitation. Clubbing of the fingers and toes may occur.\n(Mnemonic: The 5 T&rsquo;s of early cyanotic heart disease are Tetralogy of Fallot,\ntransposition of the great vessels, truncus arteriosus, total anomalous\npulmonary venous return, and tricuspid atresia.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Ventricular septal defects (VSDs)\n  </span>\n </b>\n <span>\n  are the most common\n  <i>\n   non\n  </i>\n  -cyanotic congenital heart defects.\nInfants present with dyspnea, tachypnea, and feeding difficulties. A\nholosystolic murmur may be heard.\n </span>\n</p>\n\n<p>\n <b>\n  Atrial septal defects (ASDs)\n </b>\n may be inapparent until adulthood,\nwhen the Eisenmenger syndrome may occur. (In the Eisenmenger syndrome,\nleft-to-right shunting leads to pulmonary hypertension, which in turn, causes\nincreased pressure in the right heart and reversal of the shunt in a right-to-left\ndirection.)\n</p>\n\n<p>\n <b>\n  Patent ductus arteriosus (PDA)\n </b>\n is associated with a continuous\n(systolic and diastolic) murmur. Cyanosis does not occur unless the\nEisenmenger&rsquo;s syndrome develops. In the fetus, the ductus arteriosus shunts\nblood from the left pulmonary artery to the aorta, allowing blood to bypass the\nhigh-resistance lungs. Failure of the duct to close is common in premature\nbabies and in cases of congenitally acquired rubella. Indomethacin can used to\nclose the PDA.\n</p>\n", "choices": ["A. Ventricular septal defect", "B. Atrial septal defect", "C. Tetralogy of Fallot", "D. Patent ductus arteriosus"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n19-year-old man has severe hypertension despite taking several\nanti-hypertensive medicines. He reports frequent headaches and has leg weakness\nthat is worse with activity. His blood pressure is 190/110 mm Hg in both arms\nand 130/80 mm Hg in both legs. Femoral pulses are weak and delayed when\ncompared to carotid pulses. A systolic murmur is noted in the left\ninfra-clavicular area (anteriorly) and under the left scapula (posteriorly). An\nejection click is audible in the right second intercostal space. Renal\nfunction, electrolytes, and urinalysis are normal. Chest x-ray shows\ncardiomegaly and mild pulmonary congestion. Electrocardiogram shows left\nventricular hypertrophy. Imaging studies show coarctation of the aorta. Which\nof the following congenital cardiac anomalies is most likely present in this\npatient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  The patient in this vignette has signs of\naortic coarctation (i.e., significant blood pressure gradient between the upper\nand lower extremities; weak and delayed femoral pulses) and signs of a bicuspid\naortic valve (ejection click in the aortic area).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpFirst\">\n <b>\n  <span>\n   Answer A\n  </span>\n </b>\n <span>\n  <b>\n   is incorrect\n  </b>\n  . Aortic coarctation is not usually associated with\natrial septal defect. Fixed splitting of S2 would suggest atrial septal defect.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer B\n  </span>\n </b>\n <span>\n  <b>\n   is incorrect\n  </b>\n  . Aortic coarctation may be associated with ventricular\nseptal defect, but this condition produces a holosystolic murmur.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Aortic coarctation may\nbe associated with transposition of the great arteries, but this condition\nusually presents early in life with cyanosis.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer E\n  </span>\n </b>\n <span>\n  <b>\n   is incorrect.\n  </b>\n  Aortic coarctation may be associated with patent\nductus arteriosus, but this condition produces a continuous, machine-like\nmurmur in left infra-clavicular and left scapular area.\n  <span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Coarctation of the aorta\nis a relatively common disorder, accounting for 5-8% of all congenital heart\ndefects. It is characterized by narrowing of the aorta where the ductus\narteriosus (ligamentum arteriosum after regression) inserts &ndash; i.e.,\ndistal to the origin of the left subclavian artery.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Coarctation is\nassociated with numerous congenital cardiac anomalies, including bicuspid\naortic valve, patent ductus arteriosus, ventricular septal defect, and mitral\nvalve disease. It may be associated with various types of cyanotic heart\ndisease (e.g., transposition of the great arteries), and it is the most common\ncardiovascular defect in Turner syndrome. Tests can distinguish among the\npossible causes of coarctation. A bicuspid aortic valve will present with an ejection\nclick in the aortic area. A patent ductus arteriosus produces a continuous,\nmachine-like murmur in left infra-clavicular and left scapular area.\n  <span>\n   A ventricular septal defect produces a holosystolic\nmurmur. Mitral valve disease produces a pansystolic murmur due to\nregurgitation.\n  </span>\n  Transposition of the great arteries usually presents\nearly in life with cyanosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The disorder imposes\nsignificant afterload on the left ventricle, increasing wall stress and causing\ncompensatory left ventricular hypertrophy. In some cases, afterload increases\ngradually, allowing arterial collateral vessels to form, bypassing the\nobstruction. In such cases, patients may be asymptomatic until they become\nhypertensive and complications ensue. (The mechanism of hypertension is incompletely\nunderstood.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Often the diagnosis of\ncoarctation is made when hypertension is incidentally noted during a routine\nphysical examination. The patient may present with headache, chest pain,\nfatigue, or even life-threatening intracranial hemorrhage. True claudication is\nrare, although leg pain and weakness may occur.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In adults, coarctation\nis best diagnosed by simultaneous palpation of the femoral and brachial pulses\nand by measuring blood pressure in both arms and legs. A pressure difference of\nmore than 20 mm Hg, with higher values in the arms, is suggestive of\ncoarctation. Weak and delayed femoral pulses also suggest coarctation. A\nsystolic murmur is often heard in the left infraclavicular and left scapular\nareas. An S4 indicates a hypertrophied, noncompliant left ventricle. Surgical\nor endovascular repair is the treatment of choice.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347248\" o:spid=\"_x0000_i1181\"\n type=\"#_x0000_t75\" alt=\"Description: ::18128.jpg\">\n <v:imagedata src=\"_%20Tutorials_files/image287.jpg\" o:title=\"18128.jpg\"\n  gain=\"68267f\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: ::18128.jpg\" border=\"0\" height=\"234\" src=\"_%20Tutorials_files/image288.png\" v:shapes=\"Picture_x0020_347248\" width=\"292\"/>\n </span>\n</p>\n", "choices": ["A. Atrial septal defect", "B. Ventricular septal defect", "C. Transposition of the great arteries", "D. Bicuspid aortic valve", "E. Patent ductus arteriosus"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n60-year-old man presents with an eight-month history of exertional shortness of\nbreath, wheezing, and daily sputum production.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He is a 50-pack year smoker.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  On physical examination, he has markedly\nreduced breath sounds over the posterior lung fields and mild end-expiratory\nwheezing. Spirometry shows a forced expiratory volume in 1 second (FEV\n  <sub>\n   1\n  </sub>\n  )\nof 1.5 L (60% of predicted).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  His\nforced vital capacity (FVC) is 2.3 L. The FEV\n  <sub>\n   1\n  </sub>\n  /FVC ratio is 0.65.\nWhich of the following interventions is most likely to improve his long-term\nsurvival?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  This man&rsquo;s history as a\nsmoker and his spirometry results indicating that he has an obstructive disease\nsuggest that he has chronic obstructive pulmonary disease (COPD). Smoking\ncessation is the only therapy that has been shown to improve survival in COPD.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347480\"\n o:spid=\"_x0000_i1180\" type=\"#_x0000_t75\" alt=\"Description: http://www.studentconsult.com/content/9781416061090/legends/Chapter_17-WebFig.4.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image289.jpg\" o:title=\"//www.studentconsult.com/content/9781416061090/legends/Chapter_17-WebFig.4.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.studentconsult.com/content/9781416061090/legends/Chapter_17-WebFig.4.jpg\" border=\"0\" height=\"331\" src=\"_%20Tutorials_files/image290.png\" v:shapes=\"Picture_x0020_347480\" width=\"470\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Smoking\ncessation is the single most effective method for preventing chronic\nobstructive pulmonary disease (COPD) and for slowing its progression.\nPharmacologic therapy, including inhaled corticosteroids and anticholinergic\nagents, can alleviate symptoms, increase exercise capacity, reduce the number\nand severity of exacerbations, and improve health status; however, only smoking\ncessation improves survival. No pharmacologic therapy can prevent a decline in\nlung function. Every tobacco user should be offered counseling and nicotine\nreplacement (patch, gum, inhaler, and nasal spray). A quit date should be\nestablished, abstinence should be emphasized, and involvement of family and\nfriends should be sought. Several drugs are available for treating tobacco\ndependency. These drugs can be quite effective and should be considered in\nselected patients.\n </span>\n</p>\n", "choices": ["A. Inhaled corticosteroids", "B. Oral corticosteroids", "C. Smoking cessation", "D. Inhaled ipratropium"]}, {"question": "<p class=\"MsoPlainText\">\n <span>\n  A\n68-year-old woman presents to clinic with a one-month history of dry, hacking\ncough.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She denies fever, nasal\ncongestion, sore throat, chest pain, shortness of breath, or weight loss.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She does not smoke and has not traveled\nrecently. She is unaware of any sick contacts.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She has diabetes, hypertension, and\nhyperlipidemia. Medications include aspirin 81 mg daily, metformin 500 mg twice\ndaily, lisinopril 20 mg daily, and pravastatin 20 mg each evening. Her hemoglobin\nA1C is 6.0.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  On physical\nexamination, she is afebrile, pulse is 83/minute, blood pressure is 142/83 mm\nHg, and respirations are 14/minute.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her heart is regular and without murmur, her lungs are clear, her\nabdomen is soft, and her extremities are non-edematous.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A chest X-ray shows no infiltrate. Which\nof the following is most appropriate?\n </span>\n</p>\n", "answers": ["<p class=\"MsoPlainText\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Lisinopril is an ACE-inhibitor, and\nACE-inhibitors are a common cause of non-productive cough. The cough resolves\nwith discontinuation of the medicine.\n </span>\n</p>\n", "<p class=\"MsoPlainText\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . There is no evidence\nthat the patient has a bacterial infection.\n </span>\n</p>\n", "<p class=\"MsoPlainText\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Although this might\nimprove symptoms, it is not the most appropriate solution to the scenario.\n </span>\n</p>\n", "<p class=\"MsoPlainText\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . There is no evidence\nthat the patient has an infection.\n </span>\n</p>\n", "<p class=\"MsoPlainText\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . A CT scan is not\nindicated in this patient because there is no evidence of an abnormality.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoPlainText\">\n <i>\n  <span>\n   Cough\n  </span>\n </i>\n <span class=\"apple-converted-space\">\n  <span>\n   &nbsp;\n  </span>\n </span>\n <span>\n  is a frustrating symptom for both the patient and\nthe physician. The three most common causes of chronic cough are postnasal\ndrip, asthma, and gastroesophageal reflux disease. Cough may be mild and\ninfrequent, or it may be severe enough to induce emesis or syncope. Cough may\nbe dry or may produce sputum or blood (\n </span>\n <i>\n  <span>\n   hemoptysis\n  </span>\n </i>\n <span>\n  ). The symptom may begin months after initiation of a drug (e.g.,\nangiotensin-converting enzyme [ACE] inhibitors) leading to a dry, hacking\ncough.\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n </span>\n <i>\n  <span>\n   Bordetella\npertussis\n  </span>\n </i>\n <span class=\"apple-converted-space\">\n  <span>\n   &nbsp;\n  </span>\n </span>\n <span>\n  infection (whooping cough) and viral lower respiratory infections can\nproduce a cough that may last for 3 months or longer. Patients with asthma\noften have a cough. On occasion, cough is their only symptom, a condition\nsometimes referred to as\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n </span>\n <i>\n  <span>\n   cough-variant\nasthma.\n  </span>\n </i>\n <span class=\"apple-converted-space\">\n  <span>\n   &nbsp;\n  </span>\n </span>\n <span>\n  Nocturnal cough should raise the suggestion of asthma, heart failure, or\ngastroesophageal reflux disease.\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoPlainText\">\n <span>\n  Angiotensin\nconverting enzyme (ACE) inhibitors are a common cause of subacute (3-8 weeks)\nand chronic (&gt; 8 weeks) cough.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The cough is thought to be bradykinin-mediated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It usually begins within a week of\nstarting the medication, but can occur much later. It is more common in women,\nand usually resolves 3-4 weeks after stopping the medicine. If the cough does\nnot resolve, other explanations should be sought. Switching to a different\nACE-inhibitor is not helpful because reintroduction of\n  <i>\n   any\n  </i>\n  ACE-inhibitor will likely cause the cough to recur.\n </span>\n</p>\n", "choices": ["A. Prescribe a seven-day course of antibiotic", "B. Recommend daily use of a cough suppressant/expectorant (dextromethorphan/guaifenesin)", "C. Send sputum for culture, cytology, and AFB/fungal smears", "D. Obtain a CT scan of the chest", "E. Stop lisinopril"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 6-month-old infant has poor growth despite a large food intake. He has\nhad two episodes of pneumonia and frequent bulky stools. Chest x-ray shows\nincreased markings and hyperinflation. Trypsin is absent in a fresh stool\nsample and the fat content is increased. Which of the following is the most\nlikely cause of the infant&rsquo;s disorder?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . A diagnosis of cystic\nfibrosis is suggested by the presence of poor growth, recurrent pneumonia,\nbulky stools (which suggest malabsorption), hyperinflation (which suggests\nobstructive pulmonary disease), absent trypsin in the stool (which suggests\npancreatic insufficiency), and increased fat in the stool (which indicates\nmalabsorption). Cystic fibrosis is an autosomal recessive disorder that affects\nthe chloride ion channel on the epithelial surface of exocrine glands. This\nleads to abnormally viscid secretions, which impair lung, pancreatic, and\nintestinal function.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Cystic fibrosis is not\nan autoimmune disorder.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Lactase deficiency, a\ntype of dissacharidase deficiency, causes lactose intolerance, which is manifested\nby abdominal bloating, cramping, gas, and diarrhea after ingestion of dairy\nproducts.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Villous atrophy occurs\nin celiac disease. Manifestations include abdominal pain, diarrhea, and\nmalabsorption.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Abetalipoproteinemia is\n  </span>\n  characterized\nby fat malabsorption. Features include poor growth, abdominal pain, diarrhea,\nfatty stools, muscle weakness, slurred speech, and difficulty with balance and\ncoordination.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Cystic fibrosis\n </span>\n <span>\n  (CF) is a multi-system, autosomal recessive disorder that causes progressive\ndisability and often early death. It is one of the most common life-shortening\ninherited diseases in the United States.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  CF is\ncaused by mutation of the gene for the cystic fibrosis transmembrane\nconductance regulator (CFTR), a chloride channel protein on the apical surface\nof epithelial cells in exocrine gland tissues. This channel is required to\nregulate the components of sweat, digestive juices, and mucus. Malfunction\ncauses abnormal chloride ion transport, which leads to abnormally viscid\nsecretions. Because chloride ions cannot be excreted, sodium is absorbed to\nexcess, and water follows passively. This desiccates the mucosal surface and\nalters the viscosity of the mucous blanket.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The name\n  <i>\n   cystic\nfibrosis\n  </i>\n  refers to characteristic scarring (fibrosis) and cyst formation in\nthe pancreas. Features of the disease include poor growth, recurrent sinus and\nlung infections, progressive obstructive pulmonary disease, pancreatic insufficiency,\ndiarrhea, intestinal malabsorption, and infertility. Other findings may include\nnasal polyposis, cholelithiasis, cirrhosis, and rectal prolapse.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  More than\n1500 different mutations in the CFTR gene have been identified. CF is most\ncommon among Caucasians; one in 25 people of European descent carries an allele\nfor the disease. There is no sex predilection. Affected individuals can be\ndiagnosed prenatally by genetic testing or in early childhood by a sweat test.\nThe median age at diagnosis is 6-8 months. Antibiotics are required to treat\nrecurrent lung infections. Ultimately, lung transplantation may be necessary.\n </span>\n</p>\n", "choices": ["A. Autoimmune disorder", "B. Disaccharidase deficiency", "C. Villous atrophy of the jejunum", "D. Defective ion transport at the epithelial surface", "E. Inability to synthesize apolipoprotein B"]}, {"question": "<p>\n A 41-year-old man visits his\ndoctor because of fatigue and shortness of breath. Physical examination shows\njugular venous distension, an apical impulse that is inferiorly and laterally\ndisplaced, and late inspiratory crackles in the lung bases. An echocardiogram\nshows a dilated left ventricle with an ejection fraction of 30% (normal &gt;\n55%) and diffuse hypokinesis.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Coronary arteriography shows no atherosclerotic lesions. His height is\n173 cm (5 ft 8 in) and his weight is 68 kg (150 lbs). The BMI is 23 kg/m2. His\nblood pressure is 95/65 mm Hg. He eats red meat almost every day, drinks four\nbeers every evening, and does not exercise.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Which of the following is the most\nimportant recommendation for preventing further heart damage?\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct\n </b>\n . The patient in this clinical vignette has a\ndilated heart, but no history of myocardial infarction and no evidence of\ncoronary artery disease or hypertension. Left ventricular hypokinesis is\ndiffuse rather than segmental. (Segmental hypokinesis often indicates previous\nmyocardial infarction.) Therefore, the patient has a non-ischemic dilated\ncardiomyopathy, which has many potential causes. Long-term alcohol abuse is an\nimportant cause to identify because abstinence from alcohol can prevent further\ncardiac deterioration. The patient&rsquo;s history of heavy beer consumption suggests\nalcoholic cardiomyopathy as the correct diagnosis. Alcohol avoidance should be\nrecommended to prevent a worsening of his condition.\n <b>\n </b>\n</p>\n"], "tutorial": "<p>\n Cardiac enlargement may be\ndue to hypertrophy or dilation of the heart muscle. Hypertension is the most\ncommon cause of left ventricular hypertrophy. Myocardial infarction is the most\ncommon cause of left ventricular dilation. Although hypertension and ischemic\nheart disease are the principal causes of cardiac enlargement, other causes\nexist. Identifying those causes is an important step in managing the patient.\n</p>\n\n<p>\n There are three major types\nof cardiomyopathy: dilated, hypertrophic, and restrictive.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p>\n     Types of Cardiomyopathy\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p align=\"center\">\n     Dilated\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p align=\"center\">\n     Hypertrophic\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p align=\"center\">\n     Restrictive\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n Dilated cardiomyopathy is\ncharacterized by chamber enlargement and impaired systolic function. Patients\nmay be asymptomatic for many years despite impaired left ventricular function.\nMost develop congestive heart failure, which may be gradual or abrupt in onset.\nSome present with arrhythmias or even sudden cardiac death. The main causes of\ndilated cardiomyopathy appear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"259\">\n    <p align=\"center\">\n     Causes of Dilated Cardiomyopathy\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"259\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"259\">\n    <p>\n     Genetic\n    </p>\n    <p>\n     Toxin-induced (e.g.,\n  alcohol, doxorubicin)\n    </p>\n    <p>\n     Radiation\n    </p>\n    <p>\n     Infectious (e.g., viral,\n  trypanosomiasis)\n    </p>\n    <p>\n     Metabolic (e.g., beriberi)\n    </p>\n    <p>\n     Sarcoidosis\n    </p>\n    <p>\n     Hemochromatosis\n    </p>\n    <p>\n     Peripartum or postpartum\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Lose weight", "B. Avoid heavy exertion", "C. Begin an exercise program", "D. Consume more vegetables and fruits", "E. Avoid alcoholic beverages"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n56-year-old man presents with mild confusion and abdominal swelling. He has a\nhistory of alcoholism and has been diagnosed with hepatic cirrhosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  His blood pressure is 90/60 mm Hg and\nhis pulse is 98/minute. He is mildly jaundiced. The jugular veins are not\ndistended. Shifting dullness is noted in the abdomen. Severe pitting edema is\npresent in both legs.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood test\nresults:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <sup>\n   +\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  122\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <sup>\n   +\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3.3 mEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <sup>\n   -\n  </sup>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  90 mEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  26 mEq/L\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely cause of hyponatremia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Cirrhosis is associated with low serum\nalbumin levels, low intravascular oncotic pressure, and decreased effective\ncirculating volume. This results in ADH release, reabsorption of water, and\nhyponatremia.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Cirrhosis is\nassociated with decreased effective circulating volume, which activates the\nrenin-angiotensin-aldosterone system. Aldosterone levels are increased not\ndecreased.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Congestive heart\nfailure is associated with pulmonary crackles, distended neck veins, abnormal\ncardiac findings, and dependent edema.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Metabolic alkalosis is\nassociated with an elevated serum bicarbonate (HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  )\nlevel.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Effective circulating volume\n </span>\n (\n <span>\n  ECV\n </span>\n ) is the volume of arterial blood effectively perfusing tissue.\nIt is a dynamic quantity and not a distinct, measurable compartment. The\nconcept of ECV is useful for understanding cardiovascular and renal physiology.\nAlthough ECV normally varies with extracellular fluid (ECF), the two become\nuncoupled in disorders like congestive heart failure and cirrhosis. In these\nconditions, the kidney responds as if the body were truly hypovolemic.\n</p>\n\n<p>\n There are several volume and\npressure sensing systems that influence ECF and ECV. If they contract then\nvolume preserving systems become active, and if they expand then volume\ndepletion systems become active. Volume sensors, also known as low pressure\nbaroreceptors, are located in the atria, right ventricle, and large pulmonary\nvessels. They become active when the blood volume increases; in essence they\nsense fullness of the vascular system. When active, these volume sensors send\nneural activity to the brainstem via the glossopharyngeal and vagus nerves,\nresulting in decreases in sympathetic nerve activity and antidiuretic hormone\n(ADH) secretion; these effects will enhance the excretion of sodium and water.\nAtrial and ventricular cells also secrete atrial natriuretic peptide and brain\nnatriuretic peptide, respectively, when volume is high, resulting in sodium and\nwater excretion and reduction of ADH secretion.\n</p>\n\n<p>\n High pressure baroreceptors\nare located in the carotid sinus, aortic arch, and the juxtaglomerular (JG)\napparatus of the kidneys. The baroreceptor reflex increases sympathetic\nactivity to the vasculature if blood pressure decreases and vice versa to\nincrease or decrease vascular tone, respectively, to control blood pressure. In\naddition, changes in sympathetic activity alter excretion of sodium and water.\nIncreasing sympathetic activity directly increases renin secretion from\njuxtaglomerular cells; the resultant increase in angiotensin II produces\nvasoconstriction, and the secretion of aldosterone elicited by angiotensin II\nenhances salt and water reabsorption by the kidneys. JG cells directly detect\nthe lower perfusion pressure that occurs when blood pressure decreases and\nrespond by secreting renin. Glomerular filtration rate also decreases with\nlower perfusion pressure and the resultant sympathetic-mediated constriction of\nafferent and efferent arterioles which reduces delivery of NaCl to the macula\ndensa, and this process (tubuloglomerular feedback) also enhances renin\nsecretion.\n</p>\n\n<p>\n Hepatic cirrhosis is\nassociated with decreased albumin in plasma, which results in edema due to a\nreduction in plasma oncotic pressure. Edema reduces ECV which the pressure and\nvolume sensors interpret as a contraction (reduction) of ECV. Thus, volume\nconserving mechanisms become active. The net effect is relatively more\nconservation of water than salt, resulting in hyponatremia.\n</p>\n\n<p>\n Congestive heart failure\ncauses a reduction in cardiac output and thus ECV. The resultant decrease in\nblood pressure activates volume conserving systems which overfill the vascular\nsystem, causing jugular venous distension, pulmonary crackles, edema, and\nabnormal cardiac findings.\n</p>\n", "choices": ["A. Decreased effective circulating volume", "B. Decreased aldosterone", "C. Congestive heart failure", "D. Metabolic alkalosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n66-year-old woman comes to the clinic for a first-time visit. Her pulse is\n82/minute and her blood pressure is 166/92 mm Hg. Cardiac examination reveals a\nloud S2 at the right second intercostal space and a low-pitched, late-diastolic\nheart sound at the apex, which is heard with the patient lying in the left\nlateral decubitus position. Which of the following best explains the extra\nheart sound?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  The low-pitched,\nlate-diastolic heart sound is an S4. The sound is produced by blood being\nforced into the stiff left ventricle.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  An\n  <b>\n   S4\n  </b>\n  is a low-pitched, late-diastolic\nheart sound. The sound is produced by blood being forced into the stiff left\nventricle. It is a pathological sign, usually indicating hypertrophy of the\nleft ventricular wall. The most common cause of left ventricular hypertrophy is\nhypertension, which causes accentuation of the second heart sound in the right\nsecond intercostal space (the aortic area).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Other causes of an S4 include left\nventricular hypertrophy due to aortic stenosis and restrictive\ncardiomyopathy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n An\n <b>\n  S3\n </b>\n , or\n <span>\n  ventricular gallop\n </span>\n ,\nis a low-pitched, early-diastolic heart sound. Like the S4, it is best heard in\nthe left lateral decubitus position. In adults, the S3 is often a sign of left\nventricular dilation and congestive heart failure. It is thought to be caused\nby the oscillation of blood back and forth between the walls of the left\nventricle, initiated by inrushing blood from the atria. It may also result from\ntensing of the chordae tendineae during rapid filling and expansion of the\nventricle. An S3 indicates increased volume of blood within the ventricle.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In aortic\nstenosis, the first heart sound may be followed by a sharp ejection sound at\nthe apex. This\n  <b>\n   ejection &ldquo;click&rdquo;\n  </b>\n  is\ncaused by blood flowing against the partially fused leaflets of the aortic valve.\n(It is more common with a mobile bicuspid valve than with an immobile calcified\nvalve.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Increased\nflow through the aortic valve causes a systolic\n  <b>\n   &ldquo;flow&rdquo; murmur\n  </b>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nopening\n  <b>\n   &ldquo;snap&rdquo;\n  </b>\n  of mitral stenosis is\na high-pitched, early-diastolic sound caused by forceful opening of the mitral\nvalve.\n </span>\n</p>\n", "choices": ["A. Papillary muscle tension after the rapid filling phase", "B. Increased stiffness of the left ventricular wall", "C. Restricted motion of the aortic valve cusps", "D. Increase flow through the aortic valve", "E. Forceful opening of the mitral valve"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 53-year-old woman dies 3 days after an\nautomobile collision. She sustained multiple injuries including a femoral\nfracture. Widespread petechiae are found in the cerebral white matter at\nautopsy. Which of the following is the most likely cause of these findings?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct.\n </b>\n The development of petechiae after femoral\nfracture suggests a diagnosis of fat embolism syndrome.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n"], "tutorial": "<p>\n Fat embolism syndrome (FES)\nis the occurrence of hypoxia, confusion, and petechiae a few days after a long\nbone fracture. The syndrome involves embolization of fat from the marrow of the\nbone or from soft tissue surrounding the bone. This syndrome is distinct from\n&ldquo;regular&rdquo; pulmonary embolism (a thromboembolic event) and from post-traumatic\npulmonary insufficiency, shock lung, and adult respiratory distress syndrome\n(ARDS).\n</p>\n\n<p>\n FES usually occurs after\nlower limb fractures, especially femoral fractures. The disease\ncharacteristically begins 1 to 2 days after fracture (following what has been\ncalled the &ldquo;\n <span>\n  latent&rdquo;\n </span>\n or &ldquo;\n <span>\n  lucid&rdquo;\n </span>\n period). Sixty percent of all\ncases are seen in the first 24 hours after trauma, and 90 percent of all cases\nappear within 72 hours. The major signs are respiratory insufficiency, cerebral\ninvolvement, and petechial rash. Minor signs include fever, tachycardia,\nretinal changes, jaundice, and renal changes. Petechiae are transient and are\ndistributed on the cheek, neck, axillae, palate, and conjunctivae. The\ncondition can be fatal.\n</p>\n", "choices": ["A. Acute respiratory distress syndrome", "B. Contrecoup injury", "C. Fat embolization", "D. Septicemia", "E. Subdural hematoma"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n32-year-old man has a three-month history of fatigue and shortness of breath.\nHe had rheumatic fever as a child. Physical examination reveals an early\ndiastolic sound followed by a soft, rumbling, diastolic murmur at the 4\n  <sup>\n   th\n  </sup>\n  intercostal space, four centimeters left of the sternal border. The murmur is\nheard best in the left lateral decubitus position. Which of the following valve\ndefects is most likely in this patient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Mitral stenosis\nproduces as l\n </span>\n <span>\n  ow-pitched, mid-to-late, rumbling\ndiastolic murmur at apex. (The 4\n  <sup>\n   th\n  </sup>\n  intercostal space, four\ncentimeters from the left sternal border, approximates the apical area.) The\nmurmur is often preceded by an early diastolic sound (opening snap).\n </span>\n <span>\n  Rheumatic heart disease\nis responsible for 99% of mitral valve stenosis in adults in the United States.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Aortic stenosis\nproduces a harsh, m\n </span>\n <span>\n  idsystolic murmur at right 2\n  <sup>\n   nd\n  </sup>\n  intercostal space with radiation to the neck and down the left sternal border\ntoward the apex.\n </span>\n <span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Aortic regurgitation\nproduces a h\n </span>\n <span>\n  igh-pitched, blowing, early\ndiastolic, decrescendo murmur at the 2\n  <sup>\n   nd\n  </sup>\n  to 4\n  <sup>\n   th\n  </sup>\n  left\nintercostal space with radiation to the apex.\n </span>\n <span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\n  </span>\n </b>\n <b>\n  <span>\n   C is incorrect\n  </span>\n </b>\n <span>\n  .\nPulmonic stenosis produces a midsystolic murmur at the left 2\n  <sup>\n   nd\n  </sup>\n  intercostal space with radiation to the neck and left shoulder. The murmur\nincreases with inspiration.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  . Pulmonic regurgitation produces an\nearly diastolic decrescendo murmur at the left 2\n  <sup>\n   nd\n  </sup>\n  intercostal\nspace.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nF is incorrect\n  </span>\n </b>\n <span>\n  . Mitral regurgitation produces a\nblowing, holosystolic murmur at the apex with radiation to the left axilla.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nG is incorrect\n  </span>\n </b>\n <span>\n  . Tricuspid stenosis produces a\nlow-pitched, mid-to-late, rumbling diastolic murmur at lower left sternal\nborder that increases with inspiration.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nH is incorrect\n  </span>\n </b>\n <span>\n  . Tricuspid regurgitation produces a\nblowing, holosystolic murmur at the lower left sternal border that increases\nwith inspiration.\n </span>\n</p>\n"], "tutorial": "<table align=\"left\" border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"99%\">\n <thead>\n  <tr>\n   <td colspan=\"2\" valign=\"bottom\" width=\"100%\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       &nbsp;\n      </span>\n     </b>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       &nbsp;Pathologic Heart Murmurs\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" valign=\"bottom\" width=\"100%\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Systolic\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Holosystolic&nbsp;\n     </span>\n    </i>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mitral\n  regurgitation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Blowing,\n  holosystolic murmur at apex radiating to left axilla\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     S\n     <sub>\n      1\n     </sub>\n     decreased\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     S\n     <sub>\n      3\n     </sub>\n     with severe regurgitation (volume overload)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Left\n  ventricular dilation is common\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tricuspid\n  regurgitation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Blowing,\n  holosystolic murmur at lower left sternal border; increased with inspiration\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Right\n  ventricular dilation is common\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     S\n     <sub>\n      3\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </sub>\n     sometimes audible along lower\n  left sternal border\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Jugular\n  venous pressure often elevated\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Large\n     <i>\n      v\n     </i>\n     waves in jugular veins\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ventricular\n  septal defect\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Harsh,\n  loud, holosystolic murmur at left lower sternal border with radiation to\n  right sternal border, sometimes with a thrill\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Midsystolic\n     </span>\n    </i>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Aortic\n  stenosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midsystolic\n  murmur at right 2\n     <sup>\n      nd\n     </sup>\n     interspace with radiation to neck and down\n  left sternal border toward apex; often loud, harsh, and with a thrill\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Heard\n  best with patient sitting and leaning forward\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Ejection\n  click means valve is mobile\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     As\n  stenosis worsens, S\n     <sub>\n      2\n     </sub>\n     decreases and murmur peaks later\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Paradoxical\n  splitting of S\n     <sub>\n      2\n     </sub>\n     (sometimes)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     S\n     <sub>\n      4\n     </sub>\n     (with decreased compliance of left ventricle)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sustained\n  apical impulse (with left ventricular hypertrophy)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Carotid\n  pulse may rise slowly and be weak (\n     <i>\n      pulsus\n  parvus et tardus\n     </i>\n     )\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hypertrophic\n  Cardiomyopathy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midsystolic\n  murmur at lower left sternal border with radiation to apex and sometimes base\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n  with Valsalva; decreased with squatting\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     S\n     <sub>\n      3\n     </sub>\n     and/or S\n     <sub>\n      4\n     </sub>\n     may be present\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Apical\n  impulse may be sustained\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pulmonic\n  stenosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midsystolic\n  murmur at left 2\n     <sup>\n      nd\n     </sup>\n     interspace with radiation to neck and left\n  shoulder; often harsh, sometimes with a thrill; increased with inspiration\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Early\n  pulmonic ejection sound (sometimes)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Widely\n  split S\n     <sub>\n      2\n     </sub>\n     (in severe stenosis)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Right\n  ventricular impulse may be increased\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Right-sided\n  S\n     <sub>\n      4\n     </sub>\n     may be present\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Late systolic\n     </span>\n    </i>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mitral\n  valve prolapse\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Late-systolic\n  murmur preceded by high-pitched click (usually at apex)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Diastolic\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Early diastolic\n     </span>\n    </i>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Aortic\n  regurgitation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     High-pitched,\n  blowing, early diastolic, decrescendo murmur at 2\n     <sup>\n      nd\n     </sup>\n     to 4\n     <sup>\n      th\n     </sup>\n     left interspace with radiation to apex\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Heart\n  best with patient sitting and leaning forward, in exhalation\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Ejection\n  sound may be present\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     S\n     <sub>\n      3\n     </sub>\n     and/or S\n     <sub>\n      4\n     </sub>\n     (if severe regurgitation)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Apical\n  pulse becomes progressively stronger, wider, longer, and displaced\n  (inferiorly and laterally)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n  pulse pressure, bounding pulses\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Midsystolic\n  flow murmur or Austin Flint murmur (if severe)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pulmonic\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     regurgitation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Early\n  diastolic decrescendo murmur at left 2\n     <sup>\n      nd\n     </sup>\n     interspace\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Mid&ndash;late diastolic\n     </span>\n    </i>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mitral\n  stenosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Low-pitched,\n  mid-to-late, rumbling diastolic murmur at apex\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Heard\n  best with patient in left lateral decubitus position, after exhalation\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Opening\n  snap precedes murmur\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Accentuated\n  S\n     <sub>\n      1\n     </sub>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tricuspid\n  stenosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Low-pitched,\n  mid-to-late, rumbling diastolic murmur at lower left sternal border;\n  increases with inspiration\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Continuous (Systolic and Diastolic)\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Venous\n  hum\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Continuous\n  low-pitched, humming murmur above medial third of clavicles with radiation to\n  1\n     <sup>\n      st\n     </sup>\n     an 2\n     <sup>\n      nd\n     </sup>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     interspaces\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Disappears\n  with compression of vein\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"20%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Patent\n  ductus arteriosus\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"79%\">\n   <p class=\"MsoNormal\">\n    <span>\n     Continuous\n  murmur at left 2\n     <sup>\n      nd\n     </sup>\n     interspace with radiation to left clavicle;\n  loud, harsh, and machinery-like\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Aortic stenosis", "B. Aortic regurgitation", "C. Pulmonic stenosis", "D. Pulmonic regurgitation", "E. Mitral stenosis", "F. Mitral regurgitation", "G. Tricuspid stenosis", "H. Tricuspid regurgitation"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n57-year-old man with a history of coronary artery disease, mild chronic\nobstructive pulmonary disease (COPD), and cirrhosis is brought to the emergency\nroom after being found on the floor, lethargic and confused. His medications\ninclude tiotropium inhaler, lorazepam, and nitroglycerin tablets. On physical\nexamination, he is somnolent and mildly cyanotic. The results of arterial blood\ngas measurements are as follows: pH 7.24, PCO\n  <sub>\n   2\n  </sub>\n  70 mmHg, PO\n  <sub>\n   2\n  </sub>\n  40 mmHg, and HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n  29 mEq/L. What explains the patient&rsquo;s\nhypoxemia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct\n  </span>\n </b>\n <span>\n  . The high PCO\n  <sub>\n   2\n  </sub>\n  indicates that\nhypoventilation is the cause of hypoxemia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The normal A-a gradient (see below) indicates that hypoventilation is\nthe\n  <i>\n   sole\n  </i>\n  cause of hypoxemia. Overdose\nof lorazepam could explain the presentation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Hypoxemia\n </span>\n <span>\n  is defined as a low partial pressure of oxygen in the blood, specifically a PO\n  <sub>\n   2\n  </sub>\n  &lt; 60&nbsp;mmHg.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The major\nmechanisms of hypoxemia are hypoventilation, ventilation-perfusion mismatch,\nright-to-left shunt, diffusion limitation, and reduced inspired oxygen tension.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"190\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mechanisms of Hypoxemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"190\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"190\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypoventilation\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"190\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ventilation-perfusion\n  mismatch\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"190\">\n    <p class=\"MsoNormal\">\n     <span>\n      Right-to-left\n  shunt\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"190\">\n    <p class=\"MsoNormal\">\n     <span>\n      Diffusion\n  limitation\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"190\">\n    <p class=\"MsoNormal\">\n     <span>\n      Reduced\n  inspired oxygen tension\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"headinganchor1\">\n <b>\n  Hypoventilation\n </b>\n .\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Arterial and alveolar carbon dioxide\ntensions increase during hypoventilation, causing alveolar oxygen tension to\ndecrease. As a result, diffusion of oxygen from the alveolus to the pulmonary\ncapillary declines. The net effect is hypoxemia.\n</p>\n\n<p class=\"headinganchor1\">\n The principal causes of hypoventilation appear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p align=\"center\" class=\"headinganchor1\">\n     Causes of Hypoventilation\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"headinganchor1\">\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"headinganchor1\">\n     CNS depression (e.g., drug overdose)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"headinganchor1\">\n     CNS event (e.g., stroke)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"headinganchor1\">\n     Obesity-hypoventilation\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"headinganchor1\">\n     Neurologic impairment (e.g., amyotrophic lateral\n  sclerosis)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"headinganchor1\">\n     Muscular impairment (e.g., myasthenia gravis)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"headinganchor1\">\n     Chest wall deformity (e.g., kyphoscoliosis)\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"headinganchor1\">\n Of the five major mechanisms of hypoxemia, only\nhypoventilation results in hypercapnia (increased PaCO\n <sub>\n  2\n </sub>\n ).\n</p>\n\n<p class=\"headinganchor1\">\n Hypoxemia in hypercapnic patients may be due either to\n <i>\n  pure\n </i>\n hypoventilation or to\nhypoventilation\n <i>\n  plus\n </i>\n another\nmechanism. To distinguish these, the A-a gradient is used. The A-a gradient is\nthe alveolar-arterial oxygen difference. In patients with\n <i>\n  pure\n </i>\n hypoventilation, the A-a gradient is normal. In patients with hypoventilation\n <i>\n  plus\n </i>\n another mechanism of hypoxemia,\nthe A-a gradient is increased.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p class=\"headinganchor1\">\n The A-a gradient can be calculated as follows:\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   A-a gradient = PA\n   <sub>\n    O2\n   </sub>\n   &minus; Pa\n   <sub>\n    O2\n   </sub>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Where:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PA\n  <sub>\n   O2\n  </sub>\n </span>\n <span>\n  = alveolar PO\n  <sub>\n   2\n  </sub>\n  (calculated from the Alveolar Gas\nEquation)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Pa\n  <sub>\n   O2\n  </sub>\n </span>\n <span>\n  = arterial PO\n  <sub>\n   2\n  </sub>\n  (measured by arterial blood gas\nanalysis)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Alveolar Gas Equation\n  </span>\n </u>\n <span>\n  :\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PA\n  <sub>\n   O2\n  </sub>\n  <b>\n   <sub>\n    <span style=\"mso-spacerun:yes\">\n     &nbsp;\n    </span>\n   </sub>\n  </b>\n  =\n </span>\n <span>\n  [Fi\n  <sub>\n   O2\n  </sub>\n  (P\n  <sub>\n   atm\n  </sub>\n  &ndash; P\n  <sub>\n   H2O\n  </sub>\n  )\n&ndash; (Pa\n  <sub>\n   CO2\n  </sub>\n  / 0.8) ]\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Fi\n  <sub>\n   O2\n  </sub>\n  = fraction of\ninspired oxygen (0.21 for room air)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  P\n  <sub>\n   atm\n  </sub>\n  = atmospheric\npressure (730 mm Hg in Oklahoma)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  P\n  <sub>\n   H2O\n  </sub>\n  = vapor pressure of\nwater at body temperature (47 mmHg)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Therefore,\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PA\n  <sub>\n   O2\n  </sub>\n  =\n(.21)(730 &ndash; 47) &ndash;\n </span>\n <span>\n  (Pa\n  <sub>\n   CO2\n  </sub>\n  /\n0.8)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span>\n   PA\n   <sub>\n    O2\n   </sub>\n   = 143 &ndash; (\n  </span>\n  Pa\n  <sub>\n   CO2\n  </sub>\n  / 0.8)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Take home\nmessages:\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  An\nelevated PCO\n  <sub>\n   2\n  </sub>\n  indicates that hypoventilation is the cause of\nhypoxemia.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\nnormal A-a gradient indicates that hypoventilation is the\n  <i>\n   sole\n  </i>\n  cause of hypoxemia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Ventilation-perfusion mismatch.\n  </span>\n </b>\n <span>\n  Ventilation-perfusion\n(V/Q) mismatch refers to an imbalance of blood flow and ventilation. Common\ncauses include obstructive lung diseases, pulmonary vascular disease, and\ninterstitial lung disease. V/Q mismatch is characterized by an increased A-a\ngradient. The hypoxemia can be corrected by administering supplemental oxygen.\n </span>\n</p>\n\n<p class=\"headinganchor1\">\n <b>\n  Right-to-left shunt.\n </b>\n A right-to-left shunt exists when blood passes from the right to the left side\nof the heart without being oxygenated. There are two types of right-to-left\nshunts: anatomic and physiologic. Anatomic shunts exist when the alveoli are\nbypassed. Examples include intracardiac shunts and pulmonary arteriovenous\nmalformations (AVMs). Physiologic shunts exist when non-ventilated alveoli are\nperfused. Examples include atelectasis and disorders of alveolar filling (e.g.,\npneumonia, acute respiratory distress syndrome).\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Right-to-left shunts cause extreme V/Q mismatch, with a V/Q\nratio of zero in some lung regions. The net effect is hypoxemia, which\n  <i>\n   cannot\n  </i>\n  be corrected with supplemental\noxygen.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Diffusion limitation\n  </span>\n </b>\n <span>\n  . Diffusion limitation\nexists when the movement of oxygen from the alveolus to the pulmonary capillary\nis impaired. It is usually a consequence of alveolar or interstitial\ninflammation or fibrosis (e.g., interstitial lung disease). Diffusion\nlimitation usually coexists with V/Q mismatch.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Reduced inspired oxygen tension.\n  </span>\n </b>\n <span>\n  Reduced inspired oxygen\ntension\n </span>\n <span>\n  is most commonly associated with\nhigh altitude.\n </span>\n</p>\n", "choices": ["A. Shunt", "B. Diffusion limitation", "C. Hypoventilation", "D. Ventilation-to-perfusion mismatch"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  From the alveolar gas equation,\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PA\n  <sub>\n   O2\n  </sub>\n  = 143 &ndash; (70 / 0.8)\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In the clinical vignette, the Pa\n  <sub>\n   CO2\n  </sub>\n  is 70 mm\nHg.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Therefore,\n  <span>\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PA\n  <sub>\n   O2\n  </sub>\n  = 143 &ndash; (70 / 0.8)\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PA\n  <sub>\n   O2\n  </sub>\n  = 55 mm Hg\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A-a Gradient =\n  <span>\n   PA\n   <sub>\n    O2\n   </sub>\n  </span>\n  &ndash; PaO2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In the clinical vignette, the PaO\n  <sub>\n   2\n  </sub>\n  is 40 mm Hg\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  A-a\nGradient = 55 &ndash; 40 = 15 mm Hg (Normal: 5 &ndash; 20 mm Hg)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npatient&rsquo;s A-a gradient is normal. This indicates that hypoventilation is the\nsole cause of hypoxemia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A cardiac\ncatheterization is done on a healthy person. A blood sample from the catheter\nshows an oxygen saturation of 75%. The pressure readings oscillate from 12 mm\nHg to 25 mm Hg. Where is the catheter located?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . An oxygen saturation\nof 75% indicates that blood has been taken from the right side of the\ncirculation. Pressures ranging from 12 to 25 mm Hg are consistent with\npressures in the pulmonary artery.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Right atrial pressures\nrange from 0-8 mm Hg, and oxygen saturation is 75%.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Left atrial pressures\nrange from 1-10 mm Hg, and oxygen saturation is 95%.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Left ventricular\npressures range from 100-140 mm Hg systolic, and 3-12 mm Hg diastolic. Oxygen\nsaturation is 95%.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Normal oxygen\nsaturation in the aorta is 95% and pressures range from 100-140 mm Hg systolic\nand 60-90 mm Hg diastolic.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\ntypical pressures and oxygen saturations in a normal heart appear below.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347247\"\n o:spid=\"_x0000_i1179\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image291.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"253\" src=\"_%20Tutorials_files/image292.png\" v:shapes=\"Picture_x0020_347247\" width=\"276\"/>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n      Location\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Blood pressure\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n      Oxygen saturation\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n      Right atrium\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Mean: 0-8 mm Hg\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n      75%\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n      Right ventricle\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      15-30 / 0-8 mm Hg.\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n      75%\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pulmonary artery\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      15-30 / 3-12 mm Hg\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n      75%\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n      Left atrium\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Mean: 1-10 mm Hg\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n      95%\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n      Left ventricle\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      100-140 / 3-12 mm Hg\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n      95%\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p class=\"MsoNormal\">\n     <span>\n      Aorta\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      100-140 / 60-90 mm Hg\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"63\">\n    <p class=\"MsoNormal\">\n     <span>\n      95%\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Right atrium", "B. Left atrium", "C. Pulmonary artery", "D. Left ventricle", "E. Aorta"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n55-year-old man is brought to the emergency room by his family because he has\nbeen confused for three days. He has smoked a package of cigarettes daily for\nthirty-five years. A chest radiograph shows a 6-cm mass in the left lung.\nLaboratory tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Na\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  115\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  K\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4.0\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cl\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  76\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  HCO3\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  30\nmEq/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  210\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.3\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is the mostly likely diagnosis?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct\n </b>\n . The patient in this vignette has hyponatremia\nand hyperglycemia. Given the presence of a lung mass, one should suspect lung\ncancer producing ADH (vasopressin) and ACTH (hyperglycemia), resulting in hyponatremia\nand hyperglycemia, respectively. Small cell lung carcinoma would be the most\nlikely histologic type.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n . Medullary carcinoma of the thyroid, which\noriginates from parafollicular cells of the thyroid, elicits calcitonin.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . Adenocarcinoma of the lung is not commonly\nassociated with SIADH or ACTH production.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n . Hepatocellular carcinoma may cause\nhypoglycemia and polycythemia.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n . Renal cell carcinoma may cause hypercalcemia\nand polycythemia.\n</p>\n", "<p>\n <b>\n  Answer F is incorrect\n </b>\n . The presentation of the patient suggests an\nassociation between smoking and the type of lung cancer. Mesothelioma is not\nassociated with smoking.\n</p>\n"], "tutorial": "<p>\n A diagnosis of lung cancer\nmust be considered when a lung mass is found in a longtime smoker. Most primary\nlung cancers are\n <span>\n  carcinomas\n </span>\n .\nProlonged exposure to tobacco is the most common etiology. In nonsmokers, lung\ncancer is often attributed to genetic factors, radon gas, asbestos, and air\npollution (including secondhand smoke).\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The two\nmain types of lung cancer are\n  <span>\n   small\ncell\n  </span>\n  and\n  <span>\n   non-small cell\n  </span>\n  .\nThe distinction is important because treatment varies: non-small cell lung\ncancer (NSCLC) is sometimes treated with surgery; small cell lung cancer (SCLC)\nresponds better to chemotherapy and radiation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Non-small\ncell lung cancers are grouped together because their prognosis and management\nare similar. The main types of non-small cell lung cancer are squamous cell\ncarcinoma, adenocarcinoma, and large cell carcinoma. Squamous cell carcinoma\nusually starts near a central bronchus. Cavitation and necrosis are common.\nAdenocarcinoma usually originates in the lung periphery. Although most cases\noccur in smokers, this is the principal histological type seen in non-smokers.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Small cell\ncancer is less common than non-small cell cancer. Formerly known as \"oat\ncell\" carcinoma, small cell cancer usually arises in the large airways,\nand grows rapidly. Despite being more sensitive to chemotherapy and radiation\nthan other histologic types, small cell cancer is often metastatic at\npresentation and carries a worse prognosis. It is strongly associated with\nsmoking. The cancer cells contain dense neurosecretory vesicles, which contain\nneuroendocrine hormones. These hormones are responsible for paraneoplastic\nsyndromes.\n </span>\n</p>\n\n<table align=\"left\" border=\"1\" cellpadding=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Paraneoplastic Syndrome\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Type of Cancer\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Mechanism\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     SIADH\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Small-cell\n  lung cancer\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     CNS\n  malignancies\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Antidiuretic hormone (ADH)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Cushing syndrome\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Small-cell\n  lung cancer\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Neural\n  tumors\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Thymoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Pancreatic\n  carcinoma\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Ectopic ACTH and ACTH-like substance\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <a href=\"http://en.wikipedia.org/wiki/Hypercalcemia\" title=\"Hypercalcemia\">\n     <span>\n      Hypercalcemia\n     </span>\n    </a>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Lung\n  cancer (typically squamous cell)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Breast\n  carcinoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Renal\n  carcinoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Ovarian\n  carcinoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Multiple\n  myeloma (may occur independent of osteolytic lesions)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Adult\n  T cell leukemia/lymphoma\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <a href=\"http://en.wikipedia.org/wiki/Parathyroid_hormone-related_protein\" title=\"Parathyroid hormone-related protein\">\n     <span>\n      PTHrP\n     </span>\n    </a>\n    <span>\n     (Parathyroid hormone-related protein),\n  TGF-&alpha;, TNF, IL-1\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Hypoglycemia\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Hepatocellular\n  carcinoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Sarcomas\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Insulin or insulin-like substance or\n  \"big\" IGF-II\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Polycythemia\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Cerebellar\n  hemangioblastoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Hepatocellular\n  carcinoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Renal\n  cell carcinoma\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Erythropoietin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Carcinoid syndrome\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Bronchial\n  adenoma (carcinoid type)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Gastric\n  carcinoma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Pancreatic\n  carcinoma\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Serotonin,\n    </span>\n    <a href=\"http://en.wikipedia.org/wiki/Bradykinin\" title=\"Bradykinin\">\n     <span>\n      bradykinin\n     </span>\n    </a>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  Paraneoplastic syndromes are\n </span>\n consequences of cancer that are not\nactually due to the local presence of tumor. They are mediated by substances\nproduced by the tumor or by the immune system, and may be apparent even before\nthe tumor is visible. There are four major types of paraneoplastic syndromes:\nendocrine, neurologic, mucocutaneous, and hematologic. The main endocrine\nsyndromes appear below.\n</p>\n\n<p>\n Routine laboratory studies\noften provide clues to the presence of paraneoplastic syndromes. SIADH is\nassociated with hyponatremia, Cushing syndrome is associated with\nhyperglycemia, and polycythemia is associated with an elevated hematocrit.\nThese findings can be detected with blood tests. Hypercalcemia and hypoglycemia\nare also detected with routine blood tests.\n</p>\n\n<p>\n Mesothelioma is a rare form\nof cancer that develops from the protective lining that covers many of the\nbody&rsquo;s internal organs, the mesothelium. It is usually caused by exposure to\nasbestos. It most commonly occurs in the pleura, but may occur in the\nperitoneum or the pericardium. Unlike lung cancer, there is no association\nbetween mesothelioma and smoking. Symptoms include shortness of breath due to\npleural effusion, chest wall pain, and general symptoms such as weight loss.\nX-ray may reveal pleural thickening, commonly seen after asbestos exposure. The\nclassic histopathology of the mesothelioma is a biphasic tumor with both an\nepithelioid and sarcomatoid, or &ldquo;spindle cell,&rdquo; component.\n</p>\n", "choices": ["A. Medullary carcinoma of the thyroid", "B. Small cell carcinoma of the lung", "C. Adenocarcinoma of the lung", "D. Hepatocellular carcinoma", "E. Renal cell carcinoma", "F. Mesothelioma"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 79-year-old\nwoman with advanced dementia resides in a nursing home. She is admitted to the\nhospital with a three-week history of fever and cough. The cough is productive\nof foul-smelling, yellow-green sputum. Temperature is 38.5\n  <sup>\n   o\n  </sup>\n  C (101.3\n  <sup>\n   o\n  </sup>\n  F), pulse is 85/minute, blood pressure is 120/80 mm Hg, and\nrespirations are 22/minute. Crackles are heard over the right lower lung field.\nThe white blood cell count is 15,000/mm\n  <sup>\n   3\n  </sup>\n  . A CT scan shows an\nirregular, thick-walled, cavitary lesion in the right lower lobe.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is the\nmost likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Anaerobic lung abscess usually occurs\nin individuals who are predisposed to aspiration of gastric contents (e.g.,\ndementia). The clinical presentation may be indolent, with symptoms lasting\nweeks or months. The abscess is usually right-sided and located in the lower\nlung zone. All of these characteristic apply to the patient in this vignette.\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The differential diagnosis for lung\ncavitation appears below.\n  <b>\n  </b>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Lung Cavitation: Differential Diagnosis\n      <b>\n      </b>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cavitating pneumonia\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <i>\n      <span>\n       Staphylococcus aureus\n      </span>\n     </i>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Gram-negative bacilli (Klebsiella, Pseudomonas, Legionella)\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Anaerobes\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Mycobacteria\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Fungi\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pneumocystis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p class=\"MsoNormal\">\n     <span>\n      Septic emboli (bacterial or fungal)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pulmonary vasculitis (especially Wegener&rsquo;s granulomatosis)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pulmonary embolism and infarction\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p class=\"MsoNormal\">\n     <span>\n      Infected bullae and cysts\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"352\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cancer (primary or secondary)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Infection is the most common cause of\nlung cavitation. One or more cavities may be present. If the lesion is single,\nabscess from necrotizing Gram-negative or staphylococcal pneumonia should be a\nprimary consideration, especially if the patient is acutely ill with severe\npneumonia. If multiple cavities are present, the infection is likely due to\nhematogenous dissemination (septic emboli), and a source for this dissemination\nshould be sought (e.g., right-sided endocarditis).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lung abscesses secondary to aspiration\nare frequently right-sided and most often involve the lower lobe.* Most\npatients with anaerobic lung abscess have risk factors for aspiration, such as\npoor dental hygiene, seizure disorder, or alcoholic blackouts. The\nmanifestation is often indolent, with complaints of cough, fever, and malaise\nlasting weeks to months.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Tubercular cavities are usually located\nin the upper zone, either the posterior segment of the upper lobe or apical\nsegment of the lower lobe. Because of the high concentration of tuberculous\nbacilli in the cavity, patients usually have a sputum smear that is strongly\npositive for acid-fast bacilli.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A variety of fungi can cause cavitary\nlesions.\n  <i>\n   Aspergillus, Mucor\n  </i>\n  , and\n  <i>\n   Candida\n  </i>\n  rarely cause disease in\nnormal hosts. The endemic fungi (histoplasma, blastomyces, and coccidiodes),\nhowever, can produce cavitary lesions in immunocompetent hosts. These organisms\nshould be considered if travel to an endemic area has occurred.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Pulmonary lesions due to infected\nbullae/cysts are thin-walled cavities with smooth outline. Thick-walled\ncavities may result from pulmonary vasculitis, of which Wegener&rsquo;s\ngranulomatosis is the prototype. Wegener&rsquo;s granulomatosis often results in\nbilateral cavitary lesions. Pulmonary embolism with infarction is a rare cause\nof lung cavitation. Neoplasia, either primary (bronchogenic carcinoma,\nlymphoma) or metastatic (from squamous cell) can produce cavities. These are\nusually thick-walled. A fluid level is seen more commonly with primary tumors\nthan with metastasis.\n </span>\n</p>\n\n<p>\n *\n <span class=\"h32\">\n  <span>\n  </span>\n </span>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Because the\nright main bronchus is wider and more vertical than the left, aspiration is\nmore likely to occur in the right main bronchus. The superior segmental\nbronchus of the lower lobar bronchus is the only segmental bronchus that exits\nfrom the posterior wall of the lobar bronchi. Therefore, if a patient is supine\nat the time of aspiration, the object is most likely to enter the\n   <i>\n    superior segmental bronchus of the right\nlower lobe\n   </i>\n   .\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "choices": ["A. Bacterial endocarditis with septic embolism", "B. Tuberculosis", "C. Anaerobic lung abscess", "D. Bronchogenic carcinoma", "E. Metastatic cancer"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n52-year-old man has a six-day history of fever, productive cough, and shortness\nof breath. Lung examination reveals dullness of percussion, increased tactile\nfremitus, bronchial breath sounds, and crackles in the left lung base. Which of\nthe following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Pneumonia often causes fever, productive\ncough, and shortness of breath. Physical findings include dullness of\npercussion, increased tactile fremitus, bronchial breath sounds, egophony,\nwhispered pectoriloquy, and crackles over the involved area.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Chronic bronchitis\nusually produces normal findings on lung examination. However, scattered coarse\ncrackles may be heard in early inspiration, and wheezes or rhonchi may be\npresent.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Congestive heart\nfailure is associated with late inspiratory crackles in dependent areas of\nlungs.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Pleural effusion is\nassociated with dullness to percussion, decreased breath sounds, and decreased\ntactile fremitus over the effusion.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Pneumothorax is\nassociated with hyperresonance to percussion, decreased breath sounds, and\ndecreased tactile fremitus over the pleural air.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer F is incorrect\n  </span>\n </b>\n <span>\n  . Emphysema is\nassociated with diffuse hyperresonance to percussion, decreased breath sounds,\nand decreased tactile fremitus. Wheezes, crackles, and rhonchi may be present\nwith associated chronic bronchitis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer G is incorrect\n  </span>\n </b>\n <span>\n  . Asthma is associated\nwith resonance or hyperresonance to percussion, decreased tactile fremitus, and\nwheezing, which may obscure breath sounds.\n </span>\n</p>\n"], "tutorial": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"463\">\n <tr>\n  <td colspan=\"6\" valign=\"top\" width=\"463\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Physical Signs in Selected Chest Disorders\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Condition\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Trachea\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Percussion\n  Note\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Breath\n  Sounds\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tactile\n  fremitus and transmitted voice sounds\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     Adventitious\n  sounds\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Midline\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Resonant\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal*\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     None\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Chronic\n  bronchitis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midline\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Resonant\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     None; or\n  scattered coarse crackles in early inspiration and perhaps expiration; or\n  wheezes or rhonchi\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pulmonary\n  edema (e.g., from left-sided heart failure)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midline\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Resonant\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     Late\n  inspiratory crackles in dependent\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     areas of lungs; possibly wheezes\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Consolidation\n  (e.g., lobar pneumonia)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midline\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dull\n  over consolidation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Bronchial\n  over involved area\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n  over involved area with\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     bronchophony,\n  egophony,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     whispered\n  pectoriloquy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     Late\n  inspiratory crackles over the involved area\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Atelectasis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     (lobar\n  obstruction)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     May be\n  shifted toward involved\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Side\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dull\n  over airless area\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Usually\n  absent when bronchial plug persists\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Usually\n  absent when bronchial plug persists\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     None\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pleural effusion\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Shifted\n  toward opposite side in large effusion\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dull\n  over effusion\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     (although bronchial sounds may be\n  heard at the top of a large effusion)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     (but may be increased at the top\n  of\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     effusion)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     None,\n  except possibly a pleural rub\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pneumothorax\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Shifted\n  toward opposite side if large pneumothorax\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hyperresonant\n  over pleural air\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n  over pleural air\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n  over pleural air\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     None,\n  except a possible pleural rub\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Emphysema\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midline\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Diffusely\n  hyperresonant\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     None, or\n  the crackles, wheezes, and rhonchi of associated chronic bronchitis\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Asthma\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"80\">\n   <p class=\"MsoNormal\">\n    <span>\n     Midline\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"81\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal-to-diffusely\n  hyperresonant\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"65\">\n   <p class=\"MsoNormal\">\n    <span>\n     Often\n  obscured by wheezes\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"83\">\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"73\">\n   <p class=\"MsoNormal\">\n    <span>\n     Wheezes,\n  possibly crackles\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  *A normal\nlung is characterized by vesicular breath sounds except over the trachea where\nbreath sounds are bronchial and over the large bronchi where they are\nbronchovesicular.\n </span>\n</p>\n", "choices": ["A. Chronic bronchitis", "B. Congestive heart failure", "C. Lobar pneumonia", "D. Pleural effusion", "E. Pneumothorax", "F. Emphysema", "G. Asthma"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n68-year-old man presents to the emergency room with crushing chest pain that\nradiates to the neck and jaw. He is diagnosed with a myocardial infarction. His\nleft ventricular ejection fraction is 45%. Three days later he becomes\nhypotensive and short of breath. Examination reveals a new holosystolic murmur,\nloudest at the apex, radiating to the left axilla. The ejection fraction is now\n25%. What caused the deterioration?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . The murmur described\nin this vignette is typical of acute mitral regurgitation, which in the setting\nof a recent myocardial infarction is most likely caused by rupture of one of\nthe left ventricular papillary muscles.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Rupture of the\ninterventricular septum produces a holosystolic murmur that is loudest at the\nleft sternal border.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Rupture of the left\nventricular free wall causes cardiac tamponade, which is associated with pulsus\nparadoxus, jugular venous distension, and decreased heart sounds.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Ventricular aneurysm\nmay be associated with arrhythmias and thrombus formation resulting in emboli.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Dressler&rsquo;s syndrome is\na type of pericarditis that occurs several weeks after myocardial infarction.\nSymptoms include fever, sharp chest pain, and pericardial friction rub.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span class=\"table-caption\">\n  <b>\n   <span>\n    Complications of Acute\nMyocardial Infarction\n   </span>\n  </b>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <thead>\n   <tr>\n    <td valign=\"bottom\">\n     <p class=\"MsoNormal\">\n      <b>\n       <span>\n        Complication\n       </span>\n      </b>\n     </p>\n    </td>\n    <td valign=\"bottom\">\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n        Manifestations\n       </span>\n      </b>\n     </p>\n    </td>\n   </tr>\n  </thead>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ischemic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      infarct\n  extension, recurrent infarction\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Mechanical\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      papillary\n  muscle rupture with mitral regurgitation\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      ventricular\n  septal rupture\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      cardiac\n  free wall rupture\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      ventricular\n  aneurysm\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      heart\n  failure\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Arrhythmic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      atrial\n  or ventricular arrhythmias\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      sinus or\n  atrioventricular node dysfunction\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Embolic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      embolization\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inflammatory\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      pericarditis\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Ruptured papillary muscle", "B. Ruptured interventricular septum", "C. Ruptured left ventricular free wall", "D. Ventricular aneurysm", "E. Dressler\u2019s syndrome"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n4-hour-old female newborn delivered at 30 weeks&rsquo; gestation has respiratory\ndistress. Her temperature is 36.5\n  <sup>\n   o\n  </sup>\n  C (97.7\n  <sup>\n   o\n  </sup>\n  F), pulse is\n160/minute, respirations are 85/minute, and blood pressure is 68/40 mm Hg.\nArterial blood gas analysis on room air shows:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pH\n  <span>\n  </span>\n  7.18\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pCO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  78\nmm Hg\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  pO\n  <sub>\n   2\n  </sub>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  55\nmm Hg\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Endotracheal\nintubation and mechanical ventilation are required. The primary cause of this\npatient&rsquo;s condition is a dysfunction of which of the following cell types?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Neonatal Respiratory\nDistress Syndrome (RDS) (&ldquo;hyaline membrane disease&rdquo;) should be suspected in a\npremature newborn with respiratory distress, tachypnea, tachycardia,\nhypotension, and acidosis. The fundamental abnormality is insufficient\npulmonary surfactant produced by type II pneumocytes. This results in failure\nof the lungs to expand after birth. RDS is characterized by hyaline membranes,\nwhich consist of underdeveloped epithelial cells and plasma proteins lining the\nairways. The condition can be ameliorated by prophylactic administration of\nsteroids, surfactant therapy, and by improved ventilation techniques.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  There are\nmany causes of respiratory distress in the newborn, including sepsis,\npneumonia, excessive sedation of the mother, fetal head injury during delivery,\naspiration of blood or amniotic fluid, and perinatal depression or intrauterine\nhypoxia brought about by a number of reasons including coiling of the umbilical\ncord about the neck (nuchal cord). However, the most common cause is\nrespiratory distress syndrome (RDS), also known as\n  <span>\n   hyaline membrane disease\n  </span>\n  because of the formation of &ldquo;membranes&rdquo;\nin the peripheral air spaces of infants who succumb to this condition.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  RDS is basically a disease of premature infants\n  <i>\n   .\n  </i>\n </span>\n <span>\n  Other contributing\ninfluences are\n  <span>\n   maternal diabetes,\ncesarean section\n  </span>\n  before the onset of labor, and\n  <span>\n   twin gestation.\n  </span>\n  The fundamental defect in RDS is the inability of\nthe immature lung to synthesize sufficient surfactant. Surfactant is a complex\nof surface-active phospholipids, principally dipalmitoylphosphatidylcholine\n(lecithin), and at least two groups of surfactant-associated proteins.\nSurfactant is synthesized by type II pneumocytes. With the healthy newborn&rsquo;s\nfirst breath, it rapidly coats the surface of alveoli, reducing surface tension\nand decreasing the pressure required to keep alveoli open. In a lung deficient\nin surfactant, alveoli tend to collapse, and a relatively greater inspiratory\neffort is required with each breath to open the alveoli. Thus, surface tension\nis increased and lung compliance is decreased. The infant rapidly tires from\nbreathing, and generalized atelectasis sets in. The resulting hypoxia sets into\nmotion a sequence of events that lead to epithelial and endothelial damage and\neventually to the formation of hyaline membranes.\n </span>\n</p>\n\n<p>\n RDS begins shortly after\nbirth and is manifested by tachypnea, tachycardia, chest wall retractions\n(recession), expiratory grunting, nasal flaring, and cyanosis during breathing\nefforts. As the disease progresses, the baby may develop ventilatory failure\n(rising carbon dioxide levels in the blood), and prolonged cessations of\nbreathing (apnea). Findings include hypotension and acidosis. Radiographic\nfindings include low lung volumes, diffuse reticulogranular pattern\n(homogeneous ground-glass appearance) due to diffuse alveolar atelectasis and\nair bronchograms due to alveolar collapse. The disorder may be associated with\nother conditions that accompany prematurity, such as\n <span>\n  patent ductus arteriosus, intraventricular hemorrhage,\n </span>\n and\n <span>\n  necrotizing enterocolitis.\n </span>\n The\nclinical course for the acute disease lasts about 2 to 3 days. During the first\nday, the patient worsens and requires more support. During the second day, the\nbaby may be remarkably stable on adequate support. Resolution is noted during\nthe third day, heralded by a prompt diuresis.\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4160-2973-1..50010-7--f22\">\n </a>\n <a name=\"4-u1.0-B978-1-4160-2973-1..50010-7--cese\">\n </a>\n <span>\n  A major thrust in the control of RDS focuses on\nprevention, either by delaying labor until the fetal lung reaches maturity or\nby inducing maturation of the lung in the fetus at risk. Critical to these\nobjectives is the ability to assess fetal lung maturity accurately. Because\npulmonary secretions are discharged into the amniotic fluid, analysis of\namniotic fluid phospholipids provides a good estimate of the level of\nsurfactant in the alveolar lining. Prophylactic administration of exogenous surfactant\nat birth to extremely premature infants (gestational age &lt;28 weeks) has been\nshown to be very beneficial, such that it is now uncommon for infants to die of\nacute RDS.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The introduction of\nantenatal steroids has also decreased the incidence of RDS by as much as 50% in\npremature infants.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Alveolar macrophages", "B. Pneumocytes", "C. Pulmonary chondrocytes", "D. Pulmonary vascular endothelial cells", "E. Smooth muscle cells"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n72-year-old man presents to the emergency department with a one-week history of\nprogressive shortness of breath. Two days prior to his arrival he develops a\ncough and a sharp pain in his left chest. The pain increases with inspiration.\nHe does not expectorate blood or sputum. He has lost 10 lb in two months. He\nwas healthy before the symptoms began and he takes no medication. He has a 25\npack-year history of smoking and was exposed to asbestos in the military. On\nphysical examination, temperature is 98.4 F\n  <sup>\n   o\n  </sup>\n  , blood pressure is\n156/92 mm Hg, pulse is 110/minute, and respirations are 25/minute. The O\n  <sub>\n   2\n  </sub>\n  saturation is 98% on room air. His heart is regular. Lung exam reveals dullness\nto percussion over the left posterior lung field from the lung base to just\nbelow the scapula. Tactile fremitus and breath sounds are decreased in this\nregion. Mild clubbing of the fingers is noted. There is no jugular venous\ndistention, lower extremity edema, or jaundice.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Laboratory\ntests show the following:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hgb\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  10\ng/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  9,800/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelet\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  390,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  14\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.2\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  AST\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  14\nIU/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  ALT\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  20\nIU/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Alk Phos\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  60\nIU/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  INR\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B-type\nnatriuretic peptide (BNP):\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  90\npg/ml (Normal: &lt;100 pg/ml)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Chest\nX-ray shows a large left-sided pleural effusion.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Chest CT\nshows a large left-sided fluid collection without loculation or septation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely explanation for the effusion?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  A\nmalignant effusion is likely given the risk factors for bronchogenic carcinoma\n(smoking and asbestos exposure) and the presence of weight loss and anemia.\nDullness to percussion and diminished breath sounds are common findings in\npleural effusion. Symptoms may include cough, shortness of breath, and\npleuritic chest pain. The next step in the diagnostic work-up would be\nthoracentesis to obtain fluid for analysis. Cytological analysis of the fluid\nwould be the best method for detecting a malignant source of effusion.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpFirst\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . In patients with liver\nfailure and ascites, diaphragmatic defects can lead to unilateral pleural\neffusions. In this case, hepatic hydrothorax is unlikely given the absence of\nliver disease.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Heart failure is\nunlikely given a normal heart exam and the absence of jugular venous distension\nand edema. Pleural effusions caused by heart failure are usually right-sided or\nbilateral. Pulmonary edema is usually seen on chest x-ray. An elevated B-type\nnatriuretic peptide (BNP) would be expected.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . A parapneumonic\neffusion is possible, but unlikely given the absence of fever, purulent sputum,\nand leukocytosis. The chest CT shows no septation or loculation to suggest\ninfection of the pleural space. Nevertheless, infection must be ruled out by\nfluid analysis. Thoracentesis is indicated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Pleural effusion\n </span>\n is excess fluid that accumulates in the pleura,\nthe fluid-filled space that surrounds the lungs. Excessive amounts of such\nfluid can impair breathing by limiting the expansion of the lungs during\nrespiration.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Four types of fluids can accumulate in the pleural space:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Serous fluid (hydrothorax)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Blood (hemothorax)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Chyle (chylothorax)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Pus (empyema)\n </span>\n</p>\n\n<p>\n Pleural effusion is usually\ndiagnosed on the basis of medical history and physical exam, and confirmed by\nchest x-ray. Once accumulated fluid is more than 500 ml, there are usually\ndetectable clinical signs in the patient, such as decreased movement of the\nchest on the affected side, dullness to percussion over the fluid, diminished\nbreath sounds on the affected side, decreased vocal fremitus, and pleural friction\nrub. Above the effusion, where the lung is compressed, there may be bronchial\nbreath sounds and egophony. In large effusion there may be tracheal deviation\naway from the effusion.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Common causes of\n  pleural effusion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Congestive heart failure\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pneumonia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cancer\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pulmonary embolism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lung inflammation\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cirrhosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Post open-heart surgery\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Once a\npleural effusion is diagnosed, the cause must be determined. Pleural fluid is\ndrawn out of the pleural space in a process called thoracentesis. A needle is\ninserted through the back of the chest wall in the sixth, seventh, or eighth\nintercostal space. The fluid is then sent to the laboratory for testing.\n </span>\n</p>\n", "choices": ["A. Hepatic hydrothorax", "B. Congestive heart failure", "C. Malignant pleural effusion", "D. Para-pneumonic effusion"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n62-year-old man with diabetes, hypertension, and hyperlipidemia presents with a\n3-day history of fever, chills, productive cough, and shortness of breath. Six\nmonths ago, he was admitted to the MICU with pneumonia and septic shock for\nwhich he was intubated and mechanically ventilated. Two weeks ago, he had the\n&ldquo;flu&rdquo; from which he recovered.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He\nhas no recent contact with sick people and he has not traveled out of state. He\nsmokes a pack of cigarettes daily and drinks alcohol occasionally. His\nmedications are metformin, hydrochlorothiazide, lisinopril, simvastatin, baby\naspirin, and a multi-vitamin.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  His\ntemperature is 101.4\n  <sup>\n   o\n  </sup>\n  F, pulse is 90/minute, blood pressure is\n135/85 mmHg, and respirations are 22/minute. Lung exam shows increased\nfremitus, crackles, bronchial breath sounds and whispered pectoriloquy in the\nleft upper lung field. Laboratory studies show a white blood cell count of\n14,000/mm\n  <sup>\n   3\n  </sup>\n  (80% neutrophils). Sputum gram stain shows &lt;10\nepithelial cells and &gt;25 white blood cells per high-powered field.\nGram-positive cocci in pairs and chains are seen. A chest x-ray shows\ninfiltrates in the left upper lobe with air bronchograms.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is the correct diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  The patient in the\nvignette has community-acquired pneumonia (CAP), probably due to\n  <i>\n   Streptococcus\n  </i>\n  <i>\n   pneumoniae\n  </i>\n  , which is the most common cause of CAP. The patient\nvignette developed pneumonia six months after being hospitalized for septic\nshock. This is too far out to be considered health care-associated pneumonia.\nIf pneumonia had occurred\n  <i>\n   within 90 days\n  </i>\n  of his discharge from the hospital, the diagnosis would be health\ncare-associated pneumonia, not community-acquired pneumonia.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\nclinical classification of pneumonia is important because it affects the choice\nof antibiotics. Each clinical category is associated with a spectrum of pathogens,\nwhich determines the appropriate choice of empiric therapy.\n </span>\n</p>\n\n<p>\n <span>\n  Community-acquired pneumonia (CAP) refers to pneumonia in\npeople who have not recently been in a hospital or another health care facility\n(nursing home, rehabilitation facility).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n CAP is generally divided into two categories: typical and\natypical. Whenever a bacterial cause is identified, 50% of CAP cases are due to\npneumococcus. The rest are due to\n <i>\n  Staphylococcus\naureus\n </i>\n and gram-negative bacteria like\n <i>\n  Haemophilus\ninfluenzae\n </i>\n and\n <i>\n  Moraxella catarrhalis\n </i>\n ,\nwhich are common in smokers. Atypical pneumonias (~ 20% of CAP) are caused by\n <i>\n  Mycoplasma pneumoniae\n </i>\n ,\n <i>\n  Chlamydophila pneumoniae\n </i>\n ,\n <i>\n  Legionella pneumoniae\n </i>\n and viruses\n(typically influenza A and B). Post-influenza pneumonia, which this patient\nappears to have, is often due to\n <i>\n  Streptococcus\n </i>\n <i>\n  pneumoniae\n </i>\n or\n <i>\n  Staphylococcus aureus\n </i>\n . Generally atypical pneumonia has an\ninsidious onset with a predominance of constitutional symptoms. It usually\noccurs in younger patients, causes non-productive cough, and presents with\nmultilobar involvement. Various serologic tests are available to detect typical\nand atypical pathogens.\n</p>\n\n<p>\n Hospital\nAcquired Pneumonia (HAP) is defined as pneumonia that occurs more than 48 hours\nafter hospital admission.\n</p>\n\n<p>\n Health Care\nAssociated Pneumonia (HCAP) is defined as pneumonia that occurs in residents of\nlong-term care facilities, patients on hemodialysis, patients receiving\noutpatient infusions of chemotherapy or antibiotics, and patients receiving\noutpatient wound care. HCAP also includes patients who develop pneumonia within\n90 days of hospital discharge.\n</p>\n\n<p>\n Ventilator-associated\npneumonia (VAP) is defined as pneumonia that develops 48-72 hours after being\nplaced on mechanical ventilation. It is sometimes caused by\n <i>\n  Pseudomonas\n </i>\n .\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hospital-acquired\npneumonia (HAP), health care-associated pneumonia (HCAP), and\nventilator-associated pneumonia (VAP) come under the common heading of\nnosocomial pneumonia. These are the pneumonias that are directly or indirectly\nassociated with health care and hospitals. Most nosocomial pneumonias are due\nto bacterial pathogens, especially enteric gram-negative bacteria and\nmethicillin-resistant\n  <i>\n   Staphylococcus\naureus\n  </i>\n  (MRSA). Elderly patients are at high risk of developing nosocomial\npneumonia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Aspiration\npneumonia usually occurs after material in the oropharynx is aspirated into the\nlungs in such settings as endotracheal intubation, seizure, drug/alcohol\nintoxication, and stroke (if associated with dysphagia). Poor dental hygiene\npredisposes to aspiration pneumonia and lung abscess. Lung infiltrates usually\nappear in right lower lobe. The chest X-ray may show air-fluid levels\nconsistent with lung abscess. Patients usually have bad breath and sputum\nGram-stain typically shows mixed flora. The most common pathogens are\nanaerobes.\n  <b>\n  </b>\n </span>\n</p>\n", "choices": ["A. Community-acquired pneumonia", "B. Aspiration pneumonia", "C. Hospital-acquired pneumonia", "D. Health care-associated pneumonia", "E. Ventilator-associated pneumonia"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n21-year-old man with no previous medical problems presents to the emergency\ndepartment with sudden onset of shortness of breath, dry cough, and stabbing\npain in the left chest.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Symptoms\nbegan when he was sitting on the sideline during an intramural basketball game;\nhe plays the position of center. On physical examination, he is in mild\nrespiratory distress. Temperature is 98.6\n  <sup>\n   o\n  </sup>\n  F, pulse is 115/minute,\nblood pressure is 135/75 mm Hg, and respirations are 28/minute. The oxygen\nsaturation is 93% on room air.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Lung\nexam reveals hyperresonance to percussion, decreased tactile fremitus, and\ndecreased breath sounds over the left hemithorax. What is the most likely\ndiagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Sudden onset shortness of breath and\nstabbing chest pain in a patient with hyperresonance to percussion, decreased\ntactile fremitus, and decreased breath sounds over the left hemithorax suggests\na diagnosis of spontaneous left-sided pneumothorax.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nPneumonia in a young person usually presents with fever and productive\ncough.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Findings include increased\nfremitus, dullness to percussion, bronchial breath sounds, and crackles over\nthe affected area. Egophony and whispered pectoriloquy may be heard. Chest\nx-ray often shows an infiltrate or area of consolidation.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect\n  </span>\n </b>\n <span>\n  .\nPleural effusion is unlikely in a previously healthy person. Most effusions are\ncaused by congestive heart failure, pneumonia, malignancy, pulmonary embolism,\nor cirrhosis with ascites.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients\nmay have exertional dyspnea. Findings include dullness to percussion, decreased\ntactile fremitus, and decreased breath sounds over the affected area.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  .\nPulmonary embolism is unlikely in a previously healthy person.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Risk factors include age &gt;60,\nmalignancy, prior history of deep vein thrombosis or pulmonary embolism,\nhereditary hypercoagulable state, prolonged immobilization, cardiac disease, obesity,\nnephrotic syndrome, major surgery, trauma, pregnancy, and estrogen use.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Pulmonary embolism can present with many\nof the symptoms of pneumothorax, but the physical findings are different.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect\n  </span>\n </b>\n <span>\n  .\nMyocardial infarction is unlikely in a young person with no risk factors for\ncoronary artery disease. Symptoms of myocardial infarction include left-sided\nchest tightness, radiation of pain to the left arm or jaw, shortness of breath,\ndiaphoresis, nausea, and vomiting.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Pneumothorax\nis defined as air in the normally airless pleural space.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  There are two types of pneumothorax:\nspontaneous and traumatic.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Traumatic pneumothoraces are often iatrogenic (e.g., placement of a\ncentral intravenous line).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Spontaneous pneumothoraces occur without trauma.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Spontaneous\npneumothorax can be further divided into two types.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Primary pneumothorax occurs without\nunderlying lung disease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It is\ncaused by spontaneous rupture of subpleural blebs at the apex of the lungs. Air\nescapes into the pleural space, causing lung collapse.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This condition is most common in tall,\nlean, young men, who typically have good pulmonary reserve, and who, therefore,\nmay not experience severe respiratory distress. The recurrence rate of primary\npneumothorax is 50% in two years.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Secondary\npneumothorax occurs as a complication of underlying lung disease, especially\nCOPD. Other predisposing conditions include asthma, interstitial lung disease,\nneoplasms, cystic fibrosis, and tuberculosis. Secondary pneumothorax may be\nlife-threatening if the patient lacks adequate pulmonary reserve.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Symptoms\nof a pneumothorax include ipsilateral chest pain (usually sudden in onset),\ndyspnea, and cough. Findings include hyperresonance, decreased (or absent)\ntactile fremitus, and decreased breath sounds over the affected area.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In a tension pneumothorax, the trachea\nmay deviate toward the contralateral side. Chest x-ray may show a visceral\npleural line.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Pneumonia", "B. Pleural effusion", "C. Pneumothorax", "D. Pulmonary embolism", "E. Myocardial infarction"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 60-year-old man with poorly controlled\nhypertension is admitted to the emergency department with a three-week history\nof progressive shortness of breath. He has been sleeping in a recliner for the\npast three nights. One hour prior to admission, his breathing worsened and he\nsummoned the ambulance to take him to the hospital. He is sitting upright and\nhis respirations are labored. He says he is &ldquo;suffocating.&rdquo; Blood pressure is\n220/124 mmHg, pulse is 136/minute, and respirations are 36/minute. His heart rate\nis rapid with a regular rhythm. The heart is barely audible over the\nrespiratory noise. Expiratory wheezes are present diffusely, and crackles are\nheard up to the mid-lung fields. The extremities are slightly cool and\ncyanotic. Pitting ankle edema is present.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What of the following best explains the\npatient&rsquo;s distress?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  A.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Chronic\nobstructive pulmonary disease (COPD) exacerbation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  B.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Cardiogenic\npulmonary edema\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  C.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Asthma\nexacerbation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  D.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Bilateral\ndiaphragm paralysis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Shortness of breath may be caused by lung\ndisease, heart disease, anxiety, or deconditioning. Often the medical history\nand physical examination are revealing. Orthopnea (shortness of breath with\nrecumbency) may be due to heart or lung disease. Common causes include\npulmonary edema from left ventricular heart failure, asthma, and chronic\nbronchitis. Orthopnea can cause a patient to sleep in a recliner.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Wheezing may be of cardiac or pulmonary\norigin. Remember: &ldquo;Not all that wheezes is asthma.&rdquo; Wheezing is neither\nsensitive nor specific for asthma. Patients with mild or severe asthma may not\nwheeze at all, while patients with cardiogenic pulmonary edema may wheeze\nconsiderably. The term &ldquo;cardiac asthma&rdquo; is used to describe wheezing associated\nwith cardiogenic pulmonary edema.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sometimes the patient&rsquo;s characterization\nof his breathing may be informative (i.e., certain words may suggest certain\netiologies):\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"142\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Condition\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"146\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Descriptor\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"142\">\n    <p class=\"MsoNormal\">\n     <span>\n      Asthma\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"146\">\n    <p class=\"MsoNormal\">\n     <span>\n      Chest\n  tightness or constriction\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"142\">\n    <p class=\"MsoNormal\">\n     <span>\n      COPD,\n  severe asthma, respiratory muscle weakness, pulmonary fibrosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"146\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  work or effort of breathing\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"142\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pulmonary\n  edema\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"146\">\n    <p class=\"MsoNormal\">\n     <span>\n      Suffocating,\n  smothering\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"142\">\n    <p class=\"MsoNormal\">\n     <span>\n      Deconditioning\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"146\">\n    <p class=\"MsoNormal\">\n     <span>\n      Heavy\n  breathing, breathing more than usual\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The presence of crackles in the lungs is\ncompatible with pulmonary edema. With mild pulmonary edema, late inspiratory\ncrackles are commonly heard in the lung bases.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  With severe pulmonary edema, the\ncrackles often rise to the mid-lung fields. Pulmonary edema is usually caused\nby left heart failure. Other findings suggestive of heart failure are cool,\ncyanotic extremities and ankle edema.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Many conditions can precipitate heart\nfailure. The two most important are myocardial ischemia and hypertension.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  Shortness of breath and wheezing in\na patient with very high blood pressure, pulmonary crackles, leg edema, and\ncyanotic extremities suggests a diagnosis of cardiogenic pulmonary edema. The\npatient is severely hypertensive, which provides an explanation for his heart\nfailure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Match each\nof the following clinical vignettes with the correct diagnosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n <span>\n  1.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n A\n60-year-old man with a 60 pack/year smoking history has shortness of breath on\nexertion. An arterial blood gas shows a PO\n <sub>\n  2\n </sub>\n of 56 mm Hg and a PCO\n <sub>\n  2\n </sub>\n of 44 mm Hg.\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    Patient\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    FEV1\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    FEV1/FVC\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    TLC\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    DLCO/VA\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    1\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    0.7 L (23%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    25%\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    9.7 L (150%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    0.9 (19%)\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  2.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n A\n30-year-old woman with tuberous sclerosis has shortness of breath and a cough.\nA chest radiograph shows reticulonodular infiltrates.\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    Patient\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    FEV1\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    FEV1/FVC\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    TLC\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    DLCO/VA\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    2\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    1.1 L (42%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    56%\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    3.0 L (64%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    1.5 (29%)\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  3.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n A\n36-year-old man is wheelchair bound. His arterial blood gas shows a PO\n <sub>\n  2\n </sub>\n of 60 mm Hg and a PCO\n <sub>\n  2\n </sub>\n of 52 mm Hg.\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    Patient\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    FEV1\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    FEV1/FVC\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    TLC\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    DLCO/VA\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    3\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    1.0 L (33%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    85%\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    2.7 L (50%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    8.2 (144%)\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  4.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n A\n22-year-old woman has shortness of breath when the pollen count is high. On\nphysical exam, she is wheezing.\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    Patient\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    FEV1\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    FEV1/FVC\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    TLC\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    DLCO/VA\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    4\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    1.8 L (60%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    61%\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    4.9 L (100%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    6.8 (122%)\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  5.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n A\n43-year-old woman has progressive shortness of breath with exertion. A chest\nradiograph shows reticulonodular infiltrates, especially in the lung bases.\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    Patient\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    FEV1\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    FEV1/FVC\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    TLC\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    DLCO/VA\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    5\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    1.4 L (49%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    78%\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    2.7 L (52%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    2.6 (51%)\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  6.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n A\n55-year-old woman has shortness of breath with exertion. The chest radiograph\nis normal. While breathing room air, her PO\n <sub>\n  2\n </sub>\n is 48 mm Hg. While\nbreathing 100% oxygen, her PO\n <sub>\n  2\n </sub>\n does not rise appropriately.\n <span>\n  &nbsp;\n </span>\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    Patient\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    FEV1\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    FEV1/FVC\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    TLC\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    DLCO/VA\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"19%\">\n   <p align=\"center\">\n    6\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    2.8 L (95%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    80%\n   </p>\n  </td>\n  <td width=\"19%\">\n   <p align=\"center\">\n    6.3 L (99%)\n   </p>\n  </td>\n  <td width=\"20%\">\n   <p align=\"center\">\n    1.9 (44%)\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  A. Asthma\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B.\nEmphysema\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C. Interstitial\nlung disease\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D.\n  <span>\n   Lymphangioleiomyomatosis\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  E.\nCirrhosis-associated hypoxemia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  F.\nMuscular dystrophy\n </span>\n</p>\n\n<p>\n Although pulmonary function\ntests (PFTs) provide an array of measurements, only a few are needed to assess\na patient's condition. PFTs have five basic components: spirometry, lung\nvolumes, diffusing capacity, arterial blood gas, and flow-volume loops.&nbsp;\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p>\n     Pulmonary Function Tests\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p>\n     Spirometry\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p>\n     Lung volumes\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p>\n     Diffusing capacity\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p>\n     Arterial blood gas\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p>\n     Flow-volume loops\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n The following abbreviations\nare used in this tutorial.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"401\">\n    <p align=\"center\">\n     Common Abbreviations\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"401\">\n    <p align=\"center\">\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     FEV\n     <sub>\n      1\n     </sub>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"315\">\n    <p>\n     Forced expiratory volume\n  in the first second of expiration\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     FVC\n    </p>\n   </td>\n   <td valign=\"top\" width=\"315\">\n    <p>\n     Forced vital capacity\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     TLC\n    </p>\n   </td>\n   <td valign=\"top\" width=\"315\">\n    <p>\n     Total lung capacity\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     DLCO/VA\n    </p>\n   </td>\n   <td valign=\"top\" width=\"315\">\n    <p>\n     Diffusing capacity for\n  carbon monoxide / alveolar volume\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n <b>\n  Spirometry\n </b>\n</p>\n\n<p>\n Spirometry measures air flow\nand determines if obstruction is present. Obstruction is defined as an FEV\n <sub>\n  1\n </sub>\n /FVC\nless than 75%. The severity of obstruction is determined by the FEV\n <sub>\n  1\n </sub>\n .\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"194\">\n    <p align=\"center\">\n     Severity of Obstruction\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"108\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     FEV\n     <sub>\n      1\n     </sub>\n     &gt; 70%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"108\">\n    <p>\n     Mild\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     FEV\n     <sub>\n      1\n     </sub>\n     60-70%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"108\">\n    <p>\n     Moderate\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     FEV\n     <sub>\n      1\n     </sub>\n     50-60%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"108\">\n    <p>\n     Moderately severe\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     FEV\n     <sub>\n      1\n     </sub>\n     35-50%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"108\">\n    <p>\n     Severe\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"86\">\n    <p>\n     FEV\n     <sub>\n      1\n     </sub>\n     &lt; 35%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"108\">\n    <p>\n     Very severe\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n Obstruction is considered\nreversible if there is a\n <u>\n  &gt;\n </u>\n 12% increase in the FEV\n <sub>\n  1\n </sub>\n after\nbronchodilator challenge.\n</p>\n\n<p>\n <b>\n  Lung Volumes\n </b>\n</p>\n\n<p>\n Restriction is defined as a\nreduction in the total lung capacity (&lt;80% of the predicted value). The\nseverity of restriction is determined by the total lung capacity. &nbsp;\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"141\">\n    <p align=\"center\">\n     Severity of Restriction\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"77\">\n    <p>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"64\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"77\">\n    <p>\n     TLC 70-80%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"64\">\n    <p>\n     Mild\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"77\">\n    <p>\n     TLC 60-70%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"64\">\n    <p>\n     Moderate\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"77\">\n    <p>\n     TLC &lt; 60%\n    </p>\n   </td>\n   <td valign=\"top\" width=\"64\">\n    <p>\n     Severe\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n If a TLC is not ordered,\nvital capacity (obtained by spirometry) can be used to determine the presence\nof restriction, but TLC is an overall better predictor.\n</p>\n\n<p>\n <b>\n  Diffusing Capacity\n </b>\n</p>\n\n<p>\n Diffusing capacity is the\nability of gas to move from the alveoli, across the interstitium, and into the\nblood. The DLCO/VA provides a useful measure of diffusing capacity. (In the\nlaboratory, carbon monoxide is used to measure diffusion. The VA, or alveolar\nvolume, approximates the TLC and is used as a correction factor.) A normal\nDLCO/VA is &gt;80% of the predicted value.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p align=\"center\">\n     Conditions that reduce DLCO/VA\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p>\n     Emphysema\n    </p>\n    <p>\n     Interstitial lung disease\n    </p>\n    <p>\n     Pulmonary vascular disease\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Pulmonary emboli\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Pulmonary vasculitis\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Pulmonary hypertension\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Pulmonary shunts\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n <b>\n  Arterial Blood Gas\n </b>\n</p>\n\n<p>\n Arterial blood gas analysis\ndetermines the pH, PO\n <sub>\n  2\n </sub>\n , and PCO\n <sub>\n  2\n </sub>\n of the blood.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <b>\n  Flow-Volume Loop\n </b>\n</p>\n\n<p>\n The flow-volume loop is used\nmainly to assess upper airway obstruction (e.g., laryngeal cancer).\n</p>\n\n<p>\n <b>\n  Physiologic Shunt Study&nbsp;\n </b>\n</p>\n\n<p>\n Physiologic shunt studies\nare done if pulmonary shunting is suspected as a cause of hypoxemia. The\npatient breathes 100% oxygen. If shunting is present, the PO\n <sub>\n  2\n </sub>\n does\nnot rise appropriately.\n</p>\n\n<p>\n <b>\n  <u>\n   Specific Conditions\n  </u>\n </b>\n</p>\n\n<p>\n <b>\n  Asthma\n </b>\n . In asthma, the main problem is obstruction. There is no\nreduction in lung volume and no impairment of gas transport from the alveoli to\nthe blood. PFTs show a reduced FEV1/FVC ratio, normal (or increased) TLC, and\nnormal (or increased) DLCO/VA. Typically, the obstruction improves with\nbronchodilator challenge.\n</p>\n\n<p>\n <b>\n  Emphysema\n </b>\n . In emphysema, there is obstruction and hyperinflation\nwith air trapping and impairment of gas transport. The PFTs show a reduced\nFEV1/FVC ratio, an elevated TLC, and a reduced DLCO/VA. In &ldquo;pure&rdquo; emphysema,\nobstruction is not reversible. In most patients with COPD, however, some\nbronchial hyper-reactivity is present.\n</p>\n\n<p>\n <b>\n  Interstitial lung disease\n </b>\n . Interstitial lung disease reduces lung\ncompliance, causing a restrictive pattern on PFTs. Lung volumes become\nprogressively smaller and gas transport is impaired. PFTs show a normal\nFEV1/FVC ratio (no obstruction), a low TLC, and a low DLCO/VA.\n</p>\n\n<p>\n <b>\n  Combined obstructive and restrictive lung disease.\n </b>\n Certain\nconditions cause both obstruction and restriction: cystic fibrosis,\nbronchiectasis, eosinophilic granuloma, lymphangioleiomyomatosis, and\ninterstitial disease\n <i>\n  with\n </i>\n emphysema.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Chest bellows diseases\n  </span>\n </b>\n <span>\n  . In disorders that\naffect the chest wall and muscles (e.g., kyphoscoliosis, neuromuscular\ndisease), the lungs are normal but cannot inflate maximally. The FEV1/FVC ratio\nand the DLCO/VA are normal, but the TLC is reduced.\n  <br clear=\"all\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answers\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    1.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </b>\n <b>\n  <span>\n   B.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The patient in Case 1 has emphysema,\nwhich is characterized by a low FEV\n  <sub>\n   1\n  </sub>\n  /FVC ratio, a high TLC, and a\nlow DLCO/VA.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    2.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </b>\n <b>\n  <span>\n   D.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The patient in Case 2 has\n  <b>\n  </b>\n  l\n  <span>\n   ymphangioleiomyomatosis, a condition associated with obstruction and\nrestriction. The low FEV\n   <sub>\n    1\n   </sub>\n   /FVC ratio indicates obstruction; the low\nTLC indicates restriction.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n  <b>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    3.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </b>\n <b>\n  <span>\n   F.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The patient in Case 3 has muscular\ndystrophy, a chest bellows disorder. These disorders are associated with a\nnormal FEV\n  <sub>\n   1\n  </sub>\n  /FVC ratio, a low TLC, and a normal DLCO/VA ratio.\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    4.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </b>\n <b>\n  <span>\n   A.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The patient in Case 4 has asthma, which\nis characterized by a low FEV\n  <sub>\n   1\n  </sub>\n  /FVC ratio, a normal TLC, and a normal\nDLCO/VA ratio.\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    5.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </b>\n <b>\n  <span>\n   C.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The patient in Case 5 has interstitial\nlung disease, which is characterized by a\n  <b>\n  </b>\n  normal FEV\n  <sub>\n   1\n  </sub>\n  /FVC, a low TLC, and a low DLCO/VA ratio.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   <span>\n    6.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </b>\n <b>\n  <span>\n   E.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The patient in Case 6 has\ncirrhosis-associated hypoxemia, a condition characterized by small-vessel\n  <b>\n  </b>\n  arteriovenous\n  <b>\n  </b>\n  malformations, which cause pulmonary shunting. With shunting,\noxygen administration does not adequately reverse hypoxemia.\n  <b>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 52-year-old woman presents with a six-month history of gradually\nprogressive fatigue and shortness of breath on exertion. She denies fever,\nchills, chest pain, and cough. Her past medical history is unremarkable. Her\ntemperature is 98.6\n </span>\n <sup>\n  <span>\n   o\n  </span>\n </sup>\n <span>\n  F, pulse is 88/minute,\nblood pressure is 130/80 mm Hg, and respirations are 20/minute. The heart is\nregular with a loud S2 at the left second intercostal space. A left parasternal\nheave is present. Hepatojugular reflux is noted. The lungs are clear without\ncrackles or wheezes. Chest x-ray is normal. Echocardiogram reveals normal left\nventricular function, a hypertrophied right ventricle, and an estimated\npulmonary systolic pressure of 60 mmHg. Which of the following could be\nassociated with these cardiac findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer G is correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Pulmonary\nhypertension may be associated with\n </span>\n <span>\n  HIV infection,\nscleroderma, cirrhosis, amphetamine use, obesity-hypoventilation, and chronic\nthromboembolism.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Pulmonary\nhypertension (PH) is defined as an abnormal elevation of pulmonary artery\npressure (i.e., average resting pressure &gt; 25 mmHg). Fatigue and exertional\ndyspnea may be the only symptoms, although angina, leg edema, and syncope can\noccur with advanced disease. Physical findings include a loud S2 at the left\nsecond interspace, a left parasternal heave (indicating right ventricular\nhypertrophy), and hepatojugular reflux (indicating right heart failure). In\nadvanced cases, right heart failure manifested by jugular venous distension,\nhepatomegaly, ascites, and peripheral edema may occur. Heart murmurs caused by\npulmonic and tricuspid regurgitation indicate advanced disease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  There are\nfour categories of pulmonary hypertension: arterial, venous, hypoxic, and\nthromboembolic.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"293\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Pulmonary\n  Hypertension\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"293\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"293\">\n    <p class=\"MsoNormal\">\n     <span>\n      Arterial\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Idiopathic\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      HIV infection\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Connective tissue disease (especially scleroderma)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Congenital heart disease (left-to-right shunt)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cirrhosis with portal hypertension\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Drugs (amphetamines, cocaine)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"293\">\n    <p class=\"MsoNormal\">\n     <span>\n      Venous\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Left heart failure\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Mitral stenosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"293\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypoxic\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Lung disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Sleep apnea\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Obesity-hypoventilation\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"293\">\n    <p class=\"MsoNormal\">\n     <span>\n      Thromboembolic\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. HIV infection", "B. Scleroderma", "C. Cirrhosis", "D. Amphetamine use", "E. Obesity-hypoventilation", "F. Chronic thromboembolism", "G. All of the above"]}, {"question": "<p>\n A 9-year-old girl is\nadmitted to the hospital with shortness of breath. She is agitated, her hips\nand knees are painful and swollen, and she has an erythematous rash on her\ntrunk. A chest x-ray shows an enlarged heart and findings consistent with\npulmonary edema. The heart failure gets worse and she dies on the following\nday. Infection of which of the following most likely preceded her admission?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is correct\n  </span>\n </b>\n <span>\n  . Acute rheumatic fever is a sequela\nof Group A streptococcal infection of the pharynx.\n </span>\n</p>\n"], "tutorial": "<p>\n Acute rheumatic fever (ARF)\nis an autoimmune inflammatory process that develops as a sequela of\nstreptococcal infection. It follows pharyngeal infection with group A\nstreptococci and is characterized by nonsuppurative inflammation of the joints,\nheart, subcutaneous tissue, and central nervous system. The risk of developing\nrheumatic fever after an episode of streptococcal pharyngitis is estimated at\n0.3-3%. Acute rheumatic fever may present with any of the following.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Polyarthritis\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Joint\ninvolvement ranges from arthralgias to polyarthritis characterized by redness,\nwarmth, swelling, and tenderness. Frequently involved joints include the knees,\nankles, elbows, and wrists. The small joints of the hands and the spine are\nrarely involved. Inflammation disappears within 2-4 weeks. The arthritis is\nclassically described as migratory, but, in many cases, new joints are affected\nbefore the previously involved joints improve, leaving the appearance of an\nadditive arthritis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Carditis\n  </span>\n </b>\n <span>\n  . This is the only manifestation of ARF with significant\npotential to cause long-term disability and death. The pericardium, myocardium,\nand endocardium may be involved (pancarditis). Signs may include new murmurs,\ncardiac enlargement, heart failure, and pericardial friction rub. Mitral and\naortic regurgitation may occur acutely. Mitral stenosis and aortic stenosis may\ndevelop after many years.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Erythema\nmarginatum\n  </span>\n </b>\n <span>\n  . These skin lesions are evanescent,\nmoving over the skin in serpiginous patterns. Likened to smoke rings, they have\na tendency to advance at the margins while clearing in the center. The lesions\nmay be macular and can disappear in minutes, appearing to change shape while\nbeing examined. They are found on the trunk and proximal extremities and often\ngo unnoticed by patients.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Sydenham\nchorea\n  </span>\n </b>\n <span>\n  . This is a neurological disorder\ncharacterized by emotional lability, personality change, muscular weakness, and\nuncoordinated, involuntary, purposeless movements. The patient may be unable to\nsustain a tetanic contraction (e.g., clenched fist). Other findings include\ndysarthria, gait problems, and poor fine-motor skills.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Subcutaneous\nnodules\n  </span>\n </b>\n <span>\n  . These are uncommon and usually\nassociated with severe carditis. They are usually painless and are found\nprimarily over bony prominences and in tendon sheaths. Common sites include the\nelbows, knees, wrists, ankles, Achilles tendons, back of the scalp, and spinous\nprocesses of the vertebrae.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Other symptoms of ARF include fever, malaise, and abdominal\npain.\n  <span>\n   Proceed to\n  </span>\n </span>\n <a href=\"http://emedicine.medscape.com/article/236582-differential\">\n  <span>\n   Differential Diagnoses\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  [\n </span>\n <a href=\"file://localhost/javascript/showcontent('inactive','authordisclosures')%3B\">\n  <span>\n   CLOSE WINDOW\n  </span>\n </a>\n <span>\n  ]\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Contributor Information and Disclosures\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Author\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Mark\nRaymond Wallace, MD\n  </span>\n </b>\n <span>\n  &nbsp;\nInfectious Disease Fellowship Director, Orlando Regional Healthcare; Clinical\nProfessor of Medicine, Florida State University\n  <br/>\n  <br/>\n  Mark Raymond Wallace, MD is a member of the following medical societies:\n </span>\n <span>\n  <span>\n   American College of\nPhysicians\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American Medical\nAssociation\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American Society of\nTropical Medicine and Hygiene\n  </span>\n </span>\n <span>\n  , and\n </span>\n <span>\n  <span>\n   Infectious Diseases\nSociety of America\n  </span>\n </span>\n <span>\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Coauthor(s)\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Larry I\nLutwick, MD\n  </span>\n </b>\n <span>\n  &nbsp;\nProfessor of Medicine, State University of New York, Downstate Medical School;\nDirector, Infectious Diseases, Veterans Affairs New York Harbor Health Care\nSystem, Brooklyn Campus\n  <br/>\n  <br/>\n  Larry I Lutwick, MD is a member of the following medical societies:\n </span>\n <span>\n  <span>\n   American College of\nPhysicians\n  </span>\n </span>\n <span>\n  and\n </span>\n <span>\n  <span>\n   Infectious Diseases\nSociety of America\n  </span>\n </span>\n <span>\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Jayashree\nRavishankar, MD\n  </span>\n </b>\n <span>\n  &nbsp;\nFellow, Department of Medicine, Division of Infectious Diseases, State\nUniversity of New York Health Science Center at Brooklyn\n  <br/>\n  <br/>\n  Jayashree Ravishankar, MD is a member of the following medical societies:\n </span>\n <span>\n  <span>\n   American College of\nPhysicians\n  </span>\n </span>\n <span>\n  and\n </span>\n <span>\n  <span>\n   Infectious Diseases\nSociety of America\n  </span>\n </span>\n <span>\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Specialty Editor Board\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Thomas J\nMarrie, MD\n  </span>\n </b>\n <span>\n  &nbsp;\nChair, Professor, Department of Medicine, Division of Infectious Diseases,\nUniversity of Alberta College of Medicine\n  <br/>\n  <br/>\n  Thomas J Marrie, MD is a member of the following medical societies:\n </span>\n <span>\n  <span>\n   Alpha Omega Alpha\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American College of\nPhysicians\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American Society for\nMicrobiology\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   Canadian Infectious\nDisease Society\n  </span>\n </span>\n <span>\n  , and\n </span>\n <span>\n  <span>\n   Royal College of\nPhysicians and Surgeons of Canada\n  </span>\n </span>\n <span>\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Francisco\nTalavera, PharmD, PhD\n  </span>\n </b>\n <span>\n  &nbsp;\nSenior Pharmacy Editor, eMedicine\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Richard B\nBrown, MD, FACP\n  </span>\n </b>\n <span>\n  &nbsp;\nChief, Division of Infectious Diseases, Baystate Medical Center; Professor,\nDepartment of Internal Medicine, Tufts University School of Medicine\n  <br/>\n  <br/>\n  Richard B Brown, MD, FACP is a member of the following medical societies:\n </span>\n <span>\n  <span>\n   Alpha Omega Alpha\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American College of\nChest Physicians\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American College of\nPhysicians\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American Medical\nAssociation\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American Society for\nMicrobiology\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   Infectious Diseases\nSociety of America\n  </span>\n </span>\n <span>\n  , and\n </span>\n <span>\n  <span>\n   Massachusetts\nMedical Society\n  </span>\n </span>\n <span>\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Eleftherios\nMylonakis, MD\n  </span>\n </b>\n <span>\n  &nbsp;\nClinical and Research Fellow, Department of Internal Medicine, Division of\nInfectious Diseases, Massachusetts General Hospital\n  <br/>\n  <br/>\n  Eleftherios Mylonakis, MD is a member of the following medical societies:\n </span>\n <span>\n  <span>\n   American Association\nfor the Advancement of Science\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American College of\nPhysicians\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American Society for\nMicrobiology\n  </span>\n </span>\n <span>\n  , and\n </span>\n <span>\n  <span>\n   Infectious Diseases\nSociety of America\n  </span>\n </span>\n <span>\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Chief Editor\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Burke A\nCunha, MD\n  </span>\n </b>\n <span>\n  &nbsp;\nProfessor of Medicine, State University of New York School of Medicine at Stony\nBrook; Chief, Infectious Disease Division, Winthrop-University Hospital\n  <br/>\n  <br/>\n  Burke A Cunha, MD is a member of the following medical societies:\n </span>\n <span>\n  <span>\n   American College of\nChest Physicians\n  </span>\n </span>\n <span>\n  ,\n </span>\n <span>\n  <span>\n   American College of\nPhysicians\n  </span>\n </span>\n <span>\n  , and\n </span>\n <span>\n  <span>\n   Infectious Diseases\nSociety of America\n  </span>\n </span>\n <span>\n  <br/>\n  <br/>\n  Disclosure: Nothing to disclose.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  [\n </span>\n <a href=\"file://localhost/javascript/hiderefcontent('refrenceslayer')%3B\">\n  <span>\n   CLOSE WINDOW\n  </span>\n </a>\n <span>\n  ]\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   References\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n  </span>\n </span>\n <span>\n  Cilliers AM. Rheumatic fever and\nits management.\n  <i>\n   BMJ\n  </i>\n  . Dec 2 2006;333(7579):1153-6.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n  </span>\n </span>\n <span>\n  Stollerman GH. Rheumatic fever.\n  <i>\n   Lancet\n  </i>\n  .\nMar 29 1997;349(9056):935-42.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n  </span>\n </span>\n <span>\n  Bisno AL, Pearce IA, Stollerman\nGH. Streptococcal infections that fail to cause recurrences of rheumatic fever.\n  <i>\n   J Infect Dis\n  </i>\n  . Aug 1977;136(2):278-85.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n  </span>\n </span>\n <span>\n  Shulman ST. Rheumatic heart\ndisease in developing countries.\n  <i>\n   N Engl J Med\n  </i>\n  . Nov 15 2007;357(20):2089;\nauthor reply 2089.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   5.\n  </span>\n </span>\n <span>\n  McDonald M, Currie BJ, Carapetis\nJR. Acute rheumatic fever: a chink in the chain that links the heart to the\nthroat?.\n  <i>\n   Lancet Infect Dis\n  </i>\n  . Apr 2004;4(4):240-5.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   6.\n  </span>\n </span>\n <span>\n  Carapetis JR, McDonald M, Wilson\nNJ. Acute rheumatic fever.\n  <i>\n   Lancet\n  </i>\n  . 2005;366:155-68.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   7.\n  </span>\n </span>\n <span>\n  Erdem G, Mizumoto C, Esaki D,\nReddy V, Kurahara D, Yamaga K, et al. Group A streptococcal isolates temporally\nassociated with acute rheumatic fever in Hawaii: differences from the\ncontinental United States.\n  <i>\n   Clin Infect Dis\n  </i>\n  . Aug 1 2007;45(3):e20-4.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   8.\n  </span>\n </span>\n <span>\n  Guilherme L, Kalil J, Cunningham\nM. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease.\n  <i>\n   Autoimmunity\n  </i>\n  . Feb 2006;39(1):31-9.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   9.\n  </span>\n </span>\n <span>\n  Veasy LG, Wiedmeier SE, Orsmond\nGS. Resurgence of acute rheumatic fever in the intermountain area of the United\nStates.\n  <i>\n   N Engl J Med\n  </i>\n  . Feb 19 1987;316(8):421-7.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   10.\n  </span>\n </span>\n <span>\n  Wallace MR, Garst PD, Papadimos\nTJ, Oldfield EC 3rd. The return of acute rheumatic fever in young adults.\n  <i>\n   JAMA\n  </i>\n  .\nNov 10 1989;262(18):2557-61.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   11.\n  </span>\n </span>\n <span>\n  Erdem G, Dodd A, Tuua A, Sinclair\nS, I'atala TF, Marrone JR, et al. Acute rheumatic fever in American Samoa.\n  <i>\n   Pediatr\nInfect Dis J\n  </i>\n  . Dec 2007;26(12):1158-9.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   12.\n  </span>\n </span>\n <span>\n  Carapetis JR, Steer AC, Mulholland\nEK, Weber M. The global burden of group A streptococcal diseases.\n  <i>\n   Lancet\nInfect Dis\n  </i>\n  . Nov 2005;5(11):685-94.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   13.\n  </span>\n </span>\n <span>\n  Carapetis JR. Rheumatic heart\ndisease in developing countries.\n  <i>\n   N Engl J Med\n  </i>\n  . Aug 2 2007;357(5):439-41.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   14.\n  </span>\n </span>\n <span>\n  Weiner SG, Normandin PA. Sydenham\nchorea: a case report and review of the literature.\n  <i>\n   Pediatr Emerg Care\n  </i>\n  .\nJan 2007;23(1):20-4.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   15.\n  </span>\n </span>\n <span>\n  Marijon E, Ou P, Celermajer DS,\nFerreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease\ndetected by echocardiographic screening.\n  <i>\n   N Engl J Med\n  </i>\n  . Aug 2\n2007;357(5):470-6.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   16.\n  </span>\n </span>\n <span>\n  Marijon E, Ou P, Celermajer DS,\nFerreira B, Mocumbi AO, Sidi D, et al. Echocardiographic screening for\nrheumatic heart disease.\n  <i>\n   Bull World Health Organ\n  </i>\n  . Feb 2008;86(2):84.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   17.\n  </span>\n </span>\n <span>\n  Vijayalakshmi IB, Vishnuprabhu RO,\nChitra N, Rajasri R, Anuradha TV. The efficacy of echocardiographic criterions\nfor the diagnosis of carditis in acute rheumatic fever.\n  <i>\n   Cardiol Young\n  </i>\n  .\nOct 10 2008;1-7.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   18.\n  </span>\n </span>\n <span>\n  Narula J, Kaplan EL.\nEchocardiographic diagnosis of rheumatic fever.\n  <i>\n   Lancet\n  </i>\n  . Dec 8\n2001;358(9297):2000.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   19.\n  </span>\n </span>\n <span>\n  Tubridy-Clark M, Carapetis JR.\nSubclinical carditis in rheumatic fever: a systematic review.\n  <i>\n   Int J Cardiol\n  </i>\n  .\nJun 25 2007;119(1):54-8.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   20.\n  </span>\n </span>\n <span>\n  Lopez-Benitez JM, Miller LC, Schaller\nJG, Moreno LM, de Canata ME. Erroneous diagnoses in children referred with\nacute rheumatic fever.\n  <i>\n   Pediatr Infect Dis J\n  </i>\n  . Feb 2008;27(2):181-2.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   21.\n  </span>\n </span>\n <span>\n  Kaplan EL, Anthony BF, Chapman SS,\nAyoub EM, Wannamaker LW. The influence of the site of infection on the immune\nresponse to group A streptococci.\n  <i>\n   J Clin Invest\n  </i>\n  . Jul 1970;49(7):1405-14.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   22.\n  </span>\n </span>\n <span>\n  Ayoub EM, Nelson B, Shulman ST,\nBarrett DJ, Campbell JD, Armstrong G. Group A streptococcal antibodies in\nsubjects with or without rheumatic fever in areas with high or low incidences\nof rheumatic fever.\n  <i>\n   Clin Diagn Lab Immunol\n  </i>\n  . Sep 2003;10(5):886-90.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   23.\n  </span>\n </span>\n <span>\n  Pereira BA, da Silva NA, Andrade\nLE, Lima FS, Gurian FC, de Almeida Netto JC. Jones criteria and underdiagnosis\nof rheumatic fever.\n  <i>\n   Indian J Pediatr\n  </i>\n  . Feb 2007;74(2):117-21.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   24.\n  </span>\n </span>\n <span>\n  Voss LM, Wilson NJ, Neutze JM,\nWhitlock RM, Ameratunga RV, Cairns LM. Intravenous immunoglobulin in acute\nrheumatic fever: a randomized controlled trial.\n  <i>\n   Circulation\n  </i>\n  . Jan 23\n2001;103(3):401-6.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   25.\n  </span>\n </span>\n <span>\n  Bilavsky E, Eliahou R, Keller N,\nYarden-Bilavsky H, Harel L, Amir J. Effect of benzathine penicillin treatment\non antibiotic susceptibility of viridans streptococci in oral flora of patients\nreceiving secondary prophylaxis after rheumatic fever.\n  <i>\n   J Infect\n  </i>\n  . Apr\n2008;56(4):244-8.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   26.\n  </span>\n </span>\n <span>\n  Dale JB. Current status of group A\nstreptococcal vaccine development.\n  <i>\n   Adv Exp Med Biol\n  </i>\n  . 2008;609:53-63.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   27.\n  </span>\n </span>\n <span>\n  Veasy LG. Time to take soundings\nin acute rheumatic fever.\n  <i>\n   Lancet\n  </i>\n  . Jun 23 2001;357(9273):1994-5.\n </span>\n <span>\n  <span>\n   [Medline]\n  </span>\n </span>\n <span>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347246\" o:spid=\"_x0000_i1178\" type=\"#_x0000_t75\" alt=\"Description: Previous\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image293.png\" o:title=\"Previous\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Previous\" border=\"0\" height=\"25\" src=\"_%20Tutorials_files/image294.png\" v:shapes=\"Picture_x0020_347246\" width=\"78\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347245\" o:spid=\"_x0000_i1177\" type=\"#_x0000_t75\" alt=\"Description: Next\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image295.png\" o:title=\"Next\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Next\" border=\"0\" height=\"25\" src=\"_%20Tutorials_files/image296.png\" v:shapes=\"Picture_x0020_347245\" width=\"78\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  [\n </span>\n <a href=\"file://localhost/javascript/refimghide()%3B\">\n  <span>\n   CLOSE WINDOW\n  </span>\n </a>\n <span>\n  ]\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  [\n </span>\n <a href=\"file://localhost/javascript/hiderefcontent('refimage_zoomlayer')%3B\">\n  <span>\n   CLOSE WINDOW\n  </span>\n </a>\n <span>\n  ]\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  &nbsp;The average duration of an untreated attack is 3\nmonths. Chronic rheumatic fever, generally defined as disease persisting for\nlonger than 6 months, occurs in less than 5% of cases.\n </span>\n</p>\n", "choices": ["A. Pharynx", "B. Lung", "C. Liver", "D. Skin", "E. Meninges"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n32-year-old secretary has a routine chest x-ray before undergoing elective\nsurgery. It shows bilateral hilar lymphadenopathy and a 1-cm calcified nodule\nin the left upper lobe. Physical examination shows no abnormalities. Her serum\ncalcium level is 11 mg/dL. Spirometry results are within normal limits.\nBronchoscopy and bronchoalveolar lavage yields 50% lymphocytes and 50%\nmacrophages. A bronchial biopsy specimen shows a non-necrotizing granuloma.\nStained sections of the specimen show no acid-fast bacilli or fungi. What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The presence of bilateral hilar\nlymphadenopathy, hypercalcemia, and non-necrotizing granulomas suggest a\ndiagnosis of sarcoidosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Silicosis\n </span>\n <span>\n  is a form of occupational lung disease caused by inhalation of crystalline\nsilica dust. It is characterized by inflammation, scarring, and nodule\nformation in the lungs, particularly the upper lobes. Silicosis occurs only in\nindividuals exposed to silica dust (e.g., miners, sandblasters).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Tuberculosis is characterized\nby necrotizing granulomas. The bacteria can be seen using acid-fast stains.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Coccidioidomycosis is\nassociated with granuloma formation. Special fungal stains allow detection of\nfungal organisms.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Wegener&rsquo;s granulomatosis\nis an autoimmune disease characterized by necrotizing vasculitis, necrotizing\ngranulomatous inflammation of the respiratory tract, and necrotizing\nglomerulonephritis.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Sarcoidosis\nis a disease of unknown cause characterized by the presence of noncaseating\ngranulomas in multiple organs. The lungs and the lymph nodes in the mediastinum\nand hilum are the principal sites of involvement, but the disorder is systemic\nand may affect other organs, such as the skin, eyes, nerves, heart, and joints.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nclinical course ranges from asymptomatic to rapidly progressive. The peak age\nat onset is in the 20s and 30s. Women are affected more often than men. 90% of\npatients have intrathoracic involvement on chest radiograph. Well-defined,\nnoncaseating granulomas are found in the pulmonary parenchyma. The upper lobes\nof the lung are more often affected than the lower lobes. Hilar and mediastinal\nlymphadenopathy is usually bilateral and symmetric. Respiratory symptoms may\ninclude shortness of breath, cough, and chest pain. A third of patients have\nconstitutional symptoms, including fever, weight loss, malaise, and fatigue. Up\nto 20% have bilateral hilar adenopathy and erythema nodosum (\n  <span>\n   Lofgren's syndrome), which may be\naccompanied by f\n  </span>\n  ever and arthralgias.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ndiagnosis of sarcoidosis is confirmed by the presence of well-formed\nnoncaseating granulomas in one or more organs. Special stains and cultures are\nused to exclude mycobacterial and fungal infection. Patients with sarcoidosis\noften have elevated levels of angiotensin-converting enzyme (ACE), produced by\nepithelioid cells and macrophages in the granulomas. Hypercalcemia sometimes\noccurs due to\n  <a name=\"4-u1.0-B978-1-4160-2805-5..50100-2--p670\">\n  </a>\n  elevated\nlevels of 1,25-dihydroxyvitamin D (calcitriol), also produced by macrophages\nwithin the granulomas.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347244\"\n o:spid=\"_x0000_i1176\" type=\"#_x0000_t75\" alt=\"Description: CXR\">\n <v:imagedata src=\"_%20Tutorials_files/image297.jpg\" o:title=\"CXR\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: CXR\" border=\"0\" height=\"208\" src=\"_%20Tutorials_files/image298.png\" v:shapes=\"Picture_x0020_347244\" width=\"218\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Sarcoidosis: Bilateral hilar lymphadenopathy\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347243\"\n o:spid=\"_x0000_i1175\" type=\"#_x0000_t75\" alt=\"Description: S\">\n <v:imagedata src=\"_%20Tutorials_files/image299.jpg\" o:title=\"S\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: S\" border=\"0\" height=\"191\" src=\"_%20Tutorials_files/image300.png\" v:shapes=\"Picture_x0020_347243\" width=\"253\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Sarcoidosis: Noncaseating granuloma with giant cell\n </span>\n</p>\n", "choices": ["A. Silicosis", "B. Sarcoidosis", "C. Tuberculosis", "D. Coccidioidomycosis", "E. Wegener\u2019s granulomatosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n52-year-old man presents to the hospital with dysarthria and right-sided\nhemiplegia of one hour&rsquo;s duration. He has not seen a doctor in 30 years and\ntakes no medicine. His blood pressure is 190/120 mm Hg (without orthostatic\nchange) and his pulse is 88/minute. There are no carotid bruits. The heart is\nregular and the lungs are clear. Radial and femoral pulses are simultaneous.\nThe legs are not edematous.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood test\nresults:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span lang=\"PT-BR\">\n  Na\n  <sup>\n   +\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  145\nmEq/L (normal: 136-145 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span lang=\"PT-BR\">\n  K\n  <sup>\n   +\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  2.8\nmEq/L (normal: 3.5-5.0 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span lang=\"PT-BR\">\n  Cl\n  <sup>\n   -\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  110\nmEq/L (normal: 95-105 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span lang=\"PT-BR\">\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </sup>\n  32\nmEq/L (normal: 22-28 mEq/L)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The combination of hypertension,\nhypokalemia, and an elevated serum bicrabonate level suggests a\nhigh-aldosterone state. Primary hyperaldosteronism is the most likely\ndiagnosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Essential hypertension\ndoes not cause hypokalemia or an elevated serum bicarbonate level.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Pheochromocytoma\ngenerally presents with episodic or sustained elevations of blood pressure,\naccompanied by headache, palpitations, perspiration, and pallor. Hypokalemia is\nnot typical of this condition.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Coarctation of the aorta\nis unlikely given the simultaneousness of the radial and femoral pulses. Also,\ncoarctation is not associated with hypokalemia.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . This patient does not\nhave symptoms of thyrotoxicosis, which include weight loss, increased appetite,\nanxiety, heat intolerance, tremor, and sweating.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Hypertension,\n </span>\n a chronic medical condition characterized by\nelevation of systemic arterial blood pressure, is classified as primary\n(essential) or secondary. About 90&ndash;95% of cases are &ldquo;primary,&rdquo; meaning\nthat the high blood pressure has no obvious cause. The remaining 5&ndash;10% of\ncases are &ldquo;secondary,&rdquo; meaning that some indentifiable disorder is causing high\nblood pressure. A thorough search for secondary causes is not cost-effective in\nmost patients with hypertension, but becomes critically important in two\ncircumstances: (1) when there is a compelling finding on the initial evaluation\nand (2) when the hypertensive process is so severe that it is either refractory\nto intensive multiple-drug therapy or requires hospitalization.\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   GUIDE\nTO EVALUATION OF SECONDARY HYPERTENSION\n  </span>\n </b>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td valign=\"bottom\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Suspected\n   Diagnosis\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Clinical\n   Clues\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Diagnostic\n   Testing\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Renal parenchymal\n  hypertension\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Reduced\n  GFR\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Urine\n  albumin-to-creatinine ratio &ge;30 mg/g\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Renal\n  ultrasonography\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     &nbsp;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Renovascular disease\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     New\n  elevation in serum creatinine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Marked\n  elevation in serum creatinine with initiation of ACEI or ARB\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Refractory\n  hypertension\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Flash\n  pulmonary edema\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Abdominal\n  bruit\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Doppler\n  ultrasonography\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Magnetic\n  resonance angiography\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     CT\n  angiography\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Invasive\n  angiography\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Coarctation of the aorta\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Arm\n  BP &gt; leg BP\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Chest\n  bruits\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Rib\n  notching on chest radiography\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Magnetic\n  resonance imaging\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Aortography\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Primary aldosteronism\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Hypokalemia\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Metabolic\n  alkalosis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Refractory\n  hypertension\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Plasma\n  renin and aldosterone\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     24-hour\n  urine potassium\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Adrenal\n  CT\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Adrenal\n  vein sampling\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cushing's syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Truncal\n  obesity\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Violaceous\n  striae\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Muscle\n  weakness\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     24-hour\n  urine for cortisol\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Dexamethasone\n  suppression test\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Adrenal\n  CT\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pheochromocytoma\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Paroxysmal\n  hypertension\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Headaches,\n  palpitations, perspiration, and pallor\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Plasma\n  metanephrine and normetanephrine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     24-hour\n  urine catecholamines\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Adrenal\n  CT\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Obstructive sleep apnea\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Loud\n  snoring\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Daytime\n  somnolence\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Obesity\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Large\n  neck\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Sleep\n  study\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Renal Parenchymal Hypertension\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Chronic kidney disease is the most common cause of secondary\nhypertension. Hypertension is present in more than 85% of patients with chronic\nkidney disease and is a major factor causing their increased cardiovascular\nmorbidity and mortality. The mechanisms causing the hypertension include an\nexpanded plasma volume and peripheral vasoconstriction. The peripheral\nvasoconstriction is caused by both activation of vasoconstrictor pathways\n(renin-angiotensin and sympathetic nervous systems) and inhibition of vasodilator\npathways (nitric oxide). Renal insufficiency should be considered when there is\nproteinuria by dipstick or when the serum creatinine level is greater than 1.2\nmg/dL in hypertensive women or greater than 1.4 mg/dL in hypertensive men.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Renovascular Hypertension\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The main causes of renal artery stenosis are atherosclerosis\n(85% of cases), typically in older persons with other clinical manifestations\nof systemic atherosclerosis, and fibromuscular dysplasia (15% of cases),\ntypically in women between the ages of 15 and 50 years. Renal artery stenosis\nleads to underperfusion of the juxtaglomerular cells, thereby producing\nrenin-dependent hypertension. The following clinical clues increase the\nsuspicion of renovascular hypertension: any hospitalization for urgent or\nemergent hypertension; recurrent &ldquo;flash&rdquo; pulmonary edema; recent worsening of\nlong-standing, previously well controlled hypertension; severe hypertension in\na young woman or in an older adult after the age of 50 years; precipitous and\nprogressive worsening of renal function in response to angiotensin-converting\nenzyme (ACE) inhibition or angiotensin II receptor blockade; unilateral small\nkidney; extensive peripheral arteriosclerosis; and a flank bruit.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Coarctation of the aorta\n  </span>\n </u>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Coarctation of the aorta typically occurs just distal to the\norigin of the left subclavian artery, so the blood pressure is lower in the\nlegs than in the arms (opposite of the normal situation)\n  <a name=\"4-u1.0-B978-1-4160-2805-5..50071-9--intr\">\n  </a>\n  . The clue is that pulses are\nweaker in the lower than in the upper extremities, indicating the need to\nmeasure blood pressure in the legs as well as in both arms. Intercostal\ncollaterals can produce bruits on examination and rib notching on chest\nradiograph. Coarctation can be cured with surgery or angioplasty.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Primary Aldosteronism\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The most common causes of primary aldosteronism are a\nunilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia.\nBecause aldosterone is the principal ligand for the mineralocorticoid receptor\nin the distal nephron, excessive aldosterone production causes excessive renal\nNa\n  <sup>\n   +\n  </sup>\n  -K\n  <sup>\n   +\n  </sup>\n  exchange, often resulting in hypokalemia and an\nelevated serum bicarbonate (\n </span>\n <span>\n  HCO\n  <sub>\n   3\n  </sub>\n  <sup>\n   -\n  </sup>\n </span>\n <span>\n  )\nlevel. The diagnosis should always be suspected when hypertension is\naccompanied by either unprovoked hypokalemia (serum potassium concentration\nbelow 3.5 mmol/L in the absence of diuretic therapy)\n  <a name=\"4-u1.0-B978-1-4160-2805-5..50071-9--p437\">\n  </a>\n  or a tendency to develop\nexcessive hypokalemia during diuretic therapy (serum potassium concentration\nbelow 3.0 mmol/L).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Cushing&rsquo;s syndrome\n  </span>\n </u>\n</p>\n\n<p>\n <span>\n  Cushing's syndrome\n </span>\n is a condition associated with high serum\nlevels of cortisol. It can be caused by taking glucocorticoid drugs (e.g.,\nprednisone), or by tumors that produce cortisol or adrenocorticotropic hormone\n(ACTH). Cushing's disease refers to one specific cause of the syndrome, a tumor\n(adenoma) in the pituitary gland that produces large amounts of ACTH, which in\nturn elevates cortisol. It is the most common cause of Cushing's syndrome,\nresponsible for 70% of cases, excluding glucocorticoid-related cases. Findings in\nCushing&rsquo;s syndrome include rapid weight gain, truncal obesity, &ldquo;buffalo hump,&rdquo;\n&ldquo;moon face,&rdquo; excess sweating, telangiectasia, thinning of the skin, violaceous\nstriae, proximal muscle weakness, osteoporosis, amenorrhea, decreased libido,\ninfertility, hirsutism, psychological disturbance, and hyperglycemia.\n <a href=\"http://en.wikipedia.org/wiki/Cushing's_syndrome#cite_note-1#cite_note-1\">\n </a>\n <u>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Pheochromocytoma\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Pheochromocytomas are rare catecholamine-producing tumors of\nthe adrenal (or sometimes extra-adrenal) chromaffin cells. The diagnosis should\nbe suspected when hypertension is accompanied by frequent or refractory\nheadaches or by paroxysms of palpitations, perspiration, and pallor. In some\npatients, pheochromocytoma is misdiagnosed as panic disorder. A family history\nof early-onset hypertension may suggest pheochromocytoma as part of a multiple\nendocrine neoplasia syndrome. If the diagnosis is missed, outpouring of\ncatecholamines from the tumor can cause unsuspected hypertensive crisis during\nsurgical or diagnostic procedures. In such cases, mortality exceeds 80%.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Sleep Apnea\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Clues to the presence of sleep apnea include obesity, l\n </span>\n <span>\n  oud snoring, daytime\nsomnolence, and obesity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Thyroid disease\n  </span>\n </u>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Both hyperthyroidism and hypothyroidism raise blood pressure.\nHyperthyroidism tends to cause systolic hypertension with a wide pulse\npressure, whereas hypothyroidism tends to cause mainly diastolic hypertension.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Drugs\n  </span>\n </u>\n</p>\n\n<p>\n Drugs associated with hypertension include alcohol,\namphetamines, ecstasy (MDMA and derivatives), cocaine, corticosteroids,\ncyclosporine, erythropoietin, estrogens (including birth control pills), and\nnasal decongestants.\n</p>\n", "choices": ["A. Essential hypertension", "B. Pheochromocytoma", "C. Hyperaldosteronism", "D. Coarctation of the aorta", "E. Thyrotoxicosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n45-year-old African-American man is being evaluated for hypertension. He was\ndiagnosed with high blood pressure several years ago and was treated with\namlodipine. Since then, lisinopril and hydrochlorothiazide have been added to\nhis regimen, but his blood pressure remains elevated. He does not smoke, drink\nalcohol, or use illegal drugs. He usually wakes up with a headache, and he is\ntired and sleepy throughout the day. He has gained 50 lbs in the last few\nyears. Temperature is 98\n  <sup>\n   o\n  </sup>\n  F, pulse in 95/minute, blood pressure is\n180/100 mm Hg, and weight is 350 lbs. Heart sounds are distant and lungs are\nclear. Ankles are edematous. A complete blood count, chemistry profile, and\nthyroid panel are normal.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What of\nthe following tests is most likely to confirm the diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is correct.\n  </span>\n </b>\n <span>\n  Uncontrolled hypertension in a morbidly obese\npatient with daytime sleepiness and morning headache suggests a diagnosis of\nobstructive sleep apnea. Polysomnography can be used to establish the diagnosis\nand to assess its severity.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nRenal artery stenosis may be caused by fibromuscular dysplasia or\natherosclerosis. Fibromuscular dysplasia typically occurs in young women.\nAtherosclerosis usually occurs in older patients with risk factors for vascular\ndisease. Patients with renal artery stenosis may present with hypertension\nand/or renal insufficiency. An abdominal bruit is sometimes audible. Doppler\nultrasound of the renal arteries is usually the first step in diagnosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect\n  </span>\n </b>\n <span>\n  .\nCushing&rsquo;s syndrome is associated with hyperglycemia, hypertension, central\nobesity, violaceous abdominal striae, thinning of the skin, easy bruising,\ncataracts, osteoporosis, emotional disturbance, and sexual dysfunction.\nDiagnosis can be made by measuring urinary free cortisol or with the dexamethasone\nsuppression test.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect\n  </span>\n </b>\n <span>\n  .\nPatients with pheochromocytoma may present with recurrent episodes of headache,\npalpitations, diaphoresis, and severe hypertension. Diagnosis is made by\nmeasuring catecholamines and metanephrines in the urine.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  .\nPrimary hyperaldosteronism may be caused by adrenal tumor or bilateral adrenal\nhyperplasia. Patients usually present with hypertension and hypokalemia.\nDiagnosis is made by measuring plasma renin activity and plasma aldosterone\nconcentration.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The principal causes of secondary hypertension are\nlisted below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes of Secondary Hypertension\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Drugs:\n  alcohol, NSAIDs, steroids, decongestants\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Sleep apnea\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Renal\n  artery stenosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Chronic\n  renal disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pheochromocytoma\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hyperaldosteronism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cushing&rsquo;s\n  syndrome\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hyperparathyroidism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Acromegaly\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypothyroidism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hyperthyroidism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n      Scleroderma\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Obstructive\nsleep apnea commonly presents with daytime fatigue and somnolence, morning\nheadache, and hard-to-treat hypertension. Patients are observed to be restless\nsleepers, with snoring often accompanied by episodes of gasping, choking, and\ninterrupted breathing. Male gender and obesity are major risk factors.\nDiagnosis is made by overnight sleep study (polysomnography).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Doppler ultrasound of the renal arteries", "B. 24-hour urine collection for cortisol", "C. 24-hour urine collection for catecholamines and metanephrines", "D. Measurement of plasma renin activity and plasma aldosterone concentration", "E. Polysomnography"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n74-year-old woman with congestive heart failure (ejection fraction of 30%) and\nCOPD presents to the emergency department with a 1-week history of headache,\nshortness of breath, dry cough, and swelling of the face and neck. She is\nfatigued and has lost 20 lbs in three months. Her medications include\nlisinopril, digoxin, furosemide, aspirin, and tiotropium. Family history is\npositive for a ruptured abdominal aneurysm in the father. On physical exam,\ntemperature 36.0&deg;C, pulse is 82/minute, blood pressure is 137/79 mm Hg, and\nrespirations are 22/minute. Her face is red and swollen; her neck veins are\ndistended. Heart is regular without murmurs, rubs, or gallops. Lungs are clear\nwithout crackles or wheezes. Legs are non-edematous. Laboratory tests show mild\nanemia and hypoalbuminemia. EKG shows normal sinus rhythm.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Chest\nX-ray is below:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347242\"\n o:spid=\"_x0000_i1174\" type=\"#_x0000_t75\" alt=\"Description: cava-fig1\">\n <v:imagedata src=\"_%20Tutorials_files/image301.jpg\" o:title=\"cava-fig1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: cava-fig1\" border=\"0\" height=\"240\" src=\"_%20Tutorials_files/image302.png\" v:shapes=\"Picture_x0020_347242\" width=\"231\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe correct diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is correct.\n  </span>\n </b>\n <span>\n  Superior vena cava (SVC) syndrome is usually a sign of advanced malignant\ndisease. Gradual narrowing of the SVC occurs because of tumor compression.\nLung, breast, and mediastinal neoplasms are the predominant cause of SVC\nsyndrome, with adenocarcinoma of the lung being the most common cause. Symptoms\nmay include cough, dyspnea, and dysphagia, as well as redness and swelling of\nthe face, neck, and upper extremities. Collateral venous circulation causes\ndistension of the superficial veins in the chest. SVC syndrome is a clinical\ndiagnosis. Tissue diagnosis is usually needed to guide therapy, which may\ninvolve chemotherapy or radiation to shrink the tumor. The three-year survival\nis less than 10%.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect.\n  </span>\n </b>\n <span>\n  Angioedema is characterized by rapid swelling of the mouth, tongue, and throat.\nThe rest of the face and neck are usually spared. Stridor occurs in severe\ncases.\n </span>\n <a href=\"http://en.wikipedia.org/wiki/ACE_inhibitors\" title=\"ACE inhibitors\">\n  <span>\n   ACE-inhibitors\n  </span>\n </a>\n <span>\n  (e.g., lisinopril) are\na common cause of angioedema.\n </span>\n</p>\n", "<p>\n <b>\n  Answer C is incorrect.\n </b>\n Pulmonary hypertension is associated with\n <a href=\"http://en.wikipedia.org/wiki/Shortness_of_breath\" title=\"Shortness of breath\">\n  <span>\n   shortness of breath\n  </span>\n </a>\n and\n <a href=\"http://en.wikipedia.org/wiki/Fatigue_(physical)\" title=\"Fatigue (physical)\">\n  <span>\n   fatigue\n  </span>\n </a>\n . Physical examination shows a loud S2\nat the left second interspace and a left parasternal heave. Jugular vein\ndistension, hepatomegaly, ascites, and pedal\n <a href=\"http://en.wikipedia.org/wiki/Edema\" title=\"Edema\">\n  <span>\n   edema\n  </span>\n </a>\n occur in advanced\ncases.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect.\n  </span>\n </b>\n <span>\n  Aortic\naneurysms are usually asymptomatic, but they can rupture, causing severe pain\nand internal hemorrhage. (Note: In this case, the chest X-ray shows a\nsupra-hilar lung mass, not an aneurysm.)\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Pericardial tamponade is\nan\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Medical_emergency\" title=\"Medical emergency\">\n  <span>\n   emergency\n  </span>\n </a>\n <span>\n  condition caused by\nfluid accumulation in the\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Pericardium\" title=\"Pericardium\">\n  <span>\n   pericardium\n  </span>\n </a>\n <span>\n  , which results in\nreduced ventricular filling and hemodynamic compromise. Shortness of breath is\ncommon. Extremities may be cool and clammy. Examination reveals jugular vein\ndistension, tachycardia, hypotension, and pulsus paradoxus.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. Angioedema caused by the lisinopril", "B. Superior vena cava syndrome", "C. Pulmonary hypertension", "D. Aortic aneurysm", "E. Cardiac tamponade"]}]}, {"section": "Gastrointestinal & Genitourinary", "questions": [{"question": "<p class=\"MsoNormal\">\n <span>\n  Match the\ncondition with its classic presentation.\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <span>\n  Answers\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  9.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Acute viral hepatitis is characterized\nby fever, malaise, muscle and joint aches, headache, nausea, vomiting,\nabdominal pain, jaundice, and dark urine. The AST and ALT are very high.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  7.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Biliary colic is characterized by steady\npain in the epigastrium and right upper quadrant that lasts for several hours\nand resolves spontaneously. The word &ldquo;colic&rdquo; is a misnomer because the pain is\nusually steady, not colicky. Pain occurs when a gallstone gets caught in the\ncystic duct and contraction of the gall bladder results in increased pressure\nin the gall bladder.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  6.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  Acute cholecystitis is\ncharacterized by fever, nausea, vomiting, and pain in the right upper quadrant.\nMurphy&rsquo;s sign may be present. (Palpation beneath the right costal margin in the\nmid-clavicular line causes the patient to wince with inspiration.)\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5.\nAscending cholangitis is characterized by fever, chills, rigors, jaundice, and\nright upper quadrant pain. Confusion and hypotension may occur if the patient\nbecomes septic. Serum alkaline phosphatase and bilirubin levels are elevated.\n  <span>\n   Ascending cholangitis\n  </span>\n  (sometimes\ncalled\n  <span>\n   acute cholangitis)\n  </span>\n  is an\ninfection of the bile duct (cholangitis), usually caused by bacteria ascending\nfrom the duodenum. It tends to occur if the bile duct is partially obstructed\nby gallstones (often in the hepatopancreatic ampulla, or ampulla of Vater).\n  <sup>\n  </sup>\n  Cholangitis can be life-threatening and is regarded as a medical\nemergency. Initial treatment is with intravenous fluids and antibiotics, but\nthere is often an underlying problem (such as gallstones) for which further\ntests and treatment may be necessary.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  12.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Duodenal ulcer is characterized by a\n&ldquo;gnawing&rdquo; pain in the epigastrium that improves with eating.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  13.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Gastroesophageal reflux is characterized\nby heartburn and regurgitation.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  3.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Acute pancreatitis is characterized by\nsevere upper abdominal pain, nausea, and vomiting. Serum amylase and lipase\nlevels are elevated.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  4.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  Irritable bowel syndrome is\ncharacterized by bloating, cramping, and bouts of diarrhea alternating with\nperiods of constipation. Abdominal discomfort is relieved by bowel movements.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  11.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Intestinal obstruction is characterized\nby crampy mid-abdominal pain, vomiting, and constipation. The abdomen is\ndistended and tympanitic to percussion.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   J.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  1.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Appendicitis is characterized by fever,\nnausea, vomiting, and abdominal pain at McBurney&rsquo;s point (the point that is\none-third of the distance from the right anterior superior iliac spine to the\numbilicus). The pain may improve with hip flexion and worsen with extension.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   K.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  14.\nDiverticulitis is characterized by fever and left lower quadrant abdominal\npain.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   L.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  8.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Pyelonephritis is characterized by\nburning with urination, fever, chills, abdominal pain, vomiting, and tenderness\nover the costovertebral angle.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   M.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Ureteral colic, caused by urolithiasis,\nis characterized by writhing and spasms of severe abdominal pain. The pain may\nradiate from the flank to the groin area and may be associated with nausea and\nvomiting. Hematuria may be present.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   N.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Cystitis is characterized by urinary\nfrequency, urgency, and burning.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   O.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  15.\nChronic mesenteric ischemia should be suspected in patients with\natherosclerotic vascular disease who present with post-prandial periumbilical\nabdominal pain. Classically, the pain begins 30 minutes after eating and\nresolves 2 hours later. The condition can be diagnosed by Doppler ultrasound of\nthe mesenteric arteries.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. Acute viral hepatitis", "B. Biliary colic", "C. Acute cholecystitis", "D. Ascending cholangitis", "E. Duodenal ulcer", "F. Gastroesophageal reflux", "G. Acute pancreatitis", "H. Irritable bowel syndrome", "I. Intestinal obstruction", "J. Appendicitis", "K. Diverticulitis", "L. Pyelonephritis", "M. Ureteral colic", "N. Cystitis", "O. Chronic mesenteric ischemia", "1. 22-year-old man with fever, nausea, vomiting, and abdominal pain. The pain begins in the peri-umbilical region and progresses to the right lower quadrant. The pain improves with flexion and worsens with extension of the hip. Rebound tenderness in elicited in the right lower quadrant.", "2. 29-year-old woman with frequent urination associated with urgency and burning.", "3. 32-year-old man with severe upper abdominal pain, nausea, and vomiting. Serum amylase and lipase levels are elevated.", "4. 35-year-old woman with bloating, cramping, and bouts of diarrhea alternating with periods of constipation. Bowel movements relieve abdominal discomfort.", "5. 38-year-old woman with fever, chills, rigors, jaundice, and right upper quadrant pain. She becomes confused and hypotensive. Serum alkaline phosphatase and bilirubin levels are elevated.", "6. 38-year-old woman with fever, nausea, vomiting, and pain in the right upper quadrant. Palpation beneath the right costal margin in the mid-clavicular line causes her to wince with inspiration.", "7. 38-year-old woman with steady pain in the epigastrium and right upper quadrant that lasts for several hours and resolves spontaneously. She had a similar episode last week.", "8. 41-year-old woman with a 5-day history of burning with urination develops fever, chills, abdominal pain, vomiting, and tenderness over the left costovertebral angle.", "9. 42-year-old man with fever, malaise, muscle and joint aches, headache, nausea, vomiting, abdominal pain, jaundice, and dark urine. AST and ALT are elevated.", "10. 46-year-old man with spasms of severe abdominal pain and writhing. The pain radiates from the left flank to the groin area and is associated with nausea and vomiting. Blood is noted in the urine.", "11. 50-year-old man with crampy mid-abdominal pain, vomiting, and inability to pass flatus or stool. His abdomen is distended and tympanitic to percussion.", "12. 53-year-old man with a \u201cgnawing\u201d pain in the epigastrium that improves with eating.", "13. 60-year-old man with heartburn and regurgitation.", "14. 68-year-old man with fever and abdominal pain in the left lower quadrant. The white blood cell count is elevated.", "15. 66-year-old man presents to the clinic with a 6-month history of intermittent abdominal pain that begins 30 minutes after eating a meal and resolves 2 hours later. The pain is located in the periumbilical area. He has lost weight and is afraid of eating. He has a 30 pack-year history of smoking, hypertension, coronary artery disease, and peripheral vascular disease."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Mrs. Smith\nis a pregnant woman with a marked decrease in amniotic fluid. Mrs. Jones is a\npregnant woman with a marked increase in amniotic fluid. Which of the following\ndisorders could explain these findings?\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mrs. Smith\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mrs. Jones\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      A\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inadequate\n  fusion of the maxillary and medial nasal prominences\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Congenital\n  heart disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      B\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p class=\"MsoNormal\">\n     <span>\n      Maldevelopment\n  of the dermis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Erythroblastosis\n  fetalis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      C\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p class=\"MsoNormal\">\n     <span>\n      Failure\n  of limb buds to grow\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Horseshoe\n  kidney\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      D\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p class=\"MsoNormal\">\n     <span>\n      Bilateral\n  renal agenesis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Duodenal\n  atresia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      E\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p class=\"MsoNormal\">\n     <span>\n      Arrested\n  migration of neural crest cells to the distal colon\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Neural\n  tube defect\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Amniotic\nfluid is\n  <i>\n   produced\n  </i>\n  mainly by fetal\nurination, particularly during late gestation. The fetal kidneys start making\nurine before the end of the first trimester. Urine production increases until\nterm gestation. Amniotic fluid also comes from the fetal lungs. The lungs\nproduce fluid that exits the trachea and is either swallowed or expelled into\nthe amniotic sac. Amniotic fluid is\n  <i>\n   removed\n  </i>\n  mainly by fetal swallowing, which begins early in gestation. Some amniotic\nfluid shifts into the fetal circulation through the placenta. (A large osmotic\ngradient exists between the amniotic fluid and fetal blood).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Oligohydramnios\n </span>\n <span>\n  is a deficiency of amniotic fluid. Fetal anomalies remain the most common\nreason.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Causes include:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Fetal\nurinary tract anomalies, such as renal agenesis (Potter&rsquo;s syndrome), polycystic\nkidneys, or any urinary obstructive lesion (e.g., posterior urethral valves)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  PROM\nand chronic leakage of the amniotic fluid\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Chorioamnionitis is an\nadditional important maternal complication from oligohydramnios due to rupture\nof the membranes, which has an incidence of 21-74%.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The earlier\nchorioamnionitis occurs in pregnancy, the greater the fetal risk of\nbronchopulmonary dysplasia (BPD), neurologic complications, pulmonary\nhypoplasia, and, in severe cases, respiratory failure in the neonate.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Placental\ninsufficiency, as seen in pregnancy-induced hypertension (PIH), maternal\ndiabetes, or postmaturity syndrome when the pregnancy extends beyond 42 weeks'\ngestation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Maternal\nuse of prostaglandin synthase inhibitors or ACE inhibitors and angiotensin\nreceptor blockers (ARBs).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   ACE-inhibitors and ARBs are absolutely\ncontraindicated in pregnancy\n  </i>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n <span>\n  Polyhydramnios\n </span>\n is an excess of amniotic fluid. The underlying\ncause of the excessive amniotic fluid volume is obvious in some clinical\nconditions and is not completely understood in others. Causes include the\nfollowing:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Twin\ngestation with twin-to-twin transfusion syndrome (increased amniotic fluid in\nthe recipient twin and decreased amniotic fluid in the donor) or multiple\ngestations\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Fetal\nanomalies that impair fetal swallowing, including esophageal atresia (usually\nassociated with a tracheoesophageal fistula), tracheal agenesis, duodenal\natresia, and other intestinal atresias\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  CNS\nabnormalities and neuromuscular diseases that cause swallowing dysfunction\nincluding anencephaly.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Congenital\ncardiac-rhythm anomalies associated with hydrops, fetal-to-maternal hemorrhage,\nand parvovirus infection\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Poorly\ncontrolled maternal diabetes mellitus (Oligohydramnios may also be seen if\nsevere vascular disease is present.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Chromosomal\nabnormalities, most commonly trisomy 21, followed by trisomy 18 and trisomy 13.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Fetal\nakinesia syndrome with absence of swallowing\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Idiopathic:\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  the vast majority of cases of\npolyhydramnios are idiopathic (historically up to 60%)\n </span>\n</p>\n\n<p>\n <b>\n  Answer D is correct\n </b>\n . Mrs. Smith has a deficiency of amniotic fluid\n(oligohydramnios). The main source of amniotic fluid is fetal urination, which\nis absent in patients with bilateral renal agenesis. Mrs. Jones has an excess\nof amniotic fluid (polyhydramnios). Most amniotic fluid is removed by fetal\nswallowing, which is impaired in a variety of gastrointestinal disorders such\nas duodenal atresia.\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 42-year-old woman\npresents with a 2-week history of low-grade fever and jaundice. Her medical\nhistory is significant for diabetes mellitus, rheumatoid arthritis, and\nHashimoto&rsquo;s thyroiditis. She takes metformin, plaquenil, and levothyroxine. She\ntraveled to Mexico six months ago and stayed for a week. On physical\nexamination, she has hepatomegaly and mild jaundice.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Her lab test results show:\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  AST\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  252\nU/L\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  ALT\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  368\nU/L\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Alk phos\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  90\nU/L\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Total bilirubin:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3.2\nmg/dl\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Which of the following\ndiagnostic tests would be most helpful?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . The patient most likely has autoimmune hepatitis, given her history of\nother autoimmune diseases: diabetes, rheumatoid arthritis, and Hashimoto&rsquo;s\nthyroiditis. The presence of anti-nuclear antibody and anti-smooth muscle\nantibodies would support the diagnosis of autoimmune thyroiditis.\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n <span>\n  . Wilson&rsquo;s disease is an autosomal recessive\ndisorder characterized by the accumulation of copper in tissues. Patients may\npresent with liver disease, neurological disease, or psychiatric symptoms.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Hepatitis A is unlikely to occur six months after a trip to Mexico. The\nincubation period for the virus is only 2-6 weeks.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Acetaminophen toxicity presents more acutely and is usually associated\nwith much higher AST and ALT levels (&ge; 3000 U/L).\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Antimitochondrial antibodies are associated with primary biliary\ncirrhosis. Patients with primary biliary cirrhosis have a disproportionate\nelevation of the alkaline phosphatase and total bilirubin levels. This is known\nas a &ldquo;cholestatic&rdquo; pattern. Patients with autoimmune hepatitis have a\ndisproportionate elevation of aminotransferases (AST and ALT). This is known as\na &ldquo;hepatocellular&rdquo; pattern.\n </span>\n <span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Autoimmune hepatitis\n  </span>\n </b>\n <span>\n  is a chronic inflammatory disorder of the liver\nof unknown cause. It is characterized by presence of autoantibodies, high\nlevels of serum immunoglobulins, and frequent association with other autoimmune\ndiseases. The disease is more common in women than men and typically has its\nonset either in childhood and young adulthood or around the time of menopause.\nAutoimmune hepatitis is one of the three major autoimmune liver diseases, along\nwith primary biliary cirrhosis and primary sclerosing cholangitis\n  <a name=\"4-u1.0-B978-1-4160-2805-5..50157-9--intr\">\n  </a>\n  . The pathogenesis of\nautoimmune hepatitis is not known, but it is believed to be caused by\nautoimmune reactions against normal hepatocytes. The disease seems to occur in\ngenetically predisposed individuals on exposure to as yet unidentified noxious\nenvironmental agents that trigger an autoimmune process directed at liver\nantigens.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Autoimmune hepatitis is\na heterogeneous disease with a wide spectrum of clinical features. It tends to\nbe more severe and florid in onset than chronic hepatitis B or C. Autoimmune\nhepatitis is usually progressive and leads to end-stage liver disease if not\ntreated with immunosuppression. In some patients it is detected before the\nonset of symptoms and jaundice if elevated serum aminotransferase levels are\nfound on a routine health evaluation. More typically, patients are first seen\nbecause of jaundice and fatigue. Abnormalities in routine liver test results\nare also similar to the abnormalities found in other forms of chronic hepatitis\nwith elevations in serum aminotransferase levels. Elevations in bilirubin or\nalkaline phosphatase indicate more severe or advanced disease. Perhaps most\ncharacteristic of autoimmune hepatitis are striking elevations in serum gamma\nglobulin and, specifically, immunoglobulin G (IgG), accompanied by\nautoantibodies.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The presence of serum\nautoantibodies is the basis for diagnosis of the two types of autoimmune\nhepatitis: autoimmune hepatitis is characterized by the detection of\nantinuclear (ANA) and anti&ndash;smooth muscle (SMA) antibodies. To meet\ncriteria for the diagnosis of autoimmune hepatitis, these antibodies should be\npresent in titers of at least 1:80 in adults and 1:20 in children. Liver biopsy\nspecimens in patients with autoimmune hepatitis show features characteristic of\nchronic hepatitis. Plasma cell infiltrates, which are rare in other forms of\nchronic hepatitis, are characteristic of autoimmune hepatitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Most typical of\nautoimmune hepatitis is a rapid clinical response to corticosteroid therapy in\nterms of resolution of clinical symptoms and improvement in serum\naminotransferase and serum bilirubin elevations.\n </span>\n</p>\n", "choices": ["A. Serum ceruloplasmin", "B. Anti-nuclear antibody and anti-smooth muscle antibody", "C. IgM antibody to hepatitis A", "D. Serum acetaminophen level", "E. Antimitochondrial antibodies"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n21-year-old woman who breastfeeds her child develops a painful mass in the\nupper outer quadrant of the right breast. The mass is tender and the overlying\nskin is warm and erythematous. Pain and redness resolve with antibiotic\ntherapy. Several months later, the area is firm and the overlying skin is\ndimpled. What is the most likely cause of these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  Breast abscess with\nscarring is the most likely diagnosis.\n </span>\n</p>\n"], "tutorial": "<p>\n <b>\n  BREAST DISEASE\n </b>\n</p>\n\n<p>\n <b>\n  Mastitis\n </b>\n is an infection of the breast that usually occurs with\nbreast-feeding. A break in the skin\n</p>\n\n<p>\n or an opening in the nipple\nallows bacteria to enter the breast.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The ensuing inflammatory response causes redness, warmth, pain, and\nswelling. The condition is treated with antibiotics. In some cases, a breast\nabscess may form. An abscess should be suspected in a woman with a history of\nmastitis who presents with a tender breast mass and warm, erythematous\noverlying skin. Abscesses must be drained either surgically or by needle\naspiration.\n</p>\n\n<p>\n <b>\n  Fibrocystic change\n </b>\n is the most common benign condition of the\nbreast, usually occurring in women of childbearing age. Microcysts in the\nbreast, which are too small to feel, can accumulate fluid and become palpable\nmacrocysts. Their growth compresses the surrounding breast tissue, causing\npain. Hormonal changes just before the menstrual period can cause cysts to grow\nrapidly and cause associated discomfort.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n These changes are typically best appreciated in the upper, outer\nquadrants.\n</p>\n\n<p>\n <b>\n  Fibroadenomas\n </b>\n are benign breast tumors composed of glandular and\nstromal tissue. They are most common between the ages of 15 and 35.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The etiology is unknown but a hormonal\nrelationship is likely since they persist during the reproductive years, can increase\nin size during pregnancy or with estrogen therapy, and usually regress after\nmenopause. The tumors are usually round, mobile, firm, and non-tender. They may\nbe single or multiple and usually have a distinct border. Diagnosis can be made\nby fine needle aspiration or core needle biopsy. Most fibroadenomas do not\nincrease the risk of breast cancer, but some do. The decision to surgically\nremove a fibroadenoma must be individualized.\n</p>\n\n<p>\n <b>\n  <span>\n   Fat necrosis\n  </span>\n </b>\n occurs\nwhen an area of fatty breast tissue is damaged because of trauma, surgery, or\nradiation. The damaged tissue is ultimately replaced by scar. Being firm, fat\nnecrosis with scarring can be difficult to distinguish from cancer. Diagnosis\nmay require needle biopsy or surgical excision.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <b>\n  Inflammatory breast cancer\n </b>\n is an uncommon and especially aggressive type of breast cancer. It is called\n&ldquo;inflammatory&rdquo; because it presents with inflammatory changes, such as redness,\nwarmth, and swelling. Often no tumor is seen by mammography or ultrasound.\nRapid swelling with &ldquo;peau d' orange&rdquo; skin and nipple retraction may occur.\nInflammatory breast cancer may be confused with mastitis. Biopsy may be needed\nto distinguish them.\n</p>\n", "choices": ["A. Fibrocystic change", "B. Fibroadenoma", "C. Traumatic fat necrosis", "D. Breast abscess with scarring", "E. Inflammatory breast cancer"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 29-year-old woman with type 1 diabetes\nmellitus and autoimmune thyroiditis presents with a 9-month history of fatigue,\nbloating, abdominal pain, and intermittent diarrhea. She has greasy, malodorous\nstools that float. Two weeks ago, she developed an itchy, blistering rash over\nthe elbows, knees, and buttocks. She has lost 30 lbs unintentionally. Lab tests\nshow a hemoglobin concentration of 9 g/dL with an MCV of 76. Which one of the\nfollowing is\n  <i>\n   not\n  </i>\n  likely to be true?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  Pyoderma gangrenosum is\na skin condition associated with Crohn&rsquo;s disease and ulcerative colitis, not\nceliac disease.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Celiac disease, also known as gluten-sensitive\nenteropathy or nontropical sprue, is an autoimmune condition characterized by\nan inappropriate T cell-mediated response to gluten, which results in\ninflammatory injury to the small intestine. (\n  <span>\n   Gluten\n  </span>\n  is a protein composite that appears in foods processed from\nwheat, barley, and rye.) Many people with celiac disease are asymptomatic or minimally\nsymptomatic. Classic symptoms include fatigue, diarrhea, cramping, bloating,\nand abdominal distension. Iron-deficiency anemia and malabsorption\n(characterized by weight loss and greasy, malodorous stools) may occur.\nDeficiency of fat-soluble vitamins can result in osteoporosis (vitamin D\ndeficiency) and coagulopathy (vitamin K deficiency).\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Celiac disease is associated with dermatitis\nherpetiformis, a skin condition characterized by intensely itchy,\npapulovesicular eruptions, usually distributed symmetrically on extensor\nsurfaces (buttocks, back of neck, scalp, elbows, knees, and back). Patients\nwith celiac disease may have other autoimmune diseases, such as diabetes\nmellitus type 1, autoimmune thyroiditis, and primary biliary cirrhosis. Celiac disease\npredisposes patients to adenocarcinoma and lymphoma of the small intestine.\nSerological tests show elevated levels of anti-tissue transglutaminase,\nanti-endomysial, and anti-gliadin antibodies. Biopsy of the small intestine\nshows villous atrophy. The mainstay of therapy is a gluten-free diet (i.e.,\navoiding foods derived from wheat, barley, and rye).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347283\"\n o:spid=\"_x0000_i1173\" type=\"#_x0000_t75\" alt=\"Description: DH\">\n <v:imagedata src=\"_%20Tutorials_files/image303.jpg\" o:title=\"DH\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: DH\" border=\"0\" height=\"288\" src=\"_%20Tutorials_files/image304.png\" v:shapes=\"Picture_x0020_347283\" width=\"234\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraph\">\n <span>\n  Dermatitis herpetiformis\n </span>\n</p>\n", "choices": ["A. Her symptoms are caused by an autoimmune disorder", "B. Avoiding foods that contain wheat, barley, and rye is the mainstay of therapy for this condition", "C. Serum levels of anti-tissue transglutaminase, anti-endomysium, and anti-gliadin antibodies are likely to be elevated", "D. Biopsy of the small intestine is likely to show villous atrophy", "E. Her skin condition is called pyoderma gangrenosum"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n45-year-old woman is diagnosed with cervical cancer. Which of the following is\nthe most important predisposing factor?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  Human papillomavirus\ninfection is the most important predisposing factor for cervical carcinoma.\n </span>\n</p>\n"], "tutorial": "<p>\n By far the most important\nrisk factor for cervical cancer is genital infection with human papillomavirus.\nHuman papillomavirus (HPV) is a small, double-stranded DNA virus that infects\nepithelial cells and can induce a variety of benign and malignant tumors in\nhumans. Most HPV infections are asymptomatic and unrecognized, which is\nconducive to high transmission rates. Transmission occurs through skin-to-skin\ncontact. Incubation periods range from weeks to years.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Manifestations\nof infection range from benign genital warts (condyloma acuminata) to invasive\ncervical cancer. Screening for &ldquo;high-risk&rdquo; oncogenic HPV serotypes is\nassociated with declining death rates from cervical cancer by about 2% a year.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  More than\n100 types of HPV have been described. Approximately 30 types are associated\nwith anogenital tract infections. Condyloma acuminata usually are caused by\n&ldquo;low-risk&rdquo; HPV types 6 and 11. Invasive cervical cancer usually is associated\nwith &ldquo;high-risk&rdquo; HPV types 16 and 18. Oral infection with HPV increases the\nrisk of oropharyngeal cancer independent of tobacco and alcohol use. In the\nUnited States, HPV is expected to replace tobacco as the main causative agent\nfor oral cancer.\n  <span>\n   Human papillomavirus\n  </span>\n  (\n  <span>\n   HPV\n  </span>\n  )\n  <span>\n   vaccines can\n  </span>\n  prevent infection with serotypes associated with\ncervical cancer and genital warts. Two HPV vaccines are available: Gardasil and\nCervarix. Both protect against types 16 and 18, which can cause cervical\ncancer. Gardasil also protects against types 6 and 11, which can cause genital\nwarts.\n </span>\n</p>\n\n<p>\n The human papillomavirus\n(HPV) encodes a protein, E6, which binds human p53 protein and inactivates it.\n <span>\n  p53\n </span>\n (also known as\n <span>\n  protein\n  <b>\n  </b>\n  53\n </span>\n or\n <span>\n  tumor protein 53\n </span>\n ), is a tumor\nsuppressor protein. It regulates the cell cycle and helps to prevent cancer. As\nsuch, p53 has been described as &ldquo;the guardian of the genome,&rdquo; the &ldquo;guardian\nangel gene,&rdquo; and the &ldquo;master watchman,&rdquo; referring to its role in conserving\nstability by preventing genome mutation. p53 has many mechanisms of anticancer\nfunction, and plays a role in apoptosis, genomic stability, and inhibition of\nangiogenesis. In its anti-cancer role, p53 works through several mechanisms:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  It\ncan activate DNA repair proteins when DNA has sustained damage.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  It\ncan induce growth arrest by holding the cell cycle at the G\n  <sub>\n   1\n  </sub>\n  /S\nregulation point on DNA damage recognition (if it holds the cell here for long\nenough, the DNA repair proteins will have time to fix the damage and the cell\nwill be allowed to continue the cell cycle).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  It\ncan initiate apoptosis, the programmed cell death, if DNA damage proves to be\nirreparable.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  By\ninactivating p53, the papillomavirus inhibits DNA repair, prevents growth arrest,\nand. inhibits apoptosis. Moreover, some of the HPV \"early\" genes,\nsuch as E6 and E7, are known to act as oncogenes that promote tumor growth and\nmalignant transformation.\n </span>\n</p>\n", "choices": ["A. Smoking history", "B. Family history of cervical cancer", "C. Immunocompromised state", "D. Low socioeconomic status", "E. Human papillomavirus infection"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 66-year-old man presents to the clinic with a\n6-month history of intermittent abdominal pain that begins 30 minutes after\neating a meal and resolves 2 hours later. The pain is located in the\nperiumbilical area.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He has lost\nweight and is afraid of eating. He has a 30 pack-year history of smoking,\nhypertension, coronary artery disease, and peripheral vascular disease.\nPhysical examination reveals a non-tender abdomen. Lab tests show a serum\ncreatinine concentration of 2.5 mg/dL. Which of the following diagnostic tests\nis most appropriate?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Chronic mesenteric\nischemia should be suspected in patients with atherosclerotic vascular disease\nwho present with post-prandial periumbilical abdominal pain. Classically, the\npain begins 30 minutes after eating and resolves 2 hours later. The condition can\nbe diagnosed by Doppler ultrasound of the mesenteric arteries.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Patients with chronic mesenteric ischemia\ncommonly present with postprandial abdominal pain, sitophobia (fear of eating),\nand weight loss. Often the abdominal examination is normal. Chronic mesenteric\nischemia typically occurs in patients with generalized atherosclerotic\ndisease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The patient in the\nvignette has coronary artery disease and peripheral vascular disease. Even\nwithout these conditions, one would suspect atherosclerotic disease based on\nthe history of smoking and hypertension. The mesenteric vessels can be\nevaluated by Doppler ultrasound, CT angiography, or MR angiography. Doppler\nultrasound would be simplest and least expensive approach. The patient&rsquo;s renal\ninsufficiency (serum creatinine of 2.5 mg/dL) would preclude the use of CT\nangiography, which involves the administration of nephrotoxic radiocontrast.\n </span>\n</p>\n", "choices": ["A. Upper endoscopy", "B. Endoscopic retrograde cholangiopancreatography (ERCP)", "C. Doppler ultrasonography", "D. CT angiography", "E. Colonoscopy"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n19-year-old man has severe intermittent bloody diarrhea and weight loss.\nColonoscopy shows numerous ulcers and inflammatory changes that extend from the\nrectum to the mid-transverse colon. Biopsy specimens show acute and chronic\ninflammation restricted to the mucosa. What is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Smokers have an\nincreased risk of developing Crohn&rsquo;s disease and a decreased risk of developing\nulcerative colitis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Colitis is\nan inflammation of the colon. It may be associated with enteritis (inflammation\nof the intestine) and/or proctitis (inflammation of the rectum).\n </span>\n <span>\n  The most common types of colitis appear below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Common\n  Causes of Colitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <span>\n      Necrotizing enterocolitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <span>\n      Allergic colitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Clostridium\n  difficile\n      </span>\n     </i>\n     <span>\n      -associated colitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <span>\n      Infectious colitis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Bacterial: E. Coli, Salmonella, Shigella\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpMiddle\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Viral: Cytomegalovirus\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Parasitic: Entamoeba histolytica\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inflammatory bowel disease\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Crohn&rsquo;s disease\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Ulcerative colitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ischemic colitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"217\">\n    <p class=\"MsoNormal\">\n     <span>\n      Microscopic colitis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpFirst\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Lymphocytic colitis\n     </span>\n    </p>\n    <p class=\"MsoListParagraphCxSpLast\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Collagenous colitis\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Necrotizing enterocolitis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Necrotizing enterocolitis (NEC) is a common cause of colitis\nin newborns. Very small and ill preterm infants are particularly susceptible to\nthis condition. Hypoxic ischemia and aggressive enteral feedings may play a\nrole.\n </span>\n <span>\n  The\nonset is often insidious, but illness may progress rapidly, resulting in\nperitonitis, perforation, shock, and death.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Allergic colitis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In children aged 2 weeks to 1 year, the most common form of\ncolitis is allergic colitis, which usually results from hypersensitivity to\ncow's milk and soy milk. The so-called &ldquo;breast milk allergy&rdquo; is a type of food\nallergy induced by proteins (typically cow's milk proteins) ingested by the\nmother and appearing in the breast milk. The condition\n </span>\n <span>\n  often presents with\nblood and mucous in the stool, vomiting, and diarrhea after ingestion of milk.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <i>\n   <span>\n    Clostridium difficile\n   </span>\n  </i>\n </b>\n <b>\n  <span>\n   -associated colitis\n  </span>\n </b>\n</p>\n\n<p>\n <em>\n  Clostridium difficile\n </em>\n is a spore-forming bacterium that causes disease in 1 out of 200 hospitalized\npatients. It also causes disease in the outpatient setting. Prior antibiotic\nexposure remains the most significant risk factor for developing the disease.\nSeveral synonyms are used for diseases attributable to\n <em>\n  C. difficile\n </em>\n infections (CDI):\n <em>\n  C. difficile\n </em>\n &ndash;associated diarrhea,\nantibiotic-associated colitis,\n <em>\n  C. difficile\n </em>\n colitis, and\npseudomembranous colitis.\n <em>\n  C. difficile\n </em>\n accounts for up to 25% of\nnosocomial antibiotic-associated diarrhea. The term &ldquo;pseudomembranous&rdquo; refers\nto the exudate that appears in the colon. In the last decade, an increasing\nnumber of CDIs have been reported, and the proportion of cases complicated by\nsevere outcomes has increased. This may be due to the spread of virulent\nstrains.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The condition is usually caused by antibiotic therapy.\nAntibiotics favor overgrowth and colonization of the intestine by\n  <i>\n   Clostridium\ndifficile\n  </i>\n  <span>\n   , which\n  </span>\n  causes\ndamage by releasing toxins. Almost any antibiotic can lead to pseudomembranous\ncolitis. Fluoroquinolones, macrolides, clindamycin, beta-lactam/beta-lactamase\ninhibitors, and all generations of cephalosporins have been associated with\nCDI. Symptoms typically develop 5-10 days after initiation of antibiotic\ntherapy; however, symptoms can develop after a single day of antibiotic use or\ncan occur as late as 10 weeks after antibiotic cessation. Both increased length\nof antimicrobial use and use of multiple antimicrobials increase the risk of\nCDI. Some patients may develop CDI without a clearly identified antibiotic\nexposure.\n </span>\n</p>\n\n<p>\n <i>\n  C. difficile\n </i>\n produces two similar toxins that disrupt the barrier\nfunction of the colonic mucosa. Toxin A is an enterotoxin that binds to\nreceptors in the bowel wall, leading to activation of the inflammatory cascade\nand disruption of the intercellular tight junctions, causing fluid secretion,\nmucosal injury, edema, and inflammation. Toxin B is a cytotoxin that causes\nmucosal injury and further activation of the inflammatory cascade.\n</p>\n\n<p>\n The clinical presentation of\nCDI ranges from self-limited diarrhea to severe colitis complicated by toxic\nmegacolon or colonic perforation. The classic presentation is cramping\nabdominal pain with profuse, mucoid, malodorous, watery stools. Fever,\nabdominal pain, and leukocytosis are common. Oral metronidazole and oral\nvancomycin are used to treat CDI. Metronidazole, which is much less expensive\nthan vancomycin, is the drug of choice for mild-to-moderate CDI. Oral\nvancomycin is the drug of choice for severe CDI.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Bacterial colitis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The organisms most commonly associated with bacterial\ncolitis are\n  <i>\n   Escherichia coli\n  </i>\n  ,\n  <i>\n   Salmonella\n  </i>\n  <span>\n   ,\n   <i>\n   </i>\n   and\n   <i>\n    Shigella.\n   </i>\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   E coli\n  </span>\n </i>\n <span>\n  causes diarrhea by different mechanisms. Pathologic strains\nhave been classified as enteropathogenic, enterotoxic, enteroinvasive,\nenteroaggregative, enteroadherent, and enterohemorrhagic. Enterohemorrhagic,\nincluding O157:H7 and O26:H11, cause hemorrhagic colitis and systemic\ncomplications (e.g., hemolytic uremic syndrome). The risk of developing\nhemolytic uremic syndrome after infection with\n  <i>\n   E coli\n  </i>\n  O157 is estimated\nto be 10-15%.\n  <i>\n  </i>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Salmonella\n  </span>\n </i>\n <span>\n  is typically spread by the fecal-oral route. Outbreaks are\nassociated with contaminated eggs, dairy products, and meats. Gastric acid is\nusually lethal to the organism, but susceptibility to infection is increased\nwith decreased GI motility, rapid emptying of the stomach postgastrectomy,\nlarge quantity of ingested bacteria, malnutrition, antibiotic use, and\nachlorhydria. Salmonellae can penetrate the epithelial layer of the bowel and\nevoke a leukocyte response. They cause diarrhea by producing toxins and\nprostaglandins, stimulating the secretion of fluids and electrolytes.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Shigella\n  </span>\n </i>\n <span>\n  attaches to binding sites on the surface of intestinal\nmucosal cells. The organism penetrates and proliferates in the cell, which\nleads to cell destruction and produces mucosal ulcerations and bleeding.\nShigellae also elaborate the exotoxins that produce diarrhea.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Cytomegalovirus infection\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cytomegalovirus (CMV) colitis typically occurs in\nimmunocompromised individuals, such as patients with AIDS or organ recipients\nreceiving immunosuppressive treatment.\n </span>\n <span>\n  When the colon becomes infected, ulceration\noccurs. As the body mounts an inflammatory response, watery diarrhea develops.\nThe ulcers can increase in depth, erode into blood vessels, can cause profuse\nbloody diarrhea.\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Parasitic colitis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Entamoeba histolytica\n  </span>\n </i>\n <span>\n  is the world&rsquo;s most common cause of parasitic colitis.\nTransmission occurs through the ingestion of cysts, usually from water\ncontamination or person-to-person transmission (usually from poor\nsanitation).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  After ingestion, the\ncysts differentiate into the trophozoite stage.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Trophozoites are labile outside of the\nhost and do not survive long in the environment.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Inflammatory bowel disease\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Inflammatory bowel disease (IBD) includes two conditions:\nCrohn&rsquo;s disease and ulcerative colitis. Ulcerative colitis is characterized by\ninflammation and ulceration confined to the colonic mucosa. Crohn&rsquo;s disease is\nmanifested by transmural inflammation and granulomas affecting any segment of\nthe GI tract, including the colon. Ulcerative colitis invariably involves the\nrectum and extends proximally without skipping segments. Crohn&rsquo;s disease causes\ndiscontinuous, patchy inflammation of the GI tract, usually involving the small\nbowel, ileum, and colon. N\n </span>\n <span>\n  ewly diagnosed IBD has its peak incidence in the second\ndecade of life, with the vast majority of new cases occurring in people aged\n15-40 years.\n </span>\n <span>\n </span>\n</p>\n\n<p>\n Crohn&rsquo;s disease is an\nidiopathic, chronic, transmural inflammatory process of the bowel that often\nleads to fibrosis and obstructive symptoms and can affect any part of the\ngastrointestinal tract from the mouth to the anus. Approximately 30% of Crohn&rsquo;s\ndisease cases involve the small bowel, particularly the terminal ileum, another\n30% involve the colon alone, and 40% involve both the small bowel and colon.\nThe characteristic presentation of Crohn&rsquo;s disease is abdominal pain and\ndiarrhea, which may be complicated by intestinal fistulization, obstruction, or\nboth. Additional findings may include malnutrition and bone demineralization.\nUnpredictable flares and remissions characterize the long-term course of this\ndisease. Microscopically, focal inflammatory infiltrates form around the\ncrypts. Ulceration of the superficial mucosa occurs and crypt abscesses\ndevelop. Later, inflammatory cells invade the deep mucosal layers and form noncaseating\ngranulomas. The granulomas extend through all layers of the intestinal wall and\ninto the mesentery and regional lymph nodes.\n</p>\n\n<p>\n Ulcerative colitis is a\nchronic, idiopathic condition characterized by inflammation of the colon.\nPatients typically have rectal bleeding, frequent stools, and mucous discharge\nwith or without tenesmus. Acute and chronic inflammation of the lamina propria,\ncrypt branching, and villous atrophy occur. There is discharge of mucus from\ngoblet cells. Ulcers appear and are soon covered by granulation tissue.\nExcessive fibrosis is not a feature of the disease. Mucosal ulceration with\nexcessive granulation tissue results in polypoidal mucosal excrescences, called\n&ldquo;pseudopolyps.&rdquo;\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Ischemic colitis\n  </span>\n </b>\n</p>\n\n<p>\n <span>\n  Ischemic colitis\n </span>\n is a condition caused by an inadequate blood\nsupply to the colon. It affects elderly people primarily and may be due to\natherosclerotic disease, hypotension, or blood clot. Symptoms depend on the\nseverity of ischemia. The most common symptoms are abdominal pain (often left-sided)\nand mild to moderate rectal bleeding. The pain may be out of proportion to\nabdominal tenderness. In its mildest form, mucosal and submucosal edema and\nhemorrhage occur, sometimes with mild necrosis and ulceration. With severe\nischemia, findings resembling inflammatory bowel disease (i.e. ulcerations,\ncrypt abscesses and pseudopolyps) may be present. Most patients are treated\nsupportively and recover; a minority develop sepsis and become critically ill.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Microscopic colitis\n  </span>\n </b>\n</p>\n\n<p>\n <span>\n  Microscopic colitis is\n </span>\n characterized by a triad of features:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Chronic\nwatery diarrhea\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Normal\ncolonoscopy\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Characteristic\nhistopathology\n </span>\n</p>\n\n<p>\n Patients are usually\nmiddle-aged women who present with a history of profuse watery diarrhea. They\nhave a higher-than-normal incidence of autoimmune diseases.\n</p>\n\n<p>\n There are two types of\nmicroscopic\n <span>\n  colitis\n </span>\n : lymphocytic\nand collagenous. Both are characterized by an increase in the number of\nlymphocytes in the surface epithelium and lamina propria. Collagenous colitis\nis additionally characterized by the presence of collagen in the subepithelium.\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer F is correct\n  </span>\n </b>\n <span>\n  . Ulcerative colitis is\nusually diagnosed in young people and is characterized by rectal bleeding,\nmucosal ulceration, no &ldquo;skip&rdquo; lesions, and the presence of acute and chronic\ninflammatory cells confined to the mucosa.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Necrotizing\nenterocolitis is a condition that primarily affects preterm newborns.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Allergic colitis is a\ncondition that affects infants. It is associated with milk allergy.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  .\n  <i>\n   C. difficile\n  </i>\n  -associated colitis occurs after antibiotic therapy and\nmay be associated with pseudomembranes.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  .\n  <i>\n   E. coli\n  </i>\n  -associated colitis is an acute, not a chronic, inflammatory\ncondition.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Crohn&rsquo;s disease is\nassociated with transmural inflammation, skipped lesions, and noncaseating\ngranulomas.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer G is incorrect\n  </span>\n </b>\n <span>\n  . Ischemic colitis\nusually occurs in elderly people and is caused by decreased blood flow to the\nbowel.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Answer H is incorrect\n  </span>\n </b>\n <span>\n  . Microscopic colitis\nhas no grossly visible abnormalities on colonoscopy.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Which of the following is\n  <i>\n   incorrect\n  </i>\n  regarding Crohn&rsquo;s disease?\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\ndisease is characterized by transmural inflammation\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-Saccharomyces\ncerevisiae antibodies (ASCA) are more common in Crohn&rsquo;s disease than in\nulcerative colitis\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Smoking\ndecreases the risk of Crohn&rsquo;s disease\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Perinuclear\nantineutrophil antibodies (p-ANCA) are more common in ulcerative colitis than\nin Crohn&rsquo;s disease\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\nincidence of primary sclerosing cholangitis is increased in Crohn&rsquo;s disease\n </span>\n</p>\n\n<p>\n <span>\n  Crohn's disease\n </span>\n , also known as\n <span>\n  regional enteritis\n  <i>\n   ,\n  </i>\n </span>\n is an inflammatory disease that can\naffect any part of the gastrointestinal tract from mouth to anus.\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  Crohn's ileocolitis\n </i>\n , which involves the\nileum and the colon, accounts for 50% of cases\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  Crohn's ileitis\n </i>\n , which involves the ileum\nonly, accounts for 30% of cases\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  Crohn's colitis\n </i>\n , which involves the colon\nonly, accounts for the 20% of cases (and may be hard to distinguish from\nulcerative colitis)\n</p>\n\n<p>\n Crohn's disease is an\nautoimmune disease and one type of inflammatory bowel disease. (The other major\ntype is ulcerative colitis.) Crohn&rsquo;s disease is associated with transmural\ninflammation of gastrointestinal tract. Non-caseating granulomas are seen in 50%\nof cases. The condition is more common in Western industrialized nations,\nsuggesting an environmental link. Males and females are equally affected.\nSmokers have an increased risk of developing Crohn's. (By contrast, smokers\nhave a\n <i>\n  decreased\n </i>\n risk of developing\nulcerative colitis.) Crohn&rsquo;s often presents in the teens and twenties, with\nanother peak incidence in the fifties to seventies.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal symptoms of Crohn&rsquo;s are abdominal pain, diarrhea (which may or may\nnot be bloody), vomiting, and weight loss. Intestinal inflammation\n </span>\n <span>\n  can lead to bowel stenosis and obstruction. Aphthous ulcers\nmay appear in the mouth. Rarely, the esophagus and stomach are involved,\ncausing dysphagia, abdominal pain, and vomiting. Itchiness or pain around the\nanus may indicate inflammation, fistulization, abscess formation, or the\npresence of an anal fissure.\n </span>\n <span>\n  Fistulae can develop between loops of bowel, between the\nbowel and bladder, between the bowel and vagina, or between the bowel and skin.\nPeople with extensive small bowel disease may have malabsorption and weight\nloss. Those\n </span>\n <span>\n  who have had multiple surgeries\noften develop short bowel syndrome. Crohn's disease and ulcerative colitis are\nassociated with primary sclerosing cholangitis. (The association is stronger\nwith ulcerative colitis than with Crohn&rsquo;s.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Crohn's\ndisease increases the risk of cancer in the area of inflammation. Individuals\nwith small bowel disease are at risk for small intestinal cancer. Those with\ncolitis are at high risk of developing colon cancer. Screening for colon cancer\nwith colonoscopy is recommended for anyone with Crohn's colitis.\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Two serological markers have\nclinical utility\n  <sup>\n  </sup>\n  in diagnosing inflammatory bowel disease and in\ndifferentiating Crohn&rsquo;s from\n  <sup>\n  </sup>\n  ulcerative colitis: anti-\n  <i>\n   Saccharomyces\ncerevisiae\n  </i>\n  antibody (ASCA) and perinuclear antineutrophil cytoplasmic\nantibody (pANCA). ASCA is more prevalent in Crohn&rsquo;s disease; pANCA is more\nprevalent in ulcerative colitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Crohn&rsquo;s\ndisease is characterized by periods of relapse and remission. The goal of\ntreatment is to control symptoms, maintain remission, and prevent relapse.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347282\" o:spid=\"_x0000_i1172\"\n type=\"#_x0000_t75\" alt=\"Description: colon2\">\n <v:imagedata src=\"_%20Tutorials_files/image305.jpg\" o:title=\"colon2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: colon2\" border=\"0\" height=\"339\" src=\"_%20Tutorials_files/image306.png\" v:shapes=\"Picture_x0020_347282\" width=\"470\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   +\n  </span>\n </b>\n</p>\n", "choices": ["A. Necrotizing enterocolitis", "B. Allergic colitis", "C. C. difficile-associated colitis", "D. E. coli-associated colitis", "E. Crohn\u2019s disease", "F. Ulcerative colitis", "G. Ischemic colitis", "H. Microscopic colitis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n45-year-old man has a six-month history of difficulty swallowing associated\nwith chest pain. He has lost 10 lbs in the last three months. He has not\nexperienced heartburn. His hands are not sensitive to cold. His BMI is 20 kg/m\n  <sup>\n   2\n  </sup>\n  .\nPhysical examination shows no abnormalities. Barium swallow shows esophageal\ndilation. Manometry shows high resting pressure at the lower esophageal\nsphincter, which is unchanged with swallowing. Which is the most likely\ndiagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Achalasia is an\nesophageal motility disorder involving the smooth muscle layer of the esophagus\nand the lower esophageal sphincter (LES). It is characterized by incomplete LES\nrelaxation, increased LES tone, and aperistalsis of the esophagus. Symptoms\ninclude difficulty swallowing, regurgitation, and chest pain. Diagnosis is made\nwith barium swallow and esophageal manometry. Barium swallow shows esophageal\ndilation and a bird&rsquo;s beak deformity of the distal esophagus. Manometry shows\nhigh resting pressure at the lower esophageal sphincter, which is unchanged or\nminimally changed with swallowing.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Dysphagia,\nor difficulty swallowing, is caused by impeded movement of food or drink\nanywhere from the pharynx to the stomach. It is distinct from globus, the\nsensation of having a &ldquo;lump in the throat,&rdquo; which is unrelated to swallowing.\nDysphagia is classified as oropharyngeal or esophageal.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Oropharyngeal dysphagia (OPD)\n  </span>\n </b>\n <span>\n  results from a true\noropharyngeal swallowing dysfunction. Cerebrovascular accident, dementia,\nmyasthenia gravis, and amyotrophic lateral sclerosis are common causes of OPD\nand are associated with a high morbidity and mortality risk. Dehydration,\nmalnutrition, choking, aspiration, pneumonia, sepsis, and death are all\npotential consequences. When OPD is suspected, a modified barium swallow study\nshould be performed with the assistance of a speech therapist.\n  <a name=\"4-u1.0-B978-1-4160-2467-5..50051-8--f7\">\n  </a>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Esophageal dysphagia\n  </span>\n </b>\n <span>\n  results from disorders\naffecting the tubular esophagus, including various mechanical obstructing\nlesions and motility disorders.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Esophageal webs\n  </span>\n </i>\n <span>\n  are thin, eccentric\nmembranes consisting of mucosa and submucosal. They can occur anywhere in the\nesophagus and hypopharynx. They can be associated with iron deficiency anemia,\nalthough most patients are not anemic.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Esophageal rings\n  </span>\n </i>\n <span>\n  (e.g., Schatzki's\nrings) are concentric rings of mucosal or muscular tissue that occur most commonly\nin the distal esophagus and may be associated with gastroesophageal reflux\ndisease (GERD). Most patients are asymptomatic and do not require specific\ntreatment. Some patients may require esophageal dilation to relieve dysphagia\nand acid-blocking therapy for GERD.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Benign\n  </span>\n </i>\n <span>\n  <i>\n   esophageal\nstrictures\n  </i>\n  occur in a minority of patients with persistent GERD and erosive\nesophagitis. Other causes include caustic ingestion, Crohn's disease, infection\n(e.g., candidiasis), medication (e.g., NSAIDs), radiation therapy, and\nscleroderma. Most strictures are located in the distal esophagus.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Malignant esophageal strictures\n  </span>\n </i>\n <span>\n  are usually caused by\nadenocarcinoma of the esophagus. Initially, dysphagia occurs only with solid\nfoods, but it progresses to involve liquids as well.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A primary or secondary malignancy should\nbe considered in patients with rapidly progressive dysphagia and weight loss.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Esophageal diverticula\n  </span>\n </i>\n <span>\n  are outpouchings of the\nmucosal wall of the esophagus. They lack a muscular wall and are caused by\npulsion forces secondary to esophageal motility disorders. Esophageal\ndiverticula are divided into four categories based on location: hypopharyngeal\n(Zenker's diverticula), midesophageal diverticula, epiphrenic diverticula, and\nintramural pseudodiverticulosis. Esophageal manometry is mandatory in patients\nwith diverticula to define the underlying esophageal motility disorder.\nSurgical resection is often needed in patients with symptomatic diverticula.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4160-2467-5..50051-8--f10\">\n </a>\n <b>\n  <span>\n   Esophageal dysmotility\n  </span>\n </b>\n <span>\n  <b>\n   disorders\n  </b>\n  include abnormalities of esophageal peristalsis and lower esophageal sphincter\n(LES) function. They are best evaluated by esophageal manometry.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Diffuse esophageal spasm\n  </span>\n </i>\n <span>\n  is characterized by\nintermittent chest pain (mild to severe) with\n  <span class=\"search-hit\">\n   dysphagia\n  </span>\n  ,\nusually after the ingestion of very hot or very cold foods. This condition is\noften confused with heart disease, and patients often undergo a cardiac workup.\nThe classic finding on a barium esophagram is corkscrew appearance of the\nesophageal body during contraction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Nutcracker esophagus\n  </span>\n </i>\n <span>\n  presents with chest\npain and\n  <span class=\"search-hit\">\n   dysphagia\n  </span>\n  . Distal esophageal peristaltic\namplitude higher than 180 mm Hg is required for diagnosis. The barium\nesophagram is normal.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Achalasia\n  </span>\n </i>\n <span>\n  of the esophagus is characterized by loss of\nesophageal peristalsis and incomplete relaxation of the LES. Its onset is\nusually in the third to fifth decades. Most patients present with\n  <span class=\"search-hit\">\n   dysphagia\n  </span>\n  , regurgitation, weight loss, chest pain, and\nheartburn. Patients with achalasia tend to drink fluids and perform body-straightening\nmaneuvers to facilitate emptying of food into the stomach. Barium esophagrams\nshow a narrowing at the level of the gastroesophageal junction (bird beak) and\nvarious degrees of esophageal dilation (see below). Upper endoscopy is required\nto rule out the presence of a peptic stricture, esophageal or gastric tumor,\nand gastroduodenal pathology. Esophageal manometry is the gold standard for\nestablishing the diagnosis of achalasia. The classic finding is absence of\nesophageal peristalsis and a LES that fails to relax completely with\nswallowing. Patients with achalasia are at an increased risk for developing of\nsquamous and adenocarcinoma of the esophagus.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347281\"\n o:spid=\"_x0000_i1171\" type=\"#_x0000_t75\" alt=\"Description: achalasia\">\n <v:imagedata src=\"_%20Tutorials_files/image307.jpg\" o:title=\"achalasia\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: achalasia\" border=\"0\" height=\"156\" src=\"_%20Tutorials_files/image308.png\" v:shapes=\"Picture_x0020_347281\" width=\"146\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347280\"\n o:spid=\"_x0000_i1170\" type=\"#_x0000_t75\" alt=\"Description: Achalasia1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image309.jpg\" o:title=\"Achalasia1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Achalasia1\" border=\"0\" height=\"165\" src=\"_%20Tutorials_files/image310.png\" v:shapes=\"Picture_x0020_347280\" width=\"151\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Achalasia", "B. Esophagitis", "C. Gastroesophageal reflux", "D. Systemic sclerosis (scleroderma)", "E. Esophageal diverticulum"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n27-year-old woman is brought to the emergency room with abdominal pain and\nlight-headedness. Four days prior to her arrival, she began to have\nintermittent vaginal bleeding and mild abdominal pain. This morning the pain\nbecame severe and she became light-headed. Her last normal menstrual period was\nthree months ago. Abdominal examination shows moderate tenderness in the right\nlower quadrant. Bimanual pelvic examination shows a 4-cm mass in the right\nparametrium. Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Appendicitis usually\npresents with right lower quadrant pain. Tenderness may be present at\nMcBurney&rsquo;s point (one-third of the distance from the anterior superior iliac\nspine to the umbilicus). Guarding and rebound tenderness suggest peritonitis.\nIf the appendix is retrocecal, abdominal tenderness may be absent; if the\nappendix lies entirely within the pelvis, abdominal rigidity may be absent,\nthough rectal examination may elicit tenderness in the rectovesicular pouch.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Ovarian cysts are\ncommon in women of reproductive age. Most are asymptomatic and resolve on their\nown. 95% are benign. Rare complications include cyst rupture, which may cause\nsevere abdominal pain and bleeding.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Patients with ovarian\ncancer may be asymptomatic or may have any of the following: abdominal/pelvic\npain, abdominal mass, bloating,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Back_pain\" title=\"Back pain\">\n </a>\n <span>\n  back pain, urinary\nurgency, constipation, fatigue, vaginal bleeding, or weight loss.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . In endometriosis,\nendometrial-like cells appear outside the uterus, most commonly on the ovaries.\nLike cells lining the uterine cavity, these cells are influenced by hormonal\nchanges. Typically the condition occurs during the reproductive years. The most\ncommon symptom is pelvic pain, which may occur with menses.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  In\nevaluating abdominal and pelvic pain, the clinician&rsquo;s first duty is to exclude\nlife-threatening disease. The following &ldquo;red flags&rdquo; are of particular concern.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"121\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Red Flags\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"121\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"121\">\n    <p class=\"MsoNormal\">\n     <span>\n      Severe\n  pain\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"121\">\n    <p class=\"MsoNormal\">\n     <span>\n      Signs of\n  shock\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"121\">\n    <p class=\"MsoNormal\">\n     <span>\n      Signs of\n  peritonitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"121\">\n    <p class=\"MsoNormal\">\n     <span>\n      Signs of\n  obstruction\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Severe\npain: early surgical consultation is often necessary\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   II.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Signs\nof shock: tachycardia, hypotension, diaphoresis, confusion\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   a.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Vaginal\nbleeding in a pregnant woman with an adnexal mass may suggest ectopic pregnancy\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   b.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Tender\nabdominal mass with back pain may suggest ruptured abdominal aortic aneurysm\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   c.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Ecchymoses\nof the costovertebral angles (Grey Turner&rsquo;s sign) or of the umbilicus (Cullen&rsquo;s\nsign) may suggest hemorrhagic pancreatitis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   III.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Signs\nof peritonitis: severe abdominal pain exacerbated by movement; severe abdominal\ntenderness with guarding and rebound; patient lying motionless\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   IV.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Signs\nof obstruction: abdominal distension; high-pitched, rushing bowel sounds;\ntympany to percussion\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  &ldquo;Pelvic&rdquo;\nand &ldquo;lower abdominal&rdquo; pain can overlap. Both can be caused by gynecological and\nnon-gynecological conditions. Common gynecological causes of pelvic pain are\nlisted below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"2\" valign=\"top\" width=\"443\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Gynecological Causes\n  of Pelvic Pain\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Pain related to menstrual period\n     </span>\n    </i>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dysmenorrhea\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Severe\n  pain before and/or during menses\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Endometriosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p>\n    Symptoms may include:\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Dysmenorrhea &ndash; painful, sometimes disabling cramps\n  during menses that may get worse over time\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Chronic pelvic pain &ndash; often accompanied by low back\n  pain or abdominal pain\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Dyspareunia &ndash; painful sex\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Dysuria &ndash; painful voiding sometimes with urinary\n  frequency and urgency\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Dyschezia--painful defecation\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Fixed mass or tender nodules found on bimanual or rectal\n  exam\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mittelschmertz\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden,\n  severe pain at mid-cycle (during ovulation), often with light, spotty vaginal\n  bleeding\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n      Pain unrelated to menstrual period\n     </span>\n    </i>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pelvic\n  inflammatory disease\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gradual\n  onset of pain; mucopurulent cervical discharge; marked cervical motion\n  tenderness; adnexal tenderness; may be associated with fever, dysuria,\n  dyspareunia\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ruptured\n  ovarian cyst\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden\n  onset of pain, sometimes with vaginal bleeding, nausea, vomiting, and\n  peritoneal signs\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ruptured\n  ectopic pregnancy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden\n  onset of pain with vaginal bleeding; syncope and hemorrhagic shock may occur;\n  tender adnexal mass may be present\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acute\n  degeneration of uterine fibroid\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden\n  onset of pain and vaginal bleeding; often during first 12 weeks of pregnancy\n  or after delivery\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Adnexal\n  torsion\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sudden\n  onset of severe pain, often with nausea, vomiting, peritoneal signs; risk\n  factors include pregnancy, induction of ovulation, large ovary (&gt; 4cm)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Uterine\n  or ovarian cancer\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gradual\n  onset of pain; abnormal vaginal bleeding; sometimes pelvic mass\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Adhesions\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gradual\n  onset of pain or dyspareunia; history of abdominal surgery; sometimes nausea\n  and vomiting\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Spontaneous\n  abortion\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vaginal\n  bleeding with pelvic or back pain in early pregnancy accompanied by symptoms\n  of early pregnancy like breast tenderness, nausea, and delayed menses\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer is D is correct\n  </span>\n </b>\n <span>\n  . Severe pain and\nfainting are &ldquo;red flag&rdquo; signs. The absence of menses for three months suggests\npossible pregnancy. Ectopic pregnancy is likely given the presence of vaginal\nbleeding and a parametrial mass. An\n  <span>\n   ectopic\npregnancy\n  </span>\n  is a complication of pregnancy in which the embryo implants\noutside the uterine cavity. With rare exceptions, ectopic pregnancies are not\nviable. Furthermore, they are dangerous for the parent, since internal\nhemorrhage is a life threatening complication. Most ectopic pregnancies occur\nin the Fallopian tube (so-called\n  <span>\n   tubal\npregnancies\n  </span>\n  ), but implantation can also occur in the cervix, ovaries,\nand abdomen. An ectopic pregnancy is a potential medical emergency, and, if not\ntreated properly, can lead to death.\n </span>\n</p>\n", "choices": ["A. Appendicitis", "B. Ovarian cyst", "C. Ovarian cancer", "D. Ectopic pregnancy", "E. Endometriosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n29-year-old woman has been unable to conceive for a year.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her cycles are regular, but she has very\npainful periods despite use of non-steroidal anti-inflammatory drugs (NSAIDs).\nShe also reports painful intercourse. Her mother was diagnosed with ovarian\ncancer at age 49. She has been married for five years. Physical examination\nshows mild lower abdominal tenderness bilaterally. The uterus appears normal in\nsize. A small tender mass in noted in the left adnexal area. Pelvic ultrasound\nshows a 5-cm complex cyst in the left ovary.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  What is the underlying pathophysiology\nof this condition?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct.\n </b>\n In this vignette, the combination of\ndysmenorrhea, dyspareunia, infertility, and lower abdominal tenderness suggest\na diagnosis of endometriosis. The complex ovarian cyst is most likely an\nendometrioma.\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Endometriosis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Endometriosis is the\npresence of islands of endometrium (i.e., the tissue lining the inside of the\nuterus) in locations outside of the uterus.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Cyclic changes in these cells can be\nassociated with localized bleeding and resultant pain, inflammation, and/or\nscarring.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The exact reason for the\ndevelopment of endometriosis is unknown but there appears to be a hereditary\ncomponent.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Endometriosis typically\noccurs during the reproductive years. It affects roughly 5-10% of women.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <u>\n   <span>\n    Symptoms\n   </span>\n  </u>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The main symptoms of\nendometriosis are pain and infertility, although not everyone gets these\nsymptoms.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The most common pain from\nendometriosis is pelvic pain which can be present at times other than the\nmenstrual flow, although the pain is usually noted to worsen with the menses\n(dysmenorrhea).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Pain with\nintercourse is often present (dyspareunia).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Endometriosis can cause rectal pain and\nbleeding (dyschezia), and premenstrual back pain as well.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients with relatively mild\nendometriosis may have intense pain; alternatively, some patients with severe\ndisease can be relatively symptom-free.The mechanisms by which endometriosis\ncauses infertility are unknown.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Adhesions\n(scar tissue) and destruction of the fallopian tubes, ovarian cyst formation,\nand distortion of the normal anatomical relationships can explain the pain and\ninfertility.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In mild endometriosis,\nproposed mechanisms causing pain and infertility include release of certain\nchemicals by inflammatory cells that may be toxic to eggs, sperm, or embryos. Surgery\n(usually a diagnostic laparoscopy) is the only way to diagnose\nendometriosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <u>\n   <span>\n    Therapy\n   </span>\n  </u>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Pain related to\nendometriosis can be treated with either medication or an operation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A variety of different drugs have been\nused to treat endometriosis but all of them aim to suppress stimulation to the\nendometriotic implants.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Treatment\nwith estrogen and progesterone combination hormone therapy (oral contraceptives)\nhas been used in order to create an environment similar to pregnancy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  By establishing such a hormonal state,\nendometriosis has been found to stop growing and symptoms have resolved\npartially or completely.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  Therapy with medication alone is most beneficial in mild to moderate\ndisease. For infertile women with endometriosis, the infertility evaluation\nshould be completed and factors contributing to infertility should be\naddressed. Infertility due to endometriosis is usually treated surgically followed\nby conventional infertility treatments.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Surgery alone is most effective if there is associated anatomical\ndistortion that can be corrected surgically.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  However, recurrence and formation of new\nscar tissue limit the effectiveness of surgical therapy.\n </span>\n</p>\n", "choices": ["A. Chronic inflammation of the uterus and cervix", "B. Malignant transformation of epithelial cells of the ovary", "C. Endometrial glands outside of uterine cavity", "D. Excessive production of androgens by the ovaries"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 60-year-old man with\nalcoholic cirrhosis undergoes upper endoscopy and is found to have large\nesophageal varices. He has no history of gastrointestinal bleeding or\nencephalopathy. An abdominal ultrasound shows coarse hepatic echotexture, patent\nportal and hepatic veins, and no ascites. Which one of the following is the\nmost appropriate primary prophylaxis for this gentleman?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Non-selective beta-blockers such as nadolol or propranolol are\nrecommended for patients with large varices to reduce the risk of variceal\nbleeding. They\n </span>\n <span>\n  decrease\ncardiac output through &beta;\n  <sub>\n   1\n  </sub>\n  blockade and decrease splanchnic\nblood flow through &beta;\n  <sub>\n   2\n  </sub>\n  blockade.\n  <span>\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Norfloxacin is used as prophylaxis for spontaneous bacterial\nperitonitis in cirrhotic patients who have gastrointestinal bleeding or a\nhistory of spontaneous bacterial peritonitis.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Nitrates can reduce portal pressure and may be used as an adjunct to\nnon-selective beta-blockers.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Transjugular intrahepatic portosystemic shunt (TIPS) is used in\npatients with refractory gastrointestinal bleeding or ascites.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Sclerotherapy is used to treat bleeding esophageal varices. It is\ngenerally not recommended for bleeding prophylaxis.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Esophageal varices\n </span>\n are dilated submucosal veins in the lower\nesophagus. They are a consequence of portal hypertension, usually due to\ncirrhosis, and they have a strong tendency to bleed.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  Most of the blood from the esophagus is drained\nthrough the esophageal veins, which carry blood to the azygos vein, which in\nturn drains into the superior vena cava. These veins are\n  <i>\n   not\n  </i>\n  responsible for the development of esophageal varices. The\nremaining blood from the esophagus is drained into superficial veins lining the\nmucosa, which drain into the left gastric vein, which in turn drains into the\nportal vein. These superficial veins, which are normally only 1 millimeter in\ndiameter, can expand to 1-2&nbsp;centimeters when portal hypertension is\npresent. These dilated veins have thin walls and are called &ldquo;varices.&rdquo;\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  One of the most severe complications of\ncirrhosis is esophageal variceal bleeding, which typically presents as\nhematemesis (vomiting blood). In patients with advanced cirrhosis, high\npressure in the portal vein is transmitted to the left gastric vein. Branches\nof the left gastric vein form varices in the lining of the esophagus. These\nvarices are prone to bleeding.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  In patients with portal hypertension, blood flow\nthough the portal system is redirected from the liver into areas of lower\nvenous pressure, i.e., the lower esophagus, stomach, abdominal wall, and\nrectum. This redirection of blood flow can result in esophageal varices,\ndilated veins over the anterior abdominal wall, and internal hemorrhoids.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347279\" o:spid=\"_x0000_i1169\" type=\"#_x0000_t75\" alt=\"Description: 200710291050_31783_000\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image311.jpg\" o:title=\"200710291050_31783_000\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 200710291050_31783_000\" border=\"0\" height=\"283\" src=\"_%20Tutorials_files/image312.png\" v:shapes=\"Picture_x0020_347279\" width=\"295\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Nadolol", "B. Norfloxacin", "C. Nitrates", "D. Transjugular intrahepatic portosystemic shunt (TIPS).", "E. Sclerotherapy of varices"]}, {"question": "<p>\n Two chemicals are isolated\nfrom the body. When administered at the same time, they induce gastric acid\nsecretion that is four times as great as that induced by either one alone. The\ntwo chemicals are likely to be which of the following?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Gastric acid secretion\nis stimulated by acetylcholine, gastrin, and histamine. Histamine directly\nstimulates parietal cells to produce hydrochloric acid. Gastrin also directly\nstimulates parietal cells to produce hydrochloric acid. In addition, gastrin stimulates\nECL cells to release histamine, thus magnifying the effect of the administered\nhistamine. Combined administration of gastrin and histamine has a synergistic\neffect on acid release.\n </span>\n</p>\n"], "tutorial": "<p>\n Gastric acid secretion by\nthe parietal cell is stimulated by three substances (acetylcholine, gastrin,\nand histamine) and inhibited by one substance (somatostatin). The interaction\nof these substances is shown in the figure below. A\n <span class=\"figure-caption1\">\n  <span>\n   cetylcholine is\nreleased from the vagus nerve. Gastrin is produced by G cells, histamine is\nproduced by ECL cells (enterochromaffin-like cells), and somatostatin is\nproduced by D cells.\n  </span>\n </span>\n</p>\n\n<p>\n The H\n <sup>\n  +\n </sup>\n /K\n <sup>\n  +\n </sup>\n -ATPase\nin the parietal cell is the final common pathway for gastric acid secretion.\nThis enzyme allows the parietal cell to secrete hydrogen in exchange for\npotassium. The exchange is electroneutral, but requires energy in the form of\nadenosine triphosphate (ATP) because hydrogen is secreted against a gradient of\nmore than a million-fold. This huge energy requirement explains why parietal\ncells have the largest mitochondrial content of any mammalian cell.\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347278\"\n o:spid=\"_x0000_i1168\" type=\"#_x0000_t75\" alt=\"Description: http://www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-1-4160-3675-3&amp;eid=4-u1.0-B978-1-4160-3675-3..50051-4..gr7&amp;assetType=full\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image313.jpg\" o:title=\"//www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-1-4160-3675-3&amp;eid=4-u1.0-B978-1-4160-3675-3..50051-4..gr7&amp;assetType=full\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-1-4160-3675-3&amp;eid=4-u1.0-B978-1-4160-3675-3..50051-4..gr7&amp;assetType=full\" border=\"0\" height=\"242\" src=\"_%20Tutorials_files/image314.png\" v:shapes=\"Picture_x0020_347278\" width=\"223\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Acetylcholine and secretin", "B. Secretin and cholecystokinin", "C. Cholecystokinin and gastrin", "D. Gastrin and histamine", "E. Histamine and vasoactive intestinal polypeptide"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n10-year-old girl is brought to the emergency department because of abdominal\npain.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Ultrasonography reveals\nbilateral solid adnexal masses, 10cm x 10cm in size.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The human chorionic gonadotropin (hCG)\nlevel is elevated at 62 mIU/mL, and the lactate dehydrogenase (LDH) level is\nelevated at 137 U/L.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  What is the\nmost likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Dysgerminomas are the\nmost common malignant germ cell tumor, accounting for 50% of all cases. They\nappear bilaterally in 10-15% of cases. They do not secrete alpha-fetoprotein\n(which distinguishes them from endodermal sinus tumors). Some secrete hCG. They\nare associated with elevated levels of LDH, which can be used as a tumor\nmarker.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Endodermal sinus\ntumors are usually unilateral and do not secrete hCG. They\n  <i>\n   do\n  </i>\n  secrete alpha-fetoprotein.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Immature teratomas are\nusually unilateral and do not secrete hCG.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Theca-lutein cysts\nresult from ovarian hyperstimulation by gonadotropins. They are usually\nbilateral and multicystic, contain serosanguinous fluid, and are associated\nwith significantly elevated hCG levels. Treatment is conservative, as they\nusually regress spontaneously.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Mature cystic\nteratomas are common ovarian neoplasms. They usually contain tissues derived\nfrom all three germ layers (ectoderm, mesoderm, and endoderm), and may contain\ncartilage, hair, or teeth. They are benign, appear bilaterally in 10-15% of\ncases, and do not secrete hCG.\n </span>\n</p>\n"], "tutorial": "<p>\n Germ cell tumors may be\nbenign or malignant. They usually occur in the gonads (ovaries and testes), but\nmay appear elsewhere. In females under the age of 21, 60% of ovarian tumors are\nof the germ cell type, and up to one-third are malignant.\n</p>\n\n<p>\n Germ cell tumors are\nclassified into two histological categories: germinomatous and\nnon-germinomatous. The survival rate for germinomatous tumors is higher, in\npart, because these tumors are more sensitive to radiation and chemotherapy.\nNon-germinomatous tumors, by contrast, tend to grow faster and have a lower\nfive-year survival rate.\n</p>\n\n<h3>\n <span class=\"mw-headline\">\n  <span>\n   Germinomatous\n  </span>\n </span>\n</h3>\n\n<table border=\"1\" cellpadding=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td width=\"144\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Tumor\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"44\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Peak\n     </span>\n    </b>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Age (yr)\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"125\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Benign or malignant\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"117\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Tumor marker\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"144\">\n   <p class=\"MsoNormal\">\n    <span>\n     Germinoma\n  (\n     <span>\n      dysgerminoma\n     </span>\n     and\n     <span>\n      seminoma\n     </span>\n     )\n    </span>\n   </p>\n  </td>\n  <td width=\"44\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     40-50\n    </span>\n   </p>\n  </td>\n  <td width=\"125\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Malignant\n    </span>\n   </p>\n  </td>\n  <td width=\"117\">\n   <p class=\"MsoNormal\">\n    <span>\n     10%\n  secrete hCG\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<h3>\n <span class=\"mw-headline\">\n  <span>\n   Nongerminomatous\n  </span>\n </span>\n</h3>\n\n<table border=\"1\" cellpadding=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td width=\"144\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Tumor\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"44\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Peak Age (yr)\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"125\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Benign or malignant\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"117\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Tumor marker\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"144\">\n   <p class=\"MsoNormal\">\n    <span>\n     Embryonal\n  carcinoma\n    </span>\n   </p>\n  </td>\n  <td width=\"44\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     20-30\n    </span>\n   </p>\n  </td>\n  <td width=\"125\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Malignant\n    </span>\n   </p>\n  </td>\n  <td width=\"117\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     ---\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"144\">\n   <p class=\"MsoNormal\">\n    <span>\n     Endodermal\n  sinus tumor (\n     <span>\n      yolk sac tumor)\n     </span>\n    </span>\n   </p>\n  </td>\n  <td width=\"44\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     3\n    </span>\n   </p>\n  </td>\n  <td width=\"125\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Malignant\n    </span>\n   </p>\n  </td>\n  <td width=\"117\">\n   <p class=\"MsoNormal\">\n    <span>\n     100%\n  secrete AFP\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"144\">\n   <p class=\"MsoNormal\">\n    <span>\n     Choriocarcinoma\n    </span>\n   </p>\n  </td>\n  <td width=\"44\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     20-30\n    </span>\n   </p>\n  </td>\n  <td width=\"125\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Malignant\n    </span>\n   </p>\n  </td>\n  <td width=\"117\">\n   <p class=\"MsoNormal\">\n    <span>\n     100%\n  secrete hCG\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"144\">\n   <p class=\"MsoNormal\">\n    <span>\n     Teratoma\n  (mature teratoma, dermoid cyst, immature teratoma, teratoma with malignant\n  transformation)\n    </span>\n   </p>\n  </td>\n  <td width=\"44\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     0-3, 15-30\n    </span>\n   </p>\n  </td>\n  <td width=\"125\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mature\n  teratoma and dermoid cyst are benign; others usually malignant\n    </span>\n   </p>\n  </td>\n  <td width=\"117\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     ---\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Endodermal sinus tumor", "B. Immature teratoma", "C. Dysgerminoma", "D. Theca-lutein cyst", "E. Mature cystic teratoma"]}, {"question": "<p>\n <span>\n  A 29-year-old woman has a progressive increase in her serum &beta;-human\nchorionic gonadotropin (&beta;-hCG) concentrations during a 6-week period. A\nhydatidiform mole is removed, but the &beta;-hCG concentration continues to\nincrease. Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A small fraction of hydatidiform moles\ndevelop into choriocarcinoma, a rapidly-growing, malignant tumor characterized\nby increasing levels of quantitative &beta;-hCG.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Gestational trophoblastic disease\n </span>\n (GTD) or neoplasia is a generic\nterm for a group of pregnancy-related tumors that arise from trophoblasts.\nTrophoblasts constitute the outer layer of the blastocyst (see figure). They\nnourish the embryo and differentiate to form the placenta. Tumors arising from\nthese trophoblastic cells may be benign (e.g., hydatidiform mole) or malignant\n(e.g., choriocarcinoma).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n GTD usually presents as a\nhydatidiform mole (also known as a molar pregnancy), which includes abnormal\nproliferation of the syncytiotrophoblast and replacement of normal placental\ntrophoblastic tissue by hydropic placental villi.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n They may be complete moles or partial\nmoles. Complete moles have chromosomes entirely of paternal origin as the\nresult of the fertilization of a blighted ovum by a haploid sperm that\nreduplicates, or rarely, fertilization of a blighted ovum with two sperm.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The karyotype of a complete mole is\nusually 46XX.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The fetus of a\npartial mole is usually a triploid.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n This consists of one haploid set of maternal chromosomes and two haploid\nsets of paternal chromosomes, the consequence of dispermic fertilization of a\nnormal ovum.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Complete moles are\nmore common than partial moles and more likely to undergo malignant\ntransformation.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"_x0000_i1167\" type=\"#_x0000_t75\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image315.png\" o:href=\"file://localhost/cid/image001.png@01CD123E.F41E9650\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"348\" src=\"_%20Tutorials_files/image316.png\" v:shapes=\"_x0000_i1167\" width=\"240\"/>\n </span>\n</p>\n\n<p>\n Hydatidiform moles usually\npresent with painless vaginal bleeding in the first trimester. Blood tests show\nvery high levels of human chorionic gonadotropin (hCG) and the uterus is\nusually larger than expected. Symptoms of hyperthyroidism may occur because hCG\ncan mimic the effects of thyroid-stimulating hormone (TSH). On ultrasound, the\nmole has a &ldquo;snowstorm&rdquo; pattern (if it is a complete molar pregnancy).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n In cases of partial mole,\nultrasonography reveals an abnormally formed fetus without a heartbeat.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Definitive diagnosis requires\nhistopathologic examination to differentiate between partial and complete molar\npregnancy and malignancy.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Treatment\nfor either complete or partial molar pregnancy is dilation and curettage\nfollowed by serial hCG levels until negative.\n</p>\n\n<p>\n Choriocarcinomas are a\nmalignant transformation of trophoblastic tissue.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Instead of hydropic chorionic villi, the\ntumor has a red granular appearance on cut section and consists of intermingled\nsyncytiotrophoblastic and cytotrophoblastic elements with many abnormal\ncellular forms.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Clinically,\nchoriocarcinomas are characterized by rapid myometrial and uterine vessel\ninvasion and systemic metastases resulting from hematogenous embolization.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Lung, vagina, central nervous system\n(brain), kidney and liver are common metastatic locations.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Choriocarcinoma may follow a molar\npregnancy (most common), normal-term pregnancy, abortion, or ectopic\npregnancy.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  2 to 3% of\nhydatidiform moles develop into choriocarcinoma, a rapidly-growing, malignant\ntumor. Choriocarcinoma is characterized by increased quantitative &beta;-hCG\nlevels. The tumor is exquisitely sensitive to chemotherapy (usually\nmethotrexate with other additional drugs), and the cure rate, even for\nmetastatic disease, is above 90%.\n </span>\n</p>\n\n<p align=\"center\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/7/72/Blastocyst_English.svg\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347276\" o:spid=\"_x0000_i1166\" type=\"#_x0000_t75\" alt=\"Description: Description: File:Blastocyst English.svg\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/7/72/Blastocyst_English.svg\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image317.png\" o:title=\"Blastocyst English.svg\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: Description: File:Blastocyst English.svg\" border=\"0\" height=\"241\" src=\"_%20Tutorials_files/image318.png\" v:shapes=\"Picture_x0020_347276\" width=\"290\"/>\n  </span>\n </a>\n</p>\n", "choices": ["A. A second non-invasive mole", "B. Choriocarcinoma", "C. Pituitary adenoma", "D. Adrenal adenoma", "E. Ectopic pregnancy"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n14-month-old boy is brought to the emergency room because of rectal bleeding.\nHe does not appear distressed but has mild abdominal tenderness. Radionuclide\nimaging (see below) reveals the diagnosis and surgery is recommended. What is\nthe most plausible explanation for this condition?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct\n </b>\n . This patient most likely has Meckel&rsquo;s\ndiverticulum.\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347275\"\n o:spid=\"_x0000_i1165\" type=\"#_x0000_t75\" alt=\"Description: http://www.uth.tmc.edu/radiology/publish/meckel_diverticulum/images/md05.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image319.jpg\" o:title=\"//www.uth.tmc.edu/radiology/publish/meckel_diverticulum/images/md05.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.uth.tmc.edu/radiology/publish/meckel_diverticulum/images/md05.jpg\" border=\"0\" height=\"174\" src=\"_%20Tutorials_files/image320.png\" v:shapes=\"Picture_x0020_347275\" width=\"181\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Meckel&rsquo;s diverticulum\n  </span>\n </b>\n <span>\n  , which results from\npersistence of the omphalomesenteric duct (vitelline duct or yolk stalk), is\nusually found in the mid-to-distal ileum and may end blindly or connect to the\numbilicus. Rectal bleeding with iron-deficiency anemia is the most common presentation\nin children. The bleeding is not usually associated with severe pain.\nRadionuclide imaging can detect ectopic gastric mucosa. Meckel&rsquo;s diverticulum\nis characterized by the &ldquo;rule of 2s&rdquo;: 2 inches long, 2 feet from the ileocecal\nvalve, occurs in 2% of the population, usually presents before age 2, may\ncontain 2 types of epithelium (gastric and pancreatic), only 2% of patients are\nsymptomatic, males are 2 times as likely to be affected as females, and 2% of\ncarcinoid tumors occur in Meckel&rsquo;s diverticulum.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Intussusception\n  </span>\n </b>\n <span>\n  is the principal cause\nof intestinal obstruction in children between the ages of 3 months and 6 years.\nThe condition involves &ldquo;telescoping,&rdquo; or prolapse, of one portion of the bowel\ninto an adjacent portion. Typically, the distal ileum folds into the proximal\ncolon. There is an outpouring of bloody mucus, resulting in &ldquo;red currant jelly&rdquo;\nstool. The presentation is acute and severe, with screaming, vomiting,\ndiarrhea, and bloody bowel movements. The classic triad of colicky abdominal pain,\nvomiting, and red &ldquo;currant jelly&rdquo; stools occurs in 20% of cases.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Paroxysms of pain occur 10-20 minutes\napart, and the patient often feels well between episodes.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A vertically oriented mass is sometimes\npalpable in the right upper quadrant.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Most cases (90%) are idiopathic. The male-to-female ratio is\napproximately 3:1. Contrast enema is diagnostic in 95% of cases, and usually\ncurative if administered within 24 hours of presentation.\n </span>\n</p>\n\n<p>\n <b>\n  Volvulus\n </b>\n is a bowel\nobstruction that occurs when a loop of bowel twists on itself. Midgut volvulus\noccurs in infants, who may be predisposed to volvulus because of intestinal\nmalrotation. The most common symptom is bilious vomiting (i.e., vomiting\ngreenish-yellow fluid). Severe abdominal pain and distension are typical.\nIschemia occurs in the distribution of the superior mesenteric artery. If\nuntreated, the condition may result in bowel necrosis and death. Acute volvulus\nrequires immediate surgical intervention.\n</p>\n\n<p>\n <b>\n  Pyloric stenosis\n </b>\n is\ncaused by hypertrophy of smooth muscle in the gastric pylorus, resulting in\nsevere vomiting within the first few months of life. Vomiting is non-bilious\nand \"projectile.\" Palpation of the abdomen may reveal a mass in the\nepigastrium. Males are more commonly affected than females. Blood tests show\nhypokalemic metabolic alkalosis. Surgery is curative.\n</p>\n\n<p>\n <b>\n  Esophageal atresia\n </b>\n is\na congenital condition in which the esophagus ends in a blind pouch, rather\nthan connecting with the stomach. The pouch may or may not communicate with the\nrespiratory tract through a tracheoesophageal fistula. E\n <span>\n  sophageal atresia\n </span>\n should be suspected when drooling in a newborn\nis accompanied by choking, coughing, and sneezing. The infant may swallow\nnormally, but begins to cough as fluid returns through the nose and mouth.\nCyanosis may occur if fluid is aspirated into the trachea. Surgery is curative.\n</p>\n", "choices": ["A. Ectopic gastric epithelium in a persistent omphalomesenteric duct", "B. Blockage of the intestine due to folding of the distal ileum into the proximal colon", "C. Bowel rotation resulting in obstruction of the superior mesenteric artery", "D. Hypertrophy of smooth muscle in the gastric pylorus", "E. Esophagus ending in a blind-pouch"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Match each\nof the following items with the statement that best describes its function.\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answers\n  </span>\n </b>\n <span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  11.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Secretin\nstimulates bicarbonate secretion by the pancreas.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  6.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Gastrin\nstimulates gastric contraction, hydrochloric acid secretion, histamine release,\nand pepsinogen release.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  4.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Cholecystokinin\nstimulates the pancreas to secrete digestive enzymes and the gall bladder to\ncontract and release bile.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Gastric\ninhibitory peptide (GIP) inhibits stomach motility and acid secretion and\nstimulates insulin release by the pancreas in a\n  <span>\n   glucose-dependent manner.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  13.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Substance-P\nstimulates gastrointestinal motility and transmits pain impulses in the nervous\nsystem.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  8.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Motilin\nimproves peristalsis in the small intestine.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  12.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Somatostatin\ninhibits the release of pancreatic hormones (insulin and glucagon) and\ngastrointestinal hormones (gastrin, cholecystokinin, secretin, motilin,\nvasoactive intestinal polypeptide, gastric inhibitory polypeptide).\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  14.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Vasoactive\nintestinal polypeptide relaxes smooth muscle and promotes water and electrolyte\nsecretion by the jejunum, ileum, and colon.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  7.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Goblet\ncells secrete mucin, which dissolves in water to form mucus, which in turn\nprotects and lubricates the lining of the intestine.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   J.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  9.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Parietal\ncells produce gastric acid and intrinsic factor, a glycoprotein that binds with\ndietary vitamin-B12 in the stomach and facilitates vitamin-B12 absorption in\nthe terminal ileum.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   K.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  1.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Brunner&rsquo;s\nglands produce a mucus-rich alkaline secretion (containing bicarbonate), which\nprotects the duodenum from the acidic contents of chime, and which provides an\nalkaline environment for intestinal enzymes.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   L.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Chief\ncells produce pepsinogen, the precursor of pepsin.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   M.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Peyer&rsquo;s\npatches are organized lymphoid nodules in the ileum.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   N.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  3.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Chyme\nis a semifluid mass of partly digested food expelled by the stomach into the\nduodenum.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. Secretin", "B. Gastrin", "C. Cholecystokinin", "D. Gastric inhibitory peptide (GIP)", "E. Substance-P", "F. Motilin", "G. Somatostatin", "H. Vasoactive intestinal polypeptide", "I. Goblet cell", "J. Parietal cell", "K. Brunner\u2019s gland", "L. Chief cell", "M. Peyer\u2019s patch", "N. Chyme", "1. Located in the duodenum, it produces a mucus-rich alkaline secretion (containing bicarbonate), which protects the duodenum from acidity provides an alkaline environment for intestinal enzymes to be active.", "2. Located in the stomach, it produces pepsinogen, the precursor of pepsin. (Pepsin is one of three major proteolytic enzymes in the digestive system. The other two are chymotrypsin and trypsin.)", "3. Semifluid mass of partly digested food expelled by the stomach into the duodenum.", "4. Secreted by cells lining the duodenum, it stimulates the pancreas to secrete digestive enzymes and stimulates the gall bladder to contract and release bile.", "5. Released from cells in the duodenum and jejunum, it inhibits stomach motility and acid secretion and stimulates insulin release by the pancreas in a glucose-dependent manner.", "6. Released by cells in the stomach, duodenum, and pancreas, it stimulates gastric contraction, hydrochloric acid secretion, histamine release, and pepsinogen release.", "7. Part of the mucosa of the small intestine, it secretes mucin, which dissolves in water to form mucus, which in turn protects and lubricates the lining of the intestine.", "8. Secreted by enterochromaffin cells in the duodenum and jejunum, it improves peristalsis in the small intestine.", "9. It produces gastric acid and intrinsic factor, a glycoprotein that binds with dietary vitamin-B12 in the stomach and facilitates vitamin-B12 absorption in the terminal ileum.", "10. An organized lymphoid nodule in the ileum.", "11. Secreted by cells in the duodenum, it stimulates bicarbonate secretion from the pancreas.", "12. A peptide hormone, it inhibits the release of pancreatic hormones (insulin and glucagon) and gastrointestinal hormones (gastrin, cholecystokinin, secretin, motilin, vasoactive intestinal polypeptide, gastric inhibitory polypeptide).", "13. A neuropeptide synthesized by enterochromaffin cells, it stimulates gastrointestinal motility and transmits pain impulses in the nervous system.", "14. It relaxes smooth muscle and promotes water and electrolyte secretion by the jejunum, ileum, and colon."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Drug Z\nconstricts efferent arterioles but not afferent arterioles. Which combination\nof effects is drug Z most likely to produce?\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     GFR\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Filtration Fraction\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Renal Blood Flow\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     A\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     B\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     C\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     D\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     E\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     F\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     G\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     H\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nafferent and efferent arterioles are the major resistance sites in the renal\nmicrocirculation.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347274\"\n o:spid=\"_x0000_i1164\" type=\"#_x0000_t75\" alt=\"Description: rc2\">\n <v:imagedata src=\"_%20Tutorials_files/image321.png\" o:title=\"rc2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: rc2\" border=\"0\" height=\"312\" src=\"_%20Tutorials_files/image322.png\" v:shapes=\"Picture_x0020_347274\" width=\"415\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  H.P. = Hydrostatic\npressure\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  &pi;\n  <sub>\n   b\n  </sub>\n  = Plasma\noncotic pressure\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Constriction of the afferent arteriole\n  </span>\n </i>\n <span>\n  increases resistance to\nblood flow. The fall in pressure downstream decreases GFR and renal blood flow.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Dilatation of the afferent arteriole\n  </span>\n </i>\n <span>\n  decreases resistance to\nblood flow. The rise in pressure downstream increases GFR and renal blood flow.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Constriction of the efferent arteriole\n  </span>\n </i>\n <span>\n  increases resistance to\nblood flow. The rise in pressure upstream increases GFR. The fall in pressure\ndownstream decreases renal blood flow.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Dilatation of the efferent arteriole\n  </span>\n </i>\n <span>\n  decreases resistance to\nblood flow. The fall in pressure upstream decreases GFR. The rise in pressure\ndownstream increases renal blood flow.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Here&rsquo;s a\nsummary.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"155\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     GFR\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"148\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Renal blood flow\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"155\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"148\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Afferent arteriolar constriction\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"155\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"148\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Afferent arteriolar dilatation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"155\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"148\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Efferent arteriolar constriction\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"155\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"148\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Efferent arteriolar dilatation\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"155\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"148\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Filtration\nfraction is the ratio of GFR to renal blood flow (GFR/RBF). Constriction of\nefferent arterioles increases filtration fraction. Dilatation of efferent\narterioles decreases filtration fraction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer G is correct\n  </span>\n </b>\n <span>\n  . Constriction of the\nefferent arteriole increases resistance to blood flow. The rise in pressure\nupstream increases GFR. The fall in pressure downstream decreases renal blood\nflow. Filtration fraction, which is the ratio of GFR to renal blood flow, would\nincrease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"search-hit\">\n  <span>\n   A\n5-week-old male infant is brought to the emergency room because of abdominal\ndistension. He has not had a bowel movement in 4 days. His mother says he has\nbeen constipated since birth. Physical examination shows abdominal distension.\nAn X-ray shows distended loops of proximal bowel with an abrupt narrowing to a\nsmall caliber of the distal 20-cm segment of colon. Which of the following\npathologic findings is most likely in a biopsy specimen of the distal rectum in\nthis patient?\n  </span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <span class=\"search-hit\">\n  <b>\n   <span>\n    Answer A is correct.\n   </span>\n  </b>\n </span>\n <span class=\"search-hit\">\n  <span>\n   The\ndiagnosis of Hirschsprung disease should be suspected in an infant with\nconstipation and abdominal distension associated with distended loops of bowel\nwith abrupt, distal narrowing.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span class=\"search-hit\">\n  <span>\n   Hirschsprung\n  </span>\n </span>\n <span>\n  disease, or congenital\naganglionic megacolon, is the most common cause of lower intestinal obstruction\nin neonates. The disorder is caused by an absence of ganglion cells beginning\nin the anal sphincter and extending proximally into the colon.\n  <a name=\"4-u1.0-B978-1-4160-2450-7..50331-5--p156\">\n  </a>\n  The ganglion cells are\nmissing because of an arrest of neuroblast migration from the proximal to\ndistal bowel. As a result, affected regions of bowel lack innervation.\nHirschsprung disease is usually sporadic. Males are affected more than females.\nThe aganglionic segment is limited to the rectosigmoid in 75% of patients; in\n10%, the entire colon lacks ganglion cells. Symptoms begin at birth with the\ndelayed passage of meconium. Failure to pass stool leads to dilatation of the\nproximal bowel. Surgery, the mainstay of therapy, should be undertaken before\ncomplications occur.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347273\"\n o:spid=\"_x0000_i1163\" type=\"#_x0000_t75\" alt=\"Description: HIRSCHSPRUNG\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image323.jpg\" o:title=\"HIRSCHSPRUNG\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: HIRSCHSPRUNG\" border=\"0\" height=\"302\" src=\"_%20Tutorials_files/image324.png\" v:shapes=\"Picture_x0020_347273\" width=\"206\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Absent myenteric ganglion cells", "B. Abundant inspissated mucus", "C. Hypertrophy of the muscle wall", "D. Nodular lymphoid hyperplasia", "E. Transmural coagulative necrosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 30-year-old woman has anxiety about\nepisodes of abdominal pain that have alternated with diarrhea and constipation\nover the past year. She often has these episodes when she is stressed or tired.\nPhysical examination and laboratory studies are within normal limits during\nthese episodes. Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer D is correct.\n </b>\n Irritable bowel syndrome is one of the most\ncommon GI disorders. The diagnosis should be suspected in patients with\nrecurrent abdominal pain and no structural or biochemical abnormalities.\nAffected individuals may have diarrhea, constipation, or alternating bouts of\ndiarrhea and constipation. In an otherwise healthy 30-year-old woman with\nrecurrent bouts of abdominal pain and alternating diarrhea and constipation,\nirritable bowel syndrome would be the most likely diagnosis.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n"], "tutorial": "<p>\n <b>\n  Irritable bowel syndrome\n </b>\n (IBS) is one of the most commonly\ndiagnosed gastrointestinal (GI) conditions and also one of the most common\nfunctional GI disorders seen in clinical practice. It is defined as chronic,\nrecurrent abdominal pain or discomfort that cannot be explained by structural\nor biochemical abnormality, and is associated with at least two of the\nfollowing: improvement with defecation, onset associated with a change in\nfrequency of stool, and onset associated with a change in form (appearance) of\nstool. Other symptoms that support the diagnosis include abnormal stool\nfrequency (&le;3 bowel movements per week or &gt;3 bowel movements per day),\nabnormal stool form (lumpy/hard or loose/watery), defecation straining,\nurgency, or feeling of incomplete bowel movement, passing mucus, and bloating.\nThree possible IBS subtypes include IBS with constipation, IBS with diarrhea,\nand mixed IBS.\n</p>\n\n<p>\n To date, no physiologic\nmechanism unique to IBS has been identified. Rather, it is currently viewed as\na biopsychosocial disorder resulting from an interaction among a number of\nfactors: visceral hypersensitivity, enteric infection, low grade inflammation,\nabnormal gut motility, and psychological factors. The treatment strategy is\nbased on the nature and severity of the symptoms, the character and degree of\nfunctional impairment, and the presence of psychosocial difficulties affecting\nthe course of the illness. Patients with mild symptoms usually respond to\neducation, reassurance, and simple treatments not requiring prescription\nmedication. Some patients with moderate symptoms have more disability and\nrequire pharmacologic therapy directed at altered gut physiology or\npsychological treatments. A small group of patients with severe and refractory\nsymptoms seen more often at referral centers may benefit from antidepressant\ntherapy and psychological treatment.\n</p>\n", "choices": ["A. Gastroenteritis", "B. Generalized anxiety disorder", "C. Hypochondriasis", "D. Irritable bowel syndrome", "E. Major depressive disorder", "F. Somatization disorder"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n38-year-old woman presents to her physician with jaundice, generalized itching,\nand pale stools. Her urine is dark. A blood test shows:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Aspartate\naminotransferase:\n  <span>\n   &nbsp;\n  </span>\n  52 U/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Alanine\naminotransferase:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  54\nU/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Alkaline\nphosphatase:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  279\nU/L\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Total\nbilirubin:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.9\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Conjugated\nbilirubin:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.5\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The most\nlikely cause of illness is:\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Obstructive jaundice\nis associated hyperbilirubinemia, predominantly in the form of conjugated\nbilirubin. Itching is common, stools are typically pale (acholic), and the\nurine is dark.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Intravascular\nhemolysis is associated with unconjugated hyperbilirubinemia. Liver enzymes are\nnormal. Hemoglobinuria is present. Intravascular hemolysis is usually caused by\nmechanical or toxic injury to red blood cells.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Extravascular\nhemolysis is associated with unconjugated hyperbilirubinemia. Liver enzymes are\nnormal. Hemoglobinuria is\n  <i>\n   not\n  </i>\n  present.\nSpherocytes are common. Extravascular hemolysis occurs because of defects in\nthe red blood cell membrane, which may be inherited or acquired.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Gilbert&rsquo;s syndrome is\na very common, benign condition associated with decreased levels of\nUDP-glucuronyl transferase. Unconjugated bilirubin levels are elevated. Liver\nenzymes are normal. Jaundice occurs with stress or exercise.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Crigler-Najjar\nsyndrome type 1 is caused by absence of UDP-glucuronyl transferase. This\nresults in childhood kernicterus. Unconjugated bilirubin levels are extremely\nhigh.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Jaundice\n </span>\n , also known as\n <span>\n  icterus\n </span>\n ,\nis a yellowish pigmentation of the skin, conjunctivae, and other mucous\nmembranes caused by hyperbilirubinemia. Typically, the concentration of\nbilirubin in the plasma must exceed 1.5 mg/dL, three times the usual value of\n0.5 mg/dL, for the yellow color to be visible.\n</p>\n\n<p>\n [Note: The conjunctivae are\namong the first tissues to change color. The term &ldquo;scleral icterus&rdquo; is commonly\nused, although the sclerae themselves are not icteric. The correct term is\n&ldquo;conjunctival icterus.&rdquo;]\n</p>\n\n<p>\n Jaundice is classified into\nthree categories: pre-hepatic, hepatic, and post-hepatic.\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Pre-hepatic\n  </span>\n </i>\n <span>\n  jaundice is caused by\nconditions associated with increased hemolysis, such as sickle cell disease,\nspherocytosis, thalassemia, glucose-6-phosphate dehydrogenase deficiency,\nhemolytic uremic syndrome, thrombotic thrombocytopenia purpura, and malaria.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Laboratory\nfindings include:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Serum:\nincreased unconjugated bilirubin\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Urine\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Bilirubin absent\n(because unconjugated bilirubin is not water-soluble)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Urobilinogen present\n(because biliary drainage is not obstructed)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Urine\ncolor: normal (because bilirubin is absent)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Stool\ncolor: normal (because biliary drainage is not obstructed)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Hepatic\n  </span>\n </i>\n <span>\n  jaundice is caused by\nliver damage or by genetic defects. Conditions associated with liver damage\ninclude alcoholic liver disease and viral hepatitis. Conditions caused by\ngenetic defects include Gilbert&rsquo;s syndrome and Crigler-Najjar syndrome.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Laboratory\nfindings depend on the underlying disorder. Patients with alcoholic liver\ndisease or viral hepatitis have the following findings:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Serum:\nincreased unconjugated and conjugated bilirubin\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Urine\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Bilirubin present\n(because conjugated bilirubin is water-soluble)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Urobilinogen present\n(because biliary drainage is not obstructed)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Urine\ncolor: dark (because bilirubin is present)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Stool:\nnormal (because biliary drainage is not obstructed)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Post-hepatic\n  </span>\n </i>\n <span>\n  jaundice, also called\nobstructive jaundice, involves an interruption of bile flow. The most common\ncauses are choledocholithiasis (gallstones in the common bile duct) and cancer\nof the head of the pancreas. The presence of acholic (pale or clay-colored)\nstools and dark urine suggests an obstructive process, because feces get their\ndark color from bile pigments. Patients with biliary obstruction may have\nsevere itching (pruritus) and high cholesterol levels.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Laboratory\nfindings include:\n </span>\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Serum: increased conjugated bilirubin\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Urine\n</p>\n\n<p>\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Bilirubin present (because conjugated bilirubin\nis water-soluble)\n</p>\n\n<p>\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Urobilinogen absent (because biliary drainage is\nobstructed)\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Urine\ncolor: dark (because bilirubin is present)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Stool\ncolor: pale (because biliary drainage is obstructed)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  No single\ntest can differentiate between the various types of jaundice. A combination of\ntests is essential.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"145\">\n    <p align=\"center\">\n     Types of Jaundice\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"145\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"145\">\n    <p>\n     Pre-hepatic (hemolytic)\n    </p>\n    <p>\n     Hepatic\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Liver damage\n    </p>\n    <p>\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     Genetic disorders\n    </p>\n    <p>\n     Post-hepatic (obstructive)\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Pre-hepatic\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Jaundice\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Hepatic\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Jaundice\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Post-hepatic\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Jaundice\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     AST and ALT\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Alk Phos\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Unconjugated bilirubin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Conjugated\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     bilirubin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Total bilirubin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increased\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Urine color\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dark\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dark\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Urobilinogen\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Present\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Present\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Absent\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Urine bilirubin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Not\n  present\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Present\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Present\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Stool color\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Normal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pale\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n Pearls:\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Hemolytic anemia does\n <i>\n  not\n </i>\n cause bilirubin to appear in the urine\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Biliary obstruction is associated with acholic\n(pale) stools\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Biliary obstruction can cause intense itching\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n Biliary obstruction is associated with decreased\nor absent urobilinogen in the urine\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "choices": ["A. Intravascular hemolysis", "B. Extravascular hemolysis", "C. Decreased levels of UDP-glucuronyl transferase", "D. Absence of UDP-glucuronyl transferase", "E. Biliary obstruction"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of the following is\n  <i>\n   not\n  </i>\n  true regarding the menstrual cycle?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://en.wikipedia.org/wiki/File:MenstrualCycle2_en.svg\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347272\" o:spid=\"_x0000_i1162\" type=\"#_x0000_t75\" alt=\"Description: http://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/MenstrualCycle2_en.svg/350px-MenstrualCycle2_en.svg.png\"\n href=\"http://en.wikipedia.org/wiki/File:MenstrualCycle2_en.svg\" o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image325.png\" o:title=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/MenstrualCycle2_en.svg/350px-MenstrualCycle2_en.svg.png\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: http://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/MenstrualCycle2_en.svg/350px-MenstrualCycle2_en.svg.png\" border=\"0\" height=\"331\" src=\"_%20Tutorials_files/image326.png\" v:shapes=\"Picture_x0020_347272\" width=\"344\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  MENSTRUAL CYCLE\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Between menarche and\nmenopause, the reproductive organs undergo a series of changes at monthly\nintervals. This &ldquo;menstrual cycle&rdquo; results from interactions of the\nhypothalamic-pituitary-ovarian axis with target tissues (endometrium, cervix,\nand vagina). The median length of a menstrual cycle is 28 days. Cycle lengths\nare especially variable soon after menarche and before menopause. Menstrual\nirregularities may result from abrupt changes in diet or exercise; serious\nemotional disturbance; and parturition or abortion. The menstrual cycle is\ndivided into three phases: follicular, ovulatory, and luteal.\n  <b>\n  </b>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <!--[if gte vml 1]><v:line id=\"Straight_x0020_Connector_x0020_347286\"\n o:spid=\"_x0000_s1112\" from=\"234.5pt,193.2pt\" to=\"279.5pt,202.2pt\"\n o:gfxdata=\"UEsDBBQABgAIAAAAIQDkmcPA+wAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nqwUAAAAA\n\" strokecolor=\"navy\" strokeweight=\"4.5pt\">\n <v:stroke endarrow=\"block\"/>\n</v:line><![endif]-->\n <span>\n  <img height=\"26\" src=\"_%20Tutorials_files/image327.png\" v:shapes=\"Straight_x0020_Connector_x0020_347286\" width=\"54\"/>\n </span>\n <v:line from=\"322.4pt,139.5pt\" id=\"Straight_x0020_Connector_x0020_347285\" o:gfxdata=\"UEsDBBQABgAIAAAAIQDkmcPA+wAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nqwUAAAAA\n\" o:spid=\"_x0000_s1111\" strokecolor=\"navy\" strokeweight=\"4.5pt\" to=\"331.4pt,184.5pt\">\n  <v:stroke endarrow=\"block\">\n  </v:stroke>\n </v:line>\n <span>\n  <img height=\"54\" src=\"_%20Tutorials_files/image328.png\" v:shapes=\"Straight_x0020_Connector_x0020_347285\" width=\"26\"/>\n </span>\n <v:shapetype coordsize=\"21600,21600\" id=\"_x0000_t202\" o:spt=\"202\" path=\"m0,0l0,21600,21600,21600,21600,0xe\">\n  <v:stroke joinstyle=\"miter\">\n  </v:stroke>\n  <v:path gradientshapeok=\"t\" o:connecttype=\"rect\">\n  </v:path>\n </v:shapetype>\n <v:shape id=\"Text_x0020_Box_x0020_347284\" o:gfxdata=\"UEsDBBQABgAIAAAAIQDkmcPA+wAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\ncy9kb3ducmV2LnhtbFBLBQYAAAAABAAEAPMAAACPBQAAAAA=\n\" o:spid=\"_x0000_s1110\" type=\"#_x0000_t202\">\n </v:shape>\n <span>\n  <table cellpadding=\"0\" cellspacing=\"0\">\n   <tr>\n    <td align=\"left\" bgcolor=\"white\" height=\"40\" valign=\"top\" width=\"77\">\n     <span>\n      <table cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">\n       <tr>\n        <td>\n         <div class=\"shape\" v:shape=\"Text_x0020_Box_x0020_347284\">\n          <p align=\"center\" class=\"MsoNormal\">\n           granulosa cells\n          </p>\n         </div>\n        </td>\n       </tr>\n      </table>\n     </span>\n     &nbsp;\n    </td>\n   </tr>\n  </table>\n </span>\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347271\" o:spid=\"_x0000_i1161\"\n type=\"#_x0000_t75\" alt=\"Description: ovary-04\">\n <v:imagedata src=\"_%20Tutorials_files/image329.jpg\" o:title=\"ovary-04\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: ovary-04\" border=\"0\" height=\"220\" src=\"_%20Tutorials_files/image330.png\" v:shapes=\"Picture_x0020_347271\" width=\"235\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Ovarian Follicle\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Follicular\n(Preovulatory) Phase\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The follicular phase\nbegins on the first day of menstrual bleeding, when estradiol, progesterone,\nand LH are at their lowest levels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In the early follicular phase, FSH promotes growth and development of\nthe follicles by binding to receptors in the granulosa cells, causing cell\ndivision and differentiation. The granulosa cells secrete estrogen, which\nstimulates endothelial growth. In the late follicular phase, FSH levels\ndecline, ensuring that only the most advanced follicle will proceed to\novulation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4160-2805-5..50261-5--f1\">\n </a>\n <b>\n  <span>\n   Ovulatory Phase\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Positive estrogen\nfeedback on the pituitary leads to an LH surge, which results in follicular\nmaturation and ovulation. During ovulation, an ovum is released from the mature\nfollicle. Some women experience brief, dull, unilateral pelvic pain near the\ntime of ovulation, termed\n  <i>\n   Mittelschmerz\n  </i>\n  , which may be due to leakage of\nfollicular fluid into the abdominal cavity. At peak LH levels, estrogen levels\nbegin to fall and progesterone levels begin to rise.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Luteal\n(Postovulatory) Phase\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  After ovulation, the\nfollicle transforms into the corpus luteum, which produces progesterone and\nestradiol. Progesterone converts the endometrium to its secretory stage,\npreparing the uterus for implantation. Progesterone levels peak a week after\nthe LH surge, and fall if pregnancy has not occurred. Similar (but smaller)\nchanges in estrogen occur.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  EFFECTS\nON TARGET ORGANS\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Endometrium\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Menstrual bleeding\noccurs when the corpus luteum stops secreting progesterone. After menses, the\nbasal layer of the endometrium regenerates the superficial layer of epithelial\ncells lining the uterine cavity and an intermediate layer of spongiosa, both of\nwhich are shed at each menstruation. Endometrial glands in these layers\nproliferate under the influence of estrogen in the follicular phase so that the\nmucosa thickens. In the luteal phase, under the influence of progesterone, the\nglands become coiled and secretory. As both estradiol and progesterone decline\nin the late luteal phase, endometrial necrosis occurs and bleeding ensues.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Cervix and Cervical\nMucus\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  During the follicular\nphase, cervical vascularity, congestion, and edema increase under the influence\nof estrogen. The external cervical os opens to a diameter of 3 mm at ovulation\nand then decreases to 1 mm. Cervical mucus increases in quantity (10- to\n30-fold) and in elasticity. Under the influence of progesterone during the\nluteal phase, cervical mucus thickens and loses its elasticity.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Vagina\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When estrogen levels are\nlow, the vaginal epithelium is pale and thin. During the follicular phase,\nunder the influence of estrogen, the epithelium thickens, and the number of\nmature cornified cells increases. During the luteal phase, there is an increase\nin cellular debris and clumping of shed desquamated cells.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Ovary\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  During the reproductive\nyears, the ovaries regularly produce a single dominant follicle, which grows\nand matures during the follicular phase. This process is governed by the\ncombined action of FSH and LH on the follicular wall. During ovulation, the LH\nsurge causes the release of a mature fertilizable oocyte. After ovulation, the\nfollicle wall transforms into the corpus luteum, which produces progesterone\nand estradiol during the luteal phase. If implantation does not occur, the\ncorpus luteum undergoes luteolysis and hormone production ceases and it becomes\na corpus albicans.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347270\"\n o:spid=\"_x0000_i1160\" type=\"#_x0000_t75\" alt=\"Description: http://www.anselm.edu/homepage/jpitocch/genbio/follicledevelop.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image331.jpg\" o:title=\"//www.anselm.edu/homepage/jpitocch/genbio/follicledevelop.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.anselm.edu/homepage/jpitocch/genbio/follicledevelop.jpg\" border=\"0\" height=\"193\" src=\"_%20Tutorials_files/image332.png\" v:shapes=\"Picture_x0020_347270\" width=\"282\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Follicle-stimulating hormone (FSH) promotes follicular growth by binding to receptors in the granulosa cells of the follicle.", "B. Ovulation is triggered by a surge in luteinizing hormone (LH).", "C. During the follicular phase, estrogen inhibits the release of luteinizing hormone (LH) through negative feedback.", "D. Estrogen stimulates endothelial growth and thickening of the vaginal wall.", "E. Progesterone converts the endometrium to its secretory stage, preparing the uterus for implantation."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  During\nthe follicular phase, estrogen\n  <i>\n   stimulates\n  </i>\n  the release of luteinizing\nhormone (LH) through\n  <i>\n   positive\n  </i>\n  feedback.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Follicle-stimulating hormone (FSH) promotes\n </span>\n <span>\n  follicular growth by\nbinding to receptors in the granulosa cells of the follicle.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  O\n  <span>\n   vulation is triggered by a surge of luteinizing hormone (LH).\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Estrogen\nstimulates endothelial growth and thickening of the vaginal wall. [Note:\n </span>\n <span>\n  Endometrial hyperplasia\n </span>\n <span>\n  is a condition of excessive proliferation of the cells of\nthe endometrium. It usually results from high levels of estrogen, combined with\ninsufficient levels of progesterone. This may occur in a number of settings,\nincluding obesity, estrogen producing tumors (e.g. granulosa cell tumors), and\ncertain formulations of estrogen replacement therapy. Endometrial hyperplasia\nis a significant risk factor for the development of endometrial cancer, so\ncareful monitoring and treatment of women with this disorder is essential.]\n  <span>\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   5.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Progesterone converts\nthe endometrium to its secretory stage, preparing the uterus for implantation.\n  <span>\n  </span>\n </span>\n</p>\n\n<p>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   A 65-year-old man develops oliguria\nand peripheral edema over a period of weeks. Urinalysis reveals hematuria and\nproteinuria; examination of the urinary sediment reveals red cell casts.\nRadiologic and ultrasound studies fail to demonstrate an obstructive lesion.\nRenal biopsy shows many glomerular crescents. This presentation is most\nsuggestive of which of the following conditions?\n  </span>\n </span>\n</p>\n", "answers": ["<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer A is correct.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   This\npatient has rapidly progressive glomerulonephritis (RPGN), as evidenced by the\npresence of red blood cell casts and crescentic glomeruli. RPGN is usually due\nto some form of vasculitis or to anti-glomerular basement membrane disease\n(including Goodpasture syndrome and isolated anti-glomerular basement disease).\nAs vasculitis in not one of the options listed, the correct answer is\nanti-glomerular basement membrane disease.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer B is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   &nbsp;Diabetic\nnephropathy\n  </span>\n </span>\n <strong>\n  <span lang=\"EN-GB\">\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   typically begins with microalbuminuria and\nhypertension and progresses over a 10- to 20-year period to renal failure.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer C is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Hypertensive nephropathy\n  </span>\n </span>\n <strong>\n  <span lang=\"EN-GB\">\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   typically presents with slowly\nrising BUN and creatinine (unless the patient has malignant hypertension).\n  </span>\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer D is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Minimal\nchange disease typically presents with nephrotic syndrome and is not associated\nwith recognizable glomerular changes by light microscopy. Podocyte foot-process\nfusion can be seen by electron microscopy.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Rapidly\nprogressive glomerulonephritis (RPGN) is a disease of the kidney characterized\nclinically by a rapid decrease in the glomerular filtration rate (GFR) of at\nleast 50% over a short period, from a few days to 3 months. The main pathologic\nfinding is extensive glomerular crescent formation. The ubiquitous pathological\nfeature of crescentic glomerulonephritis is a focal rupture of glomerular\ncapillary walls that can be seen by light microscopy and electron microscopy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The term\nrapidly progressive glomerulonephritis was first used to describe a group of\npatients who had an unusually fulminant poststreptococcal glomerulonephritis\nand a poor clinical outcome. Several years later, the antiglomerular basement\nmembrane (anti-GBM) antibody was discovered to produce a crescentic\nglomerulonephritis in sheep, and, following this discovery, the role of\nanti-GBM antibody in Goodpasture syndrome was elucidated. Soon afterward, the\nrole of the anti-GBM antibody in rapidly progressive glomerulonephritis\nassociated with Goodpasture disease was established.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In the\nmid-1970s, a group of patients was described who fit the clinical criteria for\nrapidly progressive glomerulonephritis but in whom no cause could be\nestablished. Many of these cases were associated with systemic signs of\nvascular inflammation (systemic vasculitis), but some cases were characterized\nonly by renal disease. A distinct feature of these cases was the virtual\nabsence of antibody deposition after immunofluorescence staining of the biopsy\nspecimens, which led to the label pauci-immune rapidly progressive\nglomerulonephritis. More than 80% of patients with pauci-immune rapidly\nprogressive glomerulonephritis were subsequently found to have circulating\nantineutrophil cytoplasmic antibodies (ANCAs).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Rapidly\nprogressive glomerulonephritis is classified into 3 categories: (1) anti-GBM\nantibody disease (approximately 3% of cases), (2) immune complex disease (45%\nof cases), and (3) pauci-immune disease (50% of cases). Immunologic\nclassification is based on the presence or absence of ANCAs.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Anti-GBM\nantibody\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Goodpasture\nsyndrome (lung and kidney involvement)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Anti-GBM\ndisease (only kidney involvement)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Immune\ncomplex\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Postinfectious\n(staphylococci/streptococci)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lupus\nnephritis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Henoch-Sch&ouml;nlein\npurpura (immunoglobulin A and systemic vasculitis)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Immunoglobulin\nA nephropathy (no vasculitis)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Mixed\ncryoglobulinemia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Membranoproliferative\nglomerulonephritis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Pauci-immune\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Wegener\ngranulomatosis (WG)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Microscopic\npolyangiitis (MPA)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Churg-Strauss\nsyndrome\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Note:\n80-90% of patients are ANCA positive.\n </span>\n</p>\n", "choices": ["A. Anti-glomerular basement membrane disease", "B. Diabetic nephropathy", "C. Hypertensive nephropathy", "D. Minimal change disease"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Combination\noral contaceptives contain an estrogen and a progestin. What is their principal\nmechanism of action?\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"144\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Estrogen\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Progestin\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"144\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      A\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"144\">\n    <p class=\"MsoNormal\">\n     <span>\n      Stimulates\n  FSH secretion\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Stimulates\n  LH secretion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      B\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"144\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inhibits\n  FSH secretion\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inhibits\n  LH secretion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      C\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"144\">\n    <p class=\"MsoNormal\">\n     <span>\n      Stimulates\n  LH secretion\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Stimulates\n  FSH secretion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      D\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"144\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inhibits\n  LH secretion\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inhibits\n  FSH secretion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      E\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"144\">\n    <p class=\"MsoNormal\">\n     <span>\n      Stimulates\n  FSH secretion\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"135\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inhibits\n  LH secretion\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Combination\noral contraceptives contain both estrogen and progestin. The estrogen component\nsuppresses FSH secretion by the pituitary. (Ethinyl estradiol is the estrogen\nin all combined contraceptives in the United States). Estrogen also potentiates\nthe action of progestin by increasing the intracellular pool of progesterone\nreceptors. The progestin component (e.g., norethindrone) inhibits LH secretion\nby the pituitary, and by preventing an LH surge, inhibits the release of\noocytes from the ovary. In combined oral contraceptives, progestin is the\ndominant component. It promotes endometrial atrophy and thickening of the\ncervical mucus.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Oral\ncontraceptives decrease acne and hirsutism.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Women normally have low serum levels of\ntestosterone, most of which is inactive due to binding with sex hormone-binding\nglobulin (SHBG).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Only 1-2% of\ntestosterone is &ldquo;free&rdquo; and, therefore, able to cause acne and hirsutism\n(conversion of villous hair to terminal hair in male-patterned areas, such as\nlip, chin, and neck).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Estrogen\nincreases SHBG production by the liver, allowing for greater binding of\ntestosterone, which lowers &ldquo;free&rdquo; testosterone levels and reduces acne and\nhirsutism. By inhibiting LH secretion, progestins reduce the stimulus for\novarian testosterone production. In addition, progestins inhibit\n5&alpha;-reductase, which converts testosterone to dihydrotestosterone, the\nprimary androgenic stimulus of hair follicles and pilosebaceous glands.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Estrogen inhibits FSH\nsecretion, and progestin inhibits LH secretion.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 28-year-old man dies in a motor vehicle\ncollision. At autopsy, the kidneys are enlarged bilaterally, and each weighs 3\nkg. The external surface of the kidneys appears to be a mass of cysts.\nMicroscopic examination of the kidneys shows intact nephrons interspersed\nbetween the cysts. The most likely cause of these changes in the kidneys\ninvolves which of the following modes of inheritance?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </b>\n The\nmost likely diagnosis is autosomal dominant polycystic kidney disease.\n</p>\n"], "tutorial": "<p>\n Polycystic kidney disease\n(PKD) is a systemic hereditary disorder characterized by the formation of cysts\nin the cortex and medulla of both kidneys. There are two types of PKD:\nautosomal dominant polycystic kidney disease (ADPKD) and the much less-common autosomal\nrecessive polycystic kidney disease (ARPKD).\n</p>\n\n<p>\n <b>\n  Autosomal dominant polycystic kidney disease.\n </b>\n</p>\n\n<p>\n ADPKD is the most common\nMendelian disorder of the kidneys. It occurs in one in 1000 people. Disease\npenetrance is 100%. Approximately 10% of individuals with end-stage renal\ndisease (ESRD) carry a diagnosis of ADPKD. 85% of cases are caused by a\nmutation in the\n <span>\n  PKD1\n </span>\n gene, and\n15% of cases are caused by mutation in the\n <span>\n  PKD2\n </span>\n gene. Polycystin 1 and polycystin 2 are the protein\nproducts of PKD1 and PKD2.\n</p>\n\n<p>\n ADPKD usually presents\nbetween the ages of 30 and 40 and results in kidney failure by the fifth or\nsixth decade. The condition is characterized by focal development of renal and\nextrarenal cysts in an age-dependent manner, resulting in a slow, gradual, and massive\nkidney enlargement. Typically kidney function does not decline until kidney\nsize is at least five times greater than normal. As the cysts accumulate fluid,\nthey enlarge, separate entirely from the nephron, compress the neighboring\nrenal parenchyma, and progressively compromise renal function.\n</p>\n\n<p>\n Findings in ADPKD may\ninclude hypertension, flank pain, palpable flank mass, hematuria, and urinary\nfrequency. Flank pain may be due to renal hemorrhage, passage of kidney stones,\nor urinary tract infection. Extrarenal manifestations include liver cysts,\npancreatic cysts, splenic cysts, central nervous system arachnoid cysts, and\ncerebral aneurysms. Individuals with ADPKD have an increased incidence of\ndiverticular disease and mitral valve prolapse.\n <a name=\"4-u1.0-B978-0-323-05611-3..00025-2--u974\">\n </a>\n <a name=\"4-u1.0-B978-0-323-05611-3..00025-2--s456\">\n </a>\n <a name=\"4-u1.0-B978-0-323-05611-3..00025-2--st48\">\n </a>\n <a name=\"4-u1.0-B978-0-323-05611-3..00025-2--l314\">\n </a>\n <a name=\"4-u1.0-B978-0-323-05611-3..00025-2--l315\">\n </a>\n</p>\n\n<p>\n <b>\n  Autosomal recessive polycystic kidney disease\n </b>\n .\n</p>\n\n<p>\n The clinical presentation of\nARPKD is highly variable. Signs and symptoms often appear shortly after birth.\nUp to 50% of affected neonates die of pulmonary hypoplasia, the result of\noligohydramnios from severe intrauterine kidney disease. In those who survive,\nthe typical presentation is systemic hypertension with progression to end-stage\nrenal disease (ESRD) by the age 15. Unlike patients with ADPKD, individuals\nwith ARPKD generally do not have extrarenal cysts.\n</p>\n", "choices": ["A. Autosomal dominant", "B. Autosomal recessive", "C. Mitochondrial", "D. X-linked"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An\n18-year-old primigravid woman at 30 weeks&rsquo; gestation has a headache and mild\ngeneralized edema. Her blood pressure, which was normal in early pregnancy, is\nnow 150/95 mm Hg. Urinalysis shows proteinuria. A 24-hour urine collection\nshows 600 mg of protein. Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct\n </b>\n . Preeclampsia is diagnosed when new-onset\nhypertension and proteinuria occur after the 20th week of gestation.\nProteinuria can lead to generalized edema. Young women in their first pregnancy\nhave a higher than normal risk of developing preeclampsia.\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n . Nephrotic syndrome is characterized by heavy\nproteinuria (&gt;3.5 grams/day), low serum albumin levels, hyperlipidemia, and\nanasarca (generalized edema). Patients may be normotensive or hypertensive.\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Acute\nglomerulonephritis is characterized by sudden onset of hematuria, proteinuria,\nand red blood cell casts, often accompanied by hypertension, edema, and\nimpaired renal function. It may be caused by primary renal or systemic\ndisease.&nbsp;\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Preeclampsia\nis one of the most common causes of perinatal morbidity and mortality. The\ncause of preeclampsia remains unknown. However, placental dysfunction can\ninitiate systemic vasospasm, ischemia, and thrombosis, which damage maternal\norgans and cause placental infarction, fetal growth restriction, and death.\n </span>\n</p>\n\n<p>\n Preeclampsia complicates\napproximately 5% to10% of all pregnancies. It occurs at both extremes of\nreproductive age but is greatest in women younger than 20 years. Risk factors\nappear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p align=\"center\">\n     Risk Factors for Preeclampsia\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p align=\"center\">\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"248\">\n    <p>\n     Extremes of maternal age\n    </p>\n    <p>\n     First pregnancy\n    </p>\n    <p>\n     African-American race\n    </p>\n    <p>\n     Multiple gestation\n    </p>\n    <p>\n     Molar pregnancy\n    </p>\n    <p>\n     Prior history of\n  preeclampsia or eclampsia\n    </p>\n    <p>\n     Family history of\n  preeclampsia or eclampsia\n    </p>\n    <p>\n     Pre-existing medical\n  conditions (diabetes, hypertension, renal disease, connective tissue disease,\n  vascular disease\n    </p>\n    <p>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n The disorder is typically\ndiagnosed when new-onset hypertension and proteinuria (greater than 300 mg in a\n24-hour urine sample) is seen after the 20th week of gestation. Mild\npreeclampsia consists of a systolic blood pressure rise of 30 mm Hg, a\ndiastolic blood pressure rise of 15 mm Hg, or an absolute reading of 140/90 mm\nHg in a pregnant woman with minimal proteinuria and nondependent edema. Severe\npreeclampsia consists of a systolic blood pressure greater than 160 mm Hg or a\ndiastolic blood pressure greater than 110 mm Hg complicated by significant\nproteinuria (greater than 5.0 g/day) and evidence of end-organ damage. Signs\nand symptoms of severe preeclampsia include headache, visual disturbances,\nconfusion, right upper quadrant or epigastric pain, impaired liver function,\nproteinuria, oliguria (less than 500 mL/24 hr), pulmonary\n <a name=\"4-u1.0-B978-1-4160-2467-5..50031-2--p514\">\n </a>\n edema, microangiopathic\nhemolytic anemia, thrombocytopenia, oligohydramnios, and intrauterine growth\nretardation.\n</p>\n\n<p>\n Treatment for mild\npreeclampsia involves bed rest and surveillance. Delivery is delayed until\nfetal maturity or the development of severe preeclampsia.\n <a name=\"4-u1.0-B978-1-4160-2467-5..50031-2--para\">\n </a>\n</p>\n", "choices": ["A. Nephrotic syndrome", "B. Acute glomerulonephritis", "C. Preeclampsia", "D. Eclampsia", "E. Essential hypertension"]}, {"question": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347269\"\n o:spid=\"_x0000_i1159\" type=\"#_x0000_t75\" alt=\"Description: red blood cell cast\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image333.jpg\" o:title=\"red blood cell cast\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: red blood cell cast\" border=\"0\" height=\"228\" src=\"_%20Tutorials_files/image334.png\" v:shapes=\"Picture_x0020_347269\" width=\"228\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Red blood cell cast\n </span>\n</p>\n\n<p>\n <b>\n  Answer D is incorrect\n </b>\n .\n <span>\n  Eclampsia\n </span>\n is an acute and life-threatening complication of pregnancy, characterized by\ntonic-clonic seizures, usually in a patient with pre-eclampsia.\n</p>\n\n<p>\n <b>\n  Answer E is incorrect\n </b>\n . Essential hypertension, also called primary\nor idiopathic hypertension, is the most common type of hypertension. In this\npatient, the appearance of high blood pressure and proteinuria in a pregnant\nwoman after the 20\n <sup>\n  th\n </sup>\n week gestation suggests preeclampsia.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  An\n8-year-old boy has a viral upper respiratory tract infection. One week later,\nhe develops swelling of the face, hands, and feet. He is afebrile and\nnormotensive. Laboratory studies show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Albumin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.8\ng/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Urea\nnitrogen\n  <span>\n  </span>\n  9.0 mg /dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0.8\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Cholesterol\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  270 mg mg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine\nprotein\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4+\n(by dipstick)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4.5\ngrams/24 hours\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Minimal change disease\nresults in nephrotic syndrome, which is characterized by heavy proteinuria,\nhypoalbuminemia, and hyperlipidemia. 90% of all children with nephrotic\nsyndrome have minimal change disease. The urinary sediment is bland. Renal\nfunction and complement levels are normal. The kidney appears normal under\nlight microscopy. Electron microscopy shows effacement of the foot processes, a\nmarker of proteinuria.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Post-streptococcal\nglomerulonephritis is associated with acute nephritic syndrome, which is\ncharacterized by renal insufficiency (elevated BUN and creatinine) and\nhematuria with red blood cell casts and/or dysmorphic red blood cells in the\nurine.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Goodpasture syndrome,\n  </span>\n  also known as\n  <span>\n   anti-glomerular basement antibody\ndisease,\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n  is a rare disease\ncharacterized by glomerulonephritis and hemorrhaging of the lungs. The\ncondition is associated with acute nephritic syndrome: renal insufficiency\n(elevated BUN and creatinine) and hematuria with red blood cell casts and/or\ndysmorphic red blood cells in the urine. Tests for anti-glomerular basement\nmembrane (anti-GBM) antibodies are useful for making the diagnosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Wegener granulomatosis\n  </span>\n  is a form of\nvasculitis that affects the nose, lungs, kidneys and other organs. Due to its\nend-organ damage, it is life-threatening and requires long-term\nimmunosuppression. The disease is associated with c-ANCAs (cytoplasmic\nantineutrophil cytoplasmic antibodies). In the kidney, it causes acute\nnephritic syndrome, which is characterized by renal insufficiency (elevated BUN\nand creatinine) and hematuria with red blood cell casts and/or dysmorphic red\nblood cells in the urine.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Polyarteritis nodosa\nis associated with acute nephritic syndrome, which is characterized by renal\ninsufficiency (elevated BUN and creatinine) and hematuria with red blood cell\ncasts and/or dysmorphic red blood cells in the urine.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\npatient in the vignette has diffuse edema (anasarca). The main causes of\nanasarca are nephrotic syndrome, cirrhosis, and severe malnutrition/protein\ndeficiency.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"122\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      Causes of Anasarca\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"122\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"122\">\n    <p class=\"MsoNormal\">\n     <span>\n      Nephrotic\n  syndrome\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"122\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cirrhosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"122\">\n    <p class=\"MsoNormal\">\n     <span>\n      Malnutrition\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  In this case,\nthe findings of heavy proteinuria, hypoalbuminemia, and hyperlipidemia are\nconsistent with nephrotic syndrome. Nephrotic syndrome is one of the major\nrenal syndromes.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"3\" valign=\"top\" width=\"479\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Major\n  Renal Syndromes\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Characteristics\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Examples\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acute renal failure\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Abrupt decline in renal\n  function resulting in retention of nitrogenous wastes (e.g., blood urea\n  nitrogen and creatinine)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n     Prerenal, intrarenal, and\n  postrenal\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acute nephritic syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Abrupt renal\n  insufficiency with hematuria of glomerular origin (red blood cell casts\n  and/or dysmorphic red blood cells in the urine)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n     Poststreptococcal\n  glomerulonephritis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Systemic lupus\n  erythematosus\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Cryoglobulinemia\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Goodpasture&rsquo;s syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Wegener&rsquo;s granulomatosis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Henoch-Schonlein purpura\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Polyarteritis nodosa\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n     Nephrotic syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Massive proteinuria\n  (&gt;3.5 grams/day) with edema, hypoalbuminemia, hyperlipidemia, and\n  hyperlipiduria\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n     Minimal change disease\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Diabetic nephropathy\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Membranous\n  glomerulonephropathy\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Focal glomerulosclerosis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Amyloidosis\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tubulointerstitial\n  nephropathy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Renal insufficiency with\n  mild proteinuria and functional tubular defects\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n     Analgesic nephropathy\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tubular defects\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tubular transport\n  defect(s) without renal insufficiency\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n     Renal tubular acidosis\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n     Asymptomatic urinary\n  abnormalities\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mild proteinuria or\n  hematuria without renal insufficiency\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n     IgA nephropathy\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Alport&rsquo;s syndrome\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"122\">\n   <p class=\"MsoNormal\">\n    <span>\n     Rapidly progressive renal\n  failure\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Rapid deterioration in\n  renal function\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"203\">\n   <p class=\"MsoNormal\">\n    <span>\n     Rapidly progressive\n  glomerulonephritis Malignant hypertension\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Obstructive uropathy\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     TTP/HUS\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Multiple myeloma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Scleroderma crisis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Bilateral renal artery\n  stenosis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Atheromatous embolic\n  disease\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347268\"\n o:spid=\"_x0000_i1158\" type=\"#_x0000_t75\" alt=\"Description: RBCCAST4\">\n <v:imagedata src=\"_%20Tutorials_files/image335.jpg\" o:title=\"RBCCAST4\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: RBCCAST4\" border=\"0\" height=\"226\" src=\"_%20Tutorials_files/image336.png\" v:shapes=\"Picture_x0020_347268\" width=\"341\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Red blood cell cast\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (a marker of nephritic syndrome)\n </span>\n</p>\n", "choices": ["A. Post-streptococcal glomerulonephritis", "B. Goodpasture syndrome", "C. Wegener granulomatosis", "D. Polyarteritis nodosa", "E. Minimal change disease"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n66-year-old man is admitted to the hospital with shortness of breath and leg\nswelling. Physical examination shows jugular vein distension, an S3 at the\ncardiac apex, bibasilar crackles in the lungs, and 2+ pitting edema of the\nankles and pretibial areas. He is given a dose of furosemide intravenously. Which\nof the following physiologic changes is most likely to occur after the\nadministration of this medicine?\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Na-K-2Cl transport in the thick ascending Loop\n  of Henle\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Osmolarity of the medullary interstitium\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Water absorption in the descending Loop of\n  Henle\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     A\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     B\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     C\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     D\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     E\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     F\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     G\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n     <b>\n     </b>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"23\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     H\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"140\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"126\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n     <b>\n     </b>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347267\"\n o:spid=\"_x0000_i1157\" type=\"#_x0000_t75\" alt=\"Description: nephron\">\n <v:imagedata src=\"_%20Tutorials_files/image337.png\" o:title=\"nephron\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: nephron\" border=\"0\" height=\"226\" src=\"_%20Tutorials_files/image338.png\" v:shapes=\"Picture_x0020_347267\" width=\"243\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p>\n The\n <span>\n  loop of Henle\n </span>\n is the portion of the nephron that extends from the\nproximal convoluted tubule to the distal convoluted tubule. The loop has a\nhairpin bend in the renal medulla. Its main function is to create a\nconcentration gradient in the medulla. By means of a countercurrent multiplier\nsystem using sodium pumps, an area of high sodium concentration is created in\nthe medulla. This increases the tonicity of the medulla. The hypertonic medulla\nthen passively draws water from the filtrate, concentrating the urine.\n</p>\n\n<p>\n The loop of Henle consists\nof a descending and an ascending limb. The descending limb is permeable to\nwater. As the filtrate travels down the descending limb in the hypertonic\nmedulla, water flows out freely until the tonicity of the filtrate and\ninterstitium equilibrate. The thick ascending limb, by contrast, is impermeable\nto water. It actively absorbs sodium from the filtrate and delivers it to the\nmedullary interstitium, raising its tonicity. The hypertonic interstitium then\npassively draws water from the descending limb and collecting ducts.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Cells in the thick ascending\nloop of Henle use the\n <span>\n  Na-K-2Cl\n  <b>\n  </b>\n  transporter\n </span>\n to reabsorb sodium. This transporter resides in the apical membrane of cells\nlining the thick ascending limb. (The apical membrane is on the luminal side).\nFor each molecule of sodium absorbed, a molecule of potassium and two molecules\nof chloride are also absorbed. Hence, the designation: Na-K-2Cl. (Na, K, and Cl\nare transported in the same direction, i.e., from the filtrate into the cell.)\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Furosemide (Lasix) and other\nloop diuretics inhibit the Na-K-2Cl transporter in the thick ascending limb of\nthe loop of Henle. This impairs sodium absorption, which is needed to raise the\ntonicity of the medullary interstitium. By inhibiting sodium absorption,\nfurosemide decreases the tonicity (osmolarity) of the medullary interstitium.\nTonicity drives water absorption in the descending limb of the loop. By\ndecreased the tonicity of the medullary interstitium, furosemide decreases\nwater absorption in the descending limb.\n</p>\n\n<p>\n <b>\n  Answer A is correct\n </b>\n . Furosemide inhibits the Na-K-2Cl transporter\nin the thick ascending limb of the loop of Henle. This reduces sodium\nabsorption. Normally, sodium is absorbed and delivered to the medullary\ninterstitium, raising its osmolarity. By inhibiting sodium absorption,\nfurosemide reduces the osmolarity of the medullary interstitium. That\nosmolarity drives passive water absorption from the descending limb of the\nloop. When the osmolarity of the interstitium is reduced after administration\nof furosemide, sodium absorption in the descending limb is reduced as well.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n38-year-old man notices dark urine after running a 15-km race.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urinalysis\nshows:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Specific\ngravity:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.010\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Dipstick\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  positive\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Nitrates:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Microscopic\nexamination\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  RBC\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is the most likely cause of these findings?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A. Acute\nglomerulonephritis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B.\nHypovolemia\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C. Renal\ninfarct\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D.\nUrolithiasis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  E.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Rhabdomyolysis\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\nvignette, the dipstick is positive for blood, but microscopic examination of\nthe urine shows no red blood cells.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Three\nconditions cause the urine dipstick to register positive for blood: hematuria,\nhemoglobinuria, and myoglobinuria. All three conditions can result in red or\nbrown urine.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Urine Dipstick: Blood (+)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Hematuria\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Hemoglobinuria\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Myoglobinuria\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The first\nstep in evaluating a patient with blood on urine dipstick is to distinguish\nhematuria from hemoglobinuria and myoglobinuria. In hematuria, red blood cells\nare seen on microscopic examination of the urine; in hemoglobinuria and\nmyoglobinuria, they are not.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\nvignette, microscopic examination of the urine shows no red blood cells;\ntherefore, hematuria is excluded. This leaves hemoglobinuria and myoglobinuria\nas potential causes. Myoglobinuria due to rhabdomyolysis is the most likely\nexplanation in a long-distance runner, as extreme exertion can lead to muscle\nbreakdown with subsequent release of myoglobin into the blood.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Hematuria\n  </span>\n </i>\n <span>\n  can result from bleeding anywhere in the\nurinary tract. Common causes include urinary tract infection, kidney stones,\nrenal injury, and cancer of the kidney, bladder, or prostate.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Hemoglobinuria\n  </span>\n </i>\n <span>\n  results from intravascular hemolysis. R\n  <span>\n   ed blood cells normally live about four months. At that\npoint they are trapped and disassembled in the spleen, bone marrow, and liver\n(extravascular hemolysis). If red blood cells break down prematurely\n   <i>\n    within\n   </i>\n   the vascular system, however, the\ncomponents are set free in the blood (intravascular hemolysis). Free hemoglobin\nbinds to haptoglobin. If the hemoglobin level rises above the capacity of\nhaptoglobin to reclaim it, the hemoglobin appears in the urine. Conditions\nassociated with hemoglobinuria include malaria, sickle cell disease, hemolytic\nuremic syndrome (HUS), thrombotic thrombocytopenia purpura (TTP), and\nparoxysmal nocturnal hemoglobinuria (PNH).\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Rhabdomyolysis\n  </span>\n </i>\n <span>\n  is the rapid breakdown\nof skeletal muscle due to physical, chemical, or biological injury. Breakdown\nproducts are released into the blood. Some of these products, such as\nmyoglobin, are harmful to the kidney and may cause acute renal failure.\nPatients with rhabdomyolysis are treated with intravenous fluids (and dialysis\nor hemofiltration if necessary).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Heavy exertion (e.g.,\nrunning a marathon) can cause muscle injury, resulting in rhabdomyolysis. This\ncondition is characterized by dark-colored urine (due to myoglobinuria), which\ntests positive for blood on urine dipstick, but which does not show red blood\ncells on microscopic examination.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . In acute\nglomerulonephritis, red blood cells (including red blood cells casts) would be\nseen on microscopic examination of the urine.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Hypovolemia would\nresult in a high urine specific gravity and a negative urine dipstick for\nblood.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Renal infarction may\nresult in flank pain and hematuria. (Red blood cells would be seen on\nmicroscopic examination of the urine.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Urolithiasis may\nresult in pain and hematuria. (Red blood cells would be seen on microscopic\nexamination of the urine.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A genetic male newborn has fully developed male sexual ducts and\nrecognizable fallopian tubes. Which of the following processes was most likely\ndisturbed during the embryonic period?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct\n </b>\n . At 6&ndash;8 weeks of gestation, a fetus has\nboth mesonephric (wolffian) and paramesonephric (mullerian) ducts. Subsequent\ndevelopment of one set and degeneration of the other depends on the presence or\nabsence of two testicular hormones: testosterone and Antimullerian hormone\n(AMH). Testosterone causes each wolffian duct to develop into epididymis, vas\ndeferens, and seminal vesicles. Without male testosterone, wolffian ducts\ndegenerate and disappear. M&uuml;llerian ducts develop into a uterus, fallopian\ntubes, and upper vagina unless Antimullerian hormone (AMH) induces degeneration\nof these ducts. In this vignette, the presence of male sexual ducts indicates\npresence of testosterone. The simultaneous presence of female sexual ducts\n(i.e., fallopian tubes) indicates deficiency or absence of Antimullerian\nhormone (AMH), which causes degeneration and disappearance of female sexual\nducts.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;&nbsp;\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Sexual differentiation\n </span>\n <span>\n  is the development of differences between males and females\nfrom an undifferentiated zygote (fertilized egg).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Gonadal differentiation\n  </span>\n </b>\n <span>\n  .\n </span>\n</p>\n\n<p>\n Early in fetal life, germ\ncells migrate from structures known as yolk sacs to the genital ridge. By week\n6, undifferentiated gonads consist of germ cells, supporting cells, and\nsteroidogenic cells.\n</p>\n\n<p>\n In a male, the\n <span>\n  SRY\n </span>\n gene (sex-determining region Y)\nand other genes induce differentiation of supporting cells into Sertoli cells\nand steroidogenic cells into Leydig cells. These comprise the testes. The germ\ncells become spermatogonia.\n</p>\n\n<p>\n In a female, the absence of\nthe\n <i>\n  SRY\n </i>\n <span>\n  gene causes\n </span>\n supporting cells to differentiate into theca cells and steroidogenic cells into\ngranulosa cells. These comprise the ovaries. The germ cells become ovarian\nfollicles.\n</p>\n\n<p>\n <b>\n  Hormonal differentiation\n </b>\n .\n</p>\n\n<p>\n In a male fetus, testes\nproduce steroid and protein hormones essential for internal and external\nanatomic differentiation. Leydig cells make testosterone by the end of the\nsecond month of gestation. From then on, male fetuses have higher levels of\nandrogens in their systemic blood than females. Antimullerian hormone (AMH),\nalso called Mullerian regression factor, is a protein produced by Sertoli cells\nthat suppresses development of m&uuml;llerian ducts in males, preventing development\nof a uterus.\n</p>\n\n<p>\n Fetal ovaries produce\nestradiol, which supports follicular maturation but plays little part in other\naspects of prenatal sexual differentiation, as maternal estrogen floods fetuses\nof both sexes.\n</p>\n\n<p>\n <b>\n  Genital differentiation\n </b>\n .\n</p>\n\n<p>\n <i>\n  Internal genital differentiation\n </i>\n .\n</p>\n\n<p>\n Gonads are histologically\ndistinguishable by 6&ndash;8 weeks of gestation. A fetus of that age has both\nmesonephric (wolffian) and paramesonephric (mullerian) ducts. Subsequent\ndevelopment of one set and degeneration of the other depends on the presence or\nabsence of two testicular hormones: testosterone and Antimullerian hormone\n(AMH). Disruption of typical development may result in the development of both,\nor neither, duct system, which may produce morphologically intersexual\nindividuals.\n</p>\n\n<p>\n Testosterone causes each\nwolffian duct to develop into epididymis, vas deferens, and seminal vesicles.\nWithout male testosterone, wolffian ducts degenerate and disappear. M&uuml;llerian\nducts develop into a uterus, fallopian tubes, and upper vagina unless\nAntimullerian hormone (AMH) induces degeneration of these ducts. (The presence\nof a uterus is stronger evidence of absent testes than the state of the\nexternal genitalia.)\n</p>\n\n<h3>\n <span class=\"mw-headline\">\n  <i>\n   <span>\n    External genital differentiation\n   </span>\n  </i>\n </span>\n <i>\n  <span>\n  </span>\n </i>\n</h3>\n\n<p>\n By 7 weeks, a fetus has a\ngenital tubercle, urogenital groove and sinus, and labioscrotal folds. In\nfemales, without excess androgens, these become the clitoris, urethra and\nvagina, and labia.\n</p>\n\n<p>\n Males become externally\ndistinct between 8 and 12 weeks, as androgens enlarge the phallus and cause the\nurogenital groove and sinus to fuse in the midline, producing an unambiguous\npenis with a phallic urethra, and a thinned, rugated scrotum.\n</p>\n\n<p>\n A sufficient amount of any\nandrogen can cause external masculinization. The most potent is\ndihydrotestosterone (DHT), generated from testosterone in skin and genital\ntissue by the action of 5&alpha;-reductase.* A male fetus may be incompletely\nmasculinized if this enzyme is deficient. In some disorders, androgens may be\npresent in high enough concentrations to cause partial or even complete\nmasculinization of the external genitalia of a genetically female fetus.\n</p>\n\n<p>\n Further sex differentiation\nof the external genitalia occurs at puberty, when androgen levels again become\ndisparate. Male levels of testosterone directly induce growth of the penis, and\nindirectly (via DHT) the prostate.\n</p>\n\n<p>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   *Differentiation\nof the Wolffian duct into the male\n   <i>\n    internal\n   </i>\n   reproductive tract requires testosterone, not dihydrotestosterone. By\ncontrast, formation of the\n   <i>\n    external\n   </i>\n   reproductive tract &ndash; penis, prostate, and scrotum &ndash; requires\ndihydrotestosterone. Consequently, congenital absence of 5&alpha;-reductase,\nwhich converts testosterone into dihydroxytestosterone, results in a male\ninternal reproductive tract, but feminized external genitalia.\n  </span>\n </span>\n <b>\n </b>\n</p>\n", "choices": ["A. Production of estrogen by the embryonic testes", "B. Production of mullerian-inhibitory substance by the embryonic testes", "C. Production of testosterone by the embryonic testes", "D. Response of the paramesonephric (m\u0171llerian) ducts to estrogen", "E. Response of the paramedonephric (m\u0171llerian) ducts to testosterone"]}, {"question": "<p>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   A\ngenotypic male (XY) is born with feminized external genitalia. The testes are\nretained within the abdominal cavity, and the internal reproductive tracts\nexhibit the normal male phenotype. Which of the following could account for\nthis abnormal development?\n  </span>\n </span>\n</p>\n", "answers": ["<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer B is correct.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Differentiation of the Wolffian ducts into the normal\nmale\n   <i>\n    internal\n   </i>\n   reproductive tract\nrequires testosterone, not dihydrotestosterone. On the other hand,\ndifferentiation into the\n   <i>\n    external\n   </i>\n   reproductive tract (penis, prostate, and scrotum) requires dihydrotestosterone.\nConsequently, congenital absence of 5&alpha;-reductase, which converts\ntestosterone to dihydroxytestosterone, results in a male internal reproductive\ntract, but feminized external genitalia.\n  </span>\n </span>\n <b>\n </b>\n</p>\n", "<p>\n <span class=\"contentmain1\">\n  <b>\n   <span lang=\"EN-GB\">\n    Answer A is incorrect.\n   </span>\n  </b>\n </span>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   With complete androgen resistance, the external\ngenitalia are feminized, but neither the male-type nor the female-type internal\ntracts develop. In the absence of the androgen receptor, the Wolffian ducts\ndegenerate, and neither internal nor external male reproductive tracts develop.\nThe M&uuml;llerian ducts also degenerate because of continued production of M&uuml;llerian\nregression factor (anti-Mullerian hormone) by the testes.\n  </span>\n </span>\n</p>\n", "<p>\n <span class=\"contentmain1\">\n  <b>\n   <span lang=\"EN-GB\">\n    Answer C is incorrect.\n   </span>\n  </b>\n </span>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   With 17a-hydroxylase deficiency, the testes cannot\nsynthesize testosterone, resulting in feminization of the external genitalia\nand degeneration of the Wolffian ducts. Normal secretion of M&uuml;llerian\nregression factor causes degeneration of the M&uuml;llerian ducts. Because of the\nexcessive secretion of deoxycorticosterone by the adrenal cortex, these\nindividuals are usually hypertensive.\n  </span>\n </span>\n</p>\n", "<p>\n <span class=\"contentmain1\">\n  <b>\n   <span lang=\"EN-GB\">\n    Answer D is incorrect.\n   </span>\n  </b>\n </span>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n  </span>\n </span>\n <span>\n  Sertoli\ncell-only syndrome\n </span>\n (\n <span>\n  germ cell\naplasia\n </span>\n ) is a disorder characterized by male sterility with normal\nsecondary male features. Sertoli cells are found in the testes, but\nseminiferous tubules are absent and spermatogenesis does not occur\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   .\n  </span>\n </span>\n</p>\n", "<p>\n <span class=\"contentmain1\">\n  <b>\n   <span lang=\"EN-GB\">\n    Answer E is incorrect.\n   </span>\n  </b>\n </span>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Testicular dysgenesis results in poor testicular\ndevelop (in utero) with concomitantly decreased secretion of testosterone and\nM&uuml;llerian regression factor. The Wolffian duct structures may degenerate and\nthe external genitalia may be feminized. Female-type internal tracts may\ndevelop because of decreased secretion of M&uuml;llerian regression factor.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. Complete androgen resistance", "B. 5a-reductase deficiency", "C. 17a-hydroxylase deficiency", "D. Sertoli-only syndrome", "E. Testicular dysgenesis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n60-year-old woman presents with urinary frequency and urge incontinence. Her\npast medical history is unremarkable.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She takes no medication.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Pelvic and neurological examination is normal. Urine analysis is\nnegative. The post-void residual is normal. A cystometrogram shows uninhibited\ndetrusor contractions with bladder filling.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Which of the following is the best\ntreatment for this condition?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . The patient in this\nvignette has detrusor instability. Anticholinergics, such as oxybutynin, are\nthe mainstay of treatment for this condition. (The parasympathetic nervous\nsystem stimulates detrusor muscle contraction by releasing acetylcholine, which\nbinds to muscarinic receptors. Anti-cholinergics inhibit this action.)\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Amitriptyline, a\ntricyclic antidepressant, has anticholinergic properties, but the potential\nside effects prevent it from being recommended as first-line therapy for\ndetrusor instability. Side effects include dry mouth, blurred vision,\nconstipation, fast heartbeat, and flushing (particularly at high doses).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Vaginal estrogen is\nused to treat atrophic vaginitis, not detrusor instability.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Pseudoephedrine has\nalpha-adrenergic properties and may improve urethral tone, which might be\nhelpful for stress urinary incontinence, but not for detrusor instability.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Kegel exercises are\nused in the treatment of stress urinary incontinence. The exercises strengthen\nthe muscles of the pelvic floor, decreasing urethral hypermobility. The pelvic\nfloor is comprised of two layers: a superficial layer (the urogenital\ndiaphragm) and a deep layer (the pelvic diaphragm).\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Urinary incontinence\n </span>\n <span>\n  is any involuntary leakage of urine. Continence and\nmicturition involve a balance between urethral closure and detrusor muscle\nactivity. Urethral pressure normally exceeds bladder pressure, allowing urine\nto remain in the bladder. During normal urination, urethral pressure falls and\nbladder pressure rises.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal types of urinary incontinence appear below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Types of urinary incontinence\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Stress\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Urge\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Overactive\n  bladder\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Overflow\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Transient\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Functional\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n <i>\n  Stress urinary incontinence\n </i>\n is characterized by leakage of small\namounts of urine during movement (coughing, sneezing, and exercising). Physical\nchanges caused by pregnancy, childbirth, and menopause often lead to stress\nincontinence. The urinary bladder is supported by the pelvic floor muscles, the\nvagina, and various ligaments. If these structures weaken, the bladder moves\ndownward, pushing slightly out of the bottom of the pelvis toward the vagina.\nThis prevents muscles that ordinarily force the urethra shut from squeezing as\ntightly as they should. As a result, urine can leak into the urethra during\nmoments of physical stress.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347266\"\n o:spid=\"_x0000_i1156\" type=\"#_x0000_t75\" alt=\"Description: Side view diagram of female urinary tract with labels pointing to the uterus, bladder, pelvic floor muscle, urethra, and vagina.  An inset shows an enlarged view of the pelvic floor muscles.\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image339.jpg\" o:title=\"Side view diagram of female urinary tract with labels pointing to the uterus, bladder, pelvic floor muscle, urethra, and vagina.  An inset shows an enlarged view of the pelvic floor muscles.\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Side view diagram of female urinary tract with labels pointing to the uterus, bladder, pelvic floor muscle, urethra, and vagina.  An inset shows an enlarged view of the pelvic floor muscles.\" border=\"0\" height=\"218\" src=\"_%20Tutorials_files/image340.png\" v:shapes=\"Picture_x0020_347266\" width=\"164\"/>\n </span>\n</p>\n\n<p>\n <i>\n  Urge incontinence\n </i>\n is characterized by leakage of large amounts of\nurine at unexpected times. It can mean that the bladder empties during sleep,\nafter the patient drinks a small amount of water, or when the patient hears\nwater running. The condition may be benign or may reflect neuromuscular disease\n(e.g., stroke, Alzheimer&rsquo;s disease, Parkinson&rsquo;s disease, multiple sclerosis).\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Overactive bladder\n  </span>\n </i>\n <span>\n  is characterized by\nurinary frequency and urgency, with or without urge incontinence. The term\n&ldquo;detrusor instability&rdquo; refers to\n  <span>\n   involuntary\ncontraction of the detrusor muscle not associated with neurological disease.\n  </span>\n </span>\n</p>\n\n<p>\n <i>\n  Overflow incontinence\n </i>\n occurs when the bladder does not empty\nproperly. It is characterized by a high post-void residual. Nerve damage from\ndiabetes and other conditions can cause &ldquo;neurogenic bladder&rdquo; with overflow\nincontinence. Urethral obstruction, which in men is usually due to an enlarged\nprostate, can also cause overflow incontinence.\n</p>\n\n<p>\n <i>\n  Transient incontinence\n </i>\n is temporary incontinence caused by a\npassing disorder (e.g., urinary tract infection, new medication).\n</p>\n\n<p>\n <i>\n  Functional incontinence\n </i>\n is untimely urination due to physical\ndisability, external obstacles, or problems in thinking or communicating that\nprevent a person from reaching a toilet. Common causes of functional\nincontinence include severe arthritis, Alzheimer&rsquo;s disease, and wheelchair\nconfinement.\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Mixed incontinence\n  </span>\n </i>\n <span>\n  is a combination of\nstress incontinence and urge incontinence.\n </span>\n</p>\n", "choices": ["A. Amitriptyline", "B. Oxybutynin", "C. Topical (vaginal) estrogen", "D. Pseudoephedrine", "E. Kegel exercises"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 64-year-old woman has had intermittent vaginal bleeding for the past\nthree months. Four years ago, she was diagnosed with breast cancer and was\ntreated with partial mastectomy, radiation therapy, and tamoxifen. Speculum and\nbimanual examination are normal. Pap smear is also normal. Was it the most\nlikely source of bleeding?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Vaginal bleeding can\noriginate from any part of the gynecological tract, but the most common source\nis the uterine lining. In a post-menopausal woman, vaginal bleeding should\nalways be evaluated. Endometrial cancer is a common cause of post-menopausal\nbleeding. Making the diagnosis is important as the condition can usually be\ncured surgically. Tamoxifen increases the risk of endometrial cancer. The\npatient in this vignette is post-menopausal, has a history of tamoxifen use,\nand has no obvious source of bleeding on pelvic examination. She should be\nevaluated for endometrial cancer\n  <span>\n  </span>\n  with an\nendometrial biopsy.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Vaginal bleeding\n </span>\n <span>\n  may be physiological (menstrual cycle) or pathological. It may occur at any age\nand always requires investigation in children, during pregnancy, and in the\npostmenopausal period. Vaginal bleeding usually originates from the uterine\nlining (endometrium) but may arise from the cervix, vagina, or (rarely)\nfallopian tube.Bleeding during pregnancy is usually, but not always, related to\nthe pregnancy itself.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Bleeding\nin Children\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Bleeding\nbefore menarche could be a sign of precocious puberty. Other causes include\nforeign body in the vagina, molestation, vaginal infection (vaginitis), and,\nrarely, tumor.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Premenopausal\nwomen\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Exceptionally\nheavy bleeding during periods is termed\n  <span>\n   menorrhagia\n  </span>\n  or\n  <span>\n   hypermenorrhea\n  </span>\n  , while light\nbleeding is called\n  <span>\n   hypomenorrhea\n  </span>\n  .\nBleeding between periods\n  <span>\n   (intermenstrual bleeding)\n  </span>\n  is not necessarily pathological. Metrorrhagia\nrefers to unpredictable bleeding with no discernible period.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Dysfunctional\nuterine bleeding is a common cause of menorrhagia and irregular bleeding. It is\ndue to hormonal imbalance resulting in anovulation. Symptoms can be managed\nwith hormonal contraception.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It is\na diagnosis of exclusion\n  <span>\n   .\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Uterine\nfibroids (leiomyoma) are benign tumors of the uterus\n  <span>\n  </span>\n  that\npresent with menorrhagia, sometimes dysmenorrhea and potentially pressure\nsymptoms from enlarged irregular uterus.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Cervical\ncancer may occur in the premenopausal period and may present with \"contact\nbleeding\" (e.g. after sexual intercourse, which is referred to as\npost-coital bleeding).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Uterine\ncancer may lead to irregular and prolonged bleeding.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  In\nwomen who have recently delivered a baby or had a miscarriage, vaginal bleeding\nmay be a sign of endometritis or retained products of conception.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Pregnant\nwomen\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  During\npregnancy, mild blood loss may be due to rupture of a small vein on the outer\nrim of the placenta. It can also herald a miscarriage or ectopic pregnancy and\nrarely a molar pregnancy. Ultrasound is required to separate these conditions.\nBleeding in early pregnancy may be a sign of threatened or incomplete\nmiscarriage. In the second or third trimester, a placenta previa (placenta\npartially or completely overlying the cervix) may bleed severely. Placental\nabruption is often associated with uterine bleeding and pain.\n  <span>\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Postmenopausal\nwomen\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  All\npostmenopausal women with vaginal bleeding should be assessed for endometrial\ncancer. Other potential causes of bleeding include endometritis, endometrial\npolyp, endometrial hyperplasia, cervical polyp, and vaginitis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Diagnostic approach\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The cause\nof vaginal bleeding can sometimes be determined from the medical history and\nphysical examination. Pregnancy test, Pap smear, and transvaginal ultrasound\nare often needed. If bleeding is excessive, testing for anemia may be\nwarranted. An abnormal endometrium may require further investigation by\nhysteroscopy with biopsy or dilation and curettage.\n </span>\n</p>\n", "choices": ["A. Ovary", "B. Fallopian tube", "C. Uterine endometrium", "D. Cervical canal", "E. Vagina"]}, {"question": "<p>\n <span>\n  A 7-year-old boy has an intra-abdominal mass in the midline just above\nthe symphysis pubis. During surgery, a cystic mass is found attached to the\numbilicus and to the apex of the bladder. Which of the following is the most\nlikely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Urachal cysts are fluid-filled structures\nderived from the urachus, a remnant of the allantois, which connects the fetal\nbladder to the umbilicus. In this vignette, the location of the mass is\nconsistent with urachal cyst.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Meckel's diverticulum\n </span>\n <span>\n  is a vestigial remnant of the omphalomesenteric duct, which\nconnects the midgut lumen to the yolk sac. About two inches in length, the\ndiverticulum protrudes from the ileum of the small bowel.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Omphalocele\n  <b>\n  </b>\n </span>\n <span>\n  is\na herniation of bowel or other viscera (e.g., liver) through the umbilical\nring. The herniated segment is surrounded by peritoneum, a thin membrane that\ncan rupture.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Gastroschisis\n </span>\n <span>\n  is a defect of the anterior abdominal wall through which bowel protrudes\nwithout a covering sac. The protrusion occurs between the rectus muscles just\nlateral to the umbilicus.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  <span>\n   Bladder exstrophy\n  </span>\n  is a congenital anomality in which part of the\nurinary bladder is present outside the body.\n </span>\n</p>\n"], "tutorial": "<p>\n <b>\n  Meckel's diverticulum\n </b>\n ,\na true congenital diverticulum, is a small bulge in the small intestine,\npresent at birth. It is a vestigial remnant of the omphalomesenteric duct, also\ncalled the vitelline duct or yolk stalk. (The omphalomesenteric duct is a long\nnarrow tube that joins the yolk sac to the midgut lumen of the developing\nfetus. The yolk sac provides nourishment to the embryo before the placenta\ndevelops.)\n</p>\n\n<p>\n Meckel&rsquo;s diverticulum is the\nmost frequent malformation of the gastrointestinal tract. A memory aid is\nthe,\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n &ldquo;rule of 2s&rdquo;:\n <i>\n  2%\n </i>\n (of\nthe population).\n <i>\n  2\n </i>\n feet (from the ileocecal valve).\n <i>\n  2\n </i>\n inches (in\nlength).\n <i>\n  2%\n </i>\n are symptomatic.\n <i>\n  2\n </i>\n types of common ectopic tissue\n(gastric and pancreatic).\n <i>\n  2\n </i>\n years is the most common age at clinical\npresentation.\n <i>\n  2\n </i>\n times\n <span>\n  more boys\nare affected.\n  <i>\n  </i>\n </span>\n</p>\n\n<p>\n The condition is part of the\nextrophy-epispadias spectrum of anomalies of the lower abdominal wall, bladder,\nanterior bony pelvis, and external genitalia. The majority of individuals are\nasymptomatic. The most common presenting symptom is painless rectal bleeding\n(typically melena). The bleeding usually occurs without warning and stops\nspontaneously. Some patients present with abdominal pain and distension due to\nintestinal obstruction, volvulus, or intussusception.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The diagnosis is made by a Meckle&rsquo;s Scan,\nwhich consists of intravenous infusion 99m technetium pertechnetate, which has\nan affinity for gastric mucosa, and performing scintigraphy.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n Occasionally, the condition can\nmimic acute appendicitis or present as an indirect hernia (usually right-sided).\n</p>\n\n<p>\n The diverticulum may be\nattached to the umbilical region by the vitelline ligament, with the\npossibility of vitelline cysts, or even a patent vitelline canal forming a\nvitelline fistula. Torsion of the intestine around the viteeline ligament can\nlead to obstruction, ischemia, and necrosis.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Umbilical\nhernia\n  </span>\n </b>\n <span>\n  is a small protrusion of bowel through the umbilical ring. The protrusion is\ncovered by skin. Umbilical hernias are often more apparent when the infant\ncries or strains. Most close spontaneously by five years of age. They can occur\nas isolated defects or as part of a larger syndrome.\n </span>\n</p>\n\n<p>\n <b>\n  Omphalocele\n </b>\n is a\nherniation of bowel or other viscera (e.g., liver) through the umbilical ring.\nIt is caused by a defect in the abdominal wall muscles. The herniated segment\nis formed from an outpouching of peritoneum and is covered by a thin membrane\nthat can easily rupture. (Normally the intestines protrude from the abdomen\ninto the umbilical cord until about the tenth week of pregnancy, after which\nthey return to the abdomen.) Omphaloceles can be mild, with only a small loop\nof intestine outside the abdomen, or severe, containing most of the abdominal\norgans. Omphaloceles are often associated with chromosomal abnormalities and\ncardiac defects.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Gastroschisis\n  </span>\n </b>\n <span>\n  is a defect of the\nanterior abdominal wall through which bowel protrudes without a covering sac.\nThe protrusion occurs between the rectus muscles just lateral to the umbilicus.\nUnlike omphalocele, gastroschisis does not involve the umbilicus itself. The\ndefect is small and there is no overlying sac. Also, gastroschisis differs from\nomphalocele in being less commonly associated with other abnormalities.\n(Gastroschisis has not been correlated with chromosomal defects.)\n </span>\n</p>\n\n<p>\n <b>\n  Ectopia cordis\n </b>\n is a\nbirth defect in which the heart is abnormally located. Most commonly, the heart\nprotrudes outside the chest through a split sternum. In some cases, the heart\nmay be situated in the abdominal cavity or neck. Other birth defects may be\npresent. This condition is usually fatal in the first days of life; however,\nsometimes surgical treatment is possible.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Pentalogy\nof Cantrell\n  </span>\n </b>\n <span>\n  (or\n  <span>\n   thoraco-abdominal syndrome\n  </span>\n  )\nis a rare syndrome characterized by defects in the diaphragm, abdominal wall,\npericardium, heart, and lower sternum.\n </span>\n</p>\n\n<p>\n <b>\n  Bladder exstrophy\n </b>\n is\na congenital anomaly in which part of the urinary bladder is present outside\nthe body.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n It is part of a spectrum\nof disorders of abdominal and pelvic fusion occurring in the first months of\nembryogenesis and known collectively as the\n <span>\n  exstrophy-epispadias complex\n </span>\n .\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n It results from failure of the abdominal wall and bony pelvis to close\nduring fetal development.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n It is\ncharacterized by protrusion of the posterior bladder through the lower\nabdominal wall and anomalies of the external genitalia.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Other disorders in the\nextrophy-epispadias complex are epispadias (in which the urethra ends in an\nopening on the upper aspect (the dorsum) of the penis) and cloacal exstrophy\n(which involves exstrophy of the bladder, large intestine and other lower\nabdominal and genito-urinary complications)\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Urachal cyst\n  </span>\n </b>\n <span>\n  is a fluid-filled structure between the\ntwo obliterated ends of the urachus, i.e., the umbilicus and bladder dome. (The\n  <span>\n   urachus\n  </span>\n  is a remnant of the\nallantois, a canal that drains the fetal urinary bladder through the umbilical\ncord.) In infancy, such cysts are rarely symptomatic, but may be detected as\nincidental findings during bladder ultrasonography. More commonly, urachal cysts\nare detected in early childhood or adolescence, when the patient presents with\nsuprapubic mass, abdominal pain, leakage of urine from the umbilicus, or signs\nof urinary infection.\n </span>\n</p>\n", "choices": ["A. Meckel\u2019s diverticulum", "B. Omphalocele", "C. Gastroschisis", "D. Bladder exstrophy", "E. Urachal cyst"]}]}, {"section": "Endocrine, Musculoskeletal, & Integument", "questions": [{"question": "<p class=\"MsoNormal\">\n <span>\n  A\n45-year-old man with AIDS is evaluated for fever and hypotension. He was\ndiagnosed with disseminated histoplasmosis three months ago and has been\ntreated with antifungal medication, as well as antiretroviral therapy.\nYesterday he had surgery for removal of an impacted wisdom tooth. Today he has\nabdominal pain and is found to have a temperature of 102\n  <sup>\n   o\n  </sup>\n  F and a\nblood pressure of 85/65 mm Hg. His blood tests show a serum sodium level of 125\nmEq/L, a potassium level of 5.7 mEq/L, and a serum creatinine level of 1.9\nmg/dL. He is started on empiric antibiotic therapy for possible bacterial\nsepsis. What other diagnosis should be considered?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Acute development of\nfever, abdominal pain, hypotension, hyponatremia, and hyperkalemia is consistent\nwith acute adrenal insufficiency (adrenal crisis). In this patient, HIV and\ndisseminated histoplasmosis might have caused primary adrenal insufficiency,\nand the added stress of surgery or sepsis might have precipitated a full-blown\n&ldquo;crisis.&rdquo;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Malignant hyperthermia\nis an inherited disorder characterized by hyperthermia, muscle rigidity, and\ncardiovascular instability, usually triggered by halogenated gas or\nsuccinylcholine administered during anesthesia for surgery.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Concomitant\naspergillosis would be very unusual.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Concomitant\nmucormycosis would be very unusual.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Neuroleptic malignant\nsyndrome is characterized by hyperthermia, muscle rigidity, and delirium,\nusually triggered by an antipsychotic medicine, such as haloperidol. Symptoms\nbegin within 1 to 3 days of drug initiation or dosage change.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Adrenal insufficiency is\na condition in which the adrenal glands do not produce adequate amounts of steroid\nhormones, primarily cortisol. The condition may be primary or secondary.\nPrimary adrenal insufficiency is caused by direct insult to the adrenal cortex.\nSecondary adrenal insufficiency is caused by hypothalamic or pituitary\ndysfunction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Primary adrenal\ninsufficiency is associated with inadequate secretion of glucocorticoid and\nmineralcorticoid hormones. Adrenocorticotropic hormone (ACTH) levels are high.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Autoimmune destruction\nof the adrenal glands (Addison's disease) is the most common cause of primary\nadrenal insufficiency in U.S. Tuberculosis is a common cause worldwide. Other\ncauses include bilateral adrenal hemorrhage, drugs (e.g., ketoconazole), and other\ninfectious diseases (e.g., HIV infection, disseminated histoplasmosis).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Secondary adrenal\ninsufficiency is associated with inadequate production of ACTH, which results\nin glucocorticoid, but not mineralcorticoid deficiency. It is commonly caused\nby discontinuation of prescribed glucocorticoids. Other causes include\npituitary macroadenomas and pituitary surgery or radiation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Patients with primary\nadrenal insufficiency experience fatigue, anorexia, nausea, vomiting, and\nweight loss. Hypotension is almost always present. Because mineralcorticoid\nlevels are low, hyponatremia, hyperkalemia, and metabolic acidosis occur. Skin\nhyperpigmentation, initially on the extensor surfaces, palmar creases, and\nbuccal mucosa, results from increased levels of ACTH. (Melanocyte-stimulating\nhormone (MSH) production is a byproduct of ACTH synthesis.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Secondary adrenal\ninsufficiency manifests more insidiously. Fatigue and hypoglycemia are typical\nmanifestations. Because mineralcorticoid levels are normal, hyperkalemia and\nmetabolic acidosis do not occur. Also, skin hyperpigmentation does not occur\nbecause ACTH levels are low.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When primary adrenal\ninsufficiency is suspected, computed tomography (CT) scanning of the adrenal\nglands may help with the differential diagnosis. Enlarged adrenal glands or\ncalcifications suggest an infectious, hemorrhagic, or metastatic cause. When\nsecondary adrenal insufficiency is suspected, magnetic resonance imaging (MRI)\nof the pituitary gland is indicated unless the cause is obvious (e.g., discontinuation\nof glucocorticoid therapy).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Acute\n  </span>\n </i>\n <span>\n  adrenal insufficiency (\n  <b>\n   <span>\n    adrenal\ncrisis\n   </span>\n  </b>\n  ) is a life-threatening emergency, which usually manifests\nwith nausea, vomiting, abdominal pain, and shock. Fever and abdominal\ntenderness are common findings, and the patient may present with an acute\nabdomen. (Surgical exploration without glucocorticoid coverage can be lethal.)\nHyponatremia, hyperkalemia, and metabolic acidosis may be noted on laboratory\ntests. Adrenal crisis occurs in patients with undiagnosed or chronic adrenal\ninsufficiency who become acutely &ldquo;stressed.&rdquo; Common precipitating causes\ninclude sepsis, surgery, and adrenal hemorrhage.\n </span>\n</p>\n", "choices": ["A. Malignant hyperthermia", "B. Concomitant aspergillosis", "C. Concomitant mucormycosis", "D. Adrenal crisis", "E. Neuroleptic malignant syndrome"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 40-year-old woman has not had a\nmenstrual period in four months. Recently she has experienced headaches and\naltered vision. She takes no medicine and she has not experienced hot flushes,\nnight sweats, or vaginal dryness. Her height is 5&rsquo;6&rdquo;. Her weight is 130 lbs.\nOphthalmologic examination shows bitemporal hemianopsia. Breast examination\nshows expressible galactorrhea bilaterally. She has no acne or abnormal facial\nhair growth. Pelvic examination is normal.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Laboratory tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Beta-hCG\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  negative\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Thyroid-stimulating hormone (TSH)\n  <span>\n  </span>\n  1.0 &mu;U/mL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (N\n= 0.5-5.0 &mu;U/mL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Serum creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  0.8\nmg/dL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (N\n= 0.6-1.2 mg/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Follicle-stimulating hormone\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4\nmIU/mL\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  (N =\n4-30 mIU/mL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Prolactin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  400\nng/mL\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;\n  </span>\n  (N &lt; 20 ng/mL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which is the most likely cause of amenorrhea\nin this patient?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A. Hypothyroidism\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B. Lactotroph tumor\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C. Menopause\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D. Pregnancy\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  E. Polycystic ovary syndrome\n  <span>\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Amenorrhea, the absence of menstruation, is classified as primary or\nsecondary. Primary amenorrhea is defined as the absence of menarche by age 15.\nSecondary amenorrhea is defined as cessation of menses after menses have begun.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Normally, the hypothalamus produces gonadotropin-releasing hormone (GnRH),\nwhich stimulates the pituitary to produce gonadotropins: follicle-stimulating\nhormone (FSH) and leutinizing hormone (LH). Gonadotropins stimulate the ovaries\nto produce estrogen (mainly estradiol), androgens (mainly testosterone), and\nprogesterone. Estrogen causes endometrial proliferation. After ovulation, the\ncorpus luteum produces progesterone, which prepares the endometrium for embryo\nimplantation. If pregnancy does not occur, the endometrium breaks down and is\nsloughed during menses.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Disruption of the hypothalamic-pituitary-ovarian axis results in\nanovulatory amenorrhea.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Amenorrhea\ncan also occur with normal ovulation (because of anatomic defects that prevent\nnormal menstrual flow).\n  <i>\n   Anovulatory\n  </i>\n  amenorrhea, however, is by far the most common type of secondary amenorrhea.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"307\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes of Anovulatory Amenorrhea\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"307\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"307\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       v\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hypothalamic\n  dysfunction\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       v\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pituitary dysfunction\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       v\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Ovarian dysfunction\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       v\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Other\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &Oslash;\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hypothyroidism/Hyperthyroidism\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &Oslash;\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Obesity (excess estrogen)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &Oslash;\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Polycystic ovary disease (excess androgen)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &Oslash;\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cushing&rsquo;s syndrome (excess androgen)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &Oslash;\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Drugs (androgens, estrogens, progestins)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &Oslash;\n       <span>\n        &nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Neoplastic (tumors producing androgens, estrogens, or human\n  chorionic gonadotropin)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Certain findings suggest certain disorders.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Finding\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Disorder\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Galactorrhea\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hyperprolactinemia\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Bitemporal\n  hemianopsia and headache\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pituitary\n  tumor, most commonly with elevated prolactin levels\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hot\n  flushes, night sweats, vaginal dryness\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Estrogen\n  deficiency (e.g., menopause)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Virilization\n  (acne, hirsutism, deepening voice)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Androgen-producing\n  tumor\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Obesity,\n  hirsutism, acanthosis nigricans\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Polycystic\n  ovary syndrome\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Fatigue,\n  weight gain, cold intolerance\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hypothyroidism\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Palpitations,\n  tremor, heat intolerance\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hyperthyroidism\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Moon\n  face, buffalo hump, truncal obesity, thin extremities, violaceous abdominal\n  striae\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"239\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cushing&rsquo;s\n  syndrome\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Note: The first step in evaluating a patient with amenorrhea is to exclude\npregnancy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . The patient in the\nvignette has amenorrhea and galactorrhea. This combination suggests the\npresence of elevated prolactin levels. Hyperprolactinemia is associated with\nmany conditions, most of which produce mild-to-moderate elevations in serum\nprolactin. Prolactin-secreting pituitary adenomas produce high levels of\nprolactin (&gt;200 ng/mL). In this clinical vignette, the prolactin level is\n400 ng/mL. The cause is likely to be a lactotroph macroadenoma. Bitemporal\nhemianopia results from disturbance of the optic chiasm, which is located above\nthe pituitary gland. Pituitary tumors are the most common cause of bitemporal\nhemianopia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . The patient does not\nhave symptoms of hypothyroidism, and the thyroid-stimulating hormone (TSH)\nlevel is normal. (It should be elevated in primary hypothyroidism).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . The patient does not\nhave symptoms of menopause (hot flushes, night sweats, or vaginal dryness).\nAlso, the follicle-stimulating hormone (FSH) level is normal. (The FSH level\nshould be elevated in menopause.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Pregnancy is unlikely\nwith a negative beta-hCG. Also, it would not explain bitemporal hemianopia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . The patient does not\nhave obesity, hirsutism, or acanthosis nigricans, which would suggest\npolycystic ovary syndrome.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  An infant is brought to the clinic because of an\nitchy facial rash. The parents have asthma and allergic rhinitis. What is the\nmost likely diagnosis?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347322\" o:spid=\"_x0000_i1151\" type=\"#_x0000_t75\" alt=\"Description: 756148-762044-762045-1710117\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image349.jpg\" o:title=\"756148-762044-762045-1710117\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 756148-762044-762045-1710117\" border=\"0\" height=\"218\" src=\"_%20Tutorials_files/image350.png\" v:shapes=\"Picture_x0020_347322\" width=\"290\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . The infant has atopic\ndermatitis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Atopic dermatitis\n  </span>\n </b>\n <span>\n  , also called &ldquo;infantile eczema,&rdquo; is a pruritic disease that usually\nstarts in early infancy. It may be associated with other atopic (IgE-mediated)\ndisorders, such as asthma, allergic rhinitis, and urticaria. Severe itching is\ntypical. In infants, lesions usually appear on the cheeks, forehead, scalp, and\nextensor surfaces of the legs.\n </span>\n <span>\n  The skin reacts abnormally to irritants, food, and\nenvironmental allergens, and becomes red, flaky (eczematous), very itchy, and\nvulnerable to bacterial infection.\n </span>\n <span>\n </span>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n <span>\n  The central face has a\ncharacteristic pallor.\n </span>\n <span>\n  75%\nof the cases improve by the time the child reaches adolescence; 25% have\ndifficulties through adulthood.\n  <span>\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347321\" o:spid=\"_x0000_i1150\" type=\"#_x0000_t75\" alt=\"Description: n1510\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image351.jpg\" o:title=\"n1510\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: n1510\" border=\"0\" height=\"124\" src=\"_%20Tutorials_files/image352.png\" v:shapes=\"Picture_x0020_347321\" width=\"190\"/>\n  <v:shape alt=\"Description: atopic_dermatitis\" id=\"Picture_x0020_347320\" o:spid=\"_x0000_i1149\" type=\"#_x0000_t75\">\n   <v:imagedata o:title=\"atopic_dermatitis\" src=\"_%20Tutorials_files/image353.jpg\">\n   </v:imagedata>\n  </v:shape>\n  <img alt=\"Description: atopic_dermatitis\" border=\"0\" height=\"124\" src=\"_%20Tutorials_files/image354.png\" v:shapes=\"Picture_x0020_347320\" width=\"183\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Rosacea\n  </span>\n </b>\n <span>\n  is rare in infants.\nClinically, there is a combination of erythema, papules and pustules. There is\nno scale.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Tinea faciale\n  </span>\n </b>\n <span>\n  is a superficial fungal\ninfection caused by dermatophytes. Lesions are usually asymmetric and exhibit\ncentral clearing.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Psoriasis\n  </span>\n </b>\n <span>\n  can affect the face but\nlesions have thicker silvery scale and pruritus is variable. Lesions tend to\ninvolve the scalp too.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Erythema infectiosum\n  </span>\n </b>\n <span>\n  , or &ldquo;fifth disease,&rdquo; is\ncaused by parvovirus B19. Bright red cheeks are a defining characteristic of\nthe disease (hence the name \"slapped cheek disease\") but lesions do\nnot have scales.\n </span>\n</p>\n", "choices": ["A. Rosacea", "B. Tinea faciale", "C. Psoriasis", "D. Erythema infectiosum", "E. Atopic dermatitis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following conditions is\n  <i>\n   least\n  </i>\n  likely to cause nail clubbing?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Emphysema does not cause nail clubbing.\nIf a patient with emphysema is found to have clubbing, a search for\nbronchogenic carcinoma should be undertaken.\n </span>\n</p>\n"], "tutorial": "<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes of Clubbing\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pulmonary\n  disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Bronchogenic carcinoma\n  (mainly large cell)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Interstitial lung\n  disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Tuberculosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Suppurative lung\n  disease (lung abscess, empyema, bronchiectasis, cystic fibrosis)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Mesothelioma\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cardiac\n  disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Congenital cyanotic\n  heart disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Subacute bacterial\n  endocarditis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Atrial myxoma\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Gastrointestinal\n  disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Crohn's disease and\n  ulcerative colitis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Primary biliary\n  cirrhosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hepatopulmonary\n  syndrome (a complication of cirrhosis)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Other\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hyperthyroidism\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Thymoma\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Bronchogenic carcinoma", "B. Emphysema", "C. Lung abscess", "D. Mesothelioma", "E. Tuberculosis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n6-year-old girl presents with a painless mass in the midline of the neck just\nbelow the hyoid bone. The mass appeared five months ago and has been growing.\nSerum T4, T3, and TSH levels are normal. What is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Thyroglossal duct\ncysts are the most common type of congenital midline neck mass. The thyroid\ngland originates as the thyroid diverticulum at the base of the pharynx. During\ndevelopment, it descends into the neck and remains connected to the tongue by the\nthyroglossal duct. The duct eventually disappears, although part of it may\nremain and form a cyst. These cysts are midline, painless, and usually located\nnear the hyoid bone. Surgical excision, which is recommended if the thyroid\ngland is normal, prevents further growth and infection.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Brachial cleft cysts\nare usually lateral in location and may be associated with fistulas or sinus\ntracts.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Dermoid cysts, the\nsecond most common midline neck mass, are usually located in the submental area\nor on the dorsum of the nose.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Lipomas are more\ncommon in adults than children and are rarely midline in location.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . An ectopic thyroid\ngland occurs when the thyroid fails to descend during development.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347313\"\n o:spid=\"_x0000_i1148\" type=\"#_x0000_t75\" alt=\"Description: http://www.cssd.us/images/medicalinfo/thryglossalcyst.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image355.jpg\" o:title=\"//www.cssd.us/images/medicalinfo/thryglossalcyst.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.cssd.us/images/medicalinfo/thryglossalcyst.jpg\" border=\"0\" height=\"156\" src=\"_%20Tutorials_files/image356.png\" v:shapes=\"Picture_x0020_347313\" width=\"160\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Congenital\nneck masses are common in children but can occur in any age group. Classifying\nthese into midline or lateral location helps in the workup.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Midline\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   a.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  <span>\n   Thyroglossal duct cysts\n  </span>\n </i>\n <span>\n  are the most common anterior midline\nneck masses in children. They are remnants of the descending tract of the\nthyroid gland from the foramen cecum at the base of the tongue to its normal\nposition in the lower neck.\n  <a name=\"4-u1.0-B978-1-4377-1160-8..10019-3--pg33\">\n  </a>\n  Cysts or fistulas can occur anywhere along this tract and can intermittently\nbecome infected. Physical examination usually reveals a 2-cm to 4-cm mass in\nthe anterior neck that moves with swallowing and elevates with tongue\nprotrusion. Treatment is surgical excision of the cyst and the tract.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4377-1160-8..10019-3--f004\">\n </a>\n <span>\n  <span>\n   b.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  <span>\n   Dermoid cysts\n  </span>\n </i>\n <span>\n  typically develop along midline embryonic\nfusion planes and are composed of ectodermal and mesodermal embryonic remnants.\nTheir usual location in the neck is in the submental area. They are also found\nfrequently along the dorsum of the nose. Dermoid cysts tend not to move with\nswallowing or elevate with tongue protrusion, unlike thyroglossal duct cysts.\nTreatment is surgical excision.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   c.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  <span>\n   Ranulas\n  </span>\n </i>\n <span>\n  are cystic lesions that are usually present in the floor of\nthe mouth. They can extend through muscle planes into the upper midneck area.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lateral\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   a.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  <span>\n   Branchial cleft cysts\n  </span>\n </i>\n <span>\n  are common congenital abnormalities found in\nthe lateral neck area. They are caused by failure of obliteration of the\nembryonic branchial clefts and can manifest as sinus tracts or fistulas. These\ncan become intermittently infected, especially after upper respiratory tract\ninfections.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   b.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <i>\n  <span>\n   Lymphangiomas\n  </span>\n </i>\n <span>\n  (cystic hygromas) are congenital lymphatic\nmasses often found in the neck. They usually manifest during the first year of\nlife and often enlarge after upper respiratory tract infection. They are caused\nby incomplete development and subsequent obstruction of the lymphatic system.\nMost are found in the posterior triangle of the neck.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   <span>\n    c.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n </i>\n <i>\n  <span>\n   Hemangiomas\n  </span>\n </i>\n <span>\n  are the most common congenital malformations.\nMost are cutaneous, but they can appear in deep tissues. They are characterized\nby appearance at or after birth, followed by a rapid proliferative phase at 6\nto 18 months of age. They then reach a plateau phase, followed by a slow,\ninvolutional phase over 6 to 8 years. Even large, uncomplicated lesions left\nuntreated usually undergo almost complete resolution.\n  <i>\n  </i>\n </span>\n</p>\n", "choices": ["A. Thyroglossal duct cyst", "B. Brachial cleft cyst", "C. Dermoid cyst", "D. Lipoma", "E. Ectopic thyroid gland"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 52-year old woman presents with a two-week\nhistory of severe itching of the eyelids. What is the most likely diagnosis?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347312\" o:spid=\"_x0000_i1147\" type=\"#_x0000_t75\" alt=\"Description: quiz010\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image357.jpg\" o:title=\"quiz010\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: quiz010\" border=\"0\" height=\"180\" src=\"_%20Tutorials_files/image358.png\" v:shapes=\"Picture_x0020_347312\" width=\"265\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The most likely\ndiagnosis is contact dermatitis.\n </span>\n</p>\n"], "tutorial": "<p>\n <b>\n  Contact dermatitis\n </b>\n is\ncaused by exposure to irritants (irritant contact dermatitis) or\n <span>\n </span>\n allergens (allergic contact\ndermatitis). The condition is characterized by inflammation of the epidermis\nand outer dermis. Symptoms include:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Red rash\n  </span>\n </b>\n <span>\n  . In irritant contact dermatitis, the rash appears\nimmediately; in allergic contact dermatitis, the rash appears 24&ndash;72 hours\nafter exposure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Blisters or wheals\n  </span>\n </b>\n <span>\n  . Blisters, wheals (welts), and urticaria\n(hives) often form in a pattern of skin exposure to the irritant or allergen.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Itchy, burning skin\n  </span>\n </b>\n <span>\n  . Irritant contact dermatitis tends to be\npainful; allergic contact dermatitis tends to be itchy.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  In irritant contact\ndermatitis, a chemical (e.g., acid, alkali, solvent, oxidant, rubber, latex)\nhas a direct cytotoxic effect on epidermal cells. An example would be &ldquo;diaper\ndermatitis.&rdquo;\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347311\" o:spid=\"_x0000_i1146\"\n type=\"#_x0000_t75\" alt=\"Description: 80m\">\n <v:imagedata src=\"_%20Tutorials_files/image359.jpg\" o:title=\"80m\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 80m\" border=\"0\" height=\"146\" src=\"_%20Tutorials_files/image360.png\" v:shapes=\"Picture_x0020_347311\" width=\"111\"/>\n </span>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  In allergic contact\ndermatitis, the appearance of the rash is usually delayed. Exposure to plants\nof the\n  <span>\n   Toxicodendron\n  </span>\n  genus\n(e.g., poison ivy, poison oak, poison sumac) can cause allergic contact\ndermatitis.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347310\" o:spid=\"_x0000_i1145\" type=\"#_x0000_t75\" alt=\"Description: Poison-Ivy-Rash-Bubbles\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image361.jpg\" o:title=\"Poison-Ivy-Rash-Bubbles\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Poison-Ivy-Rash-Bubbles\" border=\"0\" height=\"164\" src=\"_%20Tutorials_files/image362.png\" v:shapes=\"Picture_x0020_347310\" width=\"227\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Exposure to metal\nalloys, sunscreens, cements, household cleaners, formaldehyde, dyes, and\nrubbers can also cause allergic contact dermatitis. Involvement of the eyelids\nalone suggests a cosmetic etiology.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347309\" o:spid=\"_x0000_i1144\" type=\"#_x0000_t75\" alt=\"Description: dermatitis-5\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image363.jpg\" o:title=\"dermatitis-5\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: dermatitis-5\" border=\"0\" height=\"101\" src=\"_%20Tutorials_files/image364.png\" v:shapes=\"Picture_x0020_347309\" width=\"152\"/>\n </span>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347308\" o:spid=\"_x0000_i1143\" type=\"#_x0000_t75\" alt=\"Description: swollen-eyelids-rash\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image365.jpg\" o:title=\"swollen-eyelids-rash\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: swollen-eyelids-rash\" border=\"0\" height=\"103\" src=\"_%20Tutorials_files/image366.png\" v:shapes=\"Picture_x0020_347308\" width=\"162\"/>\n  </span>\n </span>\n</p>\n\n<p>\n Note: Allergic contact\ndermatitis (ACD) occurs in two stages: an\n <span>\n  induction phase\n </span>\n , which primes and sensitizes the immune system,\nand an\n <span>\n  elicitation phase\n </span>\n , in\nwhich the response is triggered.\n</p>\n\n<p>\n ACD is a Type IV delayed\nhypersensitivity reaction involving a cell-mediated immune response. Contact\nallergens are soluble haptens (low in molecular weight) that cross the stratum\ncorneum of the skin. They can elicit an immune response only as part of a\ncomplete antigen, which requires their association with epidermal proteins to\nform hapten-protein conjugates. These conjugates are recognized as foreign\nbodies by Langerhans cells, which internalize the protein; transport it through\nthe lymphatic system to regional lymph nodes; and present it to T-lymphocytes.\nThis process is controlled by cytokines and chemokines. As the Langerhans cells\nare transported to the lymph nodes, they differentiate into dendritic cells,\nwhich are immunostimulatory. In lymph glands, dendritic cells present the\nepitope to the T-lymphocytes, which differentiate and multiply so that they can\nrespond quickly and aggressively if the allergen appears again.\n</p>\n\n<p>\n <b>\n  Dermatomyositis\n </b>\n is associated with a heliotrope rash, a violaceous\ndiscoloration of the upper and lower eyelids and periorbital skin, usually with\nedema.\n</p>\n\n<p>\n <b>\n  Seborrheic dermatitis\n </b>\n is an inflammatory disorder of the scalp, face, and trunk that produces red,\nitchy, flaky skin. Rarely, the eyelids are the only site involved.\n</p>\n\n<p>\n <b>\n  Tinea faciale\n </b>\n is a superficial fungal infection caused by\ndermatophytes. Lesions are usually asymmetric and exhibit central clearing.\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Psoriasis\n  </span>\n </b>\n <span>\n  can affect the face but\nlesions have thicker silvery scale and pruritus is variable. Lesions tend to\ninvolve the scalp too.\n </span>\n</p>\n", "choices": ["A. Dermatomyositis", "B. Seborrheic dermatitis", "C. Contact dermatitis", "D. Tinea faciale", "E. Psoriasis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n45-year-old man is found to have osteopenia on pre-operative chest x-ray. His\npast medical history is significant for hypertension. Review of systems reveals\na 75 lb-weight gain in the past three years. His blood pressure is 170/105 mm\nHg. Exam findings include marked fullness of the lower face; supraclavicular\nfat pads; and deep, wide, purple striae on the flanks and anterior abdominal\nwall. Blood tests show a serum potassium level of 2.8 meq/L. The 24-hour\nurinary free cortisol level is 520 &mu;g (normal &lt; 110 &mu;g). The serum\nadrenocorticotropic hormone (ACTH) level is 30 pg/mL (normal: 10-20 pg/mL). A\nhigh-dose dexamethasone suppression test lowers the serum cortisol level to\n&lt;50% of the baseline value. MRI of the pituitary shows a 5 mm mass in the\nanterior pituitary. Which of the following correctly explains the patient&rsquo;s\nhigh blood pressure and low serum potassium level?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n</p>\n"], "tutorial": "<p>\n The term\n&ldquo;Cushing syndrome&rdquo; is used to describe a condition resulting from long-term\nexposure to excessive glucocorticoids.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Clinical\n  Features of Cushing Syndrome\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Sudden weight gain\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Central obesity\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypertension\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Facial plethora\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Proximal muscle weakness\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Glucose intolerance and\n  diabetes mellitus\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Decreased libido or\n  impotence\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Depression or psychosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Osteopenia or\n  osteoporosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Easy bruising\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hyperlipidemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Menstrual disorders\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Violaceous striae wider\n  than 1 cm\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Recurrent opportunistic\n  or bacterial infections\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Acne\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"257\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hirsutism\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n Cushing\nsyndrome is most commonly caused by administration of exogenous\nglucocorticoids. The term &ldquo;Cushing disease&rdquo; is reserved for Cushing syndrome\nthat is caused by excessive secretion of adrenocorticotropin hormone (ACTH) by\na pituitary tumor, usually an adenoma.\n</p>\n\n<p>\n Cushing\ndisease is responsible for roughly two-thirds of the cases of endogenous\nCushing syndrome. The remaining endogenous cases are caused by ectopic\nACTH-secreting tumors and primary adrenal neoplasms. Cushing disease occurs\nmost frequently in women of reproductive age, but it can affect males and\nfemales of any age.The pituitary tumors in Cushing disease are usually\nmicroadenomas, which, by definition, are 10 mm or less in diameter.\nMicroadenomas generally do not cause symptoms by local mass effect. These\ntumors are most often discovered when clinical manifestations of\nhypercortisolism resulting from hypersecretion of ACTH prompt an appropriate\ndiagnostic work-up. Occasionally, microadenomas are found incidentally during\nimaging performed for other reasons. Macroadenomas are uncommon in patients\nwith Cushing disease. These tumors cause mass effect when their size exceeds 15\nmm in diameter. Suprasellar extension and optic chiasm compression, local bone\nerosion, cavernous sinus compression, and panhypopituitarism may occur as a\nmacroadenoma enlarges.\n</p>\n\n<p>\n Although\npituitary adenomas causing Cushing disease secrete excessive amounts of ACTH,\nthey generally retain some negative feedback responsiveness to high doses of\nglucocorticoids. Ectopic sources of ACTH, usually in the form of extracranial\nneoplasms, however, are generally not responsive to negative feedback with high\ndoses of glucocorticoids. A common effect of elevated ACTH levels (whatever the\nsource) is bilateral adrenocortical hyperplasia.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When\nCushing syndrome is suspected, initial laboratory testing is usually directed\nat confirming excessive glucocorticoid production. This is best accomplished\nthrough analysis of a 24-hour urine collection for urinary free cortisol\nexcretion. Values greater than 300 &mu;g/day are considered diagnostic for\nCushing syndrome.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Once\nhypersecretion of cortisol is confirmed, the next step is to determine whether\nthe pathologic state is ACTH-dependent or ACTH-independent. This can be\naccomplished through measurement of the late-afternoon ACTH level.\n(Late-afternoon (after 4 p.m.) timing is important because ACTH levels are\nnormally low at that time.) If the plasma ACTH level is &gt; 10 pg/mL, then the\nprocess is ACTH-dependent. If the ACTH level is &lt; 5 pg/mL, then the process\nis ACTH-independent.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  If the\nprocess is ACTH-dependent, a high-dose dexamethasone suppression test combined\nwith cranial MRI studies may aid in localizing the site of ACTH overproduction.\nIn an 8-mg overnight dexamethasone suppression test, a single 8-mg dose of\ndexamethasone is given at 11 p.m., and the serum cortisol level is measured at\n8 a.m. the next morning. Suppression of the cortisol level to less than 50% of\nbaseline is considered indicative of Cushing disease (pituitary microadenoma).\nFailure of dexamethasone to suppress cortisol levels to less than 50% of\nbaseline suggests an ectopic source of ACTH production (e.g. extracranial\nneoplasm).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npatient in this vignette has signs of Cushing syndrome: moon face,\nsupraclavicular fat pads, violaceous striae, hypertension, weight gain, and\nosteopenia. A high urinary free cortisol level confirms the diagnosis of\nCushing syndrome. The high ACTH level indicates that the disorder is\nACTH-dependent. A positive high-dose dexamethasone test (suppression of serum\ncortisol to &lt; 50% baseline) indicates that the patient most likely has\nCushing disease (a pituitary microadenoma secreting ACTH).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Excessive\nACTH production stimulates the adrenal glands to produce excessive cortisol.\nFree cortisol passes easily through cellular membranes, where it binds to the\nglucocorticoid receptor. The glucocorticoid receptor is expressed in almost\nevery cell in the body and regulates genes controlling the development,\nmetabolism, and immune response. Aldosterone, which is regulated mainly through\nthe renin-angiotensin system, also passes easily through cellular membranes. It\nacts on mineralocorticoid receptors within the cells of the distal tubule and\nthe collecting duct of the kidney nephron. This activates the basolateral Na\n  <sup>\n   +\n  </sup>\n  /K\n  <sup>\n   +\n  </sup>\n  pumps, which pump three sodium ions out of the cell and two potassium ions into\nthe cell. This results in reabsorption of sodium (Na\n  <sup>\n   +\n  </sup>\n  ) ions and\nwater (which follows sodium) into the blood, and secreting potassium (K\n  <sup>\n   +\n  </sup>\n  )\nions into the urine (lumen of collecting duct).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nmineralocorticoid receptor is activated by mineralocorticoids, such as\naldosterone and deoxycorticosterone, as well as glucocorticoids, such as\ncortisol. Normally, the mineralocorticoid receptor is &ldquo;protected&rdquo; from\nglucocorticoids by co-localization of an enzyme, 11&szlig;-hydroxysteroid\ndehydrogenase type 2 (11&szlig;-HSD2), which converts cortisol to inactive cortisone.\nIn states of excess cortisol (Cushing syndrome), the enzymatic activity can be\noverwhelmed such that bound cortisol is not metabolized and there is activation\nof the mineralcorticoid receptor. Thus, cortisol will have mineralcorticoid\nactivity under this circumstance.\n </span>\n</p>\n", "choices": ["A. ACTH binding to glucocorticoid receptors", "B. ACTH binding to mineralcorticoid receptors", "C. Cortisol binding to glucocorticoid receptors", "D. Cortisol binding to mineralcorticoid receptors"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Aldosterone\nresponsive epithelial tissues express the mineralocorticoid receptor, which\nbinds both cortisol and aldosterone. In fact, this mineralocorticoid receptor\nbinds cortisol 10 times more avidly than it binds aldosterone. The effect of\ncortisol, however, is eliminated by the enzyme 11&beta;-hydroxysteroid\ndehydrogenase 2, which metabolizes cortisol to inactive cortisone. In states of\nexcess cortisol, the enzymatic activity of 11&beta;-hydroxysteroid\ndehydrogenase 2 can be overwhelmed such that bound cortisol is not metabolized\nand there is activation of the mineralcorticoid receptor. Thus, cortisol will\nhave mineralcorticoid activity under this circumstance. The mineralocorticoid\nactivity causes a rise in blood pressure (due to the absorption of sodium and\nwater from tubules) and a drop in serum potassium levels. Inactivating\nmutations of 11&beta;-hydroxysteroid dehydrogenase 2 give mineralocorticoid\nactivity that is mediated by cortisol, not aldosterone.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n A 12-year-old girl has a\n3-week history of excessive thirst and urination. She takes no medication and\nhas no history of renal disease. Her blood sugar is normal. After an 8-hour\nwater deprivation test, she continues to produce large volumes of dilute urine.\nWhen 5 units of ADH (vasopressin) is administered subcutaneously, she still\ncontinues to produce large volumes of dilute urine. Her symptoms are most\nlikely due to a relative lack of which of the following proteins from the\napical membranes of collecting duct epithelial cells?\n</p>\n", "answers": ["<p>\n <b>\n  Answer D is correct\n </b>\n .\n</p>\n"], "tutorial": "<p>\n Arginine vasopressin (AVP),\nalso known as antidiuretic hormone (ADH), is the primary determinant of free\nwater excretion in the body. Its main target is the kidney, where it acts by\naltering the water permeability of the collecting tubules. Under the influence\nof ADH, water is reabsorbed in the collecting tubules by osmotic equilibration\nwith the hypertonic interstitium. The water is returned to the systemic\ncirculation.\n</p>\n\n<p>\n <span>\n  Diabetes insipidus\n </span>\n (\n <span>\n  DI\n </span>\n )\nis a condition associated with decreased production or decreased effectiveness\nof ADH.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n It is characterized by\nexcessive thirst and large-volume excretion of dilute urine, irrespective of\nfluid intake.\n</p>\n\n<p>\n There are two major types of\nDI: central DI, which is caused by decreased production of ADH, and nephrogenic\nDI, which is caused by renal insensitivity to ADH. Central DI is usually caused\nby hypothalamic disruption. Lesions of the posterior pituitary rarely cause\npermanent DI because ADH is produced in the hypothalamus and can still be\nsecreted into the circulation.\n</p>\n\n<p>\n Nephrogenic DI may be\nhereditary or acquired. The hereditary form is usually caused by an X-linked\nmutation, which impairs the function of the vasopressin receptor (also called\nthe V2 receptor). Less commonly, hereditary nephrogenic DI is caused by a mutation\nin the aquaporin 2 gene.\n <span>\n  Aquaporins\n </span>\n are proteins that regulate the flow of water. They are imbedded in the cell\nmembrane and selectively conduct water molecules into and out of the cell,\nwhile preventing the passage of ions and other solutes. The presence of these\nwater channels increases membrane permeability to water. Aquaporin 2 is\nregulated by ADH.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Acquired nephrogenic DI may\nbe caused by lithium toxicity, hypercalcemia, hypokalemia, or\ntubulointerstitial disease. Lithium causes acquired diabetes insipidus by\ndecreasing the expression of the aquaporin 2 gene.\n</p>\n", "choices": ["A. Epithelial Na+ channel", "B. Na+-K+-ATPase", "C. Na+-K+-2Cl- cotransporter", "D. Aquaporin", "E. Urea transporter"]}, {"question": "<p>\n Polyuria, the production of\nabnormally large volumes of urine, may be caused by increased water intake,\ndiuretic use, diabetes mellitus, or diabetes insipidus. The patient in this\nvignette takes no medication, excluding diuretic use as a possible cause. Also,\nher blood sugar is normal, making diabetes mellitus unlikely. She continues to\nproduce large volumes of dilute urine despite water deprivation, excluding\nexcessive water intake as a cause. Consequently, diabetes insipidus (DI) is the\nmost likely diagnosis.\n</p>\n\n<p>\n DI may be central or\nnephrogenic. Central DI responds to the administration of ADH, which causes the\nkidneys to reabsorb water. In this vignette, the patient does not respond to\nADH administration, suggesting a nephrogenic problem. Nephrogenic DI may be\nhereditary or acquired. In an otherwise healthy young person, a hereditary\nproblem is most likely. Hereditary nephrogenic DI is usually X-linked\n(affecting males only) and results in impaired functioning of the V2 receptor.\nBy contrast, mutation of the aquaporin 2 gene is usually autosomal recessive\nand rarely autosomal dominant; both males and females can be affected. In this\nvignette, an otherwise healthy young girl has nephrogenic DI. The most likely\nexplanation is mutation of the aquaporin 2 gene.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following diabetes drugs causes neither weight gain nor hypoglycemia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Exenatide is a synthetic version of\nexendin-4, a hormone found in the saliva of the Gila monster. It displays\nbiological properties similar to human glucagon-like peptide-1 (GLP-1), a\nregulator of glucose metabolism and insulin secretion.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  GLP-1 is an incretin hormone released\nfrom the gut in response to eating.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It causes glucose-dependent insulin synthesis and release, meaning that\nthere is only an increase in insulin if the glucose is above a minimal\nthreshold.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  As glucose levels\ndecline, insulin release also declines. Because insulin secretion is\nglucose-dependent, hypoglycemia does not occur. GLP-1 has the central effect\n(at the hypothalamus) of reducing appetite. Delayed gastric emptying is another\neffect of GLP-1. This results in weight loss in most patients.\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Glipizide is a sulfonylurea agent that\nworks by binding to the sulfonylurea receptor on pancreatic &beta; cells.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This closes the receptor, preventing\npotassium efflux. Subsequent depolarization and calcium influx results in the\nrelease of insulin. The net effect is an uncontrolled increase in circulating\ninsulin.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  During periods of reduced\nor delayed caloric\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  intake,\nhypoglycemia is possible. Anti-diabetic agents with the primary mechanism of\nuncontrolled insulin release typically cause weight gain in proportion to the\nextent of glycemic improvement.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Pioglitazone is thiazolidinedione agent\nthat selectively stimulates the nuclear receptor peroxisome\nproliferator-activated receptor gamma (PPAR-&gamma;), which results in increased\nexpression of GLUT1 and GLUT2 in peripheral tissues. GLUT1 and GLUT2 are\ntransmembrane carrier proteins that enable passive glucose movement across cell\nmembranes. By increasing expression of GLUT1 and GLUT2, pioglitazone decreases\ninsulin resistance. It does not cause hypoglycemia because it does not change\nthe amount of available insulin. Weight gain commonly occurs due to fluid\nretention.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Insulin glargine, like all insulin\nproducts, can cause weight gain and hypoglycemia.\n </span>\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n . Repaglinide is a type of meglitinide.\nMeglitinides bind to ATP-dependent K\n <sup>\n  +\n </sup>\n (K\n <sub>\n  ATP\n </sub>\n ) channels on\nthe cell membrane of pancreatic &beta; cells in a similar manner to\nsulfonylureas but at a separate binding site. This binding closes the receptor,\npreventing potassium efflux. Subsequent depolarization and calcium influx\nresults in the release of insulin. Hypoglycemia and weight gain are potential\nside effects of the medicine.\n</p>\n"], "tutorial": "<table border=\"1\" cellpadding=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td colspan=\"5\" valign=\"top\">\n   <span>\n    <br clear=\"all\"/>\n   </span>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      MEDICATIONS FOR TYPE 2 DIABETES\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Classification\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Medication\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Route\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Effects\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Side effects\n     </span>\n    </b>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Sulfonylurea\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Glipizide\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Glyburide\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     Glimepiride\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Oral\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Stimulates insulin secretion\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (glucose-independent)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Hypoglycemia\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Weight gain\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Biguanide\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Metformin\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Glucophage)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Oral\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Inhibits hepatic gluconeogenesis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Abdominal pain\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Nausea\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Diarrhea\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Lactic acidosis\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Alpha-Glucosidase inhibitor\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Acarbose\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Precose)\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Miglitol\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Glycet)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Oral\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Delays carbohydrate absorption\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Abdominal pain\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Nausea\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Diarrhea\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Elevated liver enzymes\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Thiazolidinedione\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Pioglitazone\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Actos)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Oral\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Insulin sensitizer\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (PPAR-&gamma; agonist)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Fluid retention\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Weight gain\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Heart failure\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Edema\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Anemia\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Meglitinide\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Repaglinide\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Prandin)\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Nateglitinide\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Starlix)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Oral\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Stimulates insulin secretion\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Hypoglycemia\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Weight gain\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     DPP-4 inhibitor\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Sitagliptin\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Januvia)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Oral\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Increases insulin secretion\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (glucose-dependent)\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Decreases glucagon secretion\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Slows gastric emptying\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     None\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Incretin mimetic\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Exenatide\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Byetta)\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Liraglutide\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Victoza)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Injectable\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Increases insulin secretion\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (glucose-dependent)\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Decreases glucagon secretion\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Slows gastric emptying\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Nausea\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Diarrhea\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Weight loss\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Amylin analog\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Pramlintide\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     (Symlin)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Injectable\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"26%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Slows gastric emptying\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Promotes satiety\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Inhibits glucagon secretion\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"19%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Nausea\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Anorexia\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Hypoglycemia\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  PPAR-&gamma;:\n </span>\n <span>\n  peroxisome\nproliferator-activated receptor gamma\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  DPP-4:\n </span>\n <span>\n  dipeptidyl\npeptidase IV\n </span>\n</p>\n", "choices": ["A. Glipizide (Glucotrol)", "B. Pioglitazone (Actos)", "C. Exenatide (Byetta)", "D. Insulin glargine (Lantus)", "E. Repaglinide (Prandin)"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Match each\nof the following diabetes medicines with its mechanism of action.\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  6.\nGlipizide, a sulfonylurea, stimulates the pancreas to produce insulin in a\nglucose-\n  <i>\n   independent\n  </i>\n  manner.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Sulfonylureas bind the potassium channel\non the surface of beta cells, altering flux of potassium across the cell\nmembrane.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This changes the activity\nof voltage-dependent calcium channels, increasing intracellular calcium.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This increased calcium through the\ncalcium channels induces insulin-containing secretory granules to undergo\nexocytosis; thus, insulin is released.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5.\nMetformin reduces gluconeogenesis, limits glucose absorption from the gut, and\nincreases glucose uptake in peripheral tissues\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  4.\nPioglitazone, a t\n  <span>\n   hiazolidinedione, s\n  </span>\n  timulates\nthe nuclear receptor peroxisome proliferator-activated receptor gamma\n(PPAR-&gamma;), ultimately reducing insulin resistance in the liver and\nperipheral tissues\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  3.\nAcarbose inhibits\n  <span>\n   alpha-glucosidase, an\nenzyme that\n  </span>\n  breaks down carbohydrates\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2.\nExenatide mimics glucagon-like peptide 1, an incretin\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  1.\nSitagliptin inhibits dipeptidyl peptidase IV (DPP-IV), an enzyme that degrades\nincretins\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  1.\nInhibits dipeptidyl peptidase IV (DPP-IV), an enzyme that degrades incretins\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  2. Mimics\nglucagon-like peptide 1, an incretin\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  3.\nInhibits alpha-glycosidase, an enzyme that breaks down carbohydrates\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  4.\nStimulates the nuclear receptor peroxisome proliferator-activated receptor\ngamma (PPAR-&gamma;), which modulates the transcription of insulin-sensitive\ngenes, thereby reducing insulin resistance in the liver and peripheral tissues\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  5. Reduces\ngluconeogenesis, limits glucose absorption from the gut, and increases glucose\nuptake in peripheral tissues\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  6.\nStimulates pancreas to produce insulin in glucose-\n  <i>\n   independent\n  </i>\n  manner\n </span>\n</p>\n", "choices": ["A. Glipizide", "B. Metformin", "C. Pioglitazone", "D. Acarbose", "E. Exenatide", "F. Sitagliptin"]}, {"question": "<p class=\"MsoNormal\">\n <!--[if supportFields]><span><span></span><span\nstyle=\"mso-spacerun:yes\">&nbsp;</span>SEQ CHAPTER \\h \\r 1</span><![endif]-->\n <!--[if supportFields]><span\n><span></span></span><![endif]-->\n <span>\n  A 52-year-old woman was diagnosed with type 2 diabetes\nmellitus 18 years ago. Her physician recommended a diet, which she followed.\nShe lost 15 pounds and was able to maintain this weight for 3 years, during\nwhich her blood sugar levels were normal. She then gained 20 pounds over 18\nmonths and was started on metformin because her glycosylated hemoglobin level\nhad risen. Her blood sugar levels returned to normal, but 3 years later, they\nrose again. At that time, glipizide was added to her regimen. Again, her blood\nsugar levels returned to normal and her glycosylated hemoglobin levels ranged\nfrom 6.5% to 7.0% over the ensuing years. Over the past 2 years, however, the\nglycosylated hemoglobin level has remained above 10% despite adherence to her\nmedical regimen. Why are oral agents now failing to control her blood sugar\nlevels?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  Type 2 diabetes mellitus\nis characterized by progressive &beta;-cell dysfunction, which explains why\npatients who once responded to lifestyle modification may require oral\nmedicines, and patients who once responded to oral medicines may require\ninsulin.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Type 2\ndiabetes mellitus is characterized by two major metabolic defects: insulin\nresistance and decreased insulin production. Insulin resistance precedes the\nonset of diabetes, possibly by many decades. About 30% of Americans have\ninsulin resistance. This is defined as a decrease in the efficacy of insulin\n(usually determined as removal of glucose from the peripheral blood) at any\ngiven insulin level. Most people with insulin resistance do\n  <i>\n   not\n  </i>\n  have type 2 diabetes mellitus\nbecause their pancreas is able to compensate for the resistance by producing\nmore insulin. In people who develop diabetes, however, the &beta; cells begin\nto fail and insulin production declines. At the onset of type 2 diabetes\nmellitus, about 50% of maximal insulin production is lost. At this stage,\npatients may be treated of oral medicines, such as glipizide (which stimulates\n&beta; cells to produce insulin) or metformin (which decreases insulin\nresistance). Oral medicines may control blood sugar levels for years until\ninsulin secretion declines further. When insulin secretion falls to\napproximately 10% of normal levels, oral medicines fail and patients require\nexogenous insulin administration.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347307\"\n o:spid=\"_x0000_i1142\" type=\"#_x0000_t75\" alt=\"Description: natural_history\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image367.jpg\" o:title=\"natural_history\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: natural_history\" border=\"0\" height=\"268\" src=\"_%20Tutorials_files/image368.png\" v:shapes=\"Picture_x0020_347307\" width=\"377\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Metabolism of oral agents accelerates over time.", "B. The patient is not truly adherent to her medical regimen.", "C. Failure of these medications is expected as part of the natural history of type 2 diabetes mellitus."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Therapy\nmust be advanced as &beta;-cell function deteriorates.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n32-year-old woman with type 1 diabetes mellitus develops a fever and cough. Her\nappetite diminishes and she stops taking insulin because she is afraid to\nadminister it on an empty stomach. Her condition worsens and she is taken to\nthe emergency room. Her pulse is 120/minute, her blood pressure is 90/60 mm Hg,\nand her respiratory rate is 28/minute. Blood tests show hyperglycemia,\nmetabolic acidosis, and ketosis. Urine tests show glucose and ketones. Which of\nthe following sets of hepatic findings is most likely in this patient?\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      cAMP\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Protein Kinase A\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Phosphoprotein Phosphatase\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      A\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      B\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      C\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      D\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      E\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      F\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      G\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p class=\"MsoNormal\">\n     <span>\n      H\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"45\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"86\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Diabetic ketoacidosis\n(DKA), the most severe complication of type 1 diabetes mellitus, is\ncharacterized by hyperglycemia, ketosis, and metabolic acidosis with an increased\nanion gap. Rapid and aggressive treatment of DKA is essential, as metabolic\nacidosis can result in cerebral edema, coma, and death.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The ketosis of DKA is\nthe result of insulin deficiency and unregulated glucagon secretion.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Effects of Insulin\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Effects of Glucagon\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increases\n  glycogen synthesis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increases\n  glycogenolysis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increases\n  lipid synthesis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increases\n  amino acid uptake\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increases\n  potassium uptake\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n      Decreases\n  proteolysis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n      Decreases\n  lipolysis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increases\n  lipolysis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"167\">\n    <p class=\"MsoNormal\">\n     <span>\n      Decreases\n  gluconeogenesis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"171\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increases\n  gluconeogenesis\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucagon stimulates\nadipose tissue to release fatty acids stored in triglycerides. The free fatty\nacids enter the circulation and are taken up by the liver where they undergo\nfatty acid oxidation to acetyl CoA. Normally, acetyl CoA is completely oxidized\nto CO\n  <sub>\n   2\n  </sub>\n  and H\n  <sub>\n   2\n  </sub>\n  O in the Krebs cycle. In DKA, however, fatty\nacid oxidation is excessive and the liver cannot fully oxidize all the acetyl\nCoA. It diverts the excess acetyl CoA into the ketogenesis pathway. The ketones\nproduced are &beta;-hydroxybutyrate and acetoacetate, with\n&beta;-hydroxybutyrate being the most abundant. Acetoacetate is spontaneously\n(non-enzymatically) decarboxylated to form acetone. Acetone is volatile and\nreleased from the lungs, giving a sweet smell to the breath. Being acidic, the\nketones lower the pH of the blood producing a metabolic acidosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose levels rise\nbecause of gluconeogenesis and glycogenolysis in the liver.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  1. Gluconeogenesis:\nTriglyceride and protein catabolism is increased in skeletal muscle. This causes\nrelease of glycerol (from triglycerides) and alanine (from protein) into the\ncirculation. These substances enter the liver where they are used as substrates\nfor gluconeogenesis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  2. Glycogenolysis:\nGlucagon and epinephrine trigger glycogenolysis in the liver.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucose produced by the\nliver is released into the circulation, producing hyperglycemia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hyperglycemia causes an\nosmotic diuresis, whereby water and electrolytes are lost in the urine. As\nketones are excreted in the urine, there is an obligatory loss of Na\n  <sup>\n   +\n  </sup>\n  and K\n  <sup>\n   +\n  </sup>\n  , and K\n  <sup>\n   +\n  </sup>\n  losses can be severe.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  At the molecular level,\ninsulin, glucagon, and epinephrine function through the protein\nkinase/phosphatase cascades (see below). DKA is characterized by insulin\ndeficiency and counterregulatory hormone (e.g., glucagon, epinephrine)\nexcess.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Molecules activated by\nglucagon and epinephrine are increased in DKA, whereas molecules activated by\ninsulin are decreased.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Protein\nKinase / Phosphatase Cascades\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347306\" o:spid=\"_x0000_i1141\"\n type=\"#_x0000_t75\" alt=\"Description: insulin3\">\n <v:imagedata src=\"_%20Tutorials_files/image369.png\" o:title=\"insulin3\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: insulin3\" border=\"0\" height=\"402\" src=\"_%20Tutorials_files/image370.png\" v:shapes=\"Picture_x0020_347306\" width=\"402\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\">\n <b>\n  Hormonal\nRegulation of Protein Kinases and Protein Phosphatases\n </b>\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347305\"\n o:spid=\"_x0000_i1140\" type=\"#_x0000_t75\" alt=\"Description: HormoneReg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image371.png\" o:title=\"HormoneReg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: HormoneReg\" border=\"0\" height=\"122\" src=\"_%20Tutorials_files/image372.png\" v:shapes=\"Picture_x0020_347305\" width=\"295\"/>\n </span>\n</p>\n\n<p>\n <b>\n  I. Steps leading to\nglycogen catabolism\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Glucagon and epinephrine (adrenalin) bind\nto receptors on the surface of liver and muscle cells.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The receptor-ligand complex activates\nadenyl cyclase.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Adenyl cyclase converts ATP to cAMP, a\n\"second messenger.\"\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  cAMP activates protein kinase A.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Protein kinase A phosphorylates:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  1. phosphorylase kinase\n(activating it)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  2. glycogen synthase\n(inactivating it)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Phosphorylase kinase phosphorylates\nglycogen phosphorylase, activating it.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Phosphoprotein phosphatase (which removes\nphosphates) is also phosphorylated, inactivating it.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   II.\nSteps leading to glycogen synthesis\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  To reverse\nthe above effects we need to dephosphorylate the proteins that were\nphosphorylated in the above reactions. This occurs through activation of\nphosphoprotein phosphatase. To achieve this, glucose must bind to glycogen\nphosphorylase, releasing phosphoprotein phosphatase. Next, insulin-stimulated\nprotein kinase phosphorylates phosphoprotein phosphatase, activating it. The\nactive phosphoprotein phosphatase:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Removes\na phosphate group from glycogen phosphorylase, inactivating it\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Removes\na phosphate group from phosphorylase kinase, inactivating it\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Removes\na phosphate group for glycogen synthase, activating it\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  cAMP is\nhydrolyzed to AMP by a phosphodiesterase. The destruction of the\n\"messenger\" is necessary to reset the system to its normal metabolic\nstate and to make it responsive to the next set of hormonal signals.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer G is correct\n  </span>\n </b>\n <span>\n  . The patient in this\nvignette has diabetic ketoacidosis. DKA is characterized by insulin deficiency\nand counterregulatory hormone (e.g., glucagon, epinephrine) excess. Molecules\nthat are activated by glucagon and epinephrine (e.g., cAMP, protein kinase A)\nwill be increased, while molecules that are activated by insulin (e.g.,\nphosphoprotein phosphatase) will be decreased.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 16-year-old girl is brought to the\nemergency department after attempting suicide by cutting her wrist. The deepest\npart of the wound is between the tendons of the flexor carpi radialis and the\nflexor digitorum superficialis. This patient is most likely to have a deficit\nof which of the following?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The median nerve lies between the tendons\nof the flexor carpi radialis and the flexor digitorum superficialis\n(subliminis). Injury to the median nerve would prevent opposition of the thumb\nand other fingers.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The ulnar nerve is responsible for finger\nadduction and abduction.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The radial nerve is\nresponsible for extension of the index finger.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The ulnar nerve is\nresponsible for flexion of the ring and small finger.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The ulnar nerve provides\nsensation to the base of the small finger.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347304\" o:spid=\"_x0000_i1139\"\n type=\"#_x0000_t75\" alt=\"Description: gray422\">\n <v:imagedata src=\"_%20Tutorials_files/image373.png\" o:title=\"gray422\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: gray422\" border=\"0\" height=\"291\" src=\"_%20Tutorials_files/image374.png\" v:shapes=\"Picture_x0020_347304\" width=\"490\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Innervation of the Hand\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Median\nNerve\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Motor\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Allows\nfor fine control of pincer grasp\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Innervates\nthenar muscles and two radial lumbricals\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Sensation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Radial\n3.5 fingers, and their dorsal tips\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Cutaneous\ninnervation image\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Course\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Passes\nvia carpal tunnel through volar wrist\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Test\nfunction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Opposition\nof thumb to each finger\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Observe\nthenar muscles for contractions\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Ulnar\nNerve\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Motor\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Allows\nfor power grip\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Innervates\nall hand intrinsic muscles except:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Does\nnot innervate two radial lumbricals\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Does\nnot innervate thenar muscles\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Sensation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Ulnar\n1.5 fingers (palmar)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Course\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Passes\nwith ulnar artery via Guyon's Canal in wrist\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Test\nfunction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Finger\nabduction against resistance\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Palpate\nbelly of first dorsal interosseus muscle\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Radial\nNerve\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Motor\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Innervates\nextrinsic wrist and finger extensors\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Does\nnot innervate any intrinsic muscles\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Sensation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Dorsally\nfor 3.5 fingers\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Test\nfunction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Wrist\nand hand extension against resistance\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347303\"\n o:spid=\"_x0000_i1138\" type=\"#_x0000_t75\" alt=\"Description: NeuroMedianNerve\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image375.jpg\" o:title=\"NeuroMedianNerve\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: NeuroMedianNerve\" border=\"0\" height=\"282\" src=\"_%20Tutorials_files/image376.png\" v:shapes=\"Picture_x0020_347303\" width=\"376\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347302\"\n o:spid=\"_x0000_i1137\" type=\"#_x0000_t75\" alt=\"Description: NeuroRadialNerve\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image377.jpg\" o:title=\"NeuroRadialNerve\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: NeuroRadialNerve\" border=\"0\" height=\"280\" src=\"_%20Tutorials_files/image378.png\" v:shapes=\"Picture_x0020_347302\" width=\"374\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Adduction and abduction of the fingers", "B. Extension of the index finger", "C. Flexion of the ring and small fingers", "D. Sensation over the base of the small finger", "E. Opposition of the thumb and other fingers"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 72-year-old man presents with a painful rash (shown below). Which of\nthe following is\n  <i>\n   not\n  </i>\n  true regarding his condition?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347301\" o:spid=\"_x0000_i1136\" type=\"#_x0000_t75\" alt=\"Description: quiz003\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image379.jpg\" o:title=\"quiz003\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: quiz003\" border=\"0\" height=\"180\" src=\"_%20Tutorials_files/image380.png\" v:shapes=\"Picture_x0020_347301\" width=\"265\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Herpes zoster\n(&ldquo;shingles&rdquo;) is caused by varicella (&ldquo;chickenpox&rdquo; virus). The virus has a\ndormant phase in the dorsal root ganglia. The condition is more common in\nadults than in children. Pain (referred to as &ldquo;post-herpetic neuralgia&rdquo;) may\npersist long after the rash resolves. Symptoms of shingles cannot be\ntransmitted from person to person; however, during the blister phase, the virus\ncan be transmitted to non-immune persons, causing chickenpox.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Herpes zoster\n  </span>\n </b>\n <span>\n  is caused by varicella zoster virus\n(VZV), a double-stranded DNA virus that belongs to the Herpes family. VZV\ncommonly infects children, causing\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Chickenpox\" title=\"Chickenpox\">\n  <span>\n   chickenpox\n  </span>\n </a>\n <span>\n  . After an episode of\nchickenpox, the immune system eliminates the virus from most locations;\nhowever, the virus remains dormant (latent) in the dorsal root ganglia. In\nabout 10-20% of cases, the virus is &ldquo;reactivated&rdquo; later in life, causing herpes\nzoster. During reactivation, the virus leaves the nerve cell bodies and travels\nalong axons, causing infection of the skin in the region of the nerve\n(dermatome). The rash usually heals within two to four weeks, although pain may\npersist for months or years (postherpetic neuralgia).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nearliest symptoms of herpes zoster &ndash; headache, fever, and malaise &ndash;\nare nonspecific. These symptoms are often followed by pain, itching,\nhyperesthesia (oversensitivity), or paresthesia (tingling, pricking, or\nnumbness) along the dermatome. The pain ranges from mild to extreme, and is\nfollowed by a rash, usually on the torso, but sometimes on the face, eyes, or\nextremities.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  At first,\nthe rash resembles hives. Unlike hives, however, VZV spreads along a dermatome,\nproducing a rash with a unilateral, stripe-like distribution. The rash becomes\nvesicular; small blisters fill with serous exudate. The vesicles become cloudy\nor dark as they fill with blood. They crust over within ten days. Usually the\ncrust falls off and the skin heals, but scarring and discoloration occur in\nsevere cases.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cranial\nnerves can be affected.\n  <i>\n   Herpes zoster\n  </i>\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Ophthalmic_nerve\" title=\"Ophthalmic nerve\">\n  <i>\n   <span>\n    ophthalmicus\n   </span>\n  </i>\n </a>\n <span>\n  involves the orbit of\nthe eye and is caused by reactivation in the ophthalmic division of the\ntrigeminal nerve.\n  <i>\n   Herpes zoster oticus\n  </i>\n  <span>\n   , which\n  </span>\n  can cause hearing loss and vertigo, occurs when the\nvirus spreads from the facial nerve to the vestibulocochlear nerve.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Herpes\nzoster occurs only in people who have had chickenpox. Most patients are over\nage fifty. Immunocompromised patients are especially predisposed to viral\nreactivation. Symptoms of shingles cannot be transmitted from person to person;\nhowever, during the blister phase, the virus can be transmitted to non-immune\npersons, causing chickenpox. Repeated attacks of herpes zoster are rare, but\ncan occur.\n </span>\n</p>\n\n<p class=\"CM10\">\n <span>\n  A\n  <span>\n   vaccine for shingles was licensed in 2006. It reduces the\nrisk of shingles by about 50%. In people who develop shingles anyway, it\nreduces the incidence and severity of post-herpetic neuralgia. A single dose of\nthe vaccine is recommended in adults 60 years of age and older.\n  </span>\n </span>\n</p>\n", "choices": ["A. The rash is caused by the \u201cchickenpox\u201d virus", "B. The rash is caused by a virus that has a \u201cdormant phase\u201d in the dorsal root ganglia", "C. The condition is more common in adults than in children", "D. The pain may continue after the rash resolves", "E. The condition is highly contagious; exposed individuals may develop a similar rash"]}, {"question": "<p class=\"MsoNormal\">\n <!--[if supportFields]><span><span></span><span\nstyle=\"mso-spacerun:yes\">&nbsp;</span>SEQ CHAPTER \\h \\r 1</span><![endif]-->\n <!--[if supportFields]><span\n><span></span></span><![endif]-->\n <span>\n  A 28-year-old woman has had excess facial hair since she was\n21 years old. The problem has grown worse with time: She has gone from plucking\nhairs once a week to shaving three times a week. The mustache area, chin, and\nsideburns are most affected. Menarche occurred at age 12.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Menstrual periods were regular until age\n18; since then, they&rsquo;ve been heavier and have occurred every two to three\nmonths. She has gained 75 pounds in the past four years. She has been married\n18 months and has not become pregnant despite unprotected intercourse.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  On physical examination, there are\nnumerous coarse, terminal hairs in the mustache, sideburn, and chin areas.\nThere has been no deepening of the voice, male-pattern balding, or clitoromegaly.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What\nis the most likely cause of hirsutism?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  PCOS is associated with\ninsulin resistance and hyperinsulinemia. Some patients have glucose intolerance\nor even diabetes at diagnosis. For women with normal blood sugar levels, there\nis a high risk of developing diabetes in the future. Women with PCOS are at\nrisk of developing other manifestations of the metabolic syndrome, such as\ndyslipidemia, hypertension, and atherosclerosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answers A and B are\nincorrect.\n  </span>\n </b>\n <span>\n  Congenital adrenal hyperplasia may present in young adults with hirsutism,\nirregular periods, and/or infertility.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The most common enzyme defect is 21-hydroxylase, which converts\n17-hydroxyprogesterone to 11-deoxycortisol. The latter is converted to cortisol\nby action of 11-hydroxylase.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients presenting in young adulthood have a partial blockade in\ncortisol synthesis that can be overcome by a compensatory increase in ACTH.\nThis compensation, however, is at the expense of an increase in precursor\nmolecules, some of which have androgenic activity. This patient could have\n21-hydroxylase deficiency (which would be confirmed by measuring\n17-hydroxyprogesterone before and after the administration of synthetic ACTH);\nhowever, a history of regular periods, which then become abnormal, is uncommon\nin 21-hydroxylase deficiency. (Patients with this condition are more likely to\nhave\n  <i>\n   never\n  </i>\n  had normal menses.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\n  </span>\n </b>\n <span>\n  <b>\n   is incorrect.\n  </b>\n  Cushing syndrome is associated with hirsutism,\nobesity, and menstrual irregularity, but this patient lacks other clinical\nfindings of Cushing syndrome. (Besides, PCOS is much more common than Cushing\nsyndrome.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n <span class=\"search-hit\">\n  Hirsutism,\n </span>\n the presence of excess terminal (coarse) hairs in androgen-dependent areas,\naffects 5% to 15% of women. The upper lip, chin, chest, lower abdomen, and\nextremities are principally affected.\n <span class=\"search-hit\">\n  Hirsutism\n </span>\n is usually a sign of excessive androgen production (e.g., testosterone,\nandrostenedione, DHEA, or DHEA-S).\n</p>\n\n<p>\n Hirsutism as an isolated\nfinding should be distinguished from\n <span>\n  virilization,\nwhich i\n </span>\n s associated with increased muscle mass, clitoral enlargement,\nand deepening of the voice. These changes usually occur quickly (over months).\nVirilization mandates a search for neoplasia. Testosterone elevation may\nindicate an ovarian tumor; DHEAS elevation may indicate an adrenal tumor. Most\ncases of hirsutism, however, do\n <i>\n  not\n </i>\n involve virilization. The most common causes of\n <span class=\"search-hit\">\n  hirsutism\n </span>\n are idiopathic and polycystic ovary syndrome (PCOS). Less common causes are\ncongenital adrenal hyperplasia and Cushing syndrome.\n</p>\n\n<p>\n PCOS is characterized by\ninsulin resistance and hyperinsulinemia. (The pancreas produces high levels of\ninsulin to overcome resistance.) Insulin resistance is selective: Liver, fat,\nand muscles are more insulin-resistant than ovaries. Insulin in high concentrations\nbinds to receptors in ovarian theca cells, stimulating androgen production. The\nresult is hirsutism.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Women with PCOS typically\nhave abnormal menses, infertility,\n <span class=\"search-hit\">\n  hirsutism\n </span>\n ,\nacne, and obesity, all of which are related to androgen excess. PCOS is the\nsingle most common endocrine abnormality of women of reproductive age. The\nonset of symptoms is usually around menarche, but may occur after puberty. The\ndiagnosis is based on the presence of hyperandrogenism (e.g., hirsutism),\novarian dysfunction (e.g., menstrual irregularity), and exclusion of other\nconditions.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nwoman in this vignette has evidence of androgen excess (hirsutism). There is no\nvirilization (deepening of the voice, male-pattern baldness, or clitoromegaly)\nto suggest an ovarian or adrenal tumor. PCOS should be suspected because of the\npresence of menstrual irregularity, infertility, and obesity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Heterozygous mutation in an enzyme in the pathway for cortisol synthesis", "B. Heterozygous mutation in an enzyme in the pathway for aldosterone synthesis", "C. Hyperinsulinemia", "D. Pituitary tumor secreting ACTH"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n37-year-old man with schizophrenia presents with confusion, palpitations,\nmuscle rigidity, and sweating. His medicines include haloperidol and\nacetaminophen, which he takes daily. His temperature is 40.2\n  <sup>\n   o\n  </sup>\n  C\n(104.4\n  <sup>\n   o\n  </sup>\n  F), pulse is 105/minute, blood pressure is 165/85 mm Hg, and\nrespirations are 24/minute. The neck is supple, the skin is warm and moist, and\nthere is generalized muscle rigidity. Fundoscopic examination is normal. Deep\ntendon reflexes are 2+ without clonus. Plantar reflexes are normal. The\nthyroid-stimulating hormone (TSH) level is normal. Which is the most likely\ndiagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Neuroleptic malignant\nsyndrome is suggested by high temperature, haloperidol use, and muscle\nrigidity. Warm skin is consistent with hyperthermia. Of note, the temperature\nis high despite daily use of acetaminophen. Anti-pyretics lower temperature in\nfebrile patients but not in hyperthermic patients.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Sepsis can be\nassociated with high fever and tachycardia, but muscle rigidity is not typical\nand blood pressure is often low.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Graves&rsquo; disease is an\nautoimmune condition in which antibodies to the TSH receptor on the thyroid\nactivate the receptor, stimulating thyroid hormone synthesis and secretion. The\npatient develops a diffusely enlarged goiter. Graves&rsquo; disease is associated\nwith hyperthyroidism (excess thyroid hormone in the blood) and thyrotoxicosis\n(clinical syndrome resulting from excess thyroid hormone in the blood).\nHyperthermia may occur. In this case, Graves&rsquo; disease is unlikely because the\nTSH level is normal. (It should be low in patients with primary\nhyperthyroidism.)\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Cerebral hemorrhage\nmay be associated with hyperthermia, but this diagnosis is unlikely given the\nnormal fundoscopic examination (no papilledema) and normal reflexes.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Fever and\nhyperthermia are distinct conditions associated with a rise in body\ntemperature. The two conditions are contrasted below.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Fever\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Hyperthermia\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Increase in the\n  hypothalamic &ldquo;set point&rdquo;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     (Rise in body&rsquo;s\n  thermostat)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     No change in the\n  hypothalamic &ldquo;set point&rdquo; (No change in body&rsquo;s thermostat)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mediated by pyrogens\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Not mediated by pyrogens\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Antipyretics effective at\n  lowering temperature\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Antipyretics not\n  effective at lowering temperature\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Temperature elevation\n  mild, moderate, or severe\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Temperature elevation\n  usually severe\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Common\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Uncommon\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Associated with\n  peripheral vasoconstriction and possibly shivering to preserve and generate\n  heat\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Associated with\n  peripheral vasodilation and sweating to eliminate heat\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Skin usually cool due to\n  vasoconstriction\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Skin usually warm due to\n  vasodilation\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"235\">\n   <p class=\"MsoNormal\">\n    <span>\n     Mild, moderate, or severe\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"234\">\n   <p class=\"MsoNormal\">\n    <span>\n     Life-threatening if not\n  treated\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Hyperthermia\nis life-threatening and does not respond to anti-pyretics. The diagnosis is\nsuggested by preceding events. Selected causes of hyperthermia are described\nbelow.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Heat\nstroke\n  </span>\n </b>\n <span>\n  is a dangerous condition caused by heat exposure. It\nis classified as exertional or non-exertional. Findings include hyperthermia,\nconfusion, and absent sweating. In the elderly, the condition may be exacerbated\nby anti-cholinergic, antiparkinson, or diuretic drugs.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Drug-induced\nhyperthermia.\n  </span>\n </b>\n <span>\n  Internal body heat production can be increased by\ncertain drugs, such as cocaine, amphetamines, phencyclidine (PCP), lysergic\nacid diethylamide (LSD), methylenedioxymethamphetamine (MDMA, or &ldquo;ecstasy&rdquo;),\nmonoamine oxidase inhibitors (MAOIs), and tricyclic anti-depressants (TCAs).\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Neuroleptic\nmalignant syndrome\n  </span>\n </b>\n <span>\n  is a life-threatening disorder caused by use of anti-psychotic drugs\n(phenothiazines, haloperidol, prochlorperazine, metoclopramide) or withdrawal\nfrom dopaminergic drugs. In both cases, the mechanism is inhibition of central\ndopamine receptors in the hypothalamus, which results in increased heat\ngeneration and decreased heat dissipation.The condition generally presents with\nhyperthermia, delirium, muscle rigidity, extrapyramidal symptoms, and autonomic\ninstability.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Malignant\nhyperthermia\n  </span>\n </b>\n <span>\n  is a rare life-threatening condition triggered by exposure to inhalational\nanesthetics, such as halothane, or to the neuromuscular-blocking agent,\nsuccinylcholine. The condition is caused by a defect of skeletal muscle\nsarcoplasmic reticulum, inherited as an autosomal dominant trait. In\nsusceptible individuals, the drug induces drastic and uncontrolled increase in\nskeletal muscle oxidative metabolism, which leads to circulatory collapse and\ndeath, if not treated quickly.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Serotonin syndrome,\n  </span>\n </b>\n <span>\n  or serotonin storm,\n  <b>\n  </b>\n  is a potentially life-threatening\ncondition caused by serotoninergic drugs, such as selective serotonin reuptake\ninhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). Symptoms include\nhyperthermia, tremor, myoclonus, and diarrhea.\n </span>\n</p>\n", "choices": ["A. Sepsis", "B. Neuroleptic malignant syndrome", "C. Graves\u2019 disease", "D. Cerebral hemorrhage"]}, {"question": "<p>\n A 67-year-old man has\nfrequent bowel movements, weight loss, and proximal muscle weakness. He has\nbecome short-tempered with his family. His heart is irregularly irregular. An\nelectrocardiogram shows atrial fibrillation. Which of the following is the most\nlikely diagnosis?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Weight loss,\nirritability, hyperdefacation, proximal muscle weakness, and atrial\nfibrillation are consistent with a diagnosis of hyperthyroidism.\n </span>\n</p>\n"], "tutorial": "<p>\n Classic symptoms of\nhyperthyroidism include weight loss (despite a good appetite), heat\nintolerance, palpitations, tremor, and hyperdefecation (increased frequency of\nformed bowel movements). Hyperthyroidism is one of the few conditions in which\nweight loss is accompanied by\n <i>\n  increased\n </i>\n appetite.\nThe diagnosis can be missed if the patient presents with nonspecific symptoms\n(e.g., fatigue, insomnia, anxiety, irritability, weakness, chest pain,\nshortness of breath) or atypical symptoms (e.g., headache, periodic paralysis,\nnausea and vomiting). Elderly patients may present with &ldquo;apathetic&rdquo;\nhyperthyroidism, typified by weight loss unaccompanied by sympathomimetic\nsymptoms.\n</p>\n\n<p>\n Signs of hyperthyroidism\ninclude resting tachycardia; systolic hypertension; widened pulse pressure;\nwarm, moist skin with a velvety texture; onycholysis; and a staring gaze with\nlid lag (noted when a rim of sclera is visible between the upper eyelid and the\nsuperior margin of the iris on downward gaze). Cardiac examination may reveal a\nprominent apical impulse and a systolic flow murmur. Atrial fibrillation may\noccur. Neurologic findings include restlessness, irritability, pressured\nspeech, proximal muscle weakness, distal hand tremor, and brisk deep tendon\nreflexes.\n</p>\n\n<p>\n Common causes of\nhyperthyroidism appear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Common Causes of\n  Hyperthyroidism\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Graves&rsquo; disease\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Toxic thyroid adenoma\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Toxic multinodular goiter\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Autoimmune thyroiditis\n  (Hashimoto&rsquo;s)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Subacute thyroiditis\n  (DeQuervain&rsquo;s)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Oral consumption of excess\n  thyroid hormone tablets\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Amiodarone\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"203\">\n    <p>\n     Postpartum thyroiditis\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n <i>\n  Graves&rsquo; disease\n </i>\n is characterized by a diffusely enlarged thyroid\nwith smooth contour. Sometimes a bruit can be heard over the gland. Graves&rsquo;\ndisease is caused by autoantibodies that stimulate the TSH-receptor on the\nthyroid, inducing synthesis and secretion of thyroid hormone. These antibodies\nstimulate thyroid enlargement. Ophthalmopathy and dermopathy are unique to\nGrave&rsquo;s disease; they do no appear with other forms of hyperthyroidism.\n</p>\n\n<p>\n <i>\n  Toxic multinodular goiter\n </i>\n may be associated with one or more\npalpable nodules.\n</p>\n\n<p>\n In\n <i>\n  subacute thyroiditis\n </i>\n , the thyroid is firm, modestly enlarged, and\nextremely tender.\n</p>\n\n<p>\n A history of recent\npregnancy may suggest\n <i>\n  postpartum\nthyroiditis\n </i>\n .\n</p>\n\n<p>\n Recent exposure to\namiodarone or surreptitious use of thyroid hormone may indicate\n <i>\n  drug-induced\n </i>\n hyperthyroidism.\n</p>\n", "choices": ["A. Congestive heart failure", "B. Cushing syndrome", "C. Pheochromocytoma", "D. Mitral valve prolapse", "E. Hyperthyroidism"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n43-year-old woman has a six-month history of fatigue, dry skin, and\nconstipation. Examination shows mild, diffuse thyroid enlargement. The thyroid\nis non-tender. Serum studies show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Thyroid-stimulating\nhormone\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  15\n&micro;U/mL (Normal: 0.5-5 &micro;U/mL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Thyroxine\n(T4)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.2\n&micro;g/dL\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  (Normal: 5-12 &micro;g/dL)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Thyroid-peroxidase\nantibody\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  9\nIU/mL\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  (Normal: 0-2\n&micro;g/dL)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Hashimoto&rsquo;s\nthyroiditis is the most common cause of hypothyroidism and goiter in the U.S.\nTSH levels are high and T4 levels are low (primary hypothyroidism). The thyroid\ngland is non-tender and thyroid antibodies (thyroid peroxidase antibody and\nthyroglobulin antibody) are elevated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Nontoxic goiter is defined as any\nthyroid enlargement that is not associated with overt hyperthyroidism or\nhypothyroidism and that does not result from inflammation or neoplasia. The\nmost common cause is iodine deficiency.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Diffuse toxic goiter (Graves&rsquo; disease)\nis the most common cause of hyperthyroidism in children and adolescents and the\nmost common cause of severe hyperthyroidism. Thyroid stimulating hormone\nreceptor antibody levels are elevated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Subacute granulomatous (de Quervain&rsquo;s)\nthyroiditis, also called &ldquo;painful thyroiditis,&rdquo; is often preceded by a viral\nupper respiratory tract infection. Symptoms include fever, neck pain, and\ntenderness over the thyroid gland. A period of hyperthyroidism may precede a\nperiod of hypothyroidism.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\npatient in the vignette has symptoms of hypothyroidism: fatigue, dry skin, and\nconstipation. Hypothyroidism can present with any of the following symptoms.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"302\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Symptoms of Hypothyroidism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"302\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fatigue\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hair\n  loss\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cold\n  intolerance\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Dry,\n  coarse, cold skin\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Weakness\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hoarse\n  voice\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lethargy\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Brittle\n  nails\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Weight\n  gain\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Periorbital,\n  peripheral edema\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Constipation\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Delayed\n  reflexes*\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Myalgias\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Slow\n  reaction time\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Arthralgias\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Bradycardia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"140\">\n    <p class=\"MsoNormal\">\n     <span>\n      Menstrual\n  irregularities\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"162\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pleural,\n  pericardial effusions\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  *A delayed\nrelaxation phase of deep tendon reflexes is so characteristic of hypothyroidism\nthat this finding constitutes a bedside diagnostic test for\nhypothyroidism.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nrelationship between hypothyroidism and thyroid hormone levels appears\nbelow.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"148\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"48\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      TSH\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"54\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Free T\n      <sub>\n       4\n      </sub>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"148\">\n    <p class=\"MsoNormal\">\n     <span>\n      Primary\n  hypothyroidism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"48\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &uarr;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"54\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"148\">\n    <p class=\"MsoNormal\">\n     <span>\n      Secondary\n  hypothyroidism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"48\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr; or Normal\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"54\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &darr;\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\npatient, the diagnosis of primary hypothyroidism is confirmed my measuring\nserum thyroid hormone levels. The patient&rsquo;s TSH is high at 15 &mu;U/mL\n(normal: 0.5-5.0 &mu;U/mL), and the thyroxine (T4) level is low at 2.2\n&mu;g/dL (normal: 5-12 &mu;g/dL).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal causes of hypothyroidism are listed below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"325\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes of Primary Hypothyroidism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"325\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Autoimmune\n  (Hashimoto&rsquo;s) thyroiditis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Subacute (de Quervain&rsquo;s)\n  thyroiditis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Post-partum\n  thyroiditis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Surgical removal of\n  the thyroid\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Radiation treatment to\n  the neck\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Radioactive iodine\n  treatment of hyperthyroidism\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Iodine deficiency\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Anti-thyroid medicine\n  (propylthiouracil, methimazole)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Drugs (e.g.,\n  amiodarone, lithium)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Congenital defects\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Chronic\nautoimmune (Hashimoto&rsquo;s) thyroiditis is the most common cause of hypothyroidism\n(and goiter) in the U.S. This condition can be distinguished from other causes\nof hypothyroidism, in part, my measuring thyroid antibodies in the blood.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The table\nbelow lists commonly measured thyroid antibodies and the conditions that cause\nthem to be elevated.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"443\">\n <tr>\n  <td valign=\"top\" width=\"158\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Thyroid Antibody\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"63\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Acronym\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Present In\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"158\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"63\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"158\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thyroid\n  peroxidase antibody\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"63\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     TPOAb\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hashimoto&rsquo;s\n  thyroiditis; Graves&rsquo; disease\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"158\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thyroglobulin\n  antibody\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"63\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     TgAb\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thyroid cancer;\n  Hashimoto&rsquo;s thyroiditis\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"158\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thyroid\n  stimulating hormone receptor antibody\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"63\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     TRAb\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Graves&rsquo;\n  disease\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npresence of thyroid peroxidase antibodies in a patient with hypothyroidism\nsuggests chronic autoimmune (Hashimoto) thyroiditis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Chronic\nautoimmune (Hashimoto) thyroiditis is characterized by lymphocytic infiltration\nand destruction of the thyroid, resulting in goiter and hypothyroidism. The\nthyroid gland is non-tender (unlike subacute thyroiditis, which is associated\nwith exquisite thyroid tenderness) and thyroid antibodies are present in high\ntiter. Early in the disease, thyroglobulin antibody is markedly elevated,\nalthough it may disappear later. Thyroid peroxidase antibodies are present\nearly and generally remain present for years.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Diffuse non-toxic goiter", "B. Diffuse toxic goiter (Graves\u2019 disease)", "C. Chronic autoimmune (Hashimoto\u2019s) thyroiditis", "D. Subacute granulomatous (de Quervain\u2019s) thyroiditis"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 30-year-old man comes to the emergency\ndepartment 1 hour after injuring his left knee in a volleyball game. He says he\ntwisted his left leg when he fell to the floor after he and a teammate\naccidentally collided. He cannot bear weight on his left leg. Physical\nexamination shows tenderness and swelling of the left knee. When the patient\nsits on the edge of the examination table, the left knee can be displaced\nanteriorly at an abnormal degree. Which of the following is most likely injured\nin this patient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis correct.\n  </span>\n </b>\n <span>\n  The\nanterior cruciate ligament prevents anterior displacement of the knee and leg.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347300\" o:spid=\"_x0000_i1135\"\n type=\"#_x0000_t75\" alt=\"Description: knee_anatomy\">\n <v:imagedata src=\"_%20Tutorials_files/image381.jpg\" o:title=\"knee_anatomy\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: knee_anatomy\" border=\"0\" height=\"273\" src=\"_%20Tutorials_files/image382.png\" v:shapes=\"Picture_x0020_347300\" width=\"205\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The major\nligaments associated with the knee joint are the patellar ligament, the tibial\n(medial) and fibular (lateral) collateral ligaments, and the anterior and\nposterior cruciate ligaments.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Patellar ligament\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\n  <span>\n   patellar ligament\n  </span>\n  is basically the\ncontinuation of the quadriceps femoris tendon inferior to the patella. It is\nattached above to the margins and apex of the patella and below to the tibial\ntuberosity.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Collateral ligaments\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ncollateral ligaments, one on each side of the joint, stabilize the hinge-like\nmotion of the knee.\n  <a name=\"4-u1.0-B978-0-443-06952-9..00011-4--f073\">\n  </a>\n  The\ncord-like\n  <span>\n   fibular collateral ligament\n  </span>\n  is attached superiorly to the lateral femoral epicondyle and inferiorly to the\nlateral surface of the fibular head. The\n  <span>\n   tibial collateral ligament\n  </span>\n  is anchored superiorly to the medial\nfemoral epicondyle and inferiorly to the medial surface of the tibia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-0-443-06952-9..00011-4--s149\">\n </a>\n <a name=\"4-u1.0-B978-0-443-06952-9..00011-4--st14\">\n </a>\n <b>\n  <span>\n   Cruciate\nligaments\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The two\ncruciate ligaments are in the intercondylar region of the knee and interconnect\nthe femur and tibia. They are termed &ldquo;cruciate&rdquo; (Latin for &ldquo;cross-shaped&rdquo;)\nbecause they cross each other\n  <a name=\"4-u1.0-B978-0-443-06952-9..00011-4--o079\">\n  </a>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\n  <span>\n   anterior cruciate ligament\n  </span>\n  attaches to\nthe anterior part of the intercondylar area of the tibia and ascends\nposteriorly to attach to the femur. The\n  <span>\n   posterior\ncruciate ligament\n  </span>\n  attaches to the posterior aspect of the intercondylar\narea of the tibia and ascends anteriorly to attach to the femur.\n  <a name=\"4-u1.0-B978-0-443-06952-9..00011-4--f074\">\n  </a>\n  <span>\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nanterior cruciate ligament prevents anterior displacement of the tibia relative\nto the femur and the posterior cruciate ligament prevents posterior\ndisplacement of the tibia relative to the femur.\n </span>\n</p>\n", "choices": ["A. Anterior cruciate ligament", "B. Fibular collateral ligament", "C. Meniscofemoral ligament", "D. Oblique popliteal ligament", "E. Transverse ligament of the knee"]}, {"question": "<p>\n <span>\n  A 62-year-old man presents with the following skin lesion.\n </span>\n</p>\n\n<p align=\"center\">\n <a href=\"http://en.wikipedia.org/wiki/File:Melanoma.jpg\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347299\" o:spid=\"_x0000_i1134\" type=\"#_x0000_t75\" alt=\"Description: 225px-Melanoma\"\n href=\"http://en.wikipedia.org/wiki/File:Melanoma.jpg\" o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image383.jpg\" o:title=\"225px-Melanoma\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: 225px-Melanoma\" border=\"0\" height=\"114\" src=\"_%20Tutorials_files/image384.png\" v:shapes=\"Picture_x0020_347299\" width=\"171\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Which\nof the following is\n  <i>\n   not\n  </i>\n  true\nregarding his condition?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is correct.\n  </span>\n </b>\n <span>\n  The\n  <b>\n  </b>\n </span>\n <span>\n  presence of tumor-infiltrating lymphocytes\nimproves prognosis.\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Melanoma,\n </span>\n a malignant tumor of melanocytes, usually appears in the\nskin, but may appear in the bowel or eye. Though less common than other types\nof skin cancer, melanoma is responsible for 75% of deaths due to skin cancer.\nThe tumor begins as a proliferation of melanocytes at the dermis-epidermal\njunction. During the radial growth phase, the tumor grows alongside the\njunction. When it starts to grow vertically &ndash; into the epidermis and\npapillary dermis &ndash; it begins to acquire the potential for metastasis.\nMetastasis begins with the invasion of lymphatics and small blood vessels.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Early\nsigns of melanoma are summarized by the mnemonic, \"ABCDE\":\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\n </span>\n <span>\n  symmetric\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  B\n </span>\n <span>\n  order: irregular\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  C\n </span>\n <span>\n  olor: variegated (multi-colored)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  D\n </span>\n <span>\n  iameter: &gt;6&nbsp;mm more likely to be melanoma\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  E\n </span>\n <span>\n  nlarging\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  These\ncriteria do not apply to the most dangerous form of melanoma, nodular melanoma,\nwhich has its own mnemonic, &ldquo;EFG&rdquo;:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  E\n </span>\n <span>\n  levated above the skin surface\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  F\n </span>\n <span>\n  irm to the touch\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  G\n </span>\n <span>\n  rowing\n </span>\n</p>\n\n<p>\n Most melanomas begin as an\nalteration in the color and appearance of normal-looking skin. The patient may\nnotice a new dark spot or mole. Other melanomas form from an existing mole or\nfreckle. Nodular melanoma may appear as a new lump. In later stages, melanomas\nmay itch, ulcerate, or bleed. Minimizing exposure to ultraviolet radiation\n(from the sun or sun beds) and wearing sun-protective clothing may prevent\ndevelopment of melanoma. The diagnosis is made by biopsy.\n <span>\n  Excisional biopsy\n </span>\n is the treatment of\nchoice. High-risk melanomas may require adjuvant therapy.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Prognosis\nis affected by tumor thickness (Breslow's depth), depth related to skin\nstructures (Clark level), type of melanoma, presence of ulceration, presence of\nlymphatic/perineural invasion, presence of tumor-infiltrating lymphocytes\n(which confers a better prognosis), location of the lesion, presence of\nsatellite lesions, and presence of regional or distant metastasis.\n </span>\n</p>\n", "choices": ["A. If untreated, metastasis and death may occur", "B. Diagnosis is confirmed by biopsy", "C. Excisional biopsy is the treatment of choice", "D. The presence of tumor-infiltrating lymphocytes confers a poor prognosis", "E. Protection from ultraviolet radiation may prevent such lesions from developing"]}, {"question": "<p>\n A\n45-year-old woman comes to the physician for a routine health maintenance\nexamination. She says that she feels fine. She is 170 cm (5 ft 7 in) and weighs\n86 kg (190 lb); BMI is 30 kg/m\n <sup>\n  2\n </sup>\n . Her blood pressure is 132/87 mm Hg.\nPhysical examination shows no other abnormalities. Lab studies show:\n</p>\n\n<p>\n Glucose\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n 105\nmg/dL\n</p>\n\n<p>\n Cholesterol, total\n <span>\n  &nbsp;\n </span>\n 210 mg/dL\n</p>\n\n<p>\n Triglycerides\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n 185\nmg/dL\n</p>\n\n<p>\n C-reactive protein\n <span>\n </span>\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n 0.35\nmg/L (N= 0.08-3.1 mg/L)\n</p>\n\n<p>\n This\npatient is at increased risk for developing which of the following conditions?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  The patient has\nmetabolic syndrome. (She is obese and has an elevated blood pressure, blood\nglucose, and triglycerides). She is at risk of developing type 2 diabetes\nmellitus and atherosclerosis, which would predispose her to cardiovascular\ndisease (heart attack and stroke).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n Metabolic\nsyndrome is a cluster of conditions &mdash; increased blood pressure, a high\nblood sugar level, excess body fat around the waist, and abnormal cholesterol\nlevels &mdash; that occur together, increasing the risk of heart disease,\nstroke, and diabetes. To be diagnosed with metabolic syndrome, the patient must\nhave three or more of the following metabolic disorders:\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  Abdominal waist circumference:\n </b>\n <u>\n  <span>\n   &gt;\n  </span>\n </u>\n <b>\n </b>\n 40 inches in men and\n <u>\n  <span>\n   &gt;\n  </span>\n </u>\n <span>\n </span>\n 35 inches in women. Patients are typically overweight (BMI of\n25-30 kg/m\n <sup>\n  2\n </sup>\n ) or obese (BMI\n <u>\n  &gt;\n </u>\n 30 kg/m\n <sup>\n  2\n </sup>\n )\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  Increased blood pressure:\n </b>\n systolic blood\npressure\n <u>\n  &gt;\n </u>\n 130 mm Hg or diastolic blood pressure measurement\n <u>\n  &gt;\n </u>\n 85 mm Hg\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  Increased blood sugar level:\n </b>\n fasting\nblood glucose\n <u>\n  &gt;\n </u>\n 100 mg/dL\n</p>\n\n<p>\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  Abnormal lipid levels:\n </b>\n triglycerides\n <u>\n  &gt;\n </u>\n 150 mg/dL and high-density lipoprotein (HDL) cholesterol\n <u>\n  &lt;\n </u>\n 40 mg/dL\nin men or\n <u>\n  &lt;\n </u>\n 50 mg/dL in women\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Individuals\nwith one component of the metabolic syndrome are more likely to have other\ncomponents. The more components the patient has, the greater is the health\nrisk.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Risk\nfactors for metabolic syndrome:\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Age.\n  </span>\n </b>\n <span>\n  Metabolic syndrome affects &lt; 10% of people in their 20s\nand 40% of people in their 60s\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Race.\n  </span>\n </b>\n <span>\n  Hispanic and Asian\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Obesity.\n  </span>\n </b>\n <span>\n  BMI\n  <u>\n   &gt;\n  </u>\n  25 kg/m\n  <sup>\n   2\n  </sup>\n  and abdominal obesity\n(&ldquo;apple&rdquo; shape, rather than a &ldquo;pear&rdquo; shape)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   History of diabetes.\n  </span>\n </b>\n <span>\n  Personal history of gestational diabetes and\nfamily history of type 2 diabetes\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Other conditions.\n  </span>\n </b>\n <span>\n  Hypertension, cardiovascular disease, and\npolycystic ovary syndrome\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Having\nmetabolic syndrome increases the likelihood of developing the following\nconditions:\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Type 2 diabetes mellitus.\n  </span>\n </b>\n <span>\n  Metabolic syndrome is strongly\nassociated with insulin resistance.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <b>\n  <span>\n   Cardiovascular disease.\n  </span>\n </b>\n <span>\n  High blood pressure and dyslipidemia\ncontribute to a buildup of plaques in the arteries (atherosclerosis), which\npredispose the patient to heart attack and stroke.\n </span>\n</p>\n", "choices": ["A. Atherosclerosis", "B. Chronic lymphocytic (Hashimoto) thyroiditis", "C. Systemic lupus erythematosus", "D. Systemic sclerosis (scleroderma)", "E. Type 1 diabetes mellitus"]}, {"question": "<p class=\"MsoNormal\">\n <span lang=\"EN-GB\">\n  A patient consults a physician because of a small lip\nlesion that, on biopsy, proves to be a mucosal neuroma. The patient&rsquo;s mother\nhad medullary carcinoma of the thyroid. In addition to being predisposed to\nmedullary carcinoma of the thyroid, to what others condition is the patient\npredisposed? &nbsp;\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span lang=\"EN-GB\">\n   Answer D is correct.\n  </span>\n </b>\n <span lang=\"EN-GB\">\n  This patient has multiple endocrine neoplasia type\n </span>\n <span lang=\"EN-GB\">\n  III. Features include medullary carcinoma of the thyroid,\npheochromocytoma, and mucosal neuromas.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span lang=\"EN-GB\">\n   Answer A is incorrect.\n  </span>\n </b>\n <span lang=\"EN-GB\">\n  Gastrinomas are part of multiple endocrine neoplasia\ntype\n </span>\n <span lang=\"EN-GB\">\n  II.\n  <span>\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span lang=\"EN-GB\">\n   Answer B is incorrect.\n  </span>\n </b>\n <span lang=\"EN-GB\">\n  Insulinomas are part of multiple endocrine neoplasia\ntype\n </span>\n <span lang=\"EN-GB\">\n  II.\n  <span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span lang=\"EN-GB\">\n   Answer C is incorrect.\n  </span>\n </b>\n <span lang=\"EN-GB\">\n  Parathyroid adenomas are part of multiple endocrine\nneoplasia types I and\n </span>\n <span lang=\"EN-GB\">\n  II.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span lang=\"EN-GB\">\n   Answer E is incorrect.\n  </span>\n </b>\n <span lang=\"EN-GB\">\n  Pituitary adenomas are part of multiple endocrine\nneoplasia type\n </span>\n <span lang=\"EN-GB\">\n  I.\n </span>\n</p>\n"], "tutorial": "<p>\n The term\n <span>\n  multiple endocrine neoplasia\n </span>\n (\n <span>\n  MEN\n </span>\n ) encompasses several distinct\nsyndromes involving tumors of endocrine glands. Tumors of nonendocrine tissues\nalso occur in some of these syndromes. MEN syndromes are inherited as autosomal\ndominant disorders. The endocrine neoplasms may be expressed as hyperplasia,\nadenoma, or carcinoma and may develop synchronously or metachronously. The\nclassification of\n <span>\n  multiple endocrine\nneoplasia\n </span>\n (\n <span>\n  MEN\n </span>\n ) syndromes\nappears below:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  MEN I\n(Werner&rsquo;s syndrome)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Pituitary tumors\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Enteropancreatic\nneuroendocrine tumors (insulinoma, gastrinoma, glucagonoma)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Parathyroid tumors\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-0-323-07158-1..00003-1--li34\">\n </a>\n <a name=\"4-u1.0-B978-0-323-07158-1..00003-1--s104\">\n </a>\n <a name=\"4-u1.0-B978-0-323-07158-1..00003-1--st10\">\n </a>\n <span>\n  <span>\n   MEN II (Sipple&rsquo;s syndrome)\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n  <span>\n   Medullary thyroid\ncarcinoma\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n  <span>\n   Pheochromocytoma\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   <span>\n    &middot;\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </span>\n  <span>\n   Hyperparathyroidism\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-0-323-07158-1..00003-1--o949\">\n </a>\n <span>\n  MEN III (Multiple\nMucosal Neuroma syndrome)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Medullary thyroid\ncarcinoma\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Pheochromocytoma\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Marfanoid habitus\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Multiple mucosal\nneuromas\n </span>\n</p>\n", "choices": ["A. Gastrinoma", "B. Insulinoma", "C. Parathyroid adenoma", "D. Pheochromocytoma", "E. Pituitary adenoma"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  The\nnervous system increases the force of muscle contraction in a graded fashion\nprimarily by recruitment of motor units and by increasing which of the following?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  The force of muscle\ncontraction is increased by two mechanisms: recruitment of more motor units and\ntemporal summation (firing of individual motor neurons more frequently).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . The amplitude of\naction potentials is constant.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . The duration of action\npotentials does not change.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . The number of\nendplates does not change.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . The rate of synthesis\nof acetylcholine does not change.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  With\nvoluntary muscle contraction, the brain sends signals in the form of action\npotentials through the nervous system to the motor neuron, which innervates\nmuscle fibers. While nerve impulse profiles are, for the most part, always the\nsame, skeletal muscles are able to produce varying levels of contractile force.\nThis phenomenon is explained by &ldquo;\n  <i>\n   force\nsummation\n  </i>\n  .&rdquo; Force summation is the addition of individual twitch\ncontractions to increase the intensity of overall muscle contraction. It is\nachieved in two ways: by increasing the number and size of contractile units\nsimultaneously, called\n  <i>\n   recruitment of motor units\n  </i>\n  <span>\n   ,\n  </span>\n  and by increasing the frequency at which action potentials are\nsent to muscle fibers, called\n  <i>\n   temporal\n   <span>\n    summation\n   </span>\n  </i>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Recruitment of motor units:\n </span>\n <span>\n  A motor unit includes the motor neuron plus all\nof the muscle fibers it innervates. The degree of contraction of a skeletal\nmuscle is influenced by the number of motor units being stimulated. Skeletal\nmuscles consist of numerous motor units and, therefore, stimulating more motor\nunits creates a stronger contraction.\n </span>\n</p>\n\n<p>\n <span>\n  Temporal summation:\n </span>\n An increase in the frequency with which a\nmuscle is stimulated increases the strength of contraction. With rapid\nstimulation (so rapid that a muscle does not completely relax between\nsuccessive stimulations), a muscle fiber is re-stimulated while there is still\nsome contractile activity. As a result, there is a &ldquo;summation&rdquo; of the\ncontractile force. In addition, with rapid stimulation there isn&rsquo;t enough time\nbetween successive stimulations to remove all the calcium from the sarcoplasm.\nSo with several stimulations in rapid succession, calcium levels in the\nsarcoplasm increase. More calcium means more active cross-bridges and,\ntherefore, a stronger contraction. (If a muscle fiber is stimulated so rapidly\nthat it does not relax at all between stimuli, a smooth, sustained contraction\ncalled\n <span>\n  tetanus\n </span>\n occurs.)\n</p>\n\n<p>\n Skeletal muscles contract\naccording to the\n <i>\n  sliding filament model\n </i>\n <span>\n  (Figure 1).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  An\naction potential originating in the brain reaches an alpha motor neuron, which\nthen transmits an action potential down the axon.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\naction potential propagates by activating voltage-gated sodium channels along\nthe axon toward the synapse. Eventually, the action potential reaches the motor\nneuron terminal and causes a calcium ion influx through the voltage-gated\ncalcium channels.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\nCa\n  <sup>\n   2+\n  </sup>\n  influx causes vesicles containing the neurotransmitter\nacetylcholine to fuse with the plasma membrane, releasing acetylcholine into\nthe extracellular space.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   4.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\nacetylcholine diffuses across the synapse and activates nicotinic cholinergic\nreceptors on the motor end plate of the muscle cell. Activation of the\nnicotinic receptor opens its intrinsic sodium/potassium channel, causing sodium\nto rush in and potassium to trickle out. Because the channel is more permeable\nto sodium, the muscle fiber membrane depolarizes (the membrane potential\nbecomes more positive), triggering an action potential.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   5.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\naction potential spreads through the muscle fiber&rsquo;s network of T-tubules,\nepolarizing the inner portion of the muscle fiber.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   6.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\ndepolarization activates voltage-dependent calcium channels (dihydropyridine\nreceptors) in the T tubule membrane, which are in close proximity to\ncalcium-release channels (ryanodine receptors) in the adjacent sarcoplasmic\nreticulum.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   7.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  This\nactivation causes the sarcoplasmic reticulum to release calcium.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   8.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The\ncalcium binds to the troponin C present on the actin-containing thin filaments\nof the myofibrils. The troponin C then allosterically modulates the\ntropomyosin. Under normal circumstances, the tropomyosin sterically obstructs\nbinding sites for myosin on the thin filament; however, once calcium binds to\ntroponin C and causes an allosteric change in the troponin protein, troponin T\nallows tropomyosin to move, unblocking the binding sites.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   9.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Myosin\n(which has ADP and inorganic phosphate bound to its nucleotide binding pocket\nand is in a ready state) binds to the newly uncovered binding sites on the thin\nfilament (binding to the thin filament is very tightly coupled to the release\nof inorganic phosphate). Myosin is now bound to actin in the strong binding\nstate. The release of ADP and inorganic phosphate are tightly coupled to the\npower stroke, which pulls the Z-bands towards each other, thus shortening the\nsarcomere and the I-band (Figure 2).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   10.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Adenosine_triphosphate\" title=\"Adenosine triphosphate\">\n  <span>\n   ATP\n  </span>\n </a>\n <span>\n  binds myosin, allowing\nit to release actin and be in the weak binding state (a lack of ATP makes this\nstep impossible, resulting in rigor mortis). The myosin then hydrolyzes the ATP\nand uses the energy to move into the \"cocked back\" conformation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   11.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Steps\n9 and 10 repeat as long as ATP is available and calcium is present on thin\nfilament.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   12.\n   <span>\n    &nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  While\nthe above steps are occurring, calcium is actively pumped back into the\nsarcoplasmic reticulum. When calcium is no longer present on the thin filament,\nthe tropomyosin changes conformation back to its previous state so as to block\nthe binding sites again. The myosin ceases binding to the thin filament, and\nthe contractions cease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Figure 1\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347298\"\n o:spid=\"_x0000_i1133\" type=\"#_x0000_t75\" alt=\"Description: Muskel-molekulartranslation\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image385.png\" o:title=\"Muskel-molekulartranslation\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Muskel-molekulartranslation\" border=\"0\" height=\"596\" src=\"_%20Tutorials_files/image386.png\" v:shapes=\"Picture_x0020_347298\" width=\"304\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Figure 2\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/6/6e/Sarcomere.svg\">\n  <span>\n   <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347297\"\n o:spid=\"_x0000_i1132\" type=\"#_x0000_t75\" alt=\"Description: File:Sarcomere.svg\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/6/6e/Sarcomere.svg\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image387.png\" o:title=\"Sarcomere.svg\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: File:Sarcomere.svg\" border=\"0\" height=\"290\" src=\"_%20Tutorials_files/image388.png\" v:shapes=\"Picture_x0020_347297\" width=\"373\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n", "choices": ["A. Amplitude of action potentials of single motor neurons", "B. Duration of action potentials in single motor neurons", "C. Frequency of firing of individual motor neurons", "D. Number of active end-plates on the muscle fiber", "E. Rate of synthesis of acetylcholine at the motor nerve terminal"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 5-year-old boy is brought to the\nphysician by his parents because of an 8-month history of difficulty walking.\nHis parents say that he limps when he walks and has a waddling gait; he also\nhas difficulty standing. When getting up from a sitting position, he uses his\nhands to walk up his thighs and push his body into a standing position. His\nparents have not noticed any weakness of his arms. His mother is an only child,\nbut she has an uncle who became bedridden as a child and died of respiratory\narrest. Physical examination shows prominent calf muscles. Muscle strength is\n4/5 at both hips but normal elsewhere. This patient most likely has a mutation\nin the gene coding for which of the following proteins?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  Duchenne muscular dystrophy is an X-linked\ndisorder caused by mutation of the gene that codes for the protein, dystrophin.\nDystrophin is important to the stability of the cell membrane cytoskeleton.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Duchenne muscular dystrophy\n </span>\n <span>\n  has long received attention from the general\nand medical communities because it is a severe, currently untreatable,\nrelatively common disorder associated with relentless clinical deterioration\n  <a name=\"4-u1.0-B978-1-4160-3080-5..50015-8--intr\">\n  </a>\n  . The isolation of the gene\naffected in this X-linked disorder\n  <a name=\"4-u1.0-B978-1-4160-3080-5..50015-8--p368\">\n  </a>\n  and the characterization of\nits protein &ndash; dystrophin &ndash; have given insight into every aspect of\nthe disease, greatly improved the genetic counseling of affected families, and\nsuggested strategies for treatment.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4160-3080-5..50015-8--cese\">\n </a>\n <span>\n  Affected boys are normal for the first year or\ntwo of life but develop muscle weakness at the age of 3 to 5 years, when they\nbegin to have difficulty climbing stairs and rising from a sitting position.\nThe child is confined to a wheelchair by the age of 12 years and is unlikely to\nsurvive beyond the age of 20 years. Patients die of respiratory failure or,\nbecause the myocardial muscle is also affected, of cardiac failure. In the\npreclinical and early stages of the disease, the serum level of creatine kinase\nis grossly elevated (50 to 100 times the upper limit of normal) because of its\nrelease from diseased muscle. The brain is also affected; on average, there is\na modest decrease in IQ of about 20 points.\n </span>\n</p>\n\n<p>\n Duchenne muscular dystrophy,\na sex-linked recessive inherited trait, occurs in males (and in females with\nTurner syndrome); carriers are female. It is reported to occur in one in 3500\nlive births. There is a family history in 70% of patients, and the condition\noccurs as a spontaneous mutation in about 30% of patients. The disorder is the\nresult of a mutation in a region of the X chromosome that encodes the 400-kd\nprotein dystrophin. Dystrophin is important to the stability of the cell\nmembrane cytoskeleton. In patients with Duchenne muscular dystrophy, the total\nabsence of this protein results in progressive muscle degeneration and loss of\nfunction.\n</p>\n\n<p>\n Children with Duchenne\nmuscular dystrophy usually reach early motor milestones at appropriate times,\nbut independent ambulation may be delayed, and many are initially toe-walkers.\nThe disease usually becomes evident between 3 and 6 years of age. Clinical features\ninclude large, firm calf muscles; the tendency to toe-walking; a widely based\nstance; and a waddling gait. The diagnosis is usually obvious by the time the\nchild is 5 or 6 years old. A dramatically elevated level of creatine kinase (50\nto 100 times normal) and DNA analysis of blood samples confirm the diagnosis.\nMuscle biopsy shows variations in fiber size, internal nuclei, split fibers,\ndegenerating or regenerating fibers, and fibrofatty tissue deposition.\nDystrophin testing of the muscle biopsy specimen confirms the type of muscular\ndystrophy\n</p>\n\n<p>\n The degree of muscular\nweakness depends on the age of the patient. Because the proximal musculature\nweakens before the distal muscles, examination of the lower extremities shows\nan early weakness of gluteal muscle strength. The weakness in the proximal\nmuscles of the lower extremity can be shown by a decrease in the ability to\nrise from the floor without assistance of the upper extremities (Gower sign).\nCalf pseudohypertrophy is caused by infiltration of the muscle by fat and\nfibrosis, giving the calves the feel of hard rubber (see image).\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347296\"\n o:spid=\"_x0000_i1131\" type=\"#_x0000_t75\" alt=\"Description: http://www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-0-323-03329-9&amp;eid=4-u1.0-B978-0-323-03329-9..50035-0..gr7&amp;assetType=full\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image389.jpg\" o:title=\"//www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-0-323-03329-9&amp;eid=4-u1.0-B978-0-323-03329-9..50035-0..gr7&amp;assetType=full\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-0-323-03329-9&amp;eid=4-u1.0-B978-0-323-03329-9..50035-0..gr7&amp;assetType=full\" border=\"0\" height=\"451\" src=\"_%20Tutorials_files/image390.png\" v:shapes=\"Picture_x0020_347296\" width=\"273\"/>\n </span>\n</p>\n\n<p align=\"center\">\n Calf\n&ldquo;pseudohypertrophy&rdquo; in Duchenne muscular dystrophy\n</p>\n", "choices": ["A. Actin", "B. Dystrophin", "C. Frataxin", "D. Myelin", "E. Myosin"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 52-year-old woman with diabetes mellitus\npresents to the clinic with malformed toenails. Which of the following tests\nwill most likely reveal the correct diagnosis?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347295\" o:spid=\"_x0000_i1130\" type=\"#_x0000_t75\" alt=\"Description: quiz019\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image391.jpg\" o:title=\"quiz019\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: quiz019\" border=\"0\" height=\"181\" src=\"_%20Tutorials_files/image392.png\" v:shapes=\"Picture_x0020_347295\" width=\"265\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Microscopic examination of a potassium\nhydroxide smear is the most useful test for diagnosing onychomycosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Onychodystrophy, or malformation of the nails,\nmay be congenital, traumatic, infectious, inflammatory, or drug-induced. The\nmost common cause of nail deformity is fungal infection, or onychomycosis\n(about half of all cases). Toenails are affected more often than fingernails.\nThe nail plate is often yellow and thick, may become rough and crumbly, and can\nseparate from the nail bed. Dermatophytes are the fungi most commonly\nresponsible for onychomycosis. The diagnosis is made with a potassium hydroxide\n(KOH) smear. Before obtaining a specimen, the nail is clipped and cleansed with\nalcohol. A positive KOH smear shows fungal hyphae.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347294\" o:spid=\"_x0000_i1129\" type=\"#_x0000_t75\" alt=\"Description: KOHdermatophyte\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image393.jpg\" o:title=\"KOHdermatophyte\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: KOHdermatophyte\" border=\"0\" height=\"146\" src=\"_%20Tutorials_files/image394.png\" v:shapes=\"Picture_x0020_347294\" width=\"207\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  A negative smear does not rule out\nonychomycosis. Direct microscopy may be negative in up to 10% of cases, and\nculture may be negative in up to 30% of cases. An effective treatment for\nonychomycosis is oral terbinafine.\n </span>\n</p>\n", "choices": ["A. Wood\u2019s lamp examination", "B. Nail biopsy", "C. Blood chemistries", "D. Potassium hydroxide smear", "E. Fungal culture"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n65-year-old woman is diagnosed with osteoporosis of the spine. She has a 30\npack-year smoking history. Last year, she underwent a three-vessel coronary\nartery bypass graft, and five years ago, she underwent total abdominal\nhysterectomy with bilateral salpingo-oophorectomy for benign uterine disease.\nWhich of the following is the most appropriate pharmacologic therapy for her\nosteoporosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Bisphosphonates are the mainstay of\ntherapy for osteoporosis. The patient in this vignette has a history of\ncardiovascular disease and is, therefore, not a candidate for hormone therapy\nor raloxifene therapy. The Women&rsquo;s Health Initiative (WHI), one of the largest\nclinical trials, was designed to assess the effects of hormone replacement\ntherapy (HRT), dietary change, and calcium and vitamin D supplementation on\nheart disease, osteoporotic fractures, and breast and colorectal cancer risk.\nEarly data showed that combinations of estrogen and progesterone increase the\nrisk of breast cancer, myocardial infarction, stroke, and blood clots. Data\nalso showed that estrogen alone increases the risk of blood clots and stroke,\nand does not reduce the risk of myocardial infarction. Based on these results,\nthe American Heart Association has recommended that women with pre-existing\ncoronary artery disease consider non-hormonal options for the treatment of\nosteoporosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Osteoporosis\n </span>\n <span>\n  is a disease of bones that leads to an increased risk of fracture. In\nosteoporosis the bone mineral density (BMD) is reduced and bone\nmicroarchitecture deteriorates. Osteoporosis is defined by the World Health\nOrganization (WHO) as a bone mineral density that is 2.5 standard deviations or\nmore below the mean peak bone mass (average of young, healthy adults) as\nmeasured by DXA.The disease may be classified as primary type 1, primary type\n2, or secondary. The form of osteoporosis most common in women after menopause\nis referred to as primary type 1 or\n  <span>\n   postmenopausal\nosteoporosis\n  </span>\n  . Primary type 2 osteoporosis or\n  <span>\n   senile osteoporosis\n  </span>\n  occurs after age 75 and is seen in both\nfemales and males at a ratio of 2:1. Finally, secondary osteoporosis may arise at\nany age and affects men and women equally. This form of osteoporosis results\nfrom chronic predisposing medical problems or disease, or prolonged use of\nmedications such as glucocorticoids.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nunderlying mechanism in all cases of osteoporosis is an imbalance between bone\nresorption and bone formation. In normal bone, there is constant matrix\nremodeling of bone; up to 10% of all bone mass may be undergoing remodeling at\nany point in time. Bone is resorbed by osteoclasts (which derive from the\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Bone_marrow\" title=\"Bone marrow\">\n  <span>\n   bone marrow\n  </span>\n </a>\n <span>\n  ), after which new bone\nis deposited by osteoblasts. The three main mechanisms by which osteoporosis\ndevelops are an inadequate\n  <span>\n   peak bone\nmass\n  </span>\n  (the skeleton develops insufficient mass and strength during\ngrowth), excessive bone resorption by osteoclasts, and inadequate formation of\nnew bone ny osteoblasts during remodeling. An interplay of these three\nmechanisms underlies the development of fragile bone tissue.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\nnumber of medications are available for the treatment of osteoporosis:\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Bisphosphonates.\n  </span>\n </b>\n <span>\n  Bisphosphonates are the\nmainstay of therapy for osteoporosis. They inhibit bone breakdown, preserve\nbone mass, and increase bone density in the spine and hip, reducing the risk of\nfracture. Examples include alendronate (Fosamax), risedronate (Actonel),\nibandronate (Boniva), and zoledronic acid (Reclast). Bisphosphonates are\nindicated for treatment of osteoporosis in post-menopausal women, adult men,\nand people with steroid-induced osteoporosis. They are also used\nprophylactically in post-menopausal women and in people receiving long-term\nglucocorticoid therapy. Side effects include nausea, abdominal pain, difficulty\nswallowing, and increased risk of inflamed esophagus or esophageal ulcer. Rare\nside effects include osteonecrosis of the jaw, visual disturbance, and atypical\nfractures (subtrochanteric and diaphyseal femur fractures).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n <b>\n  Raloxifene (Evista).\n </b>\n Raloxifene is a selective estrogen receptor modulator (SERM). It has estrogenic\neffects on bone (i.e., it reduces bone loss) and anti-estrogenic effects on\nuterus and breast (i.e., it reduces the risk of breast and uterine cancer).\nRaloxifene is used for treatment and prevention of osteoporosis in\npostmenopausal women.\n <span>\n  In patients with coronary\nartery disease, it may increase the risk of stroke, and it is\n </span>\n contraindicated\nin individuals with a history of venous thromboembolic events, including deep\nvein thrombosis and pulmonary embolism. Hot flashes are a common side effect.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Calcitonin.\n  </span>\n </b>\n <span>\n  A hormone produced by\nthe thyroid gland, calcitonin reduces bone resorption. It may prevent spine\nfractures and relieve pain from compression fractures. It is usually\nadministered as a nasal spray and may cause nasal irritation. It is not as\npotent as the bisphosphonates, and is usually reserved for people who cannot\ntolerate these medicines.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Teriparatide\n(Forteo).\n  </span>\n </b>\n <span>\n  An analog of parathyroid hormone, t\n  <span>\n   eriparatide\n  </span>\n  works by stimulating new bone growth, rather than by preventing further bone\nloss. It is given once daily by injection under the skin. Long-term effects are\nbeing studied.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Hormone\ntherapy.\n  </span>\n </b>\n <span>\n  Estrogen,\nespecially when started soon after menopause, helps to maintain bone density.\nIt may, however, increase the risk of blood clots, endometrial cancer, and breast\ncancer. Due to safety concerns, hormone therapy is not considered first-line\ntreatment for osteoporosis.\n </span>\n</p>\n", "choices": ["A. Conjugated equine estrogens (Premarin)", "B. Conjugated equine estrogens and medroxyprogesterone acetate (Prempro)", "C. Raloxifene hydrochloride (Evista)", "D. Alendronate sodium (Fosamax)"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Breast carcinomas\noften cause the skin of the breast to become puffy and pitted, resembling\norange peel. The pits most likely correspond with which of the following?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . The pits in\n  <i>\n   peau d&rsquo;orange\n  </i>\n  represent spots where the\nretinacula cutis attach to the dermis.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347293\"\n o:spid=\"_x0000_i1128\" type=\"#_x0000_t75\" alt=\"Description: peau-d-orange-cellulite-ceinture-ventre-plat-regime-minceur-mincir-maigrir-sudation-sauna\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image395.jpg\" o:title=\"peau-d-orange-cellulite-ceinture-ventre-plat-regime-minceur-mincir-maigrir-sudation-sauna\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: peau-d-orange-cellulite-ceinture-ventre-plat-regime-minceur-mincir-maigrir-sudation-sauna\" border=\"0\" height=\"244\" src=\"_%20Tutorials_files/image396.png\" v:shapes=\"Picture_x0020_347293\" width=\"244\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Peau d&rsquo;orange\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A change\nin the color or texture of the skin of the breast or areola is an important\nsymptom of breast carcinoma. The presence of dimpling, puckering, or scaliness\nwarrants further investigation. The presence of unusually prominent pores,\nindicative of edema of the skin, is an important sign of malignancy. This\nclinical sign is called\n  <span class=\"search-hit\">\n   <i>\n    peau d'orange\n   </i>\n  </span>\n  because of its orange-peel appearance. During the early stages of breast\ncarcinoma, the lymphatic vessels of the breast are dilated and contain\noccasional emboli of carcinoma cells. Limited\n  <span class=\"search-hit\">\n   peau\nd'orange\n  </span>\n  over the lower half of the areola is present. As the disease\nprogresses, more lymphatic vessels become filled with carcinoma cells that\nblock them, creating more generalized edema. The pits in\n  <i>\n   peau d&rsquo;orange\n  </i>\n  represent spots where the retinacula cutis attach to\nthe dermis. (The retinacula cutis are small fibrous strands that attach the\ndeep surface of the dermis to the underlying deep fascia. The extent of their\nattachment determines the mobility of skin over the deep structures. These are\nparticularly well-developed over the breast where they are known as suspensory\nligaments of the breast. They are also well-developed, but short, in the palms\nand soles.)\n </span>\n</p>\n", "choices": ["A. Attachment of suspensory ligaments (retinacula cutis) to the dermis", "B. Diffuse scarring in subcutaneous fibrous tissue", "C. Focal invasion of the dermis by neoplastic cells", "D. Openings of sebaceous glands", "E. Openings of sweat glands"]}, {"question": "<p>\n A 64-year-old man has\nepisodes of headache, heart palpitations, and sweating. He has lost 22 lbs in\nthe past 3 months. During one episode, his blood pressure was found to be\n210/100 mm Hg. Urine studies show increased catecholamine concentrations. CT of\nthe abdomen shows a right adrenal mass. This tumor most likely originates from\nwhich part of the adrenal gland?\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </b>\n Pheochromocytomas\noriginate from chromaffin cells in the adrenal medulla. The adrenal medulla is\nthe core of the adrenal gland, and is surrounded by the adrenal cortex. It\nsecretes approximately 20% norepinephrine and 80% epinephrine. The chromaffin\ncells of the medulla, named for their characteristic brown staining with\nchromic acid salts, are the body's main source of the circulating catecholamines:\nadrenaline (epinephrine) and noradrenaline (norepinephrine). Catecholamines are\nderived from the amino acid tyrosine and these water-soluble hormones are the\nmajor hormones underlying the fight-or-flight response. To carry out its part\nof this response, the adrenal medulla receives input from the sympathetic\nnervous system through preganglionic fibers originating in the thoracic spinal\ncord (from T5 -T11). These fibers release acetylcholine, which stimulate the\nadrenal medulla to produce catecholamines. Because it is innervated by\npreganglionic nerve fibers, the adrenal medulla can be considered as a\nspecialized sympathetic ganglion. Unlike other sympathetic ganglia, however,\nthe adrenal medulla lacks distinct synapses and releases its secretions directly\ninto the blood.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n The outermost part of the adrenal cortex,\nthe zona glomerulosa, is the main site for production of mineralocorticoids,\nmainly aldosterone, which is largely responsible for the long-term regulation\nof blood pressure. Aldosterone's effects are on the distal convoluted tubule\nand collecting duct of the kidney where it causes increased reabsorption of\nsodium and increased excretion of both potassium and hydrogen ions. The major\nstimulus to produce aldosterone is angiotensin II, while ACTH from the\npituitary only produces a transient effect.\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Situated between the\nglomerulosa and reticularis, the zona fasciculata is responsible for producing\nglucocorticoids, such as 11-deoxycorticosterone, corticosterone, and cortisol\nin humans. Cortisol is the main glucocorticoid under normal conditions and its\nactions include mobilization of fats, proteins, and carbohydrates.\nAdditionally, cortisol enhances the activity of other hormones including\nglucagon and catecholamines. The zona fasciculata secretes a basal level of\ncortisol but can also produce bursts of the hormone in response to\nadrenocorticotropic hormone (ACTH) from the anterior pituitary.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  The inner most cortical\nlayer, the zona reticularis, produces androgens, mainly dehydroepiandrosterone\n(DHEA), DHEA sulfate (DHEA-S), and androstenedione (the precursor to\ntestosterone).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n A\n <span>\n  pheochromocytoma\n </span>\n is a neuroendocrine tumor of the medulla of the\nadrenal glands (originating in the chromaffin cells) that secretes excessive\namounts of catecholamines, usually noradrenaline (norepinephrine) and\nadrenaline (epinephrine). The most common presentation is headache, excessive\nsweating, increased heart rate, and increased blood pressure with the attack\nsubsiding in less than one hour. Palpitations, anxiety, pallor, weight loss,\nand hyperglycemia are common. A pheochromocytoma can also cause resistant\narterial hypertension and may be fatal if it produces &ldquo;malignant hypertension&rdquo;\n(severely high blood pressurer). The tumor is usually unilateral, but may be\nbilateral; it is usually benign, but maybe malignant; and it is usually\nsporadic, but may be hereditary. The diagnosis can be established by measuring\ncatecholamines and metanephrines in blood or through a 24-hour urine\ncollection. Care should be taken to rule out other causes of adrenergic excess\nlike hypoglycemia, stress, exercise, and drugs. Pheochromocytomas occur most\noften during young-adult to mid-adult life.\n</p>\n", "choices": ["A. Medulla", "B. Zona glomerulosa", "C. Zona fasciculata", "D. Zona reticularis"]}, {"question": "<p>\n A 24-year-old man visits the\nclinic for a regular check-up. His father died of a heart attack at the age of\n52. Physical examination shows a tendon xanthoma on the elbow. The serum\ncholesterol level is 360 mg/dL. A mutation is most likely to be found in which\nof the following genes?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Familial\nhypercholesterolemia, the most common primary dyslipidemia, is caused by a\nmutation in the LDL receptor gene. The disorder is autosomal dominant and is\nassociated with high LDL cholesterol levels. Physical findings include\nxanthelasmata, tendon xanthomas, and premature vascular disease. Patients\ntypically have a family history of early atherosclerotic vascular disease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Familial lipoprotein\nlipase deficiency is a rare autosomal recessive disorder associated with high\nchylomicron and VLDL cholesterol levels. Blood tests show high triglyceride\nlevels. Eruptive xanthomas and pancreatitis may occur.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Familial ApoC2\ndeficiency is similar to familial lipoprotein lipase deficiency in its clinical\nmanifestations.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Autosomal recessive\nhypercholesterolemia is similar to familial (autosomal dominant)\nhypercholesterolemia in its clinical manifestations, but it is much rarer.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Familial type III\nhyperlipoproteinemia is caused by a mutation in the ApoE gene and is associated\nwith high VLDL levels. Blood tests show high cholesterol and triglyceride\nlevels. Physical findings include palmar xanthomas, tuberous xanthomas, and\npremature atherosclerosis.\n </span>\n</p>\n"], "tutorial": "<p>\n Fats and cholesterol are\nlipid-soluble and therefore cannot travel &ldquo;alone&rdquo; in the blood. They must be\nplaced in a water-soluble &ldquo;capsule&rdquo; for transport. That water-soluble capsule\nis a lipoprotein.\n</p>\n\n<p>\n Below is an example of a\nlipoprotein.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347292\"\n o:spid=\"_x0000_i1127\" type=\"#_x0000_t75\" alt=\"Description: Lipoprotein\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image397.png\" o:title=\"Lipoprotein\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Lipoprotein\" border=\"0\" height=\"201\" src=\"_%20Tutorials_files/image398.png\" v:shapes=\"Picture_x0020_347292\" width=\"258\"/>\n </span>\n</p>\n\n<p>\n Inside the lipoprotein are\nmolecules of cholesterol (C) and triglyceride (T). These molecules are\nsurrounded by a phospholipid monolayer (represented in green). Within the\nmonolayer are various apoproteins (Apo A, B, C, and E), which interact with\nstructures outside the capsule to direct the transport of cholesterol and\ntriglyceride into and out of the capsule.\n</p>\n\n<p>\n Lipoproteins are divided\ninto four major classes based on density: chylomicrons, VLDL (very low density\nlipoprotein), LDL (low density lipoprotein), and HDL (high density\nlipoprotein). Density depends on fat-to-protein ratio. Fat is &ldquo;light&rdquo;; so high\nfat-to-protein ratios mean low density.\n <span>\n </span>\n</p>\n\n<p>\n Dyslipidemia (abnormal\nlevels of lipoprotein in the blood) occurs when production or clearance of\nlipoproteins is altered. Many factors contribute to dyslipidemia, including\ndefects in apoproteins, defects in receptors to which apoproteins bind, and\ndefects in enzymes that digest lipids.\n</p>\n\n<p>\n Dyslipidemia may be\nclassified as primary or secondary. Primary dyslipidemia results from genetic\ndefects that directly affect lipoproteins. Secondary dyslipidemia is caused by\nconditions, such as diabetes or hypothyroidism, which indirectly affect\nlipoproteins.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The most\ncommon primary dyslipidemia is familial hypercholesterolemia, an autosomal\ndominant disorder in which mutation of the LDL receptor gene results in high\nLDL cholesterol levels. LDL cholesterol normally circulates in the body for 2.5\ndays, and subsequently binds to the LDL receptor on liver cells, undergoes\nendocytosis, and is digested. LDL is removed, and synthesis of cholesterol by\nthe liver is suppressed in the HMG-CoA reductase pathway. In familial hypercholesterolemia,\nLDL receptor function is reduced or absent, and LDL circulates for an average\nduration of 4.5 days, resulting in significantly increased level of LDL\ncholesterol in the blood (with normal levels of other lipoproteins). This\nincrease occurs because the enzyme, 3-hydroxy-3-methylglutaryl (HMG)-CoA\nreductase, which is involved in cholestrol synthesis, is not repressed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  [Repression\nof 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase is an effective means of\nlowering serum cholesterol levels. In fact, the most effective and commonly\nused cholesterol-lowering drugs are &ldquo;statins,&rdquo; or 3-hydroxy-3-methylglutaryl\n(HMG)-CoA reductase inhibitors.]\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  About 1 in\n500 persons carries a mutation for familial hypercholesterolemia. About 1 in 20\nsurvivors of a myocardial infarction is heterozygous for a mutation of this\ngene.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  There are several hundred\nknown mutations resulting in the phenotype.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Persons homozygous for mutations in the\nLDL receptor have total serum cholesterol levels around 2000 mg/dl and can have\nmyocardial infarctions as young as age 3 or 4.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A liver transplant results in\nnormalization of serum cholesterol levels since the transplanted liver has\nnormal cell surface expression of LDL particle receptors. HMG Co-A reductase\ninhibitors (so called &ldquo;statins&rdquo;) block the rate-limiting enzyme in cholesterol\nsynthesis, lowering LDL-cholesterol levels.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Physical\nfindings of familial hypercholesterolemia may include xanthelasmata and tendon\nxanthomas. Affected individuals develop premature vascular disease and have a\nfamily history of early atherosclerotic vascular disease.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347291\"\n o:spid=\"_x0000_i1126\" type=\"#_x0000_t75\" alt=\"Description: Xanthelasmata\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image399.jpg\" o:title=\"Xanthelasmata\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Xanthelasmata\" border=\"0\" height=\"128\" src=\"_%20Tutorials_files/image400.png\" v:shapes=\"Picture_x0020_347291\" width=\"230\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Xanthelasmata\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347290\"\n o:spid=\"_x0000_i1125\" type=\"#_x0000_t75\" alt=\"Description: image_gallery?img_id=1318242&amp;t=1222359119603\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image401.jpg\" o:title=\"image_gallery?img_id=1318242&amp;t=1222359119603\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: image_gallery?img_id=1318242&amp;t=1222359119603\" border=\"0\" height=\"121\" src=\"_%20Tutorials_files/image402.png\" v:shapes=\"Picture_x0020_347290\" width=\"152\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Tendon xanthomas (elbow)\n </span>\n</p>\n", "choices": ["A. Lipoprotein lipase", "B. ApoC2", "C. LDL receptor", "D. ARH", "E. ApoE"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n32-year-old man is referred for evaluation of uncontrolled hypertension. He was\nfirst told he had high blood pressure at age 25. He reports no symptoms except\ndry mouth after starting clonidine.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In the past he took a &ldquo;water pill,&rdquo; but it was discontinued because it\nlowered his serum potassium level. He is presently taking metoprolol 50 mg\ntwice daily, amlodipine 10 mg once daily, and clonidine 0.2 mg three times\ndaily. Arteriolar narrowing is seen on fundoscopic examination. Blood pressure\nis 175/95 mm Hg in both arms; pulse is 62/ minute. Blood pressure over the\nthighs is 185/108 mm Hg. There is no orthostatic drop in blood pressure with\nstanding.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Blood tests show a serum\nsodium level of 147 mEq/L (normal: 136-145 mEq/L) and a potassium level of 3.7\nmEq/L (normal: 3.5-5.0 mEq/L).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Blood is\ndrawn in the morning to measure the serum aldosterone level and plasma renin\nactivity, both before and after administration of a 25-mg dose of captopril.\nThe result shows suppressed plasma renin activity and a high serum aldosterone\nlevel. A diagnosis of primary hyperaldosteronism is made (Conn&rsquo;s syndrome). CT\nof the abdomen shows a 2-cm right adrenal adenoma. Adrenal venous sampling\ndemonstrates high levels of aldosterone emerging from the right adrenal gland.\nThe patient undergoes right adrenalectomy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  After surgery, the blood pressure falls to 135/78 mm Hg off all\nmedications. Plasma renin activity and aldosterone levels are found to be\nnormal when they are measured two months later.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What\nseries of pathophysiologic events led to the high serum sodium in this patient?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Increased extracellular volume,\nincreased cardiac output as described by the Starling curve, increased\nperfusion pressure in the kidneys, increased loss of both sodium and free water\nin the distal tubule, but relatively more water than sodium\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Vasodilatation, decreased effective\nblood volume, suppressed atrial natriuretic peptide, suppressed arginine\nvasopressin, increased resorption of sodium in the kidneys\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Increased extracellular volume,\nincreased atrial natriuretic peptide, suppressed arginine vasopressin, loss of\nfree water\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Decreased extracellular volume,\nincreased arginine vasopressin, loss of free water and sodium, but relatively\nmore free water loss\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Primary\nhyperaldosteronism is a relatively common cause of secondary hypertension. 8%\nto 12% of all persons with hypertension have primary hyperaldosteronism.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Most patients have bilateral\nhyperplasia, which is treated with anti-hypertensive medicines, including an\naldosterone blocker. Proper identification and treatment of these patients is\nimportant because without aldosterone blockade outcomes are worse (more\nmyocardial infarctions and strokes).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Adrenal adenomas producing aldosterone are generally treated by surgical\nremoval (as in the patient described).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Among patients with resistant hypertension (i.e., patients on at least 3\nmedications without adequate blood pressure control), primary\nhyperaldosteronism is especially common.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Screening\nfor primary hyperaldosteronism can be accomplished with paired serum\nmeasurements (in the morning) of plasma renin activity and serum aldosterone in\nthe morning. Aldosterone levels are high and plasma renin activity is\nsuppressed, even after administration of Captopril.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A common\nfinding in untreated primary hyperaldosteronism is mild hypernatremia. Patients\nhave increased intravascular volume (due to the effects of aldosterone), which\ncauses a rise in atrial natriuretic peptide levels. Arginine vasopressin levels\nare suppressed, which leads to free water loss and hypernatremia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Thus, these patients are &ldquo;dehydrated,&rdquo;\ndefined by an elevated sodium level, despite having increased extracellular\nvolume. This highlights the fact that dehydration and volume depletion are two\ndifferent things. Dehydration is the loss of free water from both the\nextracellular and intracellular spaces; serum sodium levels are increased.\nVolume depletion, by contrast, is a loss of salt (sodium) and water from the\nextracellular space; serum sodium levels may be low, normal, or high.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  The\npathophysiologic events leading to the high serum sodium are increased\nextracellular volume, increased atrial natriuretic peptide, suppressed arginine\nvasopressin, loss of free water.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n25-year-old woman presents with weakness and fatigue.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her delivery four months ago was\ncomplicated by postpartum hemorrhage and profound hypotension, requiring a\nblood transfusion of 4 units.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She\nhas been amenorrheic since the hemorrhage and has not been able to breastfeed\nher baby due to inadequate milk production. In which of the following hormones\nis she\n  <i>\n   least\n  </i>\n  likely to be deficient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Vasopressin, which is\nsecreted by the posterior pituitary, is usually preserved in Sheehan syndrome.\nThe posterior pituitary is a direct extension of the hypothalamus. Its blood\nsupply is less dependent on the portal vasculature. Diabetes insipidus usually\ndoes not occur in Sheehan syndrome.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Sheehan syndrome\n </span>\n <span>\n  ,\nalso known as\n  <span>\n   postpartum\nhypopituitarism\n  </span>\n  or\n  <span>\n   postpartum\npituitary necrosis\n  </span>\n  , is caused by blood loss and hypovolemic shock during\nand after childbirth.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  After a\nsevere postpartum hemorrhage with hypovolemia, the pituitary gland may become\nnecrotic. In normal uncomplicated pregnancies, the pituitary enlarges because\nof hyperplasia of the lactotrophs and is more sensitive to changes in blood\nflow. A sudden decrease in blood flow can lead to complete pituitary necrosis\nor partial necrosis with preservation of pituitary function.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In severe\ncases, extreme headache, nausea, and vomiting may occur and may be confused\nwith subarachnoid hemorrhage. If the blood supply to the pituitary is only\nmarginally affected, the patient may be relatively asymptomatic until some\nstress such as infection or surgery precipitates adrenal crisis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  An orderly\nprogression of events typically occurs in Sheehan syndrome. Initially,\nprolactin production decreases, causing failure to lactate. In most cases,\ngonadotropins (FSH and LH) are affected, leading to hypogonadism and menstrual\ndisturbance (typically, absent or infrequent menses). Vasomotor symptoms,\ndyspareunia, atrophic vaginitis, and osteopenia may result from estrogen\ndeficiency. Loss of pubic and axillary hair may be attributable to low androgen\nlevels. Fatigue and decreased muscle mass may result from decreased growth\nhormone levels.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Secondary\nadrenal insufficiency (which is associated with weakness, fatigue,\nhypoglycemia, and dizziness) should be suspected when cortisol and ACTH levels\nare low and fail to increase during an insulin tolerance test. Secondary\nhypothyroidism may result from TSH deficiency.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Prolactin", "B. Follicle-stimulating hormone (FSH)", "C. Vasopressin", "D. Adrenocorticotropic hormone (ACTH)", "E. Thyroid-stimulating hormone (TSH)"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 60-year-old man has tenderness in the\nregion distally between the tendons of the extensor pollicis longus and\nextensor pollicis brevis after falling on the palm of his right hand. A\nfracture of which of the following carpal bones is most likely in this patient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  This patient has\ntenderness over the anatomic snuffbox. Fracture of the scaphoid bone should be\nsuspected.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Fracture\nof the scaphoid bone (also called the navicular bone) is the most common type\nof wrist fracture. It usually causes pain, swelling, and tenderness at the base\nof the thumb and in the anatomic &ldquo;snuffbox.&rdquo;* It is diagnosed by X-ray;\nhowever, not all scaphoid fractures are apparent initially. Consequently,\npatients with snuffbox tenderness following wrist trauma are often casted for\n7&ndash;10 days, at which point a second set of X-rays is taken. The scaphoid\nhas its own blood flow unlike other carpal bones. It receives blood primarily\nfrom lateral and distal branches of the radial artery. If blood flow is\ndisrupted, the bone may not heal and surgery may be required.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347289\"\n o:spid=\"_x0000_i1124\" type=\"#_x0000_t75\" alt=\"Description: en_carpalbones2\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image403.png\" o:title=\"en_carpalbones2\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: en_carpalbones2\" border=\"0\" height=\"166\" src=\"_%20Tutorials_files/image404.png\" v:shapes=\"Picture_x0020_347289\" width=\"297\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Carpal bones\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347288\"\n o:spid=\"_x0000_i1123\" type=\"#_x0000_t75\" alt=\"Description: IMAGE002\">\n <v:imagedata src=\"_%20Tutorials_files/image405.jpg\" o:title=\"IMAGE002\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: IMAGE002\" border=\"0\" height=\"280\" src=\"_%20Tutorials_files/image406.png\" v:shapes=\"Picture_x0020_347288\" width=\"228\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Anatomical snuffbox\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347287\"\n o:spid=\"_x0000_i1122\" type=\"#_x0000_t75\" alt=\"Description: 230px-Scaphoid_waist_fracture\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image407.png\" o:title=\"230px-Scaphoid_waist_fracture\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 230px-Scaphoid_waist_fracture\" border=\"0\" height=\"218\" src=\"_%20Tutorials_files/image408.png\" v:shapes=\"Picture_x0020_347287\" width=\"175\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Scaphoid fracture\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  *The\n  <span>\n   anatomical snuffbox\n  </span>\n  is a triangular\ndeepening on the dorsoradial aspect of the hand. The scaphoid and trapezium\nbones form the floor of the snuffbox. The snuffbox is bounded by the extensor\npollicis longus on one side and the abductor pollicis longus and extensor\npollicis brevis on the other.\n </span>\n</p>\n", "choices": ["A. Hamate", "B. Lunate", "C. Scaphoid", "D. Trapezium", "E. Triquetrum"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n36-year-old woman presents to the physician with amenorrhea.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She reports an increase in her ring and\nshoe sizes over the past year, increase sweating, and increased fatigue.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Physical examination shows a blood\npressure of 150/90 mm Hg and coarse facial features with mild\nmacroglossia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Which of the\nfollowing is most appropriate for this patient?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Finasteride\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  B.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Leuprolide\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  C.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Octreotide\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Recombinant growth hormone\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  E.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Somatrem\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Acromegaly and\n  Gigantism\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P065015\">\n    </a>\n    <span>\n     In childhood, GH\n  hypersecretion leads to gigantism; in adults whose long bone epiphyses are\n  fused, GH excess causes acromegaly with local overgrowth of bone in the acral\n  areas. GH hypersecretion is almost always caused by a GH-secreting pituitary\n  adenoma. About 70% of patients with acromegaly have macroadenomas. Ectopic\n  GHRH secretion can occur with pancreatic islet cell tumors and bronchial or\n  intestinal carcinoids.\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"HC065010\">\n    </a>\n    <b>\n     <i>\n      <span>\n       Clinical\n  Features\n      </span>\n     </i>\n    </b>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P065016\">\n    </a>\n    <span>\n     The clinical features\n  of acromegaly are insidious, and it may take several years for the\n  disfiguring features to be diagnosed. The most classic clinical feature is\n  acral enlargement, exhibited as a widening of the hands and feet and a\n  coarsening of the facial features; the frontal sinuses enlarge, leading to\n  prominent supraorbital ridges, and the mandible grows downward and forward,\n  resulting in prognathism and wide spacing of the teeth. Ring, glove, and shoe\n  sizes increase as a result of soft tissue and bony enlargement of hands and\n  feet. The bony and soft tissue changes are accompanied by endocrine,\n  metabolic, and systemic manifestations.\n    </span>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Acromegaly\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n</table>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"90%\">\n  <tr>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.50\">\n     </a>\n     <b>\n      <span>\n       Change\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"bottom\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Manifestations\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.100\">\n     </a>\n     <b>\n      <span>\n       Somatic Changes\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.150\">\n     </a>\n     <span>\n      Acral changes\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Enlarged hands and feet\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"5\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.200\">\n     </a>\n     <span>\n      Musculoskeletal\n  changes\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Arthralgias\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.250\">\n     </a>\n     <span>\n      Prognathism\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.300\">\n     </a>\n     <span>\n      Malocclusion\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.350\">\n     </a>\n     <span>\n      Carpal tunnel syndrome\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.400\">\n     </a>\n     <span>\n      Proximal myopathy\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.450\">\n     </a>\n     <span>\n      Skin changes\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Sweating\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"2\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.500\">\n     </a>\n     <span>\n      Colon changes\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Polyps\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.550\">\n     </a>\n     <span>\n      Carcinoma\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"2\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.600\">\n     </a>\n     <span>\n      Cardiovascular\n  symptoms\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cardiomegaly\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.650\">\n     </a>\n     <span>\n      Hypertension\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"3\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.700\">\n     </a>\n     <span>\n      Visceromegaly\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Tongue\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.750\">\n     </a>\n     <span>\n      Thyroid\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.800\">\n     </a>\n     <span>\n      Liver\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.850\">\n     </a>\n     <b>\n      <span>\n       Endocrine-Metabolic\n  Changes\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"3\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.900\">\n     </a>\n     <span>\n      Reproduction\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Menstrual abnormalities\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.950\">\n     </a>\n     <span>\n      Galactorrhea\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.1000\">\n     </a>\n     <span>\n      Decreased libido\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td rowspan=\"2\" valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.1050\">\n     </a>\n     <span>\n      Carbohydrate\n  metabolism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Impaired glucose tolerance\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.1100\">\n     </a>\n     <span>\n      Diabetes mellitus\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <a name=\"T065003.1150\">\n     </a>\n     <span>\n      Lipids\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypertriglyceridemia\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P065017\">\n    </a>\n    <b>\n     <i>\n      <span>\n       Treatment\n      </span>\n     </i>\n    </b>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Trans-sphenoidal\n  microsurgery is the initial therapy of choice, resulting in rapid reduction\n  of GH levels with a low rate of surgical morbidity. Radiotherapy is an\n  effective method of reducing GH hypersecretion; however, it may take as long\n  as 20 years for GH levels to fall after radiotherapy, and the incidence of\n  hypopituitarism is high. Medical management involves the use of drugs that\n  decrease GH secretion from the pituitary tumor (somatostatin analogues,\n  dopamine agonists) or block the peripheral action of GH at the hepatic\n  receptor (GH receptor antagonists). Octreotide acetate, a long-acting\n  somatostatin analogue, is effective in reducing GH and IGF-I levels to normal\n  in 40% to 65% of patients and shrinks tumor mass in about 50% of cases. Side\n  effects of octreotide include diarrhea, abdominal cramps, flatulence, and\n  gallstone formation.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   The correct answer is C.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  This patient presents with acromegaly, the\nclinical syndrome that is a result of excessive growth hormone (GH) secretion\nin adults (after closure of the physes).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Octreotide is a somatostatin analog that acts at the anterior pituitary\nto suppress GH secretion, and is used in the treatment of acromegaly.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Surgical and radiotherapeutic approaches\nare also an option, depending on the etiology.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Somatostatin is normally secreted by the\nhypothalamus to help regulate basal GH secretion.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is Incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Finasteride is a 5-&alpha;-reductase\ninhibitor that suppresses the conversion of testosterone to dihydrotestosterone\nand is used in the treatment of benign prostatic hypertrophy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B in incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Leuprolide is a gonadotropin-releasing\nhormone analog that can exhibit both agonist and antagonist actions, depending\non the timing of administration.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It\nis used to treat infertility, prostate cancer, and uterine fibroids.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Adverse effects include antiandrogen\nactions (e.g., gynecomastia, decreased libido), nausea, and vomiting.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Like somatrem, recombinant GH is useful\nin the treatment of GH deficiency, but would exacerbate the condition of a\npatient with acromegaly.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Somatrem is a somatotropin, or GH\nanalog, that stimulates the release of somatomedin/insulin-like growth factor-l\nfrom the liver and is useful in the treatment of GH deficiency.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It would exacerbate the condition of a\npatient with acromegaly.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 14-year-old boy presents with complaints of right knee pain of\napproximately 2 months' duration. He remembers falling during soccer training 2\nmonths ago, but the trauma was not severe enough to seek medical attention.\nShortly afterward, he started having pain at night or after soccer practice.\nThe pain would initially subside with rest and over-the-counter medication.\nHowever, for the past 2 weeks the pain has increased in intensity, causing him\nto limp. His mother has noticed his right thigh is slightly larger than the\nleft. It is also warm and tender to touch. X-ray of the knee shows an\nosteolytic and osteoblastic tumor in the distal femur.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347255\"\n o:spid=\"_x0000_i1121\" type=\"#_x0000_t75\" alt=\"Description: http://www.cancerindex.org/images/osteosarcoam_radiograph.jpeg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image409.jpg\" o:title=\"//www.cancerindex.org/images/osteosarcoam_radiograph.jpeg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.cancerindex.org/images/osteosarcoam_radiograph.jpeg\" border=\"0\" height=\"283\" src=\"_%20Tutorials_files/image410.png\" v:shapes=\"Picture_x0020_347255\" width=\"237\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  A tumor with\nosteoblastic and osteolytic lesions near the knee of a teenager is most likely\nto be osteosarcoma.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Primary\nBone Tumors\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4377-1604-7..00208-6--s001\">\n </a>\n <span>\n  Primary\nbone malignancies are relatively uncommon tumors (0.2% of all neoplasms) that\narise from cells that are normal components of bone tissues and that have the\npotential to metastasize. Malignant tumors are to be distinguished from a\nvariety of more common benign bone lesions, such as osteochondromas and\nenchondromas, which lack the ability to metastasize.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Clinical Manifestations and\nDiagnosis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Patients with primary malignant and benign bone tumors\npresent with pain, swelling and occasionally pathologic fracture of the\ninvolved bone. If radiologic studies suggest a malignant primary bone tumor, an\northopedic oncologist should be consulted before carrying out a biopsy because\nimproper biopsy technique may compromise subsequent surgical care, particularly\nlimb-sparing surgery. Staging of patients with bone tumors generally requires\ncomputed tomography (CT) scans of the chest, abdomen, and pelvis to assess for\nmetastatic disease. Characterization of the primary bone tumor may benefit from\nmagnetic resonance imaging (MRI) assessment of soft tissue extension or CT scan\nassessment of cortical bone involvement, or both.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4377-1604-7..00208-6--s003\">\n </a>\n <a name=\"4-u1.0-B978-1-4377-1604-7..00208-6--st00\">\n </a>\n <b>\n  <span>\n   Osteosarcoma\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Osteosarcoma\n  </span>\n </i>\n <span>\n  &nbsp;is\nthe most common malignant sarcoma of bone, representing about 35% of cases. It\nhas a bimodal age distribution, with highest incidence in patients younger than\n20 years, most likely related to the normal rapid bone growth that occurs\nduring adolescence. In this age group, most tumors arise in the metaphyseal\nareas of the long bones of the extremities, particularly around the knee.\n </span>\n <span>\n  Over 90% of tumors are located in the metaphysis (the growing ends of\nthe bone) the most common sites are the bones around the knee which account for\n80% of cases.\n </span>\n <span>\n  Males are affected more commonly\nthan females at a ratio of 3:2. A second peak of incidence occurs in adults\nolder than 60 years. The sites of origin in these older patients are somewhat\nmore heterogeneous, with craniofacial and pelvic bones each accounting for 20%\nof tumors. Radiographically, osteosarcomas usually present as mixed\nosteoblastic and osteolytic lesions, although pure forms of either appearance\ncan occur. Periosteal elevation (Codman's triangle), cortical destruction, and\ntumor extension into soft tissue are common on plain films or MRI.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The incidence of osteosarcoma is increased in families that\ncarry germline deletion of retinoblastoma (\n  <i>\n   Rb\n  </i>\n  ),&nbsp;\n  <i>\n   p53\n  </i>\n  &nbsp;(Li-Fraumeni),\nor&nbsp;\n  <i>\n   RecQ\n  </i>\n  &nbsp;DNA helicase genes. Consistent with these\nobservations, although most younger patients with osteosarcomas have no\napparent predisposing factor or family history of bone tumors, alterations in\nthe&nbsp;\n  <i>\n   p53\n  </i>\n  &nbsp;and&nbsp;\n  <i>\n   Rb\n  </i>\n  &nbsp;genes of such sporadic tumors\noccur in 40% and 60%, respectively. In older patients, a variety of conditions\nmay predispose patients to osteosarcoma, most convincingly antecedent Paget's\ndisease or prior radiation therapy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Chondrosarcoma\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Chondrosarcoma\n  </span>\n </i>\n <span>\n  , a\nmalignant tumor characterized by hyaline cartilage differentiation, is the\nsecond most common sarcoma of bone, representing 25% of bone sarcomas. The peak\nincidence is in the fifth to seventh decades of life. The most common primary\nsites are in the pelvis, proximal femur, and proximal humerus. Patients present\nwith long-standing complaints of swelling, pain, or both. Radiographically,\nchondrosarcoma is detected as an area of radiolucency with variable punctate\nmineralization, with frequent cortical bone erosion or thickening, sometimes\nwith extension into adjacent soft tissue. Distinguishing low-grade\nchondrosarcomas from benign central enchondromas can be difficult. Location in\nthe axial skeleton and size greater than 5&nbsp;cm favor malignancy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Ewing's Sarcoma\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Ewing's sarcoma and primitive neuroectodermal tumor (PNET)\nare a family of small round cell sarcomas that represent 16% of primary bone\nsarcomas. As with osteosarcoma, the peak incidence occurs during the second\ndecade of life, but unlike osteosarcoma, the incidence of Ewing's is unimodal,\nbeing distinctly unusual in older adults and in nonwhites. Ewing's sarcoma\ntends to arise in the diaphyseal region of long bones, in the pelvis, or in\nribs. Ewing's tumors are characterized radiologically by a permeative or\n&ldquo;moth-eaten&rdquo; appearance of the affected bone, with a multilayered &ldquo;onion-skin&rdquo;\nperiosteal reaction. MRI studies frequently document a significant soft tissue\nmass associated with the bone lesion. Unlike other sarcomas of bone, Ewing's\nsarcoma may present with symptoms of an inflammatory systemic illness, with\nintermittent fevers, anemia, leukocytosis, and an increased sedimentation rate.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Metastatic Tumors\nto Bone\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Tumors metastatic to bone are important\ncauses of cancer-related morbidity. Effective prevention and treatment of\nskeleton-related metastases are an important part of clinical care for many\ncancer patients. The most common tumors to metastasize to bone are breast in\nwomen and prostate in men, followed by lung, kidney, gastrointestinal tract,\nand thyroid.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Bone metastases typically present as\nlocalized or referred pain and less commonly as a fracture. Plain radiographs\nmay demonstrate blastic or lytic lesions. Although prostate cancer is generally\nblastic and multiple myeloma usually lytic, most other tumors have a mixed\nappearance. In patients with one documented bone metastasis or in patients with\nwidely metastatic disease and bone pain, a radiologic survey can identify bone\nmetastases that may ultimately place the patient at risk for a pathologic\nfracture. Technetium diphosphonate bone scans are useful to delineate the extent\nof bony metastases and in following response to therapy. However, a negative\nstudy must be interpreted cautiously for tumors that are potentially purely\nlytic because these may be undetectable by bone scan. In such tumors (e.g.,\nmultiple myeloma), a skeletal survey is therefore preferable. Routine screening\nfor bone metastases is not indicated for cancer patients with no symptoms or\nsigns of bone involvement.\n </span>\n</p>\n", "choices": ["A. Chondrosarcoma", "B. Ewing\u2019s sarcoma", "C. Metastasis to bone", "D. Osteochondroma", "E. Osteosarcoma"]}]}, {"section": "Blood & Vascular", "questions": [{"question": "<p class=\"MsoNormal\">\n <span>\n  An\n80-year-old woman has fatigue and shortness of breath. Physical examination is\nnormal. A chest radiograph is normal. Laboratory tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  8 g/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hematocrit\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  25%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mean\ncorpuscular volume (MCV)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  72&micro;m\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is the most likely cause of her condition?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . The patient in this\nvignette has a microcytic anemia (MCV= 70). Microcytic anemia in an older\nperson should raise concern for iron deficiency resulting from occult\ngastrointestinal bleeding. This patient should be tested for iron deficiency\nand undergo workup for occult gastrointestinal bleeding. Typical laboratory\nfindings in iron deficiency anemia include low serum iron level, high total\niron-binding capacity (TIBC), low transferrin saturation level (&lt;10%), and\nlow serum ferritin level (&lt;12ng/ml).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  &beta;-thallasemia minor usually\npresents as an asymptomatic, mild microcytic anemia.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Hemolysis results in a normocytic or macrocytic\nanemia. (Hemolysis is accompanied by reticulocytosis, and reticulocytes are\nlarger than mature red blood cells.)\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Folic acid deficiency results in a macrocytic\nanemia.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Pernicious anemia, which is due to\nvitamin B\n  <sub>\n   12\n  </sub>\n  deficiency, is a type of macrocytic anemia.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Anemia\n  </span>\n </b>\n <span>\n  , a reduction in red blood cell mass, may\nreflect decreased production of erythrocytes, either because of primary\nhematological disease or in response to systemic illness, or it may reflect increased\ncell turnover from hemolysis. Symptoms reflect the speed with which the red\nblood cell mass has declined. Patients with acute hemorrhage or massive\nhemolysis may present with hypovolemic shock. Patients who develop anemia\nslowly, however, may have few symptoms. Symptoms may include fatigue,\npalpitations, shortness of breath, and decreased exercise tolerance. Physical\nfindings in patients with anemia may include pallor, tachycardia, and heart\nmurmur. Jaundice and splenomegaly may be seen in patients with hemolysis. The\nmean corpuscular volume (MCV) is a helpful tool in the diagnosis of anemia.\nUsing the MCV, anemia can be classified as microcytic, normocytic, and\nmacrocytic. The differential diagnosis of anemia based on MCV appears below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"232\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Differential\n  Diagnosis of Anemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"232\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"232\">\n    <p class=\"MsoNormal\">\n     <span>\n      Microcytic (MCV &lt; 80)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Iron deficiency\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Thalassemia minor\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Sideroblastic anemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Lead poisoning\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"232\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normocytic\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      (MCV 80-100)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Early iron\n  deficiency\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Anemia of chronic\n  disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Chronic renal\n  failure\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Hemolysis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Aplastic anemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Myelophthisic\n  disorder\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Mixed nutritional\n  disorder (iron and B12\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      deficiency)\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"232\">\n    <p class=\"MsoNormal\">\n     <span>\n      Macrocytic (MCV &gt;100)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Megaloblastic\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Folate deficiency\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Vitamin B\n      <sub>\n       12\n      </sub>\n      deficiency\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Drug-induced megaloblastosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Non-megaloblastic\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Liver disease\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Hypothyroidism\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Hemolysis (with brisk reticulocytosis)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Iron\ndeficiency is the leading cause of anemia worldwide.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Early iron deficiency presents as a\nnormocytic anemia. Late iron deficiency presents as a microcytic anemia. The\nmost frequent cause of iron deficiency is occult blood loss. All men and\npostmenopausal women who are found to be iron deficient should be evaluated for\na source of gastrointestinal bleeding, regardless of whether occult blood is\nfound in the stool. In premenopausal women, iron deficiency is usually due to\nmenstruation or pregnancy. Dietary deficiency of iron is most commonly seen in\nyoung children whose growth outstrips their intake of iron, or in babies who\ndrink mostly milk at the expense of iron-containing food.\n </span>\n</p>\n", "choices": ["A. Chronic blood loss", "B. \u03b2-thallasemia minor", "C. Acquired hemolytic anemia", "D. Folic acid deficiency", "E. Pernicious anemia"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n65-year-old woman with mitral stenosis develops atrial fibrillation. Which of\nthe following drugs is most appropriate for long-term prevention of stroke?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  Warfarin is used for\nchronic anti-coagulation of patients with atrial fibrillation who are at\nhigh-risk of stoke, such as persons with mitral stenosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Atrial\nfibrillation predisposes to thrombus formation, which can lead to embolization.\nEmbolization to the cerebral arteries causes stroke.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Warfarin\n  </span>\n </b>\n <span>\n  , which inhibits gamma-carboxylation of vitamin\nK-dependent clotting factors, is used for chronic anti-coagulation of patients\nwith atrial fibrillation who are at high-risk of stoke. High-risk patients\ninclude those with valvular heart disease (e.g., rheumatic heart disease,\nprosthetic heart valve) and those with two or more CHADS criteria. (CHADS is an\nacronym for congestive heart failure, hypertension, age &gt; 75 years, diabetes\nmellitus, and stroke history). The patient described above is at high risk for\nstroke because of mitral stenosis and should be anticoagulated with warfarin.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Aspirin\n  </span>\n </b>\n <span>\n  irreversibly inhibits cyclo-oxygenase, which\nprevents conversion of arachadonic acid to prostaglandins. This inhibits\nplatelet aggregation. Aspirin is used in low-risk patients with atrial\nfibrillation. Low-risk patients are those with normal valves who meet fewer\nthan two of the CHADS criteria. The patient described above is at high risk for\nstroke and should be treated with warfarin.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Unfractionated\n  <b>\n   heparin\n  </b>\n  , a parenteral anticoagulant\nthat potentiates antithrombin III, is typically used for short-term\nanti-coagulation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Streptokinase\n  </span>\n </b>\n <span>\n  is a thrombolytic agent that breaks down\nexisting clots. In the setting of acute myocardial infarction, it is used to\nlyse the thrombus that forms after plaque rupture in a coronary artery.\n </span>\n</p>\n", "choices": ["A. Aspirin", "B. Heparin, unfractionated", "C. Warfarin", "D. Streptokinase"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  An 18-year-old woman injured her left knee while\nplaying basketball. She is scheduled for arthroscopic knee surgery.\nPreoperative laboratory tests show a platelet count of 268,000/mm\n  <sup>\n   3\n  </sup>\n  ,\nan INR of 1.0, and an activated partial thromboplastin time (aPTT) of 67\nseconds (normal: 25-40 seconds). When she was five years old, her tonsils were\nremoved without excessive bleeding. Several years later, four wisdom teeth were\npulled without significant bleeding. She has no history of heavy menstrual flow\nand she has never been anemic. Her family history is negative for bleeding\ndisorders. The orthopedic surgeon is concerned about her lab test results and\nasks for advice. What is the most appropriate response?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct\n  </span>\n </b>\n <span>\n  .\nA prolonged aPTT can result from a deficiency of clotting factors VIII, IX, XI,\nor XII. If one of these factors is deficient, mixing the patient&rsquo;s blood with\nnormal plasma will return the aPTT to normal. If, instead, the blood contains\nan antiphospholipid antibody (e.g., lupus anticoagulant), mixing will\n  <i>\n   not\n  </i>\n  return the aPTT to normal. (The aPTT will remain high). Lupus anticoagulant is\nan antiphospholipid antibody that may be present in healthy individuals.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   In vivo\n  </i>\n  , it interacts with\nplatelet membrane phospholipids, increasing adhesion and aggregation of\nplatelets. Thus, lupus anticoagulant is not really an anticoagulant. It is\n  <i>\n   prothrombotic\n  </i>\n  .\nIt is called &ldquo;anti-coagulant&rdquo; because,\n  <i>\n   in vitro\n  </i>\n  , it inhibits lipids in\nthe aPTT assay, causing prolongation of the aPTT. (The term &ldquo;anticoagulant&rdquo; is\na misnomer.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Lupus anticoagulant\nand heparin have the same effect on aPTT: They prolong it. But heparin is a\nreal anticoagulant, whereas lupus anticoagulant is a prothrombotic agent. If\nthe patient in this vignette has a mixing study and the aPTT does not\nnormalize, we assume that lupus anticoagulant is present and that there is no\nincreased risk of bleeding during surgery. If the aPTT normalizes with mixing,\nfactor deficiency should be assumed and surgery should be postponed.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nHemophilia occurs almost exclusively in males because it is an X-linked\ndisorder. Women who carry hemophilia trait can have low levels of factor VIII,\na prolonged aPTT, and a bleeding diathesis. The patient in this vignette has no\nfamily history of male &ldquo;bleeding&rdquo; to suggest hemophilia. Had there been a\nfamily history of bleeding, testing would still be needed to determine the\nexact cause.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect.\n  </span>\n </b>\n <span>\n  Insufficient\nblood in the citrate-containing tube can prolong the aPTT, but other\nexplanations must be considered.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpFirst\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Surreptitious\ninjection of heparin will elevate the aPTT, but other explanations must be\nconsidered. Note: Heparin works by activating antithrombin III, which then\ninactivates thrombin and other proteases involved in blood clotting, most\nnotably factor Xa.\n </span>\n</p>\n"], "tutorial": "<p>\n <b>\n  Coagulation Tests\n </b>\n</p>\n\n<p>\n The activated partial\nthromboplastin time (aPTT) assesses the &ldquo;intrinsic&rdquo; and common coagulation\npathways. The prothrombin time (PT) assesses the &ldquo;extrinsic&rdquo; pathway. A normal\naPTT requires the presence of the following coagulation factors: I, II, V, VIII,\nIX, X, XI, &amp; XII. A prolonged aPTT indicates heparin use, coagulation\nfactor deficiency (e.g. hemophilia), or the presence of antiphospholipid\nantibody (especially lupus anticoagulant, which paradoxically\n <i>\n  increases\n </i>\n the propensity for thrombosis).\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Causes\n  of Increased aPTT\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Heparin\n  use\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Coagulation\n  factor deficiency\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"154\">\n    <p class=\"MsoNormal\">\n     <span>\n      Antiphospholipid\n  antibody\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n To distinguish these, mixing\ntests are performed in which the patient's plasma is mixed (at a 50:50\ndilution) with normal plasma. If the aPTT remains abnormal, the patient&rsquo;s\nplasma is said to contain an \"inhibitor\" (heparin, antiphospholipid\nantibodies, or coagulation factor-specific inhibitors). If the aPTT returns to\nnormal, factor deficiency is more likely. Deficiencies of factors VIII, IX, XI\nand XII can cause a prolonged aPTT, which will return to normal upon &ldquo;mixing.&rdquo;\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"160\">\n    <p align=\"center\">\n     Disorder\n    </p>\n   </td>\n   <td valign=\"top\" width=\"151\">\n    <p align=\"center\">\n     Results of Mixing Study\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"160\">\n    <p>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"151\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"160\">\n    <p>\n     Coagulation factor\n  deficiency (usually Factor VIII, IX, XI or XII)\n    </p>\n   </td>\n   <td valign=\"top\" width=\"151\">\n    <p>\n     aPTT normalizes\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"160\">\n    <p>\n     Antiphospholipid antibody\n    </p>\n   </td>\n   <td valign=\"top\" width=\"151\">\n    <p>\n     aPTT does not normalize\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"160\">\n    <p>\n     Heparin use\n    </p>\n   </td>\n   <td valign=\"top\" width=\"151\">\n    <p>\n     aPTT does not normalize\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"160\">\n    <p>\n     Coagulation\n  factor-specific inhibitor\n    </p>\n   </td>\n   <td valign=\"top\" width=\"151\">\n    <p>\n     aPTT does not normalize\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347357\"\n o:spid=\"_x0000_i1118\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image427.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"502\" src=\"_%20Tutorials_files/image428.png\" v:shapes=\"Picture_x0020_347357\" width=\"393\"/>\n </span>\n</p>\n", "choices": ["A. Explain that the patient is a hemophilia carrier, has a deficiency of factor VIII, and will need an infusion of factor VIII before surgery.", "B. Explain that the aPTT is high because not enough blood was collected in the citrate-containing vacuum tube (laboratory error).", "C. Ask the laboratory to mix the woman\u2019s plasma with normal plasma (50-50 mixing study) and re-measure the aPTT.", "D. Tell the surgeon that the patient has been surreptitiously injecting heparin."]}, {"question": "<p>\n <span>\n  A 1-day-old neonate has hemolytic disease of\nthe newborn. Both parents are Rh-positive. IgG isohemagglutinins are found in\nthe mother's blood. Which of the following parental blood types is most likely?\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Mother\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Father\n  </span>\n </b>\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct.\n </b>\n Hemolytic disease of the newborn\n(erythroblastosis fetalis) occurs when IgG antibodies from the mother cross the\nplacenta and attack red blood cells of the fetus or newborn. The condition may\nbe caused by ABO or Rh incompatibility between mother and child. In this case,\nwe are told that the mother is Rh positive; therefore, hemolysis is not caused\nby Rh incompatibility. (For hemolysis to be due to Rh incompatibility the\nmother would have to be Rh negative and the child Rh positive.) Rather,\nhemolysis must be due to ABO incompatibility. Most antibodies directed against\nABO antigens are of the IgM class and do not cross the placenta. However,\nindividuals with type O blood group can produce IgG antibodies that cross the\nplacenta and cause hemolysis. &ldquo;E&rdquo; is the correct answer because the mother in\n&ldquo;E&rdquo; has type O blood group. She most likely has IgG antibodies against A and B,\nwhich can cross the placenta.\n</p>\n"], "tutorial": "<p>\n <span>\n  The\n  <b>\n   ABO antigens\n  </b>\n  are carbohydrates\nlinked to cell surface proteins and lipids. They are synthesized by polymorphic\nglycosyltransferase enzymes, which vary in activity depending on the inherited\nallele\n </span>\n . The ABO antigens were the first alloantigen system to be defined\nin mammals.\n</p>\n\n<p>\n All normal individuals\nsynthesize the O antigen, which is attached to plasma membrane proteins. Most\nindividuals possess a fucosyltransferase that adds a fucose moiety to the O\nantigen, resulting in an H antigen. A single gene on chromosome 9 encodes a\nglycosyltransferase enzyme, which further modifies the H antigen. There are\nthree allelic variants of this gene. The O allele gene product is devoid of\nenzymatic activity. The A allele-encoded enzyme transfers a terminal\n <span>\n  N\n </span>\n -acetylgalactosamine moiety, and the\nB allele gene product transfers a terminal galactose moiety.\n</p>\n\n<p>\n Individuals who are\nhomozygous for the O allele cannot attach terminal sugars to the H antigen and\nexpress only the H antigen. In contrast, individuals who possess an A allele\n(AA homozygotes, AO heterozygotes, or AB heterozygotes) form the A antigen by\nadding terminal\n <span>\n  N\n </span>\n -acetylgalactosamine\nto some of their H antigens. Similarly, individuals who express a B allele (BB\nhomozygotes, BO heterozygotes, or AB heterozygotes) form the B antigen by\nadding terminal galactose to some of their H antigens. AB heterozygotes form\nboth A and B antigens from some of their H antigens. The terminology has been\nsimplified so that OO individuals are said to be blood type O; AA and AO\nindividuals are blood type A; BB and BO individuals are blood type B; and AB\nindividuals are blood type AB.\n</p>\n\n<p>\n <span>\n  Individuals who express a particular ABO\nantigen are tolerant to that antigen, but individuals who do not express that\nantigen produce natural antibodies that recognize the antigen.\n </span>\n Individuals who express A or B antigens are tolerant to these molecules and do\nnot produce anti-A or anti-B antibodies, respectively. However, bacteria\npresent in the GI tract contain antigens similar to the A and B blood group\nantigens, therefore blood group O and A individuals produce anti-B IgM\nantibodies, and blood group O and B individuals produce anti-A IgM antibodies.\n</p>\n\n<p>\n <span>\n  In clinical transfusion, the choice of blood\ndonors for a particular recipient is based on the expression of blood group\nantigens and the antibody responses to them.\n </span>\n If a patient receives a\ntransfusion of red blood cells from a donor who expresses the antigen not\nexpressed on self red blood cells, a transfusion reaction may result. It\nfollows that AB individuals can tolerate transfusions from all potential donors\nand are therefore called universal recipients; similarly, O individuals can\ntolerate transfusions only from O donors but can provide blood to all\nrecipients and are therefore called universal donors. In general, differences\nin\n <i>\n  minor\n </i>\n blood groups lead to red\ncell lysis only after repeated transfusions trigger a secondary antibody\nresponse.\n</p>\n\n<p>\n ABO antigens are expressed\non many other cell types in addition to blood cells, including endothelial\ncells. For this reason, ABO typing is critical to avoid hyperacute rejection of\ncertain solid organ allografts. ABO incompatibility between mother and fetus\ngenerally does not cause problems for the fetus because most of the\nanti-carbohydrate antibodies are IgM and do not cross the placenta. Individuals\nwith blood group O, however, can produce IgG antibodies against A and B\nantigens, which can cross the placenta and can cause intrauterine hemolysis in\nthe fetus, although clinically significant hemolysis related to ABO\nincompatibility is rare.\n</p>\n\n<p>\n The\n <b>\n  Rhesus (Rh) antigens\n </b>\n , named after the monkey species in which they\nwere originally identified, are another clinically important group of blood\ngroup antigens. Rh proteins are encoded by two tightly linked genes, but only\none of them, called RhD, is commonly considered in clinical blood typing. This\nis because up to 15% of the population has an alteration of the RhD allele.\nThese people, called Rh negative, are not tolerant to the RhD antigen and will\nmake antibodies to the antigen if they are exposed to Rh-positive blood cells.\n</p>\n\n<p>\n The major clinical\nsignificance of anti-Rh antibodies is related to hemolytic reactions associated\nwith pregnancy that are similar to transfusion reactions. Rh-negative mothers\ncarrying an Rh-positive fetus can be sensitized by fetal red blood cells that\nenter the maternal circulation, usually during childbirth. Since the Rh antigen\nis a protein, as opposed to the carbohydrate ABO antigens, class-switched IgG\nantibodies are generated in Rh-negative mothers. Subsequent pregnancies in\nwhich the fetus is Rh positive are at risk because the maternal anti-Rh IgG\nantibodies can cross the placenta and mediate the destruction of the fetal red\nblood cells. This causes\n <span>\n  erythroblastosis\nfetalis\n </span>\n (hemolytic disease of the newborn) and can be lethal for the\nfetus.\n</p>\n\n<p>\n Rh alloimmunization in\nRh-negative women can be prevented by administration of anti-RhD antibodies to\nthe mother at 28 weeks of gestation, after amniocentesis or chorionic villus\nsampling, after vaginal bleeding or within 72 hours of birth of an Rh-positive\nbaby. The treatment prevents the baby's Rh-positive red blood cells that\nentered the mother's circulation from inducing the production of anti-Rh\nantibodies in the mother. The exact mechanism of action of the administered\nantibodies is not clear.\n</p>\n", "choices": ["A. A   O", "B. AB   O", "C. B   A", "D. B   O", "E. O   AB"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 60-year-old woman with polycythemia vera\npresents with 3-day history of progressive abdominal pain and distension. She\ndoes not consume alcoholic beverages and has no risk factors for viral\nhepatitis. Physical examination shows tender hepatomegaly and severe ascites.\nLiver enzymes are moderately elevated. Which one of the following diagnostic\ntests would be most helpful?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Hepatic vein\nthrombosis (Budd-Chiari syndrome) should be suspected in a patient with\npolycythemia vera who develops abdominal pain and distension, tender\nhepatomegaly, and ascites. Hepatic venography is the best test for diagnosing\nhepatic vein occlusion.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  An\n  <span>\n   octreotide\n   <b>\n   </b>\n   scan\n   <b>\n   </b>\n  </span>\n  is a\ntype of nuclear scan used to find carcinoid and other tumors. Octreotide, a\ndrug similar to somatostatin, is radiolabeled with indium-111. After injection\ninto a vein, it travels through the bloodstream and attaches to tumor cells\nthat have receptors for somatostatin.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Serum ferritin levels are high in patients with\nhemochromatosis.\n </span>\n</p>\n", "<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer D is\nincorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Serum alpha-fetoprotein\nlevels are elevated in patients with hepatocellular carcinoma.\n  <b>\n  </b>\n </span>\n</p>\n", "<p>\n <b>\n  Answer E is incorrect.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </b>\n Endoscopic\nretrograde cholangiopancreatography (ERCP) is a technique that combines the use\nof endoscopy and fluoroscopy to diagnose and treat certain problems of the\nbiliary or pancreatic ductal systems. Through the endoscope, the physician can\nsee the inside of the stomach and duodenum and inject dyes into the ducts in\nthe biliary tree and pancreas so they can be seen on x-rays. ERCP is used primarily\nto diagnose and treat conditions of the bile ducts, including gallstones,\ninflammatory strictures (scars), leaks (from trauma and surgery), and cancer.\nERCP can be performed for diagnostic and therapeutic reasons, although the\ndevelopment of safer and relatively non-invasive investigations such as\nmagnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound\nhas meant that ERCP is now rarely performed without therapeutic intent.\n</p>\n"], "tutorial": "<p>\n <b>\n  Budd-Chiari syndrome\n </b>\n (hepatic vein obstruction)\n <span>\n  prevents blood from flowing out of the liver and back to\nthe heart. The blockage can cause liver damage\n </span>\n . Findings include\nvomiting, tender hepatomegaly, a\n <span>\n  bdominal swelling,\nelevated liver enzymes, and jaundice. The condition occurs is a\n </span>\n number\nof thrombogenic disorders. Listed in decreasing order of frequency, they are:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Polycythemia vera\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Pregnancy\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Post-partum state\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Oral contraceptive use\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Paroxysmal nocturnal\nhemoglobinuria\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hepatocellular carcinoma\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  Hepatic venography is the best test for\ndiagnosing hepatic vein occlusion.\n </span>\n</p>\n", "choices": ["A. Octreotide scan", "B. Hepatic venography", "C. Serum ferritin", "D. Serum alpha-fetoprotein", "E. Endoscopic retrograde cholangiopancreatography (ERCP)"]}, {"question": "<p>\n <span>\n  A 53-year-old woman with cancer is being treated with a hematopoietic\ngrowth factor. Leukocyte differentials before and after treatment are shown:\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p>\n     <span>\n      Before treatment\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p>\n     <span>\n      After treatment\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p>\n     <span>\n      Leukocyte count\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p>\n     <span>\n      1,000/mm\n      <sup>\n       3\n      </sup>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p>\n     <span>\n      10,000/mm\n      <sup>\n       3\n      </sup>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Eosinophils\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      1%\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      1%\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Lymphocytes\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      90%\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      9%\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"95\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      Neutrophils\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"99\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      9%\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"90\">\n    <p>\n     <span>\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n      90%\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n <span>\n  The growth factor is most likely to be which of the following?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct\n </b>\n . Granulocyte colony-stimulating factor is used\nin cancer patients who have become neutropenic from chemotherapy. It stimulates\nhematopoietic stem cells to proliferate and differentiate into granulocytes,\nprincipally neutrophils. The result is an increase in the white blood cell\ncount and an increase in the number and proportion of neutrophils.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect\n </b>\n . Macrophage colony-stimulating factor\nstimulates stem cells to proliferate and differentiate into macrophages.\n</p>\n", "<p>\n <b>\n  Answers C, D, E, and F are incorrect\n </b>\n . Interleukins 1, 6, 12, and 17\nare important cytokine mediators of acute and chronic inflammation, as shown\nbelow.\n</p>\n"], "tutorial": "<p>\n <b>\n  Colony-stimulating\nfactors\n </b>\n <b>\n  (CSFs)\n </b>\n are glycoproteins\nthat stimulate hemopoietic stem cells to proliferate and differentiate into\nspecific kinds of blood cells (usually white blood cells). CSFs can be\nsynthesized and administered exogenously, although exogeous molecules differ\nslightly from their endogenous counterparts because the latter undergo\nposttranslational modification.\n</p>\n\n<p>\n The term\n\"colony-stimulating factor\" refers to the method of discovery.\nHemopoietic stem cells are cultured on a matrix that prevents cells from\nmoving, so that if a single cell starts to proliferate all cells derived from\nit remain clustered around it. These cells, originating from a common\nprecursor, are called &ldquo;colonies.&rdquo; By adding various substances to cultures of\nhemopoietic stem cells, it is possible to determine which colonies are\nstimulated by these substances.\n</p>\n\n<p>\n The substance that\nstimulates formation of colonies of macrophages is called macrophage\ncolony-stimulating factor. The substance that stimulates formation of colonies\nof granulocytes is called granulocyte colony-stimulating factor.\n</p>\n\n<p>\n The principal\ncolony-stimulating factors are:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Granulocyte\ncolony-stimulating factors (G-CSF)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Macrophage\ncolony-stimulating factor\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Granulocyte macrophage\ncolony-stimulating factors (GM-CSF)\n </span>\n</p>\n\n<p>\n <span>\n  Granulocyte\ncolony-stimulating factor\n </span>\n (G-CSF) stimulates stems cells to proliferate\nand differentiate into mature granulocytes (principally neutrophils). It also\nmobilizes stem cells, sending them from the bone marrow into the bloodstream.\n</p>\n\n<p>\n In oncology and hematology,\na recombinant form of G-CSF is used in certain cancer patients to accelerate\nrecovery from neutropenia after chemotherapy, allowing higher-intensity\ntreatment regimens. (Chemotherapy can cause myelosuppression and unacceptably\nlow levels of white blood cells, making patients prone to infections.) G-CSF is\nalso used to increase the number of hematopoietic stem cells in the blood of a\nstem cell donor, and may be given to stem-cell receivers to compensate for\n&ldquo;conditioning&rdquo; regimens (chemotherapy or irradiation given before transplantation).\n</p>\n", "choices": ["A. Granulocyte colony-stimulating factor", "B. Macrophage colony-stimulating factor", "C. Interleukin 1", "D. Interleukin 6", "E. Interleukin 12", "F. Interleukin 17"]}, {"question": "<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <thead>\n   <tr>\n    <td valign=\"bottom\">\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n        Cytokine\n       </span>\n      </b>\n     </p>\n    </td>\n    <td valign=\"bottom\">\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n        Principal\n   Sources\n       </span>\n      </b>\n     </p>\n    </td>\n    <td valign=\"bottom\" width=\"138\">\n     <p align=\"center\" class=\"MsoNormal\">\n      <b>\n       <span>\n        Principal\n   Actions in Inflammation\n       </span>\n      </b>\n     </p>\n    </td>\n   </tr>\n  </thead>\n  <tr>\n   <td colspan=\"3\" valign=\"top\" width=\"380\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       ACUTE\n  INFLAMMATION\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      TNF\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"178\">\n    <p class=\"MsoNormal\">\n     <span>\n      Macrophages, mast cells,\n  T lymphocytes\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"138\">\n    <p class=\"MsoNormal\">\n     <span>\n      Stimulates expression of\n  endothelial adhesion molecules and secretion of other cytokines; systemic\n  effects\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      IL-1\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"178\">\n    <p class=\"MsoNormal\">\n     <span>\n      Macrophages, endothelial\n  cells, some epithelial cells\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"138\">\n    <p class=\"MsoNormal\">\n     <span>\n      Similar to TNF; greater\n  role in fever\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      IL-6\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"178\">\n    <p class=\"MsoNormal\">\n     <span>\n      Macrophages, other cells\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"138\">\n    <p class=\"MsoNormal\">\n     <span>\n      Systemic effects\n  (acute-phase response)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Chemokines\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"178\">\n    <p class=\"MsoNormal\">\n     <span>\n      Macrophages, endothelial\n  cells, T lymphocytes, mast cells, other cell types\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"138\">\n    <p class=\"MsoNormal\">\n     <span>\n      Recruitment of leukocytes\n  to sites of inflammation; migration of cells to normal tissues\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"3\" valign=\"top\" width=\"380\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       CHRONIC\n  INFLAMMATION\n      </span>\n     </b>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      IL-12\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      Dendritic cells,\n  macrophages\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"138\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increased production of\n  IFN-&gamma;\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      IFN-&gamma;\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      T lymphocytes, NK cells\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"138\">\n    <p class=\"MsoNormal\">\n     <span>\n      Activation of macrophages\n  (increased ability to kill microbes and tumor cells)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      IL-17\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      T lymphocytes\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"138\">\n    <p class=\"MsoNormal\">\n     <span>\n      Recruitment of\n  neutrophils and monocytes\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p align=\"center\">\n TNF=\ntumor necrosis factor; IL = interleukin; IFN = interferon\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n55-year-old woman presents with a 1-month history of right leg swelling. Her\nmedical history is significant for ovarian cancer for which she underwent radical\nhysterectomy and chemotherapy. Physical examination reveals edema of the right\nlower extremity with induration of the overlying skin. Which of the following\nis the most likely cause of edema?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Lymphedema should be\nconsidered in a patient who has undergone regional lymph node resection and who\npresents with localized swelling of the corresponding extremity. Lymphedema is\nusually non-pitting and may appear months or years after lymph node resection.\nThe overlying skin may be indurated.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Increased, not\ndecreased, capillary hydrostatic pressure causes edema in congestive heart\nfailure and venous stasis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Decreased, not\nincreased, capillary oncotic pressure causes edema in cirrhosis and nephrotic\nsyndrome.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Increased, not\ndecreased, capillary permeability causes edema in allergic reactions and burns.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Edema\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Several\nfactors determine whether fluid will be filtered or reabsorbed in a capillary\nbed.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Capillary hydrostatic\npressure tends to produce filtration since a higher pressure in the capillary\nwill force more fluid to leave the capillary.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Interstitial fluid\nhydrostatic pressure will have the opposite effect since higher pressure in the\ninterstitium will force fluid to move from the interstitium into the capillary.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The net\nosmotic pressure in capillaries, also termed oncotic pressure, is primarily\ncreated by the presence of the non-diffusible protein albumin. It is important\nto realize, though, that the total osmotic pressure in the capillary is created\nmainly by electrolytes because their concentration is far higher than the\nconcentration of albumin. The reason electrolytes are not important for fluid\ntransport across a capillary is that the electrolyte concentrations are similar\nin the capillary and interstitium, so that there is no net drive for diffusion.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Capillary oncotic\npressure tends to draw fluid into the capillary\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Interstitial fluid\noncotic pressure tends to draw fluid into the interstitium.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Under\nnormal circumstances the capillary hydrostatic pressure and capillary oncotic\npressures are relatively high and the other two pressures are relatively low,\nthe net result being that some fluid leaves the typical capillary. This fluid\nreturns to the circulation via the lymphatic system.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  If too\nmuch fluid leaves the capillary, then the result is edema. Edema can be caused\nby anything that affects the four factors mentioned above so that the net\neffect is more fluid leaving the capillary. Common causes of edema include\ndiseases that increase capillary hydrostatic pressure.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  In congestive heart\nfailure, venous pressure increases because of an inadequate cardiac output.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Venous thrombosis also\nincreases venous pressure proximal to the obstruction (that is, on the\ncapillary side of the obstruction), leading to edema in the vascular bed\naffected.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Renal retention of salt\nand water increases capillary hydrostatic pressure simply because the vascular\nsystem is more &ldquo;full&rdquo; of fluid.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Some\ndisease states (e.g., cirrhosis, nephrotic syndrome) produce hypoalbuminemia\nwhich reduces capillary oncotic pressure. This reduces the osmotic pressure of\nfluid within the capillary, resulting in less drive for fluid to return to the\ncapillary. The result is edema.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lymphatic\nobstruction or surgical removal of lymph nodes produces edema by reducing the\ndrainage of fluid from the interstitium. Although interstitial fluid\nhydrostatic pressure increases in this situation which reduces the drive for\nfluid movement from capillary to interstitium, the pressures forcing pressure\nout of the capillary still exceed the pressures favoring fluid movement into\nthe capillary.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Finally,\nedema can be produced by conditions that damage capillaries and thus increase\ncapillary permeability.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal mechanisms of edema are summarized below.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"3\" valign=\"top\" width=\"419\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Edema\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mechanism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Cause\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Characteristics\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  capillary hydrostatic pressure\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n      Heart\n  failure\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pitting\n  edema\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Jugular\n  vein distension\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Hepatojugular\n  reflux\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  capillary hydrostatic pressure\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n      Renal\n  failure\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pitting\n  edema\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  capillary hydrostatic pressure\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n      Deep\n  vein thombosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pitting\n  edema\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Limited\n  to area of blockage\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n      Decreased\n  capillary oncotic pressure\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cirrhosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Nephrotic\n  syndrome\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Severe\n  malnutrition\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pitting\n  edema\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Generalized\n  (anasarca)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Peri-orbital\n  edema\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      &darr;\n  Serum albumin\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lymphatic\n  obstruction\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n      Removal\n  of lymph nodes\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Radiation\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Tumor\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Injury\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n      Non-pitting\n  edema\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Limited\n  to area of blockage\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Indurated\n  skin\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"111\">\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  capillary permeability\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"156\">\n    <p class=\"MsoNormal\">\n     <span>\n      Allergic\n  reactions\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Burns\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Snake bites\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"153\">\n    <p class=\"MsoNormal\">\n     <span>\n      Variable\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Decreased capillary hydrostatic pressure", "B. Increased capillary oncotic pressure", "C. Decreased capillary permeability", "D. Lymphatic obstruction"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 32-year-old woman with type 1 diabetes mellitus\nhas had progressive renal failure over the past 2 years. She has not yet\nstarted dialysis. Her hemoglobin concentration is 9 g/dL, hematocrit is 28%,\nand mean corpuscular volume is 94 &mu;m3. A blood smear shows normochromic,\nnormocytic cells. What is the most likely cause of anemia?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct.\n  </span>\n </b>\n <span>\n  The\nprincipal cause of anemia in patients with chronic kidney disease is\nerythropoietin deficiency. This typically presents as a normochromic,\nnormocytic anemia. White blood cell and platelet counts remain unaffected.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The total mass of red blood cells in the\ncirculatory system is regulated within very narrow limits so that an adequate\nnumber of red blood cells is available to provide sufficient tissue oxygenation\nand, yet, so that the cells do not become so concentrated that they impede\nblood flow. Any condition that causes the quantity of oxygen transported to the\ntissues to decrease ordinarily increases the rate of red blood cell production.\nThus, when a person becomes extremely anemic as a result of hemorrhage, for example,\nthe bone marrow immediately begins to produce large quantities of red blood\ncells.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The principal factor that stimulates red\nblood cell production is a circulating hormone called\n  <b>\n   erythropoietin\n  </b>\n  (a glycoprotein). In the absence of erythropoietin,\nhypoxia has either no effect or very little effect in stimulating red blood\ncell production. On the other hand, when the erythropoietin system is\nfunctional, hypoxia causes marked increase in erythropoietin production, and\nthe erythropoietin in turn enhances red blood cell production until hypoxia is\nrelieved.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In a normal person, 80-90% of all\nerythropoietin is formed in the kidneys; the remainder, mainly in the liver.\nIndividuals with\n  <b>\n   chronic kidney disease\n  </b>\n  (CKD) invariably become anemic because the 10-20% of the normal erythropoietin\nformed in other tissues (mainly the liver) is insufficient to stimulate\nproduction of adequate numbers of red blood cells. In normal subjects, serum\nerythropoietin levels increase in response to a reduction in red blood cell mass\n(i.e., anemia). In CKD, erythropoietin concentrations are inappropriately low\nfor the degree of anemia. The adequacy of erythropoietin production in response\nto anemia appears to decline in rough proportion to the degree of reduction in\nnephron mass.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Anemia in CKD can develop because of any\nof the hematologic diseases that may affect individuals without kidney disease,\nsuch as iron, vitamin B\n  <sub>\n   12\n  </sub>\n </span>\n <a href=\"http://www.mdconsult.com.webproxy.ouhsc.edu/books/linkTo?type=bookPage&amp;isbn=978-1-4160-6193-9&amp;eid=4-u1.0-B978-1-4160-6193-9..10056-9--bib202&amp;appID=MDC\">\n </a>\n <span>\n  , or folic acid\ndeficiency. But the form of anemia most common in CKD is a normocytic,\nnormochromic (or slightly hypochromic) anemia with insufficient production of\nerythrocytes, due primarily to erythropoietin deficiency. The greatest proof\nthat erythropoietin deficiency is the primary cause of renal anemia is the\nconsistent success of treating renal anemia with recombinant human\nerythropoietin (rHuEPO).\n </span>\n</p>\n", "choices": ["A. Acute blood loss", "B. Chronic lymphocytic leukemia", "C. Erythropoietin deficiency", "D. Immunohemolysis", "E. Microangiopathic hemolysis", "F. Sickle cell disease", "G. Sideroblastic anemia", "H. \u03b2-Thalassemia trait"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A healthy\n18-year-old man is undergoing an exercise stress test. Which of the following\nis occurring in this man&rsquo;s skeletal muscle during exercise?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  During exercise, blood flow to muscle\nincreases due to arteriolar dilatation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Arteriolar dilatation\ndecreases vascular resistance (Poiseuille's equation).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  As blood flow increases,\ncapillary hydrostatic pressure increases.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Flow = Pressure x Resistance. (The capillaries cannot control resistance\nas arterioles can.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  An exercising muscle\nuses oxygen to burn fuel. Oxygen levels decrease.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Metabolites produced by\nburning fuel increase during exercise.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  During\nexercise, blood flow to muscle must increase to meet the greater demand for\nnutrients and oxygen. This is achieved primarily through arteriolar dilatation,\nwhich lowers vascular resistance and increases blood flow.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Poiseuille's\nequation:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347356\"\n o:spid=\"_x0000_i1117\" type=\"#_x0000_t75\" alt=\"Description: 58a785aa20836091240538adaaefe0ee\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image429.png\" o:title=\"58a785aa20836091240538adaaefe0ee\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 58a785aa20836091240538adaaefe0ee\" border=\"0\" height=\"34\" src=\"_%20Tutorials_files/image430.png\" v:shapes=\"Picture_x0020_347356\" width=\"60\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  R = resistance\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  &eta; = viscosity\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  l = length of vessel\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  r = radius of vessel\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Resistance\nfalls dramatically as blood vessel radius increases.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  As\nresistance falls, blood flow increases:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Q = P / R\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Q = blood flow\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  P = pressure\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  R = resistance\n </span>\n</p>\n", "choices": ["A. Increased arteriolar diameter", "B. Increased vascular resistance", "C. Decreased capillary hydrostatic pressure", "D. Increased oxygen concentration", "E. Decreased metabolite concentration"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A husband and wife are in your office.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Their daughter developed a deep vein\nthrombosis during the third trimester of pregnancy and was told she has the\nFactor V Leiden mutation. She was also told that her whole family needed to be\nscreened for the trait.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The couple\nis in excellent health and has three other children and eight\ngrandchildren.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  None of them have\nhad a deep vein thrombosis (DVT) or pulmonary embolism. Two uncles have had\nheart attacks before age 60 and several elderly family members have had strokes.\nWhich of the following is most appropriate?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The family needs to know the signs and symptoms\nof deep vein thrombosis (leg pain, swelling, redness) and of pulmonary embolism\n(shortness of breath and chest pain).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  If any of these symptoms occur, medical care should be sought regardless\nof mutation status. Hip and knee replacements increase the risk of DVT in all\npatients. Anyone undergoing these procedures should receive DVT prophylaxis.\nScreening asymptomatic family members for Factor V Leiden is controversial.\nTreatment of asymptomatic carriers with warfarin is never indicated.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Factor V Leiden is a genetic mutation.\nIt is not affected by pregnancy.\n </span>\n</p>\n"], "tutorial": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Factor V Leiden (FVL) mutation\n     </span>\n    </b>\n    <span>\n     is the most common inherited disorder leading to venous\n  thromboembolism (VTE). About 5% of individuals with European ancestry are\n  heterozygous for FVL. The FVL mutation occurs at a site where activated\n  protein C (APC) cleaves and inactivates normal factor Va (Arg506); abolition\n  of this cleavage site results in APC resistance. Failure to inactivate the\n  mutant factor Va allows the prothrombinase complex to be relatively uninhibited\n  and leads to increased thrombin generation and a thrombophilic phenotype.\n  About one fourth of patients with an initial occurrence of VTE or PE will\n  have heterozygous FVL, and this percentage increases to nearly 60% in those\n  with recurrent VTE or a strong family history of VTE or PE. APC resistance\n  can be demonstrated by specialized clotting tests showing that the addition\n  of APC fails to prolong the partial thromboplastin time (PTT). Genotyping can\n  then confirm whether FVL is present and whether heterozygous or homozygous.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P054011\">\n    </a>\n    <span>\n     Inheritance of\n  heterozygous FVL conveys an about seven-fold increased risk for VTE or PE.\n  However, at 50 years of age, only 25% of persons with heterozygous FVL have\n  had VTE or PE compared with much higher percentages in persons with other\n  inherited thrombophilias. It is with concomitant&nbsp;\n     <i>\n      acquired\n     </i>\n     &nbsp;risk\n  factors such as immobilization, pregnancy, or oral contraceptive use that the\n  risk for VTE or PE in persons with FVL becomes more significant.\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     Homozygotes for FVL have an increased\n  risk for VTE that is estimated to be between 20- and 80-fold. Only occasional\n  reports exist of patients with homozygous FVL who are asymptomatic into old\n  age.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Explain that factor V Leiden testing is often abnormal during pregnancy and needs to be repeated.", "B. Recommend complete testing for hypercoagulability on the entire family, including protein C, protein S, antithrombin III, prothrombin mutation 20210, and Factor V Leiden.", "C. Test the family for Factor V Leiden and place all members with the mutation on warfarin.", "D. Educate the parents about Factor V Leiden and about the signs and symptoms of deep vein thrombosis and pulmonary embolism."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <b>\n   Answer\nB is incorrect\n  </b>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  There is no\nneed for such extensive testing in asymptomatic individuals.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect.\n  </span>\n </b>\n <span>\n  In\nthis vignette, it is not surprising that no one else in the family has had a\nDVT. Factor V Leiden is often only one of many risk factors (e.g., surgery,\npregnancy, leg injury) for thrombosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Warfarin carries a 1-3% chance of serious bleeding each year and should\nnot be used in asymptomatic Factor V Leiden carriers.\n </span>\n</p>\n\n<p>\n <span>\n  An otherwise healthy 20-year-old man of Mediterranean descent is given\nsulfamethoxazole to treat a bladder infection. Three days after beginning the\nantibiotic, he becomes jaundiced and his urine becomes dark. His hemoglobin\nconcentration is 7 gm/dL. On blood smear examination, Heinz bodies are detected\nin numerous red blood cells. His condition worsens until day 6 of antibiotic\ntherapy, when it begins to improve. Symptoms are gone by day 9 of continued\nantibiotic therapy. Which of the following conditions is the most likely\nexplanation for these findings?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct.\n </b>\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n <span>\n  Heinz bodies\n </span>\n are small round\ninclusions of denatured (&ldquo;damaged&rdquo;) hemoglobin in red blood cells, usually\ncaused by oxidative stress or genetic mutation.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The abnormal hemoglobin results in\nreactive oxygen species (ROS) formation, which damages the cell. This causes\npremature lysis of red blood cells, as damaged cells are cleared by macrophages\nin the spleen. Acute development of anemia, jaundice, and dark urine in this\npatient suggests a hemolytic process. G6PD deficiency should be suspected when\nhemolysis occurs in a person of Mediterranean descent after administration of a\nsulfa antibiotic. G6PD deficiency is the most common enzyme deficiency in the\nworld.\n</p>\n"], "tutorial": "<p>\n <b>\n  Glucose-6-phosphate\ndehydrogenase (G6PD) deficiency\n </b>\n is the most common human enzyme defect,\naffecting more than 400 million worldwide. People of African, Middle Eastern,\nSouth Asian, and Mediterranean descent are predominantly affected. G6PD\ndeficiency is an X-linked disorder characterized by abnormally low levels of\nglucose-6-phosphate dehydrogenase, an enzyme involved in the pentose phosphate\npathway, which is especially important in red blood cell metabolism.\nIndividuals with the disease exhibit nonimmune hemolytic anemia in response to\na number of causes, most commonly infection or exposure to certain medications\nor chemicals. G6PD deficiency is closely linked to\n <span>\n  favism\n </span>\n , a disorder characterized by a hemolytic response to broad\nbean consumption. (The name is derived from the Italian name for broad bean:\n <i>\n  fava\n </i>\n ).\nMost individuals with G6PD deficiency are asymptomatic. Symptomatic patients\nare usually male (due to an X-linked pattern of inheritance), but female\ncarriers can be clinically affected due to unfavorable Lyonization, where\nrandom inactivation of an X-chromosome in certain cells creates a population of\nG6PD-deficient red blood cells coexisting with normal red cells.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Many\nsubstances are potentially harmful to people with G6PD deficiency. Certain\nantimalarial drugs (e.g. primaquine, pamaquine and chloroquine) can cause\nhemolysis in people with G6PD deficiency. Sulfonamides (e.g. sulfamethoxazole),\nmethylene blue, and naphthalene should also be avoided by people with G6PD\ndeficiency, as should certain analgesics (e.g. aspirin) and a few non-sulfa\nantibiotics (nalidixic acid, nitrofurantoin, isoniazid, and dapsone). Glucose-6-phosphate\ndehydrogenase is an enzyme in the pentose phosphate pathway. It converts\nglucose-6-phosphate to 6-phosphoglucono-&delta;-lactone, and it is the\nrate-limiting enzyme in this pathway. The pentose phosphate pathway supplies\nreducing equivalents to cells by maintaining the level of nicotinamide adenine\ndinucleotide phosphate (NADPH). NADPH, in turn, maintains the supply of reduced\nglutathione, which is used to mop up free radicals that cause oxidative damage.\nThe G6PD / NADPH pathway is the\n  <i>\n   only\n  </i>\n  source of biochemical reductant\nneeded to maintain reduced glutathione in red blood cells. The role of red\ncells as oxygen carriers puts them at substantial risk of damage from oxidizing\nfree radicals except for the protective effect of G6PD/NADPH/glutathione.\n </span>\n</p>\n\n<p>\n People with G6PD deficiency\nare at risk of hemolytic anemia in states of oxidative stress. Oxidative stress\ncan result from infection, chemical exposure, medication, or certain foods.\nWhen reduced glutathione is consumed, enzymes and other proteins (including\nhemoglobin) are damaged by oxidants. Damaged red cells are phagocytosed and\nsequestered in the spleen; the hemoglobin is metabolized to bilirubin, which\nmay cause jaundice at high concentrations.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ndiagnosis should be suspected when patients from certain ethnic groups (e.g.,\npeople of Mediterranean descent) develop hemolysis after an oxidative\nchallenge, especially when there is a positive family history. Findings include\nanemia, elevated reticulocyte counts, Heinz bodies in red blood cells (seen on\nblood smear), elevated bilirubin levels, elevated lactate dehydrogenase levels\n(from hemolysis), low haptoglobin levels (from hemolysis), and negative Coombs&rsquo;\ntest (because hemolysis is not immune-mediated). &ldquo;Bite cells&rdquo; may be seen.\n(&ldquo;Bite cells&rdquo; are red blood cells whose Heinz bodies have been &ldquo;bitten out&rdquo; by\nmacrophages in the spleen).\n </span>\n</p>\n\n<p>\n The most important step in\nmanaging patients with this disease is prevention. Affected individuals should\navoid drugs and foods that cause hemolysis. Also, they should be vaccinated\nagainst pathogens (e.g. hepatitis A and B) that can induce attacks.\n</p>\n", "choices": ["A. Aplastic anemia", "B. Cytochrome-b5 reductase deficiency", "C. Glucose-6-phosphate dehydrogenase deficiency", "D. Pyruvate kinase deficiency", "E. Sepsis successfully treated with antibiotics"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n3-year-old boy is brought to your office with a 3-day history of abdominal\npain, vomiting, and diarrhea. The parents are worried because the diarrhea\nbecame bloody this morning and the boy has not been urinating. The family ate\nhamburgers at a cook-out last weekend, after which the mother and sister\ndeveloped mild abdominal pain and diarrhea. On physical examination, the boy is\npale and irritable. Lab tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  7.0 g/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  8,500/mm3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelets\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  37,000/mm3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  40\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4.8\nmg/dL\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Examination\nof the blood smear shows decreased platelet numbers, fragmented red blood\ncells, and polychromatophilic red cells (reticulocytes).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347355\"\n o:spid=\"_x0000_i1116\" type=\"#_x0000_t75\" alt=\"Description: Schistocytes\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image431.jpg\" o:title=\"Schistocytes\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Schistocytes\" border=\"0\" height=\"144\" src=\"_%20Tutorials_files/image432.png\" v:shapes=\"Picture_x0020_347355\" width=\"192\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  You admit\nthe boy to the hospital. Which of the following diagnostic and therapeutic\napproaches is most appropriate?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  A.\nStool culture for bacterial pathogens (Salmonella and Shigella species);\nadminister antibiotics\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  B.\nStool culture for bacterial pathogens (Salmonella and Shigella species);\nperform kidney biopsy\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  C.\nStool culture with sorbitol-MacConkey and ELISA assay for stool Shiga toxin;\nmanage with supportive care, including hemodialysis if necessary\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D.\nStool culture with sorbitol-MacConkey and ELISA assay for stool Shiga toxin;\nmanage with plasma exchange\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Hemolytic-uremic syndrome (HUS)\n  </span>\n </b>\n <span>\n  is associated with\nmicroangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure.\nThe presence of fragmented red blood cells indicates a microangiopathic process\nin which red cells are forced through partially occluded vessels. The abdominal\npain and bloody diarrhea are consistent with enterohemorrhagic colitis caused\nby Shiga toxin-secreting bacteria. The most common of these bacteria is\n  <i>\n   E. coli\n  </i>\n  O157:H7.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <i>\n   E.\ncoli\n  </i>\n  O157:H7 is part of the normal intestinal flora of cattle, and is\ncommonly acquired by eating undercooked meat. Children are more susceptible to\ninfection than adults.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Shiga toxin\ncauses microvascular thrombosis in the kidneys, which results in red cell\nfragmentation and platelet consumption (causing thrombocytopenia).\nReticulocytes and nucleated red cells appear, indicating increased red blood\ncell production as a response to hemolysis. Most children recover spontaneously\nand completely. About half may require hemodialysis until renal failure\nresolves.\n  <b>\n  </b>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Conditions associated with microangiopathic hemolysis\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Microangiopathic Hemolysis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hemolytic-uremic\n  syndrome (HUS)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Thrombotic\n  thrombocytopenic purpura (TTP)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Pre-eclampsia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Malignant\n  hypertension\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"239\">\n    <p class=\"MsoNormal\">\n     <span>\n      Disseminated\n  microvascular metastases of carcinoma\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  .\n  <i>\n   E. coli\n  </i>\n  O157:H7 can be cultured on sorbitol-MacConkey agar. An\nELISA assay can detect Shiga toxin in the stool. Supportive care is the\nmainstay of management. Dialysis may be needed in some patients.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Hemolytic-uremic\nsyndrome is caused predominantly by\n  <i>\n   E.\ncoli\n  </i>\n  O157:H7. Antibiotics are not needed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Hemolytic-uremic\nsyndrome is caused predominantly by\n  <i>\n   E.\ncoli\n  </i>\n  O157:H7. Kidney biopsy is unnecessary and inappropriate.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Plasma exchange is\nrecommended for thrombotic thrombocytopenic purpura (TTP), not hemolytic-uremic\nsyndrome (HUS).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n25-year-old male presents to his primary care provider with a slowly enlarging,\nnonpainful right neck mass. He denies recent upper respiratory tract\ninfections, fevers, night sweats, or unintentional weight loss. He is otherwise\nhealthy. Social history and family history are unremarkable. On examination he\nis afebrile with normal vital signs. Pertinent findings include a 3-cm, firm,\nround, nontender, mobile mass in the mid-right neck. There is no other\nperipheral lymphadenopathy. The liver and spleen are not enlarged. Biopsy of\nthe mass shows large numbers of the following cell type:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347354\"\n o:spid=\"_x0000_i1115\" type=\"#_x0000_t75\" alt=\"Description: HP-Home-Image\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image433.jpg\" o:title=\"HP-Home-Image\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: HP-Home-Image\" border=\"0\" height=\"122\" src=\"_%20Tutorials_files/image434.png\" v:shapes=\"Picture_x0020_347354\" width=\"152\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct.\n </b>\n This is a classic presentation of Hodgkin&rsquo;s\nlymphoma with Reed-Sternberg cells seen on microscopic examination of a lymph\nnode biopsy.\n</p>\n"], "tutorial": "<p>\n <b>\n  Hodgkin lymphoma\n </b>\n <span>\n </span>\n is a type of cancer that originates\nfrom lymphocytes. It is characterized by the orderly spread of disease from one\nlymph node group to another and by the development of systemic symptoms with\nadvanced disease. Multinucleated Reed-Sternberg cells are the characteristic\nhistopathologic finding. Hodgkin lymphoma may be treated with radiation\ntherapy, chemotherapy, or hematopoietic stem cell transplantation, the choice\nof treatment depending on the stage, bulk, and histological subtype of the\ndisease.\n</p>\n\n<p>\n The disease occurrence shows\ntwo peaks: the first in young adulthood (age 15&ndash;35) and the second in\nthose over 55 years old. The 10-year overall survival rate is more than 90% for\nany stage, though early diagnosis may help. Since many patients are young, they\noften live 40 years or more after treatment. It is now known that approximately\nhalf of cases of Hodgkin lymphoma are related to Epstein-Barr virus (EBV).\nPatients with a history of infectious mononucleosis due to Epstein-Barr virus\nhave a slightly increased risk of Hodkin lymphoma.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The most\ncommon presentation of Hodgkin&rsquo;s lymphoma is painless cervical and/or\nsupraclavicular lymphadenopathy. Axillary and inguinal lymphadenopathy is less\ncommon. The mediastinum is frequently involved; symptoms may include shortness\nof breath and/or cough. Approximately 30% of patients present with B symptoms,\ndefined as unexplained, recurrent fevers &ge;100.4&deg;F (38&deg;C), drenching night\nsweats requiring change of bed clothes, or &ge;10% weight loss in the last 6\nmonths. B symptoms are more common in patients with advanced disease. Other\nsystemic symptoms not categorized as B symptoms include generalized pruritus\nand alcohol-induced pain at the site of a tumor mass.\n </span>\n</p>\n\n<p>\n Hodgkin lymphoma must be\ndistinguished from other types of cancer, as well as from non-cancerous\n(generally, infectious) causes of lymph node swelling. Definitive diagnosis is\nby lymph node biopsy, usually excisional biopsy with microscopic examination.\nMicroscopic examination of the lymph node biopsy reveals complete or partial\neffacement of the lymph node architecture by scattered large malignant cells\nknown as Reed-Sternberg cells. Reed-Sternberg cells are large and are either\nmultinucleated or have a bilobed nucleus (thus resembling an &ldquo;owl&rsquo;s eye&rdquo;) with\nprominent eosinophilic inclusion-like nucleoli. In approximately 50% of cases,\nthe Reed-Sternberg cells are infected by the Epstein-Barr virus.\n</p>\n", "choices": ["A. Cytomegalovirus", "B. Hodgkin lymphoma", "C. Non-Hodgkin lymphoma", "D. Toxoplasmosis", "E. Tuberculosis"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 1-week-old neonate develops marked unconjugated\nhyperbilirubinemia and dies the following week. Lab tests show no evidence of\nhemolysis. Liver enzymes are normal. What is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  Of the four hereditary\ndisorders listed, only Crigler-Najjar syndrome and Gilbert syndrome cause\n  <i>\n   unconjugated\n  </i>\n  hyperbilirubinemia.\nCrigler-Najjar syndrome is life-threatening; Gilbert syndrome is benign. This\nneonate has Crigler-Najjar syndrome.\n </span>\n</p>\n"], "tutorial": "<h3>\n <span>\n  Bilirubin\n </span>\n <span>\n  is produced by the breakdown of\nred blood cells. When erythrocytes get old or damaged, they are disposed of in\nthe spleen. This releases hemoglobin, which is broken down to heme and &ldquo;globin&rdquo;\nprotein. The heme is then turned into unconjugated bilirubin in the\nreticuloendothelial cells of the spleen. This unconjugated bilirubin is not\nsoluble in water. It binds to albumin and is sent to the liver.\n </span>\n</h3>\n\n<h3>\n <span>\n  In the liver it\nis conjugated with glucuronic acid by the enzyme glucuronyltransferase, making\nit soluble in water. Much of it goes into the bile, which travels through the\nbiliary system into the bowel. In the colon, some of the conjugated bilirubin\nis metabolized by colonic bacteria to urobilinogen, which is further\nmetabolized to stercobilinogen, and finally oxidized to stercobilin. This\nstercobilin gives feces its brown color. Some of the urobilinogen is reabsorbed\nand excreted in the urine. Normally, only a tiny amount of bilirubin, if any,\nis excreted in the urine.\n </span>\n</h3>\n\n<h3>\n <span>\n  If the liver&rsquo;s\nfunction is impaired or if biliary drainage is blocked, some of the conjugated\nbilirubin leaks out of the hepatocytes and appears in the urine, turning it\ndark amber. However, in disorders involving hemolytic anemia, an increased\nnumber of red blood cells are broken down, causing an increase in the amount of\nunconjugated bilirubin in the blood. The unconjugated bilirubin is not water\nsoluble, and thus will not appear in the urine. Because there is no problem\nwith the liver or biliary system in hemolytic anemia, the excess unconjugated\nbilirubin will go through the normal processing mechanisms (e.g., conjugation,\nexcretion in bile, metabolism to urobilinogen, reabsorption) and will show up\nas an increase in urine urobilinogen.\n </span>\n</h3>\n\n<h3>\n <span>\n  Therefore, urine\nbilirubin is increased when the liver is impaired or when biliary drainage is\nblocked, but not in hemolytic anemia. Urobilinogen, by contrast, is increased\nin hemolytic anemia and decreased when biliary drainage is blocked.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</h3>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  There are five known hereditary defects in\nbilirubin metabolism: Crigler-Najjar syndrome types 1 and type II, Gilbert&rsquo;s\nsyndrome, Dubin-Johnson syndrome, and Rotor syndrome.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Crigler-Najjar syndrome and Gilbert\nsyndrome cause\n  <i>\n   unconjugated\n  </i>\n  hyperbilirubinemia. Crigler-Najjar syndrome is life-threatening; Gilbert\nsyndrome is benign. Dubin-Johnson syndrome and Rotor syndrome cause\n  <i>\n   conjugated\n  </i>\n  hyperbilirubinemia.\nDubin-Johnson syndrome is differentiated from Rotor syndrome by the presence of\nblack pigmentation in the liver.\n </span>\n</p>\n", "choices": ["A. Gilbert\u2019s syndrome", "B. Rotor syndrome", "C. Dubin-Johnson syndrome", "D. Crigler-Najjar syndrome, type 1"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Five days\nafter undergoing a right total hip replacement, a 68-year old man experiences\nsharp chest pain and shortness of breath. He has a low-grade fever and\ntachycardia. His right leg is swollen and painful. Which of the following would\npredispose him to this event?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . The clinical scenario\nis most consistent with deep vein thrombosis and pulmonary embolism. Factor V\nLeiden, the most common hereditary hypercoagulability disorder, is a mutation\nof the Factor V gene that prevents Factor V from being deactivated by protein\nC. Unopposed Factor V leads to a hypercoagulable state that may result in deep\nvenous thrombosis and pulmonary embolism.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Proteins C and S\ninhibit the coagulation cascade. Deficiency, not overproduction of these\nproteins, leads to a hypercoagulable state.\n </span>\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . High, not low, levels of homocysteine are\nassociated with a hypercoagulable state.\n <span>\n  Hyperhomocysteinemia\n </span>\n is a medical condition characterized by an\nabnormally large level of homocysteine in the blood. As a consequence of the\nbiochemical reactions in which homocysteine is involved, deficiencies of the\nvitamins pyridoxine (B\n <sub>\n  6\n </sub>\n ), folic acid (B\n <sub>\n  9\n </sub>\n ), or B\n <sub>\n  12\n </sub>\n can lead to high homocysteine levels. Supplementation with pyridoxine, folic\nacid, or B\n <sub>\n  12\n </sub>\n reduces the concentration of homocysteine in the\nbloodstream. A high level of homocysteine makes a person more prone to\nendothelial injury, which leads to vascular inflammation, which in turn may\nlead to atherogenesis, which can result in ischemic injury.\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Risk factors for deep venous thrombosis (DVT)\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Genetic\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Acquired\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Factor V\n  Leiden*\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Prothrombin\n  G20210A mutation\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Antithrombin\n  III deficiency\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Protein\n  S deficiency\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Protein\n  C deficiency\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     *Suspect\n  genetic cause if patient has&hellip;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Unexplained DVT\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Recurrent DVT\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span>\n      &middot;\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     FMH of DVT\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"221\">\n   <p class=\"MsoNormal\">\n    <span>\n     Surgery/Trauma\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Immobilization\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;&nbsp;&nbsp;&nbsp;\n     </span>\n     Bedridden &gt; 3\n  days\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;&nbsp;&nbsp;&nbsp;\n     </span>\n     Air flights &gt; 6-8\n  hours\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Obesity\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Venous\n  stasis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Pregnancy\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Stroke\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Congestive\n  heart failure\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Nephrotic\n  syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Cancer\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Medicine:\n  OCs, HRT\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Antiphospholipid\n  antibody syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Hyperhomocysteinemia\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  * Factor V Leiden is the most common hereditary\nhypercoagulability disorder.\n </span>\n</p>\n", "choices": ["A. Overproduction of protein C", "B. Mutation of Factor V gene", "C. Low serum homocysteine levels", "D. von Willebrand factor deficiency", "E. Factor VIII deficiency"]}, {"question": "<p>\n Hyperhomocysteinemia is a\nrisk factor for blood clots, heart attacks, and strokes. It can cause\nmiscarriage and is associated with pre-eclampsia. Hyperhomocysteinemia usually\noccurs in people with at least one defective gene that affects breakdown of\nhomocysteine. Defects in methylenetetrahydrofolate reductase (MTHFR) or\nmethioninesynthetase are associated with hyperhomocysteinemia. Both enzymes are\ninvolved in the conversion of homocysteine to methionine. Consequently,\nindividuals with hyperhomocysteinemia often have decreased levels of\nmethionine.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Von Willebrand\ndeficiency predisposes to bleeding, not hypercoagulability.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Factor VIII deficiency\n(hemophilia A) predisposes to bleeding, not hypercoagulability.\n </span>\n</p>\n\n<p>\n <span>\n  Blood flow is studied in an anesthetized animal. After an initial control\nperiod, a tourniquet is placed around one extremity to occlude blood flow for\nexactly 1 minute. When the tourniquet is released, blood flow increases\nabruptly and exceeds the control value for several minutes (reactive\nhyperemia). After an appropriate recovery period, the procedure is repeated,\nbut this time, the extremity is actively exercised during the period of\nocclusion. How will the reactive hyperemia after the second occlusion compare\nwith the reactive hyperemia after the first?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  Hyperemia may be triggered by increased metabolic activity\n(active) or by ischemia (reactive).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In this vignette, the animal&rsquo;s extremity is occluded twice. Both\nocclusions result in\n  <i>\n   reactive\n  </i>\n  hyperemia after the tourniquet is released. During the second occlusion,\nhowever, the extremity is actively exercised, adding a component of\n  <i>\n   active\n  </i>\n  hyperemia to the\n  <i>\n   reactive\n  </i>\n  hyperemia already in place.\nExercise increases oxygen consumption, and oxygen consumption is strongly\ncorrelated with blood flow. The combined effects of exercise and ischemia\nduring the second occlusion will increase the metabolic stimulus for\nvasodilation and increase hyperemia beyond the level seen after the first\nocclusion.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p>\n <b>\n  &ldquo;Hyperemia&rdquo;\n </b>\n <span>\n  is increased blood flow to\n </span>\n a\nparticular area of the body. It may be &ldquo;\n <em>\n  <span>\n   active&rdquo; or\n  </span>\n </em>\n <i>\n </i>\n &ldquo;\n <em>\n  <span>\n   reactive,&rdquo;\nand it is typically associated with\n  </span>\n </em>\n erythema.\n <span class=\"fadewordcontainer\">\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Active\n  </span>\n </i>\n <span>\n  hyperemia is increased blood flow caused by\n  <span>\n   increased metabolic activity.\n  </span>\n  During\nskeletal muscle contraction, for example, vasoactive substances are released\nthat dilate resistance vessels and increase blood flow. Similarly, blood flow\nis increased in the gastrointestinal tract during digestion and in the coronary\narteries during periods of increased heart rate. Under normal circumstances\ntotal blood flow to the brain is relatively constant due to autoregulation, but\nregional brain blood flow can vary depending on metabolic activity.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347353\" o:spid=\"_x0000_i1114\" type=\"#_x0000_t75\" alt=\"Description: Relationship between skeletal muscle blood flow and oxygen consumption\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image435.png\" o:title=\"Relationship between skeletal muscle blood flow and oxygen consumption\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Relationship between skeletal muscle blood flow and oxygen consumption\" border=\"0\" height=\"157\" src=\"_%20Tutorials_files/image436.png\" v:shapes=\"Picture_x0020_347353\" width=\"190\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The figure\nabove shows that basal oxygen consumption is associated with a resting blood\nflow rate. As oxygen consumption increases, there is a near-linear increase in\nblood flow until the vessels are maximally dilated. A 50-fold increase in\nmuscle blood flow may occur during heavy exercise. Active hyperemia is caused\nby tissue hypoxia and by the release of vasodilators (e.g., adenosine, nitric\noxide, carbon dioxide,\n  <span>\n   potassium ion)\n  </span>\n  .\n </span>\n</p>\n\n<p>\n <i>\n  <span>\n   Reactive\n  </span>\n </i>\n <span>\n  hyperemia is increased blood flow that\n  <em>\n   <span>\n    occurs after a brief period of ischemia.\n   </span>\n  </em>\n  For example, reactive hyperemia occurs after a tourniquet is removed from the\narm, after a clamp is removed from an artery during surgery, or after a\nstenosed coronary artery is recanalized.\n </span>\n</p>\n\n<p>\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347352\" o:spid=\"_x0000_i1113\"\n type=\"#_x0000_t75\" alt=\"Description: reactive hyperemia in skeletal muscle\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image437.png\" o:title=\"reactive hyperemia in skeletal muscle\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: reactive hyperemia in skeletal muscle\" border=\"0\" height=\"176\" src=\"_%20Tutorials_files/image438.png\" v:shapes=\"Picture_x0020_347352\" width=\"453\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p>\n Figure 2\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n Figure\n3\n</p>\n\n<p>\n Figure 2 shows the effects\nof a 2-minute arterial occlusion on blood flow. Blood flow goes to zero during\narterial occlusion. When the occlusion is released, blood flow rises rapidly\nand the excess flow lasts for several minutes. Hyperemia occurs because, during\nthe period of occlusion, tissue\n <em>\n  <span>\n   hypoxia\n  </span>\n </em>\n and vasodilators (e.g.,\n <em>\n  <span>\n   adenosine\n  </span>\n </em>\n ) dilate arterioles and\ndecrease vascular resistance. When perfusion pressure is restored, blood flow\nis increased because of reduced vascular resistance.\n</p>\n\n<p>\n During hyperemia, the tissue\nbecomes reoxygenated and the vasodilators are washed away. This causes vessels\nto regain their normal\n <em>\n  <span>\n   vascular tone\n  </span>\n </em>\n , with blood flow returning to normal. Longer\nperiods of occlusion create a greater metabolic stimulus for vasodilation,\nresulting in greater and more prolonged hyperemia (Figure 3).&nbsp;\n</p>\n", "choices": ["A. Abolished", "B. Decreased", "C. Unchanged", "D. Increased"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n66-year-old man with alcohol dependence and cirrhosis is admitted to the\nhospital with abdominal pain. Three months ago he was hospitalized with\nbleeding esophageal varices. On physical examination, he is somnolent. Spider\nangiomas are noted on his chest. His abdomen is remarkable for tense ascites.\nThe liver and spleen are not palpable through the fluid. Deep tendon reflexes\nare hyperactive and asterixis is present.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Lab tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  10.2 g/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3,750/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelets\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  52,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Examination\nof the blood smear reveals target cells, normal white blood cell morphology,\nand decreased platelets.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347351\"\n o:spid=\"_x0000_i1112\" type=\"#_x0000_t75\" alt=\"Description: Target\">\n <v:imagedata src=\"_%20Tutorials_files/image439.jpg\" o:title=\"Target\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Target\" border=\"0\" height=\"137\" src=\"_%20Tutorials_files/image440.png\" v:shapes=\"Picture_x0020_347351\" width=\"183\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most important cause of thrombocytopenia in this patient?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  A.\nIncreased pooling of platelets in the spleen\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  B.\nMarrow suppression of platelet production by alcohol\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  C.\nThrombopoietin deficiency\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  D.\nThalassemia minor\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347483\" o:spid=\"_x0000_i1111\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image441.jpg\" o:title=\"\"/>\n</v:shape><![endif]-->\n   <img border=\"0\" height=\"326\" src=\"_%20Tutorials_files/image442.png\" v:shapes=\"Picture_x0020_347483\" width=\"431\"/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Advanced\ncirrhosis is associated with portal hypertension, and portal hypertension leads\nto splenomegaly, hypersplenism, and thrombocytopenia. The splenic sinusoids\nbecome congested, which results in platelet pooling, or\n  <b>\n   &ldquo;sequestration.&rdquo;\n  </b>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In\nnormal people, one-third of circulating platelets are pooled in the sinusoids.\nThis is because platelets, the smallest of blood elements, drift into the\nsluggish sinusoidal circulation rather than moving directly from arteriole to\nvenule.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Platelets in the spleen are\nfreely exchangeable with circulating platelets. Under stress, epinephrine\ncontracts the sinusoids, increasing the number of circulating platelets. In\npatients with congestive splenomegaly, the spleen can accommodate more\nplatelets; 90% of platelets may be pooled in the sinusoids. Platelet\nsequestration is typical of patients with advanced cirrhosis and portal\nhypertension.\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Increased pooling of platelets in the\nspleen is the most important cause of thrombocytopenia in this patient.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Rarely, severe alcohol\ntoxicity can cause marrow suppression, but this would not be the principal\ncause of thrombocytopenia in this patient.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Thrombopoietin, a\nhormone required for platelet production, is synthesized in the liver.\nThrombopoietin deficiency may contribute to this patient&rsquo;s thrombocytopenia,\nbut it is not the main cause.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . &ldquo;Target&rdquo; cells are\nseen in thalassemia and liver disease. Thalassemia is not associated with thrombocytopenia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n34-year-old woman visits her physician because of &ldquo;tiny spots&rdquo; that have\nappeared on her legs. She has no other symptoms. Examination shows petechiae on\nthe legs. Laboratory tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  14.0\ng/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mean\ncorpuscular volume:\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  84\n&mu;m3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Leukocyte\ncount:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  8,000/mm3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Neutrophils\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  65%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lymphocytes\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  30%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Monocytes\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  5%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelet\ncount\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  18,000/mm3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\nperipheral blood smear shows normal red cell morphology. A bone marrow smear\nshows\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  mature\nmegakaryocytic hyperplasia. Which of the following conditions is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Several findings suggest a diagnosis of immune\nthrombocytopenic purpura (ITP): severe thrombocytopenia, normal hemoglobin\nconcentration, normal leukocyte count, no adenopathy, no splenomegaly, and no\nsymptoms of systemic disease. The presence of megakaryocytic hyperplasia in the\nbone marrow suggests platelet destruction (as opposed to decreased production)\nas a cause of thrombocytopenia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Cirrhosis may be associated with portal\nhypertension, splenomegaly, and hypersplenism, resulting in thrombocytopenia.\nTypically, the thrombocytopenia is not severe. Examination may show\nsplenomegaly and stigmata of chronic liver disease. Anemia may be present and\ntarget cells may be seen on examination of the peripheral blood smear.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Patients with aplastic anemia typically\npresent with pancytopenia. The bone marrow is unable to produce enough new\ncells to maintain normal blood cell counts. Megakaryocytic hyperplasia does not\noccur.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Thrombotic thrombocytopenia\npurpura (TTP) is characterized by microangiopathic hemolytic anemia and\nthrombocytopenia. Fever, neurological dysfunction, and renal insufficiency may\nbe present. Microangiopathic hemolysis results in schistocytes (fragmented red\nblood cells), which are visible on examination of the peripheral blood smear.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The most\nsalient findings in this case are petechiae and\n  <b>\n   thrombocytopenia\n  </b>\n  . Petechiae are small, non-blanching red or purple\nspots on the skin or mucous membranes caused by minor bleeding. Bleeding\nbeneath the skin is classified by the size of the discoloration.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Petechia\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1-3\nmm\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Purpura\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3\nmm-1 cm\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Ecchymosis\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  &gt;1 cm\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Any of the\nfollowing factors may predispose a patient to bleeding.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Platelet deficiency or\ndysfunction\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Coagulation disorders\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Increased capillary\nfragility\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\nvignette, the cause of the bleeding is suggested by the low platelet count. A\nnormal platelet count is 150,000 &ndash; 450,000/mm\n  <sup>\n   3\n  </sup>\n  .\nThrombocytopenia is defined as a platelet count less than 150,000/ mm\n  <sup>\n   3\n  </sup>\n  .Generally,\nbleeding caused by minor trauma is not observed until the platelet count falls\nbelow 50,000/ mm\n  <sup>\n   3\n  </sup>\n  . Spontaneous bleeding usually occurs when the\ncount falls below 10,000/ mm\n  <sup>\n   3\n  </sup>\n  .\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Thrombocytopenia\nmay cause bleeding in the skin or mucous membranes. Common presentations\ninclude gingival bleeding, epistaxis, menorrhagia, and minor bleeding of the\ngastrointestinal or genitourinary tracts. In the absence of trauma, gross\nhematuria and major gastrointestinal bleeding are rare. By contrast, patients\nwith a coagulation disorder may present with deep muscular bleeding,\nhemarthrosis, or retroperitoneal bleeding.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"146\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Thrombocytopenia\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"146\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Coagulation disorders\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"146\">\n    <p class=\"MsoNormal\">\n     <span>\n      Easy\n  bruising\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Mucosal\n  bleeding\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Gum bleeding\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Epistaxis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      GI bleeding (mild)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      GU bleeding (mild)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"146\">\n    <p class=\"MsoNormal\">\n     <span>\n      Deep\n  muscular bleeding\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Hemarthrosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Retroperitoneal\n  bleeding\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Usually,\npatients with a consumptive process (immune thrombocytopenic purpura,\nhypersplenism) have a lower risk of bleeding than patients with impaired\nplatelet production. Intracranial bleeding, though extremely rare, is the most\ncommon cause of death from thrombocytopenia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Acute\n  </span>\n </i>\n <span>\n  ITP is a transient, mostly postinfectious\ndisorder characterized by platelet destruction. It occurs mainly in children\nwith a peak age between 2 and 5 years.\n  <i>\n   Chronic\n  </i>\n  immune thrombocytopenic purpura (ITP) is an immune-mediated\nthrombocytopenia occurring primarily in adults (although children may be\naffected). Platelets coated with IgG autoantibodies undergo accelerated\nclearance by macrophages, predominantly in the spleen and liver. The condition\nis more common in women than men. ITP is a diagnosis of exclusion. The criteria\nfor diagnosing ITP appear below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Criteria for ITP\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Thrombocytopenia\n  (with large platelets)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normal\n  hemoglobin concentration\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normal\n  leukocyte count\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      No\n  adenopathy or splenomegaly\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normal\n  or increased numbers of megakaryocytes in bone marrow\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      No other\n  explanation for thrombocytopenia\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Cirrhosis", "B. Aplastic anemia", "C. Immune thrombocytopenic purpura", "D. Thrombotic thrombocytopenic purpura"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Match each\nof the following vignettes with the most likely type of leukemia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  1. A\n62-year-old man visits his doctor for a routine physical. He denies any complaints,\nsuch as fever or chills, weight loss, or fatigue. Of note, his blood tests show\nan elevated white blood cell count of 16,000/mm\n  <sup>\n   3\n  </sup>\n  . 80% of the white\nblood cells are mature lymphocytes.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  2. A\n54-year-old man has a 2-month history of fever, malaise, and weight loss. He\nalso reports abdominal fullness, early satiety, and frequent nosebleeds. On\nexam, he is found to have splenomegaly. Cytogenetic analysis reveals a t(9;22)\nchromosomal translocation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  3. A\n38-year-old man has a 1-month history of fatigue, nosebleeds, and weight loss.\nPhysical examination shows mild pallor and petechial hemorrhages over his lower\nlimbs. He has multiple, widespread small lymph nodes that are palpable and mild\nsplenomegaly. Peripheral blood smear shows numerous &ldquo;blast&rdquo; cells.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  4. A\n58-year-old man has fatigue, bruising on his legs, and aching bones. On\nexamination, he is pale and has bony tenderness over the sternum and tibia.\nPetechiae are present on the legs. There are no palpable lymph nodes. The liver\nand spleen are not palpable. Bone marrow biopsy shows Auer rods are seen in the\ncytoplasm of &ldquo;blast&rdquo; cells.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<p>\n Answers\n</p>\n"], "tutorial": "<p>\n <b>\n  Chronic\n  <span>\n   lymphoid leukemia\n  </span>\n  (CLL)\n </b>\n is the most common type of leukemia. It affects B cell lymphocytes,\nwhich originate in the bone marrow, develop in lymph nodes, and normally fight\ninfection by producing antibodies. In CLL, the DNA of a B cell is damaged, so\nthat it cannot produce antibodies; patients are often immunocompromised as a\nresult. B cells grow out of control and accumulate in the bone marrow and\nblood, where they crowd out healthy blood cells. CLL usually presents in\nadults; most newly diagnosed patients are over the age of 50. Affected\nindividuals are often symptomatic. The clue to the diagnosis may be an abnormal\nblood test; patients typically have a high white blood cell count with a\npreponderance of mature lymphocytes. As CLL progresses, lymphadenopathy,\nsplenomegaly, hepatomegaly, and eventually anemia and infections occur. Early\nCLL is typically not treated; late CLL is treated with chemotherapy and other\nmodalities. Molecular\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n analysis has\ndistinguished two major types of CLL with different survival times. CLL lacking\nsomatic hypermutation of the immunoglobulin heavy chain gene is usually\npositive for the marker ZAP-70 has an average survival of 5 years. CLL with\nsomatic hypermutation of the immunoglobulin heavy chain gene is negative for\nZAP-70 and has an average survival of more than 25 years. Many patients,\nespecially older ones, with slowly progressing disease can be reassured that\nthey may not need any treatment in their lifetime.\n</p>\n\n<p>\n <b>\n  Chronic myelogenous\nleukemia\n </b>\n <b>\n  (\n  <span>\n   CML\n  </span>\n  )\n </b>\n is a form of leukemia characterized by the increased and\nunregulated growth of predominantly myeloid cells in the bone marrow and the\naccumulation of these cells in the blood. CML is a clonal bone marrow stem cell\ndisorder in which proliferation of mature granulocytes (neutrophils,\neosinophils, and basophils) and their precursors is the main finding. It is a\ntype of myeloproliferative neoplasm associated with a characteristic\nchromosomal translocation called the Philadelphia chromosome. Patients are\noften asymptomatic at diagnosis, presenting incidentally with an elevated white\nblood cell count on a routine laboratory test. Symptoms of CML may include\nleft-sided abdominal pain due to an enlarged spleen, malaise, joint or hip\npain, anemia, and thrombocytopenia with easy bruising (although an\n <i>\n  increased\n </i>\n platelet count may also occur). CML is often suspected on the basis of an\nabnormal blood count, which shows increased granulocytes of all types,\ntypically including mature myeloid cells. Basophils and eosinophils are almost\nalways increased. A bone marrow biopsy is performed as part of the evaluation.\nCML is diagnosed by detecting the Philadelphia chromosome. The\n <span>\n  Philadelphia chromosome\n </span>\n is specific\nfor CML. It is the result of a reciprocal translocation between chromosome 9\nand 22. The genes involved are\n <i>\n  abl1\n </i>\n (Abelson protoncogene) on chromosome 9, a tyrosine kinase, and\n <i>\n  bcr\n </i>\n (breakpoint cluster region) on\nchromosome 22; the resulting fusion gene leads to dysregulation of the abl\ntyrosine kinase. CML is now largely treated with tyrosine kinase inhibitors\n(TKIs) such as imatinib mesylate (Gleevec), which have led to dramatically\nimproved survival rates.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347350\"\n o:spid=\"_x0000_i1110\" type=\"#_x0000_t75\" alt=\"Description: philadelphia_chromosome\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image443.jpg\" o:title=\"philadelphia_chromosome\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: philadelphia_chromosome\" border=\"0\" height=\"186\" src=\"_%20Tutorials_files/image444.png\" v:shapes=\"Picture_x0020_347350\" width=\"240\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Acute\nlymphoblastic leukemia\n  </span>\n </b>\n <b>\n  <span>\n   (\n   <span>\n    ALL\n   </span>\n   )\n  </span>\n </b>\n <span>\n  is a form of leukemia characterized by\nexcess lymphoblasts. It is most common in childhood with a peak incidence at\n2-5 years of age, and another peak in old age. The overall cure rate in\nchildren is about 80%. &ldquo;\n  <span>\n   Acute&rdquo;\n  </span>\n  refers to the relatively short time course of the disease, being fatal in as\nlittle as a few weeks if untreated. Findings may include fatigue, anemia,\nweight loss, loss of appetite, excessive bruising, bone pain, joint pain,\nbreathlessness, enlarged lymph nodes, hepatomegaly, splenomegaly, and petechiae\n(due to thrombocytopenia).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Symptoms\nare so general that many other diseases must be considered in the differential\ndiagnosis. Typically, the higher the white blood cell count, the worse the\nprognosis. Blast cells are seen on blood smears in majority of cases.\nDefinitive diagnosis is made by flow cytometry on peripheral blood or bone\nmarrow. Important prognostic factors include age, WBC count and cytogenetic\nanalysis. The majority of cases are composed of immature B lineage cells (B\nlymphoblastic leukemia or precursor B-cell ALL); a minority are composed of\nimmature T lineage cells (T lymphoblastic or precursor T-cell ALL). Treatment\nis prolonged (2.5 to 3 years) and includes a long maintenance phase. Central\nnervous system relapse is common if prophylactic treatment is not used.\n </span>\n</p>\n\n<p>\n <b>\n  Acute myeloid leukemia\n </b>\n is a cancer of the myeloid line of blood cells, characterized by the rapid\ngrowth of immature myeloid cells that accumulate in the bone marrow and\ninterfere with the production of normal mature blood cells. AML is the most\ncommon acute leukemia affecting adults. Symptoms are caused by replacement of\nnormal bone marrow with leukemic cells, which causes a drop in red blood cells,\nplatelets, and normal white blood cells. These symptoms include fatigue,\nshortness of breath, easy bruising and bleeding, bone pain, joint pain, and\nincreased risk of infection. As an acute leukemia, AML progresses rapidly and\nis typically fatal within weeks or months if untreated. Enlargement of the\nspleen may occur but is usually mild and asymptomatic. Lymph node swelling is\nrare, in contrast to acute lymphoblastic leukemia. The first clue to a\ndiagnosis of AML is typically an abnormal blood count.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n While an excess of abnormal white blood\ncells (leukocytosis) is a common finding, and leukemic blasts are sometimes\nseen, AML can also present with\n <i>\n  low\n </i>\n white blood cell count. Definitive\ndiagnosis usually requires an adequate bone marrow aspiration and biopsy. Auer\nrods, which are specific for AML, may be seen. Auer rods are clumps of\nazurophilic granular material that form elongated needles seen in the cytoplasm\nof leukemic blasts. Important prognostic factors include age, results of\ncytogenetic analysis, and more recently the presence of specific genetic\nmutations.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347349\"\n o:spid=\"_x0000_i1109\" type=\"#_x0000_t75\" alt=\"Description: stains1\">\n <v:imagedata src=\"_%20Tutorials_files/image445.jpg\" o:title=\"stains1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: stains1\" border=\"0\" height=\"204\" src=\"_%20Tutorials_files/image446.png\" v:shapes=\"Picture_x0020_347349\" width=\"293\"/>\n </span>\n</p>\n\n<p align=\"center\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/f/f1/Myeloblast_with_Auer_rod_smear_2010-01-27.JPG\">\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347348\" o:spid=\"_x0000_i1108\" type=\"#_x0000_t75\" alt=\"Description: Description: File:Myeloblast with Auer rod smear 2010-01-27.JPG\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/f/f1/Myeloblast_with_Auer_rod_smear_2010-01-27.JPG\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image447.jpg\" o:title=\"Myeloblast with Auer rod smear 2010-01-27.JPG\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: Description: File:Myeloblast with Auer rod smear 2010-01-27.JPG\" border=\"0\" height=\"265\" src=\"_%20Tutorials_files/image448.png\" v:shapes=\"Picture_x0020_347348\" width=\"353\"/>\n  </span>\n </a>\n</p>\n\n<p align=\"center\">\n Auer\nrods in a patient with AML\n</p>\n", "choices": ["A. Acute lymphoblastic leukemia", "B. Acute myeloid leukemia", "C. Chronic lymphoid leukemia", "D. Chronic myelogenous leukemia"]}, {"question": "<p>\n <span>\n  1.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n C.\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n An\nelevated white blood cell count, comprised mainly of mature lymphocytes, is\nconsistent with CLL.\n</p>\n\n<p>\n <span>\n  2.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n D.\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n The\nPhiladelphia chromosome is specific for CML.\n</p>\n\n<p>\n <span>\n  3.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n A.\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n The\npresence of lymphadenopathy and blasts in the blood is consistent with ALL.\n</p>\n\n<p>\n <span>\n  4.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n B.\n <span>\n  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n </span>\n Auer\nrods are specific for AML.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n52-year-old woman has adenocarcinoma of the left breast. Resection of the tumor\nis scheduled, and the physician plans to obtain samples of the draining nodes.\nTo find these nodes, a radiotracer is injected adjacent to the tumor and images\nare obtained. The first draining sentinel node in this patient is most likely\nfound at which of the following locations?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct\n </b>\n .\nMultiple myeloma is a cancer of plasma cells (white blood cells that produce\nantibodies). Image E depicts a plasma cell. (Other images: A = neutrophil, B =\nlymphocyte, C = basophil, D = eosinophil.)\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  A\n12-year-old boy is brought to the physician by his father because of redness\nand swelling of his left foot for 24 hours. Three days ago the boy scraped his\nfoot while wading in a drainage ditch. Examination of the left foot shows a\npurulent abrasion with edema, erythema, and tenderness on the lateral side.\n&nbsp;Infection is most likely to next spread from the lateral side of the foot\nto the regional lymph nodes in which of the following areas?\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lateral surface of the thigh\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Medial malleolus, posteriorly\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Popliteal fossa\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Sole of the foot\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Superficial inguinal area\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Head and Neck\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nlymphatic drainage system of the head and neck is shown below. Nodes in the\nneck are located either in the anterior triangle (anterior to the\nsternocleidomastoid) or posterior triangle (posterior to the\nsternocleidomastoid). Please note that lung cancer, gastrointestinal cancer,\nand genitourinary cancers can present with supraclavicular lymphadenopathy.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347347\"\n o:spid=\"_x0000_i1107\" type=\"#_x0000_t75\" alt=\"Description: afp20021201p2103-f1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image449.png\" o:title=\"afp20021201p2103-f1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: afp20021201p2103-f1\" border=\"0\" height=\"311\" src=\"_%20Tutorials_files/image450.png\" v:shapes=\"Picture_x0020_347347\" width=\"453\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Breast\n  </span>\n </b>\n <span>\n  <b>\n   and\nupper extremity\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lymph\ndrainage of the breast and upper extremity is shown below. Approximately 75% of\nthe lymph from the breast travels to ipsilateral axillary lymph\n  <i>\n  </i>\n  nodes; 25% travels to the internal\nthoracic nodes, to the contralateral breast, and to the abdominal lymph nodes.\nThe\n  <i>\n   axillary lymph nodes\n  </i>\n  include the\nanterior (pectoral), posterior (subscapular), medial (apical), lateral\n(brachial), and central lymph-node groups. The lymphatic drainage of the\nbreasts is especially relevant to oncology, because breast cancer cells can be\ndispersed through the lymphatic system. Usually, the first place to which\nbreast cancer spreads is the ipsilateral axillary nodes.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347346\" o:spid=\"_x0000_i1106\"\n type=\"#_x0000_t75\" alt=\"Description: image002\">\n <v:imagedata src=\"_%20Tutorials_files/image451.jpg\" o:title=\"image002\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: image002\" border=\"0\" height=\"271\" src=\"_%20Tutorials_files/image452.png\" v:shapes=\"Picture_x0020_347346\" width=\"358\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nlymph glands of the upper extremity are divided into two sets,\n  <span>\n   superficial\n  </span>\n  and\n  <span>\n   deep. Superficial lymph glands\n  </span>\n  include\nthe\n  <span>\n   supratrochlear glands\n  </span>\n  and\nthe\n  <span>\n   deltopectoral glands. The\n  </span>\n  <i>\n   <span>\n    supratrochlear\nglands\n   </span>\n  </i>\n  are above the medial epicondyle of the humerus. Their\nafferents drain the middle, ring, and little fingers, the medial portion of the\nhand, and the superficial area over the ulnar side of the forearm. The\n  <i>\n   <span>\n    deltopectoral\nglands\n   </span>\n  </i>\n  <span>\n   collect lymph from\nthe lateral side of the hand, forearm, and arm. Ultimately, these superficial\nlymph channels drain into deeper channels. All upper extremity lymph flows\ntoward the\n   <i>\n    axillary nodes\n   </i>\n   .\n  </span>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Chest\n   <a name=\"thoracic_duct\">\n   </a>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\n  <i>\n   thoracic duct\n  </i>\n  is the\n  <span>\n   largest lymphatic channel\n  </span>\n  in the body.\nIt extends from the\n  <span>\n   1st lumbar vertebra\n  </span>\n  to the\n  <span>\n   root of the neck, and drains t\n  </span>\n  he\n  <span>\n   left arm\n  </span>\n  ,\n  <span>\n   left neck\n  </span>\n  and\n  <span>\n   head\n  </span>\n  ,\n  <span>\n   left thorax\n  </span>\n  ,\n  <span>\n   left upper abdomen\n  </span>\n  (to umbilicus),\n  <span>\n   both sides\n  </span>\n  of the\n  <span>\n   abdomen below the umbilicus,\n  </span>\n  and\n  <span>\n   both lower limbs.\n  </span>\n  The thoracic duct is\nlocated anterior to the vertebral bodies, posterior to the esophagus, and to\nthe right of the descending aorta.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  It terminates at the junction of the left internal jugular and left\nsubclavian veins.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  On the right, a\nsimilar lymph channel, the\n  <i>\n   right\nlymphatic duct\n  </i>\n  , receives lymph from the right upper chest, the right side\nof the head, and the right upper limb.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347345\"\n o:spid=\"_x0000_i1105\" type=\"#_x0000_t75\" alt=\"Description: 91776-1\">\n <v:imagedata src=\"_%20Tutorials_files/image453.png\" o:title=\"91776-1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: 91776-1\" border=\"0\" height=\"317\" src=\"_%20Tutorials_files/image454.png\" v:shapes=\"Picture_x0020_347345\" width=\"320\"/>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Abdomen and Pelvis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lymph from\norgans below the diaphragm flows toward the paraaortic nodes. Lymph carrying\nnutrients from the mid-gut and hind-gut (organs supplied by the superior\nmesenteric and inferior mesenteric arteries) flows toward the liver.\nConsequently, cancer of the pancreas, intestine, and colon can easily\nmetastasize to the liver. (The liver then sends lymph to the paraaortic,\nmediastinal, axillary, and umbilical nodes). Lymph from the gonads travels\nthrough lymphatic vessels near the vertebral bodies. Consequently, gonadal\ncancer can easily metastasize to bone.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Lower extremity\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The lymph\nglands of the lower extremity consist of the\n  <span>\n   anterior tibial gland,\n  </span>\n  the\n  <span>\n   popliteal\n  </span>\n  glands, and the\n  <span>\n   inguinal glands.\n  </span>\n  The\n  <i>\n   <span>\n    anterior\ntibial gland\n   </span>\n  </i>\n  is small and inconstant. The\n  <i>\n   <span>\n    popliteal lymph glands\n   </span>\n  </i>\n  ,\nsmall in size, are imbedded in the fat contained in the popliteal fossa. They receive\nlymph drainage from the lateral aspect of the foot. The\n  <i>\n   <span>\n    inguinal glands\n   </span>\n  </i>\n  are\nsituated at the upper part of the femoral triangle and receive lymph from the\nlower extremity and scrotum.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Question 1. Answer B is correct.\n  </span>\n </b>\n <span>\n  Most lymph from the\nbreast travels to the ipsilateral axillary lymph nodes.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Question 2. Answer C is correct.\n  </span>\n </b>\n <span>\n  Lymph from the lateral\naspect of the foot travels first to the popliteal nodes in the popliteal fossa.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n72-year-old man presents to the clinic with low back pain of two months\nduration. His blood tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  10.5 g/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hematocrit\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  30%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  BUN\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  40\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Creatinine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2.0\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Calcium\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  11\nmg/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Albumin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3.0\ng/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Total\nprotein\n  <span>\n   &nbsp;&nbsp;\n  </span>\n  8.4 g/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Urine\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4+\nprotein\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Bone\nmarrow examination is most likely to show uncontrolled proliferation of which\nof the following cells?\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347344\" o:spid=\"_x0000_i1104\"\n type=\"#_x0000_t75\" alt=\"Description: http://www.oncolink.org/coping/images/neutrophil.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image455.jpg\" o:title=\"//www.oncolink.org/coping/images/neutrophil.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.oncolink.org/coping/images/neutrophil.jpg\" border=\"0\" height=\"125\" src=\"_%20Tutorials_files/image456.png\" v:shapes=\"Picture_x0020_347344\" width=\"122\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347343\" o:spid=\"_x0000_i1103\"\n type=\"#_x0000_t75\" alt=\"Description: http://sashiimii.files.wordpress.com/2010/08/lymphocyte-01a.jpeg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image457.jpg\" o:title=\"//sashiimii.files.wordpress.com/2010/08/lymphocyte-01a.jpeg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://sashiimii.files.wordpress.com/2010/08/lymphocyte-01a.jpeg\" border=\"0\" height=\"121\" src=\"_%20Tutorials_files/image458.png\" v:shapes=\"Picture_x0020_347343\" width=\"121\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347342\" o:spid=\"_x0000_i1102\"\n type=\"#_x0000_t75\" alt=\"Description: http://www.profelis.org/neu/ap2/jpegs/basophil-01a.jpeg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image459.jpg\" o:title=\"//www.profelis.org/neu/ap2/jpegs/basophil-01a.jpeg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.profelis.org/neu/ap2/jpegs/basophil-01a.jpeg\" border=\"0\" height=\"122\" src=\"_%20Tutorials_files/image460.png\" v:shapes=\"Picture_x0020_347342\" width=\"122\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347341\" o:spid=\"_x0000_i1101\"\n type=\"#_x0000_t75\" alt=\"Description: http://www.phartoonz.com/wp-content/uploads/2010/11/eosinophil4.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image461.jpg\" o:title=\"//www.phartoonz.com/wp-content/uploads/2010/11/eosinophil4.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.phartoonz.com/wp-content/uploads/2010/11/eosinophil4.jpg\" border=\"0\" height=\"115\" src=\"_%20Tutorials_files/image462.png\" v:shapes=\"Picture_x0020_347341\" width=\"121\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347340\" o:spid=\"_x0000_i1100\"\n type=\"#_x0000_t75\" alt=\"Description: http://pathology.mc.duke.edu/website/images/grad/Histo_course/plasmacell.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image463.jpg\" o:title=\"//pathology.mc.duke.edu/website/images/grad/Histo_course/plasmacell.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://pathology.mc.duke.edu/website/images/grad/Histo_course/plasmacell.jpg\" border=\"0\" height=\"169\" src=\"_%20Tutorials_files/image464.png\" v:shapes=\"Picture_x0020_347340\" width=\"123\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p>\n <b>\n  Multiple myeloma\n </b>\n is a cancer of plasma cells. The malignant cells\naccumulate in bones, where they cause bone lesions, and in bone marrow where\nthey interfere with the production of normal blood cells. Most patients produce\nan abnormal antibody called a &ldquo;paraprotein,&rdquo; which causes renal disease and\ninterferes with normal antibody production.\n</p>\n\n<p>\n A tetrad of findings is\ncommon in myeloma: hypercalcemia, renal failure, normocytic anemia, and bone\ndisease. The mnemonic, CRAB, is often used for this tetrad: C = calcium\n(hypercalcemia), R = renal failure, A = anemia, B = bone lesions. Because\nparaproteins enter the blood and spill into urine, most patients have high\nserum protein levels (despite having low serum albumin levels) and proteinuria.\n</p>\n\n<p>\n <span>\n  Hypercalcemia and Bone lesions\n </span>\n</p>\n\n<p>\n <span>\n  Multiple\nmyeloma is unique in its propensity to cause osteolysis. Most patients suffer\nprogressive bone destruction, especially of the spine and ribs. Osteolysis is\ncaused by osteoclast activation, and commonly results in hypercalcemia, severe\nand unremitting bone pain, pathologic fractures, and spinal cord compression.\nThe hypercalcemia may be mild to life-threatening. Osteolysis produces\n </span>\n \"punched-out\"\nbone lesions (see radiograph of &ldquo;pepper pot\" skull below).\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Renal failure\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Renal\nfailure, which may be acute or chronic, is commonly caused by hypercalcemia.\nSome patients with myeloma produce abnormal light chains, called Bence-Jones\nproteins, which damage renal tubules.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"mw-headline\">\n  <span>\n   Anemia\n  </span>\n </span>\n</p>\n\n<p>\n The anemia of multiple\nmyeloma is usually normocytic and normochromic. It results from marrow\nreplacement by malignant cells and by cytokine-mediated inhibition of\nhematopoiesis.\n</p>\n\n<p>\n <span>\n  Infection\n </span>\n</p>\n\n<p>\n Patients with myeloma are\npredisposed to infection because of immunodeficiency. (Normal antibody\nproduction is suppressed). The most common infections are pneumonia and\npyelonephritis.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n The presence of unexplained\nhypercalcemia, bone pain, renal failure, and anemia should prompt further\ntesting for multiple myeloma, especially in the presence of high serum protein\nlevels and low serum albumin levels. Serum and urine protein electrophoresis\nshould be undertaken to look for a &ldquo;monoclonal spike,&rdquo; evidence of a\nparaprotein (see figures below).\n</p>\n\n<p>\n Myelomas can produce all\nclasses of immunoglobulin, IgG being the most common. Some myelomas produce\nlight and/or heavy chains (&kappa;- or &lambda;-light chains or any of the five\ntypes of heavy chains: &alpha;, &gamma;, &delta;, &epsilon; or &mu;).\n</p>\n\n<p>\n Multiple myeloma is the\nsecond most common hematological malignancy, constituting 1% of all cancers.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347339\"\n o:spid=\"_x0000_i1099\" type=\"#_x0000_t75\" alt=\"Description: wcd spep normal c graph\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image465.jpg\" o:title=\"wcd spep normal c graph\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: wcd spep normal c graph\" border=\"0\" height=\"108\" src=\"_%20Tutorials_files/image466.png\" v:shapes=\"Picture_x0020_347339\" width=\"162\"/>\n </span>\n</p>\n\n<p align=\"center\">\n Normal\nserum protein electrophoresis\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347338\"\n o:spid=\"_x0000_i1098\" type=\"#_x0000_t75\" alt=\"Description: wcd spep monoclonal iga\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image467.jpg\" o:title=\"wcd spep monoclonal iga\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: wcd spep monoclonal iga\" border=\"0\" height=\"108\" src=\"_%20Tutorials_files/image468.png\" v:shapes=\"Picture_x0020_347338\" width=\"162\"/>\n </span>\n</p>\n\n<p align=\"center\">\n Serum\nelectrophoresis with &ldquo;monoclonal spike&rdquo;\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347337\"\n o:spid=\"_x0000_i1097\" type=\"#_x0000_t75\" alt=\"Description: myeloma_skull+xray\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image469.jpg\" o:title=\"myeloma_skull+xray\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: myeloma_skull+xray\" border=\"0\" height=\"205\" src=\"_%20Tutorials_files/image470.png\" v:shapes=\"Picture_x0020_347337\" width=\"213\"/>\n </span>\n</p>\n\n<p align=\"center\">\n &ldquo;Punched\nout&rdquo; skull lesions in multiple myeloma\n</p>\n", "choices": ["A. Contralateral neck", "B. Ipsilateral axilla", "C. Ipsilateral mediastinum", "D. Ipsilateral supraclavicle", "E. Medial contralateral breast"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  The\nquaternary structure of hemoglobin adapts to the chemical environment of the\nblood. In its relaxed (R) form, hemoglobin has a high affinity for oxygen; in\nits taut (T) form, hemoglobin has a lower affinity for oxygen. At a given\npartial pressure of oxygen, which of the following will increase the amount of\ntaut hemoglobin?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Factors that increase\nthe amount of taut hemoglobin are those that shift the oxygen dissociation\ncurve to the right. Shifting the curve to the right facilitates oxygen\nunloading; shifting the curve to the left facilitates oxygen uptake. Factors\nthat shift the curve to the right include binding of carbon dioxide to\nhemoglobin, increased temperature, increased 2,3-DPG, and increased acidity\n(lower pH). Factors that shift the curve to the left include binding of oxygen\nto hemoglobin, decreased temperature, decreased 2,3-DPG, decreased acidity\n(higher pH), and carbon monoxide binding to hemoglobin.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347336\"\n o:spid=\"_x0000_i1096\" type=\"#_x0000_t75\" alt=\"Description: Oxygen dissociation curve\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image471.jpg\" o:title=\"Oxygen dissociation curve\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Oxygen dissociation curve\" border=\"0\" height=\"350\" src=\"_%20Tutorials_files/image472.png\" v:shapes=\"Picture_x0020_347336\" width=\"360\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\n  <b>\n   oxygen-hemoglobin dissociation curve\n  </b>\n  shows the saturation of hemoglobin as a function of pO\n  <sub>\n   2\n  </sub>\n  . The\nsigmoidal shape of the curve indicates that as pO\n  <sub>\n   2\n  </sub>\n  increases,\nbinding of O\n  <sub>\n   2\n  </sub>\n  to hemoglobin increases until a plateau is reached.\nThis effect is due to the structure of hemoglobin.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\nis a tetramer. Each of the four monomers consists of a heme group that binds O\n  <sub>\n   2\n  </sub>\n  and a globin chain. In the absence of O\n  <sub>\n   2\n  </sub>\n  the four chains interact in\nsuch a way that the affinity for O\n  <sub>\n   2\n  </sub>\n  is very low; this state of\nhemoglobin is termed the taut or tensed (T) state. Once some O\n  <sub>\n   2\n  </sub>\n  molecules have bound to hemoglobin, the four monomers reduce their affinity for\neach other which facilitates the binding of more O\n  <sub>\n   2\n  </sub>\n  ; this state of\nhemoglobin is termed the relaxed (R) state.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The four\nbinding sites in a hemoglobin molecule are said to express cooperativity,\nbecause at low pO\n  <sub>\n   2\n  </sub>\n  levels there is not much binding of O\n  <sub>\n   2\n  </sub>\n  to hemoglobin, but as pO\n  <sub>\n   2\n  </sub>\n  increases the binding of O\n  <sub>\n   2\n  </sub>\n  to\nhemoglobin increases. The pO\n  <sub>\n   2\n  </sub>\n  in arterial blood is normally about\n100 mm Hg, which means hemoglobin saturation is about 97.5%. The pO\n  <sub>\n   2\n  </sub>\n  in venous blood is normally about 40 mm Hg, which means that hemoglobin\nsaturation is about 75%.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Several\nfactors can alter the O\n  <sub>\n   2\n  </sub>\n  binding affinity of hemoglobin. As\ntemperature, the concentration of 2,3-diphosphoglycerate (2,3-DPG), [H\n  <sup>\n   +\n  </sup>\n  ],\nand/or CO\n  <sub>\n   2\n  </sub>\n  increase, the O\n  <sub>\n   2\n  </sub>\n  binding affinity of\nhemoglobin decreases, resulting in a rightward shift of the oxygen-hemoglobin\ndissociation curve. The result is that more O\n  <sub>\n   2\n  </sub>\n  is unloaded from\nhemoglobin. Decreases in these same factors, or the presence of carbon monoxide\n(CO), increase the O\n  <sub>\n   2\n  </sub>\n  binding affinity of hemoglobin. The result is\nthat unloading of O\n  <sub>\n   2\n  </sub>\n  is reduced.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Are the\nfactors that can change affinity of O\n  <sub>\n   2\n  </sub>\n  to hemoglobin physiologically\nsignificant? Yes. A metabolically active tissue requires more O\n  <sub>\n   2\n  </sub>\n  .\nMetabolism produces heat which increases temperature and produces a reduction\nin pH (increased [H\n  <sup>\n   +\n  </sup>\n  ]) and increase in CO\n  <sub>\n   2\n  </sub>\n  . Each of these\nfactors shifts the oxygen-hemoglobin dissociation curve to the right, reducing\nthe O\n  <sub>\n   2\n  </sub>\n  affinity of hemoglobin, which facilitates the unloading of\nmore O\n  <sub>\n   2\n  </sub>\n  to the metabolizing tissue. In contrast, in the lungs CO\n  <sub>\n   2\n  </sub>\n  is excreted which reduces CO\n  <sub>\n   2\n  </sub>\n  and [H\n  <sup>\n   +\n  </sup>\n  ], and the\ntemperature is lower because of less metabolism. Each of these factors shifts\nthe curve to the left which enhances O\n  <sub>\n   2\n  </sub>\n  affinity of hemoglobin,\nfacilitating O\n  <sub>\n   2\n  </sub>\n  uptake.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  2,3-DPG is\na product of metabolism in red blood cells (RBCs) that binds to hemoglobin,\ninhibiting the binding of O\n  <sub>\n   2\n  </sub>\n  . Low pO\n  <sub>\n   2\n  </sub>\n  (hypoxia) enhances\nthe metabolism in RBCs which increases the blood level of 2,3-DPG. This does\ninhibit the loading of O\n  <sub>\n   2\n  </sub>\n  onto hemoglobin, but this effect is\nmodest. More importantly, at the tissue level the rightward shift of the curve\nincreases unloading of O\n  <sub>\n   2\n  </sub>\n  to tissues in the hypoxic state.\n </span>\n</p>\n", "choices": ["A. Excess carbon monoxide", "B. Decreasing pH", "C. Increasing the number of oxygen molecules bound to hemoglobin", "D. Decreasing 2,3-DPG (diphosphoglycerate) in RBCs", "E. Decreased binding of carbon dioxide to hemoglobin"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n58-year-old man with a 40 pack-year smoking history presents with exertional\nleg pain of six months duration. He experiences cramping in both calves with\nwalking. The pain is relieved by rest. Six months ago, he could walk 5 blocks before\nthe onset of pain. Now he can only walk 3 blocks. Which of the following\nvascular structures is most likely diseased in this man?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct.\n </b>\n This patient has classic leg claudication,\nwhich suggests a diagnosis of peripheral artery disease (PAD). Smoking is a\nmajor risk factor for PAD, a condition in which large arteries become narrowed\nby atherosclerotic plaque. The ankle-brachial index (ABI) should be measured to\nconfirm the diagnosis. Smoking cessation (and management of other risk factors)\nis essential. A regular exercise program (e.g., treadmill walking) should be\nrecommended if the diagnosis is confirmed. Daily aspirin should also be\nrecommended, and revascularization (angioplasty, stent placement, or bypass\ngrafting) may be needed if the condition becomes severe.\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Peripheral\nartery disease (PAD)\n  </span>\n </b>\n <span>\n  is a narrowing of the peripheral arteries, most\ncommonly in the pelvis and lower extremities.\n </span>\n <span>\n  PAD is similar to coronary artery\ndisease (CAD) and carotid artery disease in that all three conditions are\ncaused by atherosclerotic narrowing of arteries in critical regions of the\nbody. Atherosclerosis of the coronary arteries restricts blood flow to the\nheart; atherosclerosis of the carotid arteries restricts blood flow to the\nbrain; and atherosclerosis of the arteries in the pelvis and lower extremities\nrestricts blood flow to the thighs, legs, and feet.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The classic symptom of PAD is pain, cramping, or tiredness in the leg or\nhip muscles that occurs with walking and subsides with rest (claudication);\nhowever, p\n </span>\n <span>\n  atients\nwith mild PAD are usually asymptomatic. Patients with moderate-to-severe PAD\nmay have any of these findings:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Claudication &ndash;\nexertional pain, cramping, or tiredness in affected muscles\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Weak or absent arterial\npulses in the lower extremities\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Sores, wounds, or ulcers\nthat heal slowly or not at all\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Pallor, cyanosis, or\ncoolness of the affected extremity\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Shiny skin or diminished\nhair and nail growth\n </span>\n</p>\n\n<p>\n The first diagnostic test\nusually performed in patients with suspected PAD is the ankle brachial index\n(ABI). The ABI is calculated by dividing the systolic blood pressure at the\nankle by the systolic blood pressures in the arm. When the systolic blood\npressure in the ankle is lower than the pressure in the arm, PAD is suspected.\nA normal ABI is 1.0-1.2. An ABI less than 0.9 is consistent with PAD; values\nbelow 0.5 indicate severe PAD. If the ABI is abnormal, the next step is usually\na Doppler ultrasound examination to determine the location and extent of\natherosclerosis.\n</p>\n\n<p>\n People with PAD have a\n4-to-5-fold greater risk of having a myocardial infarction or stroke. If\nsevere, PAD can lead to gangrene and amputation of the leg or foot. Major risk\nfactors for PAD include smoking, diabetes, hypertension, and dyslipidemia. Complications\nof PAD include thromboembolism. Rupture of an atherosclerotic plaque can\ntrigger clot formation, and the newly formed thrombus can further narrow the\nartery, block the artery, or embolize distally.\n</p>\n\n<p>\n Management of PAD includes\nthe following:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Risk factor management\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Smoking\ncessation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Diabetes\nmanagement\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hypertension\nmanagement\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   o\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lipid\nmanagement\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Antiplatelet drugs\n(i.e., aspirin, clopidogrel)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Exercise: Regular\nexercise improves walking\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Medicine: Cilostazol may\nimprove symptoms of claudication\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Revascularization:\nreserved for severe cases\n </span>\n</p>\n", "choices": ["A. Arteries", "B. Arterioles", "C. Capillaries", "D. Venules", "E. Veins"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Match each\nof the following clinical scenarios with the corresponding peripheral blood\nsmear.\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <span>\n  Answers.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  10.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Multiple myeloma is associated with\nRouleaux (red blood cells stacked like coins.)\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  9.\nSchistocytes are broken red blood cells that occur in microangiopathic\nhemolytic anemia, such as thrombotic thrombocytopenia purpura.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  8.\nTeardrop cells occur\n  <span>\n   in marrow disorders (e.g.,\nmyelofibrosis) associated with extramedullary hematopoiesis.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  7.\nSpherocytes occur in patients with hereditary spherocytosis. [\n  <span>\n   Hereditary spherocytosis\n  </span>\n  is an\nautosomal dominant condition characterized by production of red blood cells\nthat are sphere-shaped rather than bi-concave-disk-shaped. The cells are\nosmotically fragile and, therefore, prone to hemolysis. Hemolysis results in\nanemia, pallor, fatigue, jaundice (from hyperbilirubinemia), and splenomegaly.\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Hereditary_spherocytosis#cite_note-isbn0-7216-0187-1-0#cite_note-isbn0-7216-0187-1-0\">\n </a>\n <span>\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  6.\nIron deficiency anemia is characterized by hypochromic, microcytic red blood\ncells.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   F.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  4.\nSickle cells can be seen in patients with sickle cell anemia.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   G.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  3.\nTarget cells occur in patients with advanced liver disease. They are also\nassociated with a variety of hemoglobinopathies.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   H.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  2.\nHowell-Jolly bodies are basophilic nuclear remnants in red blood cells. They\nare usually removed by the spleen and can be seen in asplenic patients.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   I.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  1.\nBasophilic stippling occurs in patients with lead poisoning.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   J.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  5.\nHypersegmented neutrophils are associated with vitamin B12 and folic acid\ndeficiency.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. 72-year old man with multiple myeloma", "B. 43-year old woman with thrombotic thrombocytopenia purpura", "C. 67-year old man with myelofibrosis", "D. 4-year old boy with hereditary spherocytosis", "E. 42-year old woman with iron deficiency anemia", "F. 12-year old girl with sickle cell anemia", "G. 68-year old man with cirrhosis", "H. 42-year old man whose spleen has been removed", "I. 6-year old boy with lead poisoning", "J. 52-year old woman with vitamin B12 deficiency", "1.", "2.", "3.", "4.", "5.", "6.", "7.", "8.", "9.", "10."]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 57-year-old man develops a deep vein\nthrombosis in his right lower extremity. He has sustained no injury to his leg\nnor taken any long flights. He is a nonsmoker. His only medicines are aspirin\nand lisinopril. He works as a medical technician and enjoys good health. His\nhemogram shows the following:\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  20\ng/dL\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Hematocrit\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  60%\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  WBC count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  18,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Platelet\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  890,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  His chest x-ray is negative.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Treatment with low-molecular-weight\nheparin and warfarin is initiated. What should be ordered next?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The patient has elevated red blood cell,\nwhite blood cell, and platelet counts, suggestive of polycythemia vera. The\nvast majority of patients with polycythemia vera have a mutation in the JAK2\ngene.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Inherited risk factors for thrombosis\nwould not explain the abnormal hemogram.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Occult solid\nmalignancy would not explain the abnormal hemogram.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Bone marrow\nexamination is unlikely to provide a diagnosis.\n </span>\n</p>\n"], "tutorial": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"8\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <b>\n        <span>\n         Polycythemia Vera\n        </span>\n       </b>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"HC048004\">\n       </a>\n       <span>\n        ETIOLOGY AND PATHOGENESIS\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T048001\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T048001.100\">\n    </a>\n    <a name=\"T048001.50\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <div align=\"center\">\n    <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"90%\">\n     <tr>\n      <td width=\"100%\">\n      </td>\n     </tr>\n    </table>\n   </div>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P048004\">\n       </a>\n       <span>\n        PV, literally meaning\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         increased red blood cells in\n    the blood,\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        is a syndrome\n    of increased red blood cell mass in the peripheral blood resulting from a\n    clonal multipotent hematopoietic stem cell defect. When patients are first\n    diagnosed with an elevated hemoglobin per unit volume\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         (erythrocytosis),\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        initial evaluation should focus on\n    whether this increase reflects an enhanced red cell mass (i.e.,\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         absolute erythrocytosis or\n    polycythemia\n        </i>\n        ) or a normal red cell mass in the presence of a decreased\n    plasma volume (i.e.,\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         relative\n    erythrocytosis\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        caused by\n    dehydration or other causes). The latter condition is not true\n    polycythemia. Polycythemia or absolute erythrocytosis is defined as\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         an absolute increase in red\n    cellmass caused by increased red blood cell production.\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        Under normal conditions, the\n    body's ability to increase red blood cell production in states of\n    hypoxemia, anemia, hemolysis, and acute blood loss ensures continuous\n    oxygen delivery to tissues. In response to physiologic stimuli, pluripotent\n    stem cell precursors are activated by erythropoietin (EPO) to differentiate\n    into erythroid progenitor cells and eventually hemoglobin-carrying\n    erythrocytes. When numbers of mature red blood cells are adequate, a\n    negative feedback mechanism suppresses further EPO production, and the\n    serum hemoglobin level remains normal.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P048006\">\n       </a>\n       <span>\n        PV is a primary clonal stem cell\n    disorder of unknown origin that is characterized by predominant erythrocytosis\n    associated with other hematopoietic abnormalities. Although one half of all\n    patients have concurrent leukocytosis or thrombocytosis, erythrocytosis is\n    the hallmark and the cause of the most serious clinical complications of\n    this disease. Diagnosis of PV was formerly one of\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         exclusion\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        based on an elevated red cell\n    mass, splenomegaly, thrombocytosis, leukocytosis, lack of hypoxemia and\n    other secondary causes of polycythemia, and elevated levels of leukocyte\n    alkaline phosphatase and serum vitamin B\n        <sub>\n         12\n        </sub>\n        -binding protein\n    levels. More recent information on the disease pathophysiology has led to\n    new diagnostic criteria based on the discovery of JAK2 mutations in\n    virtually all patients with PV. Identification of low serum EPO levels and\n    EPO-independent erythroid colony growth are now regarded as the only\n    secondary criteria helpful in establishing a primary PV diagnosis.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"HC048005\">\n       </a>\n       <span>\n        CLINICAL FEATURES AND LABORATORY\n    STUDIES\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <a name=\"T048002\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T048002.100\">\n    </a>\n    <a name=\"T048002.50\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T048003\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T048003.150\">\n    </a>\n    <a name=\"T048003.100\">\n    </a>\n    <a name=\"T048003.50\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <div align=\"center\">\n    <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"90%\">\n     <tr>\n      <td width=\"100%\">\n      </td>\n     </tr>\n    </table>\n   </div>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P048007\">\n       </a>\n       <span>\n        The median age at onset of 65\n    years. Early recognition and treatment of PV are important because\n    untreated patients with PV suffer significant morbidity and mortality from\n    thromboembolic disease in the cerebral, coronary, and mesenteric\n    circulations. Twenty percent of patients show symptoms of arterial and\n    venous thrombosis, and thrombosis remains the most common cause of death.\n    Typically, patients complain of headache, visual problems, mental clouding,\n    and pruritus after bathing. Occlusive vascular events such as stroke,\n    transient ischemic attacks, myocardial ischemia, and digital pain, paresthesias,\n    or gangrene are common. In addition, pulmonary, deep vein, hepatic, and\n    portal vein thromboses may occur. Paradoxically, patients are also\n    predisposed to hemorrhagic events, which are presumably caused by abnormal\n    platelet function, and such patients may exhibit gastrointestinal bleeding.\n    Physical examination often shows retinal vein occlusion, ruddy cyanosis,\n    and splenomegaly.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P048011\">\n       </a>\n       <span>\n        <span style=\"mso-spacerun:yes\">\n         &nbsp;\n        </span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n        Peripheral blood often appears microcytic, with or without\n    iron deficiency. Bone marrow examination shows a hypercellular marrow with\n    pronounced hyperplasia of erythroid lineage cells. Cytogenetic features at\n    the time of diagnosis are usually normal; the development of clonal\n    cytogenetic abnormalities heralds transformation in the later stages of\n    disease. The incidence of the JAK2 V617F mutation in patients with PV\n    ranges up to 97% in various studies.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"HC048006\">\n       </a>\n       <span>\n        TREATMENT\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P048012\">\n       </a>\n       <span>\n        Without treatment, one half of\n    all patients with PV die of thrombotic complications within 18 months of\n    diagnosis. With therapy, PV is a chronic, progressive disease. Patients\n    with advanced age, prior history of thrombosis, and high hematocrit values\n    are at high risk for subsequent vascular events. Therefore, intermittent\n    phlebotomy is the mainstay of treatment and usually results in iron\n    deficiency anemia, which further reduces the rate of red blood cell\n    production.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Blood tests for protein C, protein S, antithrombin III, Factor V Leiden, and prothrombin mutation 20210", "B. CT of the chest, abdomen, and pelvis to search for occult malignancy", "C. Bone marrow examination", "D. Blood test for a mutation of the Janus kinase 2 (JAK2) gene"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 60-year-old woman\nwith alcoholic cirrhosis has ascites and esophageal varices. Which of the\nfollowing contributes to the development of ascites?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nB is correct\n  </span>\n </b>\n <span>\n  . Ascites in patients with cirrhosis is caused by\nportal hypertension, and portal hypertension is associated with increased\nhydrostatic pressure in the splanchnic capillaries.\n </span>\n</p>\n"], "tutorial": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n     PORTAL HYPERTENSION\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P045011\">\n    </a>\n    <span>\n     The normal portal\n  venous pressure is low (5 to 10 mm Hg), and the hepatic venous pressure\n  gradient (HVPG), which reflects sinusoidal pressure, is less than 5 mm Hg. In\n  cirrhosis, the distortion of hepatic architecture by fibrous tissue and\n  regenerative nodules, as well as a dynamic component caused by an increase in\n  intrahepatic vascular tone, leads to increased resistance to portal venous\n  flow, resulting in increased portal venous pressure (&gt;10 mm Hg). The HVPG\n  is measured using a transvenous approach by subtracting free hepatic venous\n  pressure from the wedged hepatic venous pressure.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P045012\">\n    </a>\n    <span>\n     Although cirrhosis is\n  the most important cause of portal hypertension, any process leading to\n  increased resistance to portal blood flow into (presinusoidal) or through\n  (sinusoidal) the liver or to hepatic venous outflow from the liver\n  (postsinusoidal) may result in portal hypertension. In addition, cirrhosis is\n  associated with increased cardiac output, which leads to greater splanchnic\n  blood flow, further aggravating portal hypertension. It is important to\n  recognize that the HVPG is reliably increased only in sinusoidal portal\n  hypertension.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P045013\">\n    </a>\n    <span>\n     In an attempt to\n  decompress the portal system, venous collaterals form between the portal and\n  systemic circulations. Major sites of collateral vessel formation include the\n  gastroesophageal junction, retroperitoneum, rectum, and falciform ligament of\n  the liver (abdominal and periumbilical collaterals). Clinically, the most\n  important collaterals are those connecting the portal vein to the azygos vein\n  through dilated, tortuous veins (varices) in the submucosa of the gastric\n  fundus and esophagus.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Causes of Portal Hypertension\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n</table>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"68%\">\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Increased Resistance to Flow\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <b>\n      <i>\n       <span>\n        Presinusoidal\n       </span>\n      </i>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Extrahepatic\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Portal or splenic vein\n  occlusion (thrombosis, sclerosis, tumor)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Intrahepatic\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Schistosomiasis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Congenital hepatic\n  fibrosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Sarcoidosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <b>\n      <i>\n       <span>\n        Sinusoidal\n       </span>\n      </i>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cirrhosis (many causes)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <span>\n      Alcoholic hepatitis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <b>\n      <i>\n       <span>\n        Postsinusoidal\n       </span>\n      </i>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Intrahepatic\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Veno-occlusive disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <i>\n      <span>\n       Extrahepatic\n      </span>\n     </i>\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Budd-Chiari syndrome\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Cardiac causes:\n  constrictive pericarditis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <b>\n      <span>\n       Increased Portal Blood Flow\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <span>\n      Splenomegaly not caused by liver disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"100%\">\n    <p class=\"MsoNormal\">\n     <span>\n      Arterioportal fistula\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Increased hepatic lymph flow", "B. Increased capillary hydrostatic pressure", "C. Increased plasma oncotic pressure", "D. Increased plasma albumin concentration", "E. Decreased plasma ephinephrine and norephinephrine"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n37-year-old woman with diabetes mellitus undergoes an abdominal\nhysterectomy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Twenty-four hours\npostoperatively, she develops chest pain and difficulty breathing. The pain is\n&ldquo;sharp like a knife&rdquo; and worse with inspiration.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her temperature is 38&ordm;C (100.4&ordm;F), pulse\nis 110/minute, blood pressure is 90/60 mm Hg, and respirations are 18/minute.\nShe appears anxious and her breathing is shallow. The heart is regular and the\nlungs are clear. Pulse oximetry shows an oxygen saturation of 80%. What is the\nmost likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Sudden onset chest\npain and shortness of breath with hypoxemia in a young person who recently\nunderwent surgery suggests a diagnosis of pulmonary embolism.\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . In sepsis,\nhyperventilation (as compensation for metabolic acidosis) may cause the patient\nto feel short of breath.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Confusion\nand disorientation may be present, along with tachycardia and paradoxical\nhypothermia.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Musculoskeletal\ndisease causes chest discomfort that may worsen with movement.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Spontaneous\npneumothorax may present with chest pain, shortness of breath, and absent\nbreath sounds on the affected side.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Chest pain associated\nwith myocardial ischemia is often &ldquo;heavy&rdquo; or &ldquo;squeezing.&rdquo;\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Dyspnea is common. The pain may radiate\nto the neck, jaw, back, or upper extremity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In patients with diabetes mellitus,\nchest discomfort may be diminished or absent due to neuropathy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"8\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <b>\n        <span>\n         Pulmonary Thromboembolic Disease\n        </span>\n       </b>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P019002\">\n       </a>\n       <span>\n        Pulmonary embolism is a\n    relatively common entity. It is usually a complication of venous\n    thrombosis. The deep veins of the femoral and popliteal systems of the\n    lower extremities are most often affected, but right atrial, right\n    ventricular, and upper extremity thromboses can also embolize to the lung.\n    In view of this, predisposing factors for pulmonary embolism are the same\n    as those for venous thrombosis and include venous stasis,\n    hypercoagulability, and endothelial injury. Congenital or acquired\n    procoagulant disorders (e.g., activated protein C deficiency) are also considered\n    predisposing factors.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P019003\">\n       </a>\n       <span>\n        After a clot dislodges from the\n    lower extremity circulation, it travels to the pulmonary circulation, where\n    it can obstruct a branch of the pulmonary artery. The affected lung segment\n    develops an increased ventilation-perfusion ratio (V/Q). This increases\n    overall dead space ventilation, which leads to an inefficient excretion of\n    partial pressure of carbon dioxide in arterial blood (Pa\n        <span>\n         co\n        </span>\n        <sub>\n         2\n        </sub>\n        ). In addition, blood\n    flow is shifted from the obstructed site to other areas, which may include\n    areas of low V/Q, thereby leading to shunting and hypoxemia. Pulmonary\n    infarction of the area distal to the occlusion is rare because of the\n    redundancy of the pulmonary circulation and because of oxygenation of lung\n    parenchyma by bronchial arteries and by alveolar oxygen.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"HC019002\">\n       </a>\n       <span>\n        CLINICAL PRESENTATION\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T019001\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T019001.250\">\n    </a>\n    <a name=\"T019001.200\">\n    </a>\n    <a name=\"T019001.150\">\n    </a>\n    <a name=\"T019001.100\">\n    </a>\n    <a name=\"T019001.50\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <div align=\"center\">\n    <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"90%\">\n     <tr>\n      <td width=\"100%\">\n      </td>\n     </tr>\n    </table>\n   </div>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P019004\">\n       </a>\n       <span>\n        The classic presentation of\n    acute pulmonary embolism includes acute shortness of breath accompanied by\n    chest pain, hemoptysis, severe hypoxemia, and circulatory collapse as a\n    result of shock. However, more often than not, the presentation is subtle,\n    and the diagnosis might be difficult to make without a high level of\n    suspicion, particularly in young individuals with otherwise healthy lungs.\n    Dyspnea on exertion and atypical chest pain might be the only symptoms on\n    initial presentation. Therefore, a careful history is paramount when\n    evaluating patients for thromboembolic disease, especially those at high\n    risk for this disorder as a result of stasis, malignancy, and previous\n    history of venous thrombosis as well as other risk factors. The physical\n    examination might reveal abnormalities in lung auscultation ranging from\n    isolated crackles to diffuse wheezing. Pleural effusions might be\n    underlying areas of dullness to percussion during the physical examination.\n    Edema of the extremities, especially if the edema is asymmetrical, might\n    point to venous thrombosis. In deep vein thrombosis, dorsiflexion of the\n    foot may cause calf pain as a result of stretching the calf muscles and\n    deep veins (Homan sign). Signs of pulmonary hypertension and right\n    ventricular strain, such as increased pulmonary component of the second\n    heart sound or right ventricular heave, are not usually appreciated unless\n    there is a massive pulmonary embolus or preexisting heart or lung disease.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"HC019003\">\n       </a>\n       <span>\n        EVALUATION\n       </span>\n       <span>\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P019010\">\n       </a>\n       <span>\n        In severe cases, arterial blood\n    gas measurement may show acidemia, hypoxemia, and hypercapnia, but subtle\n    changes such as mild alkalosis might be the only abnormalities. A normal Pa\n        <span>\n         co\n        </span>\n        <sub>\n         2\n        </sub>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        in a patient with tachypnea and\n    presumably hyperventilation suggests increased dead space and, in the\n    appropriate setting, might point to the diagnosis. However, a normal\n    alveolar-arterial oxygen-tension gradient (A-aD\n        <span>\n         o\n        </span>\n        <sub>\n         2\n        </sub>\n        ) does not exclude acute pulmonary\n    embolism. An elevated level of lactic dehydrogenase (LDH) might be the\n    result of tissue infarction, but this test is also insensitive and\n    nonspecific. Some have advocated the use of plasma D-dimer levels in\n    patients who might have pulmonary thromboembolism, but these are not\n    specific either because they are elevated in patients with several\n    unrelated medical conditions such as congestive heart failure, chronic\n    illness, and connective tissue disorders. The main usefulness of plasma\n    D-dimer levels is its negative predictive value.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"F019001\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"P019011\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P019012\">\n       </a>\n       <span>\n        The electrocardiogram may show atrial\n    tachyarrhythmias or evidence of right heart strain as evidenced by a new\n    right bundle branch block, right ventricular strain pattern, and the S\n        <sub>\n         I\n        </sub>\n        Q\n        <sub>\n         II\n        </sub>\n        T\n        <sub>\n         III\n        </sub>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        pattern that mimics inferior\n    myocardial infarction. The chest radiograph is often normal but may show\n    atelectasis, isolated infiltrates, or a small pleural effusion.\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n       </span>\n      </p>\n      <p class=\"MsoNormal\">\n       <span>\n        Three diagnostic methods are used for the diagnosis of\n    pulmonary embolism: the V/Q scan, chest computed tomography (CT), and\n    pulmonary arteriography. The V/Q scan compares lung ventilation by\n    radiolabeled tracer gas with lung perfusion by radiolabeled micro-occlusive\n    particles. The usefulness of the V/Q scan depends greatly on the pre-test\n    probability of the disease, which, in turn, is dependent on the expertise\n    of the clinician and his or her level of certainty. A\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         high-probability\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        V/Q scan is characterized by lobar\n    or multilobar perfusion defects that coincide with areas of normal or\n    relatively normal ventilation and is more than 90% accurate in diagnosing\n    pulmonary embolism. A\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         normal\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        V/Q scan shows no perfusion or\n    ventilation defects and can exclude pulmonary embolism in essentially all\n    cases. However, the test is less reliable when interpreted as\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         low, intermediate,\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        or\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        <i>\n         indeterminate\n        </i>\n        <span class=\"apple-converted-space\">\n         &nbsp;\n        </span>\n        probability.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T019002\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <a name=\"T019002.400\">\n    </a>\n    <a name=\"T019002.350\">\n    </a>\n    <a name=\"T019002.300\">\n    </a>\n    <a name=\"T019002.250\">\n    </a>\n    <a name=\"T019002.200\">\n    </a>\n    <a name=\"T019002.150\">\n    </a>\n    <a name=\"T019002.100\">\n    </a>\n    <a name=\"T019002.50\">\n    </a>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P019013\">\n       </a>\n       <span>\n        Spiral CT angiography provides a\n    noninvasive and sensitive way to evaluate for pulmonary emboli. Pulmonary\n    arteriography is the gold standard and should be considered in patients\n    without contraindications to the procedure when other tests are\n    inconclusive and a high likelihood of pulmonary embolism exists.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"HC019004\">\n       </a>\n       <span>\n        MANAGEMENT\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n    <tr>\n     <td width=\"100%\">\n      <p class=\"MsoNormal\">\n       <a name=\"P019014\">\n       </a>\n       <span>\n        Pulmonary embolism is treated\n    with supportive measures directed at sustaining organ function (e.g., fluid\n    replacement for hypotension, mechanical ventilation for respiratory\n    failure). To date, the only mechanical way to dislodge reliably a pulmonary\n    artery clot is with surgical thromboembolectomy, a procedure with high\n    mortality that requires a high level of expertise. Thromboembolectomy is\n    only used for proximal clots that are long-standing (\n        <i>\n         chronic\n    thromboembolism syndrome\n        </i>\n        ). Consequently, medical treatments are\n    preferred, and these are directed to prevent further clotting or to\n    dissolve an existing clot. Anticoagulation with regular or\n    low-molecular-weight heparin is recommended in patients without major\n    contraindications to anticoagulation (e.g., upper gastrointestinal\n    bleeding, hemorrhagic stroke). The use of thrombolytic medications (e.g.,\n    tissue plasminogen activator) is usually reserved for patients with\n    increased risk for mortality as a result of circulatory collapse caused by\n    obstruction to the flow in large or multiple pulmonary vessels.\n       </span>\n      </p>\n     </td>\n    </tr>\n   </table>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Pulmonary embolus", "B. Septic shock", "C. Musculoskeletal disease", "D. Pneumothorax", "E. Myocardial infarction"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n4-year-old boy is brought to the emergency room with severe left-sided\nabdominal pain. Physical examination shows pallor, tachycardia, and\nhypotension. The spleen tip is palpated 6 cm below the left costal margin. Lab\nstudies show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  5.0\ng/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Hematocrit\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  15%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  White\nblood cell (WBC) count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  4,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Platelet\ncount\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  70,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\nphotomicrograph of a Wright-stained peripheral blood smear is shown below:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which\nof the following most likely explains the patient&rsquo;s condition?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer D is correct.\n </b>\n The presence of sickling, splenic enlargement,\npancytopenia, and circulatory compromise suggests splenic sequestration.\n</p>\n", "<p>\n <b>\n  Answer A is incorrect.\n </b>\n Cirrhosis can cause portal hypertension and\nsplenomegaly, which may lead to hypersplenism. Hypersplenism may present as\nthrombocytopenia or pancytopenia. Target cells are commonly seen in the\nperipheral blood smear of patients with cirrhosis. Cirrhosis, however, would\nnot cause sickling or rapid enlargement of the spleen.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n Aplastic crisis is associated with worsening\nanemia, but not splenic enlargement. Reticulocytosis does not occur in aplastic\ncrisis.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n <b>\n </b>\n</p>\n", "<p>\n <b>\n  Answer C is incorrect.\n </b>\n Autoimmune hemolysis is associated with\nanemia and reticulocytosis. It is not, however, associated with sickling,\ntarget cells, leukopenia, or thrombocytopenia.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n <b>\n </b>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\nperipheral blood smear in this patient shows sickle cells, target cells, and\nreticulocytes. The presence of &ldquo;sickling&rdquo; suggests a diagnosis of sickle-cell\ndisease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nterm sickle-cell disease refers to a group of related hemoglobinopathies. In\nhumans, the hemoglobin molecule is an assembly of four globular protein\nsubunits: 2 \u03ac chains and 2 &beta; chains. Each chain is tightly associated\nwith a non-protein heme group. The heme group consists of an iron ion held in a\nring, known as a porphyrin.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347325\" o:spid=\"_x0000_i1084\" type=\"#_x0000_t75\" alt=\"Description: hemoglobin\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image500.jpg\" o:title=\"hemoglobin\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: hemoglobin\" border=\"0\" height=\"194\" src=\"_%20Tutorials_files/image501.png\" v:shapes=\"Picture_x0020_347325\" width=\"227\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sickle\ncell disease results from a genetic mutation in the &beta;-globin gene, which\ncodes for the &beta;-protein subunit. Specifically, there is an\nadenine-to-thymidine substitution in codon 6 of the &beta;-globin gene, which\nresults in replacement of glutamic acid by valine. This change results in an\nabnormal type of hemoglobin, hemoglobin S (HbS), which polymerizes when\ndeoxygenated. This causes red blood cell sickling. The term\n  <i>\n   sickle cell\n  </i>\n  <i>\n   anemia\n  </i>\n  refers to patients who are homozygous for the sickle-cell\nmutation (HbSS). Sickle cell anemia is, therefore, one of many types of\nsickle-cell disease, all of which are characterized by varying degrees of red\nblood cell sickling, hemolytic anemia, vasculopathy, vaso-occlusion, acute and\nchronic organ damage, and reduced lifespan. Sickle-cell anemia is the most\nsevere type of sickle cell disease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nmain features of sickle cell disease appear below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Features of\n  Sickle-Cell Disease\n      </span>\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n      </span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"185\">\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Sickle-Cell\n  &ldquo;Crises&rdquo;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Painful\n  episodes\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Acute\n  chest syndrome\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Aplastic\n  crisis\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Splenic\n  sequestration\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       Complications\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Sepsis\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Stroke\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Retinopathy\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Cardiac\n  disease\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Pulmonary\n  hypertension\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Gallstones\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Splenic\n  infarction\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Renal\n  disease\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Bone\n  disease (osteomyelitis, osteonecrosis, osteopenia)\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Leg\n  ulcers\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Priapism\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span class=\"text\">\n      <span>\n       <span>\n        &middot;\n        <span>\n         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n        </span>\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Placental\n  insufficiency\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span class=\"text\">\n      <span>\n       Nutritional\n  deficiencies\n      </span>\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  In\npatients with sickle cell anemia, the hemoglobin concentration usually ranges\nbetween 6 and 10 g/dL. The anemia may be microcytic, normocytic, or macrocytic.\nMicrocytic anemia usually indicates concomitant iron deficiency or thalassemia.\nMacrocytic anemia occurs when the reticulocyte count is high. (Reticulocytes\nare larger than mature red blood cells.) The presence of nucleated red cells\n(erythroblastosis) indicates a regenerative response by the marrow to anemia\n&ndash; a response that leads to reticulocytosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Target\ncells are often seen in sickle-cell disease.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Conditions Associated with Target Cells\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Sickle-cell\n  disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hemoglobin\n  C disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Liver\n  disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Thalassemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Iron\n  deficiency anemia (severe)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Asplenia\n  (anatomic or functional)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npatient in the clinical vignette has a large painful spleen with signs of\ncirculatory compromise. This suggests a complication of sickle-cell disease\ncalled &ldquo;splenic sequestration,&rdquo; in which rapid pooling of blood in the spleen\nis accompanied by splenic enlargement, pancytopenia (due to hypersplenism), and\nhypovolemia. If untreated, the patient may die of circulatory collapse.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  It is\nuseful to remember that splenomegaly, defined as a spleen size greater than 12\ncm, has many potential causes.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"333\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes of\n  Splenomegaly\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Type\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Examples\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"sidetable\">\n     <span>\n      Congestive\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"sidetable\">\n     <span>\n      Cirrhosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"sidetable\">\n     <span>\n      Infectious\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"sidetable\">\n     <span>\n      Acute\n     </span>\n    </p>\n    <p class=\"sidetable\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Infectious\n  mononucleosis\n     </span>\n    </p>\n    <p class=\"sidetable\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Subacute\n  bacterial endocarditis\n     </span>\n    </p>\n    <p class=\"sidetable\">\n     <span>\n     </span>\n    </p>\n    <p class=\"sidetable\">\n     <span>\n      Chronic\n     </span>\n    </p>\n    <p class=\"sidetable\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Malaria\n     </span>\n    </p>\n    <p class=\"sidetable\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Miliary\n  tuberculosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inflammatory\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n      Connective tissue\n  disorders\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Systemic lupus erythematosus\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Rheumatoid arthritis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Other\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Sarcoidosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Secondary amyloidosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n      Neoplastic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n      Myeloproliferative\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Polycythemia vera\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Chronic myelogenous leukemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Primary thrombocythemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Myelofibrosis with myeloid metaplasia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lymphoproliferative\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Lymphoma\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Chronic lymphocytic leukemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hemolytic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n      RBC shape disorders\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hereditary spherocytosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      RBC enzyme disorders\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pyruvate kinase deficiency\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Hemoglobinopathies\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Hemoglobinopathies\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Sickle-cell variants\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Sickle-cell anemia with splenic sequestration crisis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"90\">\n    <p class=\"MsoNormal\">\n     <span>\n      Storage diseases\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"243\">\n    <p class=\"MsoNormal\">\n     <span>\n      Gaucher, Niemann-Pick\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Most\ncauses of splenomegaly are not associated with rapid and painful enlargement of\nthe spleen. Splenic sequestration from sickle cell disease, however,\n  <i>\n   does\n  </i>\n  have this effect.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Pancytopenia,\ndefined as a reduction in red blood cell, white blood cell, and platelet\ncounts, has many potential causes.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"338\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Causes of\n  Pancytopenia\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Type\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Examples\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Congenital\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fanconi&rsquo;s anemia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Metabolic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Gaucher, Niemann-Pick\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Nutritional\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Folate and B12\n  deficiency (severe)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Anorexia nervosa\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hematologic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Aplastic anemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Myelodysplastic\n  syndrome\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Myelofibrosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Paroxysmal nocturnal\n  hemoglobinuria\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Infectious\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Viral (HIV,\n  parvovirus)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bacterial\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Mycobacterial\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Fungal\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Protozoal\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Sepsis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inflammatory\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Systemic lupus\n  erythematosus\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Sarcoidosis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Toxic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Drugs\n  (anti-neoplastic, anti-epileptic)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Toxins (benzene,\n  arsenic)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Irradiation\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Neoplastic\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lymphoma\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Leukemia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Multiple myeloma\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Polycythemia vera\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Myelophthisis\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"104\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hypersplenism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cirrhosis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Sickle-cell disease with\n  splenic sequestration\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\nclinical vignette, the presence of sickling and an enlarged spleen suggests\nsplenic sequestration as the cause of pancytopenia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sickle\ncell anemia is clinically heterogeneous. Some patients have almost all known complications;\nothers have almost none but die suddenly; still others skip one or more phases\nof disease but suffer intensely from others. Although sickle-cell disease is a\nprototypic Mendelian, single-gene disorder, it behaves clinically as a\nmultigenic trait with phenotypic variability.\n </span>\n</p>\n\n<p>\n Hemolysis is mainly\nextravascular due to erythrophagocytosis by reticuloendothelial cells, which\nrecognize the damaged sickle cells. In some patients, intravascular hemolysis\noccurs, liberating excessive amounts of hemoglobin into the circulation.\nCertain complications, such as pulmonary hypertension, priapism, leg ulcer, and\nstroke, are closely linked to the intensity of hemolysis, whereas other\ncomplications, such as painful episodes, acute chest syndrome, and osteonecrosis,\nare linked to high blood viscosity and the interactions among sickle cells,\nleukocytes, and the endothelium.\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Painful Crisis\n   </span>\n  </b>\n </span>\n <span class=\"text\">\n  <b>\n   <span>\n   </span>\n  </b>\n </span>\n</p>\n\n<p>\n Pain caused by sickle\nvaso-occlusion often starts in young children as the hand-foot syndrome:\npainful swelling of the hands and feet caused by inflammation of the metacarpal\nand metatarsal periosteum. Acute painful episodes are the most common\nvaso-occlusive events. What triggers them is usually unknown. They are usually\nsevere and last from hours to days. These attacks of acute pain must be\ndistinguished from chronic pain caused by osteonecrosis of the hips and\nshoulders, neuropathic pain, and milder non-specific pains that are often\npresent between episodes. Painful crises are usually stereotypical, affecting\nindividuals in the same manner from episode to episode. Because patients often\nmanage these events at home, hospital visits may underestimate the frequency of\nevents.\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Acute Chest Syndrome\n   </span>\n  </b>\n </span>\n <span class=\"text\">\n  <b>\n   <span>\n   </span>\n  </b>\n </span>\n</p>\n\n<p>\n Acute chest syndrome is\ncharacterized by fever, chest pain, wheezing, cough, hypoxia, and lung\ninfiltrate. It is clinically indistinguishable from pneumonia and can be\nlethal. It is second only to painful crisis as a cause of hospitalization, and\nit is more common in children. The course is often mild in children and severe\nin adults.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Aplastic crisis\n   <i>\n   </i>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Aplastic\ncrisis is usually triggered by parvovirus B19, which invades and destroys red\nblood cell precursors. Red blood cell production is arrested for two to three\ndays. In normal individuals, this would be of little consequence, but in patients\nwith sickle-cell disease, it is life-threatening (because red blood cell life\nis shortened). Reticulocyte counts drop dramatically and patient becomes\nseverely anemic, resulting in fatigue, pallor, and tachycardia. The crisis\ntakes about a week to resolve.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Splenic sequestration crisis\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Splenic sequestration is characterized by\n </span>\n <span>\n  sudden pooling of blood\nin the spleen; acute, painful enlargement of the spleen; and hypovolemia, which\nresults in tachycardia and hypotension. It is a medical emergency; if\nuntreated, the patient may die within hours of circulatory collapse.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<h4>\n <span>\n  In patients with sickle cell\nanemia, splenic infarction usually occurs by age 10. A &ldquo;functional asplenia&rdquo;\nensues, increasing the patient&rsquo;s risk of infection with encapsulated organisms.\nHowell-Jowell bodies (indicative of an asplenic state) are often present in the\nblood at this time. Once splenic infarction has occurred, the patient is no\nlonger predisposed to splenic sequestration. (Sequestration requires a\nfunctioning spleen.)\n </span>\n</h4>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Sepsis\n   </span>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Functional\nasplenia predisposes patients to infection by encapsulated organisms, such as\n  <i>\n   Streptococcus pneumoniae\n  </i>\n  and\n  <i>\n   Hemophilus influenzae\n  </i>\n  . Patients benefit\nfrom routine vaccination for\n  <i>\n   H. influenzae\n  </i>\n  ,\n  <i>\n   S. pneumoniae\n  </i>\n  , and\n  <i>\n   Neisseria\nmeningitidis\n  </i>\n  .\n  <span class=\"section-title-10\">\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Stroke\n   </span>\n  </b>\n </span>\n <span class=\"text\">\n  <b>\n   <span>\n   </span>\n  </b>\n </span>\n</p>\n\n<p>\n A major complication of\nsickle cell anemia in early life is stroke caused by stenosis and occlusion of\nlarge vessels. Ischemic stroke predominates in children; hemorrhagic stroke\npredominates in adults. Subclinical neurologic events and silent cerebral infarction\nare even more common than stroke.\n</p>\n\n<p>\n <b>\n  Retinopathy\n </b>\n</p>\n\n<p>\n Proliferative sickle\nretinopathy is more common in HbSC disease that in sickle-cell anemia (HbSS).\nVitreal hemorrhage and retinal detachment can cause vision loss.\n</p>\n\n<p>\n <b>\n  Cardiac disease\n </b>\n</p>\n\n<p>\n In sickle-cell disease, the\nheart may be enlarged. Typically, the precordium is hyperactive and a systolic\nejection is present. Myocardial infarction is rare. Sudden death is usually due\nto arrhythmia.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Pulmonary Hypertension\n   </span>\n  </b>\n </span>\n <span class=\"text\">\n  <b>\n   <span>\n   </span>\n  </b>\n </span>\n</p>\n\n<p>\n Pulmonary hypertension is\nfound in 30 to 40% of adult patients with sickle cell anemia. It is often\nasymptomatic and occurs primarily in patients above the age of 35 years. Half\nof all patients with pulmonary hypertension die within 2 years of diagnosis.\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Gallstones\n   </span>\n  </b>\n </span>\n <span class=\"text\">\n  <b>\n   <span>\n   </span>\n  </b>\n </span>\n</p>\n\n<p>\n Cholelithiasis is a consequence\nof hemolysis and increased bilirubin production. More than half of adults are\naffected.\n</p>\n\n<p>\n <b>\n  Renal disease\n </b>\n</p>\n\n<p>\n Sickle cell disease, which\ncan affect any part of the kidney, may result in hematuria, proteinuria,\nhyposthenuria (inability to concentrate the urine), acidosis, and renal\nfailure.\n</p>\n\n<p>\n <b>\n  Bone disease\n </b>\n</p>\n\n<p>\n Osteonecrosis of the hips\nand shoulders is a common occurrence. Its onset is insidious and progressive.\nMost patients with early-stage disease progress to collapse of the femoral head\nwithin two years. Advanced disease may be visible on plain radiographs; early\ndisease may require magnetic resonance imaging for diagnosis. Osteomyelitis,\nwhich is often difficult to distinguish from bone infarction, is usually caused\nby\n <i>\n  Staphylococcus aureus\n </i>\n or\nsalmonella infection.\n <a name=\"4-u1.0-B978-1-4160-2805-5..50172-5--intr\">\n </a>\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Leg Ulcers\n   </span>\n  </b>\n </span>\n <span class=\"text\">\n  <b>\n   <span>\n   </span>\n  </b>\n </span>\n</p>\n\n<p>\n About 5 to 10% of patients\nwith sickle cell anemia above the age of 10 years develop leg ulcers.\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"section-title-10\">\n  <b>\n   <span>\n    Priapism\n   </span>\n  </b>\n </span>\n <span class=\"text\">\n  <b>\n   <span>\n   </span>\n  </b>\n </span>\n</p>\n\n<p>\n Priapism, a prolonged\npainful erection, may be seen in men with sickle cell anemia. Affected patients\nhave a higher incidence of stroke, pulmonary hypertension, renal failure, leg\nulcers, and premature death than individuals without priapism.\n</p>\n\n<p>\n <b>\n  Pregnancy\n </b>\n</p>\n\n<p>\n There is no absolute\ncontraindication to pregnancy for patients with sickle cell anemia. Rates of\npyelonephritis, pre-eclampsia, spontaneous abortion, and intrauterine growth\nretardation are increased.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <b>\n  Nutritional deficiencies\n </b>\n</p>\n\n<p>\n Sickle cell disease routinely\ncauses growth retardation.\n <a name=\"4-u1.0-B978-1-4160-2805-5..50172-5--para\">\n </a>\n</p>\n", "choices": ["A. Cirrhosis", "B. Aplastic crisis", "C. Autoimmune hemolysis", "D. Splenic sequestration"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following causes of thrombocytopenia is associated with arterial and venous\nthrombosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--para90\">\n </a>\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--celist21\">\n </a>\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--spara4\">\n </a>\n <b>\n  <span>\n   Answer D\nis correct\n  </span>\n </b>\n <span>\n  .\nHeparin-induced thrombocytopenia is associated with arterial and venous\nthrombosis.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n Thrombocytopenia, defined as\nan abnormally low platelet concentration, may be due to decreased platelet\nproduction, increased platelet destruction, or abnormal platelet distribution\n(hypersplenism). Assuming normal platelet function, the symptoms and signs\nexpected with various platelet counts appear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"136\">\n    <p align=\"center\">\n     Platelet Count\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p align=\"center\">\n     Signs and\n  Symptoms\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"136\">\n    <p align=\"center\">\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p align=\"center\">\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"136\">\n    <p>\n     &gt; 50,000/&mu;L\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p>\n     No symptoms or signs, although patients may bleed\n  longer with major trauma\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"136\">\n    <p>\n     25,000 to 50,000/&mu;L\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p>\n     Petechiae and bruising with minor trauma\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"136\">\n    <p>\n     10,000 to 25,000/&mu;L\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p>\n     Spontaneous petechiae and bruising greater on the\n  lower extremities; menorrhagia\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"136\">\n    <p>\n     &lt; 10,000/&mu;L\n    </p>\n   </td>\n   <td valign=\"top\" width=\"234\">\n    <p>\n     Prominent bruising, mucosal bleeding (epistaxis,\n  gum bleeding, gastrointestinal,\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     or genitourinary bleeding), and possibly central nervous system\n  bleeding\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Selected\ncauses of thrombocytopenia are discussed below.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--cesectit\">\n </a>\n <b>\n  <span>\n   Chronic liver disease\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Thrombocytopenia\nis a common complication of chronic liver disease.\n  <a name=\"4-u1.0-B0-323-03748-8..50048-8--p507\">\n  </a>\n  The primary cause is portal\nhypertension with congestive splenomegaly and platelet sequestration. Also,\npatients with cirrhosis have reduced levels of thrombopoietin, which is mainly\nproduced by the liver and is the main regulator of thrombopoiesis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Idiopathic\nthrombocytopenic purpura (ITP)\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Acute\n  </span>\n </i>\n <span>\n  ITP is a transient, mostly postinfectious\ndisorder characterized by platelet destruction. It occurs mainly in children.\n  <i>\n   Chronic\n  </i>\n  immune thrombocytopenic purpura\n(ITP) is an immune-mediated thrombocytopenia occurring primarily in adults.\nPlatelets coated with IgG autoantibodies undergo accelerated clearance by\nmacrophages, predominantly in the spleen and liver. The condition is more\ncommon in women than men. ITP is a diagnosis of exclusion. The criteria for diagnosing\nITP appear below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Criteria for ITP\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Thrombocytopenia\n  (with large platelets)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normal\n  hemoglobin concentration\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normal\n  leukocyte count\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      No\n  adenopathy or splenomegaly\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      Normal\n  or increased numbers of megakaryocytes in bone marrow\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"255\">\n    <p class=\"MsoNormal\">\n     <span>\n      No other\n  explanation for thrombocytopenia\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Disease-associated\nimmune\n   <span>\n   </span>\n   thrombocytopenia\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Autoimmune\n  <span>\n   thrombocytopenia\n  </span>\n  is most commonly seen\nin patients with collagen vascular or lymphoproliferative disorders.\n  <span>\n   Thrombocytopenia\n  </span>\n  is noted in 14 to 26%\nof patients with systemic lupus erythematosus\n  <a name=\"4-u1.0-B978-1-4160-2805-5..50184-1--p129\">\n  </a>\n  . Splenomegaly and mild\nadenopathy are relatively common. Laboratory findings show increased numbers of\nmegakaryocytes in the bone marrow.\n  <a name=\"4-u1.0-B978-1-4160-2805-5..50184-1--cese\">\n  </a>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A low platelet count is\ncommonly seen in patients with lymphoproliferative disorders. In most cases it\nis due to decreased platelet production because of marrow infiltration or the\neffects of treatment. However, immune\n  <span>\n   thrombocytopenia\n  </span>\n  is sometimes noted, particularly in individuals with chronic lymphocytic\nleukemia and non-Hodgkin's lymphoma.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Post-transfusion\npurpura\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  This rare\ndisorder almost always occurs in women and appears about 7 to 10 days after\ntransfusion. There is usually a history of either a previous transfusion or\npregnancy, and most cases occur in multiparous women after their first blood transfusion.\n </span>\n <span class=\"Heading3Char\">\n  <span>\n  </span>\n </span>\n <span class=\"Heading3Char\">\n  <span>\n   Thrombocytopenia is\n  </span>\n </span>\n <span>\n  usually severe, and about 10% of cases\nhave intracranial hemorrhage.\n  <b>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Drug-induced\nthrombocytopenia\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Drug-induced\nthrombocytopenia is common and usually immune-mediated\n  <b>\n   .\n  </b>\n  The drugs most\ncommonly implicated are heparin, quinine, quinidine, chlorothiazide,\npenicillin, sulfa drugs, linezolid, rifampin, cimetidine, and anticonvulsants.\nThrombocytopenia typically occurs 2 to 3 weeks after initial drug exposure and\nresolves within 10 days of discontinuation of the drug. Of note, glycoprotein\nIIb/IIIa receptor inhibitors can cause platelet counts to fall within a few\nhours of exposure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Heparin-induced\nthrombocytopenia (HIT)\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Heparin-induced thrombocytopenia (HIT) is different than other types of d\n </span>\n <span>\n  rug-induced\nthrombocytopenia. In HIT, thrombosis is the most feared complication;\nsignificant bleeding rarely occurs.\n  <span>\n   Heparin-induced\nthrombocytopenia\n   <b>\n   </b>\n  </span>\n  may result in potentially lethal arterial and\nvenous thromboses. IgG antibodies form against a complex of heparin and\nplatelet factor 4. A\n  <span class=\"text\">\n   rapid decline in platelet count may be\nseen in patients previously exposed to heparin. The condition can be severe.\n  </span>\n  Even small doses of heparin (the amount used in an intravenous line flush) can\ncause significant thrombocytopenia and thrombosis.\n </span>\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--para107\">\n </a>\n <span class=\"Heading3Char\">\n  <span>\n  </span>\n </span>\n <span class=\"text\">\n  <span>\n   Although\nunfractionated heparin is 10 times more likely to cause HIT than low molecular\nweight heparin, almost all patients with HIT display cross-reactivity.\nConsequently, low molecular weight heparin should be avoided in patients with a\nhistory of HIT.\n  </span>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Infection\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--para56\">\n </a>\n <span>\n  Thrombocytopenia\nassociated with some viral infections, such as rubella, mumps, infectious\nmononucleosis, and cytomegalovirus\n  <a name=\"4-u1.0-B978-1-4160-2805-5..50184-1--intr\">\n  </a>\n  , is primarily\nimmune-mediated and closely mimics acute ITP. In HIV, thrombocytopenia is due\nto both immune-mediated platelet destruction and decreased platelet production,\nprobably secondary to infection of megakaryocytes.\n  <span class=\"text\">\n   Sepsis is a\ncommon and often overlooked cause of thrombocytopenia in the critically ill.\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span class=\"text\">\n  <b>\n   <span>\n    Thrombotic\nMicroangiopathies: T\n   </span>\n  </b>\n </span>\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--para55\">\n </a>\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--para30\">\n </a>\n <a name=\"4-u1.0-B0-323-03748-8..50048-8--celist5\">\n </a>\n <b>\n  <span>\n   hrombotic thrombocytopenic purpura (TTP)\nand\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Hemolytic-uremic\nsyndrome (HUS)\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nthrombotic microangiopathies are characterized by excessive platelet\naggregation, which leads to microvascular occlusion, thrombocytopenia, and\nmechanical injury to erythrocytes (microangiopathic hemolytic anemia). In TTP,\nplatelet aggregation occurs primarily in the systemic microvasculature; in HUS,\nit occurs predominantly in the renal circulation. Distinguishing these two\nconditions is not always possible. TTP may be associated with medication,\ncancer, chemotherapy, bone marrow transplantation, or HIV infection. HUS is\nusually caused by\n  <i>\n   Escherichia coli\n  </i>\n  (\n  <i>\n   E. coli\n  </i>\n  0157).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  TTP is a\nlife-threatening condition. HUS occurs primarily in children; proteinuria,\nhematuria, and elevated blood urea nitrogen and creatinine levels reflect the\ndegree of renal failure.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Disseminated\nintravascular coagulation (DIC)\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Disseminated\nintravascular coagulation (DIC) is characterized by systemic activation of\ncoagulation cascade, which leads to the intravascular formation of fibrin,\nthrombotic occlusion of small and medium-sized vessels, and organ ischemia. The\nprocess depletes platelets and coagulation factors, which can result in\nhemorrhage. DIC is a disorder associated with many disease states, most\ncommonly infection, cancer, burns, trauma, and pregnancy. While\nmicroangiopathic hemolysis is invariably present in TTP and HUS, it is only\nsometimes present in DIC.\n </span>\n</p>\n", "choices": ["A. Hypersplenism", "B. Quinidine-induced thrombocytopenia", "C. Sulfa-induced thrombocytopenia", "D. Heparin-induced thrombocytopenia", "E. Idiopathic thrombocytopenia purpura"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n37-year-old woman presents to the emergency department with a 3-day history of\nabdominal pain, nausea, and diarrhea. Lab tests show:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  9.5 g/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  7,500/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelet\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  10,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Examination\nof the blood smear confirms severe thrombocytopenia and shows fragmented red\nblood cells and numerous polychromatophilic red cells (reticulocytes).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347324\"\n o:spid=\"_x0000_i1083\" type=\"#_x0000_t75\" alt=\"Description: Schistocytes\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image502.jpg\" o:title=\"Schistocytes\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Schistocytes\" border=\"0\" height=\"178\" src=\"_%20Tutorials_files/image503.png\" v:shapes=\"Picture_x0020_347324\" width=\"236\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The diagnosis of TTP is suggested by the\ncombination of anemia, thrombocytopenia, and fragmented red blood cells.\nPatients with TTP commonly present with gastrointestinal symptoms. This patient\nshould be admitted to the hospital and treated with plasma exchange.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . EDTA-dependent\n&ldquo;pseudothrombocytopenia&rdquo; is, basically, a laboratory error. The lab reports a\nlow platelet count, but the true platelet count is actually normal.\nEDTA-dependent &ldquo;pseudothrombocytopenia&rdquo; occurs in 1 in 1,000 normal adults.\nThese individuals have autoantibodies that cause platelet agglutination in the\npresence of EDTA, an anticoagulant used in certain blood tubes.\nPseudothrombocytopenia has no clinical significance, except that it can trick\nthe doctor into believing that the patient is thrombocytopenic, leading to\nunnecessary tests. In this vignette, the patient&rsquo;s thrombocytopenia is real, as\nconfirmed by the blood smear.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Chronic blood loss\ndoes not cause thrombocytopenia. (It often causes an increased platelet count.)\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Idiopathic\nthrombocytopenia purpura is not associated with microangiopathic hemolysis and,\ntherefore, does not result in fragmented red blood cells.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Thrombotic\nthrombocytopenia purpura (TTP) is classically associated with a pentad of\nfindings: fever, neurologic symptoms, renal failure, thrombocytopenia, and\nmicroangiopathic hemolytic anemia. However, many patients with TTP are not\nacutely ill on presentation and do not have fever, neurologic symptoms, or\nrenal failure. In such cases, the diagnosis is made solely by the presence of\nmicroangiopathic hemolytic anemia and thrombocytopenia. The most common\npresenting symptoms in TTP are gastrointestinal &ndash; abdominal pain,\nvomiting, and diarrhea. Severe thrombocytopenia is confirmed by examination of\nthe blood smear. Microangiopathic hemolysis is evident by the presence of\nfragmented red blood cells.\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <span>\n     TTP may be congenital\n  or acquired. In patients with congenital or familial TTP, mutations in the\n  vWF-cleaving protease, ADAMTS-13, abrogate its activity. Patients with\n  acquired TTP without a family history usually have an antibody, often\n  immunoglobulin G (IgG) that blocks the normal function of this vWF-cleaving\n  protease to less than 10% of normal. Ultralarge vWF multimers released by endothelial\n  cells normally anchor to endothelial cells through P-selectin and form long\n  strings that adhere and aggregate platelets in the microcirculation.\n  ADAMTS-13 downregulates the size of these multimers. Deficient cleaving\n  protease function in TTP leads to higher circulating levels of the larger,\n  high-molecular-weight vWF multimers; these, in turn, cause increased platelet\n  adhesion and clearance&nbsp;\n     <i>\n      without\n     </i>\n     &nbsp;activating the coagulation\n  cascade. Therefore, both the PT and PTT are normal in TTP, unlike DIC. TTP\n  after chemotherapy (mitomycin C) and in association with pregnancy, stem cell\n  transplantation, lupus, or HIV infection appears to have a similar pathogenic\n  mechanism of thrombosis. Thrombocytopenia (often severe) is accompanied by\n  microangiopathy with schistocytes on the peripheral smear and increased serum\n  lactate dehydrogenase. Microvascular occlusions in multiple organs cause many\n  of the symptoms, especially in the kidney and brain. The classic pentad of\n  signs (fever, thrombocytopenia, microangiopathic hemolysis, neurologic\n  symptoms, and renal insufficiency) is present in fewer than 25% of patients\n  with TTP. The diagnosis is generally made on the clinical assessment of\n  thrombocytopenia and microangiopathic hemolytic anemia; assays for ADAMTS-13\n  activity and inhibitor are not yet widely available and do not have a rapid\n  turn-around time.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"100%\">\n <tr>\n  <td width=\"100%\">\n   <p class=\"MsoNormal\">\n    <a name=\"P054026\">\n    </a>\n    <span>\n     Treatment of familial\n  TTP is based on replenishment of cleaving protease activity with plasma\n  transfusion; acquired TTP additionally requires removal of the antibody. The\n  latter is accomplished by plasma exchange, whereby patient plasma is removed\n  (plasmapheresis) and replaced with fresh-frozen plasma, often\n  \"cryo-poor\" to reduce ultralarge vWF multimers in transfused\n  plasma.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. EDTA-dependent pseudothrombocytopenia", "B. Chronic blood loss", "C. Idiopathic thrombocytopenic purpura (ITP)", "D. Thrombotic thrombocytopenia purpura (TTP)"]}, {"question": "<p>\n <span>\n  A 66-year-old man was diagnosed with deep vein thrombosis in his left leg\ntwo years ago. He has since had persistent swelling of that leg. Physical\nexamination reveals leg edema up to the knee with mild thickening and\nhyperpigmentation of the skin. Which of the following is true?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct\n </b>\n <span>\n  .\n </span>\n The condition is due to incompetent\nvalves.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect\n </b>\n . Venous hypertension resulting from\nincompetent valves plays a pathophysiologic role, not arterial hypertension.\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . He may develop ulcers, but they are not\nexquisitely painful.\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n . He is at increased, not decreased, risk of\ndeveloping cellulitis.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n . Vascular compression stockings are the\ntreatment of choice.\n</p>\n"], "tutorial": "<p>\n <span>\n  Chronic venous insufficiency\n </span>\n occurs when valves in the veins\n(usually of the legs) become damaged, or \"incompetent,\" because of\ndeep vein thrombosis (DVT) or phlebitis. DVT is the most common cause of\nchronic venous insufficiency. Damage to the valves results in venous\nhypertension, which causes chronic leg swelling and calf discomfort. Symptoms\ncan last a lifetime. Physical findings may include varicosities, leg and ankle\nswelling, lymphedema, and ulceration. (Unlike ulcers due to arterial\ncompromise, venous stasis ulcers are not exquisitely painful.) The involved\nskin is often dry, pruritic, thickened, and hyperpigmented. The patient is at\nincreased risk of developing cellulitis. Vascular compression stockings can\nimprove venous hemodynamics, reduce edema, and minimize skin discoloration.\n</p>\n", "choices": ["A. His condition is due to \u201cincompetent\u201d valves.", "B. Arterial hypertension plays a pathophysiologic role.", "C. He is at increased risk of developing exquisitely painful ulcers.", "D. He is at reduced risk of developing cellulitis.", "E. Antihypertensive drugs are the treatment of choice."]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n60-year-old woman with a past medical history of hypertension and colon cancer\npresents to the emergency department with sudden onset of shortness of breath.\nShe was diagnosed with colon cancer last week and underwent partial colectomy.\nOn physical examination, temperature is 98.5\n  <sup>\n   o\n  </sup>\n  F, pulse is 125\n/minute, blood pressure is 98/72 mm Hg, and respirations are 32/minute. The\noxygen saturation is 84% on room air. The heart is regular without murmurs,\nrubs, or gallops. The lungs are clear without rhonchi, crackles, or wheezes.\nThe patient is placed on oxygen by nasal cannula. An EKG shows sinus\ntachycardia with no ischemic changes.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Brain natriuretic peptide is 80 ng/L. Electrolytes, TSH, and complete\nblood count are normal. Cardiac enzymes are drawn. Arterial blood gases show a\npH of 7.48, PO\n  <sub>\n   2\n  </sub>\n  of 58 mm Hg, and PCO\n  <sub>\n   2\n  </sub>\n  of 20 mm Hg on room\nair (F\n  <sub>\n   I\n  </sub>\n  O\n  <sub>\n   2\n  </sub>\n  of 21%). Which of the following is the best\ntest to confirm the diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . This\npatient most likely has pulmonary embolism. A contrast-enhanced CT scan (CT\nangiography) would be the best noninvasive test for making the diagnosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  The D-dimer test can be used to\nscreen for DVT and PE when the pre-test probability of either is low. A normal\nD-dimer essentially rules out thromboembolism. An elevated D-dimer, however, is\nnon-specific and of no diagnostic benefit.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Doppler\nultrasound of the veins of the lower extremities can be used to diagnose deep\nvein thrombosis (DVT), but will not confirm the presence of pulmonary emboli.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Chest\nx-ray is helpful to rule out other causes of shortness of breath, but is not\nsensitive for pulmonary embolism.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Urgent\ncardiac catheterization is recommended in patients with acute myocardial\ninfarction, but not in patients with pulmonary embolism.\n </span>\n <span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  This\npatient is at high risk for pulmonary embolism (PE) because of her recent\nhospitalization and cancer. Sudden onset of shortness of breath, tachycardia,\nhypoxemia, and respiratory alkalosis are consistent with PE. Patients with PE\nmay have a relatively normal EKG and chest X-ray. A contrast-enhanced CT scan\n(CT angiography) would be the best noninvasive test for making the diagnosis.\n </span>\n</p>\n", "choices": ["A. D-Dimer", "B. CT Angiography", "C. Venous Doppler of the lower extremities", "D. Chest X-ray", "E. Cardiac catheterization"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 19-year-old woman has had heavy menstrual\nperiods and anemia since menarche. She has increased bruising if she takes\naspirin.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her sister is also\nanemic.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her hemoglobin\nconcentration is 8 g/dL (normal: 12-16 g/dL) and her mean corpuscular volume\n(MCV) is 67 &mu;m\n  <sup>\n   3\n  </sup>\n  (normal is 80-100 &mu;m\n  <sup>\n   3\n  </sup>\n  ).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The white count and platelet count are\nnormal.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Her prothrombin time (PT)\nis normal. Her activated partial thromboplastin time (aPTT) is mildly prolonged\nat 46 seconds (normal: 25-40 seconds). Her bleeding time is mildly prolonged at\n9 minutes (normal: 2-7 minutes). What is the most appropriate next step?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Von Willebrand disease would explain the\npropensity for bleeding (resulting in heavy menstrual periods, chronic blood\nloss, and iron deficiency anemia) and an elevated aPTT.\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The underlying bleeding disorder should\nbe evaluated before consulting the gynecologist.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Platelet abnormalities do not prolong\nthe aPTT.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect\n  </span>\n </b>\n <span>\n  .\nHemophilia A (due to Factor VIII deficiency) and hemophilia B (due to Factor IX\ndeficiency) occur almost exclusively in males because they are X-linked\ndisorders.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Von\nWillebrand disease is the most common inherited bleeding disorder. It is caused\nby a qualitative or quantitative deficiency of von Willebrand factor (vWF). The\ncondition may be associated with bruising, nosebleeds, gum bleeds, and heavy\nmenses. Severe internal bleeding and joint bleeding are rare. The von\nWillebrand protein has a dual role: 1) It is a carrier protein for Factor\nVIII.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  If von Willebrand protein\nlevels are low, more factor VIII circulates unbound and unprotected from rapid\ndegradation. Factor VIII levels drop and the aPTT increases.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  2) It tethers platelets to the site of\nvessel injury.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Without functional\nvon Willebrand protein, platelet plug formation is poor and prolonged bleeding\nmay occur.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  If surgery is required,\nconcentrates containing von Willebrand protein can be given.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nfollowing table shows the effect of various conditions on the prothrombin time,\npartial thromboplastin time, bleeding time, and platelet count.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" class=\"MsoNormalTable\">\n <thead>\n  <tr>\n   <td width=\"127\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Condition\n     </span>\n    </p>\n   </td>\n   <td width=\"80\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Prothrombin time\n   (PT)\n     </span>\n    </p>\n   </td>\n   <td width=\"116\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Partial\n   thromboplastin time (aPTT)\n     </span>\n    </p>\n   </td>\n   <td width=\"89\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Bleeding time\n     </span>\n    </p>\n   </td>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Platelet count\n     </span>\n    </p>\n   </td>\n  </tr>\n </thead>\n <tr>\n  <td width=\"127\">\n   <p class=\"MsoNormal\">\n    <span>\n     Aspirin\n    </span>\n   </p>\n  </td>\n  <td width=\"80\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td width=\"116\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"127\">\n   <p class=\"MsoNormal\">\n    <span>\n     Disseminated\n  intravascular coagulation (DIC)\n    </span>\n   </p>\n  </td>\n  <td width=\"80\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"116\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"127\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hemophilia\n    </span>\n   </p>\n  </td>\n  <td width=\"80\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td width=\"116\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"127\">\n   <p class=\"MsoNormal\">\n    <span>\n     Liver\n  failure, end-stage\n    </span>\n   </p>\n  </td>\n  <td width=\"80\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"116\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"127\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thrombocytopenia\n    </span>\n   </p>\n  </td>\n  <td width=\"80\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td width=\"116\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &darr;\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"127\">\n   <p class=\"MsoNormal\">\n    <span>\n     Vitamin\n  K deficiency or warfarin\n    </span>\n   </p>\n  </td>\n  <td width=\"80\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"116\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N or &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"127\">\n   <p class=\"MsoNormal\">\n    <span>\n     von\n  Willebrand disease\n    </span>\n   </p>\n  </td>\n  <td width=\"80\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td width=\"116\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     &uarr;\n    </span>\n   </p>\n  </td>\n  <td>\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n", "choices": ["A. Consult a gynecologist", "B. Order platelet aggregation studies", "C. Test for von Willebrand disease", "D. Order Factor VIII and IX levels"]}]}, {"section": "Neuroscience & Psychiatry", "questions": [{"question": "<p>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   A 54-year-old man presents to the\nemergency department with intense pain of sudden onset in his right eye.\nExamination reveals injection surrounding the limbus and elevated intraocular\npressure in the same eye. After obtaining a careful history, the emergency room\nphysician concludes that this episode was triggered by which of the following\nagents?\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "answers": ["<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer A is correct.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n   The patient described is suffering from\nan attack of acute or narrow angle glaucoma (also called angle-closure\nglaucoma). Attacks can be precipitated by drugs with anticholinergic actions\nbecause muscarinic receptors on the pupillary constrictor muscle of the iris\nare blocked. This causes pupillary dilation, which further &ldquo;narrows&rdquo; the angle\nin the anterior chamber of the eye. Amitriptyline is a tricyclic antidepressant\nwith significant anticholinergic side effects.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer B is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Cimetidine\nis an H\n   <sub>\n    2\n   </sub>\n   antagonist that reduces gastric acid release.\n  </span>\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer C is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Diazepam\nis a benzodiazepine.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer D is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Malathion\nis an organophosphorus cholinesterase inhibitor that is used as an insecticide.\nThis agent would increase levels of acetylcholine, thereby widening the angle.\n  </span>\n </span>\n <span lang=\"EN-GB\">\n </span>\n</p>\n", "<p>\n <strong>\n  <span lang=\"EN-GB\">\n   Answer E is incorrect.\n  </span>\n </strong>\n <span class=\"contentmain1\">\n  <span lang=\"EN-GB\">\n   Propranolol is a non-selective, beta-adrenergic antagonist.\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Acute angle-closure glaucoma\n  </span>\n </b>\n <span>\n  . Acute elevations in\nintraocular pressure can occur when the outflow of aqueous humor from the\nciliary body to the angle is suddenly blocked. (The condition is more common in\nAsians and people who are farsighted but may occur in any patient.) An acute angle-closure\nattack may follow an episode of emotional or physical stress, dilation of the\npupil in dim lighting, or rarely, after instillation of dilating eyedrops. A\npatient having an acute attack usually has severe ocular pain and redness,\nblurred vision, rainbow-colored halos around lights, and often nausea and\nvomiting. On examination, the eye is usually red, the pupil is dilated and\npoorly reactive, and intraocular pressure is greatly elevated. Generally, only\none eye is affected. Corneal clouding or corneal edema may be present in\nadvanced cases. An acute episode of angle-closure glaucoma is an ocular\nemergency and requires immediate treatment to lower intraocular pressure to\nprevent permanent visual loss. Acute angle-closure glaucoma can be caused by adrenergic\nagents, either locally (phenylephrine drops, nasal ephedrine) or systemically\n(epinephrine for anaphylactic shock). It can also be caused by drugs with\nanticholinergic properties (e.g., tricyclic anti-depressants).\n </span>\n</p>\n", "choices": ["A. Amitriptyline", "B. Cimetidine", "C. Diazepam", "D. Malathion", "E. Propranolol"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n59-year-old man was hospitalized after an acute myocardial infarction. The day\nafter his discharge, he is readmitted with sudden difficulty speaking. He\nunderstands the speech of others and is able to speak clearly and fluently, but\nhe has trouble naming objects and finding the appropriate words. He often makes\nparaphasic errors (i.e., incorrect substitution of a similar-sounding word\n&ndash; as &ldquo;giss&rdquo; for &ldquo;kiss&rdquo; &ndash; or a word with similar meaning, as &ldquo;hug&rdquo;\nfor &ldquo;kiss&rdquo;). His ability to repeat words and phrases is greatly impaired.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What type\nof aphasia is he exhibiting?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The patient is\nexhibiting conduction aphasia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  There are\ntwo types of acquired speech defect: impaired articulation (dysarthria) and\nimpaired language (aphasia). Dysarthria is limited to the spoken word; aphasia\naffects oral and written language. Dysarthria usually indicates motor\ndysfunction; aphasia represents dysfunction of the language system.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  All\naphasic syndromes are characterized by difficulty recalling words and naming\nobjects. This difficulty is not limited to a single sensory modality. For\nexample, a patient who cannot identify a set of keys will have trouble whether\nhe sees the keys, feels them, or hears them jangle. In right-handed persons,\naphasia is almost always rooted in the left cerebral hemisphere (usually in the\ncortex). More than half of left-handed aphasics have had damage to the left\nhemisphere; the others have right hemispheric or bilateral damage.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  If a\npatient&rsquo;s only language deficit is recalling words or naming objects, the\naphasia is described as &ldquo;anomic.&rdquo; Anomia implies dysfunction somewhere in the\nleft hemispheric language system. Other language disturbances allow a more\nprecise anatomic localization.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Two\ncortical areas adjacent to the left sylvian fissure are especially important\nfor language: Broca&rsquo;s area, which is located anteriorly, and Wernicke&rsquo;s area,\nwhich is located posteriorly (Figure 10-1). These areas are connected by the\narcuate fasciculus (a bundle of white matter). Broca&rsquo;s area, Wernicke&rsquo;s area,\nand the pathways connecting these two areas constitute the perisylvian core of\nthe language system. The perisylvian core includes inferior portions of the\nleft frontal and parietal lobes and a superior portion of the left temporal\nlobe.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Wernicke&rsquo;s\narea is important for language reception and comprehension. Broca&rsquo;s area is\nimportant for reproduction of speech. Damage to Wernicke&rsquo;s area causes poor\ncomprehension. Damage to Broca&rsquo;s area causes decreased fluency. A lesion in any\npart of the perisylvian core impairs repetition (see table below).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npatient in this vignette has trouble naming objects, which occurs in all types\nof aphasia. His inability to repeat words indicates a lesion in the perisylvian\ncore. His comprehension is normal, indicating that Wernicke&rsquo;s area is intact,\nand his speech is fluent, indicating that Broca&rsquo;s area is intact. The lesion\nmust lie, therefore, in the conduction pathways between these two locations.\nSuch aphasia is termed &ldquo;conduction&rdquo; aphasia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\npatient, a CT scan showed an embolic infarct in the inferior left parietal\nlobe.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347383\"\n o:spid=\"_x0000_i1082\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image504.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"244\" src=\"_%20Tutorials_files/image505.png\" v:shapes=\"Picture_x0020_347383\" width=\"313\"/>\n </span>\n <span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Aphasic syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Naming (Language system)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Repetition (Perisylvian core)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Fluency (Anterior)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Comprehension (Posterior)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n     Anomic\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n     Broca&rsquo;s\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n     Conduction\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n     Wernicke&rsquo;s\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     N\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"89\">\n   <p class=\"MsoNormal\">\n    <span>\n     Global\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"89\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     I\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  N = normal\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  I =\nimpaired\n </span>\n</p>\n", "choices": ["A. Anomic", "B. Broca\u2019s", "C. Conduction", "D. Wernicke\u2019s", "E. Global"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following figures best illustrates the relationship between blood flow and\nmean arterial pressure (MAP) in a vascular bed that demonstrates autoregulation\nof blood flow?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347382\"\n o:spid=\"_x0000_i1081\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image506.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"214\" src=\"_%20Tutorials_files/image507.png\" v:shapes=\"Picture_x0020_347382\" width=\"434\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Autoregulation\n  </span>\n </b>\n <span>\n  is the\n  <span>\n   intrinsic ability of an organ to maintain a constant blood flow despite\nchanges in perfusion pressure\n  </span>\n  . This occurs in the absence of neural and\nhormonal influences and is, therefore, intrinsic to the organ.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  If\nperfusion pressure decreases in a\n  <i>\n   passive\n  </i>\n  vascular bed, i.e., one that does\n  <i>\n   not\n  </i>\n  show autoregulation, a rapid and sustained fall in blood flow occurs. Passive\nconstriction of the arterioles will cause increased vascular resistance. If,\nhowever, perfusion pressure decreases in a vascular bed that\n  <i>\n   is\n  </i>\n  capable of autoregulatory behavior,\nthe initial drop in pressure and flow triggers arteriolar dilation, which\nincreases blood flow over the next few minutes.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347381\"\n o:spid=\"_x0000_i1080\" type=\"#_x0000_t75\" alt=\"Description: hyper1\">\n <v:imagedata src=\"_%20Tutorials_files/image508.png\" o:title=\"hyper1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: hyper1\" border=\"0\" height=\"179\" src=\"_%20Tutorials_files/image509.png\" v:shapes=\"Picture_x0020_347381\" width=\"301\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  CBF = cerebral blood flow\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  MAP = mean arterial pressure\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The figure\nabove shows the relationship between blood flow and perfusion pressure in an\nautoregulating and non-autoregulating vascular bed. In the autoregulating\nvascular bed (designated &ldquo;normal&rdquo;) flow changes relatively little despite a\nlarge change in perfusion pressure. In the non-autoregulating bed (designated\n&ldquo;absent&rdquo;) flow drops significantly as pressure drops.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Different\norgans display varying degrees of autoregulatory behavior. The renal, cerebral,\nand coronary circulations show excellent autoregulation, whereas skeletal\nmuscle and splanchnic circulations show moderate autoregulation. The cutaneous\ncirculation shows little or no autoregulatory capacity. Autoregulation ensures\nthat critical organs have an adequate blood flow and oxygen delivery.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  In the autoregulating\nvascular bed, flow changes relatively little despite a large change in\nperfusion pressure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  An\n8-year-old girl has bilateral peripheral vision defects. CT scan shows\ncalcification of the pituitary fossa. MRI shows a sellar and suprasellar mass\nwith high signal intensity on T1 images. Which of the following is the most\nlikely origin of her brain tumor?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . In children,\ncraniopharyngioma is the most common tumor to arise from the sella turcica.\nFindings may include headache, pituitary dysfunction, and bitemporal\nhemianopsia (due to impingement of the optic chiasm). Craniopharyngiomas are\nderived from Rathke&rsquo;s pouch, an embryological structure that buds from the roof\nof the mouth to form the anterior pituitary.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347380\"\n o:spid=\"_x0000_i1079\" type=\"#_x0000_t75\" alt=\"Description: craniopharyngioma.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image510.jpg\" o:title=\"craniopharyngioma.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: craniopharyngioma.jpg\" border=\"0\" height=\"176\" src=\"_%20Tutorials_files/image511.png\" v:shapes=\"Picture_x0020_347380\" width=\"157\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p>\n Primary central nervous\nsystem (CNS) tumors are a heterogeneous group of diseases that are,\ncollectively, the second most common malignancy in childhood and adolescence.\nThe treatment approach is multimodal. Surgery with complete resection, if\nfeasible, is the foundation, with radiation therapy and chemotherapy utilized\naccording to the diagnosis, patient age, and other factors.\n</p>\n\n<p class=\"MsoNormal\">\n <a name=\"4-u1.0-B978-1-4377-0755-7..00491-7--s001\">\n </a>\n <a name=\"4-u1.0-B978-1-4377-0755-7..00491-7--st00\">\n </a>\n <span class=\"figure-caption\">\n  <span>\n   Childhood brain tumors\noccur at any location within the central nervous system. The relative frequency\nof different histologic types and the anatomic distribution are shown below.\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347379\"\n o:spid=\"_x0000_i1078\" type=\"#_x0000_t75\" alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0755-7&amp;eid=4-u1\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image512.jpg\" o:title=\"bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0755-7&amp;eid=4-u1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0755-7&amp;eid=4-u1\" border=\"0\" height=\"341\" src=\"_%20Tutorials_files/image513.png\" v:shapes=\"Picture_x0020_347379\" width=\"452\"/>\n </span>\n <span class=\"figure-caption\">\n  <span>\n  </span>\n </span>\n</p>\n", "choices": ["A. Ventricular lining", "B. Vascular endothelium", "C. Rathke\u2019s pouch", "D. Fourth ventricle neuroectoderm", "E. Adenohypophyseal lactotrophs"]}, {"question": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347378\"\n o:spid=\"_x0000_i1077\" type=\"#_x0000_t75\" alt=\"Description: http://www.cytochemistry.net/endocrine_system/pitdraw2.jpg\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image514.jpg\" o:title=\"//www.cytochemistry.net/endocrine_system/pitdraw2.jpg\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: http://www.cytochemistry.net/endocrine_system/pitdraw2.jpg\" border=\"0\" height=\"128\" src=\"_%20Tutorials_files/image515.png\" v:shapes=\"Picture_x0020_347378\" width=\"403\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Ependymomas arise from\ncells lining the ventricles. Usually they appear in the fourth ventricle, where\nthey may block the flow of cerebrospinal fluid, causing hydrocephalus.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Hemangioblastomas\narise from vascular endothelium, usually in the cerebellum or spinal cord.\nSymptoms include cerebellar ataxia and motor/sensory dysfunction.\nHemangioblastomas may be sporadic or part of von Hippel-Lindau disease, an\nautosomal dominant disease associated with pheochromocytoma, pancreatic cysts,\nand cerebellar and retinal hemangioblastomas.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Medulloblastomas arise\nfrom neuroectoderm of the fourth ventricle. Hydrocephalus results from blockage\nof cerebrospinal fluid. Findings include headache, vomiting, and head\ntilt.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Pituitary adenomas are\nrare in children. The most common types in adults are non-secreting tumors, prolactinomas\n(derived from lactotrophs that secrete prolactin, causing galactorrhea and\namenorrhea), growth-hormone secreting tumors (derived from somatotrophs,\ncausing acromegaly), and ACTH-producing tumors (derived from corticotrophs,\ncausing Cushing&rsquo;s syndrome).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 58-year-old woman is admitted to the hospital because of\nmetastatic breast cancer. She begs her best friend to stay with her at the\nhospital because she is afraid of being left alone. Which of the following\ndefense mechanisms explains this behavior?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis correct.\n  </span>\n </b>\n <span>\n  Regression is the reversion to an earlier stage of development\nin the face of unacceptable thoughts.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect.\n  </span>\n </b>\n <span>\n  Denial is the refusal to accept reality.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect.\n  </span>\n </b>\n <span>\n  Displacement is the redirection of thoughts about one person so\nthey are &ldquo;aimed&rdquo; at another person.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis incorrect.\n  </span>\n </b>\n <span>\n  Repression is the unconscious blocking of unacceptable thoughts.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect.\n  </span>\n </b>\n <span>\n  Sublimation is the channeling of unacceptable thoughts into\nacceptable ones.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Defense mechanisms are subconscious &ldquo;protective&rdquo; techniques used\nby individuals to distance themselves from unpleasant thoughts, feelings, or\nbehaviors. The most common defense mechanisms appear below.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   1. Denial\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Denial is the refusal to accept reality. Example: An alcoholic\ndenies he has a drinking problem.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   2. Regression\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Regression is the reversion to an earlier stage of development\nin the face of unacceptable thoughts. Example: An adult with a terminal illness\nbegs a friend to stay with her overnight.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   3. Acting Out\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Acting out is performing an extreme behavior to express a\nthought or feeling. Example: A boy throws a book at someone instead of saying,\n&ldquo;I&rsquo;m mad at you.&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   4. Dissociation\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Dissociation is a temporary,\n </span>\n <span>\n  drastic modification of one&rsquo;s personal identity.\nExample: A victim of spousal abuse imagines herself as a beloved princess.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   5. Compartmentalization\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Compartmentalization is a form of dissociation in which a part\nof oneself is &ldquo;mentally separated&rdquo; from another part. Example: An honest person\ncheats on his income tax return and does not &ldquo;see&rdquo; that he has behaved dishonestly.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   6. Projection\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Projection is the misattribution of one&rsquo;s own undesired thoughts\nonto another person. Example: A woman expresses anger at her husband for &ldquo;not\nlistening,&rdquo; but does not listen herself.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   7. Reaction formation\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Reaction formation is the converting of unwanted thoughts into\ntheir opposite. Example: A woman who is angry with her boss is overly kind and\ngenerous toward him.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   8. Repression\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Repression is the unconscious blocking of unacceptable thoughts.\nExample: A physician subconsciously blocks his memories of medical school.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   9. Displacement\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Displacement is the redirection of thoughts about one person so\nthey are &ldquo;aimed&rdquo; at another person. Example: A man who is angry at his boss\nyells at his wife instead.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   10. Intellectualization\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Intellectualization is the overemphasis on thinking and the\nabandonment of normal emotion. Example: A man who has just been diagnosed with\nterminal cancer focuses on the details of the medical procedures he has\nundergone.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   11. Rationalization\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Rationalization is offering a different explanation for one&rsquo;s\nperceptions. Examples: A boy who fails an examination decides that the test was\npoorly written.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   12. Undoing\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Undoing is the attempt to take back or counteract an\nunacceptable thought or act. Example: A man praises his wife&rsquo;s intelligence\nafter calling her &ldquo;dumb.&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   13. Sublimation\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sublimation is the channeling of unacceptable thoughts into\nacceptable ones. Example: A man who is angry over an injustice writes a book\nabout injustice.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   14. Compensation\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Compensation is the process of counterbalancing perceived\nweaknesses with perceived strengths. Example: A man who is unsuccessful at his\ncareer tells himself that he&rsquo;s a good husband and father.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   15. Assertiveness\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Assertiveness is the expression of a person&rsquo;s needs in a manner\nthat is respectful, direct, and firm.\n </span>\n</p>\n", "choices": ["A. Denial", "B. Displacement", "C. Regression", "D. Repression", "E. Sublimation"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n78-year-old man is admitted to the intensive care unit after sustaining a burn\nover 20% of his body. The following day he cannot recall why he is in the\nhospital, and he accuses the staff of torturing him. He is disoriented to place\nand date. His wife says he was &ldquo;normal&rdquo; before the burn. What is the most\nlikely diagnosis?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct\n </b>\n . Delirium is the\nmost likely diagnosis.\n <b>\n </b>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n .\n <span>\n  Major depressive disorder\n </span>\n is a\nsyndrome characterized by low mood, low self-esteem, and loss of interest or\npleasure in normally enjoyable activities. It is a disabling condition that\nadversely affects sleep and appetite; work, school, and family life; and\ngeneral health.\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n .\n <span class=\"header3\">\n  D\n </span>\n ementia is characterized by a progressive decline in\nmemory and at least one other cognitive function, such as attention,\norientation, judgment, abstract thinking, or personality.&nbsp; Delirium and\ndementia are the most common causes of cognitive dysfunction (defined as the\ninability to acquire, retain, and use knowledge normally). Although these\nconditions may occur together, they are quite different. Delirium begins\nsuddenly, causes fluctuations in mental function, and is usually reversible. Dementia\nbegins gradually, is slowly progressive, and is usually irreversible.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n Delirium affects mainly attention;\ndementia affects mainly memory. Both are more common in older people.\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Mania\n  </span>\n  is characterized by excessive\nelevation\n  <span class=\"mmdefinition1\">\n   <span>\n    of mood that is disproportionate to the situation\n   </span>\n   .\n  </span>\n  Mania\nmay be caused by drugs (e.g., cocaine, methamphetamine), medication (e.g.,\nglucocorticoids), and malignancy, but is most commonly associated with bipolar\ndisorder, where episodes of mania alternate with episodes of major depression.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Schizophrenia\n   <b>\n   </b>\n  </span>\n  is a severe,\npersistent, and debilitating condition characterized by disintegration of\nthought and poor emotional responsiveness. Common symptoms include auditory\nhallucinations, paranoid and bizarre delusions, and disorganized speech and\nthinking. The onset of symptoms typically occurs in young adulthood, with a\nglobal lifetime prevalence of about 0.3&ndash;0.7%.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Delirium\n  </span>\n </b>\n <span>\n  is an acute confusional state. It is not a\ndisease but a syndrome with many potential causes. The principal symptoms are\nclouding of consciousness, difficulty maintaining or shifting attention,\ndisorientation, delusions, hallucinations, abnormal behavior, and fluctuating\nlevels of consciousness. Disturbance of the sleep-wake cycle manifested by\ninsomnia, daytime drowsiness, or disturbing dreams or nightmares may occur.\nSymptoms tend to fluctuate over the course of the day, with improvement during\nthe daytime and worsening at night. Often patients cannot remember why they are\nin the hospital or what happened while they were delirious.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Emotional\ndisturbances such as depression, anxiety, fear, and irritability are sometimes\nseen.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Many\nmedical disorders, intoxications, and medicines can cause delirium. Often\ndelirium is multifactorial, and the physician must investigate each\ncontributing cause. Common causes include hypoxia, hypoglycemia, hyperthermia,\nanticholinergic medicine, alcohol or sedative withdrawal, infection, fluid and\nelectrolyte abnormality, hepatic and renal failure, cerebral hypoperfusion,\nstructural lesion of the brain, postoperative state, vitamin deficiency\n(especially thiamine and cyanocobalamin), and endocrinopathy. Medications can\ncause delirium in elderly people even at therapeutic doses. Dementia is a\nstrong risk factor for delirium; dysphoria and depression are also major risk\nfactors.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Delirium\nis a medical emergency associated with increased morbidity and mortality. It is\ntransient, appears rapidly, and is usually reversible. The diagnosis is made\nclinically; laboratory and imaging tests do not establish the diagnosis.\nDelirious patients are often given an incorrect diagnosis of dementia,\ndepression, mania, or schizophrenia due to the presence of overlapping\nfeatures.\n </span>\n</p>\n", "choices": ["A. Major depressive disorder", "B. Delirium", "C. Dementia", "D. Mania", "E. Schizophrenia"]}, {"question": "<p>\n <span>\n  A 74-year-old man has a two-year history of progressive change in\nbehavior. He writes everything down on a notepad; otherwise, he forgets. He\ncannot remember the names of his cousins or his birthday. His blood test\nresults are normal, including thyroid hormone and vitamin B12 levels. A drug\nfrom which of the following classes is most likely to improve symptoms?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer A is correct.\n </b>\n Dementia is associated with acetylcholine\ndeficiency. Symptoms may improve with use of an acetylcholinesterase inhibitor,\nwhich would increase levels of acetylcholine.\n</p>\n"], "tutorial": "<p>\n <b>\n  Dementia\n </b>\n is a serious\nloss of cognitive ability in a previously unimpaired person, beyond what might\nbe expected from normal aging. It may be static, the result of a unique global\nbrain injury, or progressive, resulting in long-term decline due to damage or\ndisease in the body. Although dementia is far more common in the geriatric\npopulation, it can occur before the age of 65, in which case it is termed\n&ldquo;early onset dementia.&rdquo;\n</p>\n\n<p>\n Dementia is a syndrome\n(i.e., set of signs and symptoms) in which affected areas of cognition may be\nmemory, attention, language, and problem solving. It is normally required to be\npresent for at least 6 months to be diagnosed. In all types of general\ncognitive dysfunction, higher mental functions are affected first in the\nprocess.Dementia reduces the ability to learn, reason, retain or recall past\nexperiences. There is also loss of patterns of thoughts, feelings and\nactivities. As dementia worsens individuals may neglect themselves and may\nbecome disinhibited or incontinent. Especially in the later stages of the\ncondition, affected persons may be disoriented in time (not knowing what day of\nthe week, day of the month, or even what year it is), in place (not knowing\nwhere they are), and in person (not knowing who they, or others around them, are).\n</p>\n\n<p>\n Dementia, though often\ntreatable to some degree, is usually due to causes that are progressive and\nincurable.\n</p>\n\n<p>\n Symptoms of dementia can be\nclassified as either reversible or irreversible. Less than 10% of cases of\ndementia are due to causes that may presently be reversed with treatment.\nWithout careful assessment of history, the short-term syndrome of delirium\n(often lasting days to weeks) can easily be confused with dementia, because they\nhave all symptoms in common, save duration. Some mental illnesses, including\ndepression and psychosis, may produce symptoms that must be differentiated from\nboth delirium and dementia.\n</p>\n\n<p>\n There are many specific\ntypes (causes) of dementia, often showing slightly different symptoms. However,\nthe symptom overlap is such that it is impossible to diagnose the type of\ndementia by symptomatology alone, and in only a few cases are symptoms enough\nto give a high probability of some specific cause. Certainty cannot be attained\nexcept with brain biopsy during life or at necropsy in death. Some of the most\ncommon forms of dementia are: Alzheimer disease, vascular dementia,\nfrontotemporal dementia, semantic dementia, and dementia with Lewy bodies.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Currently,\nthere are no medications that are clinically proven to be preventative or\ncurative of dementia. Although some medications are approved for use in the\ntreatment of dementia, these treat the behavioral and cognitive symptoms of\ndementia, but have no effect on the underlying pathophysiology.\nAcetylcholinesterase inhibitors -- Tacrine (Cognex), donepezil (Aricept),\ngalantamine (Razadyne), and rivastigmine (Exelon) -- are approved for treatment\nof dementia induced by Alzheimer disease. They may be useful for other similar\ndiseases causing dementia such as Parkinson disease or vascular dementia.\nAcetylcholinesterase inhibitors aim to increase the amount of the\nneurotransmitter acetylcholine, which is deficient in people with dementia.\nThis is done by inhibiting the action of the enzyme acetylcholinesterase, which\nbreaks down acetylcholine as part of normal brain function. Though these\nmedications are commonly prescribed, in a minority of patients these drugs can\ncause side effects including bradycardia and syncope.\n </span>\n</p>\n", "choices": ["A. Acetylcholinesterase inhibitor", "B. Benzodiazepine", "C. Opioid receptor antagonist", "D. Phenothiazine", "E. Tricyclic antidepressant"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Part 1.\nMs. Streetwise is a 58-year old homeless widow brought to the Emergency\nDepartment after jumping off an overpass in an apparent suicide attempt.\nFortunately, she fell on a grassy bank and sustained only superficial cuts.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She is alert and fully oriented. Psychomotor\nactivity and speech are slow.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She\nis tearful and states that she has felt despondent and alone for quite some\ntime. She decided it was time to end her suffering. Her energy is low, she has\nlost 15 pounds due to poor appetite, and she does not sleep well.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She has not enjoyed life lately. She\nleft her senior retirement center because she felt she didn&rsquo;t deserve such a\ngood place. She believes that she has caused great suffering in the world, as\nshe has not attended church to pray for others in two years.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Prior to retiring five years ago, she\nwas a successful school teacher who regularly won teaching awards.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following tests would be\n  <i>\n   least\n  </i>\n  helpful at this time?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Although functional MRI may be abnormal\nin chronic mood disorders, dementia, and other brain conditions, it is costly,\nunnecessary, and not available in most medical centers.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Thyroid function tests\nwould be helpful because untreated hypothyroidism can cause depressed mood.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Urine drug screen would be helpful because CNS\ndepressants, such as benzodiazepines and alcohol, can cause depressed mood.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Deficiencies of vitamin B12, folate, and\nthiamine can adversely affect mood.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Because of her fall, a\nhead CT should be ordered to exclude intracranial bleed.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Part 2.\nYou order thyroid function tests, a urine drug screen, a head CT, and serum\nlevels of vitamin B12, folate, and thiamine.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  All results are normal. You believe that\nMs. Streetwise&rsquo;s suicide attempt was the result of a mental disorder. What is\nthe most likely diagnosis?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Schizoaffective\nDisorder\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Major\nDepression\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Malingering\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Alcoholism\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Delusional\nDisorder\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Part 3.\nHow would you treat Ms. Anderson?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Start\na tricyclic antidepressant and refer her to a shelter\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Start\nan SSRI (selective serotonin reuptake inhibitor) and place her in the care of\nconcerned family members\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Start\na second-generation antipsychotic and refer her to a community mental health\ncenter\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hospitalize\nher in a psychiatric inpatient unit\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Keep\nher under observation status for 24 hours in the emergency department\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Part 1\n </span>\n</p>\n", "choices": ["A. Thyroid function tests", "B. Urine drug screen", "C. Serum vitamin B12, folate, and thiamine levels", "D. Functional MRI to assess brain metabolism", "E. CT to rule out head injury"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Part 2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  Ms. Anderson has more\nthan 5 of the 9 criteria required to make the diagnosis of major depression:\ndepressed mood, low energy, decreased appetite and weight loss, suicidality,\nloss of interest, sleep disturbance, and excessive guilt. She has major\ndepression with psychotic features.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Ms. Anderson has been highly functional\nin the past, which argues against schizoaffective disorder. There is no known\nhistory of at least two weeks of psychosis\n  <i>\n   outside\n  </i>\n  of a mood disturbance, which could suggest schizoaffective disorder. Also, her\ndelusional guilt appears to be mood congruent.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Malingering involves\nfaking illness for secondary gain. There is no evidence that Ms. Anderson is\nseeking secondary gain.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  The negative urine drug\nscreen makes alcoholism unlikely. The urine drug test can detect alcohol\nseveral days after consumption.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Delusional disorder\ninvolves having a delusion\n  <i>\n   about\nsomething that is feasible.\n  </i>\n  (Causing the world&rsquo;s problems is not feasible.)\nAlso, delusional disorder would not be associated with a predominant mood\ndisturbance.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Part 3\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  After a significant\nsuicide attempt, hospitalization is indicated to ensure the patient&rsquo;s safety\nand compliance with treatment. Discharging a suicidal patient can lead to\nadverse consequences (not to mention a malpractice suit).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Tricyclics are fatal in\noverdose. A shelter cannot provide adequate monitoring.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Family members should\nnot be entrusted to care for an actively suicidal patient.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  A second-generation\nantipsychotic would not be the primary treatment for depression, but might be\nindicated adjunctively for her psychosis. Outpatient treatment at a community\nmental health center is not acceptable.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Nothing is gained by\n24-hour observation. Moreover, an attendant would be necessary to ensure that\nno further suicide attempts occur.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nchildren of a 67-year-old woman ask their family physician for advice about\ntheir mother's behavior 4 weeks after the death of her husband of 40 years.\nThey are concerned because she weeps whenever she comes upon an object in her\nhome that she associates with him. Her appetite has decreased, and she has had\na 2-kg (4.4-lb) weight loss. She awakens 1 hour before the alarm goes off each\nmorning. She is able to care for herself. Although she does not leave her home\nfor any social activities, she does enjoy visits from her family. Which of the\nfollowing is the most likely explanation for her symptoms and the most\nappropriate management?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is correct.\n  </span>\n </b>\n <span>\n  The patient is having a normal grief reaction and\nrequires no medication.\n </span>\n <span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Normal grief reactions are time limited\n(less than 2 months) and do not warrant antidepressant therapy.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <i>\n  <span>\n   Grief\n  </span>\n </i>\n <span class=\"apple-converted-space\">\n  <span>\n   &nbsp;\n  </span>\n </span>\n <span>\n  may be defined as\nthe physical and emotional pain precipitated by a significant loss. The loss\nmay be of a person or pet, but it can also be of a meaningful place, job, or\nobject. A term closely related to grief is\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  <i>\n   bereavement,\n  </i>\n  which\nliterally means to be robbed by death. Many subtypes of grief have been\nsuggested; some of the more commonly used subtypes appear below.\n </span>\n <span>\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Anticipatory grief\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     A grief reaction that\n  occurs in anticipation of an impending loss; its symptoms include anger,\n  guilt, anxiety, irritability, sadness, feelings of loss, and a decreased\n  ability to perform usual tasks.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acute grief\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     The first stage of the\n  process of bereavement. Symptoms may begin immediately following the loss, or\n  may be delayed.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Delayed grief\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     The absence of the\n  expression of grief at the time of a loss.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Unresolved grief\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Grief symptoms that reach\n  extremes of intensity, duration, or tenacity.\n    </span>\n    <a href=\"http://www.mdconsult.com.webproxy.ouhsc.edu/books/linkTo?type=bookPage&amp;isbn=978-0-323-04743-2&amp;eid=4-u1.0-B978-0-323-04743-2..50040-8--bib2&amp;appID=MDC\">\n     <sup>\n      <span>\n       [2]\n      </span>\n     </sup>\n    </a>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Complicated grief\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <span>\n     Unresolved grief plus\n  clinical complications (e.g., physical symptoms) that interfere with daily\n  function.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347495\"\n o:spid=\"_x0000_i1076\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image516.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"390\" src=\"_%20Tutorials_files/image517.png\" v:shapes=\"Picture_x0020_347495\" width=\"319\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Normal grief reaction, and she requires no medical attention", "B. Normal grief reaction, and she would benefit from an antidepressant", "C. Major depression, and she should be treated with an antidepressant", "D. Pathologic grief reaction, and she should be treated with psychotherapy", "E. Pathologic grief reaction, and she should be encouraged to move in with one of her children"]}, {"question": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC and D are incorrect.\n  </span>\n </b>\n <span>\n  Bereavement may become a Major Depressive Episode or a\npathologic grief reaction if it persists for more than 2 months or includes\nmarked impairment, morbid preoccupation with worthlessness, suicidal ideation,\npsychotic symptoms, hallucinatory experiences (other than thoughts of hearing\nthe voice of, or transiently seeing, the deceased person), or psychomotor\nretardation. Major Depression may be treated with an antidepressant, and both\ndepression and pathologic grief may respond to psychotherapy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect.\n  </span>\n </b>\n <span>\n  Moving in with children is not generally recommended by physicians unless\npatients cannot care for themselves, whether for physical or mental health\nproblems.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A 4-month-old boy is brought to the\nphysician by his mother for a well-child examination. He is at the 98th\npercentile for head circumference. Physical examination shows dilation of the\nscalp veins and spasticity of the lower extremities. The physician suspects\nexcessive cerebrospinal fluid accumulation in the ventricular system of the\nbrain. The source of this fluid is most likely which of the following?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  Enlarged head, dilated\nscalp veins, and lower extremity spasticity are consistent with hydrocephalus\nand increased intracranial pressure. Hydrocephalus can be caused by obstruction\nof CSF flow or by overproduction of CSF by the choroid plexus (e.g. choroid\nplexus papilloma).\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Hydrocephalus\n </span>\n is a medical condition in which there is an abnormal\naccumulation of cerebrospinal fluid (CSF) in the ventricles of the brain. This\nmay cause increased intracranial pressure inside the skull and progressive\nenlargement of the head, convulsion, tunnel vision, mental disability, and\ndeath. The clinical presentation of hydrocephalus varies with chronicity.\n</p>\n\n<p>\n Acute dilatation of the\nventricular system is more likely to manifest with the signs and symptoms of\nincreased intracranial pressure, such as headache, vomiting, papilledema,\nsleepiness, or coma.\n</p>\n\n<p>\n Elevated intracranial\npressure may result in uncal and/or cerebellar tonsil herniation, with\nresulting life threatening brain stem compression. By contrast chronic\ndilatation (especially in the elderly population) may have a more insidious\nonset, presenting, for instance, with Hakim's triad: gait instability, urinary\nincontinence and dementia. This triad is typical of the condition, normal\npressure hydrocephalus (NPH). In infants with hydrocephalus, CSF builds up in\nthe central nervous system, causing the fontanelle to bulge and the head to be\nlarger than expected.\n</p>\n\n<p>\n Early symptoms may also\ninclude downward gaze, irritability, seizures, sleepiness, vomiting, and\nspasticity of the extremities.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hydrocephalus\ncan be caused by impaired CSF flow, impaired CSF reabsorption, or excessive CSF\nproduction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  The most common cause of\nhydrocephalus is CSF flow obstruction, hindering the free passage of\ncerebrospinal fluid through the ventricular system and subarachnoid space (e.g.,\nstenosis of the cerebral aqueduct or obstruction of the interventricular\nforamina secondary to tumor, hemorrhage, infection, or congenital\nmalformation).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347377\"\n o:spid=\"_x0000_i1075\" type=\"#_x0000_t75\" alt=\"Description: csf\">\n <v:imagedata src=\"_%20Tutorials_files/image518.png\" o:title=\"csf\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: csf\" border=\"0\" height=\"271\" src=\"_%20Tutorials_files/image519.png\" v:shapes=\"Picture_x0020_347377\" width=\"243\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hydrocephalus can also\nbe caused by overproduction of cerebrospinal fluid (e.g., papilloma of choroid\nplexus). The choroid plexus consists of a layer of cuboidal epithelial cells\nsurrounding a core of capillaries and loose connective tissue. The epithelial\nlayer is continuous with the ependymal cell layer that lines the ventricles,\nbut unlike the ependyma, the choroid plexus layer has tight junctions in\nbetween cells on the side facing the ventricle (apical surface). These tight\njunctions prevent the majority of substances from crossing the cell layer into\nthe CSF; thus, the choroid plexus acts as a blood-CSF barrier. The choroid\nplexus folds into many villi around each capillary, creating frond-like\nprocesses that project into the ventricles. These villi greatly increase the\nsurface area of the choroid plexus. CSF is formed as plasma is filtered from\nthe blood through the epithelial cells. In addition to CSF production, the\nchoroid plexus acts as a filtration system, removing metabolic waste, foreign\nsubstances, and excess neurotransmitters. In this way, the choroid plexus has\nan important role in helping to maintain the delicate extracellular environment\nrequired by the brain to function optimally.\n </span>\n</p>\n", "choices": ["A. Choroid plexus", "B. Dura mater", "C. Pia mater", "D. Roof of the third ventricle"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Normal\ninfant development involves timely acquisition of specific cognitive, social,\nand motor skills. Which of the following skills would\n  <i>\n   not\n  </i>\n  be expected in a 7-month old infant?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . &ldquo;Pulling self up to\nstand&rdquo; is a 9-month milestone.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . &ldquo;Recognizing mother&rdquo;\nis a 3-month milestone. &ldquo;Preferring mother&rdquo; is a 6-month milestone.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . &ldquo;Explores with hands\nand mouth&rdquo; is a 3-4 month milestone.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . &ldquo;Using voice to\nexpress joy and displeasure&rdquo; is a 4-5-month milestone.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . &ldquo;Transferring object\nfrom hand to hand&rdquo; is a 6-month milestone.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Important milestones for an infant at 2 months,\n6 months, and 1 year of age appear below.\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <u>\n   <span>\n    2 MONTHS\n   </span>\n  </u>\n </b>\n <u>\n  <span>\n   :\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Social and Emotional\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Begins\nto smile responsively\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Responds\nto familiar voices\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Recognizes\nmother\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Gross Motor Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  When\non stomach, able to lift head almost 45 degrees\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Less\nflexing of the arms and legs while lying on the stomach\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Disappearance\nof stepping reflex (baby appears to dance or step when placed upright on solid\nsurface)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Fine Motor Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Grasp\nreflex (grasping a finger) starts to disappear\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hands\nare fisted 50% of the time\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Language Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Turns\nto sounds\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Coos\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <u>\n   <span>\n    6 MONTHS:\n   </span>\n  </u>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Social and Emotional\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Removes\na covering over face (start of the peekaboo game)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Vocalizes\nto own image in a mirror and in response to toys\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Recognizes\nand prefers mother\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Gross Motor Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Able\nto roll from back to stomach (rolled from stomach to back at age 4 months)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Able\nto sit alone while propped on hands\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Fine Motor Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Able\nto drop and object and pick it up again\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Rakes\na small object with hand to pick it up\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Language Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Babbles\nwith consonants (&ldquo;bababa, gagaga&rdquo;)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Listens\nthen vocalizes when adult stops\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <u>\n   <span>\n    12 months:\n   </span>\n  </u>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Social and Emotional\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Separation\nanxiety (Cries when mother or father leaves)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Has\nstranger anxiety that developed around 9 months of age (Shy or anxious with\nstrangers)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Enjoys\nimitating people in his/her play\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Shows\nspecific preferences for certain people and toys\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Shows\nobjects to parent to share interest\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Points\nto get desired object\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  **lack\nof these Social/Emotional milestones by 12 months are &ldquo;red flags&rdquo; for autism\nspectrum disorders**\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Gross Motor Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Stands\nalone (with arms help high and legs splayed)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Takes\nindependent steps\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Pulled\nto stand at 9 months and cruised around furniture holding on with hands at 10\nmonths\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Fine Motor Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Has\na fine pincer grasp (can pick up a small object with thumb and forefinger)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Scribbles\nwith a crayon after demonstration\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Attempts\nto build a tower of two\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Language Development\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Says\none word in addition to &ldquo;dada&rdquo; and &ldquo;mama&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Responds\nto &ldquo;no&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Uses\nsimple gestures, such as shaking head for &ldquo;no&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Waves\n&ldquo;bye-bye&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Tries\nto imitate words\n </span>\n</p>\n", "choices": ["A. Recognizes and prefers mother", "B. Explores with hands and mouth", "C. Uses voice to express joy and displeasure", "D. Transfers object from hand to hand", "E. Pulls self up to stand"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n23-year-old woman has a 7-year history of unilateral, throbbing, increasingly\nsevere headaches. The headaches last about 8 hours, are associated with nausea\nand vomiting, and are exacerbated by loud noises. Physical examination shows no\nabnormalities. Which of the following medicines is most likely to provide pain\nrelief if administered soon after the onset of headache?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct.\n </b>\n Sumatriptan belongs to the triptan class.\nTriptans are useful as abortive therapy for migraines, especially when taken\nsoon after the headache begins.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect.\n </b>\n Propranolol is a beta-blocker. Beta-blockers\nare useful for prophylactic (not abortive) therapy of migraines.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n Amitriptyline is a tricyclic\nanti-depressant. Tricyclic anti-depressants are useful for prophylactic (not\nabortive) therapy of migraines.\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . Divalproex is an anti-convulsant drug that\nis useful for prophylactic (not abortive) therapy of migraines.\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n . Topiramate is an anti-convulsant drug that\nis useful for prophylactic (not abortive) therapy of migraines.\n</p>\n"], "tutorial": "<p>\n Migraine headaches may be\nunilateral or bilateral and may occur with or without an aura. The headache\ntypically lasts from 4-72 hours. Pain intensity is usually moderate to severe\nand intensifies with movement or physical activity. Many patients prefer to lie\nquietly in a dark room. The pain usually subsides gradually within a day or\nafter sleep. A majority of patients feel tired or weak afterward. Nausea and\nvomiting usually occur, and photophobia and/or phonophobia are common findings.\n</p>\n\n<p>\n Many patients report\npremonitory symptoms that occur hours to days before the onset of\n</p>\n\n<p>\n headache. These include\nheightened sensitivity to light, sound, or odors; lethargy or yawning; food\ncravings; or mental and mood changes. Many patients also describe an aura (a\ncomplex of neurologic symptoms preceding or accompanying the headache). Auras\nusually develop over 5-20 minutes and last less than 60 minutes. They can be\nvisual, sensory, or motor. Most are visual, and the most common visual\nphenomenon is the scintillating scotoma, which is an arc of absent vision with\na shimmering, zigzag border. Common migraine triggers include food, hormonal\nchanges, physical exertion, fatigue, and medication.\n</p>\n\n<p>\n Migraine treatment involves\nacute (abortive) and preventive (prophylactic) therapy, as well as avoiding\nmigraine triggers. Acute treatment aims to eliminate or halt progression of the\nheadache. Preventive treatment aims to reduce the frequency and severity of\nmigraine attacks.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n Abortive therapies include\nacetaminophen and non-steroidal anti-inflammatory drugs for mild to moderate\nheadache, and triptans for moderate to severe headache. The triptans work by\nbinding to serotonin 5-HT receptors in nerve endings and on cranial blood\nvessels (causing vasoconstriction). They are most effective when taken at the\nbeginning of a migraine. The safety of triptans is well established, and the\nrisk of coronary vasospasm is exceedingly rare. Still, triptans should not be\ntaken by patients with known or suspected coronary artery disease, as they may\nincrease risk of cardiovascular and cerebrovascular events.\n</p>\n\n<p>\n Migraine prophylaxis should\nbe considered in patients with frequent or prolonged headaches. First-line\ndrugs for prophylaxis include beta-blockers such as propranolol, tricyclic\nantidepressants such as amitriptyline, and anticonvulsants such as divalproex and\ntopiramate.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "choices": ["A. Propranolol", "B. Amitriptyline", "C. Divalproex", "D. Topiramate", "E. Sumatriptan"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n34-year-old woman presents with a one-week history of decreased vision in the\nright eye. She can see objects in the peripheral field, but not directly in\nfront of her. She has experienced pain behind the right eye that worsens with\neye movement. Her vision is clear in the left eye, and she has no blurred\nvision. Two years ago, she went through a &ldquo;spell&rdquo; in which she had trouble\nclimbing stairs. She would drag her right leg while walking. Also, she could\nnot feel warm or cold water in the left leg when she took a bath. The lower\nextremity symptoms improved after a few weeks.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  On\nphysical examination, visual acuity is 20/200 in the right eye and 20/20 in the\nleft. Visual field testing shows central loss of vision in the right eye. The\npupillary responses are sluggish when light is directed into the right eye, but\nnormal when light is directed into the left eye. Swinging the light from the\nleft to the right eye causes both pupils to enlarge. Fundoscopic examination is\nnormal. There is mild weakness and increased tone in the right lower extremity.\nThe right knee and ankle reflexes are hyperactive; other reflexes are normal.\nBabinski sign is present on the right. Pinprick sensation is slightly decreased\nin the left leg.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  This patient has two\nseparate sites of neurological involvement &ndash; the right optic nerve and\nthe right spinal cord. The most likely diagnosis in a 34-year old woman is\nmultiple sclerosis. Multiple sclerosis is a demyelinating disease that, by\ndefinition, affects more than one CNS site. (Myelin is a substance that\nprovides &ldquo;electrical insulation.&rdquo; It forms a layer, the myelin sheath, which is\nusually around only the axon of a neuron. Schwann cells supply the myelin for\nperipheral neurons, whereas oligodendrocytes myelinate the axons of the central\nnervous system.) Demyelination of the optic nerve (optic neuritis) explains the\nvisual findings and demyelination of the spinal cord explains the lower\nextremity findings. The diagnosis of multiple sclerosis requires the presence\nof multiple CNS lesions, a history of relapse and remission, involvement of\nwhite matter, and exclusion of other diagnoses. The most common cause of optic\nneuritis is multiple sclerosis. Up to 50% of patients with multiple sclerosis\nwill develop optic neuritis, and in 20-30% of cases, optic neuritis is the\npresenting sign.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\npathway for the pupillary light reflex begins in the retina (Figure 6-2). The\naxons from the retinal ganglion cell (RET) run through the optic nerve (ON),\noptic chiasm (CHI), and optic tract (OT). They synapse in the pretectal nucleus\n(PTN) of the midbrain at the level of the oculomotor nerve. Fibers then run\nfrom the pretectal nucleus to both Edinger-Westphal nuclei (EWN) of the\noculomotor nerve complex. The nerve fibers from the Edinger-Westphal nuclei run\nin the oculomotor nerve to the ciliary ganglion (CG) and then through short\nciliary nerves to the iris sphincter.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When light\nis directed into one eye, the information regarding light brightness is\nsummated in the pretectal region of the midbrain. That information goes to both\nEdinger-Westphal nuclei equally. Consequently, both pupils constrict equally\nwhen a bright light is directed into one eye. If for some reason (e.g., optic\nnerve lesion, retinal detachment, opacified cornea), less light is &ldquo;conveyed&rdquo;\nthrough the optic nerve, the pretectal region will detect this, both\nEdinger-Westphal nuclei will receive less input, and the pupillary response\nwill be bilaterally sluggish or absent. However, when light is projected into\nthe normal eye, both pupils will constrict briskly.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\nvignette, light directed into the right eye causes both pupils to react\nsluggishly, whereas light directed into the left eye causes both pupils to\nconstrict briskly. The efferent arc (oculomotor nerve) of the light reflex is,\ntherefore, normal. The lesion must be in the afferent limb of the reflex arc.\nFibers carrying information on light brightness cross at the optic chiasm.\nSince the patient has a uniocular deficit, the lesion must be anterior to the\noptic chiasm. This afferent pupillary defect is called the Marcus Gunn\npupillary sign. Because the cornea, lens, ocular media, and macula appear\nnormal, the lesion must be in the optic nerve.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lower\nextremity findings include right-sided weakness and left-sided loss of pinprick\nand temperature sensation (Figure 6-4). These findings are consistent with a\nlesion in the right half of the spinal cord. Such a lesion would affect\ncorticospinal fibers to the right lower extremity and spinothalamic fibers from\nthe left lower extremity. If the dorsal columns were involved, loss of\nvibratory sensation and proprioception would be present on the ipsilateral\nside. Because the lower, but not the upper, extremities are affected, the\nlesion must be caudal to T1 and rostral to L2 (spinal levels). (The upper\nextremities are innervated by spinal nerves C5 to T1; the lower extremities are\ninnervated by spinal nerves L2 to S1. For a lesion to &ldquo;miss&rdquo; the upper\nextremities and &ldquo;hit&rdquo; the lower extremities, it must be located below T1 and\nabove L2.)\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347400\"\n o:spid=\"_x0000_s1087\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image520.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\">\n   <tr>\n    <td height=\"0\" width=\"68\">\n    </td>\n   </tr>\n   <tr>\n    <td>\n    </td>\n    <td>\n     <img height=\"371\" src=\"_%20Tutorials_files/image521.png\" v:shapes=\"Picture_x0020_347400\" width=\"298\"/>\n    </td>\n   </tr>\n  </table>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347399\"\n o:spid=\"_x0000_s1086\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image522.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <span>\n   <img height=\"644\" src=\"_%20Tutorials_files/image523.png\" v:shapes=\"Picture_x0020_347399\" width=\"416\"/>\n  </span>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Intracranial hemorrhage", "B. Occipital lobe tumor", "C. Amyotrophic lateral sclerosis", "D. Multiple sclerosis", "E. Ocular migraine"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Drug X applied to a nerve axon decreases\nthe duration of the action potential without affecting the resting potential or\npeak amplitude of the action potential. Which of the following is the most\nlikely mechanism of action of Drug X?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\nis correct.\n  </span>\n </b>\n <span>\n  Increasing\nthe rate of opening of voltage-gated K\n  <sup>\n   +\n  </sup>\n  channels would speed\nrepolarization and shorten the action potential.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis incorrect.\n  </span>\n </b>\n <span>\n  Blocking\nvoltage-gated Na\n  <sup>\n   +\n  </sup>\n  channels would prevent an action potential from\noccurring. This is how many anesthetics work.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B\nis incorrect.\n  </span>\n </b>\n <span>\n  Slowing\nthe rate at which Na\n  <sup>\n   +\n  </sup>\n  channels close (i.e., Na\n  <sup>\n   +\n  </sup>\n  inactivation) would lengthen the time during which Na\n  <sup>\n   +\n  </sup>\n  could enter\nthe cell, thereby increasing the peak amplitude of the action potential and\ndelaying the onset of repolarization.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\nis incorrect.\n  </span>\n </b>\n <span>\n  Decreasing the rate of opening of voltage-gated Na\n  <sup>\n   +\n  </sup>\n  channels would\ninhibit depolarization and lengthen the action potential.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E\nis incorrect.\n  </span>\n </b>\n <span>\n  Inhibition of the Na\n  <sup>\n   +\n  </sup>\n  /K\n  <sup>\n   +\n  </sup>\n  -ATPase pump would depolarize the\nneuron and prevent the establishment of a resting potential.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Nerve fibers conduct &ldquo;messages&rdquo; in the\nform of action potentials. An action potential is an electrical current that\ntravels down a nerve fiber. An action potential can occur only when opposite\ncharges exist on two sides of a cell membrane. Nerve fibers are positively\ncharged on the outside and negatively charged on the inside. An action\npotential represents a brief reversal of that charge (positive on the inside\nand negative on the outside) as it travels down the nerve fiber.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Neurons use Na\n  <sup>\n   +\n  </sup>\n  and K\n  <sup>\n   +\n  </sup>\n  to maintain polarity. Na\n  <sup>\n   +\n  </sup>\n  is highly concentrated outside the cell\nand K\n  <sup>\n   +\n  </sup>\n  is highly concentrated inside the cell. When a nerve is\nresting (not transmitting an electrical message), Na\n  <sup>\n   +\n  </sup>\n  and K\n  <sup>\n   +\n  </sup>\n  move down their concentration gradients through\n  <i>\n   potassium-sodium leak channels\n  </i>\n  to opposite sides of the membrane.\nThese leak channels are always open. Na\n  <sup>\n   +\n  </sup>\n  travels from outside to\ninside the nerve, and K\n  <sup>\n   +\n  </sup>\n  travels from inside to outside the nerve.\nThis continuous process is possible because the cell membrane contains a\n  <i>\n   Na\n   <sup>\n    +\n   </sup>\n   /K\n   <sup>\n    +\n   </sup>\n   ATPase\n  </i>\n  <i>\n   pump\n  </i>\n  , which returns Na\n  <sup>\n   +\n  </sup>\n  and K\n  <sup>\n   +\n  </sup>\n  to their original positions. The pump moves Na\n  <sup>\n   +\n  </sup>\n  from inside to\noutside the nerve and K\n  <sup>\n   +\n  </sup>\n  from outside to inside the nerve. This\nrequires energy in the form of ATP. For every 3 Na\n  <sup>\n   +\n  </sup>\n  pumped out of\nthe cell, 2 K\n  <sup>\n   +\n  </sup>\n  are pumped in. This 3-to-2 discrepancy allows the\ninside of the neuron to be negatively charged relative to the outside. This\n&ldquo;charged&rdquo; state is called the\n  <b>\n   resting\npotential.\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The first step in sending an electrical\nsignal (action potential) is called depolarization. During\n  <b>\n   depolarization\n  </b>\n  ,\n  <i>\n   voltage-gated\nNa\n   <sup>\n    +\n   </sup>\n   channels\n  </i>\n  open, allowing Na\n  <sup>\n   +\n  </sup>\n  to &ldquo;rush&rdquo; into the\ncell, causing the inside of the nerve to become positive. During\n  <b>\n   repolarization\n  </b>\n  , the cell must return to\nits resting potential. This is achieved by opening\n  <i>\n   voltage-gated K\n   <sup>\n    +\n   </sup>\n   channels\n  </i>\n  , which allow K\n  <sup>\n   +\n  </sup>\n  to\nrush out of the cell, causing the outside of the neuron to become positive.\nOnce again, the resting potential is restored.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347376\" o:spid=\"_x0000_i1074\"\n type=\"#_x0000_t75\" alt=\"Description: biological-membrane\">\n <v:imagedata src=\"_%20Tutorials_files/image524.jpg\" o:title=\"biological-membrane\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: biological-membrane\" border=\"0\" height=\"205\" src=\"_%20Tutorials_files/image525.png\" v:shapes=\"Picture_x0020_347376\" width=\"416\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The figure above shows different types of\ntransmembrane proteins in a cell membrane.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   1.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Channel\nprotein (always open): Example: potassium-sodium leak channel\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   2.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Gated\nchannel proteins (open or closed): Examples: voltage-gated Na\n  <sup>\n   +\n  </sup>\n  channel and voltage-gated K\n  <sup>\n   +\n  </sup>\n  channel\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   3.\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Transport\nprotein: Na\n  <sup>\n   +\n  </sup>\n  /K\n  <sup>\n   +\n  </sup>\n  pump ATPase pump\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347375\" o:spid=\"_x0000_i1073\"\n type=\"#_x0000_t75\" alt=\"Description: ActionPotential\">\n <v:imagedata src=\"_%20Tutorials_files/image526.jpg\" o:title=\"ActionPotential\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: ActionPotential\" border=\"0\" height=\"169\" src=\"_%20Tutorials_files/image527.png\" v:shapes=\"Picture_x0020_347375\" width=\"329\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Phases of an\naction potential\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347374\" o:spid=\"_x0000_i1072\"\n type=\"#_x0000_t75\" alt=\"Description: ap3\">\n <v:imagedata src=\"_%20Tutorials_files/image528.png\" o:title=\"ap3\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: ap3\" border=\"0\" height=\"191\" src=\"_%20Tutorials_files/image529.png\" v:shapes=\"Picture_x0020_347374\" width=\"342\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  The opening\nand closing of voltage-gated channels causes ion shifts during an action\npotential\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Also, see demonstration at:\n </span>\n <a href=\"http://outreach.mcb.harvard.edu/animations/actionpotential.swf\">\n  <span>\n   http://outreach.mcb.harvard.edu/animations/actionpotential.swf\n  </span>\n </a>\n <span>\n </span>\n</p>\n", "choices": ["A. Blockade of voltage-gated Na+ channels", "B. Decrease in the rate of Na+ inactivation", "C. Decrease in rate of opening of voltage-gated Na+ channels", "D. Increase in the rate of opening of voltage-gated K+ channels", "E. Inhibition of the Na+/K+-ATPase pump"]}, {"question": "<p>\n A 35-year-old man sustained\nan injury to his left leg. Examination shows left foot drop with numbness and\nparesthesias over the lateral leg and dorsal foot. Injury to which of the\nfollowing nerves is most likely?\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Common peroneal nerve\ndysfunction is associated with foot drop and numbness and paresthesias of the\nlateral leg and dorsal foot.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Femoral nerve\ndysfunction is associated with decreased patellar reflex, numbness of the\nmedial thigh and anteromedial calf, and weakness of the quadriceps muscle (knee\nextension).\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Dysfunction of the\nlateral femoral cutaneous nerve is associated with pain, numbness, and\nparesthesias over the anterolateral thigh.\n </span>\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . Posterior tibial nerve dysfunction causes\ntarsal tunnel syndrome, which is associated with pain and numbness over the\nplantar surface of the foot.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Sciatic nerve\ndysfunction is associated with decreased ankle reflex and pain anywhere from\nthe lower back and upper buttock to the back of the thigh and leg.\n </span>\n</p>\n"], "tutorial": "<p>\n Nerves traveling from the\nspinal cord to the extremities may become entrapped due to injury or\ninflammation. The most common entrapment neuropathies appear below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"443\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Entrapment Neuropathy\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Nerve(s)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Symptoms\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Brachial plexus and/or subclavian artery or vein (\n      <i>\n       Thoracic outlet syndrome\n      </i>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias along the ulnar aspect of the forearm, hand, and 4\n      <sup>\n       th\n      </sup>\n      and 5\n      <sup>\n       th\n      </sup>\n      fingers\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Swelling and pain in\n  the arm\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Episodic cramping of\n  the hand, especially with arm elevation\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Axillary\n  nerve\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias over\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      the outer\n  shoulder\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Shoulder weakness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Difficulty lifting\n  objects\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Difficulty lifting arm\n  above the head\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Radial\n  nerve\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias of the forearm, the &ldquo;thumb side\" of the dorsal hand, and\n  the 2\n      <sup>\n       nd\n      </sup>\n      and 3\n      <sup>\n       rd\n      </sup>\n      fingers\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Difficulty extending\n  the elbow\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Difficulty extending\n  the wrist\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Median\n  nerve (\n      <i>\n       Carpal tunnel syndrome\n      </i>\n      )\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness and\n  paresthesias over the\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      wrist,\n  palm, thumb, and\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      2\n      <sup>\n       nd\n      </sup>\n      and 3\n      <sup>\n       rd\n      </sup>\n      fingers\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Difficulty with finger\n  coordination\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Wasting of thenar\n  eminence (in advanced cases)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Weak grip\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ulnar\n  nerve\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias in the 4th and 5th fingers, usually on the palm side\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Weak grip\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Difficulty with finger\n  coordination\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Muscle wasting (in\n  advanced cases)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Femoral\n  nerve\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias of the medial thigh and anteromedial calf\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Weakness of the\n  quadriceps muscle (knee extension)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Difficulty walking up\n  and down stairs, especially down\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Feeling knee\n  \"give way\"\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Decreased patellar\n  reflex\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lateral femoral cutaneous nerve\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n      (\n      <i>\n       Meralgia\n  paresthetica\n      </i>\n      )\n     </span>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias over the anterolateral thigh\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Posterior tibial nerve (\n      <i>\n       Tarsal tunnel syndrome\n      </i>\n      )\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias over the plantar surface of the foot\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Common\n  peroneal nerve\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness, and\n  paresthesias over the dorsal foot and lateral leg\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      \"Slapping\"\n  gait (walking pattern in which each step makes a slapping noise)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Foot drop\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Toes dragging while\n  walking\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"194\">\n    <p class=\"MsoNormal\">\n     <span>\n      Sciatic\n  nerve\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"248\">\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Pain, numbness,\n  paresthesias ranging from the lower back and upper buttock to the back of the\n  thigh and leg\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      <span>\n       &middot;\n       <span>\n        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n       </span>\n      </span>\n     </span>\n     <span>\n      Decreased ankle reflex\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n", "choices": ["A. Femoral", "B. Lateral femoral cutaneous nerve", "C. Posterior tibial", "D. Common fibular (peroneal)", "E. Sciatic"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n32-year-old college student is having trouble at school. He cannot complete his\nexperiments in the laboratory because he worries about germs. He spends two\nhours each day cleaning his workbench with alcohol to reduce his anxiety. He is\nstudying\n  <i>\n   E. Coli\n  </i>\n  in the lab and has\npersistent, intrusive worries about becoming infected. He gets angry when\nothers use his workbench. Which of the following is the most appropriate\npharmacotherapy for this patient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Fluoxetine is an\nantidepressant medication of the selective serotonin reuptake inhibitor (SSRI)\nclass. Medicines in this class are effective in the treatment of\nobsessive-compulsive disorder.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Obsessive-compulsive\ndisorder (OCD) is an anxiety disorder that causes significant distress and\nfunctional impairment. OCD is characterized by obsessive thoughts and/or\nrepetitive compulsive actions. Obsessions are recurrent and persistent thoughts\nthat are intrusive, inappropriate, and not merely excessive worries about\nreal-life problems. Affected individuals try to suppress or ignore these\nthoughts, recognizing them as abnormal. Compulsions are repetitive behaviors\n(e.g., hand washing, ordering, checking) or mental acts (e.g., praying,\ncounting, repeating words silently) in response to an obsession or according to\nrules that must be applied rigidly. These behaviors are aimed at reducing\ndistress or preventing some dreaded event; however, they are either excessive\nor unrelated to the problem at hand.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Obsessions\nand their related compulsions often fall into one of the following categories.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"193\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Obsessions\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Associated Compulsions\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"193\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"193\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fear of\n  contamination\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Washing,\n  cleaning\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"193\">\n    <p class=\"MsoNormal\">\n     <span>\n      Need for\n  symmetry or precise arranging\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ordering,\n  arranging, balancing, straightening until \"just right\"\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"193\">\n    <p class=\"MsoNormal\">\n     <span>\n      Unwanted\n  sexual or aggressive thoughts or images\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Checking,\n  praying, &ldquo;undoing&rdquo; actions, asking for reassurance\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"193\">\n    <p class=\"MsoNormal\">\n     <span>\n      Doubts\n  (e.g., gas jets off, doors locked)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Repeated\n  checking behaviors\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"193\">\n    <p class=\"MsoNormal\">\n     <span>\n      Concerns\n  about throwing away something valuable\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n      Hoarding\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n Obsessive-compulsive\ndisorder can usually be treated in an outpatient setting. The mainstays of\ntreatment include serotoninergic antidepressant medications, behavior therapy,\neducation, and family interventions.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "choices": ["A. Ciprofloxacin", "B. Chlorpromazine", "C. Phenytoin", "D. Fluoxetine", "E. Amitriptyline"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 48-year-old man has a 1-month history of progressive headache.\nFunduscopic examination shows:\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://upload.wikimedia.org/wikipedia/commons/1/1a/Papilledema.jpg\">\n  <span>\n   <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347373\"\n o:spid=\"_x0000_i1071\" type=\"#_x0000_t75\" alt=\"Description: File:Papilledema.jpg\"\n href=\"http://upload.wikimedia.org/wikipedia/commons/1/1a/Papilledema.jpg\"\n\n o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image530.jpg\" o:title=\"Papilledema.jpg\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: File:Papilledema.jpg\" border=\"0\" height=\"202\" src=\"_%20Tutorials_files/image531.png\" v:shapes=\"Picture_x0020_347373\" width=\"210\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is the most likely cause of these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  Venous engorgement,\nblurred optic margins, and hemorrhages adjacent to the optic disc suggest\npapilledema, a sign of increased intracranial pressure. Patients with increased\nintracranial pressure often present with headache. (By contrast, patients with\ncentral retinal artery occlusion, optic neuritis, or anterior uveitis are more\nlikely to present with eye/visual changes.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  With central retinal\nartery occlusion, there is complete loss of vision in the eye. The entire\nretina (with the exception of the fovea) becomes pale and swollen and opaque\nwhile the central fovea still appears reddish. This is the basis of the famous\n\"cherry red spot\" seen on fundoscopy.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Anterior uveitis\n </span>\n <span>\n  usually presents with eye pain, eye redness, photophobia, and, to a variable\ndegree, decreased vision.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Optic neuritis is\nusually due to multiple sclerosis. Symptoms include sudden loss of vision or\nsudden blurred or \"foggy\" vision and pain on movement of the affected\neye.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Papilledema\n </span>\n <span>\n  is optic disc swelling that is caused by increased intracranial pressure. The\nswelling is usually bilateral and can occur over a period of hours to weeks.\nWhen papilledema is found on fundoscopy, further evaluation is warranted as\nvision loss can result if the underlying condition\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  is not\ntreated. Further evaluation with a CT or MRI of the brain is usually performed.\nPapilledema may be asymptomatic or present with headache in the early stages.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The signs\nof papilledema that are seen using an ophthalmoscope include\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  venous\nengorgement (usually the first signs)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  loss\nof venous pulsation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  hemorrhages\nover and / or adjacent to the optic disc\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  blurring\nof optic margins\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  elevation\nof optic disc\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Checking\nthe eyes for signs of papilledema should be carried out whenever there is a\nclinical suspicion of raised intracranial pressure, and is recommended in\nnew-onset headaches.\n </span>\n</p>\n", "choices": ["A. Acute occlusion of the retinal artery", "B. Increased intracranial pressure", "C. Inflammation of the anterior chamber", "D. Inflammation of the optic nerve"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 32-year-old man with schizophrenia develops difficulty walking while\ntaking haloperidol. Physical examination shows diffuse muscular rigidity. The\npatient is slow in initiating movement and walks with a shuffling gait. Which\nof the following drug properties is most likely responsible for this effect?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  Neuroleptic\nantipsychotics cause parkinsonism through their anti-dopaminergic properties.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Parkinsonism\n </span>\n <span>\n  (also known as\n  <span>\n   Parkinson syndrome)\n  </span>\n  is a neurological syndrome characterized by tremor, hypokinesia, rigidity, and\npostural instability. The underlying causes of parkinsonism are numerous, and\ndiagnosis can be complex.\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Parkinsonism#cite_note-1#cite_note-1\">\n </a>\n <span>\n  While the\nneurodegenerative condition Parkinson disease (PD) is the most common cause of\nparkinsonism, a wide-range of other etiologies can lead to a similar set of\nsymptoms, including some toxins, a few metabolic diseases, and a handful of\nnon-PD neurological conditions. Its most common cause is as a side effect of\nmedications, mainly neuroleptic antipsychotics, especially the phenothiazines\n(such as perphenazine and chlorpromazine), thioxanthenes (such as flupenthixol\nand zuclopenthixol), and butyrophenones (such as haloperidol), and piperazines\n(such as ziprasidone).\n </span>\n</p>\n\n<p>\n <span>\n  Parkinson disease\n </span>\n is a degenerative disorder of the central\nnervous system. The motor symptoms of Parkinson disease result from the death\nof dopamine-generating cells in the substantia nigra, a region of the midbrain;\nthe cause of this cell death is unknown. Early in the course of the disease,\nthe most obvious symptoms are movement-related; these include shaking,\nrigidity, slowness of movement and difficulty with walking and gait. Later,\ncognitive and behavioral problems may arise, with dementia commonly occurring\nin the advanced stages of the disease. Other symptoms include sensory, sleep,\nand emotional problems. PD is more common in the elderly, with most cases\noccurring after the age of 50.\n</p>\n", "choices": ["A. Anti-adrenergic", "B. Anti-dopaminergic", "C. Anti-histaminergic", "D. Anti-muscarinic", "E. Anti-serotoninergic"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n34-year-old woman is brought to the emergency room after slitting her wrists\nwith a sharp object. She is incarcerated and serving a life sentence for\nmurder. Once she is stabilized, she demands to be hospitalized until she is\ncompletely &ldquo;healed.&rdquo; She threatens to harm the attending physician if he writes\nfor her discharge. Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This patient has anti-social personality\ndisorder, characterized by disregard for the law and the rights of others.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Personality disorders\n </span>\n <span>\n  , formerly known as\n  <span>\n   character\ndisorders\n  </span>\n  , are characterized by \"an enduring pattern of inner\nexperience and behavior that deviates markedly from the expectations of the\nculture.\" The behavior pattern is chronic, inflexible, and associated with\nconsiderable personal and social disruption.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Personality\ndisorders are classified into three major &ldquo;clusters.&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cluster A (odd or eccentric)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Paranoid personality disorder:\n </span>\n <span>\n  irrational suspicion\nand mistrust of others\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Schizoid personality disorder:\n </span>\n <span>\n  lack of interest in\nsocial relationships; seeing no point in sharing time with others; anhedonia;\nintrospection\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Schizotypal personality disorder:\n </span>\n <span>\n  social withdrawal; odd\nbehavior; magical thinking\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cluster B (dramatic or emotional)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Antisocial personality disorder:\n </span>\n <span>\n  pervasive disregard for\nthe law and the rights of others\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Borderline personality disorder:\n </span>\n <span>\n  extreme \"black and\nwhite\" thinking; mood instability; suicidal or self-mutilating behavior;\nunstable and intense relationships; impulsivity; anger control problems;\ndisturbed self-image\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Histrionic personality disorder:\n </span>\n <span>\n  pervasive\nattention-seeking, including inappropriate sexual seductiveness and shallow or\nexaggerated emotions\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Narcissistic personality disorder:\n </span>\n <span>\n  pervasive pattern of\ngrandiosity; need for admiration; lack of empathy\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Cluster C (anxious or fearful)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Avoidant personality disorder:\n </span>\n <span>\n  social inhibition;\nfeelings of inadequacy; extreme sensitivity to negative evaluation; avoidance\nof social interaction.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Dependent personality disorder:\n </span>\n <span>\n  pervasive psychological\ndependence on others\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Obsessive-compulsive personality disorder (not the\nsame as obsessive-compulsive disorder):\n </span>\n <span>\n  rigid conformity to rules, moral codes, and\nexcessive orderliness\n </span>\n</p>\n", "choices": ["A. Schizoid personality disorder", "B. Antisocial personality disorder", "C. Borderline personality disorder", "D. Narcissistic personality disorder", "E. Obsessive-compulsive personality disorder"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Part 1\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mr. Jones\nis a 32-year-old man who is brought to the emergency room by police because he\nwas standing in the street proclaiming to passersby that he is a messenger of\nGod.\n  <a name=\"31419\">\n  </a>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  On\nexamination, he is alert and oriented to person, place, time, and\nsituation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  His hygiene is poor. He\nis malodorous and appears not to have shaved or bathed in days.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He has trouble sitting still through the\ninterview and is at times physically intrusive. He fails to maintain normal\nsocial space between himself and others. His speech is rapid and loud; his\nthought process is tangential. He describes his &ldquo;religious insights&rdquo; in\ngrandiose terms, but avoids details because he believes that the examining\npsychiatrist is part of a conspiracy to keep him from spreading his divine\nword.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He denies suicidal or\nhomicidal ideation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He has little\ninsight into his delusional nature.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  His judgment is impaired. The remainder of the physical examination is\nnormal, including the pulse and blood pressure.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following tests should be ordered first?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A urine drug screen can detect\nstimulants (e.g., methamphetamines) and other drugs (illicit or prescribed)\nthat cause hyperactivity and psychosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect.\n  </span>\n </b>\n <span>\n  A CT scan is costly and should not be ordered as a preliminary test, especially\ngiven the normal physical exam and the absence of a history of head\ntrauma.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect.\n  </span>\n </b>\n <span>\n  Thyroid function tests (TSH, T4) can detect thyrotoxicosis &ndash; and\nthyrotoxicosis when extreme (thyroid storm) can be associated with\nhyperactivity and psychosis. Thyrotoxicosis, however, is associated with\nelevated pulse and blood pressure. (In this patient, the pulse and blood\npressure are normal.) Also, urine drug screen results can be obtained more\nquickly than thyroid function test results.\n </span>\n</p>\n", "<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nD is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A 24-hour urine sample for metanephrines\nand catecholamines is useful for making the diagnosis of pheochromocytoma, but\nthis diagnosis is unlikely given the normal pulse and blood pressure.\n </span>\n</p>\n", "<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nE is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A normal erythrocyte sedimentation rate\n(ESR) helps to exclude active inflammation, such as would occur with autoimmune\ndisease (e.g., systemic lupus erythematosus). Autoimmune diseases are more\ncommon in women than in men. Sometimes they cause psychosis, but this occurs\nless commonly than drug-induced psychosis.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Part 2\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Blood tests, a urine drug screen, and a head CT\nare normal.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Mr. Jones is\nhospitalized in an inpatient psychiatric facility.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Which of the following medicines is most\nuseful in treating his condition?\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lithium\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Valproate\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Carbamazepine\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Lamotrigine\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  A\nsecond-generation antipsychotic medicine\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Part 1\n </span>\n</p>\n", "choices": ["A. Urine drug screen", "B. CT scan to rule out head trauma", "C. Thyroid function tests", "D. 24-hour urine sample for metanephrine and catecholamines", "E. Erythrocyte sedimentation rate (ESR)"]}, {"question": "<p class=\"MsoListParagraph\">\n <span>\n  Part\n2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Second-generation antipsychotics are\napproved for treatment of bipolar disorder and schizophrenia. Their efficacy as\nanti-psychotics and as mood stabilizers make them doubly suited for Mr. Jones.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is incorrect.\n  </span>\n </b>\n <span>\n  Lithium\nis useful as a mood stabilizer, but not as an anti-psychotic.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect.\n  </span>\n </b>\n <span>\n  Valproate is useful as a mood stabilizer, but not as an anti-psychotic.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is incorrect.\n  </span>\n </b>\n <span>\n  Carbamazepine\nis useful as a mood stabilizer, but not as an anti-psychotic.\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nD is incorrect.\n  </span>\n </b>\n <span>\n  Lamotrigine\nis useful as a mood stabilizer, but not as an anti-psychotic.\n </span>\n</p>\n\n<p>\n <span>\n  A 32-year-old woman visits the emergency room because she thinks she has\nhad a heart attack. One hour ago, she developed sudden onset chest pain, heart\npounding, shortness of breath, nausea, dizziness, and flushed skin. The episode\nlasted 30 minutes. She now feels better. Last week, she had two similar\nepisodes, which convinced her to limit her activity. Physical examination is\nnormal. Which of the following is the most appropriate nonpharmacologic\ntherapy?\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct\n </b>\n .\n <span>\n  Panic\nattacks\n </span>\n are characterized by sudden, intense, and relatively brief\nperiods of fear and apprehension. Patients often think they are having a heart\nattack or nervous breakdown. They may report a fear of dying or of &ldquo;going\ncrazy.&rdquo; The attacks involve activation of the sympathetic nervous system.\nSymptoms may include trembling, shortness of breath, palpitations, chest pain,\nhot flashes, sweating, nausea, dizziness, and paresthesias.\nCognitive-behavioral therapy (CBT) is an effective therapeutic approach. The\nfirst part of CBT is informational. Patients benefit from learning what a panic\nattack is and how common it is. They also benefit from knowing that their\nsymptoms are not due to heart disease or some other dangerous pathology.\nUltimately they learn to replace inappropriate thoughts, which provoke anxiety,\nwith appropriate thoughts that reflect a correct understanding of the\ncondition.\n</p>\n"], "tutorial": "<p>\n <span>\n  Psychotherapy\n </span>\n aims to increase the individual&rsquo;s sense of\nwell-being. Most forms of psychotherapy use spoken conversation. Some use other\nforms of communication such as the written word, artwork, drama, narrative\nstory, or music. Psychotherapy with children often involves play, dramatization\n(i.e. role-play), and drawing. Psychotherapy occurs within a structured\nencounter between a trained therapist and client. Purposeful,\ntheoretically-based psychotherapy began in the 19th century with\npsychoanalysis. Since then, scores of other approaches have appeared. There are\nseveral broad systems of psychotherapy:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Psychoanalysis,\nthe first practice to be called &ldquo;psychotherapy,&rdquo; encourages verbalization of\nthe patient&rsquo;s thoughts, including free associations, fantasies, and dreams. From\nthese, the analyst formulates the nature of the unconscious conflicts that are\ncausing the patient&rsquo;s symptoms.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Cognitive-behavioral\ntherapy (CBT) is based on the idea that our feelings and behaviors are rooted\nin thoughts. We can change the way we feel and act by changing the content of\nour thoughts. There is empirical evidence that CBT is effective for a variety\nof mood, anxiety, personality, eating, and substance abuse disorders. Treatment\nis often brief, direct, and &ldquo;tailored&rdquo; to the specific problem. CBT can be used\nin individual and group settings. Many techniques have been adapted for\nself-help applications.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Psychodynamic\ntherapy attempts to reveal the unconscious content of a person&rsquo;s psyche in an\neffort to alleviate psychic tension. Its roots are in psychoanalysis, but\npsychodynamic therapy tends to be briefer and less intensive than traditional\npsychoanalysis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Existential\ntherapy is based on the idea that human beings are alone in the world, and that\nisolation leads to feelings of meaninglessness that can be overcome by creating\none&rsquo;s own set of values and meanings.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Humanistic\ntherapy emphasizes the growth and fulfillment of the individual\n(self-actualization) through self-mastery, self-examination, and creative\nexpression. Freedom of choice in creating one&rsquo;s experience is at the core of\nthis form of therapy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  &ldquo;Brief\ntherapy&rdquo; focuses on a specific problem and aims at direct intervention. It is\nsolution-based rather than problem-oriented. It is less concerned with how a\nproblem arose than how it is sustained.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Systemic\ntherapy addresses people in the context of their relationships. Family therapy\nand marriage counseling are included in this category.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Transpersonal\ntherapy is based on a spiritual understanding of consciousness. It draws from\nthe spiritual traditions, including eastern philosophies (e.g., Buddhism and\nthe Yogic traditions of India) and the Western contemplative traditions. These\ntraditions are integrated with contemporary psychology.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Body\npsychotherapy assumes that problems of the mind are related to problems of the\nbody, including aberrant physiology, posture, breathing, muscularity, and\nsexuality. Massage and exercise therapy are included in this category.\n </span>\n</p>\n", "choices": ["A. Psychoanalysis", "B. Cognitive-behavioral therapy", "C. Psychodynamic therapy", "D. Group therapy", "E. Systemic therapy"]}, {"question": "<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347372\"\n o:spid=\"_x0000_i1070\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image532.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"135\" src=\"_%20Tutorials_files/image533.png\" v:shapes=\"Picture_x0020_347372\" width=\"231\"/>\n </span>\n</p>\n\n<p>\n Tyramine is a drug that\ncauses adrenergic neurons to release norepinephrine. The circles above\nrepresent the size of a patient&rsquo;s pupils without treatment and following\ntreatment with tyramine and with epinephrine. Which of the following is\ncompatible with findings shown for the left eye?\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct.\n </b>\n Left-sided sympathetic denervation explains\nthe pupillary findings. Epinephrine acts directly on the &alpha;1 adrenergic\nreceptor, causing pupillary dilation, even when the sympathetic nerves are not\nfunctioning. Tyramine, by contrast, relies on an intact sympathetic nervous\nsystem to release norepinephrine, stimulating &alpha;1 adrenergic receptors.\nSympathetic denervation prevents this effect.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect.\n </b>\n If &alpha;1 adrenergic receptors were\nblocked, neither epinephrine nor tyramine would cause pupillary dilation. The\nfact that epinephrine is effective at causing pupillary dilation indicates that\n&alpha;-blockade is not present.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n &beta;-blockade would have no effect on\npupillary size. Pupillary size is mediated by &alpha; receptors (dilation) and\nmuscarinic receptors (constriction).\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n <b>\n </b>\n</p>\n", "<p>\n <b>\n  Answer C is incorrect.\n </b>\n Muscarinic blockade would cause pupillary\ndilation, not constriction. This patient&rsquo;s left pupil is constricted in the\nuntreated state. Furthermore, epinephrine and tyramine would have no effect on muscarinic\nreceptors, which are part of the parasympathetic nervous system.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect.\n </b>\n Inhibition of cholinesterase would increase\nacetylcholine levels. (Acetylcholine stimulates muscarinic receptors, causing\npupillary constriction.) At first, this seems like a plausible explanation for\nthe small left pupil. But cholinesterase inhibition would not explain the\nfailure of tyramine to produce pupillary dilation. That failure, as explained\nabove, is due to sympathetic denervation.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n"], "tutorial": "<p>\n Two types of muscle control\nthe size of the iris: circular muscle and radial muscle. Circular muscle is\ninnervated by the parasympathetic nervous system; radial muscle is innervated\nby the sympathetic nervous system. Sympathetic stimulation of &alpha;\n <sub>\n  1\n </sub>\n adrenergic receptors causes the contraction of the radial muscle and subsequent\ndilation of the pupil (mydriasis).\n</p>\n\n<p>\n Parasympathetic stimulation\nof M3 muscarinic receptors causes contraction of the circular muscle and\nconstriction of the pupil (miosis). In the normal operation of the autonomic\nnervous system, action potentials cause neurons to release their\nneurotransmitters.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Following\nrelease, the neurotransmitters interact with receptors on the effector to\nproduce a response, in this instance contraction or dilation of the pupil.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Pupillary responses can be used to\npredict the effects of agonists or antagonists of autonomic receptors.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n\n<p>\n <b>\n  Pupillary diameter\n </b>\n is determined by a balance of parasympathetic\nand sympathetic activation.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The\nparasympathetic control dominates under most conditions.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Increasing parasympathetic activity will\nproduce enhanced pupillary constriction and decreasing parasympathetic activity\nwill produce pupillary dilation.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n The reverse is true for decreasing and increasing sympathetic activity,\nrespectively.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Therefore, pupillary\ndilation can be elicited in two ways: blockade of muscarinic receptors or\nexcitation of alpha\n <sub>\n  1\n </sub>\n receptors.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Drugs that produce either one of these effects are used to dilate eyes\nfor an ophthalmological exam.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Analogously, pupillary constriction can be elicited by exciting\nmuscarinic receptors or blocking alpha\n <sub>\n  1\n </sub>\n receptors.\n</p>\n\n<p>\n Administration of a drug\nthat stimulates alpha\n <sub>\n  1\n </sub>\n receptors, such as norepinephrine or\nepinephrine, will produce pupillary dilation; a drug that stimulates muscarinic\nreceptors will produce pupillary constriction.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n These effects will occur regardless of\nwhether the autonomic nervous system is intact because the drugs bypass the\nnervous system to act directly on the receptors.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Tyramine is a drug that produces\nsympathoexcitation by causing the release of norepinephrine from sympathetic\npostganglionic nerve terminals.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n It\ndoes this by displacing norepinephrine from the storage vesicles.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Because tyramine must act through the\nsympathetic nervous system, it is classified as an indirect sympathomimetic\ndrug.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n If there is damage to\nsympathetic postganglionic neurons so that they are not functional or do not\ncontain norepinephrine in vesicles, then tyramine will not have an effect.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n If this situation occurs, administration\nof norepinephrine or epinephrine can still have an effect because they do not\nrequire the presence of an intact sympathetic nervous system to produce an\neffect.\n</p>\n\n<p>\n In this vignette, the left\npupil is smaller than the right. (We are not told which pupil is normal).\nTreatment with epinephrine causes the left pupil to dilate, which would be\nexpected because epinephrine stimulates &alpha;\n <sub>\n  1\n </sub>\n adrenergic\nreceptors, causing contraction of the radial muscle and dilation of the pupil\n(mydriasis). Contrary to expectation, however, treatment with tyramine has no\neffect on left pupillary size. Normally, tyramine should stimulate neuronal\nrelease of norepinephrine, causing pupillary dilation. If this is not\nhappening, the neuron must be dysfunctional. Nerves that release norepinephrine\nbelong to the sympathetic nervous system; therefore, sympathetic denervation\nwould explain the inability of the nerves to release norepinephrine in response\nto tyramine.\n</p>\n\n<p>\n In other words, epinephrine\nis effective because it stimulates the &alpha;\n <sub>\n  1\n </sub>\n adrenergic receptor\n <i>\n  directly\n </i>\n . Tyramine works\n <i>\n  indirectly\n </i>\n by stimulating the\nsympathetic nerves to release norepinephrine. If the sympathetic system is not\nfunctioning (i.e., because of denervation), then norepinephrine is not released\nand the &alpha;\n <sub>\n  1\n </sub>\n adrenergic receptor is not stimulated. Notice that\nin the right eye (where sympathetic nerves are intact), tyramine causes\npupillary dilation. The subsequent administration of epinephrine has no effect\nbecause the &alpha;-receptors have already been stimulated.\n</p>\n", "choices": ["A. Blockade of \u03b1-adrenergic receptors", "B. Blockade of \u03b2-adrenergic receptors", "C. Blockade of muscarinic receptors", "D. Inhibition of cholinesterase", "E. Sympathetic denervation"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 36-year-old woman comes to the\nphysician because of a 10-month history of difficulty falling asleep due to a\ncrawling sensation in her legs. She has to get up several times during the\nnight to relieve the feeling. The symptoms started shortly after she delivered\nher son 1 year ago. She says her husband complains because she has become a\n&ldquo;jumpy&rdquo; sleeper, and her movements sometimes wake him up. Physical examination\nshows no abnormalities. Which of the following is the most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  The patient&rsquo;s symptoms\nare classic for restless legs syndrome.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Restless\nlegs syndrome\n  </span>\n </b>\n <b>\n  <span>\n   (\n   <span>\n    RLS\n   </span>\n   )\n  </span>\n </b>\n <span>\n  is a neurological disorder characterized\nby an irresistible urge to move in order to stop an uncomfortable or odd\nsensation. It most commonly affects the legs, but can affect the arms, torso,\nand even phantom limbs. Movement of the affected body part provides temporary\nrelief. More than half of RLS cases are familial and are inherited in an\nautosomal dominant fashion with variable penetrance. RLS affects an estimated\n7% to 10% of the general population in North America and Europe. A minority of\nsufferers experience daily or severe symptoms.\n </span>\n</p>\n\n<p>\n RLS sensations are sometimes\ncompared to an itching or tickling in the muscles. The sensations typically\nbegin or intensify when the patient is at rest (relaxing, reading, studying, or\ntrying to sleep). Symptoms are generally worse in the evening or at night, and\nimprove with activity. Most individuals with RLS have limb-jerking during\nsleep, which is associated with sleep disruption. Some people experience only a\nminor annoyance, while others experience major disruptions of sleep and\nsignificant impairment in quality of life.\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  RLS may be\nprimary or secondary. Primary, or idiopathic, RLS usually begins slowly before\nage 45, and progresses with age. Secondary RLS often has a sudden onset after\nage 40, and may be associated with specific medical conditions or the use of\ncertain drugs. Most research on RLS has focused on the dopamine and iron\nsystems. (Iron and levodopa, a prodrug that can center the CNS, where it is\nmetabolized to dopamine) can be used to treat RLS. Differences in dopamine- and\niron-related markers have also been demonstrated in the cerebrospinal fluid of\nindividuals with RLS.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Conditions\nassociated with RLS include varicose veins, folate deficiency, magnesium\ndeficiency, fibromyalgia, sleep apnea, uremia, diabetes, thyroid disease,\nperipheral neuropathy, Parkinson disease, and certain auto-immune disorders\nsuch as Sj&ouml;gren syndrome, celiac disease, and rheumatoid arthritis. Symptoms of\nRLS may worsen during pregnancy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Certain\ndrugs can also worsen symptoms of RLS:\n </span>\n</p>\n\n<ul type=\"disc\">\n <li class=\"MsoNormal\">\n  <span>\n   antiemetics (with\n     antidopaminergic properties)\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   antihistamines\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   antidepressants\n     (both tricyclics and selective serotonin reuptake inhibitors)\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   antipsychotics\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   anticonvulsants\n  </span>\n </li>\n</ul>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Amyotrophic\n     lateral sclerosis</span></li>\n<li class=\"MsoNormal\"><span>Multiple\n     sclerosis</span></li>\n<li class=\"MsoNormal\"><span>REM\n     sleep behavior disorder</span></li>\n<li class=\"MsoNormal\"><span>Restless\n     legs syndrome</span></li>\n<li class=\"MsoNormal\"><span>Sleep\n     myoclonus<span></span></span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Part 1\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mr. Alioto\nis a 19-year old man brought to the Emergency Department after he was found\ncamped out under a bridge in sub-freezing weather.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He was malnourished, cold, and unable to\ncare for himself. He said he would not go to a shelter because the CIA was waiting\nthere to arrest him for having angry thoughts about the current national\nadministration and the economic downturn. His speech is normal, but his affect\nis inappropriate. Thought production is goal directed. He hears angry voices\ntelling him to beware of government agents.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Because he is guarded and will not offer\nmuch information, you contact his parents, who tell you that he has been\nhospitalized a year ago for similar symptoms. They tell you that he was shy but\notherwise normal until age 15, when he began to withdraw. He has become\nincreasingly reclusive.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Although\nhis mood has been relatively normal, he has not been able to work or attend\ncollege since his first hospitalization.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Physical examination is otherwise normal and basic lab tests, including\nurine drug screen, are normal.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  He\nhas no history of medical illnesses.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is correct\n  </span>\n </b>\n <span>\n  .\nSchizophrenia presents with two or more psychotic symptoms in a one-month\nperiod, with deterioration in functioning lasting at least six months.\nSubstance abuse, medical disorders, and other psychiatric disorders must be\nruled out. Mr. Alioto has premorbid withdrawal (which is common in\nschizophrenia), delusions, and auditory hallucinations. Because he lacks\ndisorganized or catatonic symptoms, his schizophrenia is of the paranoid\nsubtype.\n </span>\n</p>\n", "<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nA is incorrect\n  </span>\n </b>\n <span>\n  .\nSchizoaffective disorder includes mood disturbance (not present in Mr. Alioto,\naccording to his family) and psychotic symptoms for at least two weeks\n  <i>\n   outside\n  </i>\n  a mood disturbance.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nB is incorrect\n  </span>\n </b>\n <span>\n  .\nSchizophreniform disorder may present similarly to schizophrenia, but lasts for\nonly one to six months.\n </span>\n</p>\n", "<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nC is incorrect\n  </span>\n </b>\n <span>\n  .\nIn delusional disorder, &ldquo;non-bizarre&rdquo; delusions are present, hallucinations are\nabsent, and there is no deterioration in functioning as in schizophrenia.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nE is incorrect\n  </span>\n </b>\n <span>\n  .\nThe drug screen is negative. A positive screen would\n  <i>\n   not\n  </i>\n  have ruled out\nschizophrenia, as a dual diagnosis is common in people with schizophrenia.\n(Drug-induced psychosis and schizophrenia can occur concurrently.)\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Part 2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which is\nthe next most appropriate step?\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   A.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Start\na second-generation antipsychotic and refer to a community mental health\ncenter.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   B.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Start\na first-generation (typical) antipsychotic and observe for 24 hours in the\nemergency department.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   C.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Hospitalize\n(with an emergency order of detention) so that an appropriate antipsychotic can\nbe started.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <span>\n   D.\n   <span>\n    &nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Have\nhim transported to a shelter with a 2-week supply of an antipsychotic medicine\nand have the social worker arrange for an appointment with a community mental\nhealth center.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpLast\">\n <span>\n  <span>\n   E.\n   <span>\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Start\nrapid neuroleptization with haloperidol in the E.R.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Part 1\n </span>\n</p>\n", "choices": ["A. Schizoaffective disorder", "B. Schizophreniform disorder", "C. Delusional disorder", "D. Schizophrenia", "E. Substance-induced psychotic disorder"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Part 2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nC is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Mr. Alioto is unable to care for himself\nand he is in danger of developing hypothermia (and dying) if he returns to the\nstreets. An Emergency Order of Detention (EOD) should be initiated and Mr.\nAlioto should be hospitalized. (In his current state, Mr. Jones is not\ncompetent to sign himself in voluntarily for treatment.) Antipsychotic\nmedication should be initiated.\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nA is incorrect.\n  </span>\n </b>\n <span>\n  Starting\nan antipsychotic medicine on an outpatient basis is unacceptable, as Mr. Alioto\nis unable to care for himself.\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nB is incorrect.\n  </span>\n </b>\n <span>\n  First-generation\nantipsychotics are cheaper than second-generation antipsychotics, but they take\nlonger to have effect and have major side effects. Mr. Jones needs closer\nattention than can be provided in an emergency department.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nD is incorrect.\n  </span>\n </b>\n <span>\n  Shelters\ndo not provide adequate structure or guidance with medication in patients who\nare acutely psychotic.\n </span>\n</p>\n\n<p class=\"MsoListParagraph\">\n <b>\n  <span>\n   Answer\nE is incorrect.\n  </span>\n </b>\n <span>\n  Rapid\n&ldquo;neuroleptization&rdquo; requires multiple doses of medicine, such as haloperidol or\nrisperdol, given orally or intramuscularly. This should be undertaken in\npatients who are violent due to psychotic illnesses. Mr. Alioto is not violent.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mrs. Smith is a 43-year-old married woman\nwith a history of depression previously responsive to antidepressant therapy.\nShe presents to Dr. Jones with a 6-month history of lack of motivation and\nfatigue.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Recent stressors include\nfinancial and family problems: Her husband lost his job and her daughter may be\nusing drugs. Dr. Jones restarts her on the same antidepressant medicine she\nresponded to in the past. At a follow up visit six weeks later, she reports no\nimprovement in her motivation or energy level. Also, she continues to\nexperience weight gain and constipation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is the most appropriate course of action at this time?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Hypothyroidism should be considered as a\ndiagnosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Based on the information provided in the\nvignette, there is no reason to think that the patient wouldn&rsquo;t respond to the\nsame antidepressant medicine\n  <i>\n   if she truly\nhad depression\n  </i>\n  . (What worked in the past is likely to work again.) Had the\ndiagnosis turned out to be depression, increasing the dose of the current\nmedication would likely have been a better choice than switching medicines.\nPatients are often switched from one antidepressant to another without an\nadequate trial (not enough time is allowed or the dose is too low). This\nresults in so-called &ldquo;treatment failures,&rdquo; which demoralize the patient, making\nit harder to find appropriate treatment in the future.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  While increasing the\ndose of the antidepressant medicine may be a better choice than switching\nmedications, the more appropriate course of action is to re-assess the\ndiagnosis. The patient has symptoms of hypothyroidism.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  While referring Mrs.\nSmith to a therapist would be appropriate if she truly had depression, it is\nmore likely that her symptoms are non-psychiatric.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Referral for psychotherapy would likely\nfrustrate the patient and embarrass Dr. Jones when he learns that Mrs. Smith is\nnot truly depressed.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Secondary depression\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  True\nmedical illness is often missed in patients with a history of psychiatric\ndisease because it is assumed that all symptoms are of psychiatric origin. In\nthe case of Mrs. Smith, Dr. Jones assumes that &ldquo;lack of motivation and fatigue&rdquo;\nare due to depression because Mrs. Smith has a history of depression. A careful\nhistory would have uncovered weight gain and constipation in addition to &ldquo;lack\nof motivation and fatigue.&rdquo; Also, a careful history would have noted the\nabsence of other symptoms of depression (e.g., depressed mood). While it is\ntempting to attribute weight gain and constipation to the antidepressant\nmedicine, the patient says she\n  <i>\n   has\ncontinued to experience\n  </i>\n  these symptoms &ndash; i.e., they were present\nbefore the antidepressant medicine was started. Common medical causes of\n&ldquo;depression&rdquo; include hypothyroidism, vitamin B12 deficiency, and anemia. Mrs.\nSmith may well have hypothyroidism.\n </span>\n</p>\n", "choices": ["A. Switch to a different antidepressant medicine \u2013 one with a different mechanism of action", "B. Increase the dose of the antidepressant medicine", "C. Reconsider the diagnosis", "D. Refer Mrs. Smith to a therapist for treatment of depression"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An 8-year-old boy is brought to the\nphysician by his mother because he is not paying attention in class. His mother\nsays that his teacher has described his in-school behavior as \"frequently\nstopping what he is doing and then blinking and making chewing movements.\"\nHis mother has noticed that he sometimes \"stares off into space\" and\nseems to be daydreaming. Physical examination shows no abnormalities. An EEG\nduring one of the episodes shows generalized spike-and-wave bursts at 3 Hz per\nsecond. This patient most likely has which of the following types of seizures?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  The patient&rsquo;s symptoms\nare consistent with a diagnosis of absence seizures.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Seizures\n  </span>\n </b>\n <span>\n  are divided into two\nbroad categories: generalized and partial. Generalized seizures are produced by\nelectrical impulses from throughout the entire brain; partial seizures are\nproduced (at least initially) by electrical impulses in a relatively small part\nof the brain. The part of the brain generating the seizures is sometimes called\nthe focus. The most common types of seizures are listed below:\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"1\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Generalized Seizures\n    </span>\n    <span>\n     <br/>\n     <br/>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Symptoms\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td nowrap=\"\">\n   <p class=\"MsoNormal\">\n    <span>\n     1. \"Grand Mal\" or Generalized\n  tonic-clonic\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Unconsciousness,\n  convulsions, muscle rigidity\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     2. Absence\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Brief\n  loss of consciousness\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     3. Myoclonic\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Sporadic\n  (isolated), jerking movements\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     4. Clonic\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Repetitive,\n  jerking movements\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     5. Tonic\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Muscle\n  stiffness, rigidity\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     6. Atonic\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Loss of\n  muscle tone\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Generalized Seizures\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  There are\nsix types of\n  <span>\n   generalized seizures\n  </span>\n  .\nThe most common and dramatic is the generalized convulsion, also called the\n  <span>\n   grand-mal seizure\n  </span>\n  . In this type of\nseizure, the patient loses consciousness and usually collapses. The loss of\nconsciousness is followed by generalized body stiffening (called the &ldquo;tonic&rdquo;\nphase of the seizure) for 30 to 60 seconds, then by violent jerking (the\n&ldquo;clonic&rdquo; phase) for 30 to 60 seconds, after which the patient goes into a deep\nsleep (the &ldquo;postictal&rdquo; or after-seizure phase). During grand-mal seizures,\ninjuries and accidents may occur, such as tongue biting and urinary\nincontinence.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Absence seizures\n </span>\n <span>\n  cause a short loss of consciousness (just a few seconds) with few or no\nsymptoms. The patient, most often a child, typically interrupts an activity and\nstares blankly. These seizures begin and end abruptly and may occur several\ntimes a day. Patients are usually not aware that they are having a seizure,\nexcept that they may be aware of &ldquo;losing time.&rdquo;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Myoclonic seizures\n </span>\n <span>\n  consist of sporadic jerks, usually on both sides of the body. Patients\nsometimes describe the jerks as brief electrical shocks. When violent, these\nseizures may result in dropping or involuntarily throwing objects.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Clonic seizures\n </span>\n <span>\n  are repetitive, rhythmic jerks that involve both sides of the body at the same\ntime.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Tonic seizures\n </span>\n <span>\n  are characterized by stiffening of the muscles.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Atonic seizures\n </span>\n <span>\n  consist of a sudden and general loss of muscle tone, particularly in the arms\nand legs, which often results in a fall.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"1\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Partial Seizures\n    </span>\n    <span>\n     <br/>\n     <br/>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Symptoms\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     1. Simple\n    </span>\n    <span>\n     <br/>\n     <br/>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     a.\n     <span>\n      Motor\n     </span>\n     <br/>\n     b.\n     <span>\n      Sensory\n     </span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     c. Autonomic\n    </span>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     d.\n     <span>\n      Psychological\n     </span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpFirst\">\n    <span>\n     <span>\n      a.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Jerking, muscle rigidity, spasms, head-turning\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpMiddle\">\n    <span>\n     <span>\n      b.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Unusual sensations affecting either the senses\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpMiddle\">\n    <span>\n     <span>\n      c.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Nausea, diarrhea, incontinence, tachycardia\n    </span>\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoListParagraphCxSpLast\">\n    <span>\n     <span>\n      d.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n    </span>\n    <span>\n     Memory or emotional disturbances\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     2. Complex\n    </span>\n    <span>\n     <br/>\n     <br/>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Automatisms\n  such as lip smacking, chewing, fidgeting, walking and other repetitive,\n  involuntary but coordinated movements\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     3. Secondary generalization\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n  <td>\n   <p class=\"MsoNormal\">\n    <span>\n     Symptoms\n  that are initially associated with a preservation of consciousness that then\n  evolves into a loss of consciousness and convulsions.\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Further Reading:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/understanding-epilepsy-basics\">\n  <span>\n   The Basics of\nEpilepsy\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/epilepsy-convulsive-disorders\">\n  <span>\n   Epilepsy / Convulsive\nDisorders\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/guide/types-epilepsy\">\n  <span>\n   Types of Epilepsy\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/news/20070322/best-first-choice-drugs-epilepsy-idd\">\n  <span>\n   Best First-Choice\nDrugs for Epilepsy ID'd\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/guide/epilepsy-causes-index\">\n  <span>\n   Epilepsy: Causes\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/guide/epilepsy-living-coping\">\n  <span>\n   Epilepsy: Living\nand Coping\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/guide/epilepsy-non-surgical-treatments\">\n  <span>\n   Epilepsy:\nNon-Surgical Treatments\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n  </span>\n </span>\n <a href=\"http://www.webmd.com/epilepsy/epilepsy-types-directory\">\n  <span>\n   See All Epilepsy\nTypes Topics\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Partial Seizures\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Partial seizures\n </span>\n <span>\n  are divided into simple, complex, and those that evolve into secondary\ngeneralized seizures. During simple partial seizures, patients retain\nawareness; during complex partial seizures, they lose awareness.\n  <span>\n   Simple partial seizures\n  </span>\n  are further\nsubdivided into four categories: motor, sensory, autonomic, and psychological.\nMotor symptoms include movements such as jerking and stiffening. Sensory\nsymptoms involve unusual sensations affecting any of the five senses (vision,\nhearing, smell, taste, or touch). When simple partial seizures cause sensory\nsymptoms only (and not motor symptoms), they are called \"auras.\"\nAutonomic symptoms include nausea, diarrhea, incontinence, and tachycardia.\nSimple partial seizures with psychological symptoms are characterized by various\nexperiences involving memory (the sensation of deja-vu), emotions (such as fear\nor pleasure), or other complex psychological phenomena.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Complex partial seizures\n </span>\n <span>\n  , by definition, include impairment of awareness. Patients\nseem to be &ldquo;out of touch,&rdquo; &ldquo;out of it,&rdquo; or &ldquo;staring into space&rdquo; during these\nseizures. There may also be some &ldquo;complex&rdquo; symptoms called automatisms.\nAutomatisms consist of involuntary but coordinated movements that tend to be\npurposeless and repetitive. Common automatisms include lip smacking, chewing,\nfidgeting, and walking.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The third\nkind of partial seizure is one that begins as a focal seizure and evolves into\na generalized convulsive (&ldquo;grand-mal&rdquo;) seizure.\n </span>\n</p>\n", "choices": ["A. Absence", "B. Akinetic", "C. Complex partial", "D. Generalized tonic-clonic", "E. Myoclonic"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Part 1\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Ms.\nAnderson, a 29-year old mother of two children, is referred to your primary\ncare practice by a colleague, who told her after treating her for five years\nthat &ldquo;maybe Dr. X can help you &ndash; I don&rsquo;t seem to be able to.&rdquo; Her medical\nrecords, which she brings with her, are thick and contain many appropriate\nlaboratory studies and medical procedures, all negative.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She is unable to work, and now she\nstates that her medical problems affect her ability to take care of her\nhousehold.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She appears genuinely\nupset that she can&rsquo;t work or complete her housework.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  She has an elementary school teaching credential\nand would like to resume teaching, an enjoyable career for her. She is upset that\nher medical bills are high, and she does not like to depend on physicians, but\nshe wants to be well and independent.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Today she\nstates that one of her biggest problems is continuing pain &ndash; pain in her\nmuscles, headache, abdominal pain, and pain during urination.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Moreover, she has intermittent nausea,\nvomiting, and a sensation of abdominal bloating. She reports that she vomited\nconstantly throughout her pregnancies. She has experienced double vision and\nperiods of deafness, but has had normal evaluations by an ophthalmologist and\nan audiologist.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  She is\nneatly groomed, but appears distressed by her symptoms. She is alert and fully\noriented. Intellect and abstract concept formation are normal. Despite her many\nsymptoms, her mood is generally good. She sleeps well, her energy level is\nnormal, and she does not have significant anxiety.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Speech is normal in rate and rhythm;\nthought production is goal-directed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most likely diagnosis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  Ms. Anderson presents\nwith hallmark symptoms of somatization disorder, in which patients seek\ntreatment for many physical complaints before age 30 and have significant\nfunctional impairment. She fulfills criteria of having at least 4 pain\nsymptoms, 2 gastrointestinal symptoms, 1 sexual symptom, and 1\npseudo-neurological symptom. She has had complete evaluations which have ruled\nout a medical problem, and her symptoms don&rsquo;t appear to have been intentionally\nproduced.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Somatization disorder can\nbe frustrating for physicians and very costly to patients and society.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  With factitious\ndisorder, physical symptoms are intentionally feigned in order to assume a sick\nrole. Our patient wants to be well and independent.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  In hypochondriasis, fear\npredominates &ndash; fear of having a serious disease based on\nmisinterpretation of bodily symptoms. This fear does not respond to medical\nevaluation and reassurance. Ms. Anderson denies anxiety and we don&rsquo;t see the\nexcessive worry about having a serious disease that characterizes\nhypochondriasis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  With malingering,\nphysical symptoms are intentionally produced for secondary gain, such as\navoiding a duty or seeking financial compensation.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  There is no evidence that Ms. Anderson\nis seeking secondary gain. She wants to work.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  In pain disorder, the\npredominant focus is pain in one or more body areas resulting in distress and\nimpairment. Psychological factors appear to have a role in the onset or\nmaintenance of symptoms. Ms. Anderson has a diffuse array of symptoms of which\npain is only a part.\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Part 2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe most helpful approach to treating Ms. Anderson?\n </span>\n</p>\n\n<ol start=\"1\" type=\"A\">\n <li class=\"MsoNormal\">\n  <span>\n   Tell her not to worry: Her medical\n     evaluation reveals no medical illness and her symptoms are &ldquo;all in her\n     head.&rdquo;\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Tell her that her medical evaluation is\n     normal and schedule her for a return visit in one year.\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Advise her that you will conduct more tests\n     because some medical problems are elusive.\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Refer her to a psychiatrist because she has\n     a mental disorder, not a medical disorder.\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Tell her that while her medical evaluation\n     shows no medical illness, her symptoms are real.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n   Schedule her for regular\n     appointments to reassure her, and refer her to a mental health\n     practitioner to help her &ldquo;cope with stress.&rdquo;\n  </span>\n </li>\n</ol>\n\n<p class=\"MsoNormal\">\n <span>\n  Part 1\n </span>\n</p>\n", "choices": ["A. Factitious disorder", "B. Hypochondriasis", "C. Malingering", "D. Somatization disorder", "E. Pain disorder"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Part 2\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Scheduling regular appointments and\nacknowledging that symptoms are real can be reassuring to patients with\nsomatization disorder. This helps to establish trust, which can facilitate the\npatient&rsquo;s acceptance of psychiatric referral later on. Patients often accept\nthat their symptoms are related to stress and that they may benefit with help\nin coping.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Although reassurance is helpful, telling\nthe patient that her problem is &ldquo;all in her head&rdquo; is disrespectful and damages\nthe therapeutic relationship. The patient is not purposefully creating\nsymptoms, is distressed about them, and has incurred considerable medical\nexpense.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Putting off the patient\nfor a year does not address the issue. The patient will likely call for more\nfrequent appointments or seek another physician.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Although it is tempting\nto take on a hero role, performing additional testing at this time is wasteful\nand reinforces the patient&rsquo;s concerns.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Although referral to a\npsychiatrist may helpful later, this abrupt referral is unlikely to be accepted\nby the patient, who will likely believe that you are minimizing or dismissing\nher problems.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n67-year-old man develops a tremor in his fingers. The tremor is most pronounced\nwhen he reaches for a cup of coffee or points to an object. A disorder of which\nof the following is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  Intention tremors are\nusually caused by cerebellar dysfunction. These tremors appear with activity\nand worsen as the target is approached.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Parkinson&rsquo;s disease is\ncaused by death of dopamine-producing cells in the substantia nigra, located in\nthe midbrain. The classic tremor is a relatively slow, fine, pill-rolling\ntremor, which occurs at rest.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Hyperthyroidism produces\na fine, rapid tremor. This is an example of postural tremor.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Liver failure can\nresult in asterixis, which is a specific type of postural tremor.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  A\n  <span>\n   tremor\n  </span>\n  is an involuntary, somewhat\nrhythmic, muscle contraction and relaxation involving to-and-fro movements\n(oscillations or twitching) of one or more body parts. It is the most common of\nall involuntary movements and can affect the hands, arms, eyes, face, head,\nvocal cords, trunk, and legs. Most tremors occur in the hands. There are three\nbasic types of tremor: resting, intention, and postural.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A resting\n(or static) tremor is most prominent at rest and decreases or disappears with\nvoluntary movement. An example is the relatively slow, fine, pill-rolling\ntremor of Parkinson&rsquo;s disease.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Resting tremor\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Intention\ntremors appear with activity and often get worse as the target is neared.\nDisorders of the cerebellar hemispheres commonly cause intention tremors.\n  <span>\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347371\"\n o:spid=\"_x0000_i1068\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image535.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"212\" src=\"_%20Tutorials_files/image536.png\" v:shapes=\"Picture_x0020_347371\" width=\"150\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Intention tremor\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Postural\ntremors appear when a certain posture (e.g., holding the hand still and prone\nin front of the body) is maintained. Examples include the fine, rapid tremor of\nhyperthyroidism and the tremors of anxiety and fatigue. Some postural tremors\nare familial. Asterixis is a postural tremor characterized by nonrhythmic,\nflapping movements of wide amplitude. To detect asterixis, the patient is asked\nto hold both hands forward with hands cocked up and fingers spread. The\nextended wrist or fingers flex suddenly and briefly, and then return to their\noriginal position. Causes of asterixis include liver failure, renal failure,\nand pulmonary insufficiency.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347370\"\n o:spid=\"_x0000_i1067\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image537.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"93\" src=\"_%20Tutorials_files/image538.png\" v:shapes=\"Picture_x0020_347370\" width=\"191\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Postural tremor\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347369\"\n o:spid=\"_x0000_i1066\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image539.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"138\" src=\"_%20Tutorials_files/image540.png\" v:shapes=\"Picture_x0020_347369\" width=\"172\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Asterixis\n </span>\n</p>\n", "choices": ["A. Substantia nigra", "B. Cerebellum", "C. Thyroid", "D. Liver"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n71-year-old man visits his family doctor. A routine blood test shows:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hemoglobin:\n10 g/dL\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hematocrit:\n30%\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Mean\ncorpuscular volume (MCV): 104 &mu;m\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  WBC count:\n5,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Platelet:\n160,000/mm\n  <sup>\n   3\n  </sup>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The serum\nmethylmalonic acid level is elevated. A peripheral blood smear shows the\nfollowing:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347368\" o:spid=\"_x0000_i1065\"\n type=\"#_x0000_t75\" alt=\"Description: hypersegmented neutrophil\">\n <v:imagedata src=\"_%20Tutorials_files/image541.jpg\" o:title=\"hypersegmented neutrophil\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: hypersegmented neutrophil\" border=\"0\" height=\"290\" src=\"_%20Tutorials_files/image542.png\" v:shapes=\"Picture_x0020_347368\" width=\"434\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Failure to\ntreat this condition may result in which of the following neurological\nsymptoms?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . Macrocytic anemia with\nhypersegmented neutrophils suggests either folic acid or vitamin B12\ndeficiency. Only vitamin B12 deficiency produces neurologic symptoms. The\nsymptoms are due to impaired myelin synthesis. The posterior and lateral spinal\ncolumns are primarily affected, causing paresthesias and diminished\nproprioception.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\n  </span>\n </b>\n <span>\n  <b>\n   is\nincorrect\n  </b>\n  . Syncope results from cerebral hypoperfusion.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C\n  </span>\n </b>\n <span>\n  <b>\n   is\nincorrect\n  </b>\n  . Diplopia and dysarthria can be caused by cerebrovascular\naccident (stroke), among other things.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Parkinson&rsquo;s disease is\ncharacterized by tremor, bradykinesia, rigidity, and postural instability.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Both folic\nacid and vitamin B12\n  <b>\n  </b>\n  deficiency can\nproduce a macrocytic anemia, characterized by an elevated mean corpuscular\nvolume (MCV). Examination of a peripheral blood smear may show hypersegmented\nneutrophils (as shown in the image). Folic acid deficiency is associated with\nelevated homocysteine levels; vitamin B12 deficiency is associated with both\nelevated homocysteine and elevated methylmalonic acid levels. Folic acid\ndeficiency does not have neurologic sequela; vitamin B12 deficiency\n  <i>\n   can\n  </i>\n  result in neurologic sequela.\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Lethargy and\n     syncope </span></li>\n<li class=\"MsoNormal\"><span>Ataxia and\n     paresthesias</span></li>\n<li class=\"MsoNormal\"><span>Diplopia and\n     dysarthria</span></li>\n<li class=\"MsoNormal\"><span>Tremor,\n     bradykinesia, rigidity, and postural instability</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n52-year-old man has gradually progressive weakness in the hands. Physical\nexamination shows normal sensorium, normal sensation, and the following\nabnormalities: atrophy of the forearm muscles, fasciculations of the muscles of\nthe upper extremities, hyperreflexia of the lower extremities, and extensor\nplantar reflexes bilaterally (Babinski sign). Which diagnosis is most likely?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  The combination of\nupper motor neuron findings (hyperreflexia and extensor plantar reflexes) and\nlower motor neuron findings (fasciculations and atrophy) suggests a diagnosis\nof amyotrophic lateral sclerosis. Normal sensorium and normal sensation are\ntypical of ALS.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The first\nstep in evaluating a weak patient is to exclude life-threatening disease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      &ldquo;Red\n  Flag&rdquo; Signs\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n      Rapid onset of weakness\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n      Dyspnea\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n      Inability to raise head\n  against gravity\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n      Bulbar symptoms\n  (difficulty chewing, talking, or swallowing)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"311\">\n    <p class=\"MsoNormal\">\n     <span>\n      Loss of ambulation\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The major\nmechanisms of weakness appear below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"428\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mechanisms\n  of Weakness\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Mechanism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"279\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Findings\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"279\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p class=\"MsoNormal\">\n     <span>\n      Upper motor neuron\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"279\">\n    <p class=\"MsoNormal\">\n     <span>\n      Spasticity (increase\n  muscle tone)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Hyperreflexia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Extensor plantar reflex\n  (Babinski sign)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p class=\"MsoNormal\">\n     <span>\n      Lower motor neuron\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"279\">\n    <p class=\"MsoNormal\">\n     <span>\n      Flaccidity (decreased\n  muscle tone)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Hyporeflexia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Fasciculations\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Muscle atrophy\n  (eventually)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p class=\"MsoNormal\">\n     <span>\n      Peripheral polyneuropathy\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"279\">\n    <p class=\"MsoNormal\">\n     <span>\n      Distal muscles affected\n  more than proximal muscles\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lower extremities\n  affected more than upper extremities\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;\n      </span>\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lower motor neuron\n  pattern\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p class=\"MsoNormal\">\n     <span>\n      Neuromuscular junction\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"279\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fluctuating weakness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      (worse with activity;\n  better with rest)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"149\">\n    <p class=\"MsoNormal\">\n     <span>\n      Muscle\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"279\">\n    <p class=\"MsoNormal\">\n     <span>\n      Proximal muscles affected\n  more than distal muscles\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  Certain\nfindings are especially useful.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Disorder\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Findings\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Brain lesion (stroke,\n  tumor, abscess)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Unilateral weakness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Upper motor neuron\n  pattern\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cervical myelopathy due\n  to spondylosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Progressive quadriplegia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Upper motor neuron\n  pattern\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Botulism\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Weakness preceded by\n  gastroenteritis\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Acute generalized\n  weakness\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bulbar symptoms\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Extraocular muscle palsy\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Myasthenia gravis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Fatigability with\n  eye-blinking\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Extraocular muscle palsy\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Amyotrophic lateral\n  sclerosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Dysarthria\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Dysphagia\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Tongue fasciculations\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Multiple sclerosis\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"221\">\n    <p class=\"MsoNormal\">\n     <span>\n      Relapses and remissions\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Visual changes (optic\n  neuritis)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Internuclear\n  ophthalmoplegia\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Amyotrophic lateral sclerosis\n  </span>\n </b>\n <span>\n  <b>\n   (ALS)\n  </b>\n  . ALS is a disease that affects upper and lower motor neurons.\nMost patients present with spasticity and hyperreflexia (upper motor neuron\nsigns) and progressive muscle weakness and atrophy (lower motor neuron signs).\nCognitive function, bowel and bladder function, and eye movements are usually\npreserved. The disease is relentless and progressive: Affected individuals lose\ncontrol of voluntary movements, and respiratory paralysis ensues. Sensory and\nautonomic nerves are usually spared. ALS may be familial or acquired. The two\nforms are clinically and pathologically indistinguishable.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  <b>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </b>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Botulism.\n  </span>\n </b>\n <span>\n  Botulism is a rare, toxin-mediated,\nparalytic disease. The toxin is produced by the bacterium\n  <i>\n   Clostridium botulinum\n  </i>\n  . The disease may be acquired by bacterial\ncolonization of the digestive tract, by direct ingestion of toxin, or by wound\ncontamination. Paralysis typically starts with the cranial nerves and spreads\nto the limbs. The patient may present with double vision, drooping of the\neyelids, loss of facial expression, or difficulty with swallowing or talking.\nThe weakness then spreads to the arms (starting in the shoulders and proceeding\nto the forearms) and legs (starting with the thighs and proceeding to the\nfeet). The autonomic nervous sytem may be affected, causing dry mouth and\nthroat, postural hypotension, and constipation. Nausea and vomiting may occur,\nand, in severe forms, respiratory paralysis ensues.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Myasthenia gravis\n  </span>\n </b>\n <span>\n  .\n  <span>\n   Myasthenia gravis\n  </span>\n  is an autoimmune\nneuromuscular disease that causes fluctuating muscle weakness and fatigability.\nWeakness is caused by circulating antibodies that block acetylcholine receptors\nat the post-synaptic neuromuscular junction. The hallmark of myasthenia gravis\nis fatigability: Muscles become weaker with activity and stronger with rest.\nEspecially susceptible are the muscles that control eye and eyelid movements,\nfacial expression, chewing, talking, and swallowing. Presenting symptoms\ninclude ptosis, diplopia, dysarthria, dysphagia, and change in facial expression.\nNeck and limb movements may be affected, gait may be unsteady, and breathing\nmay be impaired.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Multiple sclerosis\n  </span>\n </b>\n <span>\n  . Multiple sclerosis is\nan inflammatory disease in which the myelin sheaths around the axons of the\nbrain and spinal cord are damaged, leading to demyelination and scarring. (The\nmyelin sheath is usually around only the axon of a neuron. Schwann cells supply\nthe myelin for peripheral neurons, whereas oligodendrocytes myelinate the axons\nof the central nervous system.) Multiple sclerosis usually begins in young\nadults. Women are more commonly affected than men. Patients can have almost any\nneurological finding,\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  including\nfatigue, visual changes, altered sensation, pain, muscle weakness, difficulty with\nmovement or balance, problems with speech or swallowing, and bowel or bladder\ndysfunction. Cognitive and mood changes may occur. Uhthoff&rsquo;s phenomenon\n(exacerbation of symptoms with exposure to heat) and Lhermitte&rsquo;s sign (an\nelectrical sensation running down the back when bending the neck) are characteristic\nbut not specific for multiple sclerosis. Symptoms may progress gradually or\nalternate between relapse and remission.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <sup>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Guillain-Barr&eacute; syndrome\n  </span>\n </b>\n <span>\n  . Guillain-Barr&eacute;\nsyndrome is an\n  <span>\n   acute inflammatory\ndemyelinating polyneuropathy\n  </span>\n  (AIDP), an autoimmune disorder affecting\nthe peripehral nervous system, usually triggered by an acute infectious\nprocess. Typically, the patient experiences ascending paralysis, in which leg\nweakness spreads to the upper limbs and\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  face. There is complete loss of deep tendon reflexes. With prompt\ntreatment, the majority of patients recover. Death may result, however, from\nrespiratory or autonomic nervous system dysfunction.\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Botulism</span></li>\n<li class=\"MsoNormal\"><span>Myasthenia\n     gravis<span style=\"mso-spacerun:yes\">\u00a0 </span></span></li>\n<li class=\"MsoNormal\"><span>Amyotrophic lateral\n     sclerosis</span></li>\n<li class=\"MsoNormal\"><span>Multiple sclerosis</span></li>\n<li class=\"MsoNormal\"><span>Guillain-Barr\u00e9\n     syndrome</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n60-year-old man developed sudden clumsiness in his right hand and arm while he\nwas watering the garden. His hand, which was holding a hose, shook\nuncontrollably as he reached toward his plants. The shaking stopped when he put\nhis hand down. He maintained a strong grip on the nozzle, which felt cold\nagainst his right hand, but not against his left hand. He became nauseated and\ndizzy, and felt as if the garden were spinning around him. When he tried to\nwalk, he staggered, falling toward the right.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  On examination,\nhis voice is hoarse and his walking is unbalanced. He tends to fall to the\nright. Standing with his feet together, he is equally unsteady with eyes opened\nand closed. The right eyelid is somewhat droopy. Pupil diameter is 2 mm on the\nright and 5 mm on the left. Horizontal nystagmus is noted on lateral gaze.\nTouching the right cornea causes neither eye to blink; touching the left causes\nblinking bilaterally. Pinprick is less sharp on the right side of the face.\nSweating is present on the left but not the right side of the face. Right\npalatal paralysis is noted with the gag reflex. There is decreased sensation to\npinprick and temperature on the left side of the body, but proprioceptive and\nvibratory sensation is normal. The right arm and leg are hypotonic, but with\nnormal strength. The right patellar tendon reflex is pendular (i.e., the leg\ncontinues to swing after the tendon is struck). Movements of the right limbs\nare dysmetric, and fine motor movements are clumsy.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A lesion\nin which of the following areas would explain these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer G is correct.\n  </span>\n </b>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Loss of\nsensation to the face can occur at three different levels (Figure 5-2). The\nfirst-order neuron has its cell body in the trigeminal nerve ganglion. Its\ndendrites are sensory receptors and its axon enters the spinal trigeminal\nnucleus, which extends from the upper pons to the C2 level of the spinal cord.\nSecond-order neurons, whose cell bodies lie in the spinal trigeminal nucleus,\nsend their axons to the contralateral side, where they ascend in the\ncontralateral medial lemniscus and synapse with the third-order neurons in the\nthalamus. The third-order neurons send their neurons to the somatosensory\ncortex in the parietal lobe. A lesion anywhere along this pathway can decrease\npain and temperature sensation on the right side of the face and cause a loss\nof the corneal reflex.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Decreased\npain and temperature sensation on the left side of the body indicates\ninvolvement of the spinothalamic tract. The only place where the spinothalamic\ntract receiving input from the left side of the body approximates the trigeminal\nsystem from the right side of the body is in the right brainstem between the\nupper pons and C2 (These are the upper and lower limits of the spinal\ntrigeminal nucleus).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Hoarseness\nand an abnormal gag reflex further localize the lesion (Figure 5-3). Hoarseness\nis caused by vocal cord dysfunction. The vocal cords are innervated by the\nvagus nerve from the nucleus ambiguus. The gag reflex involves cranial nerves\nIX and X. The afferent limb is supplied by the glossopharyngeal nerve and the\nefferent limb is supplied by the vagus nerve. Thus, dysfunction of the nucleus\nambiguus and the vagus nerve on the right side will cause hoarseness and right\npalatal paralysis. The nucleus ambiguus is located in the upper medulla.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npatient has clumsiness and incoordination. These could be due to loss of\nposition sense, weakness, vestibular dysfunction, or cerebellar dysfunction.\nThe findings of ataxia (gross lack of coordination), dysmetria (inability to\njudge distance with the water hose), and intention tremor (right hand shaking\nwhen holding the water hose, but not at rest) suggest ipsilateral cerebellar\ndysfunction. We already suspect a lesion in the upper medulla due to the\npatient&rsquo;s hoarseness and palatal paralysis. The inferior cerebellar peduncle is\nlocated in the upper medulla; therefore, a lesion in the upper medulla could\nexplain the cerebellar findings (Figure 5-4).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npatient also has vertigo, nausea, and nystagmus, which suggest vestibular\ndysfunction. Vestibular input is conveyed from the labyrinth of the inner ear\nto the vestibular nucleus in the lower pons and upper medulla.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Romberg&rsquo;s\nsign is absent. This sign is elicited by asking the patient to stand with his\nfeet together and with his eyes open, and then closed. If unsteadiness\nincreases when the eyes are closed, the patient is said to have Romberg&rsquo;s sign,\nwhich suggests proprioceptive or vestibular dysfunction. If unsteadiness does\nnot change, Romberg sign is said to be absent. Cerebellar dysfunction is\nassociated with an absent Romberg sign: Unsteadiness is equally severe with the\neyes opened and closed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Finally,\nthe patient has Horner&rsquo;s syndrome &ndash; ptosis, miosis, and hemifacial\nanhidrosis &ndash; which indicates dysfunction of the sympathetic nervous\nsystem. Horner&rsquo;s syndrome can result from damage to first-, second-, or\nthird-order neurons ipsilaterally.\n </span>\n</p>\n\n<ul type=\"disc\">\n <li class=\"MsoNormal\">\n  <i>\n   <span>\n    First-order neuron:\n   </span>\n  </i>\n  <span>\n   Central lesions\n     that involve the hypothalamospinal pathway (e.g., transection of the\n     cervical spinal cord).\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <i>\n   <span>\n    Second-order\n     neuron:\n   </span>\n  </i>\n  <span>\n   Preganglionic lesions (e.g., compression of the sympathetic chain by lung\n     tumor).\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <i>\n   <span>\n    Third-order neuron:\n   </span>\n  </i>\n  <span>\n   Postganglionic\n     lesions at the level of the internal carotid artery (e.g., a tumor in the\n     cavernous sinus).\n  </span>\n </li>\n</ul>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\ncase, dysfunction of the first-order neuron, which travels through the upper\nmedulla, could explain the findings.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Of note,\nptosis occurs with oculomotor dysfunction and with Horner&rsquo;s syndrome. Oculomotor\ndysfunction usually leads to\n  <i>\n   complete\n  </i>\n  ptosis and an unreactive pupil. Horner&rsquo;s syndrome usually leads to\n  <i>\n   incomplete\n  </i>\n  ptosis and a constricted\npupil. The partial ptosis of Horner&rsquo;s syndrome is due to weakness of the tarsal\nmuscle of M\u0171ller, which is innervated by the sympathetic nerves. The\nlevator is still intact and prevents the eyelid from drooping completely.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347396\"\n o:spid=\"_x0000_s1082\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image543.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\">\n   <tr>\n    <td height=\"5\" width=\"0\">\n    </td>\n   </tr>\n   <tr>\n    <td>\n    </td>\n    <td>\n     <img height=\"623\" src=\"_%20Tutorials_files/image544.png\" v:shapes=\"Picture_x0020_347396\" width=\"419\"/>\n    </td>\n   </tr>\n  </table>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347395\" o:spid=\"_x0000_s1081\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image545.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\">\n   <tr>\n    <td height=\"8\" width=\"18\">\n    </td>\n   </tr>\n   <tr>\n    <td>\n    </td>\n    <td>\n     <img height=\"644\" src=\"_%20Tutorials_files/image546.png\" v:shapes=\"Picture_x0020_347395\" width=\"404\"/>\n    </td>\n   </tr>\n  </table>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347367\"\n o:spid=\"_x0000_i1064\" type=\"#_x0000_t75\" alt=\"Description: Gray677\">\n <v:imagedata src=\"_%20Tutorials_files/image547.png\" o:title=\"Gray677\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Gray677\" border=\"0\" height=\"280\" src=\"_%20Tutorials_files/image548.png\" v:shapes=\"Picture_x0020_347367\" width=\"302\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Figure 5-4\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Right thalamus</span></li>\n<li class=\"MsoNormal\"><span>Left thalamus</span></li>\n<li class=\"MsoNormal\"><span>Right midbrain</span></li>\n<li class=\"MsoNormal\"><span>Left midbrain</span></li>\n<li class=\"MsoNormal\"><span>Right pons</span></li>\n<li class=\"MsoNormal\"><span>Left pons</span></li>\n<li class=\"MsoNormal\"><span>Right medulla</span></li>\n<li class=\"MsoNormal\"><span>Left medulla</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  The\npatient in this vignette has lateral medullary syndrome (also called Wallenberg\nsyndrome or posterior inferior cerebellar artery syndrome). Lateral medullary\nsyndrome results from occlusion of the posterior inferior cerebellar artery\n(PICA) or one of its branches or of the vertebral artery. Symptoms are caused\nby infarction of the lateral part of the medulla oblongata.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" width=\"435\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Wallenberg\n  Syndrome\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td colspan=\"2\" width=\"435\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n      </span>\n     </b>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Dysfunction\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td width=\"210\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <b>\n      <span>\n       Effects\n      </span>\n     </b>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n      Vestibular nuclei\n     </span>\n    </p>\n   </td>\n   <td width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n      Vomiting,\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Vertigo_(medical)\" title=\"Vertigo (medical)\">\n      <span>\n       vertigo\n      </span>\n     </a>\n     <span>\n      ,\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Pathologic_nystagmus\" title=\"Pathologic nystagmus\">\n      <span>\n       nystagmus\n      </span>\n     </a>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n      Inferior cerebellar\n  peduncle\n     </span>\n    </p>\n   </td>\n   <td width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ipsilateral\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Ataxia\">\n      <span>\n       ataxia\n      </span>\n     </a>\n     <span>\n      , dysmetria (past pointing),\n  dysdiadokokinesia\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n      Lateral spinothalamic\n  tract\n     </span>\n    </p>\n   </td>\n   <td width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n      Contralateral loss of\n  pain and temperature sensation from body\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n      Spinal trigeminal nucleus\n     </span>\n    </p>\n   </td>\n   <td width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ipsilateral loss of pain\n  and temperature sensation from face\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n      Nucleus ambiguus (which\n  affects\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Vagus_nerve\">\n      <span>\n       vagus\n      </span>\n     </a>\n     <span>\n      and\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Glossopharyngeal_nerve\">\n      <span>\n       glossopharyngeal nerve\n      </span>\n     </a>\n     <span>\n      s)\n     </span>\n    </p>\n   </td>\n   <td width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ipsilateral laryngeal,\n  pharyngeal, and palatal hemiparesis;\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Dysphagia\">\n      <span>\n       dysphagia\n      </span>\n     </a>\n     <span>\n      ,\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Hoarseness\" title=\"Hoarseness\">\n      <span>\n       hoarseness\n      </span>\n     </a>\n     <span>\n      ,\n  diminished\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Gag_reflex\" title=\"Gag reflex\">\n      <span>\n       gag reflex\n      </span>\n     </a>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td>\n    <p class=\"MsoNormal\">\n     <span>\n      Sympathetic fibers\n  (descending)\n     </span>\n    </p>\n   </td>\n   <td width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ipsilateral\n     </span>\n     <a href=\"http://en.wikipedia.org/wiki/Horner%27s_syndrome\">\n      <span>\n       Horner's syndrome\n      </span>\n     </a>\n     <span>\n      (ptosis, miosis, and anhydrosis)\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n70-year-old man is brought to the emergency room because he is unable to walk.\nSeveral weeks ago, he began dragging his right leg while walking. He had to\nlean on a chair to stand, and he pushed the chair around in order to walk. When\nthe right leg became so weak that he could not get out of bed, he allowed his\ndaughter to bring him to the emergency room. During the same period of time,\nhis right upper extremity became increasingly weak. He would drop objects from\nhis right hand and could not raise his hand above his head. His left eyelid\nbegan to droop until it closed completely. When he manually lifted his left\neyelid, he saw double.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  He is\nalert, oriented, and cooperative. His speech is well articulated and fluent.\nNaming, repetition, and comprehension are normal. Visual fields are full. The\nright pupil is 3 mm in diameter and reacts normally to light. The left pupil is\n7 mm in diameter and unreactive to light. He cannot adduct, elevate, or depress\nthe left eye; abduction, however, is normal.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Looking down results in counterclockwise\nrotation of the left eye. Right eye movements are full. A complete drooping of\nthe left eyelid is noted. The lower part of the right face does not move as\nwell as the left. Both sides of the forehead wrinkle well. Pinprick, proprioceptive,\nand vibratory sensation are normal. Weakness, increased muscle tone, and\nhyperreflexia are noted in the right upper and lower extremity. Babinski&rsquo;s sign\nis present on the right. The finger-to-nose test shows no ataxia or tremor on\nthe left. The right arm is too weak to test. The patient cannot walk due to\nweakness in the right leg.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A lesion\nin which of the following areas would explain these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . A lesion in the left\nmidbrain would explain these findings.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Weakness,\nincreased tone, hyperreflexia, and Babinski&rsquo;s sign indicate a lesion of the\ncorticospinal system (Figure 1-2). The weakness is right-sided; therefore, a\nlesion above the pyramidal decussation would have to be left-sided; a lesion\nbelow the pyramidal decussation would have to be right-sided. Also, the lesion\nmust be above the level of C4 because the arm is involved.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  (The upper extremity is innervated by\nspinal nerves C5 to T1. The biceps reflex involves C5 and C6.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Weakness\nof the lower face is consistent with an upper motor neuron lesion. (A lower\nmotor neuron lesion would cause weakness of the upper and lower face.) Upper\nmotor neurons that supply the right lower face originate in the left cerebral\nhemisphere and travel through the left cerebral peduncle of the midbrain before\ncrossing in the pons to the right facial nerve nucleus (Figure 3-3). Thus, a\nlesion that affects both the corticospinal tract and the corticobulbar fibers to\nthe right facial nucleus must be located on the left side at or above the level\nof the lower pons.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\npatient&rsquo;s inability to adduct, elevate, or depress the left eye indicates\ndysfunction of the oculomotor nerve, which supplies the superior rectus, medial\nrectus, inferior rectus, and inferior oblique muscles. The oculomotor nerve\nalso innervates the levator palpebrae muscle and carries the efferent limb of\nthe papillary light reflex. Therefore, nerve dysfunction results in ptosis and\nan unreactive pupil, as seen in this patient. The patient has normal intorsion\nof the left eye, which indicates normal function of the superior oblique muscle\nand the trochlear nerve. Also, the patient has normal abduction of the eye,\nindicating normal function of the lateral rectus muscle and the abducens\nnerve.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\noculomotor nerve arises from the anterior aspect of the midbrain (Figure 3-4).\nTherefore, a lesion of the left midbrain would explain the ocular, facial, and\nextremity findings in this patient.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A CT scan ultimately showed a tumor in the left cerebral peduncle of the\nmidbrain.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347394\" o:spid=\"_x0000_s1080\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image549.png\" o:title=\"\"/>\n</v:shape><v:shape id=\"Picture_x0020_347393\" o:spid=\"_x0000_s1079\" type=\"#_x0000_t75\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image550.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <span>\n   <img height=\"1290\" src=\"_%20Tutorials_files/image551.png\" v:shapes=\"Picture_x0020_347394 Picture_x0020_347393\" width=\"466\"/>\n  </span>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347392\" o:spid=\"_x0000_s1078\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image552.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <span>\n   <img height=\"661\" src=\"_%20Tutorials_files/image553.png\" v:shapes=\"Picture_x0020_347392\" width=\"398\"/>\n  </span>\n </span>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n", "choices": ["A. Right cerebral hemisphere", "B. Left cerebral hemisphere", "C. Right midbrain", "D. Left midbrain", "E. Right pons", "F. Left pons", "G. Right medulla", "H. Left medulla"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n65-year-old man is brought to the emergency room because of sudden difficulty\nwith walking. He fell while trying to get out of bed this morning. He was able\nto get back up but later dragged his right leg while walking. He noticed\nweakness in his right arm when he tried to grasp objects for support. His\nfamily notes that he has been drooling from the left side of his mouth and that\nhis speech is slurred. He has noticed no change in vision or loss of sensation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  On\nphysical examination, the patient is alert, oriented, and cooperative. His\nspeech is slurred but fluent. Speech and reading comprehension are normal. The\npupils are 3mm in diameter and reactive to light. He can look conjugately to\nthe right, up, and down, but not to the left. Visual fields are intact. When he\nspeaks and tries to smile, the left side of his face does not move. When he is\nasked to close his eyes tightly, the eyelashes on the right become buried but\nthose on the left remain visible. Wrinkling on the left side of the forehead is\nless pronounced. The tongue protrudes and the palate elevates in the midline.\nPinprick, proprioceptive, and vibratory sensations are intact. The right upper\nand lower extremities are weak and hyperreflexic. Babinski&rsquo;s sign is present on\nthe right. The right upper extremity is slightly flexed at the elbow, and the\nright lower extremity is slightly extended. The right lower extremity moves\nslowly and stiffly when he tries to walk.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A lesion\nin which of the following areas would explain these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer F is correct\n  </span>\n </b>\n <span>\n  . A lesion in the left\npons would explain these findings.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Hyperreflexia\nand Babinski&rsquo;s sign indicate a lesion of the corticospinal system (Figure 1-2).\nThe abnormalities of the patient&rsquo;s gait are typical of hemiparesis and\nconsistent with an upper motor neuron lesion. The upper motor neuron, or\ncorticospinal pathway, runs the entire length of the CNS. Muscles of the upper\nextremity are innervated by the C4-T1 spinal cord segments. Therefore, a lesion\nabove the C4 level would explain upper extremity weakness. The biceps reflex is\nsupplied by C5 and C6. Hyperactivity of that reflex indicates a lesion at or\nabove the C4 level.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Each\nfacial nerve nucleus is functionally divided into two separate regions, one\nthat supplies the muscles of the upper face and one that supplies the muscles\nof the lower face (Figure 2-3). The part that supplies the upper face receives\ninput from both cerebral hemispheres, while the part that supplies the lower\nface receives only contralateral input. Therefore, a lower motor neuron lesion\nwould result in loss of innervation to the upper and lower face. This is known\nas a &ldquo;peripheral&rdquo; type of facial weakness. A lesion of the contralateral\nhemisphere would result in a loss of innervation to the lower face. (The upper\nface would still be innervated by the intact ipsilateral hemisphere.) The patient\nwould be able to move the upper but not the lower face. This is known as a\n&ldquo;central&rdquo; type of facial weakness.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\nvignette, both upper and lower parts of the face are affected, consistent with\na peripheral pattern. The lesion could be in the facial nucleus, the facial\nnerve fasciculus (the portion of the facial nerve within the brainstem), the\nperipheral nerve, the neuromuscular junction, or the muscle. Knowing that the\ncorticospinal tract is involved, the lesion must be in the CNS. Therefore, the problem\nmust lie in the facial nucleus or fasciculus, not in the peripheral nerve,\nneuromuscular junction, or muscle\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Only a\nlesion in the left pons could cause left facial weakness and right arm and leg\nweakness (Figure 2-4), as the facial nucleus and fasciculus are located in the\npons. This is an example of &ldquo;crossed paralysis&rdquo; in which there is cranial nerve\nweakness on one side of the body and extremity weakness on the other side.\nCrossed paralysis indicates a brainstem lesion. The slurred speech is caused by\nfacial weakness. (Certain sounds like &ldquo;me&rdquo; and &ldquo;pa&rdquo; require closure of the\nobicularis oris, which is affected in facial paralysis.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The system\ninvolved in moving the eyes conjugately to the left originates in the right\nfrontal eye field of the cerebral cortex (Figure 2-5). Fibers descend through\nthe internal capsule to the right side of the midbrain. Here, fibers cross to\nthe left side at the level of the lower midbrain. These fibers then descend to\nthe lower pontine level and synapse in an area called the paramedian pontine\nreticular formation (PPRF). Fibers then leave the PPRF and synapse in the\nipsilateral abducens nucleus. There are two populations of neurons in the\nabducens nucleus: motor neurons, which run to the lateral rectus muscle to\nabduct the ipsilateral eye, and interneurons, which cross the midline at the\nlevel of the abducens nucleus to ascend in the contralateral medial\nlongitudinal fasciculus (MLF) and synapse in the medial rectus subnucleus of\nthe oculomotor nucleus. When the PPRF activates the abducens nucleus, the eyes\nmove conjugately to the ipsilateral side by innervating the ipsilateral lateral\nrectus and contralateral medial rectus muscles. A lesion of the PPRF or closely\nadjacent abducens nucleus produces horizontal gaze palsy when the patient tries\nto look toward the side of the lesion (as in this case).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\nvignette, we have established that the lesion is in the left pons, because of\nthe presence of left facial weakness and right upper and lower extremity\nweakness. The left pons contains the PPRF and abducens nucleus, which upon\nbeing damaged result in left gaze paresis (Figure 2-6).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  This\npatient was ultimately found to have an infarct in the left pons.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347391\" o:spid=\"_x0000_s1077\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image554.png\" o:title=\"\"/>\n</v:shape><v:shape id=\"Picture_x0020_347390\" o:spid=\"_x0000_s1076\" type=\"#_x0000_t75\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image555.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <img height=\"1154\" src=\"_%20Tutorials_files/image556.png\" v:shapes=\"Picture_x0020_347391 Picture_x0020_347390\" width=\"462\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347389\" o:spid=\"_x0000_s1075\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image557.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <span>\n   <img height=\"659\" src=\"_%20Tutorials_files/image558.png\" v:shapes=\"Picture_x0020_347389\" width=\"439\"/>\n  </span>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347388\" o:spid=\"_x0000_s1074\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image559.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\">\n   <tr>\n    <td height=\"0\" width=\"26\">\n    </td>\n   </tr>\n   <tr>\n    <td>\n    </td>\n    <td>\n     <img height=\"628\" src=\"_%20Tutorials_files/image560.png\" v:shapes=\"Picture_x0020_347388\" width=\"382\"/>\n    </td>\n   </tr>\n  </table>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347387\" o:spid=\"_x0000_s1073\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image561.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <span>\n   <img height=\"667\" src=\"_%20Tutorials_files/image562.png\" v:shapes=\"Picture_x0020_347387\" width=\"452\"/>\n  </span>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Right internal\n     capsule</span></li>\n<li class=\"MsoNormal\"><span>Left internal\n     capsule</span></li>\n<li class=\"MsoNormal\"><span>Right midbrain</span></li>\n<li class=\"MsoNormal\"><span>Left midbrain</span></li>\n<li class=\"MsoNormal\"><span>Right pons</span></li>\n<li class=\"MsoNormal\"><span>Left pons</span></li>\n<li class=\"MsoNormal\"><span>Right medulla</span></li>\n<li class=\"MsoNormal\"><span>Left medulla</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n38-year-old man with a history of Hodgkin&rsquo;s disease presents with right hand\nweakness. Four weeks prior to his visit, he began having trouble opening jars.\nOccasionally he would drop objects from his right hand. His left leg and,\nlater, his left hand began to go numb. His wife noticed that he seemed to drag\nhis right leg and to have trouble climbing stairs.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Physical\nexamination shows decreased proprioception and vibratory sensation in the toes,\nankles, and fingers on the right side. Pinprick and temperature sensation are\ndiminished in the left arm, trunk, and leg, but not on the neck and face. Mild\nweakness without wasting or fasciculation is noted in the right arm and leg.\nGrip and finger abduction are weaker in the right hand than in the left, but shoulder\nabduction, as well as elbow flexion and extension, are normal. Right hip\nflexion and ankle dorsiflexion are weak. Tendon reflexes (biceps, triceps,\nknee, and ankle) are increased on the right side. Babinski&rsquo;s sign is present on\nthe right.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Injury to which\nof the following areas would explain these findings?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . A lesion in the right\nspinal cord at C3 would explain these findings.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\npresence of hyperreflexia and Babinski&rsquo;s sign indicates an upper motor neuron\nlesion, i.e., a lesion of the corticospinal (pyramidal) system. In this case,\nhyperreflexia is noted as high as the biceps, which is innervated by the C5 and\nC6 spinal segments. Therefore, the lesion must be above the C5 level.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td colspan=\"2\" valign=\"top\" width=\"293\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Deep Tendon Reflexes\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"117\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Biceps\n  reflex\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"117\">\n    <p class=\"MsoNormal\">\n     <span>\n      C5, C6\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Brachioradialis\n  reflex\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"117\">\n    <p class=\"MsoNormal\">\n     <span>\n      C5, C6,\n  C7\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Triceps\n  reflex\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"117\">\n    <p class=\"MsoNormal\">\n     <span>\n      C6, C7,\n  C8\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Patellar\n  reflex or knee-jerk reflex\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"117\">\n    <p class=\"MsoNormal\">\n     <span>\n      L2, L3,\n  L4\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Ankle\n  jerk reflex (Achilles reflex)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"117\">\n    <p class=\"MsoNormal\">\n     <span>\n      S1, S2\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"176\">\n    <p class=\"MsoNormal\">\n     <span>\n      Plantar\n  reflex or Babinski&rsquo;s reflex\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"117\">\n    <p class=\"MsoNormal\">\n     <span>\n      L5, S1,\n  S2\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  The\ninvolved corticospinal tract begins in the left frontal lobe and descends in\nthe left cerebral peduncle of the midbrain and the left basis pontis (Figure\n1-2). In the pyramids of the medulla, it crosses to the right side and descends\nin the right lateral funiculus of the spinal cord. The corticospinal fibers\nsynapse with second-order neurons in the ventral horn of the spinal cord. Axons\nof these neurons innervate muscles on the right side of the body.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Numbness\nin the left upper and lower extremities suggests involvement of the\nspinothalamic tract (Figure 1-3). This is confirmed by the absence of pinprick\nand temperature sensation on the left side.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The first-order neuron has its cell body\nin the dorsal root ganglion and enters the spinal cord via the dorsal root. It\nsynapses with the second-order neuron in the dorsal horn of the spinal cord.\nThe second-order neuron then crosses to the other side of the spinal cord\nthrough the anterior white commissure. It ascends in the lateral funiculus to\nsynapse in the ventral posterior lateral nucleus of the thalamus. From there,\nthe third-order neuron ascends to the somatosensory area of the cerebral\ncortex.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The only\nanatomic site where a single small lesion can affect both the corticospinal and\nspinothalamic tracts and produce the symptoms seen in this patient is on the\nright side below the pyramidal decussation and above the C5 level of the spinal\ncord.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nascending fibers in the spinal cord are laminated such that fibers entering\nfrom the lower levels are more lateral and superficial. These fibers are more\nvulnerable to compression by an extrinsic lesion. As an extrinsic lesion\nexpands, more fibers are involved and the sensory symptoms appear to ascend.\nFibers of the corticospinal system are similarly laminated, and progressive\nspinal cord compression can cause an ascending pattern of weakness. (This\npattern is sometimes confused with the ascending symptoms of Guillain-Barr&eacute;\nsyndrome.)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Vibratory\nand proprioceptive sensation is mediated by the dorsal column-medial lemniscal\npathway (Figure 1-4). The first-order neuron, whose cell body is in the dorsal\nroot ganglion, enters the spinal cord via the dorsal root. It ascends in the\nipsilateral dorsal column of the spinal cord without synapsing or crossing to\nthe other side. In the medulla, the first-order neurons from spinal segments\nbelow T6 synapse in the nucleus gracilis, while those from rostral spinal\nsegments synapse in the nucleus cuneatus. The second-order neuron axons cross\nto the other side to form the medial lemniscus. These fibers then ascend to\nsynapse with the third-order neurons in the thalamus. The thalamic neuron axons\nascend to the somatosensory areas in the parietal lobe cortex.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nproposed lesion &ndash; a right-sided lesion located between the pyramidal\ndecussation and the C5 level of the spinal cord &ndash; would account not only\nfor the patient&rsquo;s right-sided weakness and left-sided loss of pinprick\nsensation, but also for the loss of right-sided vibratory and proprioceptive\nsensation. The patient has symptoms and signs of a hemispinal cord lesion\n(lesion of one-half of the spinal cord). This is known as the Brown-Sequard\nsyndrome. In this case, the patient was found to have right-sided spinal cord\ncompression at the level of C3. The cause was Hodgkin&rsquo;s lymphoma.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347386\" o:spid=\"_x0000_s1072\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image563.png\" o:title=\"\"/>\n</v:shape><v:shape id=\"Picture_x0020_347385\" o:spid=\"_x0000_s1071\" type=\"#_x0000_t75\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image564.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\">\n   <tr>\n    <td height=\"0\" width=\"4\">\n    </td>\n   </tr>\n   <tr>\n    <td>\n    </td>\n    <td>\n     <img height=\"1345\" src=\"_%20Tutorials_files/image565.png\" v:shapes=\"Picture_x0020_347386 Picture_x0020_347385\" width=\"462\"/>\n    </td>\n   </tr>\n  </table>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347384\" o:spid=\"_x0000_s1070\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image566.png\" o:title=\"\"/>\n</v:shape><![endif]-->\n <span>\n  <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\">\n   <tr>\n    <td height=\"0\" width=\"20\">\n    </td>\n   </tr>\n   <tr>\n    <td>\n    </td>\n    <td>\n     <img height=\"663\" src=\"_%20Tutorials_files/image567.png\" v:shapes=\"Picture_x0020_347384\" width=\"430\"/>\n    </td>\n   </tr>\n  </table>\n </span>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Right thalamus</span></li>\n<li class=\"MsoNormal\"><span>Left thalamus</span></li>\n<li class=\"MsoNormal\"><span>Right spinal cord\n     at C3</span></li>\n<li class=\"MsoNormal\"><span>Left spinal cord at\n     C3</span></li>\n<li class=\"MsoNormal\"><span>Right spinal cord\n     at C7</span></li>\n<li class=\"MsoNormal\"><span>Left spinal cord at\n     C7</span></li>\n</ol>"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A\n12-year-old girl presents to the clinic with fatigue, sadness, and\nuncontrollable shaking. Physical examination reveals gold-colored deposits in\nthe corneas and a Parkinson-like tremor. Lab tests show mild elevation of liver\nenzymes. Which of the following would you expect?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . The neuropsychiatric\nfindings in this patient, along with Kayser-Fleischer rings, point to a\ndiagnosis of Wilson&rsquo;s disease, which is associated with low ceruloplasmin\nlevels.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Wilson&rsquo;s disease is an autosomal recessive\ndisorder of copper metabolism that results in copper accumulation in various\norgans. Patients usually present in childhood or adolescence with liver\ndisease, neurological disease (e.g., movement disorder) or psychiatric disease.\nCopper deposition in Descemet&rsquo;s membrane of the cornea results in\nKayser-Fleischer rings, which are pathognomic for the disease. Laboratory tests\nshow decreased serum ceruloplasmin levels, increased tissue copper levels, and\nincreased urinary excretion of copper. The mainstay of therapy is copper\nchelation (using D- penicillamine). Liver transplantation is curative.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347366\" o:spid=\"_x0000_i1063\" type=\"#_x0000_t75\" alt=\"Description: Kayser-Fleischer_ring\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image568.jpg\" o:title=\"Kayser-Fleischer_ring\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Kayser-Fleischer_ring\" border=\"0\" height=\"193\" src=\"_%20Tutorials_files/image569.jpg\" v:shapes=\"Picture_x0020_347366\" width=\"290\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpLast\">\n <span>\n  Kayser-Fleischer rings\nare gold-colored rings that appear to encircle the iris of the eye.\n </span>\n</p>\n", "choices": ["A. Decreased urinary copper excretion", "B. Decreased serum ceruloplasmin", "C. Increased serum ferritin", "D. Decreased serum alpha-1 antitrypsin", "E. Increased iron saturation"]}]}, {"section": "Nutrition & Pharmacology", "questions": [{"question": "<p class=\"MsoNormal\">\n <span>\n  A 45-year-old man is brought to the\nemergency room after suffering a seizure during his first day at an alcohol\ntreatment center. The seizure lasted one minute and resolved spontaneously. The\npatient had been drinking a fifth of bourbon and 6 to 12 beers daily for many\nyears. The seizure occurred 36 hours after his last drink. On examination, the\npatient is sweaty, anxious, and tremulous, but oriented to person, place, and\ntime. Temperature is 100.1\n  <sup>\n   o\n  </sup>\n  F, blood pressure is 180/100 mm Hg, and\npulse is 113/minute. The urine toxicology screen is negative. The blood alcohol\nlevel is zero. The patient is given a loading dose of phenytoin and admitted to\nthe hospital for general medical observation. Eight hours later, he becomes agitated,\ndiaphoretic, and disoriented. He screams that his room is infested with bugs\nthat are crawling on top of him. What is the most likely cause of the patient&rsquo;s\naltered sensorium?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A\nis correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Alcohol withdrawal is\nthe most likely cause of the patient&rsquo;s altered sensorium.\n </span>\n</p>\n", "<p>\n <b>\n  Answer B is incorrect\n </b>\n . Although definitions vary, status\nepilepticus is often defined as a continuous, unremitting seizure lasting\nlonger than 30 minutes, or as recurrent seizures without intervening\nconsciousness lasting more than 30 minutes. Status elipepticus is a medical\nemergency.\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . Psychiatrists are often called to evaluate\npatients for &ldquo;schizophrenia&rdquo; who turn out to have delirium.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Hallucinations are common in delirium\nand do not suggest underlying schizophrenia.\n <b>\n </b>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n <span>\n  .\n </span>\n Thyroid storm is a medical emergency\n <span>\n  characterized by\n </span>\n fever, tachycardia,\narrhythmia, heart failure, nausea/vomiting, diarrhea, confusion, and\ndisorientation. The patient in this vignette has many symptoms compatible with\nthyroid storm, but DT is a more likely given the medical history.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n . The patient&rsquo;s symptoms are not due to\nphenytoin use.\n</p>\n"], "tutorial": "<p>\n Alcohol withdrawal delirium,\nalso known as delirium tremens (DT), u\n <span>\n  sually\ndevelops 48&ndash;72 hours after discontinuation of alcohol, peaks around day\n4, and may persist for 2 weeks. A\n </span>\n functional decrease in GABA (\n <span>\n  &gamma;-aminobutyric acid)\n </span>\n when alcohol\nis no longer being consumed leads to loss of the inhibitory control of\nexcitatory neurotransmitters, such as norepinephrine, glutamate, and dopamine.\nSymptoms of DT include fever, tachycardia, hypertension, confusion, agitation,\ndisorientation, hallucinations, and diarrhea. DT is life-threatening emergency.\nIt occurs most often in those who drink large quantities of alcohol daily\n(e.g., 4 - 5 pints of wine; 7 - 8 pints of beer; 1 pint of \"hard\"\nliquor), and in those with a history of habitual alcohol use for more than 10\nyears. Of note, withdrawal from sedative-hypnotics, such as benzodiazepines or\nbarbiturates, can also result in seizures, DT, and death if not properly\nmanaged.\n</p>\n\n<p>\n Patients with DT should be\nadmitted to the intensive care unit and treated aggressively with\nbenzodiazepines. Benzodiazepines are the treatment of choice because they have\nsimilar GABA-potentiating effects to alcohol.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n In addition, benzodiazepines have\nexcellent anticonvulsant effects. Antipsychotics (e.g., haloperidol) may be\nrequired to control extreme agitation. Before the advent of ICUs and modern\npharmacotherapy, mortality rates for DT approached 35%.\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Alcohol\n     withdrawal delirium</span></li>\n<li class=\"MsoNormal\"><span>Status\n     epilepticus</span></li>\n<li class=\"MsoNormal\"><span>Schizophrenia</span></li>\n<li class=\"MsoNormal\"><span>Thyroid\n     storm</span></li>\n<li class=\"MsoNormal\"><span>Adverse\n     reaction to phenytoin</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 30-year-old man presents to his physician with the sense that his heart\noccasionally races, and this sense occurs more frequently when he is\nexercising.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Treadmill testing with\nECG analysis indicates that his AV node has enhanced automaticity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Which of the following drugs could be\nprescribed to treat this man because it slows conduction, prolongs refractory\nperiod, and decreases automaticity in the sinoatrial and atrioventricular\nnodes?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Verapamil is a class IV antiarrhythmic drug that\nblocks Ca\n  <sup>\n   ++\n  </sup>\n  channels to produce its therapeutic effects.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  C.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Lidocaine\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  D.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Procainamide\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  E.\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Verapamil\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Antiarrhythmic\ndrugs are classified based on the mechanism of action of the drugs.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The advantage of the system is that it\nallows prediction for pharmacological effect, therapeutic use and side effects.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The classification is not precise.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Some drugs may have multiple mechanisms\nand may overlap several classes.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  There are other antiarrhythymic drugs that do not fall into any of these\nclasses.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Class\nI &ndash; Na\n  <sup>\n   +\n  </sup>\n  channel blockers (local anesthetics)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Class\nII &ndash; Sympatholytic agents (\uf062-blockers)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Class\nIII &ndash; Prolonged repolarization (potassium channel blockers)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Class\nIV &ndash; Calcium channel blockers\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Class\nV &ndash; Other mechanisms\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  &ldquo;Some\nBlock Potassium Channels&rdquo; is a pneumonic to remember the first four classes.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   S\n  </span>\n </u>\n <span>\n  ome (Class I - sodium\nchannel blockers)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   B\n  </span>\n </u>\n <span>\n  lock (Class II - beta\nblockers)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   P\n  </span>\n </u>\n <span>\n  otassium (Class III -\npotassium channel blockers)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   C\n  </span>\n </u>\n <span>\n  hannels (Class IV -\ncalcium channel blockers)\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"469\">\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Class\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Examples\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <b>\n     <span>\n      Mechanism\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Ia\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <ul type=\"disc\">\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Quinidine\" title=\"Quinidine\">\n      <span>\n       Quinidine\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Procainamide\" title=\"Procainamide\">\n      <span>\n       Procainamide\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Disopyramide\" title=\"Disopyramide\">\n      <span>\n       Disopyramide\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n   </ul>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <a href=\"http://en.wikipedia.org/wiki/Sodium_channel\" title=\"Sodium channel\">\n     <span>\n      Na\n      <sup>\n       +\n      </sup>\n      -channel\n     </span>\n    </a>\n    <span>\n     blocker (intermediate\n  association/dissociation)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Ib\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <ul type=\"disc\">\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Lidocaine\" title=\"Lidocaine\">\n      <span>\n       Lidocaine\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Phenytoin\" title=\"Phenytoin\">\n      <span>\n       Phenytoin\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Mexiletine\" title=\"Mexiletine\">\n      <span>\n       Mexiletine\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <span>\n      Tocainide\n     </span>\n    </li>\n   </ul>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <a href=\"http://en.wikipedia.org/wiki/Sodium_channel\" title=\"Sodium channel\">\n     <span>\n      Na\n      <sup>\n       +\n      </sup>\n      -channel\n     </span>\n    </a>\n    <span>\n     blocker (fast\n  association/dissociation)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Ic\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <ul type=\"disc\">\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Flecainide\" title=\"Flecainide\">\n      <span>\n       Flecainide\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <span>\n      Encainide\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Propafenone\" title=\"Propafenone\">\n      <span>\n       Propafenone\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Moricizine\" title=\"Moricizine\">\n      <span>\n       Moricizine\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n   </ul>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <a href=\"http://en.wikipedia.org/wiki/Sodium_channel\" title=\"Sodium channel\">\n     <span>\n      Na\n      <sup>\n       +\n      </sup>\n      -channel\n     </span>\n    </a>\n    <span>\n     blocker (slow\n  association/dissociation)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      II\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <ul type=\"disc\">\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Propranolol\" title=\"Propranolol\">\n      <span>\n       Propranolol\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Esmolol\" title=\"Esmolol\">\n      <span>\n       Esmolol\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Timolol\" title=\"Timolol\">\n      <span>\n       Timolol\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Metoprolol\" title=\"Metoprolol\">\n      <span>\n       Metoprolol\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Atenolol\" title=\"Atenolol\">\n      <span>\n       Atenolol\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Bisoprolol\" title=\"Bisoprolol\">\n      <span>\n       Bisoprolol\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n   </ul>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <span>\n     B\n    </span>\n    <a href=\"http://en.wikipedia.org/wiki/Beta_blocker\" title=\"Beta blocker\">\n     <span>\n      eta-block\n     </span>\n    </a>\n    <span>\n     er\n     <br/>\n     <br/>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      III\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <ul type=\"disc\">\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Amiodarone\" title=\"Amiodarone\">\n      <span>\n       Amiodarone\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Sotalol\" title=\"Sotalol\">\n      <span>\n       Sotalol\n      </span>\n     </a>\n     <span>\n      *\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Ibutilide\" title=\"Ibutilide\">\n      <span>\n       Ibutilide\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Dofetilide\" title=\"Dofetilide\">\n      <span>\n       Dofetilide\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n   </ul>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <a href=\"http://en.wikipedia.org/wiki/Potassium_channel_blocker\" title=\"Potassium channel blocker\">\n     <span>\n      K\n      <sup>\n       +\n      </sup>\n      -channel\n  blocker\n     </span>\n    </a>\n    <span>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     (*\n    </span>\n    <a href=\"http://en.wikipedia.org/wiki/Sotalol\" title=\"Sotalol\">\n     <span>\n      Sotalol\n     </span>\n    </a>\n    <span>\n     is also a\n    </span>\n    <a href=\"http://en.wikipedia.org/wiki/Beta_blocker\" title=\"Beta blocker\">\n     <span>\n      beta-blocker\n     </span>\n    </a>\n    <span>\n     )\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      IV\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <ul type=\"disc\">\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Verapamil\" title=\"Verapamil\">\n      <span>\n       Verapamil\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Diltiazem\" title=\"Diltiazem\">\n      <span>\n       Diltiazem\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n   </ul>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <a href=\"http://en.wikipedia.org/wiki/Calcium_channel_blocker\" title=\"Calcium channel blocker\">\n     <span>\n      Ca\n      <sup>\n       2+\n      </sup>\n      -channel\n  blocker\n     </span>\n    </a>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      V\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"133\">\n   <ul type=\"disc\">\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Adenosine\" title=\"Adenosine\">\n      <span>\n       Adenosine\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n    <li class=\"MsoNormal\">\n     <a href=\"http://en.wikipedia.org/wiki/Digoxin\" title=\"Digoxin\">\n      <span>\n       Digoxin\n      </span>\n     </a>\n     <span>\n     </span>\n    </li>\n   </ul>\n  </td>\n  <td valign=\"top\" width=\"298\">\n   <p class=\"MsoNormal\">\n    <span>\n     Other\n  mechanisms\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Class I\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Class I\nantiarrhythmic drugs block Na\n  <sup>\n   +\n  </sup>\n  conduction through voltage-gated Na\n  <sup>\n   +\n  </sup>\n  channels.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  These drugs are in the\nclass of local anesthetics (LAs).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Class I drugs are the oldest of the antiarrhythmic drugs and still in\nwide use.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Local\nanesthetics in the\n  <b>\n   charged form\n  </b>\n  <b>\n   bind to the pore of the voltage-gated Na\n   <sup>\n    +\n   </sup>\n   channels and block Na\n   <sup>\n    +\n   </sup>\n   conductance through the channel\n  </b>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Class I\ndrugs have broad spectrum antiarrhythmic activity and are used for\nsupraventricular and ventricular arrhythmias, atrial fibrillation, and atrial\nflutter.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Class II\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   The acute antiarrhythmic effects of the\n   <span>\n    <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347425\"\n o:spid=\"_x0000_i1062\" type=\"#_x0000_t75\" alt=\"Description: betalower\">\n <v:imagedata src=\"_%20Tutorials_files/image570.png\" o:title=\"betalower\"/>\n</v:shape><![endif]-->\n    <img alt=\"Description: betalower\" border=\"0\" height=\"11\" src=\"_%20Tutorials_files/image571.png\" v:shapes=\"Picture_x0020_347425\" width=\"8\"/>\n   </span>\n   <i>\n    -\n   </i>\n   blockers\nare primarily due to the inhibition of abnormal automaticity of the SA and AV\nnodes or a portion of a reentry loop.\n  </span>\n </b>\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n   They also help to inhibit ventricular\nresponse to atrial tachycardia by decreasing conduction through the AV node.\n  </b>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  These drugs can also reduce ventricular\nectopic beats, particularly if the ectopic activity has been precipitated by\ncatecholamines.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  They are also\nuseful in suppressing exercise-induced tachycardias.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   Beta\n  </span>\n  <span>\n   -\n  </span>\n  blockers are also useful in chronic\nantiarrhythmic therapy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   They\n  </span>\n  decrease the likelihood of sudden cardiac\ndeath after myocardial infarction, but the mechanism is not well understood.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Class III\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The class\nIII antiarrhythmic drugs include those agents that specifically prolong\nrefractoriness in atrial and ventricular tissue.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The drugs share the common effect of\n  <b>\n   delaying repolarization by blocking the\nrapidly activating delayed rectifier potassium channels (I\n   <sub>\n    Kr\n   </sub>\n   )\nresponsible for phase 2 and phase 3 repolarization\n  </b>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Most drugs in this class prolong the QT\ninterval.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The common side effect of\nall class III agents is that they may also be proarrhythmic in the form of\n  <b>\n   provoking early afterdepolarizations\n  </b>\n  by\nblocking potassium channels and delaying repolarization.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Class IV\n  </span>\n </b>\n</p>\n\n<p class=\"contentbody\">\n <span>\n  Class IV is comprised of\nthe\n  <b>\n   non-dihydropyridine\n  </b>\n  calcium\nchannel blockers,\n  <b>\n   verapamil and\ndiltiazem\n  </b>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n   The primary site of action of these drugs is the slow response action\npotentials in the SA and AV nodes.\n  </b>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n   Both verapamil and diltiazem\nblock L-type calcium channels and slow conduction, prolong refractoriness, and\ndecrease automaticity in the calcium-dependent tissue in the SA and AV nodes.\n  </b>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  These agents are effective in automatic\nor reentrant tachycardias, which arise from or use the SA or AV nodes.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  These drugs will slow ventricular\nresponse during atrial fibrillation by slowing AV conduction.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This class of drugs is also effective in\nexercise-triggered tachycardias or tachycardias triggered by automaticity since\ncalcium may play a role in these arrhythmias.\n </span>\n</p>\n\n<p class=\"MsoNormalCxSpMiddle\">\n <b>\n  <span>\n   Other antiarrythmic\ndrugs\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormalCxSpMiddle\">\n <span>\n  Adenosine\n </span>\n</p>\n\n<p class=\"MsoNormalCxSpMiddle\">\n <b>\n  <span>\n   Administered as an acute\nIV bolus for treatment of reentrant supraventricular arrhythmias.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Adenosine binds to a specific adenosine receptor\nand also\n  <b>\n   activates the\nacetylcholine-sensitive K\n   <sup>\n    +\n   </sup>\n   channel in the atrium, SA and AV nodes\n  </b>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  This causes a shortening of the action\npotential duration, hyperpolarization and slowing of automaticity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormalCxSpMiddle\">\n <span>\n  Digitalis\n </span>\n</p>\n\n<p class=\"MsoNormalCxSpMiddle\">\n <b>\n  <span>\n   Digitalis has vagotonic\neffects\n  </span>\n </b>\n <span>\n  by causing an inhibition of Ca\n  <sup>\n   ++\n  </sup>\n  currents in the AV node and\nactivation of acetylcholine-sensitive K\n  <sup>\n   +\n  </sup>\n  currents in the atrium.\nThis results in a hyperpolarization, shortening of atrial action potentials and\nincrease in the refractory period of the AV node.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n   Digitalis\nis used in patients with reentry arrhythmias in the AV node and atrial\nfibrillation.\n  </b>\n </span>\n</p>\n", "choices": ["A. Dofetilide", "B. Flecainide"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n3-year-old girl presents with a temperature of 101\n  <sup>\n   o\n  </sup>\n  F, nasal\ndischarge, and severe paroxysms of coughing. She is diagnosed with whooping\ncough (pertussis), and erythromycin is prescribed. How does this antibiotic\nwork?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Erythromycin, a\nmacrolide antibiotic, binds selectively to the 50S ribosomal subunit in\nbacteria, interfering with the transfer of aminoacyl-tRNA from the &ldquo;A&rdquo; site to\nthe &ldquo;P&rdquo; site of the rRNA complex. As a result, the &ldquo;A&rdquo; site cannot accept\nanother aminoacyl-tRNA, thereby preventing extension of the protein chain. A\nnotable difference between prokaryotic and eukaryotic cells is the structure\nand composition of their ribosomes. There are several classes of antibiotics\n(e.g., macrolides, aminoglycosides) that block the action of the bacterial\nribosome with no effect on eukaryotic ribosomes.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Beta-lactam antibiotics\n(i.e., penicillins, cephalosporins, carbapenems, and monobactams) inhibit the\nformation of peptidoglycan cross-links, which are necessary in the synthesis of\nbacterial cell walls. Beta-lactams and macrolides are used extensively to treat\ngram-positive infections.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <!--[if gte vml 1]><v:group id=\"Group_x0020_347426\" o:spid=\"_x0000_s1027\"\n\n coordorigin=\"1536,2124\" coordsize=\"3184,10916\" o:gfxdata=\"UEsDBBQABgAIAAAAIQBP7BGHCQEAABUCAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBBG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\nAQAAAA==\n\">\n <v:shape id=\"Picture_x0020_3\" o:spid=\"_x0000_s1028\" type=\"#_x0000_t75\" alt=\"ch1f10\"\n  o:gfxdata=\"UEsDBBQABgAIAAAAIQCzI1IS/QAAAOYBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAgAAZHJzL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9wAAAI8DAAAAAA==\n\">\n  <v:imagedata src=\"_%20Tutorials_files/image572.jpg\" o:title=\"ch1f10\"\n   cropbottom=\"18407f\"/>\n </v:shape><v:shape id=\"Text_x0020_Box_x0020_7\" o:spid=\"_x0000_s1029\" type=\"#_x0000_t202\"\n  o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nb3ducmV2LnhtbFBLBQYAAAAABAAEAPUAAACJAwAAAAA=\n\">\n  <v:textbox>\n   <![if !mso]>\n   <table cellpadding=0 cellspacing=0 width=\"100%\">\n    <tr>\n     <td><![endif]>\n     <div>\n     <p class=MsoNormal><span>Alberts, B. <i\n    >et al.</i> <u>Molecular Biology of the\n     Cell</u>, 4<sup>th</sup> Ed. New York: Garland Science, 2002</span></p>\n     <p class=MsoNormal></p>\n     </div>\n     <![if !mso]></td>\n    </tr>\n   </table>\n   <![endif]></v:textbox>\n </v:shape><v:group id=\"Group_x0020_18\" o:spid=\"_x0000_s1030\" coordorigin=\"2216,4144\"\n  coordsize=\"1440,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAAA=\n\">\n  <v:group id=\"Group_x0020_11\" o:spid=\"_x0000_s1031\" coordorigin=\"2520,784\" coordsize=\"528,656\"\n   o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_9\" o:spid=\"_x0000_s1032\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >E</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_10\" o:spid=\"_x0000_s1033\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_12\" o:spid=\"_x0000_s1034\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAA==\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_13\" o:spid=\"_x0000_s1035\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >P</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_14\" o:spid=\"_x0000_s1036\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_15\" o:spid=\"_x0000_s1037\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF\n90jcwfIWJQ4sEEJJuiDADhCUA4zsSWKRjC2PG9rbY7dlg1ARS3vm/f9k16vtPIkFA1tHjbwsKymQ\ntDOWhka+rx+KGyk4AhmYHGEjd8hy1Z6f1eudRxaJJm7kGKO/VYr1iDNw6TxSmvQuzBDTMQzKg/6A\nAdVVVV0r7SgixSLmDNnWHfawmaK436brg0nCpbg77OWqRoL3k9UQk6jKU/UrF3DiE+BC5oddcTQr\nE7kP59F6vjg2PKenCdageIEQn2BOHsoEVkNwG88jeEyL5WnZ3Dlz4freaiy7wI8ZfsvwXzXGfVLA\n5b8FXcJecflOV/u/ar8AAAD//wMAUEsDBBQABgAIAAAAIQDA01aB2gAAAJkBAAALAAAAX3JlbHMv\nLnJlbHOkkEFLAzEQhe+C/yHM3c22BxFptjeh11rBa0hms8FNJszE1f57U0RwpTcPc5h5zPceb7f/\nTLNakCVSNrDpelCYHfmYg4GX09PdAyipNns7U0YDZxTYD7c3uyPOtrYnmWIR1ShZDEy1lketxU2Y\nrHRUMDdlJE62tpWDLta92YB62/f3mn8zYFgx1cEb4IPfgDqdS3P+w07RMQmNtXOUNI1jdNeoOjC9\nl+fJFnxNc2NZDlgNeJZvSS5SC9m1AX09w/afGTx95CMua/fLkXH58dWrQocvAAAA//8DAFBLAwQU\nAAYACAAAACEAMy8FnkEAAAA5AAAAFQAAAGRycy9ncm91cHNoYXBleG1sLnhtbLKxr8jNUShLLSrO\nzM+zVTLUM1BSSM1Lzk/JzEu3VQoNcdO1UFIoLknMS0nMyc9LtVWqTC1Wsrfj5QIAAAD//wMAUEsD\nBBQABgAIAAAAIQApujnyyQAAAN8AAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9Pa8JAFMTvBb/D8gRv\ndZPG2hKzikiVHqRQLRRvj+zLH8y+Ddk1id++Wyj0OMzMb5hsM5pG9NS52rKCeB6BIM6trrlU8HXe\nP76CcB5ZY2OZFNzJwWY9ecgw1XbgT+pPvhQBwi5FBZX3bSqlyysy6Oa2JQ5eYTuDPsiulLrDIcBN\nI5+iaCkN1hwWKmxpV1F+Pd2MgsOAwzaJ3/rjtdjdL+fnj+9jTErNpuN2BcLT6P/Df+13rSBZvCyS\nJfz+CV9Arn8AAAD//wMAUEsBAi0AFAAGAAgAAAAhAJoksUABAQAA7AEAABMAAAAAAAAAAAAAAAAA\nAAAAAFtDb250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEAwNNWgdoAAACZAQAACwAAAAAA\nAAAAAAAAAAAyAQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEAMy8FnkEAAAA5AAAAFQAAAAAA\nAAAAAAAAAAA1AgAAZHJzL2dyb3Vwc2hhcGV4bWwueG1sUEsBAi0AFAAGAAgAAAAhACm6OfLJAAAA\n3wAAAA8AAAAAAAAAAAAAAAAAqQIAAGRycy9kb3ducmV2LnhtbFBLBQYAAAAABAAEAPoAAACfAwAA\nAAA=\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_16\" o:spid=\"_x0000_s1038\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >A</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_17\" o:spid=\"_x0000_s1039\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group></v:group><v:group id=\"Group_x0020_19\" o:spid=\"_x0000_s1040\"\n \n  coordorigin=\"2216,4144\" coordsize=\"1440,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAAA=\n\">\n  <v:group id=\"Group_x0020_20\" o:spid=\"_x0000_s1041\" coordorigin=\"2520,784\" coordsize=\"528,656\"\n   o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_21\" o:spid=\"_x0000_s1042\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >E</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_22\" o:spid=\"_x0000_s1043\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_23\" o:spid=\"_x0000_s1044\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAA==\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_24\" o:spid=\"_x0000_s1045\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >P</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_25\" o:spid=\"_x0000_s1046\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_26\" o:spid=\"_x0000_s1047\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAA==\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_27\" o:spid=\"_x0000_s1048\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >A</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_28\" o:spid=\"_x0000_s1049\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group></v:group><v:group id=\"Group_x0020_29\" o:spid=\"_x0000_s1050\"\n \n  coordorigin=\"2216,4144\" coordsize=\"1440,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAAA=\n\">\n  <v:group id=\"Group_x0020_30\" o:spid=\"_x0000_s1051\" coordorigin=\"2520,784\" coordsize=\"528,656\"\n   o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_31\" o:spid=\"_x0000_s1052\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >E</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_32\" o:spid=\"_x0000_s1053\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_33\" o:spid=\"_x0000_s1054\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAA==\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_34\" o:spid=\"_x0000_s1055\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF\n90jcwfIWJQ4sEEJNuiCwBATlACN7klgkY8tjQnt7Jm3ZIFTE0p55/z/Zq/V2GtWMiX2gWl+WlVZI\nNjhPfa3fNg/FjVacgRyMgbDWO2S9bs7PVptdRFZCE9d6yDneGsN2wAm4DBFJJl1IE2Q5pt5EsO/Q\no7mqqmtjA2WkXOQlQzerFjv4GLO638r1wURwre4Oe0tVrSHG0VvIImqWqfmVSzjyCXAm98OuOJqV\nQu7DefCRL44NT/I0yTtUz5DyI0ziYVxiwwNElJ3ytOdSN3ERus5bLNvErwv3V7gLn5Rw/m92K9gL\nzt/pZv9DzRcAAAD//wMAUEsDBBQABgAIAAAAIQCqi10N0wAAAI8BAAALAAAAX3JlbHMvLnJlbHOk\nkLFqAzEMhvdA38Fo7/mSoZQQX7ZC1pBCV2Hr7kzOlrHMNXn7uJRCL2TLoEG/0PcJ7faXMKmZsniO\nBtZNC4qiZefjYODz9PH6DkoKRocTRzJwJYF997LaHWnCUpdk9ElUpUQxMJaStlqLHSmgNJwo1knP\nOWCpbR50QnvGgfSmbd90/s+AbsFUB2cgH9wa1OmaqvmOHbzNLNyXxnLQ3PfePqJqGTHRV5gqBvNA\nxYDL8pvW05paoB+bN0+aHX/HI81L8U+Yaf7z6sUbuxsAAAD//wMAUEsDBBQABgAIAAAAIQAzLwWe\nQQAAADkAAAAQAAAAZHJzL3NoYXBleG1sLnhtbLKxr8jNUShLLSrOzM+zVTLUM1BSSM1Lzk/JzEu3\nVQoNcdO1UFIoLknMS0nMyc9LtVWqTC1Wsrfj5QIAAAD//wMAUEsDBBQABgAIAAAAIQCDiC/qxwAA\nAN8AAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9La8MwEITvgf4HsYXcEqmN86gbJZSWQk4JeUJvi7Wx\nTa2VsdTY/fdRIJDjMDPfMPNlZytxocaXjjW8DBUI4syZknMNh/33YAbCB2SDlWPS8E8eloun3hxT\n41re0mUXchEh7FPUUIRQp1L6rCCLfuhq4uidXWMxRNnk0jTYRrit5KtSE2mx5LhQYE2fBWW/uz+r\n4bg+/5wStcm/7LhuXack2zepdf+5+3gHEagLj/C9vTIaRsk0GSdw+xO/gFxcAQAA//8DAFBLAQIt\nABQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10u\neG1sUEsBAi0AFAAGAAgAAAAhAKqLXQ3TAAAAjwEAAAsAAAAAAAAAAAAAAAAALAEAAF9yZWxzLy5y\nZWxzUEsBAi0AFAAGAAgAAAAhADMvBZ5BAAAAOQAAABAAAAAAAAAAAAAAAAAAKAIAAGRycy9zaGFw\nZXhtbC54bWxQSwECLQAUAAYACAAAACEAg4gv6scAAADfAAAADwAAAAAAAAAAAAAAAACXAgAAZHJz\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >P</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_35\" o:spid=\"_x0000_s1056\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_36\" o:spid=\"_x0000_s1057\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF\n90jcwfIWJQ4sEEJJuiDADhCUA4zsSWKRjC2PG9rbY7dlg1ARS3vm/f9k16vtPIkFA1tHjbwsKymQ\ntDOWhka+rx+KGyk4AhmYHGEjd8hy1Z6f1eudRxaJJm7kGKO/VYr1iDNw6TxSmvQuzBDTMQzKg/6A\nAdVVVV0r7SgixSLmDNnWHfawmaK436brg0nCpbg77OWqRoL3k9UQk6jKU/UrF3DiE+BC5oddcTQr\nE7kP59F6vjg2PKenCdageIEQn2BOHsoEVkNwG88jeEyL5WnZ3Dlz4freaiy7wI8ZfsvwXzXGfVLA\n5b8FXcJecflOV/u/ar8AAAD//wMAUEsDBBQABgAIAAAAIQDA01aB2gAAAJkBAAALAAAAX3JlbHMv\nLnJlbHOkkEFLAzEQhe+C/yHM3c22BxFptjeh11rBa0hms8FNJszE1f57U0RwpTcPc5h5zPceb7f/\nTLNakCVSNrDpelCYHfmYg4GX09PdAyipNns7U0YDZxTYD7c3uyPOtrYnmWIR1ShZDEy1lketxU2Y\nrHRUMDdlJE62tpWDLta92YB62/f3mn8zYFgx1cEb4IPfgDqdS3P+w07RMQmNtXOUNI1jdNeoOjC9\nl+fJFnxNc2NZDlgNeJZvSS5SC9m1AX09w/afGTx95CMua/fLkXH58dWrQocvAAAA//8DAFBLAwQU\nAAYACAAAACEAMy8FnkEAAAA5AAAAFQAAAGRycy9ncm91cHNoYXBleG1sLnhtbLKxr8jNUShLLSrO\nzM+zVTLUM1BSSM1Lzk/JzEu3VQoNcdO1UFIoLknMS0nMyc9LtVWqTC1Wsrfj5QIAAAD//wMAUEsD\nBBQABgAIAAAAIQD0ZdxSyAAAAN8AAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9Pa8JAFMTvBb/D8gre\ndBP/k7qKiC0eRFALxdsj+0yC2bchu03it+8KQo/DzPyGWa47U4qGaldYVhAPIxDEqdUFZwq+L5+D\nBQjnkTWWlknBgxysV723JSbatnyi5uwzESDsElSQe18lUro0J4NuaCvi4N1sbdAHWWdS19gGuCnl\nKIpm0mDBYSHHirY5pffzr1Hw1WK7Gce75nC/bR/Xy/T4c4hJqf57t/kA4anz/+FXe68VjCfzyXQG\nzz/hC8jVHwAAAP//AwBQSwECLQAUAAYACAAAACEAmiSxQAEBAADsAQAAEwAAAAAAAAAAAAAAAAAA\nAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQDA01aB2gAAAJkBAAALAAAAAAAA\nAAAAAAAAADIBAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQAzLwWeQQAAADkAAAAVAAAAAAAA\nAAAAAAAAADUCAABkcnMvZ3JvdXBzaGFwZXhtbC54bWxQSwECLQAUAAYACAAAACEA9GXcUsgAAADf\nAAAADwAAAAAAAAAAAAAAAACpAgAAZHJzL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA+gAAAJ4DAAAA\nAA==\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_37\" o:spid=\"_x0000_s1058\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >A</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_38\" o:spid=\"_x0000_s1059\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group></v:group><v:group id=\"Group_x0020_39\" o:spid=\"_x0000_s1060\"\n \n  coordorigin=\"2216,4144\" coordsize=\"1440,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAA==\n\">\n  <v:group id=\"Group_x0020_40\" o:spid=\"_x0000_s1061\" coordorigin=\"2520,784\" coordsize=\"528,656\"\n   o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_41\" o:spid=\"_x0000_s1062\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >E</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_42\" o:spid=\"_x0000_s1063\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_43\" o:spid=\"_x0000_s1064\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAAA=\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_44\" o:spid=\"_x0000_s1065\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF\n90jcwfIWJQ4sEEJNuiCwBATlACN7klgkY8tjQnt7Jm3ZIFTE0p55/z/Zq/V2GtWMiX2gWl+WlVZI\nNjhPfa3fNg/FjVacgRyMgbDWO2S9bs7PVptdRFZCE9d6yDneGsN2wAm4DBFJJl1IE2Q5pt5EsO/Q\no7mqqmtjA2WkXOQlQzerFjv4GLO638r1wURwre4Oe0tVrSHG0VvIImqWqfmVSzjyCXAm98OuOJqV\nQu7DefCRL44NT/I0yTtUz5DyI0ziYVxiwwNElJ3ytOdSN3ERus5bLNvErwv3V7gLn5Rw/m92K9gL\nzt/pZv9DzRcAAAD//wMAUEsDBBQABgAIAAAAIQCqi10N0wAAAI8BAAALAAAAX3JlbHMvLnJlbHOk\nkLFqAzEMhvdA38Fo7/mSoZQQX7ZC1pBCV2Hr7kzOlrHMNXn7uJRCL2TLoEG/0PcJ7faXMKmZsniO\nBtZNC4qiZefjYODz9PH6DkoKRocTRzJwJYF997LaHWnCUpdk9ElUpUQxMJaStlqLHSmgNJwo1knP\nOWCpbR50QnvGgfSmbd90/s+AbsFUB2cgH9wa1OmaqvmOHbzNLNyXxnLQ3PfePqJqGTHRV5gqBvNA\nxYDL8pvW05paoB+bN0+aHX/HI81L8U+Yaf7z6sUbuxsAAAD//wMAUEsDBBQABgAIAAAAIQAzLwWe\nQQAAADkAAAAQAAAAZHJzL3NoYXBleG1sLnhtbLKxr8jNUShLLSrOzM+zVTLUM1BSSM1Lzk/JzEu3\nVQoNcdO1UFIoLknMS0nMyc9LtVWqTC1Wsrfj5QIAAAD//wMAUEsDBBQABgAIAAAAIQBN5OVXxwAA\nAN8AAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9La8MwEITvgf4HsYXcEqmN86gbJZSWQk4JeUJvi7Wx\nTa2VsdTY/fdRIJDjMDPfMPNlZytxocaXjjW8DBUI4syZknMNh/33YAbCB2SDlWPS8E8eloun3hxT\n41re0mUXchEh7FPUUIRQp1L6rCCLfuhq4uidXWMxRNnk0jTYRrit5KtSE2mx5LhQYE2fBWW/uz+r\n4bg+/5wStcm/7LhuXack2zepdf+5+3gHEagLj/C9vTIaRsk0mSRw+xO/gFxcAQAA//8DAFBLAQIt\nABQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10u\neG1sUEsBAi0AFAAGAAgAAAAhAKqLXQ3TAAAAjwEAAAsAAAAAAAAAAAAAAAAALAEAAF9yZWxzLy5y\nZWxzUEsBAi0AFAAGAAgAAAAhADMvBZ5BAAAAOQAAABAAAAAAAAAAAAAAAAAAKAIAAGRycy9zaGFw\nZXhtbC54bWxQSwECLQAUAAYACAAAACEATeTlV8cAAADfAAAADwAAAAAAAAAAAAAAAACXAgAAZHJz\nL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA9QAAAIsDAAAAAA==\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >P</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_45\" o:spid=\"_x0000_s1066\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group><v:group id=\"Group_x0020_46\" o:spid=\"_x0000_s1067\"\n  \n   coordorigin=\"2520,784\" coordsize=\"528,656\" o:gfxdata=\"UEsDBBQABgAIAAAAIQCaJLFAAQEAAOwBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\nAAA=\n\">\n   <v:shape id=\"Text_x0020_Box_x0020_47\" o:spid=\"_x0000_s1068\" type=\"#_x0000_t202\"\n    o:gfxdata=\"UEsDBBQABgAIAAAAIQAyPL0++wAAAOIBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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\ncy9kb3ducmV2LnhtbFBLBQYAAAAABAAEAPUAAACMAwAAAAA=\n\" filled=\"f\" stroked=\"f\">\n    <v:textbox>\n     <![if !mso]>\n     <table cellpadding=0 cellspacing=0 width=\"100%\">\n      <tr>\n       <td><![endif]>\n       <div>\n       <p class=MsoNormal><b><span\n      >A</span></b></p>\n       </div>\n       <![if !mso]></td>\n      </tr>\n     </table>\n     <![endif]></v:textbox>\n   </v:shape><v:line id=\"Line_x0020_48\" o:spid=\"_x0000_s1069\" from=\"2720,784\" to=\"2720,1136\"\n    o:connectortype=\"straight\" o:gfxdata=\"UEsDBBQABgAIAAAAIQAypgsz/gAAAOoBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRTU7DMBCF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\n\">\n    <v:stroke endarrow=\"block\"/>\n   </v:line></v:group></v:group><w:wrap type=\"square\"/>\n</v:group><![endif]-->\n <img align=\"left\" height=\"550\" src=\"_%20Tutorials_files/image573.png\" v:shapes=\"Text_x0020_Box_x0020_47 Line_x0020_48 Group_x0020_46 Text_x0020_Box_x0020_44 Line_x0020_42 Group_x0020_40 Line_x0020_38 Group_x0020_36 Text_x0020_Box_x0020_34 Line_x0020_32 Group_x0020_30 Line_x0020_28 Group_x0020_26 Text_x0020_Box_x0020_24 Line_x0020_22 Group_x0020_20 Line_x0020_17 Group_x0020_15 Text_x0020_Box_x0020_13 Line_x0020_10 Group_x0020_11 Text_x0020_Box_x0020_7 Group_x0020_347426 Picture_x0020_3 Group_x0020_18 Text_x0020_Box_x0020_9 Group_x0020_12 Line_x0020_14 Text_x0020_Box_x0020_16 Group_x0020_19 Text_x0020_Box_x0020_21 Group_x0020_23 Line_x0020_25 Text_x0020_Box_x0020_27 Group_x0020_29 Text_x0020_Box_x0020_31 Group_x0020_33 Line_x0020_35 Text_x0020_Box_x0020_37 Group_x0020_39 Text_x0020_Box_x0020_41 Group_x0020_43 Line_x0020_45\" width=\"163\"/>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprimary function of the ribosome is protein synthesis. Protein synthesis occurs\nin distinct phases: initiation, elongation, and termination.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Initiation\ninvolves association of the mRNA with the smaller subunit of the ribosome that\nis bound by an initiating aminoacyl-tRNA (i.e., tRNA bound to an amino acid).\nThe large ribosomal subunit then binds to form an initiation complex. The\ninitiating aminoacyl-tRNA &ldquo;pairs up&rdquo; with the mRNA codon AUG, which signals the\nbeginning of the polypeptide.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In the\nelongation phase, amino acids are successively linked through the formation of\ncovalent peptide bonds, thereby lengthening the polypeptide chain. Each of the\nincoming amino acids is attached to its respective tRNA. The codon on the mRNA\nis recognized and bound by the anticodon of the tRNA portion of the\naminoacyl-tRNA.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  [Binding\noccurs on the &ldquo;A&rdquo; site of the ribosome, where the aminoacyl-tRNA #4 binds in\nstep 1 of the figure. In step 2, the peptide bond is formed between residues 3\nand 4, which releases tRNA #3 from its amino acid. This enzymatic activity is\ncoupled with the translocation of tRNA #3 to site &ldquo;E&rdquo;, and tRNA #4, which is\nstill linked to its respective amino acid, is translocated from the &ldquo;A&rdquo; site to\nthe &ldquo;P&rdquo; site.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  In step 3, tRNA #3\ndissociates from the ribosome. The process begins again with the association of\ntRNA #5.]\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Lastly,\ntermination of synthesis of the polypeptide chain occurs when a stop codon is\nencountered in the mRNA.\n </span>\n</p>\n", "choices": ["A. Inhibits the interaction between the bacterial 50S ribosomal subunit and tRNA", "B. Inhibits the formation of peptidoglycan cross-links", "C. Inhibits DNA gyrase", "D. Inhibits DNA topoisomerases", "E. Inhibits synthesis of ergosterol"]}, {"question": "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C and D are incorrect.\n  </span>\n </b>\n <span>\n  Quinolones inhibit DNA\nreplication and transcription by inhibiting DNA gyrase and DNA topoisomerases.\nFor many Gram-negative bacteria, DNA gyrase is the target; for many\nGram-positive bacteria, topoisomerase IV is the target. (Eukaryotic cells do\nnot contain DNA gyrase or topoisomerase IV). DNA gyrase is necessary for the\nunwinding DNA prior to replication. DNA topoisomerases relieve torsional strain\nthat results from DNA replication and transcription.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Azole antifungal drugs\n(e.g., ketoconazole, fluconazole, clotrimazole) inhibit the enzyme that\nconverts lanosterol to ergosterol. Depletion of ergosterol disrupts the\nstructure of the fungal membrane, leading to inhibition of fungal growth.\n </span>\n</p>\n\n<p>\n <i>\n  Escherichia coli\n </i>\n strains X and Y are both resistant to ampicillin.\nAmpicillin resistance is stable in strain X when it is grown for multiple\ngenerations in the absence of antibiotic. However, strain Y loses ampicillin\nresistance when it is grown in media without the antibiotic. Which of the\nfollowing best explains the acquisition of ampicillin susceptibility in strain\nY?\n</p>\n", "answers": ["<ol start=\"1\" type=\"1\">\n <li class=\"MsoNormal\">\n  <span>\n   Drug deactivation\n     (e.g., some bacteria produce &beta;-lactamase, which deactivates p\n   <span>\n    enicillin\n   </span>\n   ).\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Alteration of the\n     target site (e.g., MRSA can alter PBP, the binding site of penicillin).\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Alteration of a\n     metabolic pathway (e.g., some bacteria do not require para-aminobenzoic\n     acid to synthesize folic acid and nucleic acids. These bacteria are\n     resistant to sulfonamides.)\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Reduced drug\n     accumulation (e.g., some bacteria alter the permeability of their cell\n     surface to antibiotics; others increase the efflux of antibiotic across\n     the cell surface).\n  </span>\n </li>\n</ol>\n"], "tutorial": "<p>\n <span>\n  Antibiotic resistance\n </span>\n <span>\n  is a quality that allows microorganisms to survive exposure to antibiotics.\nBacteria acquire resistance either by mutation of the bacterial genome or by by\nhorizontal gene transfer.\n  <span>\n   Horizontal\ngene transfer\n  </span>\n  , also called\n  <span>\n   lateral\ngene transfer\n  </span>\n  , is a process by which an organism incorporates genetic\nmaterial from another organism without being the offspring of that organism. By\ncontrast,\n  <span>\n   vertical transfer\n  </span>\n  occurs when an organism receives genetic material from its ancestor.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nprincipal mechanisms of horizontal gene transfer are:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Conjugation: transfer of\ngenetic material from one bacterium to another through cell-to-cell contact\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Transduction: viral\n(bacteriophage) transport of genetic material from one bacterium to another\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Transformation:\nalteration of a cell by introducing foreign genetic material\n </span>\n</p>\n\n<p>\n <span>\n  Through\nhorizontal gene transfer, genes that confer antibiotic resistance can be\nshared. Evolutionary stress (such as exposure to antibiotics) selects for\nantibiotic-resistant bacteria. If a bacterium carries several resistance genes,\nit is called multiresistant or, informally, a\n  <span>\n   superbug\n  </span>\n  or\n  <span>\n   super-bacterium\n  </span>\n  .\nThe high prevalence of antibiotic-resistance is due to widespread antibiotic\nuse.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  There are\nfour major mechanisms of antibiotic resistance:\n </span>\n</p>\n", "choices": ["A. Downregulation of the resistance gene", "B. Insertion of a transposon into the resistance gene", "C. Loss of a plasmid carrying the resistance gene", "D. Point mutations in the resistance gene", "E. Recombination with a defective copy of the resistance gene"]}, {"question": "<p>\n <span>\n  Beta-lactamases\n </span>\n are enzymes produced by some bacteria that are\nresponsible for their resistance to beta-lactam antibiotics like penicillins,\ncephalosporins, cephamycins, and carbapenems. These antibiotics have a common\nelement in their molecular structure: a four-atom ring known as a beta-lactam.\nThe lactamase enzyme breaks that ring open, deactivating the molecule's\nantibacterial properties.\n</p>\n\n<p>\n Genes that encode\nbeta-lactamases are widespread in the bacterial kingdom and are found on the\nchromosome and on plasmids. The\n <span class=\"search-hit\">\n  beta\n </span>\n -\n <span class=\"search-hit\">\n  lactamases\n </span>\n of gram-positive bacteria (e.g.\n <i>\n  Staphylococcus aureus\n </i>\n ) are released into\nthe extracellular environment. The\n <span class=\"search-hit\">\n  beta\n </span>\n -\n <span class=\"search-hit\">\n  lactamases\n </span>\n of gram-negative bacteria remain within the\nperiplasm.\n <b>\n </b>\n <span>\n  (The\n  <b>\n  </b>\n  periplasm\n </span>\n is the space between the peptidoglycan cell wall and the external outer\nmembrane of gram-negative bacteria.) Hundreds of different\n <span class=\"search-hit\">\n  beta\n </span>\n -\n <span class=\"search-hit\">\n  lactamase\n </span>\n enzymes\nhave been described. All have the same function but with differing amino acid\nsequences that influence their affinity for different\n <span class=\"search-hit\">\n  beta\n </span>\n -lactam\nsubstrates.\n</p>\n\n<p>\n Some enzymes specifically\ntarget penicillins or cephalosporins, while others are especially broadly\nattack most\n <span class=\"search-hit\">\n  beta\n </span>\n -lactam compounds (i.e.\nextended-spectrum\n <span class=\"search-hit\">\n  beta\n </span>\n -\n <span class=\"search-hit\">\n  lactamases\n </span>\n ,\nor ESBLs).\n</p>\n\n<p>\n <span>\n  Many\nantibiotic resistance genes reside on plasmids. A\n  <span>\n   plasmid\n  </span>\n  is a DNA molecule that is separate from, and can replicate\nindependently of, the chromosomal DNA. Plasmids are double-stranded and, in\nmany cases, circular. Unlike viruses, plasmids are &ldquo;naked&rdquo; DNA and do not\nencode genes necessary to encase the genetic material for transfer to a new\nhost.\n </span>\n</p>\n\n<p>\n Plasmids provide a mechanism\nfor horizontal gene transfer within a population of microbes and typically\nprovide a selective advantage under a given environmental state. They can be\nclassified by function:\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Fertility\nplasmids, which are capable of conjugation\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Resistance\nplasmids, which confer resistance to antibiotics or poisons\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Col\nplasmids, which produce bactericidal proteins\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Degradative\nplasmids, which enable digestion of foreign substances\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Virulence\nplasmids, which render the bacterium pathogenic\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  Bacteria acquire\nantibiotic resistance either by mutation of the bacterial genome or by\nhorizontal gene transfer. Mutation of the bacterial genome is unlikely to\nexplain changing patterns of resistance based on antibiotic exposure. Through\nhorizontal gene transfer, however, a plamid carrying a gene conferring\nresistance can enter and leave the cell, altering its resistance pattern.\n  <i>\n   Escherichia coli\n  </i>\n  strain Y most likely\nhas a plasmid that confers resistance to ampicillin. When selective pressure is\nremoved from the strain (i.e., growth in a media without antibiotics), loss of\nthe plasmid renders the organism susceptible to ampicillin. By contrast,\n  <i>\n   Escherichia coli\n  </i>\n  strain X retains its\nresistance to ampicillin even when selective pressure is removed from that\nstrain (i.e., the resistance is &ldquo;stable.&rdquo;) Consequently, in strain X, the gene\nconferring resistance may well reside on the bacterial chromosome itself.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In the\nfigure below, drug X causes a rise in blood pressure. Drug Y is added, which\nhas little effect on blood pressure. Drug X is then readministered, which\ncauses a drop in blood pressure. Which are drugs X and Y, respectively?\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347424\" o:spid=\"_x0000_i1061\"\n type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image574.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"94\" src=\"_%20Tutorials_files/image575.png\" v:shapes=\"Picture_x0020_347424\" width=\"215\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Epinephrine is a\nnon-selective agonist of &alpha; and &beta; adrenergic receptors. &alpha;\n  <sub>\n   1\n  </sub>\n  receptor stimulation causes vasoconstriction and increased systemic vascular\nresistance. &beta;\n  <sub>\n   1\n  </sub>\n  stimulation causes increased heart rate and\ncontractility. &beta;\n  <sub>\n   2\n  </sub>\n  stimulation causes vasodilation. When\nepinephrine is administered, there is an increase in blood pressure because of\n&alpha;\n  <sub>\n   1\n  </sub>\n  and &beta;\n  <sub>\n   1\n  </sub>\n  stimulation. (The effect of &beta;\n  <sub>\n   2\n  </sub>\n  stimulation is minimal.) Phentolamine blocks &alpha; receptors, so when\nepinephrine is readministered after phentolamine has been given, the &beta;\nresponse is unopposed. Blood pressure drops because of &beta;\n  <sub>\n   2\n  </sub>\n  stimulation.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . Phenylephrine is an\n&alpha;-agonist. Administration causes a rise in blood pressure. Phentolamine\nblocks the &alpha; effect, lowering blood pressure and preventing a rise in\nblood pressure when phenylephrine is re-administered.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Phenylephrine is an &alpha;-agonist.\nAdministration causes a rise in blood pressure. Metoprolol, a &beta;-blocker,\nlowers blood pressure. It does not inhibit the effect of phenylephrine, so\nreadministration of phenylephrine would raise blood pressure once again.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Norepinephrine, which\nhas a predominantly &alpha; effect, causes blood pressure to rise. Propranolol,\na &beta;-blocker, lowers blood pressure. It does not inhibit the &alpha;\nstimulatory effect of norepinephrine, so readministration of norepinephrine would\nraise blood pressure once again.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Isoproterenol, which\nhas a predominantly &beta; effect, causes blood pressure to drop (&beta;\n  <sub>\n   2\n  </sub>\n  effect).\nClonidine, an &alpha;\n  <sub>\n   2\n  </sub>\n  agonist, also causes blood pressure to drop\n(central CNS effect). Readministration of isoproterenol would drop blood\npressure even further.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Relative\n </span>\n <span>\n  <span>\n   a\n  </span>\n </span>\n <span>\n  and\n </span>\n <span>\n  <span>\n   b\n  </span>\n </span>\n <span>\n  effects of catecholamines\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <u>\n  <span>\n   Selective\n  </span>\n </u>\n <u>\n  <span>\n   <span>\n    a\n   </span>\n  </span>\n </u>\n <u>\n  <span>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </u>\n <u>\n  <span>\n   <span>\n    a\n   </span>\n  </span>\n </u>\n <u>\n  <span>\n   =\n  </span>\n </u>\n <u>\n  <span>\n   <span>\n    b\n   </span>\n  </span>\n </u>\n <u>\n  <span>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Selective\n  </span>\n </u>\n <u>\n  <span>\n   <span>\n    b\n   </span>\n  </span>\n </u>\n <u>\n  <span>\n  </span>\n </u>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  phenylephrine\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  norepinephrine\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  epinephrine\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span>\n   dobutamine\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  isoproterenol\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The list\nabove shows the relative efficacies of several autonomic agonist drugs in\nstimulating alpha- and beta-adrenergic receptors. Thus, phenylephrine\nselectively activates alpha receptors and isoproterenol selectively activates\nbeta receptors. Epinephrine effectively stimulates both receptor subtypes.\nNorepinephrine more effectively stimulates alpha receptors than beta receptors,\nand dobutamine more effectively stimulates beta receptors than alpha receptors.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Clonidine\nis unique because it stimulates alpha\n  <sub>\n   2\n  </sub>\n  -adrenergic receptors in the\nbrain, resulting in vasodilation.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Major\neffects of stimulating adrenergic receptors are presented below.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"192\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Alpha-adrenergic receptor\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"210\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Beta-adrenergic receptor\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"192\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"192\">\n    <p class=\"MsoNormal\">\n     <span>\n      Vasoconstriction\n  (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Pupillary\n  dilation (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Intestinal\n  relaxation (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Pilomotor\n  contraction (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bladder\n  sphincter contraction(&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Glycogenolysis\n  and gluconeogenesis (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lipolysis\n  (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Ejaculation\n  (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Renin\n  secretion (&alpha;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"210\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cardiac\n  acceleration (&beta;\n      <sub>\n       1\n      </sub>\n      &gt; &beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Increased\n  myocardial contractility (&beta;\n      <sub>\n       1\n      </sub>\n      &gt; &beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Vasodilation\n  (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Intestinal\n  relaxation (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Uterus\n  relaxation (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bronchodilation\n  (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Bladder\n  wall relaxation (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Glycogenolysis\n  and gluconeogenesis (&beta;\n      <sub>\n       2\n      </sub>\n      )\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Lipolysis\n  (all &beta; receptors)\n     </span>\n    </p>\n    <p class=\"MsoNormal\">\n     <span>\n      Renin\n  secretion (&beta;\n      <sub>\n       1\n      </sub>\n      )\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  An example\nof a drug that selectively blocks alpha-adrenergic receptors is phentolamine. A\ndrug that selectively blocks beta\n  <sub>\n   1\n  </sub>\n  -adrenergic receptors is\nmetoprolol. A drug that non-selectively blocks beta-adrenergic receptors is\npropranolol.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\neffects of administering multiple drugs are predictable based on their agonist\nand antagonist properties. An alpha blocking drug would block the effects of an\nalpha agonist but have no effects on responses to beta agonists, and a beta\nblocker would block the effects of a beta agonist but not an alpha agonist. A\nbeta\n  <sub>\n   1\n  </sub>\n  -selective blocker would block the beta\n  <sub>\n   1\n  </sub>\n  -mediated\neffects of a non-selective beta agonist, but beta\n  <sub>\n   2\n  </sub>\n  -mediated effects\nwould still occur. For example, metoprolol would block the increases in heart\nrate and contractility that occur with epinephrine, but bronchodilation would\nstill occur.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Epinephrine\neffectively stimulates both alpha- and beta-adrenergic receptors. An alpha\nantagonist would block the alpha-mediated effects of administering epinephrine\nbut have no effect on the beta-mediated responses, and a beta blocker would\nblock the beta-mediated effects but have no effect on the alpha-mediated\nresponses.\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Phenylephrine,\n     phentolamine</span></li>\n<li class=\"MsoNormal\"><span>Phenylephrine,\n     metoprolol</span></li>\n<li class=\"MsoNormal\"><span>Norepinephrine,\n     propranolol</span></li>\n<li class=\"MsoNormal\"><span>Isoproterenol,\n     clonidine</span></li>\n<li class=\"MsoNormal\"><span>Epinephrine,\n     phentolamine</span></li>\n</ol>"]}, {"question": "<p>\n <span class=\"search-hit\">\n  Oral\nadministration of grapefruit juice increases the bioavailability of many drugs,\nincluding felodipine, midazolam, saquinavir, and verapamil. After oral\nadministration of any one of these drugs, which of the following is most likely\nto be increased in the presence of grapefruit juice?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer C is correct\n </b>\n . Grapefruit juice increases the bioavailability\nof many drugs by inhibiting the cytochrome P450 CYP3A4 enzyme. This is one of\nthe most important enzymes involved in the metabolism of drugs. It exists in\nenterocytes and in liver cells. It functions prinicipally by deactivating and\nfacilitating the excretion of drugs before they enter the systemic circulation.\nGrapefruit juice, by inhibiting this enzyme, prevents drug deactivation and\nelimination, allowing more drug to enter the systemic circulation. Thus,\nbioavailability and peak serum drug concentration rise.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n . Grapefruit juice decreases (not increases)\nintestinal drug metabolism. This allows more drug to be delivered to the\nsystemic circulation. Bioavailability is increased.\n</p>\n", "<p>\n <b>\n  Answer B is incorrect.\n </b>\n Grapefruit juice inhibits intestinal\n <span class=\"search-hit\">\n  CYP3A4 activity. It does not increase hepatic CYP3A4 activity.\n </span>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect.\n </b>\n Grapefruit juice would not affect volume of\ndistribution.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect.\n </b>\n Grapefruit juice would not increase total\nbody clearance.\n</p>\n"], "tutorial": "<p>\n <span class=\"search-hit\">\n  Bioavailability\n </span>\n is defined as the fraction of the drug reaching the systemic circulation after\nadministration. When a drug is administered by IV injection, the entire dose\nenters the circulation and bioavailability is 100%. However, this is not true\nfor most drugs administered by other routes, especially drugs given orally. The\nbioavailability of a drug is a function of its absorption and ultimate entry\ninto the systemic circulation. Factors that affect\n <span class=\"search-hit\">\n  bioavailability\n </span>\n are listed below.\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p align=\"center\">\n     Factors affecting bioavailability\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Drug properties\n  (solubility, hydrophobicity, pKa)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Drug formulation\n  (immediate-release, delayed-release)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Drug interactions (with\n  foods or other drugs)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Drug metabolism (by\n  intestinal or liver cells)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Drug efflux (from\n  enterocyte by protein transporters)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Structural disorders of\n  the GI tract\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Motility disorders of the\n  GI tract\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     Age of patient (neonate,\n  elderly)\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"278\">\n    <p>\n     &ldquo;First-pass&rdquo; metabolism in\n  the liver\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n Factors that increase drug\nabsorption (and, therefore, bioavailability) will increase peak serum drug\nconcentration. Factors that decrease drug absorption will decrease peak serum\ndrug concentration.\n</p>\n\n<p>\n Bioavailability is usually\nassessed by determining the maximum (peak) plasma drug concentration, peak time\n(when maximum plasma drug concentration occurs), and area under the plasma\nconcentration&ndash;time curve.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347423\"\n o:spid=\"_x0000_i1060\" type=\"#_x0000_t75\" alt=\"Description: Representative plasma concentration&#8211;time relationship after a single oral dose of a hypothetical drug.\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image576.png\" o:title=\"Representative plasma concentration&#8211;time relationship after a single oral dose of a hypothetical drug.\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Representative plasma concentration&ndash;time relationship after a single oral dose of a hypothetical drug.\" border=\"0\" height=\"115\" src=\"_%20Tutorials_files/image577.png\" v:shapes=\"Picture_x0020_347423\" width=\"166\"/>\n </span>\n</p>\n\n<p>\n Grapefruit juice is a potent\ninhibitor of the cytochrome P450 CYP3A4 enzyme, which is one of the most\nimportant enzymes involved in the metabolism of drugs. The enzyme exists in\nenterocytes and hepatocytes, where it deactivates and facilitates the excretion\nof certain drugs before they enter the systemic circulation, thus reducing\ntheir bioavailability. By inhibiting this enzyme, grapefruit juice increases\nthe bioavailability of these drugs. Rarely, this can lead to drug toxicity and\ndeath, as has occurred with astemizole and terfenadine.\n</p>\n", "choices": ["A. Intestinal drug metabolism", "B. Hepatic CYP3A4 activity", "C. Peak serum concentration", "D. Volume of distribution", "E. Total body clearance"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is true regarding breast milk?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Prolactin stimulates\nmilk production and breast development.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Breast milk is a major\nsource of IgA, not IgG.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Most ingested drugs that\nare soluble in maternal blood\n  <i>\n   do\n  </i>\n  cross into breast milk.\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Breast milk is low in\niron.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect.\n  </span>\n </b>\n <span>\n  Breast milk is a poor\nsource of Vitamin K.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Human milk\nis recognized by the American Academy of Pediatrics as an optimal feeding for\nall infants, which is why the academy recommends exclusive breastfeeding in the\nfirst six months of life.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Physicians can influence a patient&rsquo;s feeding choice, and prenatal\neducation is important in the initiation and maintenance of breastfeeding.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Studies have shown that women are more\nlikely to initiate breastfeeding if their physicians or nurses encourage it.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Breastfeeding\nis good for the mother and the baby. For the mother, breastfeeding triggers the\nhypothalamus to produce oxytocin, which is secreted by the posterior pituitary.\nOxytocin increases uterine contractions, which decreases uterine blood loss.\nFor the infant, breast milk is a major source of IgA (but not IgM or IgG). IgA\nhelps to prevent newborns from developing gastrointestinal infections. Breast\nmilk is very low in iron, which must be supplemented. It is also not a good\nsource of vitamin K. Most drugs taken by the mother will enter breast milk;\ntherefore, caution must be taken before prescribing medicine to a breastfeeding\nmother.\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Breast milk is a\n     major source of immunoglobulin G (IgG)</span></li>\n<li class=\"MsoNormal\"><span>Most ingested drugs\n     that are soluble in maternal blood do not cross into breast milk</span></li>\n<li class=\"MsoNormal\"><span>Breast milk\n     contains large amounts of iron</span></li>\n<li class=\"MsoNormal\"><span>Prolactin\n     stimulates milk production and breast development</span></li>\n<li class=\"MsoNormal\"><span>Breast milk is a\n     good source of Vitamin K</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A 62-year-old man is being treated with\ncisplatin for small cell carcinoma of the lungs. The efficacy of cisplatin\ndepends on interaction with which of the following?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer\nA is correct\n  </span>\n </b>\n <span>\n  .\nAs an alkylating agent, cisplatin chemically modifies the cell&rsquo;s DNA.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\nmajority of chemotherapeutic drugs can be divided in to alkylating agents,\nantimetabolites,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Anthracycline\" title=\"Anthracycline\">\n  <span>\n   anthracyclines\n  </span>\n </a>\n <span>\n  , plant alkaloids,\ntopoisomerase inhibitors, and other antitumor agents. All of these drugs affect\ncell division or DNA synthesis and function in some way. Some newer agents do\nnot directly interfere with DNA. These include monoclonal antibodies and the new\ntyrosine kinase inhibitors, e.g.\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Imatinib\" title=\"Imatinib\">\n  <span>\n   imatinib mesylate\n  </span>\n </a>\n <span>\n  (Gleevec), which\ndirectly target a molecular abnormality in certain types of cancer (e.g.,\nchronic myelogenous leukemia). These are examples of targeted therapies. In\naddition, some drugs that modulate tumor cell behavior without directly\nattacking those cells may be used. Hormone treatments fall into this category.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Alkylating\nagents\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Alkylating\nagents chemically modify the cell&rsquo;s DNA, usually by forming covalent bonds with\nthe amino, carboxyl, sulfhydryl, or phosphate groups in DNA. Examples include\ncisplatin, cyclophosphamide, and chlorambucil.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Anti-metabolites\n  </span>\n </b>\n <i>\n  <span>\n  </span>\n </i>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Anti-metabolites\nmasquerade as purines (e.g., azathioprine, mercaptopurine) or pyrimidines. They\nprevent these substances from becoming incorporated into DNA during the\n\"S\" phase of the cell cycle, stopping normal development and\ndivision. They also affect RNA synthesis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Plant\nalkaloids and terpenoids\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Plant\nalkaloids block cell division by preventing microtubule function. Microtubules\nare vital for cell division, and, without them, cell division cannot occur. The\nmain examples are vinca alkaloids (e.g., vincristine) and taxanes.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Topoisomerase\ninhibitors\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Topoisomerases\n(e.g., etoposide) are essential enzymes that maintain the topology of DNA.\nInhibition of type I or type II topoisomerases interferes with both\ntranscription and replication of DNA by upsetting proper DNA supercoiling.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Cytotoxic\nantibiotics\n  </span>\n </b>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  These\ninclude\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Actinomycin\" title=\"Actinomycin\">\n  <span>\n   actinomycin\n  </span>\n </a>\n <span>\n  , anthracyclines (e.g.,\ndoxorubicin),\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Bleomycin\" title=\"Bleomycin\">\n  <span>\n   bleomycin\n  </span>\n </a>\n <span>\n  ,\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Plicamycin\" title=\"Plicamycin\">\n  <span>\n   plicamycin\n  </span>\n </a>\n <span>\n  , and\n </span>\n <a href=\"http://en.wikipedia.org/wiki/Mitomycin\" title=\"Mitomycin\">\n  <span>\n   mitomycin\n  </span>\n </a>\n <span>\n  .\n </span>\n</p>\n", "choices": ["A. DNA", "B. DNA polymerase", "C. Growth factor receptors", "D. Reverse transcriptase", "E. Ribosomes"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A normal\nchest x-ray is shown below. Which chamber of the heart is delineated by &ldquo;E&rdquo;?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . The right atrium is\ndelineated by &ldquo;E.&rdquo; See image below.\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347422\"\n o:spid=\"_x0000_i1059\" type=\"#_x0000_t75\" alt=\"Description: newpicturenb5\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image578.png\" o:title=\"newpicturenb5\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: newpicturenb5\" border=\"0\" height=\"295\" src=\"_%20Tutorials_files/image579.png\" v:shapes=\"Picture_x0020_347422\" width=\"443\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Left atrium</span></li>\n<li class=\"MsoNormal\"><span>Left ventricle</span></li>\n<li class=\"MsoNormal\"><span>Right atrium</span></li>\n<li class=\"MsoNormal\"><span>Right vetricle</span></li>\n</ol>"]}, {"question": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347421\"\n o:spid=\"_x0000_i1058\" type=\"#_x0000_t75\" alt=\"Description: CXRNLPA385\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image580.jpg\" o:title=\"CXRNLPA385\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: CXRNLPA385\" border=\"0\" height=\"327\" src=\"_%20Tutorials_files/image581.png\" v:shapes=\"Picture_x0020_347421\" width=\"260\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  Which of the\nfollowing represents the precision of the estimate of the association between\nthe exposure and outcome in a harm study?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <strong>\n  <span>\n   Confidence intervals\n  </span>\n </strong>\n <span>\n  quantify uncertainty in measurement. In a sense, they represent\n  <strong>\n   <span>\n    a range of\nplausible values\n   </span>\n  </strong>\n  <span>\n   . A narrow confidence\ninterval implies high precision (i.e., we can specify plausible values to\nwithin a tiny range). A wide interval implies poor precision (i.e., we can only\nspecify plausible values to a broad and uninformative range).\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Relative risk is the risk of an event\nrelative to exposure. Specifically, it is the ratio of the probability of the\nevent occurring in the exposed group versus a control group.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n <span>\n  Epidemiologic studies use a quantitative\napproach to describing both exposures and outcomes. Whether RCT, cohort study,\nor case-control study, all of these studies attempt to present their results as\na single number, usually referred to as the point estimate, that quantifies the\nrelationship between the exposure and the outcome. This number is an estimate\nof the truth rather than the truth itself because each study, however large,\nincludes only a sample of all the people who are affected by the exposure-outcome\nrelationship. The point estimate expresses the strength of the association\nbetween the exposure and outcome. In an RCT or a cohort study, the point\nestimate is the\n  <b>\n   relative risk\n  </b>\n  (RR).\nRisk in the study subjects is the number of cases or outcomes that occur over\ntime. The RR is simply the risk of disease (or other outcome) among the exposed\nor treated subjects divided by the risk in the unexposed subjects. A\ncase-control study does not measure risk directly but calculates its results as\nan\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  <b>\n   odds ratio\n  </b>\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  (OR), which is generally equivalent to\nan RR from a cohort study\n  <a name=\"4-u1.0-B978-0-323-06986-1..00005-6--t001\">\n  </a>\n  .\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      RRs and ORs &lt; 1.0\n  indicate protection from outcome.\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      RRs and ORs &gt; 1.0\n  indicate risk of outcome.\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\">\n    <p class=\"MsoNormal\">\n     <span>\n      RRs and ORs = 1.0\n  indicate no association to outcome.\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n <span>\n  If there is no association at all between\nthe exposure and outcome, then the RR or OR would be 1.0. RRs and ORs greater\nthan 1.0 indicate an increased risk of the outcome. RRs and ORs less than 1.0\nindicate a decreased risk of the outcome. For both RRs and ORs, the further\naway the value is from 1.0, the stronger the relationship between the exposure\nand the outcome.\n </span>\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347498\"\n o:spid=\"_x0000_i1057\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image582.gif\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"227\" src=\"_%20Tutorials_files/image583.png\" v:shapes=\"Picture_x0020_347498\" width=\"289\"/>\n </span>\n</p>\n\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" width=\"99%\">\n <tr>\n  <td valign=\"top\" width=\"97%\">\n   <p class=\"figure-text\">\n    <a name=\"4-u1.0-B978-0-323-06986-1..00005-6--f001\">\n    </a>\n    <span class=\"figure-title\">\n     <b>\n     </b>\n    </span>\n   </p>\n   <p class=\"figure-text\">\n    <span class=\"figure-title\">\n     <b>\n      Figure\n  5-2&nbsp;\n     </b>\n    </span>\n    <span class=\"apple-converted-space\">\n     <b>\n      &nbsp;\n     </b>\n    </span>\n    <span class=\"figure-caption\">\n     Examples of point estimates (\n     <i>\n      open circles\n     </i>\n     ) and\n  confidence intervals (\n     <i>\n      between the crossbars\n     </i>\n     ) of two studies with\n  reduced risk and two studies with increased risk. If the confidence interval\n  overlaps 1.0, the change in risk is statistically insignificant.\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\">\n   <p class=\"MsoNormal\">\n    <!--[if mso & !supportInlineShapes & supportFields]><span\n ></span><span\n  style=\"mso-spacerun:yes\">&nbsp;</span>SHAPE <span\n  style=\"mso-spacerun:yes\">&nbsp;</span>\\* MERGEFORMAT <span></span><![endif]-->\n    <!--[if gte vml 1]><v:rect id=\"Rectangle_x0020_347496\"\n   o:spid=\"_x0000_s1026\" alt=\"Description: http://www.mdconsult.com.webproxy.ouhsc.edu/images/blank.gif\"\n   o:gfxdata=\"UEsDBBQABgAIAAAAIQDkmcPA+wAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF\n90jcwfIWJQ5dIISSdEHaJSBUDjCyJ4nVZGx53NDeHictG4SKWNrj9//TuFwfx0FMGNg6quR9XkiB\npJ2x1FXyY7fNHqXgCGRgcISVPCHLdX17U+5OHlkkmriSfYz+SSnWPY7AufNIadK6MEJMx9ApD3oP\nHapVUTwo7SgixSzOGbIuG2zhMESxOabrs0nCpXg+v5urKgneD1ZDTKJqnqpfuYADXwEnMj/ssotZ\nnsglnHvr+e7S8JpWE6xB8QYhvsCYPJQJrHDlGqfz65Zz2ciZa1urMW8Cbxbqr2zjPing9N/wJmHv\nOH2nq+WD6i8AAAD//wMAUEsDBBQABgAIAAAAIQAjsmrh1wAAAJQBAAALAAAAX3JlbHMvLnJlbHOk\nkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr28w6DZfS2o36h7xP//vCZFrUiS6Rs\nYNf1oDA78jEHA++X49MLKKk2e7tQRgM3FDiMjw/7My62tiOZYxHVKFkMzLWWV63FzZisdFQwt81E\nnGxtIwddrLvagHro+2fNvxkwbpjq5A3wye9AXW6lmf+wU3RMQlPtHCVN0xTdPaoObMsc3ZFtwjdy\njWY5YDXgWTQO1LKu/Qj6vn74p97TRz7jutV+h4zrj1dvuhy/AAAA//8DAFBLAwQUAAYACAAAACEA\ngQreReUCAAAEBgAADgAAAGRycy9lMm9Eb2MueG1srFTbbtswDH0fsH8Q9O5b6lxs1Cm6XIYB3Vas\n2wcolmwLlSVPUuJ0w/59lJykSbunbX4wJEo65CEPeX2zbwXaMW24kgVOwhgjJktFuawL/O3rOphh\nZCyRlAglWYGfmME387dvrvsuZyPVKEGZRgAiTd53BW6s7fIoMmXDWmJC1TEJh5XSLbGw1XVENekB\nvRXRKI4nUa807bQqmTFgXQ6HeO7xq4qV9nNVGWaRKDDEZv1f+//G/aP5NclrTbqGl4cwyF9E0RIu\nwekJakksQVvNX0G1vNTKqMqGpWojVVW8ZJ4DsEniF2weGtIxzwWSY7pTmsz/gy0/7e414rTAV+k0\nzSYYSdJCnb5A5oisBUNHO2WmhMQdCtT3fdjSUkmzFZ5L2LMN1GH/FKptY8qQ0W3EW1IzE20EkY9h\nzSuX7b4zOTh96O61y5fp7lT5aJBUiwb8sVvTgWdQEgRyNGmt+oYRCrQTBxFdYLiNATS06T8qCqGT\nrVW+FvtKt84HZBntfcmfTiVne4tKMGZJmoIuSjhJxiNYOnySH5922tj3TLXILQqsITYPTXZ3xg5X\nj1ecJ6nWXAiwk1zICwNgDhZwDE/dmQvBS+RnFmer2WqWBulosgrSmNLgdr1Ig8k6mY6XV8vFYpn8\ncn6TNG84pUw6N0e5JumpKse2+aPKDo0zCO0kWKMEpw7OhWR0vVkIjXYE2mXtv0NCzq5Fl2H4fAGX\nF5QSSOa7URasJ7NpkFbpOMim8SyIk+xdNonTLF2uLyndccn+nRLqoabj0dhX6SzoF9xi/73mRvKW\nWxhIgrcFnp0ukdzpbyWpL60lXAzrs1S48J9TAeU+Ftqr1Ql00P5G0ScQq1YgJxAejE5YNEr/wKiH\nMVRg831LNMNIfJAg+IM+rd+k4+kI3ujzk835CZElQBXYYjQsF3aYddtO87oBT4lPjFS30CQV9xJ2\nDTREdWgtGDWeyWEsull2vve3nof3/DcAAAD//wMAUEsDBBQABgAIAAAAIQCjnVQy2gAAAAIBAAAP\nAAAAZHJzL2Rvd25yZXYueG1sTI9Ba8JAEIXvhf6HZYReim4qoUjMRkQolVKQxtbzmJ0modnZmF2T\n9N937UUvA4/3eO+bdDWaRvTUudqygqdZBIK4sLrmUsHn/mW6AOE8ssbGMin4JQer7P4uxUTbgT+o\nz30pQgm7BBVU3reJlK6oyKCb2ZY4eN+2M+iD7EqpOxxCuWnkPIqepcGaw0KFLW0qKn7ys1EwFLv+\nsH9/lbvHw9byaXva5F9vSj1MxvUShKfRX8NwwQ/okAWmoz2zdqJREB7x//fixTGIo4J5DDJL5S16\n9gcAAP//AwBQSwECLQAUAAYACAAAACEA5JnDwPsAAADhAQAAEwAAAAAAAAAAAAAAAAAAAAAAW0Nv\nbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQAjsmrh1wAAAJQBAAALAAAAAAAAAAAAAAAA\nACwBAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQCBCt5F5QIAAAQGAAAOAAAAAAAAAAAAAAAA\nACwCAABkcnMvZTJvRG9jLnhtbFBLAQItABQABgAIAAAAIQCjnVQy2gAAAAIBAAAPAAAAAAAAAAAA\nAAAAAD0FAABkcnMvZG93bnJldi54bWxQSwUGAAAAAAQABADzAAAARAYAAAAA\n\" filled=\"f\" stroked=\"f\">\n   <o:lock v:ext=\"edit\" aspectratio=\"t\"/>\n   <w:wrap type=\"none\"/>\n   <w:anchorlock/>\n  </v:rect><![endif]-->\n    <!--[if mso & !supportInlineShapes & supportFields]><v:shape\n   id=\"_x0000_i1056\" type=\"#_x0000_t75\">\n   <v:imagedata croptop=\"-65520f\" cropbottom=\"65520f\"/>\n  </v:shape><span></span><![endif]-->\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n <span>\n  The RR is based on results from the people in a particular\nstudy and not the entire population possible, thus there is always a\npossibility of sampling error. The quantitative description of the study\nresults needs to include a measure of this uncertainty. The\n  <b>\n   confidence interval\n  </b>\n  is widely used to\nexpress the precision of the point estimate; a wide confidence interval\nindicates less precision, and a narrow confidence interval indicates more. In\ngeneral, the larger the study, the narrower the confidence interval. There are\nseveral cautions about interpreting confidence intervals correctly. First, the\nconfidence interval indicates only uncertainty that is due to the play of\nchance; it does not inform us about uncertainty in the results because of other\nfactors, such as confounders that have not been controlled for, or of\npeculiarities of the population that was studied, or poor study quality.\nSecond, a wide confidence interval does not mean there is no association\nbetween the exposure\n </span>\n <span>\n  and the outcome; even an imprecise point estimate\nremains the best explanation of\n </span>\n <span>\n  the relationship until a larger or better study is performed. Finally,\nconfidence intervals are often drawn as a straight line around the point\nestimate to show the width of their range; this might seem to suggest that the\nlocation of the true point estimate would be equally likely to fall anywhere\nwithin that interval. In fact, the confidence interval could better be shown as\na bell-shaped curve centered on the point estimate.\n </span>\n</p>\n\n<p>\n <span>\n  Relative risk estimates do not take into\naccount the incidence or the importance of the problem being evaluated. A\nrelative risk of 4 says that the outcome increases 400% in exposed individuals\ncompared with unexposed individuals. This increase often causes great worry or\nexcitement (particularly in the media). However, the relative risk must be\ninterpreted in the context of the frequency of the outcome. For instance, the\nincidence of venous thromboembolism (VTE) in young women without using oral\ncontraceptives is about 1 in 10,000, and the incidence while using oral\ncontraceptives is 4 in 10,000; thus, the relative risk is 4. However, the\n  <b>\n   absolute risk\n  </b>\n  of VTE is still low in\nboth groups of women with a difference in risk of 3 in 10,000. The risk in the\nexposed minus the risk in the unexposed is the risk difference. The\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  <i>\n   risk difference\n  </i>\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  describes the size of the effect in\nabsolute terms. This is also called\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  <b>\n   attributable\nrisk\n  </b>\n  <i>\n   ,\n  </i>\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  and it is very\nuseful for putting large relative risks into a clinically useful perspective.\nThis is also called the\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  <i>\n   absolute\nrisk reduction\n  </i>\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  when a benefit\nis identified, and the\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  <i>\n   absolute\nrisk increase\n  </i>\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  when a harm is\nidentified.\n </span>\n</p>\n\n<p>\n <span>\n  For clinicians and patients, even the\ncalculation of absolute risk differences in a population may not be helpful in\nassessing possible risks or benefits. An alternative calculation looks at the\ncomplementary concept: how many patients need to be treated to observe one\nbenefit or one adverse event? The\n  <span class=\"apple-converted-space\">\n   &nbsp;\n  </span>\n  <b>\n   number\nneeded to treat (NNT)\n  </b>\n  , the number of patients who need to be treated to\nachieve an additional positive outcome, is the reciprocal of the\n  <b>\n   absolute risk reduction\n  </b>\n  (the risk\ndifference for good outcomes). If the effect is dangerous, the value is called\nthe\n  <b>\n   number needed to harm (NNH)\n  </b>\n  . The\nnumber of patients who, if they received the treatment, would lead to one\nadditional patient being harmed, compared with patients not receiving the\ntreatment, is the reciprocal of the absolute risk increase (the risk difference\nfor bad outcomes). Thus, using the example of oral contraceptives, with a risk\nof VTE of 4 in 10,000, the number needed to harm (NNH)&mdash;that is, to experience\none extra VTE&mdash;is 3333, the reciprocal of 3 in 10,000, which is the\n  <b>\n   absolute risk increase\n  </b>\n  .\n </span>\n</p>\n", "choices": ["A. Relative risk", "B. Absolute risk increase", "C. Confidence interval", "D. Number-needed-to-harm"]}, {"question": "<p align=\"center\" class=\"MsoNoSpacing\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347420\" o:spid=\"_x0000_i1055\" type=\"#_x0000_t75\" alt=\"Description: RR= \\frac {p_\\text{exposed}}{p_\\text{non-exposed}} \"\n>\n <v:imagedata src=\"_%20Tutorials_files/image584.png\" o:title=\"text{non-exposed}} \"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: RR= \\frac {p_\\text{exposed}}{p_\\text{non-exposed}} \" border=\"0\" height=\"34\" src=\"_%20Tutorials_files/image585.png\" v:shapes=\"Picture_x0020_347420\" width=\"111\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Absolute risk increase, or excess risk, is\nthe absolute difference between the event rate in the exposed group and the\nevent rate in the control group. Specifically, it is difference between the\nproportion of subjects in a population with a particular disease who were\nexposed to a specified risk factor and the proportion of subjects with that\nsame disease who were not exposed. Absolute risk increase is the inverse of\n&ldquo;the number needed to treat&rdquo; (the average number of patients who need to be\ntreated to prevent one additional bad outcome).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Number-needed-to-harm is the number of\npeople who need to be exposed to a risk factor over a specific period to cause\nharm in one patient who would otherwise not have been harmed. It is the\nreciprocal of the absolute risk increase.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A study\nwas conducted to determine if one method of measuring pain intensity, the\nVerbal Rating Scale (VRS), could be substituted for another method, the Visual\nAnalog Scale (VAS). 85 patients with chronic pain were surveyed using both the\nVRS and VAS. The results appear below. Which of the following values most\nlikely represents the correlation coefficient?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  A correlation\ncoefficient of +0.9 indicates a strong positive correlation between the VAS and\nVRS for measuring pain intensity.\n  <b>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347419\"\n o:spid=\"_x0000_i1054\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image586.png\" o:title=\"\" cropbottom=\"5432f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"257\" src=\"_%20Tutorials_files/image587.png\" v:shapes=\"Picture_x0020_347419\" width=\"367\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\n  <span>\n   correlation coefficient\n  </span>\n  (r) measures\nthe strength and direction of a linear relationship between two\nvariables.&nbsp;The correlation coefficient ranges from &minus;1 to +1. &nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <br/>\n  <i>\n   Positive correlation\n  </i>\n  <span>\n   :\n  </span>\n  &nbsp;&nbsp; If\n  <span>\n   x\n  </span>\n  and\n  <span>\n   y\n  </span>\n  have a strong positive linear\ncorrelation,\n  <span>\n   r\n  </span>\n  is close to\n+1.&nbsp; An\n  <span>\n   r\n  </span>\n  <span>\n  </span>\n  value of exactly +1 indicates a\nperfect positive fit.&nbsp;Positive values indicate that as\n  <span>\n   x\n  </span>\n  increases,\n  <span>\n   y\n  </span>\n  also increases.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <br/>\n  <i>\n   Negative correlation\n  </i>\n  <span>\n   :\n  </span>\n  &nbsp; If\n  <span>\n   x\n  </span>\n  and\n  <span>\n   y\n  </span>\n  have a strong negative linear\ncorrelation,\n  <span>\n   r\n  </span>\n  is close to\n&minus;1.&nbsp; An\n  <span>\n   r\n  </span>\n  <span>\n  </span>\n  value of exactly &minus;1 indicates a\nperfect negative fit.&nbsp;Negative values indicate that as\n  <span>\n   x\n  </span>\n  increases,\n  <span>\n   y\n  </span>\n  decreases.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   No\ncorrelation\n  </span>\n </i>\n <span>\n  :\n </span>\n <span>\n  &nbsp; If there is no linear correlation between x and y,\n  <span>\n   r\n  </span>\n  is 0.&nbsp; A value of zero means\nthat there is a random, nonlinear relationship between the two variables.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <br/>\n  A\n  <span>\n   perfect\n  </span>\n  correlation of +1 or\n&minus;1 occurs only when all data points lie exactly on a straight line.&nbsp;\nIf\n  <span>\n   r\n  </span>\n  is +1, the slope of the\nline is positive.&nbsp; If\n  <span>\n   r\n  </span>\n  is\n&minus;1, the slope of the line is negative.&nbsp;\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\ncorrelation greater than 0.8 is generally considered &ldquo;\n  <span>\n   strong\n  </span>\n  &rdquo;; a correlation less than 0.5 is generally considered &ldquo;\n  <span>\n   weak\n  </span>\n  .&rdquo;&nbsp; (This depends, however,\non the type of data being examined.)\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <a href=\"http://en.wikipedia.org/wiki/File:Correlation_examples.png\">\n  <span>\n   <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347418\"\n o:spid=\"_x0000_i1053\" type=\"#_x0000_t75\" alt=\"Description: 400px-Correlation_examples\"\n href=\"http://en.wikipedia.org/wiki/File:Correlation_examples.png\" o:button=\"t\">\n <v:fill o:detectmouseclick=\"t\"/>\n <v:imagedata src=\"_%20Tutorials_files/image588.png\" o:title=\"400px-Correlation_examples\"/>\n</v:shape><![endif]-->\n   <img alt=\"Description: 400px-Correlation_examples\" border=\"0\" height=\"128\" src=\"_%20Tutorials_files/image589.png\" v:shapes=\"Picture_x0020_347418\" width=\"302\"/>\n  </span>\n </a>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The figure\nabove shows several sets of data (\n  <i>\n   x\n  </i>\n  ,&nbsp;\n  <i>\n   y\n  </i>\n  ) points, with the\ncorrelation coefficient listed above each set. Note that the correlation\ncoefficient reflects the &ldquo;noisiness&rdquo; and direction of a linear relationship\n(top row), but not the slope of the relationship (middle), nor many aspects of\nnonlinear relationships (bottom).\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>\u2013 0.9</span></li>\n<li class=\"MsoNormal\"><span>\u2013 0.2</span></li>\n<li class=\"MsoNormal\"><span><span style=\"mso-spacerun:yes\">\u00a0\u00a0 </span>0</span></li>\n<li class=\"MsoNormal\"><span>+ 0.2</span></li>\n<li class=\"MsoNormal\"><span>+ 0.9</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An\nabdominal CT is done on a normal 50-year-old man. An image from the scan is shown\nbelow. What structure is labeled &ldquo;8&rdquo;?\n </span>\n</p>\n", "answers": ["<ol start=\"1\" type=\"1\">\n <li class=\"MsoNormal\">\n  <span>\n   Liver\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Spleen\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Pancreas\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Gall bladder\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   ---\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Left adrenal gland\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Inferior vena cava\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Aorta\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Portal vein\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Superior mesenteric\n     artery\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Ascending colon\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Descending colon\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Transverse colon\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Stomach\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Distal stomach\n  </span>\n </li>\n</ol>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . &ldquo;8&rdquo; indicates the\naorta.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347417\"\n o:spid=\"_x0000_i1052\" type=\"#_x0000_t75\" alt=\"Description: Abdomen04\">\n <v:imagedata src=\"_%20Tutorials_files/image590.jpg\" o:title=\"Abdomen04\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Abdomen04\" border=\"0\" height=\"178\" src=\"_%20Tutorials_files/image591.png\" v:shapes=\"Picture_x0020_347417\" width=\"209\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nfollowing structures are depicted:\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Adrenal gland</span></li>\n<li class=\"MsoNormal\"><span>Aorta</span></li>\n<li class=\"MsoNormal\"><span>Inferior vena cava</span></li>\n<li class=\"MsoNormal\"><span>Lymph node</span></li>\n<li class=\"MsoNormal\"><span>Superior vena cava</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A chest CT\nis done on a normal 50-year-old man. An image from the scan is shown below.\nWhat structure is labeled &ldquo;22&rdquo;?\n </span>\n</p>\n", "answers": ["<ol start=\"1\" type=\"1\">\n <li class=\"MsoNormal\">\n  <span>\n   Trachea\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Esophagus\n  </span>\n </li>\n</ol>\n"], "tutorial": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347416\"\n o:spid=\"_x0000_i1051\" type=\"#_x0000_t75\" alt=\"Description: Med10\">\n <v:imagedata src=\"_%20Tutorials_files/image592.jpg\" o:title=\"Med10\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Med10\" border=\"0\" height=\"204\" src=\"_%20Tutorials_files/image593.png\" v:shapes=\"Picture_x0020_347416\" width=\"327\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nfollowing structures are depicted:\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Aorta</span></li>\n<li class=\"MsoNormal\"><span>Esophagus</span></li>\n<li class=\"MsoNormal\"><span>Inferior vena cava</span></li>\n<li class=\"MsoNormal\"><span>Lymph node</span></li>\n<li class=\"MsoNormal\"><span>Superior vena cava </span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  18. Sternum\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  19. Aortic arch\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  22. Superior vena cava\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct.\n  </span>\n </b>\n <span>\n  &ldquo;22&rdquo; indicates the\nsuperior vena cava.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n72-year-old woman with diabetes and hypertension is taking three medications:\nmetformin, lisinopril, and amitriptyline. She feels well. Her blood pressure is\n125/75 mm Hg and her HbA1c is 6.5. Her husband dies suddenly of a heart attack\nand she becomes severely depressed. Her physician prescribes paroxetine 20 mg\ndaily for her depression. Her mood improves but she begins to experience\nblurred vision, dry mouth, dizziness, and difficulty with urination. What is\nthe most likely cause of her symptoms?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . In this patient, the\naddition of paroxetine to the medical regimen caused amitriptyline levels to\nrise, resulting in anti-cholinergic side effects.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  The\npatient presents with classic anticholinergic symptoms: blurred vision, dry\nmouth, dizziness, and difficulty with urination. Tricyclic drugs, such as\namitriptyline, are a common cause of anticholinergic symptoms (which is why\nthey should be used cautiously in the elderly). This patient was feeling well\nuntil paroxetine was added to her regimen, which suggests that paroxetine may\nbe involved in her symptomatology. Understanding drug metabolism can clarify\nthe issue.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A basic\npurpose of drug metabolism is to make drugs water-soluble so they can be\nexcreted in the urine or bile. Many drugs are metabolized by the cytochrome\nP450 (CYP) system of enzymes, which predominate in the liver. Such drugs are\nconsidered &ldquo;substrates&rdquo; of the CYP system. In addition, many drugs can induce\nor inhibit the enzymes. &ldquo;Inducers&rdquo; will accelerate the metabolism of a\nsubstrate, while &ldquo;inhibitors&rdquo; will interfere with metabolism. If a patient\nreceives a CYP &ldquo;substrate&rdquo; and a CYP &ldquo;inhibitor&rdquo; concomitantly, enzyme\ninhibition will cause the level of the substrate to rise. If a patient receives\na CYP &ldquo;substrate&rdquo; and a CYP &ldquo;inducer&rdquo; concomitantly, enzyme induction will\ncause the level of the substrate to fall.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  In this\ncase, amitriptyline is a substrate for CYP and paroxetine is an inhibitor of\nCYP. By inhibiting CYP, paroxetine can cause the level of amitriptyline to\nrise, resulting in anticholinergic symptoms.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <b>\n  <span>\n   <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347415\" o:spid=\"_x0000_i1050\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image594.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n   <img border=\"0\" height=\"638\" src=\"_%20Tutorials_files/image595.png\" v:shapes=\"Picture_x0020_347415\" width=\"505\"/>\n  </span>\n </b>\n <b>\n  <span>\n  </span>\n </b>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Excessive dose of\n     paroxetine</span></li>\n<li class=\"MsoNormal\"><span>Drug interaction\n     with metformin</span></li>\n<li class=\"MsoNormal\"><span>Drug interaction\n     with lisinopril</span></li>\n<li class=\"MsoNormal\"><span>Drug interaction\n     with amitriptyline</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n70-year-old woman with chronic kidney disease is diagnosed with pneumonia. She\nis treated with levofloxacin. How would her dosing regimen differ from the\ndosing regimen of someone with normal kidney function?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . Levofloxacin is\nexcreted by the kidney. The presence of chronic kidney disease will not affect\nthe loading dose but will necessitate a reduction in the maintenance dose.\n </span>\n</p>\n"], "tutorial": "<p>\n Chronic\nkidney disease is defined as the presence of kidney damage or a reduction in\nthe glomerular filtration rate (GFR) for three months or longer.\n <span>\n  Inappropriate dosing in patients with chronic kidney\ndisease can lead to toxicity. In particular, older patients (especially those\ntaking many medicines) are at a high risk of complications due to age-related\ndecline in renal function.\n </span>\n</p>\n\n<p>\n <span>\n  Chronic kidney disease can affect glomerular filtration,\ntubular secretion and reabsorption, and renal metabolism. Drug absorption,\nbioavailability, protein binding, distribution volume, and non-renal clearance\nmay be altered. Physicians should be careful when considering drug therapies\nbecause toxic metabolites may accumulate and contribute to exaggerated\npharmacologic effects or adverse drug reactions.\n </span>\n</p>\n\n<p>\n <span>\n  The loading dose does\n  <i>\n   not\n  </i>\n  need to be adjusted in patients with chronic kidney disease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Maintenance dosing, however,\n  <i>\n   should\n  </i>\n  be adjusted. Such an adjustment\nmay include dose reduction, lengthening the dosing interval, or both. Dose\nreduction allows for a more stable drug concentration, but carries a higher\nrisk of toxicity if the dosing interval is not changed. Lengthening the dosing\ninterval, by contrast, carries a lower risk of toxicity because time is allowed\nfor drug elimination.\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Lower loading dose,\n     lower maintenance dose </span></li>\n<li class=\"MsoNormal\"><span>Lower loading dose,\n     same maintenance dose</span></li>\n<li class=\"MsoNormal\"><span>Lower loading dose,\n     higher maintenance dose</span></li>\n<li class=\"MsoNormal\"><span>Same loading dose,\n     lower maintenance dose</span></li>\n<li class=\"MsoNormal\"><span>Same loading dose,\n     same maintenance dose</span></li>\n<li class=\"MsoNormal\"><span>Same loading dose,\n     higher maintenance dose</span></li>\n<li class=\"MsoNormal\"><span>Higher loading\n     dose, lower maintenance dose</span></li>\n<li class=\"MsoNormal\"><span>Higher loading\n     dose, same maintenance dose</span></li>\n<li class=\"MsoNormal\"><span>Higher loading\n     dose, higher maintenance dose</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Match each\nof the following adverse effects with the drug most likely to cause it.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<ol start=\"1\" type=\"1\">\n <li class=\"MsoNormal\">\n  <span>\n   Niacin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Doxorubicin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Chloramphenicol\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Sulfonamide\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Methotrexate\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Captopril\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Bleomycin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Spironolactone\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Phenytoin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Tetracycline\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Lovastatin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Procainamide\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Ciprofloxacin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Cyclophosphamide\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Lithium\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Haloperidol\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Metronidazole\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Gentamicin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Tamoxifen\n  </span>\n </li>\n</ol>\n"], "tutorial": "", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Uterine cancer</span></li>\n<li class=\"MsoNormal\"><span>Ototoxicity</span></li>\n<li class=\"MsoNormal\"><span>Disulfiram-like\n     reaction</span></li>\n<li class=\"MsoNormal\"><span>Tardive dyskinesia</span></li>\n<li class=\"MsoNormal\"><span>Diabetes insipidus</span></li>\n<li class=\"MsoNormal\"><span>Hemorrhagic\n     cystitis</span></li>\n<li class=\"MsoNormal\"><span>Tendon rupture</span></li>\n<li class=\"MsoNormal\"><span>Drug-induced lupus</span></li>\n<li class=\"MsoNormal\"><span>Muscle pain</span></li>\n<li class=\"MsoNormal\"><span>Teeth discoloration\n     </span></li>\n<li class=\"MsoNormal\"><span>Gingival\n     hyperplasia</span></li>\n<li class=\"MsoNormal\"><span>Gynecomastia</span></li>\n<li class=\"MsoNormal\"><span>Pulmonary fibrosis</span></li>\n<li class=\"MsoNormal\"><span>Cough</span></li>\n<li class=\"MsoNormal\"><span>Megaloblastic\n     anemia</span></li>\n<li class=\"MsoNormal\"><span>Hemolysis in\n     patients with glucose-6-phosphate dehydrogenase deficiency</span></li>\n<li class=\"MsoNormal\"><span>Gray baby syndrome</span></li>\n<li class=\"MsoNormal\"><span>Dilated\n     cardiomyopathy</span></li>\n<li class=\"MsoNormal\"><span>Flushing</span></li>\n</ol>"]}, {"question": "<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Selected Drug Reactions\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td valign=\"top\" width=\"147\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     System\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Drug Reaction\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Drug\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"5\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cardiovascular\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Anti-cholinergic\n     <sup>\n      1\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tricyclics\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Coronary\n  vasospasm\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sumatriptan\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Flushing\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Niacin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Vancomycin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     (red man\n  syndrome)\n     <sup>\n      2\n     </sup>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Dilated\n  cardiomyopathy\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Doxorubicin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Daunorubicin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Torsades\n  de Pointes\n     <sup>\n      3\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Class IA\n  anti-arrhythmics (quinidine)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Class\n  III anti-arrhythmics\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     (sotalol)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"8\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hematologic\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Agranulocytosis\n     <sup>\n      <span>\n       4\n      </span>\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Carbamazepine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Propylthiouracil\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Methimazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Clozapine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Colchicine\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Aplastic\n  anemia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Carbamazepine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Propylthiouracil\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Methimazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Chloramphenicol\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Direct\n  Coombs-positive\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Hemolytic\n  Anemia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Methyldopa\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thrombocytopenia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Heparin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Quinidine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Penicillin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sulfa\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     NSAIDs\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Anti-convulsants\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gray\n  baby syndrome\n     <sup>\n      <span>\n       5\n      </span>\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Chloramphenicol\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hemolysis\n  in G6PD-deficient patients\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Aspirin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     NSAIDs\n  (ibuprofen)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sulfonamides\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Nitrofurantoin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Primaquine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Isoniazid\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Megaloblastic\n  anemia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Methotrexate\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sulfa\n  drugs\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thrombosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Estrogens\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Progestins\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"2\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pulmonary\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cough\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     ACE-inhibitors\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pulmonary\n  fibrosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Bleomycin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Busulfan\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Amiodarone\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"4\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     GI\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acute\n  cholestasis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Macrolides\n  (erythromycin)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Penicillins\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Nitrofurantoin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Anabolic\n  steroids\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Oral\n  contraceptives\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Cimetidine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Chlorpromazine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Prochlorperazine\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acute\n  hepatic necrosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acetaminophen\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Halothane\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Valproic\n  acid\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hepatitis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Isoniazid\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pseudomembranous\n  enterocolitis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Antibiotics\n  (any)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"3\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Endocrine\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Adrenocortical\n  insufficiency\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Glucocorticoid\n  withdrawal\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gynecomastia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Spironolactone\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Digitalis\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Cimetidine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Alcohol\n  (chronic use)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Estrogens\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Ketoconazole\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hot\n  flashes\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tamoxifen\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"9\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Musculoskeletal/Connective\n  tissue\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gingival\n  hyperplasia\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Teeth\n  discoloration\n     <sup>\n      <span>\n       6\n      </span>\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tetracycline\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Muscle\n  pain/injury\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Statins\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Gout\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Diuretics\n  (by causing hyperuricemia)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Osteoporosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Corticosteroids\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Heparin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Photosensitivity\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Sulfonamides\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Amiodarone\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Tetracycline\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Stevens-Johnson\n  syndrome\n     <sup>\n      <span>\n       7\n      </span>\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Penicillin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sulfa\n  drugs\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Carbamazepine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenobarbital\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Ethosuximide\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Lamotrigine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Allopurinol\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Lupus-like\n  syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hydralazine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Isoniazid\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Procainamide\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tendon\n  rupture\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Fluoroquinolones\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"3\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Renal\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Acute\n  tubular necrosis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Aminoglycosides\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Amphotericin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Radiographic\n  contrast media\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Cyclosporin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Cisplatin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Interstitial\n  nephritis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Penicillins\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sulfa\n  drugs\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Thiazides\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Loop\n  diuretics\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     NSAIDs\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Long-term\n  use of analgesics (acetaminophen, aspirin, NSAIDs)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hemorrhagic\n  cystitis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cyclophosphamide\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Ifosfamide\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"5\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Neurologic\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cinchonism\n     <sup>\n      8\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Quinidine,\n  quinine\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Diabetes\n  insipidus\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Lithium\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Demeclocycline\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Parkinson-like\n  syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Haloperidol\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Chlorpromazine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Metoclopramide\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Seizures\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Bupropion\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Imipenem/cilastatin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Isoniazid\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tardive\n  dyskinesia\n     <sup>\n      9\n     </sup>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Anti-psychotics\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td rowspan=\"3\" valign=\"top\" width=\"147\">\n   <p class=\"MsoNormal\">\n    <span>\n     Other\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Disulfiram-like\n  reaction\n     <sup>\n      10\n     </sup>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     (severe\n  symptoms after alcohol consumption)\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Metronidazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ototoxicity\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Aminoglycosides\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Vancomycin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Loop\n  diuretics\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Cisplatin\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"153\">\n   <p class=\"MsoNormal\">\n    <span>\n     Uterine\n  cancer\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"142\">\n   <p class=\"MsoNormal\">\n    <span>\n     Tamoxifen\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   1\n  </span>\n </sup>\n <span>\n  Anti-cholinergic side\neffects include dry mouth, dry eyes, dry skin, blurred vision, hyperthermia,\ntachycardia, constipation, urinary retention, ataxia, and confusion\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   2\n  </span>\n </sup>\n <b>\n  <span>\n  </span>\n </b>\n <span>\n  Red man syndrome,\n </span>\n <span>\n  or\n  <span>\n   red neck syndrome, is associated\nwith vancomycin use. It\n  </span>\n  is characterized by flushing and/or an\nerythemaous rash on the face, neck, and upper torso. The syndrome usually\nappears within 4&ndash;10 minutes after the start of vancomycin infusion (or\nsoon after completion of the infusion). Symptoms may be treated (and prevented)\nwith antihistamines and a slower infusion rates.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   3\n  </span>\n </sup>\n <span>\n  Torsades de Pointes\n  <b>\n  </b>\n  is\na French term that means \"twisting of the points.\" It refers to\na\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  rapid,\n  <span>\n   polymorphic ventricular tachycardia\n  </span>\n  with a characteristic twist\nof the QRS complex around the isoelectric baseline.\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347414\"\n o:spid=\"_x0000_i1049\" type=\"#_x0000_t75\" alt=\"Description: torsades\">\n <v:imagedata src=\"_%20Tutorials_files/image596.jpg\" o:title=\"torsades\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: torsades\" border=\"0\" height=\"68\" src=\"_%20Tutorials_files/image597.png\" v:shapes=\"Picture_x0020_347414\" width=\"263\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   4\n  </span>\n </sup>\n <span>\n  Agranulocytosis\n </span>\n <span>\n  is an acute condition of\nsevere and dangerous leukopenia, most commonly involving neutrophils.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   5\n  </span>\n </sup>\n <span>\n  Gray baby syndrome\n </span>\n <span>\n  is a serious side\neffect that occurs in newborn infants (especially premature babies) following\nthe intravenous administration of chloramphenicol. Findings include vomiting,\nashen gray color of the skin, limp body tone, hypotension, cyanosis, hypothermia,\nand cardiovascular collapse.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   6\n  </span>\n </sup>\n <span>\n  Tetracyclines can\ncause permanent discoloration of the teeth (yellow-gray-brown) if given to\nchildren under the age of eight. Tetracycline consumption during pregnancy may\nstain the teeth of the fetus.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   7\n  </span>\n </sup>\n <b>\n  <span>\n  </span>\n </b>\n <span>\n  Stevens&ndash;Johnson syndrome\n </span>\n <span>\n  is a life-threatening\ncondition affecting the skin and mucous membranes in which the epidermis\nseparates from the dermis. Although most cases are idiopathic, the main class\nof known causes is medications, followed by infections and (rarely) cancers.\n </span>\n</p>\n\n<h2>\n <sup>\n  <span>\n   8\n  </span>\n </sup>\n <span>\n  Cinchonism is a pathological condition\ncaused by an overdose of quinine. S\n  <span class=\"mw-headline\">\n   ymptoms include\n  </span>\n  flushed\nand sweaty skin, blurred vision, ringing of the ears, impaired hearing,\nconfusion, dizziness, headache, abdominal pain, vomiting, diarrhea, and rash.\n </span>\n</h2>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   9\n  </span>\n </sup>\n <span>\n  Tardive dyskinesia\n </span>\n <span>\n  is a difficult-to-treat form of dyskinesia (disorder resulting in involuntary,\nrepetitive body movements) that often appears after long-term or high-dose use\nof antipsychotic drugs. Tardive dyskinesia is characterized by repetitive,\ninvoluntary, purposeless movements, such as grimacing, tongue protrusion, lip\nsmacking, puckering and pursing of the lips, and rapid eye blinking.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <sup>\n  <span>\n   10\n  </span>\n </sup>\n <span>\n  A disulfiram-like\nreaction occurs with consumption of small amounts of alcohol. Symptoms include\nheadache, confusion, flushing, blurred vision, chest pain, shortness of breath,\nnausea, vomiting, weakness, and anxiety.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answers\n  </span>\n </b>\n <span>\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer B is correct\n </b>\n . Acetaminophen intoxication most likely caused\nthe patient&rsquo;s symptoms.\n <b>\n </b>\n</p>\n", "<p>\n <b>\n  Answer A is incorrect\n </b>\n <span>\n  . Aspirin overdose,\n </span>\n or\n <span>\n  salicylism,\n </span>\n may be acute or chronic. Mild intoxication produces nausea and vomiting,\nabdominal pain, tinnitus, and dizziness. Severe poisoning causes hyperthermia,\ntachypnea, metabolic acidosis, and coma.\n</p>\n", "<p>\n <b>\n  Answer C is incorrect\n </b>\n . Amitriptyline is a tricyclic\nanti-depressant. Tricyclics have a narrow therapeutic index. Overdose produces\nanti-cholinergic symptoms, such as dry mouth, nausea and vomiting, urinary\nretention, constipation, tachycardia, and confusion. Severe complications\ninclude dysrhythmia, hypotension, and seizure. Common electrocardiographic\nabnormalities include tachycardia and prolongation of the QRS complex.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n</p>\n", "<p>\n <b>\n  Answer D is incorrect\n </b>\n . Alprazolam is a benzodiazepine. Overdose can\ncause fatigue, drowsiness, ataxia, and slurred speech. Severe symptoms include\nrespiratory depression and coma.\n</p>\n", "<p>\n <b>\n  Answer E is incorrect\n </b>\n . Diphenhydramine is an antihistaminic and\nanticholinergic drug. Overdose can cause fatigue, somnolence, dry mouth, nausea\nand vomiting, urinary retention, constipation, tachycardia, ataxia, and\ndelirium.\n</p>\n"], "tutorial": "<p>\n A 37-year-old woman presents\nto the emergency room with a 12-hour history of nausea, vomiting, and right\nupper quadrant abdominal pain. She attempted suicide three days ago by taking\n&ldquo;lots of pills.&rdquo; Today she is jaundiced. Which of the following drugs is most\nlikely to have caused her symptoms?\n</p>\n\n<p>\n <span>\n  A.\n  <span>\n   &nbsp;&nbsp;\n  </span>\n </span>\n Aspirin\n</p>\n\n<p>\n <span>\n  B.\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n Acetaminophen\n</p>\n\n<p>\n <span>\n  C.\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n Amitriptyline\n</p>\n\n<p>\n <span>\n  D.\n  <span>\n   &nbsp;&nbsp;\n  </span>\n </span>\n Alprazolam\n</p>\n\n<p>\n <span>\n  E.\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n Diphenhydramine\n</p>\n\n<p>\n Acetaminophen intoxication\nis a relatively common form of drug poisoning. Patients may at first be\nasymptomatic or have nausea and abdominal pain. Disease progression can result\nin liver failure, which may be manifested by jaundice, elevated transaminases,\nhypoglycemia, acidosis, easy bruising, and encephalopathy. Some patients\nimprove spontaneously; others progress; some ultimately die. Liver damage is\nnot caused by the acetaminophen itself, but by a metabolite,\n <i>\n  N\n </i>\n -acetyl-\n <i>\n  p\n </i>\n -benzoquinoneimine\n(NAPQI), which depletes the liver&rsquo;s natural antioxidant, glutathione. Risk\nfactors for acetaminophen toxicity include excessive alcohol intake, fasting or\nanorexia nervosa, and use of certain drugs such as isoniazid. Treatment\nincludes removing acetaminophen from the body and replacing the depleted\nglutathione. Administration of acetylcysteine, a precursor of glutathione, is a\nmainstay of therapy.\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>19</span></li>\n<li class=\"MsoNormal\"><span>18</span></li>\n<li class=\"MsoNormal\"><span>17</span></li>\n<li class=\"MsoNormal\"><span>16</span></li>\n<li class=\"MsoNormal\"><span>15</span></li>\n<li class=\"MsoNormal\"><span>14</span></li>\n<li class=\"MsoNormal\"><span>13</span></li>\n<li class=\"MsoNormal\"><span>12</span></li>\n<li class=\"MsoNormal\"><span>11</span></li>\n<li class=\"MsoNormal\"><span>10</span></li>\n<li class=\"MsoNormal\"><span>9</span></li>\n<li class=\"MsoNormal\"><span>8</span></li>\n<li class=\"MsoNormal\"><span>7</span></li>\n<li class=\"MsoNormal\"><span>6</span></li>\n<li class=\"MsoNormal\"><span>5</span></li>\n<li class=\"MsoNormal\"><span>4</span></li>\n<li class=\"MsoNormal\"><span>3</span></li>\n<li class=\"MsoNormal\"><span>2</span></li>\n<li class=\"MsoNormal\"><span>1</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A\n60-year-old woman has a prosthetic heart valve. She takes warfarin daily. Which\nof the following antibiotics can be safely prescribed without additional\nmonitoring of the INR or adjustment of the warfarin dose?\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . All the antibiotics\nlisted &ndash;\n </span>\n <span>\n  ciprofloxacin, erythromycin,\nmetronidazole, and trimethoprim-sulfamethoxazole &ndash;\n </span>\n <span>\n  have potentially\ndangerous interactions with warfarin. In patients taking warfarin, these\nantibiotics should be avoided if possible. If avoidance is impossible, the INR\nshould be monitored at least every other day and the dosage of warfarin\nreduced.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Recognizing\ndrug-drug interactions is a daily challenge for physicians. Most pharmacies\nhave drug-interaction software programs; however, these programs tend to\n\"flag\" all interactions, making it difficult for the pharmacist to\ninterpret clinical significance.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nfollowing table lists many of the most important drug interactions.\n </span>\n</p>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td colspan=\"3\" valign=\"bottom\" width=\"479\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Serious Drug Interactions\n     </span>\n    </b>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"bottom\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Interaction\n     </span>\n    </b>\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n   <div align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      <hr align=\"center\" noshade=\"\" size=\"1\" width=\"100%\"/>\n     </span>\n    </b>\n   </div>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"bottom\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Potential\n  effect\n     </span>\n    </b>\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n   <div align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      <hr align=\"center\" noshade=\"\" size=\"1\" width=\"100%\"/>\n     </span>\n    </b>\n   </div>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td valign=\"bottom\" width=\"160\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Comments\n     </span>\n    </b>\n   </p>\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Warfarin\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n      <span style=\"mso-spacerun:yes\">\n       &nbsp;&nbsp;\n      </span>\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     ciprofloxacin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     erythromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     clarithromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     metronidazole,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     TMP-SMZ\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased effect of warfarin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Select alternative antibiotic.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Warfarin\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     acetaminophen\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased bleeding, increased INR\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Use lowest possible acetaminophen\n  dosage and monitor INR.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Warfarin\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     acetylsalicylic acid (aspirin)\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased bleeding, increased INR\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Limit aspirin dosage to 100 mg per\n  day and monitor INR.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Warfarin\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\\\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     NSAID\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased bleeding, increased INR\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Avoid combination if possible; if\n  not, use a COX-2 inhibitor and monitor INR.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Fluoroquinolone\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     sucralfate\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased absorption of\n  fluoroquinolone\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Space administration by 2 to 4\n  hours.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Carbamazepine\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     cimetidine,\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     erythromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     clarithromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     fluconazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased carbamazepine levels\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor carbamazepine levels.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     cimetidine,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     erythromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     clarithromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     fluconazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased phenytoin levels\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor phenytoin levels.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenobarbital\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     cimetidine,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     erythromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     clarithromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     fluconazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased phenobarbital levels\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor phenobarbital levels.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenytoin\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     rifampin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased phenytoin levels\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor phenytoin levels.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Phenobarbital\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     rifampin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased phenobarbital levels\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor phenobarbital levels.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Carbamazepine\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     rifampin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased carbamazepine levels\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor carbamazepine levels.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Lithium\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     NSAID\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     diuretic\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased lithium levels\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Decrease lithium dosage by 50% and\n  monitor lithium levels.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Oral contraceptive pills\n     <i>\n      plus\n     </i>\n     rifampin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Decreased effectiveness of oral\n  contraception\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Avoid combination if possible.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sildenafil\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     nitrates\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Dramatic hypotension\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Absolute contraindication.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Sildenafil\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     cimetidine\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     erythromycin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     itraconazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     ketoconazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased sildenafil levels\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Initiate sildenafil at a 25-mg\n  dose.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     HMG-CoA reductase inhibitor\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     niacin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     gemfibrozil,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     erythromycin,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     itraconazole\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Possible rhabdomyolysis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Avoid if possible. If combination\n  therapy is necessary, monitor the patient for toxicity.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Lovastatin\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     warfarin\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased effect of warfarin\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor INR.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     SSRI\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     tricyclic antidepressant\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased tricyclic antidepressant\n  level\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor for anticholinergic excess\n  and consider lower dosage of tricyclic antidepressant.\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     SSRI\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     selegiline or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     nonselective MAOI\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Hypertensive crisis\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Avoid.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     SSRI\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     tramadol\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Increased potential for seizures;\n  serotonin syndrome\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Monitor the patient for signs and\n  symptoms of serotonin syndrome.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     SSRI\n     <i>\n      plus\n     </i>\n     St. John's wort\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Serotonin syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Avoid.\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     SSRI\n     <i>\n      plus\n     </i>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <i>\n     <span>\n     </span>\n    </i>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     naratriptan,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     rizatriptan,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     sumatriptan,\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     or\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     zolmitriptan\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Serotonin syndrome\n    </span>\n   </p>\n  </td>\n  <td valign=\"top\" width=\"160\">\n   <p class=\"MsoNormal\">\n    <span>\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Avoid if possible. If combination\n  therapy is necessary, monitor the patient for signs and symptoms of serotonin\n  syndrome\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td colspan=\"3\" valign=\"top\" width=\"479\">\n   <p class=\"MsoNormal\">\n    <span>\n     INR =\n  International Normalized Ratio; NSAID = nonsteroidal anti-inflammatory drug;\n  HMG-CoA = 3-hydroxy-3-methylglutaryl&shy;coenzyme A reductase inhibitor; SSRI\n  = selective serotonin reuptake inhibitor; MAOI = monoamine oxidase inhibitor\n    </span>\n    <span>\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p class=\"MsoNormal\">\n <span>\n  Warfarin\nis the most widely prescribed anticoagulant drug in the U.S. It works by\ninhibiting vitamin K-dependent synthesis of clotting factors II, VII, IX, and\nX, and regulatory factors protein C and protein S. When warfarin is\nadministered, anticoagulation does not occur immediately because it takes about\na day for the already-formed clotting factors to be metabolized. The duration\nof action of a single dose of warfarin is 2 to 5 days.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Despite\nits effectiveness, warfarin has several shortcomings. It interacts with many\nfoods (particularly fresh plant-based foods containing vitamin K) and with many\ncommonly used medications (see below). Its activity must be monitored using the\nInternational Normalized Ratio (INR) to ensure proper dosing.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Drug\ninteractions involving warfarin are among the most dangerous interactions seen\nin clinical medicine. Not surprisingly, warfarin is associated with more\nlawsuits that any other drug on the market.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Warfarin + Antibiotics\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Almost all\nantibiotics can potentiate the effect of warfarin by inhibiting intestinal\nflora, which produce vitamin K. In addition, some antibiotics inhibit warfarin\nmetabolism, resulting in increased bleeding. These antibiotics include\nciprofloxacin, clarithromycin, erythromycin, metronidazole, and\ntrimethoprim-sulfamethoxazole.\n  <i>\n   Unless the\nprothrombin International Normalized Ratio (INR) can be monitored every other\nday, ciprofloxacin, macrolide antibiotics, metronidazole and\ntrimethoprim-sulfamethoxazole should not be prescribed to patients who are\ntaking warfarin\n  </i>\n  . Alternative antimicrobial therapy is recommended for these\npatients.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Warfarin + Acetaminophen\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Recent\ndata suggest that the warfarin-acetaminophen interaction may be clinically\nsignificant even at low dosages of acetaminophen. Because acetaminophen is the\nmost frequently ingested medicine in the United States, physicians should\ncounsel warfarin-treated patients about potential toxicity. If acetaminophen\ntherapy is needed, the dosage should be as low as possible, and the drug should\nbe taken for only a short period. The INR should be monitored closely.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Warfarin + Aspirin\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Coadministration\nof acetylsalicylic acid (aspirin) and warfarin increases the risk of bleeding.\nAlthough concomitant use of warfarin and aspirin should generally be avoided,\ncertain patients may benefit from this combination. In these patients, the dose\nof aspirin should not exceed 100 mg per day.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  Warfarin + NSAID\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Coadministration\nof nonsteroidal anti-inflammatory drugs (NSAIDs) and warfarin increases the\nrisk of bleeding. The data suggest that the cyclooxygenase-2 inhibitors may be\nsafer options in patients requiring an NSAID and warfarin because these agents\nhave fewer antiplatelet effects. Concomitant use of NSAIDs and warfarin should\nbe avoided in patients who are at increased risk of gastropathy (e.g., age\ngreater than 65 years, history of peptic ulcer disease, systemic steroid\ntherapy, heavy smoking, or high NSAID dosage). If NSAID therapy is necessary, a\ncyclooxygenase-2 inhibitor should be used, and the INR should be closely\nmonitored.\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Ciprofloxacin</span></li>\n<li class=\"MsoNormal\"><span>Erythromycin</span></li>\n<li class=\"MsoNormal\"><span>Metronidazole </span></li>\n<li class=\"MsoNormal\"><span>Trimethoprim-sulfamethoxazole</span></li>\n<li class=\"MsoNormal\"><span>None of the above</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span lang=\"EN-GB\">\n  A 47-year-old woman presents to the emergency room\nwith a two-day history of fever, cough, and shortness of breath. She has a\nhistory of recurrent urinary tract infections and takes an antibiotic. Physical\nexamination shows a diffuse maculopapular rash and crackles in both lung bases.\nLaboratory tests are normal except for an absolute eosinophil count of 950/mm\n  <sup>\n   3\n  </sup>\n  (normal: &lt;350/mm\n  <sup>\n   3\n  </sup>\n  ). Sputum and blood cultures are negative.\nA chest x-ray shows bilateral diffuse infiltrates and a small right pleural\neffusion. Which of the following conditions is most likely?&nbsp;\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  Drug-induced lung\ndisease should be suspected in this case.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Nitrofurantoin is an antibiotic commonly used to treat and prevent\nurinary tract infections. It is one of the most common causes of drug-induced\nlung disease. Findings may include fever, cough, shortness of breath, rash,\neosinophilia, basilar pulmonary infiltrates, and pleural effusion. Symptoms\nusually resolve with discontinuation of the medicine. Failure to discontinue\nthe medicine may lead to chronic fibrosis.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  Streptococcal pneumonia\noften presents with signs of lobar consolidation, which include dullness to\npercussion, increased fremitus, bronchial breath sounds, egophony, and\nwhispered pectoriloquy.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  Congestive heart\nfailure can cause shortness of breath, basilar crackles, and right pleural\neffusion, but it is not associated with rash or eosinophilia.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . Acute asthma causes\nshortness of breath and wheezing.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . Sarcoidosis is a\nsystemic disease characterized by the presence of noncaseating granulomas.\nWomen and African-Americans are disproportionately affected. The disease\ncommonly affects the lungs and lymph nodes, although any organ system can be\ninvolved. Symptoms may include coughing and shortness of breath. Hilar\nlymphadenopathy is often present on chest x-ray.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  More than\n400 drugs have been associated with lung disease. Recognition of drug-induced\nlung disease is difficult because clinical, radiological, and histological\nfindings are nonspecific. To make the diagnosis, physicians must be aware of\ncommon drug-induced lung reactions. Ultimately, drug-induced lung disease is a\ndiagnosis of exclusion. Drugs commonly associated with lung disease appear\nbelow.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"97\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Drug-Induced\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Lung Disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"97\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"97\">\n    <p class=\"MsoNormal\">\n     <span>\n      Bleomycin\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"97\">\n    <p class=\"MsoNormal\">\n     <span>\n      Methotrexate\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"97\">\n    <p class=\"MsoNormal\">\n     <span>\n      Nitrofurantoin\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"97\">\n    <p class=\"MsoNormal\">\n     <span>\n      Amiodarone\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"97\">\n    <p class=\"MsoNormal\">\n     <span>\n      Procainamide\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Bleomycin\n  </span>\n </i>\n <span>\n  causes dose-related toxicity.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Methotrexate\n  </span>\n </i>\n <span>\n  can cause interstitial pneumonitis, which\nis often reversible; progression to pulmonary fibrosis is unusual.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Nitrofurantoin\n  </span>\n </i>\n <span>\n  is one of the most common causes of\ninterstitial lung disease. It can cause acute or chronic lung injury. Fever,\nrash, eosinophilia, basilar infiltrates, and pleural effusion are common.\nFailure to discontinue the medication can result in chronic fibrosis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Amiodarone\n  </span>\n </i>\n <span>\n  can cause acute and chronic lung\ndisease. Acute disease is rare; chronic disease occurs more commonly in\npatients taking 400 mg daily or more.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Procainamide\n  </span>\n </i>\n <span>\n  is associated with drug-induced lupus,\nwhich may result in pulmonary infiltrates and pleural effusion.\n </span>\n</p>\n", "choices": ["A. Streptococcal pneumonia", "B. Congestive heart failure", "C. Acute asthma", "D. Drug-induced lung disease", "E. Sarcoidosis"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 49-year old man is diagnosed with sinusitis\nand given a prescription for an antibiotic. He develops a rash ten days later.\nWhich antibiotic most likely caused the rash?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347413\" o:spid=\"_x0000_i1048\" type=\"#_x0000_t75\" alt=\"Description: drug_eruption\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image598.jpg\" o:title=\"drug_eruption\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: drug_eruption\" border=\"0\" height=\"289\" src=\"_%20Tutorials_files/image599.png\" v:shapes=\"Picture_x0020_347413\" width=\"204\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpMiddle\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  . Amoxicillin is one of\nthe most common causes of morbilliform rash.\n </span>\n</p>\n", "<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answers B, C, D, and E\nare incorrect.\n  </span>\n </b>\n <span>\n  Erythromycin,\nazithromycin, ciprofloxacin and levofloxacin do not usually produce a\nmorbilliform rash.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Drug eruptions can mimic a wide range of skin\ndisorders. They can produce different types of rash &ndash; morbilliform,\nurticarial, papulosquamous, pustular, and bullous. (Some drugs cause pruritus\nand dysesthesia without rash.) A drug-induced reaction should be considered in\nany patient who is taking medicine and who develops a symmetric cutaneous\neruption. Drugs that commonly cause cutaneous reactions include antimicrobial\nagents,\n </span>\n <a href=\"file://localhost/javascript/showcontent('active','references')%3B\">\n </a>\n <sup>\n  <span>\n  </span>\n </sup>\n <span>\n  nonsteroidal\nanti-inflammatory drugs, cytokines, chemotherapeutic agents, anticonvulsants,\nand psychotropic agents.\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  The most common morphology for a drug-induced\nrash is morbilliform (&ldquo;measles-like&rdquo;), which has both\n  <span>\n   macular\nand papular components. Morbilliform rashes\n  </span>\n  usually develop\n  <span>\n   in the second week of exposure to a drug.\nPenicillins (e.g., amoxicillin) and trimethoprim/sulfamethoxazole (Bactrim) are\nthe most common antibiotics causing this type of rash. Patients with\nEpstein-Barr virus and Human Immunodeficiency Virus have a higher incidence of\nthis reaction. Morbilliform rashes present as pruritic, erythematous, finely\nmaculopapular lesions. They usually appear on the trunk and groin and spread\ncentrifugally over 24 hours. Fever is usually absent and laboratory tests are\noften normal. The rash resolves in a few days to a week after the medication is\nstopped. The patient&rsquo;s medical record must be appropriately labeled to make\nsure so that the drug is not readministered.\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347412\" o:spid=\"_x0000_i1047\" type=\"#_x0000_t75\" alt=\"Description: Penicillin_Allergy_Resulting_in_Morbilliform_Rash-124\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image600.jpg\" o:title=\"Penicillin_Allergy_Resulting_in_Morbilliform_Rash-124\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Penicillin_Allergy_Resulting_in_Morbilliform_Rash-124\" border=\"0\" height=\"146\" src=\"_%20Tutorials_files/image601.png\" v:shapes=\"Picture_x0020_347412\" width=\"96\"/>\n  <v:shape alt=\"Description: image_gallery?img_id=1584227&amp;t=1276092298705\" id=\"Picture_x0020_347411\" o:spid=\"_x0000_i1046\" type=\"#_x0000_t75\">\n   <v:imagedata o:title=\"image_gallery?img_id=1584227&amp;t=1276092298705\" src=\"_%20Tutorials_files/image602.jpg\">\n   </v:imagedata>\n  </v:shape>\n  <img alt=\"Description: image_gallery?img_id=1584227&amp;t=1276092298705\" border=\"0\" height=\"146\" src=\"_%20Tutorials_files/image603.png\" v:shapes=\"Picture_x0020_347411\" width=\"104\"/>\n  <v:shape alt=\"Description: 79m\" id=\"Picture_x0020_347410\" o:spid=\"_x0000_i1045\" type=\"#_x0000_t75\">\n   <v:imagedata o:title=\"79m\" src=\"_%20Tutorials_files/image604.jpg\">\n   </v:imagedata>\n  </v:shape>\n  <img alt=\"Description: 79m\" border=\"0\" height=\"146\" src=\"_%20Tutorials_files/image605.png\" v:shapes=\"Picture_x0020_347410\" width=\"109\"/>\n </span>\n <span>\n </span>\n</p>\n", "choices": ["A. Amoxicillin", "B. Erythromycin", "C. Azithromycin", "D. Ciprofloxacin", "E. Levofloxacin"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Which of\nthe following is used as a metabolic energy source by erythrocytes after an\novernight fast?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  Red blood cells use\nglucose as a metabolic energy source.\n  <b>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </b>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  In red blood cells,\nglucose is broken down to pyruvate during glycolysis. The pyruvate is then\nconverted to lactic acid.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  Triglycerides are broken\ndown to produce fatty acids, which are used by the heart and skeletal muscle\nfor energy. Fatty acids do not cross the blood-brain barrier, and so the brain\ncannot use them for energy. The process of breaking down fatty acids is called\n&beta;-oxidation. This process requires mitochondria and oxygen. Red blood\ncells, which lack mitochondria, cannot perform &beta;-oxidation.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect.\n  </span>\n </b>\n <span>\n  Free fatty acids are\nused by the heart and skeletal muscle for energy. They do not cross the\nblood-brain barrier, and so the brain cannot use them for energy. The process\nof breaking down fatty acids is called &beta;-oxidation. This process requires\nmitochondria and oxygen. Red blood cells, which lack mitochondria, cannot\nperform &beta;-oxidation.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  . &beta;-hydroxybutyrate\nis a ketone. Unlike fatty acids, ketones cross the blood-brain barrier. They are\nused by the brain for energy when glucose in not available (e.g., fasting). Red\nblood cells cannot metabolize ketones.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Red blood\ncells are structurally simpler that most other cells in the body. They consist\nmainly of hemoglobin. Although they contain many organelles in the early stages\nof erythropoiesis, these organelles are extruded as the cells mature. By\n&ldquo;dumping&rdquo; their organelles, red blood cell makes room for hemoglobin.\nOrganelles &ldquo;dumped&rdquo; by red blood cells include the nucleus, mitochondria, Golgi\napparatus, and endoplasmic reticulum. Because mature red blood cells have no\nmitochondria, they cannot undertake metabolic reactions that use oxygen to\nproduce energy. Thus, although they can\n  <i>\n   carry\n  </i>\n  oxygen because of the hemoglobin, they cannot\n  <i>\n   use\n  </i>\n  it. Since red blood cells lack the metabolic machinery to\noxidize metabolites for energy, they must rely on lactic acid fermentation of\nglucose for energy. This is an anaerobic process that produces ATP. The first\nstep of the process is glycolysis, in which glucose is broken down to produce\npyruvate. The pyruvate is then converted to lactic acid. The entire process is\nperformed in the cytoplasm without the need for oxygen, mitochondria, or other\norganelles.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Glucose</span></li>\n<li class=\"MsoNormal\"><span>Pyruvate</span></li>\n<li class=\"MsoNormal\"><span>Triglycerides</span></li>\n<li class=\"MsoNormal\"><span>Free fatty acids</span></li>\n<li class=\"MsoNormal\"><span>\u03b2-hydroxybutyrate</span></li>\n</ol>"]}, {"question": "<p class=\"MsoListParagraphCxSpFirst\">\n <span>\n  A 58-year-old woman presents with fatigue and\narthritis. Her blood tests show the following:\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Hemoglobin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  12\ng/dl\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  WBC count\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  6,500/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Platelet\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  110,000/mm\n  <sup>\n   3\n  </sup>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Glucose (fasting)\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  140\nmg/dl\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  AST\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  110\nU/L\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  ALT\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  86\nU/L\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Albumin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  3.1\ng/dl\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  INR\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  1.3\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Serum iron\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  184\nug/dl (normal: 50-170 ug/dl)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Total iron binding capacity\n  <span>\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  282 ug/dl (normal: 262-474\nug/dl)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Transferrin saturation\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  65%\n(normal: 25% - 35%)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Serum ferritin\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  2689\nng/ml (normal: 12-150)\n </span>\n</p>\n\n<p class=\"MsoListParagraphCxSpMiddle\">\n <span>\n  Which of the following tests should be ordered\nnext?\n </span>\n</p>\n", "answers": ["<p class=\"MsoListParagraphCxSpLast\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  . The presence of\nelevated liver enzymes and high serum iron levels, along with arthritis and\ndiabetes, suggests a diagnosis of hemochromatosis. The diagnosis can be\nconfirmed by testing for mutation of the hemochromatosis gene (HFE).\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Viral hepatitis is a common cause of\nelevated liver enzymes, but would not explain the abnormal serum iron studies.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  H\n </span>\n <span>\n  emochromatosis is an autosomal recessive disease with a high\nprevalence in Caucasians. The gene responsible for the disease is known as the\nHFE gene. Hemochromatosis is characterized by an accelerated rate of intestinal\niron absorption and progressive iron deposition in various tissues. Patients\nmay present with liver disease, heart failure, diabetes, arthritis,\nhyperpigmentation, or testicular failure. A third of untreated patients develop\nhepatocellular carcinoma.\n </span>\n <span>\n  Individuals who are homozygous for the C282Y mutation are at\nvery high risk of developing the disease.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Other mutations increase risk, but homozygosity of the C282Y mutation\ncarries the greatest risk.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Once a patient\nis found to be homozygous for the C282Y mutation, all first-degree relatives\nshould be screened. Patients with hemochromatosis should be instructed not to\nconsume iron supplements. Repeated phlebotomy is undertaken to bring the serum\nferritin level below 50ng/ml. Maintenance phlebotomy is needed thereafter.\n </span>\n</p>\n", "choices": ["A. Blood test for viral hepatitis", "B. Blood test for alpha-fetoprotein", "C. Liver biopsy", "D. Blood test for mutation of the hemochromatosis gene (HFE)"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <b>\n   Answer B is incorrect\n  </b>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  An alpha-fetoprotein level should be\nmeasured if hepatocellular carcinoma is suspected, but this is not a prime\ndiagnostic consideration at this time.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  A liver biopsy would establish the\ndegree of hepatic impairment, but is not necessary for diagnosis.\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  Which of the\nfollowing is true regarding intention-to-treat analysis?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  ITT means that\n  <span>\n   all patients are analyzed in the group to which they are assigned,\nregardless of the treatment they received.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer A is incorrect.\n  </span>\n </b>\n <span>\n  ITT does not contribute to blinding.\nConcealment of randomization helps to avoid the breaking of blinding.\n </span>\n</p>\n", "<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer B is incorrect.\n  </span>\n </b>\n <span>\n  ITT should be used in superiority trials, not\nequivalency trials.\n </span>\n</p>\n", "<p class=\"MsoNoSpacing\">\n <b>\n  <span>\n   Answer C is incorrect.\n  </span>\n </b>\n <span>\n  ITT\n  <b>\n  </b>\n  minimizes\nthe difference in results between treatment groups.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  A classical clinical trial with\na superiority design is analyzed on the basis of&nbsp;\n  <i>\n   intention to treat\n(ITT)\n  </i>\n  &nbsp;by default. ITT means that every patient is analyzed as\nbelonging to the group to which he or she was allocated by randomization,\nregardless of what happened with this patient afterward. In the extreme\nscenario, a patient who is randomized to group A may drop out even before the\nfirst drug dose is administered, and may be treated outside the clinical trial\nby his or her physician with the drug that is actually being administered in\ngroup B (cross-over of treatment). True ITT requires that this patient,\nregardless of the data that are present or missing, is analyzed in group A,\neven if he or she has experienced the effects of the drug in group B. ITT is\nconsidered the only means of analysis that preserves the prognostic similarity\nthat was created at baseline. It should be noted here that many trial reports\nmention an ITT analysis, but that such an analysis often is not rigorously\nperformed. For example, randomized patients who did not receive treatment are\noften excluded from the analysis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Alternatively, a trial analysis may be limited to\nonly those patients who completed the study (completers analysis), or to those\nwho completed the study while complying with the study protocol (per-protocol\nanalysis). Both types of analysis may introduce bias; as a consequence,\nprognostic similarity should not be assumed. Dropout, for example, can occur\nbecause of lack of efficacy, and completers may provide a less severe\nrepresentation of the entire trial population (see later). Often, a completers\nanalysis tends to magnify the treatment effect, and an ITT analysis is more\nconservative. In a noninferiority trial, however, the situation is just the\nreverse: The ITT analysis tends to favor noninferiority, and the completers\nanalysis or the per-protocol analysis is more conservative in this regard.\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  ITT is generally preferred in\n  <b>\n   superiority\n  </b>\n  trials (i.e., trials to\ndetermine if one intervention is superior to another). This is because ITT\ntends to minimize the difference in outcomes between treatment groups. If,\ndespite using ITT, there is a significant difference between groups, that\ndifference is more likely to be real.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNoSpacing\">\n <span>\n  <span>\n   &middot;\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </span>\n <span>\n  ITT is generally\n  <i>\n   not\n  </i>\n  preferred in\n  <b>\n   equivalency\n  </b>\n  ,\nor non-inferiority, trials (i.e., trials to determine if two interventions are\nequivalent). This is because ITT, by minimizing the difference between\ntreatment groups, may make outcomes appear equivalent, even when they are\nnot.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. It is a way of avoiding the breaking of blinding", "B. It should always be used in equivalency trials", "C. It maximizes the difference in results between treatment groups", "D. It means that all patients are analyzed in the group to which they were assigned, regardless of which treatment they received"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  In the\nfollowing schematic of lipid metabolism, the targets of lipid-lowering therapy\nare labeled. Which site is targeted by drugs that produce the greatest reduction\nin LDL cholesterol levels?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347409\"\n o:spid=\"_x0000_i1044\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image606.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"329\" src=\"_%20Tutorials_files/image607.png\" v:shapes=\"Picture_x0020_347409\" width=\"416\"/>\n </span>\n <span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  .\n3-hydroxy-3-methyglutaryl coenzyme A (HMG-CoA) reductase inhibitors block the\nsynthesis of mevalonate. This is an essential step in cholesterol synthesis.\nThese medicines, sometimes called &ldquo;statins,&rdquo; are the most effective drugs for\nlowering LDL cholesterol.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  . No lipid-lowering\ndrugs target this site.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . Bile acid sequestrants\nlike cholestyramine block the absorption of bile acids from the gut. The liver\nmanufactures bile acids through the oxidation of cholesterol. When bile acid\nabsorption is inhibited, the liver must metabolize more cholesterol to generate\nnew bile acids. This lowers cholesterol, principally LDL cholesterol, levels.\nAlthough bile acid sequestrants lower LDL cholesterol levels, they are less effective\nthan HMG-CoA reductase inhibitors (&ldquo;statins&rdquo;) at doing so.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D\n  </span>\n </b>\n <span>\n  <b>\n   is\nincorrect\n  </b>\n  . Fibrates like gemfibrozil lower triglyceride levels. They work\nby increasing the expression of lipoprotein lipase on endothelial cells.\nLipoprotein lipase hydrolyzes lipids, increasing the clearance of\ntriglyceride-rich lipoproteins.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. A", "B. B", "C. C", "D. D"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Thoracentesis\nand lumbar puncture are two commonly performed procedures. Which of the\nfollowing locations are most appropriate for needle insertion in adult patients?\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Thoracentesis\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      (performed in midscapular line)\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Lumbar puncture\n     </span>\n    </p>\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      (performed in intervertebral space)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      A\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Above the 2\n      <sup>\n       nd\n      </sup>\n      rib\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      L1/L2 or L2/L3\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      B\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Below the 2\n      <sup>\n       nd\n      </sup>\n      rib\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      L1/L2 or L2/L3\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      C\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Above the 5\n      <sup>\n       th\n      </sup>\n      rib\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      L2/L3 or L3/L4\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      D\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Below the 5\n      <sup>\n       th\n      </sup>\n      rib\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      L2/L3 or L3/L4\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      E\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Above the 9\n      <sup>\n       th\n      </sup>\n      rib\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      L3/L4 or L4/L5\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"23\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      F\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"180\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Below the 9\n      <sup>\n       th\n      </sup>\n      rib\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"189\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      L3/L4 or L4/L5\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is correct\n  </span>\n </b>\n <span>\n  . Thoracentesis is\ncommonly performed above the 9\n  <sup>\n   th\n  </sup>\n  rib in the midscapular line. The\nneedle should not be inserted below the rib, where nerves and vascular\nstructures lie. Lumbar puncture should be performed in the L3/L4 or L4/L5\nintervertebral space.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Additive nephrotoxicity\nwould be expected with which of the following drug combinations?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  . Both amphotericin B\nand gentamicin can damage the kidneys.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Many drugs\ncan cause renal disease. The most important are listed here.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Drug-induced renal disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Radiographic\n  contrast media\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Nonsteroidal\n  anti-inflammatory drugs (NSAIDs)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cyclooxygenase-2\n  inhibitors (COX-2 inhibitors)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Aminoglycosides\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Amphotericin\n  B\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Angiotensin-converting\n  enzyme inhibitors (ACE-inhibitors)\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cisplatin\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"246\">\n    <p class=\"MsoNormal\">\n     <span>\n      Cyclosporine\n  and tacrolimus\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Radiographic contrast media\n  </span>\n </i>\n <span>\n  are a common cause of\nacute renal failure. The most important risk factors are pre-existing renal\ndisease, dehydration, and exposure to other nephrotoxins.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Nonsteroidal anti-inflammatory drugs (NSAIDs)\n  </span>\n </i>\n <span>\n  have several acute\nrenal effects. The most common pattern of injury is prerenal azotemia, which\noccurs in patients who are volume contracted or who have reduced effective\ncirculating volume (e.g., congestive heart failure, cirrhosis). Other injury\npatterns include renal tubular acidosis (hyporeninemic hypoaldosteronism, which\nresults in hyperkalemia and a normal-anion gap metabolic acidosis) and acute\ninterstitial nephritis.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Cyclooxygenase-2 inhibitors (COX-2 inhibitors)\n  </span>\n </i>\n <span>\n  are similar to NSAIDs\nin their effects on the kidney.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Aminoglycosides\n  </span>\n </i>\n <span>\n  cause acute renal\nfailure in 10% of patients receiving these drugs even when levels are within\ntherapeutic range. Renal failure is usually mild and the prognosis is generally\ngood. The risk of aminoglycoside-induced renal failure is increased by concomitant\nuse of other nephrotoxic drugs (e.g., amphotericin B, radiocontrast media,\ncisplatin).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Amphotericin B\n  </span>\n </i>\n <span>\n  causes potassium and magnesium wasting\nand metabolic acidosis by damaging multiple segments of the renal tubule\n(proximal tubule, ascending limb, and collecting duct).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Angiotensin-converting enzyme inhibitors\n  </span>\n </i>\n <span>\n  <i>\n   (ACE-inhibitors)\n  </i>\n  can cause acute renal failure in patients with\nbilateral renal artery stenosis and in patients with advanced azotemia.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Cisplatin\n  </span>\n </i>\n <span>\n  causes magnesium wasting by damaging the proximal\nand distal tubules.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <i>\n  <span>\n   Cyclosporine and tacrolimus\n  </span>\n </i>\n <span>\n  can cause acute renal\nfailure by inducing afferent arteriolar vasoconstriction.\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>ceftriaxone and\n     azithromycin</span></li>\n<li class=\"MsoNormal\"><span>fluconazole and\n     amoxicillin<b> </b></span></li>\n<li class=\"MsoNormal\"><span>amphotericin B and\n     gentamicin</span></li>\n<li class=\"MsoNormal\"><span>moxifloxacin and\n     clindamycin</span></li>\n<li class=\"MsoNormal\"><span>micafungin and\n     doxycycline</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  An\ninexpensive screening test is available through analysis of venous blood. The\ndistributions of blood concentrations for persons with and without the disease\nare depicted in the graph. The disease is irreversible and fatal if not\ndiscovered and treated early. Which of the following letters represents the\nmost appropriate cutoff point between normal and abnormal?\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347408\"\n o:spid=\"_x0000_i1043\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image608.emz\" o:title=\"\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"140\" src=\"_%20Tutorials_files/image609.png\" v:shapes=\"Picture_x0020_347408\" width=\"257\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Using lab\ntests to distinguish &ldquo;normal&rdquo; and &ldquo;abnormal&rdquo; states can be challenging. Rarely\nare normality and abnormality defined by a\n  <i>\n   single\n  </i>\n  test value. Instead, they are usually defined by a\n  <i>\n   range\n  </i>\n  of values &ndash; and those ranges can overlap. While values\nin the non-overlapping regions are easily categorized as normal or abnormal,\nvalues in the overlapping region are not easily categorized. The cutoff between\nnormal and abnormal can be placed anywhere within the region of overlap,\ndepending on the level of sensitivity and specificity that is sought.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  When it is\nextremely important to identify a disease, even at the cost of misidentifying a\nfew normal individuals, the range of abnormal values should be expanded so that\n  <i>\n   every\n  </i>\n  person with the disease is\ncorrectly identified. In other words, the cutoff point between normal and\nabnormal should maximize test sensitivity. On the other hand, when it is not\ncrucial to identify every person with the disease, and when it is more\nimportant to ensure that no normal person is misidentified, then the abnormal\nrange should be narrowed so\n  <i>\n   only\n  </i>\n  persons with the disease are identified. In other words, the cutoff point\nbetween normal and abnormal should maximize test specificity.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct\n  </span>\n </b>\n <span>\n  . In this vignette, we\nare told that the disease is irreversible and fatal if not discovered and\ntreated early. This means that the abnormal range must be defined so that every\naffected patient is identified, even at the cost of misidentifying normal patients.\nIn other words, the cutoff point between normal and abnormal should be placed\nto maximize test sensitivity. That place is represented by &ldquo;B.&rdquo; If the cutoff\npoint is placed at &ldquo;C&rdquo;, &ldquo;D,&rdquo; or &ldquo;E,&rdquo; some people with disease will be missed.\nPlacing the cutoff point at &ldquo;A&rdquo; would identify no additional people with\ndisease (compared to &ldquo;B&rdquo;), and would misidentify too many normal individuals.\nAs one moves from &ldquo;B&rdquo; to &ldquo;E,&rdquo; test specificity increases, while sensitivity\ndecreases; as one moves from &ldquo;E&rdquo; to &ldquo;B,&rdquo; sensitivity increases, while\nspecificity decreases.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n68-year-old man presents with urinary f\n  <span>\n   requency,\nurgency, hesitancy, and intermittency. The urine stream is weak. The patient\nfeels that his bladder is not emptying completely. On examination, he is found\nto have an enlarged prostate. His doctor prescribes a medicine to &ldquo;shrink the\nprostate.&rdquo; What is the mechanism by which this medicine works?\n  </span>\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct\n  </span>\n </b>\n <span>\n  .\n  <span>\n   5&alpha;-reductase\n  </span>\n  inhibitors like finasteride work\nby inhibiting the conversion of testosterone to dihydrotestosterone, which\nreduces the size of the prostate over time.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  . PDE-5 inhibitors like\nsildenafil increase the concentration of\n  <span>\n   cyclic\nguanosine monophosphate (cGMP), which causes vasodilation and increased blood\nflow to the corpus cavernosum. These medicines are used for erectile\ndysfunction.\n  </span>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is incorrect\n  </span>\n </b>\n <span>\n  . GnRH\nanalogs like leuprolide bind to the luteinizing hormone-releasing hormone (LH-RH)\nreceptor in the pituitary. This leads to a reduction in luteinizing hormone\nsecretion. These medicines are used to treat metastatic prostate cancer.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Androgen\nreceptor antagonists like flutamide are used in conjunction with GnRH analogs\nto treat metastatic prostate cancer.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer E is incorrect\n  </span>\n </b>\n <span>\n  .\n5&alpha;-reductase\n </span>\n <span>\n  inhibitors like finasteride do not interact with cytochrome P450 enzymes.\n </span>\n</p>\n"], "tutorial": "", "choices": ["A. Inhibition of 5\u03b1-reductase", "B. Inhibition of cyclic guanosine monophosphate-specific phosphodiesterase type 5 (PDE-5 inhibitor)", "C. Gonadotropin-releasing hormone (GnRH) analog", "D. Inhibition of testosterone\u2019s negative feedback on gonadotropin secretion", "E. Inhibition of cytochrome P450 enzymes"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  A new\nlaboratory test has been developed to identify patients with a particular\ndisease.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The table\nbelow summarizes the results of research involving 200 subjects.\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"72\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td colspan=\"2\" valign=\"top\" width=\"119\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Disease\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"72\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td colspan=\"2\" valign=\"top\" width=\"119\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"72\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Present\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"60\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      Absent\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"72\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"60\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"72\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n      Positive\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      80\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"60\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      20\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"72\">\n    <p class=\"MsoNormal\">\n     <span>\n      Test\n  Result\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"60\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"72\">\n    <p class=\"MsoNormal\">\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p class=\"MsoNormal\">\n     <span>\n      Negative\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"59\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      40\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"60\">\n    <p align=\"center\" class=\"MsoNormal\">\n     <span>\n      60\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <span>\n  What is\nthe sensitivity of a positive test result?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct\n  </span>\n </b>\n <span>\n  .\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Sensitivity,\nspecificity, positive predictive value, and negative predictive value are\nimportant statistical concepts.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Imagine a\nstudy evaluating a new test that screens people for a disease. Each person\ntaking the test either does or does not have the disease. The test outcome can\nbe positive (predicting that the person has the disease) or negative\n(predicting that the person does not have the disease). The test results for\neach subject may or may not match the subject's actual status. In that setting:\n </span>\n</p>\n\n<ul type=\"disc\">\n <li class=\"MsoNormal\">\n  <span>\n   True positive: Sick\n     people correctly identified as sick\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   False positive:\n     Healthy people incorrectly identified as sick\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   True negative:\n     Healthy people correctly identified as healthy\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   False negative:\n     Sick people incorrectly identified as healthy\n  </span>\n </li>\n</ul>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Sensitivity\n  </span>\n </b>\n <span>\n  measures the proportion\nof actual positives that are correctly identified as such (e.g. the percentage\nof sick people who are correctly identified as having the condition).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sensitivity\n=\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  ___________\n  <u>\n   Number of True Positives_____________\n  </u>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Number of\nTrue Positives + Number of False Negatives\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Specificity\n  </span>\n </b>\n <span>\n  measures the proportion\nof actual negatives that are correctly identified as such (e.g. the percentage\nof healthy people who are correctly identified as not having the condition).\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Specificity\n=\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <u>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Number\nof True Negatives____________\n  </u>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Number of\nTrue Negatives + Number of False Positives\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Positive\npredictive value\n  </span>\n </b>\n <span>\n  <b>\n   (PPV)\n  </b>\n  is the proportion of patients\nwith positive test results who are correctly diagnosed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  PPV=\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  ____________\n  <u>\n   Number of True Positives____________\n  </u>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Number of\nTrue Positives + Number of False Positives\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Negative\npredictive value\n  </span>\n </b>\n <span>\n  <b>\n   (NPV)\n  </b>\n  is the proportion of patients\nwith negative test results who are correctly diagnosed.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  NPV=\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  ____________\n  <u>\n   Number of True Negatives____________\n  </u>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Number\nof True Negatives + Number of False Negatives\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>0.30 </span></li>\n<li class=\"MsoNormal\"><span>0.33</span></li>\n<li class=\"MsoNormal\"><span>0.60</span></li>\n<li class=\"MsoNormal\"><span>0.67</span></li>\n<li class=\"MsoNormal\"><span>0.75</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  The\nquestion above provides the following data:\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Number of\ntrue positives:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  80\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Number of\ntrue negatives:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  60\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Number of\nfalse positives:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  20\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Number of\nfalse negatives:\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  40\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Sensitivity=\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  <u>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Number\nof True Positives____________\n  </u>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  = __\n  <u>\n   80\n  </u>\n  __ =\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  0.67\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Number of True Positives + Number of False Negatives\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  80+40\n </span>\n</p>\n\n<p>\n Which of the following drugs\nis\n <i>\n  not\n </i>\n considered teratogenic?\n</p>\n", "answers": ["<p>\n <b>\n  Answer E is correct\n </b>\n . All of the listed drugs are considered\nteratogenic.\n</p>\n"], "tutorial": "<p>\n Approximately 10% of all\nbirth defects are caused by prenatal exposure to teratogenic agents. These\nagents include drugs, medications, infectious agents, and environmental and\noccupational toxins. Medications can cause birth defects through any of six mechanisms:\nfolate antagonism, neural crest cell disruption, endocrine disruption,\noxidative stress, vascular disruption, and specific receptor- or\nenzyme-mediated teratogenesis.\n</p>\n\n<p>\n The following drugs are\nconsidered teratogenic.\n</p>\n\n<ul type=\"disc\">\n <li class=\"MsoNormal\">\n  <span>\n   Tobacco, ethanol,\n     marijuana, cocaine\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Blood pressure\n     medicines\n  </span>\n </li>\n <ul type=\"disc\">\n  <li class=\"MsoNormal\">\n   <span>\n    ACE-Is\n      (angiotensin-converting enzyme inhibitors)\n   </span>\n  </li>\n  <li class=\"MsoNormal\">\n   <span>\n    ARBs\n      (Angiotensin-receptor blockers)\n   </span>\n  </li>\n </ul>\n <li class=\"MsoNormal\">\n  <span>\n   Acne drug:\n     isotretinoin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Alkylating agents:\n     busulfan, cyclophosphamide\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Androgens\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Antibiotics:\n     tetracycline, doxycycline, metronidazole, and streptomycin\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Anticoagulant:\n     warfarin\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Anticonvulsants:\n     phenytoin, carbamazepine, valproic acid\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Antithyroid agents:\n     propylthiouracil, methimazole\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Chelating agent:\n     penicillamine\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Estrogen:\n     diethylstilbestrol\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Folic acid\n     antagonists: aminopterin, methotrexate\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Mood stabilizer:\n     lithium\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   Sedatives:\n     benzodiazepines, thalidomide\n  </span>\n </li>\n</ul>\n\n<p>\n <b>\n  Alcohol\n  <br/>\n  <br/>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  F\n </span>\n etal alcohol syndrome is characterized by intrauterine growth\nretardation, microcephaly, developmental delay, and dysmorphic faces. Cleft\npalate and cardiac anomalies may also occur.\n</p>\n\n<p>\n <b>\n  Angiotensin converting\nenzyme inhibitors (ACE-Is) and Angiotensin receptor blockers (ARBs)\n  <br/>\n  <br/>\n </b>\n</p>\n\n<p>\n ACE-Is and ARBs have been\nassociated with intrauterine renal insufficiency and neonatal hypotension,\noliguria, renal failure, and hyperkalemia. The teratogenicity of ACE-Is and\nARBs is greatest in late pregnancy. ACE-Is and ARBs are absolutely\ncontraindicated in pregnancy.\n</p>\n\n<p>\n <b>\n  Carbamazepine\n  <br/>\n  <br/>\n </b>\n</p>\n\n<p>\n Exposure to carbamazepine\n <i>\n  in utero\n </i>\n carries a 1% risk of neural\ntube defects (10 times the baseline risk).\n</p>\n\n<p>\n <b>\n  Cocaine\n  <br/>\n  <br/>\n </b>\n</p>\n\n<p>\n Cocaine use during pregnancy\nhas been associated with abruptio placentae, prematurity, fetal loss, decreased\nbirth weight, microcephaly, limb defects, and poor neurologic development.\n</p>\n\n<p>\n <b>\n  <span>\n   Warfarin\n   <span>\n    <br/>\n    <br/>\n   </span>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Exposure\nto warfarin in the first trimester can cause fetal warfarin syndrome, which is\ncharacterized by nasal hypoplasia and calcific stippling of the epiphyses.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Diethylstilbestrol\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Clear\ncell adenocarcinoma of the vagina was found to be associated with\ndiethylstilbestrol treatment of the patient's mother during the first trimester\nof pregnancy. Over 90% of the cancers occurred\n  <i>\n   after\n  </i>\n  14 years of age.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Folic acid antagonists: aminopterin and methotrexate\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Aminopterin\ncan cause fetal death.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Hydantoins (phenytoin and trimethadione)\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  The\n </span>\n <span>\n  fetal\nhydantoin syndrome is characterized by craniofacial dysmorphology as well as\nhypoplasia of the distal phalanges and nail hypoplasia.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Isotretinoin (13-cis-retinoic acid)\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Isotretinoin,\na synthetic vitamin A derivative used for severe cystic acne, is a potent\nteratogen. Retinoic acid embryopathy is characterized by craniofacial\nanomalies, cardiac defects, abnormal thymic development, and neurologic\nabnormalities.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Lithium\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Lithium use is associated with an increased\nincidence of\n </span>\n <span>\n  Ebstein's anomaly, a rare\nmalformation of the tricuspid valve.\n  <span>\n  </span>\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Misoprostol\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Misoprostol,\na prostaglandin analogue used to treat duodenal and gastric ulcers, can cause\nfetal death.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Tetracyclines\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  Use of tetracyclines in late pregnancy can cause y\n </span>\n <span>\n  ellow-brown discoloration of the teeth of the fetus.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Thalidomide\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  T\n </span>\n <span>\n  he\nthalidomide tragedy alerted the world to the teratogenic potential of drugs.\nThalidomide was available for four years before its teratogenicity was\nrecognized. The drug produced malformations of mesodermal tissues, primarily\nlimbs, ears, cardiovascular system, and gut musculature.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   <br/>\n   Valproate\n   <br/>\n   <br/>\n  </span>\n </b>\n <span>\n </span>\n</p>\n\n<p>\n <span>\n  First\ntrimester exposure to valproate is associated with neural tube defects and\ncarries a 1-2% risk of meningomyelocele.\n </span>\n</p>\n", "choices": ["A. Lisinopril", "B. Isotretinoin", "C. Tetracycline", "D. Phenytoin", "E. All of these drugs are teratogenic"]}, {"question": "<p>\n <span>\n  Five drugs produce the same therapeutic effect by the same mechanism, but\neach has a unique toxicity. When used at a maximally effective therapeutic\ndose, the drug with which of the following characteristics is most likely to have\nthe highest incidence of toxicity?\n </span>\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"26\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p align=\"center\">\n     <span>\n      Median Effective Dose\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"174\">\n    <p align=\"center\">\n     <span>\n      Toxic Dose\n      <sub>\n       1\n      </sub>\n      /\n  Effective Dose\n      <sub>\n       99\n      </sub>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"26\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"174\">\n    <p>\n     <span>\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"26\">\n    <p>\n     <span>\n      A\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p align=\"center\">\n     <span>\n      2x\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"174\">\n    <p align=\"center\">\n     <span>\n      3.5\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"26\">\n    <p>\n     <span>\n      B\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p align=\"center\">\n     <span>\n      0.5x\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"174\">\n    <p align=\"center\">\n     <span>\n      2.8\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"26\">\n    <p>\n     <span>\n      C\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p align=\"center\">\n     <span>\n      1x\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"174\">\n    <p align=\"center\">\n     <span>\n      2.1\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"26\">\n    <p>\n     <span>\n      D\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p align=\"center\">\n     <span>\n      5x\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"174\">\n    <p align=\"center\">\n     <span>\n      4.0\n     </span>\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"26\">\n    <p>\n     <span>\n      E\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"148\">\n    <p align=\"center\">\n     <span>\n      33x\n     </span>\n    </p>\n   </td>\n   <td valign=\"top\" width=\"174\">\n    <p align=\"center\">\n     <span>\n      3.0\n     </span>\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n <span>\n  The therapeutic index\n </span>\n (also known as\n <span>\n  therapeutic ratio\n </span>\n ) is the ratio of the toxic dose of a drug\ndivided by the therapeutic dose. Usually it is expressed as the toxic dose of a\ndrug for 50% of the population (TD\n <sub>\n  50\n </sub>\n ) divided by the minimum\neffective dose for 50% of the population (ED\n <sub>\n  50\n </sub>\n ).\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347407\"\n o:spid=\"_x0000_i1042\" type=\"#_x0000_t75\" alt=\"Description: \\mbox{Therapeutic ratio} = \\frac{\\mathrm{TD}_{50}}{\\mathrm{ED}_{50}}\"\n>\n <v:imagedata src=\"_%20Tutorials_files/image610.png\" o:title=\"mathrm{ED}_{50}}\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: \\mbox{Therapeutic ratio} = \\frac{\\mathrm{TD}_{50}}{\\mathrm{ED}_{50}}\" border=\"0\" height=\"35\" src=\"_%20Tutorials_files/image611.png\" v:shapes=\"Picture_x0020_347407\" width=\"169\"/>\n </span>\n</p>\n\n<p>\n A high therapeutic index is better\nthan a low one because a high index means the patient has to take a much higher\ndose of the drug to cause toxicity than is needed for therapeutic effect.\n</p>\n\n<p>\n Typically, a drug with a\nnarrow therapeutic window (i.e., a low therapeutic index) must have its dosage\nadjusted based on serum blood levels of the drug. This may be achieved through\ntherapeutic drug monitoring (TDM) protocols. Drugs with a very low therapeutic\nindex (&ldquo;dangerous&rdquo; drugs) include warfarin, digoxin, theophylline, and lithium\ncarbonate. Antimicrobials such as aminoglycosides, vancomycin, and amphotericin\nB have a low therapeutic index and require careful monitoring to balance\nefficacy and toxicity.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  .\n  <span>\n   The drug with the lowest therapeutic index\n  </span>\n  (t\n  <span>\n   oxic dose\n   <sub>\n    1\n   </sub>\n   / effective dose\n   <sub>\n    99\n   </sub>\n   )\nhas the greatest potential for toxicity. In this case, the lowest therapeutic\nindex is 2.1 (Drug C). Drug C is, therefore, said to have the narrowest\ntherapeutic window of the five drugs.\n  </span>\n  The safest drug is the one with\nthe highest therapeutic index\n  <span>\n   . That\nwould be Drug D, which has an index of 4.0. (The median effective drug doses\nare irrelevant in this case.)\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  A\n32-year-old man is brought to the emergency department because of confusion,\nwheezing, vomiting, and diarrhea for the past 6 hours. He is sweating and\nsalivating profusely. There is generalized muscle weakness. Which of the\nfollowing substances is the most likely cause of these findings?\n </span>\n</p>\n", "answers": ["<p>\n <b>\n  Answer D is correct.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </b>\n The\npatient&rsquo;s symptoms &ndash; wheezing; vomiting and diarrhea; profuse sweating\nand salivation &ndash; are cholinergic symptoms. These symptoms suggest an\nexcess of acetylcholine, which would occur after exposure to a drug that\ninhibit cholinesterase. Organophosphate insecticides, such as parathion, are\ncholinesterase inhibitors. They have cholinergic (i.e., parasympathomimetic)\neffects.\n <b>\n </b>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347264\" o:spid=\"_x0000_i1041\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image612.png\" o:title=\"\" croptop=\"21845f\"\n  cropbottom=\"7282f\" cropleft=\"11833f\" cropright=\"4902f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"268\" src=\"_%20Tutorials_files/image613.png\" v:shapes=\"Picture_x0020_347264\" width=\"472\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347265\" o:spid=\"_x0000_i1040\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image614.png\" o:title=\"\" croptop=\"12547f\"\n  cropbottom=\"11651f\" cropleft=\"12743f\" cropright=\"16734f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"331\" src=\"_%20Tutorials_files/image615.png\" v:shapes=\"Picture_x0020_347265\" width=\"461\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347479\" o:spid=\"_x0000_i1039\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image616.png\" o:title=\"\" croptop=\"14563f\"\n  cropbottom=\"6385f\" cropleft=\"7702f\" cropright=\"31647f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"496\" src=\"_%20Tutorials_files/image617.png\" v:shapes=\"Picture_x0020_347479\" width=\"466\"/>\n </span>\n <span>\n  <br clear=\"all\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347481\" o:spid=\"_x0000_i1038\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image618.png\" o:title=\"\" croptop=\"11315f\"\n  cropbottom=\"3249f\" cropleft=\"7561f\" cropright=\"31858f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"563\" src=\"_%20Tutorials_files/image619.png\" v:shapes=\"Picture_x0020_347481\" width=\"462\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347482\" o:spid=\"_x0000_i1037\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image620.png\" o:title=\"\" croptop=\"11987f\"\n  cropbottom=\"8963f\" cropleft=\"9313f\" cropright=\"30247f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"499\" src=\"_%20Tutorials_files/image621.png\" v:shapes=\"Picture_x0020_347482\" width=\"466\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347484\" o:spid=\"_x0000_i1036\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image622.png\" o:title=\"\" croptop=\"10867f\"\n  cropbottom=\"4929f\" cropleft=\"9383f\" cropright=\"30318f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"552\" src=\"_%20Tutorials_files/image623.png\" v:shapes=\"Picture_x0020_347484\" width=\"459\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347485\" o:spid=\"_x0000_i1035\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image624.png\" o:title=\"\" croptop=\"11314f\"\n  cropbottom=\"8179f\" cropleft=\"7771f\" cropright=\"31859f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"510\" src=\"_%20Tutorials_files/image625.png\" v:shapes=\"Picture_x0020_347485\" width=\"459\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347486\" o:spid=\"_x0000_i1034\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image626.png\" o:title=\"\" croptop=\"16804f\"\n  cropbottom=\"31256f\" cropleft=\"7562f\" cropright=\"31858f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"195\" src=\"_%20Tutorials_files/image627.png\" v:shapes=\"Picture_x0020_347486\" width=\"462\"/>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape\n id=\"Picture_x0020_347487\" o:spid=\"_x0000_i1033\" type=\"#_x0000_t75\">\n <v:imagedata src=\"_%20Tutorials_files/image628.png\" o:title=\"\" croptop=\"43579f\"\n  cropbottom=\"14563f\" cropleft=\"7492f\" cropright=\"8892f\"/>\n</v:shape><![endif]-->\n  <img border=\"0\" height=\"45\" src=\"_%20Tutorials_files/image629.png\" v:shapes=\"Picture_x0020_347487\" width=\"459\"/>\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Glutethimide\n  </span>\n </b>\n <span>\n  is a non-barbiturate hypnotic sedative.\n  <a name=\"s00129238\">\n  </a>\n  <a name=\"s00129239\">\n  </a>\n  <a name=\"s00129240\">\n  </a>\n  <a name=\"s00129241\">\n  </a>\n  <a name=\"s00129242\">\n  </a>\n  <a name=\"s00129243\">\n  </a>\n  <a name=\"s00129244\">\n  </a>\n  <a name=\"s00129245\">\n  </a>\n  <a name=\"s00129246\">\n  </a>\n  Side effects may\ninclude drowsiness, blurred vision, clumsiness, unsteadiness, confusion,\ndizziness, &ldquo;hangover&rdquo; effect, headache, nausea, and vomiting.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Heroin\n  </span>\n </b>\n <span>\n  is an opioid analgesic synthesized from morphine, a derivative of the\nopium poppy. Effects include euphoria (&ldquo;rush&rdquo;), dry mouth, a warm flushing of\nthe skin, heaviness of the extremities, and clouded mental functioning. With\nregular use, tolerance develops, in which the user&rsquo;s physiological (and\npsychological) response to the drug decreases, and more heroin is needed to achieve\nthe same intensity of effect.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Jimson weed\n  </span>\n </b>\n <span>\n  is a common name for a plant whose main ingredients\nare the belladonna alkaloids, atropine and scopolamine. Atropine and\nscopolamine block the neurotransmitter acetylcholine, causing anti-cholinergic\nsymptoms: dry mouth, dilated pupils, high temperature, reduced sweating, and\nblurred vision. Psychological effects include euphoria and confusion. The\nphrase &ldquo;red as a beet, dry as a bone, blind as a bat, mad as a hatter&rdquo; has been\nused to describe Jimson&rsquo;s (anti-cholinergic) effects.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Parathion\n  </span>\n </b>\n <span>\n  is an\norganophosphate &ndash; an insecticide that functions as a cholinesterase\ninhibitor. Symptoms of acute toxicity include nausea, vomiting, abdominal\ncramps, diarrhea, excessive salivation and sweating, headache, confusion, wheezing,\nand shortness of breath. These symptoms are caused by increased levels of\nacetylcholine, which have a parasympathomimetic effect.\n </span>\n</p>\n\n<p>\n <b>\n  <span>\n   Phencyclidine (PCP)\n  </span>\n </b>\n <span>\n  works primarily as an NMDA receptor antagonist. (\n  <span>\n   NMDA receptor antagonists\n  </span>\n  are\nanesthetics that block the N-methyl d-aspartate receptor.)\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  PCP is known as a &ldquo;dissociative\nanesthetic&rdquo; because it distorts sight and sound and produces feelings of\ndetachment from one&rsquo;s environment and self.&nbsp; Its pharmacological effects\ninclude sedation, immobility, amnesia, and marked analgesia.&nbsp;Numbness,\nslurred speech and loss of coordination may be accompanied by a sense of\nstrength and invulnerability. &nbsp;A blank stare, rapid and involuntary eye\nmovements, and an exaggerated gait are among the more observable effects.\n </span>\n</p>\n", "choices": ["A. Glutethimide", "B. Heroin", "C. Jimson weed (belladonna alkaloids)", "D. Parathion", "E. Phencyclidine (PCP)"]}, {"question": "<p class=\"MsoNoSpacing\">\n <span>\n  Which of the\nfollowing is true regarding type 2 error?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct.\n  </span>\n </b>\n <span>\n  Type 2 errors are often\ndue to not having enough subjects in the trial, referred to as being\n&ldquo;under-powered.&rdquo;\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is correct.\n  </span>\n </b>\n <span>\n  The risk of a type 1\nerror is represented by the alpha value. The risk of a type 2 error is\nrepresented by the beta value.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is correct.\n  </span>\n </b>\n <span>\n  A\n  <span>\n   type I error is\n  </span>\n  an error in which a\nsignificant difference is detected between treatment groups when, in fact, no\nsuch difference truly exists. A\n  <span>\n   type II\nerror\n  </span>\n  is an error in which no significant difference is detected between\ntreatment groups when, in fact, such a difference truly exists.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is correct.\n  </span>\n </b>\n <span>\n  Type 2 errors can occur\nin any trial and have nothing to do with investigator honesty.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n"], "tutorial": "<p>\n A\n <b>\n  type I error\n </b>\n <span>\n  is\n </span>\n also known as a\n <b>\n  false positive\n </b>\n <span>\n  .\n </span>\n It is an error in which a\nsignificant difference is detected between treatment groups when, in fact, no\nsuch difference exists in the larger population.\n <span>\n  T\n </span>\n he rate of the type I error is denoted by the Greek letter\n <b>\n  alpha (&alpha;)\n </b>\n and usually equals the\n <b>\n  significance level\n </b>\n of a test.\n</p>\n\n<p>\n A\n <b>\n  type II error\n </b>\n is\nalso known as a\n <b>\n  false negative\n </b>\n . It is an error in which no significant\ndifference is detected between treatment groups when, in fact, such a\ndifference exists in the larger population. The rate of the type II error is\ndenoted by the Greek letter\n <b>\n  beta\n(&beta;)\n </b>\n and related to the\n <b>\n  power\n </b>\n of\na test (which equals 1-&beta;).\n</p>\n", "choices": ["A. The rate is reflected by the alpha value", "B. It is the finding of a significant difference between treatment groups when, in fact, none exists", "C. It is often due to inadequate study power", "D. It means the investigators were dishonest in reporting their results"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  Match each\nclinical vignette with the corresponding vitamin deficiency.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n\n<ol start=\"1\" type=\"1\">\n <li class=\"MsoNormal\">\n  <span>\n   A 69-year-old man has ecchymoses,\n     perifollicular petechiae, and swelling of the gingiva. He has lived alone\n     since the death of his wife two years ago. His diet consists primarily of\n     cola and hot dogs.\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   A 52-year-old with a history of alcoholism\n     has difficulty with short-term memory. He is unable to recall the date and\n     cannot remember what he ate for breakfast this morning. He thinks the\n     examiner is a lost long friend and carries a conversation with the\n     examiner as if they have known each other for years.\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   A 74-year-old woman has a two-month history\n     of weakness and tingling of the arms and legs. Neurologic examination\n     shows weakness of the flexor and extensor muscles of the lower\n     extremities. Deep tendon reflexes over the knee and ankle are exaggerated.\n     Sensation to vibration and position is diminished in all extremities, but\n     the decrease is more pronounced in the lower extremities.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   A 43-year-old man with a history of\n     alcoholism is brought to the hospital by friends because he is difficult\n     to rouse. He is emaciated and lethargic. Examination shows severely\n     restricted horizontal eye movements and ataxia.\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   A 14-year-old girl who is a ballet dancer\n     has not had a menstrual period for the past three months. She has lost\n     weight over the past year; her weight is 70% of that expected for her\n     height. She has purpuric lesions on her extremities and trunk. Laboratory\n     tests show a macrocytic anemia. Neutrophil, lymphocyte, and platelet\n     counts are below the reference range.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   A 2-month-old female infant from South\n     America is adopted. She has been exclusively breast-fed. The only known\n     medical history is treatment with an antibiotic for a gastrointestinal\n     infection prior to arrival in the Unites States. Three days after\n     receiving the infant, the adoptive parents note that she no longer moves\n     her left upper and lower extremity. Radiologic examination shows an\n     intracranial hemorrhage without signs of head trauma. Laboratory studies\n     show anemia and prolonged partial thromboplastin and prothrombin times.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;\n   </span>\n  </span>\n </li>\n <li class=\"MsoNormal\">\n  <span>\n   A 51-year-old man develops neuropathy and\n     sideroblastic anemia after taking isoniazid for latent tuberculosis\n  </span>\n </li>\n</ol>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answers.\n  </span>\n </b>\n</p>\n", "<ol start=\"1\" type=\"1\">\n <li class=\"MsoNormal\">\n  <b>\n   <span>\n    E.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </b>\n  <span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n   Scurvy, which is caused by vitamin C\n     (ascorbic acid) deficiency, is associated with ecchymoses, perifollicular\n     petechiae, and swelling of the gingiva.\n   <b>\n   </b>\n  </span>\n </li>\n</ol>\n", "<ol start=\"2\" type=\"1\">\n <li class=\"MsoNormal\">\n  <b>\n   <span>\n    A.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </b>\n  <span>\n   Korsakoff\n     psychosis, which is caused by vitamin B\n   <sub>\n    1\n   </sub>\n   (thiamine) deficiency,\n     is characterized by memory loss and confabulation. It typically occurs in\n     alcoholics.\n   <b>\n   </b>\n  </span>\n </li>\n</ol>\n", "<ol start=\"3\" type=\"1\">\n <li class=\"MsoNormal\">\n  <b>\n   <span>\n    D.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </b>\n  <span>\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n   Vitamin B\n   <sub>\n    12\n   </sub>\n   (cobalamin)\n     deficiency can cause subacute degeneration of the spinal cord. Findings\n     include diminished proprioception, bilateral spastic paresis, and\n     hyperreflexia of the lower extremities.\n   <b>\n   </b>\n  </span>\n </li>\n</ol>\n", "<ol start=\"4\" type=\"1\">\n <li class=\"MsoNormal\">\n  <b>\n   <span>\n    A.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </b>\n  <span>\n   Wernicke&rsquo;s\n     encephalopathy, which is caused by vitamin B\n   <sub>\n    1\n   </sub>\n   (thiamine)\n     deficiency, is associated with ophthalmoplegia, ataxia, and confusion.\n   <b>\n   </b>\n  </span>\n </li>\n</ol>\n", "<ol start=\"5\" type=\"1\">\n <li class=\"MsoNormal\">\n  <b>\n   <span>\n    C.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </b>\n  <span>\n   Folate deficiency\n     causes megaloblastic anemia, which is a macrocytic anemia often associated\n     with pancytopenia. Vitamin B12 deficiency also causes megaloblastic\n     anemia, but in this patient, poor nutrition and growth suggest folate\n     deficiency as a more likely cause. (Vitamin B12 deficiency is almost never\n     caused by inadequate intake.)\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;\n   </span>\n   <b>\n   </b>\n  </span>\n </li>\n</ol>\n", "<ol start=\"6\" type=\"1\">\n <li class=\"MsoNormal\">\n  <b>\n   <span>\n    G.\n    <span>\n     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n    </span>\n   </span>\n  </b>\n  <span>\n   Vitamin K\n     deficiency causes hemorrhagic disease of the newborn. Factors predisposing\n     to vitamin K deficiency include exclusive breast feeding and antibiotic\n     use.\n   <b>\n   </b>\n  </span>\n </li>\n</ol>\n", "<ol start=\"7\" type=\"1\">\n <li class=\"MsoNormal\">\n  <b>\n   <span>\n    B\n   </span>\n  </b>\n  <span>\n   .\n   <span>\n    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n   </span>\n   Vitamin\n     B\n   <sub>\n    6\n   </sub>\n   (pyridoxine) deficiency causes neuropathy and sideroblastic\n     anemia. Patients taking isoniazid are predisposed to pyridoxine\n     deficiency.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;&nbsp;&nbsp;\n   </span>\n   <b>\n   </b>\n  </span>\n </li>\n</ol>\n"], "tutorial": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Generic Name\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Chemical Name\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Solubility\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Deficiency Disease\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n     </span>\n    </b>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin A\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Retinol\n  and carotenes\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Fat\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Night-blindness\n  and\n     <br/>\n     Keratomalacia\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin B\n      <sub>\n       1\n      </sub>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Thiamine\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Water\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Wernicke-Korsakoff;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Beriberi\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin B\n      <sub>\n       3\n      </sub>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Niacin\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Water\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pellagra\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin B\n      <sub>\n       6\n      </sub>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Pyridoxine\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Water\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Peripheral\n  neuropathy, sideroblastic anemia\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin B\n      <sub>\n       9\n      </sub>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Folate\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Water\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Megaloblastic\n  anemia;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Neural\n  tube defects in the newborn (if mother is folate deficient)\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin B\n      <sub>\n       12\n      </sub>\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Cobalamin\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Water\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Megaloblastic\n  anemia;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Neurologic\n  disease\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin C\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ascorbic\n  acid\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Water\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Scurvy\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin D\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     Ergocalciferol,\n  cholecalciferol\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Fat\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Rickets\n  and Osteomalacia\n    </span>\n   </p>\n  </td>\n </tr>\n <tr>\n  <td width=\"111\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <b>\n     <span>\n      Vitamin K\n     </span>\n    </b>\n   </p>\n  </td>\n  <td width=\"111\">\n   <p class=\"MsoNormal\">\n    <span>\n     phylloquinone,\n  menaquinones\n    </span>\n   </p>\n  </td>\n  <td width=\"68\">\n   <p align=\"center\" class=\"MsoNormal\">\n    <span>\n     Fat\n    </span>\n   </p>\n  </td>\n  <td width=\"154\">\n   <p class=\"MsoNormal\">\n    <span>\n     Hemorrhagic\n  disease of the newborn;\n    </span>\n   </p>\n   <p class=\"MsoNormal\">\n    <span>\n     Bleeding\n  diathesis in adults\n    </span>\n   </p>\n  </td>\n </tr>\n</table>\n\n<p>\n Vitamins are divided into\ntwo groups: water-soluble (B-complex and C) and fat-soluble (A, D, E and K).\nFat-soluble vitamins are absorbed through the intestinal tract with the help of\nlipids (fats). Unlike water-soluble vitamins that need regular replacement in\nthe body, fat-soluble vitamins are stored in the liver and fatty tissues, and\nare eliminated much more slowly than water-soluble vitamins. Because\nfat-soluble vitamins are stored for long periods, they generally pose a greater\nrisk for toxicity than water-soluble vitamins when consumed in excess.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <u>\n   <span>\n    Selected Vitamin Deficiency Syndromes\n   </span>\n  </u>\n </b>\n</p>\n\n<p>\n <b>\n  Folate and Vitamin B\n  <sub>\n   12\n  </sub>\n  deficiency.\n </b>\n Megaloblastic anemia\nmay be caused by folate or vitamin B\n <sub>\n  12\n </sub>\n deficiency. Both folate and B\n <sub>\n  12\n </sub>\n are required to sustain one-carbon metabolism, which is essential for\npyrimidine and purine biosynthesis.\n</p>\n\n<p align=\"center\">\n Actions\nof Folate and Vitamin B\n <sub>\n  12\n </sub>\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347406\"\n o:spid=\"_x0000_i1032\" type=\"#_x0000_t75\" alt=\"Description: B12\">\n <v:imagedata src=\"_%20Tutorials_files/image630.png\" o:title=\"B12\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: B12\" border=\"0\" height=\"275\" src=\"_%20Tutorials_files/image631.png\" v:shapes=\"Picture_x0020_347406\" width=\"412\"/>\n </span>\n</p>\n\n<p>\n Folate and cobalamin\ndeficiency affect DNA synthesis. Cell growth and division are impaired.\nMegaloblastic cells with DNA values between 2N and 4N appear because of delayed\ncell division. These cells have large &ldquo;immature&rdquo; nuclei and a large &ldquo;mature&rdquo;\ncytoplasm. This nuclear-cytoplasmic asynchrony is called &ldquo;megaloblastic.&rdquo;\n <span style=\"mso-spacerun:yes\">\n  &nbsp;\n </span>\n Megaloblastic hematopoiesis often\npresents as anemia. Leukopenia and thrombocytopenia may also occur, and\nhypersegmented neutrophils are commonly seen in the peripheral blood smear.\n</p>\n\n<p align=\"center\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347405\"\n o:spid=\"_x0000_i1031\" type=\"#_x0000_t75\" alt=\"Description: PMN\">\n <v:imagedata src=\"_%20Tutorials_files/image632.jpg\" o:title=\"PMN\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: PMN\" border=\"0\" height=\"177\" src=\"_%20Tutorials_files/image633.png\" v:shapes=\"Picture_x0020_347405\" width=\"255\"/>\n </span>\n</p>\n\n<p align=\"center\">\n Folate\nand B\n <sub>\n  12\n </sub>\n deficiency: hypersegmented neutrophils\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Thus, both\nfolic acid and vitamin B12\n  <b>\n  </b>\n  deficiency\ncan produce a macrocytic anemia, characterized by an elevated mean corpuscular\nvolume (MCV). Folic acid deficiency is associated with elevated homocysteine\nlevels; vitamin B12 deficiency is associated with elevated homocysteine\n  <i>\n   and\n  </i>\n  elevated methylmalonic acid levels.\nFolic acid deficiency does not have neurologic sequela; vitamin B12 deficiency\n  <i>\n   can\n  </i>\n  result in neurologic sequela.\n </span>\n</p>\n\n<p>\n Neurologic symptoms of B\n <sub>\n  12\n </sub>\n deficiency include memory loss, irritability, and sleep disturbance.\nPeripheral nerve demyelination causes numbness and tingling of the extremities,\naltered proprioception, poor coordination, and an ataxic gait. In extreme\ncases, subacute degeneration of the spinal cord occurs, characterized by patchy\nloss of myelin in the posterior and lateral columns. Patients with subacute\ndegeneration of the spinal cord present with progressive numbness and tingling\nin the extremities, and weakness of the arms, legs, and trunk. Findings include\nbilateral spastic paresis, diminished touch and vibratory sense, and a positive\nBabinksi sign. Vision and cognitive changes (depression, personality change,\nand psychosis) may occur.\n</p>\n\n<p>\n Anemia and neurological\ndeficits may exist together or separately. The anemia resolves with B\n <sub>\n  <span>\n   12\n  </span>\n </sub>\n supplementation, but\nneurological symptoms may persist depending on the degree and duration of the\ndeficiency. Patients with vitamin B\n <sub>\n  12\n </sub>\n deficiency typically have\nelevated homocysteine and methylmalonate levels, which may be helpful\ndiagnostically.\n</p>\n\n<p>\n The main causes of B12\ndeficiency are:\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"379\">\n    <p align=\"center\">\n     Causes of Vitamin B\n     <sub>\n      12\n     </sub>\n     deficiency\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"379\">\n    <p>\n     <span>\n      1.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Inadequate\n  intake of vitamin B12 (e.g., vegan diet)\n    </p>\n    <p>\n     <span>\n      2.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Gastrectomy\n    </p>\n    <p>\n     <span>\n      3.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Achlorhydria\n  (e.g., use of H2-blockers and proton-pump inhibitors)\n    </p>\n    <p>\n     <span>\n      4.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Intrinsic\n  factor loss (e.g., pernicious anemia, which involves\n     <span style=\"mso-spacerun:yes\">\n      &nbsp;\n     </span>\n     autoimmune destruction of parietal\n  cells causing atrophic gastritis)\n    </p>\n    <p>\n     <span>\n      5.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Chronic\n  pancreatitis\n    </p>\n    <p>\n     <span>\n      6.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Generalized\n  malabsorption (celiac disease)\n    </p>\n    <p>\n     <span>\n      7.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Terminal\n  ileal disease (e.g., Crohn&rsquo;s disease, ileal resection)\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p>\n Folate deficiency also\ncauses megaloblastic anemia, but not neurologic disease. In pregnant women,\nfolate deficiency can lead to premature delivery, low-birth-weight baby, and\nneural tube defects in the newborn. The main causes of folate deficiency are:\n</p>\n\n<div align=\"center\">\n <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\">\n  <tr>\n   <td valign=\"top\" width=\"325\">\n    <p align=\"center\">\n     Causes of Folate deficiency\n    </p>\n   </td>\n  </tr>\n  <tr>\n   <td valign=\"top\" width=\"325\">\n    <p>\n     <span>\n      1.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Decreased\n  intake (e.g., fad diets, institutionalization)\n    </p>\n    <p>\n     <span>\n      2.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Increased\n  requirement (e.g., pregnancy, hemolysis)\n    </p>\n    <p>\n     <span>\n      3.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Malabsorption\n  (e.g., celiac disease, Crohn&rsquo;s disease)\n    </p>\n    <p>\n     <span>\n      4.\n      <span>\n       &nbsp;&nbsp;&nbsp;&nbsp;\n      </span>\n     </span>\n     Drugs\n  (e.g., methotrexate, alcoholism)\n    </p>\n   </td>\n  </tr>\n </table>\n</div>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Wernicke-Korsakoff and Beriberi.\n   <span style=\"mso-spacerun:yes\">\n    &nbsp;\n   </span>\n  </span>\n </b>\n <span>\n  Wernicke-Korsakoff syndrome and beriberi are\ncaused by thiamine (vitamin B\n  <sub>\n   1\n  </sub>\n  ) deficiency. This typically occurs in\nalcoholics. Wernicke-Korsakoff syndrome is a combination of two disorders:\nWernicke&rsquo;s encephalopathy, which is characterized by confusion,\nophthalmoplegia, nystagmus, and ataxia; and Korsakoff syndrome, which is\ncharacterized by amnesia, hallucinations, and confabulation. The syndrome is\nassociated with dysfunction of the mammillary bodies of the diencephalon.\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Beriberi\nexists in two forms: wet and dry. &ldquo;Wet&rdquo; beriberi involves the cardiovascular\nsystem; &ldquo;dry&rdquo; beriberi, like Wernicke-Korsakoff syndrome, involves the nervous\nsystem. &ldquo;Wet&rdquo; beriberi is characterized by vasodilation, arteriovenous shunt,\ntachycardia, and high-output heart failure. Symptoms include shortness of\nbreath and leg edema. &ldquo;Dry&rdquo; beriberi is characterized by confusion, abnormal\neye movements, paresthesias, and motor weakness.\n </span>\n</p>\n\n<p>\n <b>\n  Scurvy.\n </b>\n Scurvy is caused\n <b>\n </b>\n by\ndeficiency of vitamin C (ascorbic acid), which is needed for collagen synthesis\nin humans. Vitamin C is required for\n <span class=\"ft\">\n  <span>\n   conversion of proline to\n  </span>\n </span>\n <span class=\"Emphasis2\">\n  <span>\n   hydroxyproline,\n  </span>\n </span>\n a nonessential amino acid that is necessary for the construction\nof the body&rsquo;s major structural protein, collagen. Vitamin C deficiency causes\ndefects in collagen synthesis, which, in turn, lead to easy bruising, internal\nbleeding, breakdown of connective tissue of the ligaments and tendons, and\nincreased risk to blood vessel damage. The breakdown of connective tissue\ncauses hydroxyproline to be spilled in the urine. Symptoms of vitamin C\ndeficiency include softening of the gums and loss of teeth, bleeding into the\nskin and mucous membranes, weakness, depression, and poor wound healing.\nPerifollicular petechiae are a &ldquo;classic&rdquo; finding. Scurvy is, therefore, a\ndisease of collagen synthesis resulting from vitamin C deficiency and,\nultimately, deficiency of the amino acid, hydroxyproline.\n <span style=\"mso-spacerun:yes\">\n  &nbsp;&nbsp;&nbsp;\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347404\"\n o:spid=\"_x0000_i1030\" type=\"#_x0000_t75\" alt=\"Description: scurvy1\">\n <v:imagedata src=\"_%20Tutorials_files/image634.jpg\" o:title=\"scurvy1\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: scurvy1\" border=\"0\" height=\"230\" src=\"_%20Tutorials_files/image635.png\" v:shapes=\"Picture_x0020_347404\" width=\"217\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Scurvy: perifollicular petechiae\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Rickets and Osteomalacia.\n  </span>\n </b>\n <span>\n  Vitamin D is necessary\nfor proper calcium absorption in the small bowel. Deficiency of the vitamin\ncauses hypocalcemia, which, in turn, causes skeletal deformity and\nneuromuscular symptoms (including tetany). The result is rickets (in children)\nand osteomalacia (in adults).\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347403\"\n o:spid=\"_x0000_i1029\" type=\"#_x0000_t75\" alt=\"Description: bow\">\n <v:imagedata src=\"_%20Tutorials_files/image636.jpg\" o:title=\"bow\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: bow\" border=\"0\" height=\"311\" src=\"_%20Tutorials_files/image637.png\" v:shapes=\"Picture_x0020_347403\" width=\"197\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Rickets: bowed legs\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347402\"\n o:spid=\"_x0000_i1028\" type=\"#_x0000_t75\" alt=\"Description: rosary\">\n <v:imagedata src=\"_%20Tutorials_files/image638.jpg\" o:title=\"rosary\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: rosary\" border=\"0\" height=\"224\" src=\"_%20Tutorials_files/image639.png\" v:shapes=\"Picture_x0020_347402\" width=\"149\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  Rickets: &ldquo;rachitic rosary&rdquo;\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  (bony knobs at the costochondral joints)\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  The\nclinical signs of osteomalacia are nondescript. Patients may be asymptomatic or\nmay have diffuse skeletal pain and muscular weakness. Common laboratory\nfindings include hypocalcemia, hypophosphatemia, and increased alkaline\nphosphatase levels.\n  <b>\n  </b>\n </span>\n</p>\n\n<p>\n <b>\n  Vitamin K deficiency.\n </b>\n <span>\n  Hemorrhagic\ndisease of the newborn\n </span>\n is a coagulation disturbance caused by vitamin K\ndeficiency. Vitamin K is responsible for &gamma;-carboxylation of coagulation\nfactors II, VII, IX, X, C, and S by the liver. Deficiency of the vitamin\nresults in a bleeding diathesis. Newborns are relatively vitamin K deficient\nfor a variety of reasons: They have low vitamin K stores at birth, vitamin K\npasses the placenta poorly, the levels of vitamin K in breast milk are low, and\nthe gut flora has not yet been developed (vitamin K is normally produced by\nbacteria in the intestines). Antibiotics can eliminate bacteria that produce\nvitamin K, thus increasing the likelihood of bleeding.\n</p>\n\n<p class=\"MsoNormal\">\n <b>\n  <span>\n   Pyridoxine deficiency.\n  </span>\n </b>\n <span>\n  Pyridoxine deficiency\n </span>\n <span>\n  is rare in developed countries. Isoniazid use can cause\npyridoxine deficiency. Findings include neuropathy and a sideroblastic anemia.\n(Pyridoxine is a required cofactor in heme synthesis.) Patients taking\nisoniazid should receive pyridoxine supplementation.\n  <b>\n  </b>\n </span>\n</p>\n", "choices": ["<ol start=\"1\" type=\"A\">\n<li class=\"MsoNormal\"><span>Vitamin B<sub>1</sub> (thiamine) deficiency</span></li>\n<li class=\"MsoNormal\"><span>Vitamin B<sub>6</sub> (pyridoxine)\n     deficiency</span></li>\n<li class=\"MsoNormal\"><span>Vitamin B<sub>9</sub> (folate) deficiency</span></li>\n<li class=\"MsoNormal\"><span>Vitamin B<sub>12</sub> (cobalamin)\n     deficiency</span></li>\n<li class=\"MsoNormal\"><span>Vitamin C (ascorbic acid) deficiency</span></li>\n<li class=\"MsoNormal\"><span>Vitamin D deficiency</span></li>\n<li class=\"MsoNormal\"><span>Vitamin K deficiency</span></li>\n</ol>"]}, {"question": "<p class=\"MsoNormal\">\n <span>\n  What is\nthe primary reason for the delay in clinical effect following initiation of\nwarfarin therapy?\n </span>\n</p>\n", "answers": ["<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer C is correct\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The primary reason for the delayed onset\nof warfarin is that factor II, which has a half-life of 60-100 hours, must be\nmetabolized before the effect can be seen.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  <b>\n  </b>\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer A is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Onset of warfarin is unaffected by the\npresence of acute thromboembolism.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer B is incorrect\n  </span>\n </b>\n <span>\n  .\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Warfarin has a long half-life, about 40\nhours. This influences dosing strategy, but does not affect onset of action.\n </span>\n</p>\n", "<p class=\"MsoNormal\">\n <b>\n  <span>\n   Answer D is incorrect\n  </span>\n </b>\n <span>\n  . Low-molecular-weight\nheparin does not inhibit warfarin.\n </span>\n</p>\n"], "tutorial": "<p class=\"MsoNormal\">\n <span>\n  Warfarin\nfunctions as a vitamin K antagonist.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Coagulation factors II, VII, IX, and X are biologically inactive unless\ntheir amino-terminal glutamate residues are carboxylated. This requires reduced\nvitamin K. Following the carboxylation reaction, vitamin K is converted to\nvitamin K epoxide. Vitamin K epoxide is converted back to vitamin K by vitamin\nK epoxide reductase.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  Vitamin K is\nsubsequently reduced and can be used again in the carboxylation of coagulation factors.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n  The primary mechanism of warfarin is\ninhibition of vitamin K epoxide reductase, which results in diminished\nrecycling of vitamin K and diminished production of fully functional\ncoagulation factors II, VII, IX, and X.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p align=\"center\" class=\"MsoNormal\">\n <span>\n  <!--[if gte vml 1]><v:shape id=\"Picture_x0020_347401\"\n o:spid=\"_x0000_i1027\" type=\"#_x0000_t75\" alt=\"Description: Graphic\">\n <v:imagedata src=\"_%20Tutorials_files/image640.jpg\" o:title=\"Graphic\"/>\n</v:shape><![endif]-->\n  <img alt=\"Description: Graphic\" border=\"0\" height=\"211\" src=\"_%20Tutorials_files/image641.png\" v:shapes=\"Picture_x0020_347401\" width=\"200\"/>\n </span>\n <span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Vit\nKH\n  <sub>\n   2\n  </sub>\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;\n  </span>\n  &ndash;\nreduced vitamin K\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n  Vit\nKO\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;&nbsp;&nbsp;\n  </span>\n  &ndash; vitamin K\nepoxide\n  <span>\n   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n  </span>\n </span>\n</p>\n\n<p class=\"MsoNormal\">\n <span>\n  Coagulation\nfactors\n  <i>\n   that have already been produced\n  </i>\n  are unaffected by warfarin. They must be metabolized before the effect of\nwarfarin can be seen. Factor II has the longest half-life, about 60-100 hours.\nThe primary reason for the delayed onset of warfarin is that factor II must be\nmetabolized before the effect can be seen.\n  <span style=\"mso-spacerun:yes\">\n   &nbsp;\n  </span>\n </span>\n</p>\n", "choices": ["A. Elevated concentration of clotting factors present during acute thromboembolism", "B. Long half-life of the drug", "C. Long half-life of clotting factor II", "D. Inhibition of warfarin effect by concurrent administration of low-molecular-weight heparin."]}]}]
